Citrus Sinensis ID: 011694
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 479 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C562 | 479 | CBL-interacting serine/th | yes | no | 0.912 | 0.912 | 0.721 | 0.0 | |
| Q9LYQ8 | 456 | CBL-interacting serine/th | no | no | 0.945 | 0.993 | 0.692 | 0.0 | |
| Q7X996 | 443 | CBL-interacting protein k | yes | no | 0.897 | 0.970 | 0.688 | 0.0 | |
| Q5W736 | 457 | CBL-interacting protein k | no | no | 0.908 | 0.951 | 0.687 | 1e-178 | |
| Q0JI49 | 502 | CBL-interacting protein k | no | no | 0.972 | 0.928 | 0.625 | 1e-174 | |
| Q10LQ2 | 451 | CBL-interacting protein k | no | no | 0.922 | 0.980 | 0.653 | 1e-171 | |
| Q6H7U5 | 493 | CBL-interacting protein k | no | no | 0.956 | 0.929 | 0.585 | 1e-168 | |
| A3B529 | 435 | CBL-interacting protein k | no | no | 0.899 | 0.990 | 0.618 | 1e-165 | |
| Q9LWM4 | 461 | CBL-interacting protein k | no | no | 0.910 | 0.945 | 0.6 | 1e-162 | |
| Q9FJ54 | 439 | CBL-interacting serine/th | no | no | 0.906 | 0.988 | 0.609 | 1e-160 |
| >sp|Q9C562|CIPKA_ARATH CBL-interacting serine/threonine-protein kinase 10 OS=Arabidopsis thaliana GN=CIPK10 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 686 bits (1770), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/453 (72%), Positives = 384/453 (84%), Gaps = 16/453 (3%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
NKPSVLT+KY+VGRLLGQG FAKVYY RSI TNQSVA+K+IDK+K+M+VGL +QIKREIS
Sbjct: 3 NKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VMRI RHPN+V+LYEVMATK++I+FVMEY KGGELFNKVAKGKL++D A +YF QLINAV
Sbjct: 63 VMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINAV 122
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSR VYHRDIKPENLLLD+NENLK+SDFGLSALA CK QDGLLHTTCGTPAYVAPEV
Sbjct: 123 DFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
INRKGYDG K DIWSCGVVLFVLLAGYLPFHDSNL+EMYRKIGKA+FK P+WF PEVR+L
Sbjct: 183 INRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRRL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQ------- 299
LCK+LDPNP TRI++A+IRESSWFRKG++ KQK+ K+ S +AG +
Sbjct: 243 LCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAGPS 302
Query: 300 ----GSSSIAAEIKQE--LGQLPNLNAFDIISLSAGFDLSGFF-DENPLIREARFTSKRP 352
G S + +E + NLNAFD+I+LSAGFDL+G F D+N RE+RFTS++P
Sbjct: 303 ENGAGPSENGDRVTEENHTDEPTNLNAFDLIALSAGFDLAGLFGDDNK--RESRFTSQKP 360
Query: 353 ASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKK 412
ASVIISKLEE+A+ L+L + K++ GL K E LKEGRKGI+SMDAEIFQ+TPNFHLVE+KK
Sbjct: 361 ASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEVKK 420
Query: 413 SNGDTLEYKKLLKDDIRPALQDIVWVWQGEQQQ 445
SNGDTLEY+KL+ +D+RPAL DIVWVWQGE+ +
Sbjct: 421 SNGDTLEYQKLVAEDLRPALSDIVWVWQGEKDE 453
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LYQ8|CIPK2_ARATH CBL-interacting serine/threonine-protein kinase 2 OS=Arabidopsis thaliana GN=CIPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 637 bits (1644), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/455 (69%), Positives = 378/455 (83%), Gaps = 2/455 (0%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
NKPSVLTE+YEVGRLLGQG FAKVY+ RS TN+SVA+K+IDKDK+MRVGL+ QIKREIS
Sbjct: 3 NKPSVLTERYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VMRI +HPN+V+LYEVMATKS+I+FV+EY KGGELFNKVAKGKLKED A +YF QLI+AV
Sbjct: 63 VMRIAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLISAV 122
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSRGVYHRDIKPENLLLD+N+NLK+SDFGLSALA CK QDGLLHTTCGTPAYVAPEV
Sbjct: 123 DFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
INRKGY+G K DIWSCGVVLFVLLAGYLPFHD+NL+EMYRKIGKA+FKCP+WF PEV++L
Sbjct: 183 INRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVKRL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAA 306
LCK+LDPN TRI++AKI+ESSWFRKG++ KQK+ K + GS
Sbjct: 243 LCKMLDPNHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNPMEAGGSGQNEN 302
Query: 307 EIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAKS 366
E +L LNAFDII+LS GF L+G F + RE+RF S++PAS IISKL E+AK
Sbjct: 303 GENHEPPRLATLNAFDIIALSTGFGLAGLFGDVYDKRESRFASQKPASEIISKLVEVAKC 362
Query: 367 LRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKD 426
L+LK+ K+ GL K E +KEG+ GI++MDAEIFQ+TP FHLVE+KK NGDT+EY+KL+++
Sbjct: 363 LKLKIRKQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGDTMEYQKLVEE 422
Query: 427 DIRPALQDIVWVWQGEQQQPLQQQLELQQQQDQRP 461
D+RPAL DIVWVWQGE+++ ++QL +Q +Q P
Sbjct: 423 DLRPALADIVWVWQGEKEK--EEQLLQDEQGEQEP 455
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7X996|CIPK2_ORYSJ CBL-interacting protein kinase 2 OS=Oryza sativa subsp. japonica GN=CIPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 635 bits (1639), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 300/436 (68%), Positives = 363/436 (83%), Gaps = 6/436 (1%)
Query: 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR 63
M + ++L +KYE+G+LLGQG FAKVY+AR+ T++SVA+K+IDK+K+++ GL DQIKR
Sbjct: 1 MAEQRGNMLMKKYEMGKLLGQGTFAKVYHARNTETSESVAIKMIDKEKVLKGGLMDQIKR 60
Query: 64 EISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI 123
EISVM++VRHPNIVQLYEVMATK+KI+FV+E+ KGGELFNKV +G+LKEDAAR+YFQQLI
Sbjct: 61 EISVMKLVRHPNIVQLYEVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLI 120
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
AVDFCHSRGVYHRD+KPENLLLDEN NLK+SDFGLSALA CK QDGLLHTTCGTPAYVA
Sbjct: 121 CAVDFCHSRGVYHRDLKPENLLLDENSNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVA 180
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV 243
PEVINR+GYDG K DIWSCGV+LFVLLAGYLPFHD NL++MY+KIGKAEFKCP+WF +V
Sbjct: 181 PEVINRRGYDGAKADIWSCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPSWFNTDV 240
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSS 303
R+LL +ILDPNPSTRISM KI E+ WFRKG++ K + + KDA D +S+
Sbjct: 241 RRLLLRILDPNPSTRISMDKIMENPWFRKGLDAKLLRYNLQPKDAIPVDMSTDFDSFNSA 300
Query: 304 IAAEIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEI 363
E K NLNAFDIISLS G DLSG F+E+ +E++FTS AS IISK+E+I
Sbjct: 301 PTLEKKPS-----NLNAFDIISLSTGLDLSGMFEESD-KKESKFTSTSTASTIISKIEDI 354
Query: 364 AKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKL 423
AK LRLK+ KKDGGLLK EG K GRKG++ +DAEIF++TPNFHLVE+KK+NGDTLEY+K+
Sbjct: 355 AKGLRLKLTKKDGGLLKMEGSKPGRKGVMGIDAEIFEVTPNFHLVELKKTNGDTLEYRKV 414
Query: 424 LKDDIRPALQDIVWVW 439
L ++RPAL+DIVW W
Sbjct: 415 LNQEMRPALKDIVWAW 430
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5W736|CIPKI_ORYSJ CBL-interacting protein kinase 18 OS=Oryza sativa subsp. japonica GN=CIPK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 625 bits (1613), Expect = e-178, Method: Compositional matrix adjust.
Identities = 302/439 (68%), Positives = 369/439 (84%), Gaps = 4/439 (0%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
++L +YE+G+LLGQG FAKVY+ R+I T+QSVA+KVIDKDKI +VGL DQIKREISVM+
Sbjct: 9 NILLRRYEIGKLLGQGTFAKVYHGRNIVTSQSVAIKVIDKDKIFKVGLMDQIKREISVMK 68
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFC 129
+VRHPNIVQLYEVMATKSKI+FV+EY KGGELFNKVAKG+LKEDAAR+YFQQL++AVDFC
Sbjct: 69 LVRHPNIVQLYEVMATKSKIYFVLEYVKGGELFNKVAKGRLKEDAARKYFQQLVSAVDFC 128
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
HSRGVYHRD+KPENLL+DEN NLKI+DFGLSALA+ + QDGLLHTTCGTPAYVAPEVI+R
Sbjct: 129 HSRGVYHRDLKPENLLVDENGNLKITDFGLSALAESRRQDGLLHTTCGTPAYVAPEVISR 188
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCK 249
KGYDG KVD WSCGV+LFVL+AGYLPF DSNL+EMYRKIGKAEFKCP WF +VRKL+ +
Sbjct: 189 KGYDGVKVDTWSCGVILFVLMAGYLPFQDSNLMEMYRKIGKAEFKCPAWFSSDVRKLVSR 248
Query: 250 ILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASA----PQGSSSIA 305
ILDPNP +R+ + KI E+ WF+KG++ K K E+ + + A + SSS
Sbjct: 249 ILDPNPRSRMPITKIMETYWFKKGLDSKLILKNVETNEPVTALADVNVVFSSMGSSSSKK 308
Query: 306 AEIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAK 365
E KQ+ G+L NLNAFDIISLS GFDLSG F+E +EARFTS + AS IISKLE++A
Sbjct: 309 TEEKQDAGKLTNLNAFDIISLSEGFDLSGLFEETDKKKEARFTSSQSASAIISKLEDVAS 368
Query: 366 SLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLK 425
+L + KK+GG+LK EG EGRKG++++DAEIF++TP+FHLVE+KK+NGDTLEY+ L K
Sbjct: 369 CSKLTVKKKEGGVLKMEGASEGRKGVLAIDAEIFEVTPSFHLVEIKKNNGDTLEYQHLWK 428
Query: 426 DDIRPALQDIVWVWQGEQQ 444
+D++PAL+DIVW WQGE+Q
Sbjct: 429 EDMKPALKDIVWAWQGERQ 447
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0JI49|CIPKB_ORYSJ CBL-interacting protein kinase 11 OS=Oryza sativa subsp. japonica GN=CIPK11 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 610 bits (1573), Expect = e-174, Method: Compositional matrix adjust.
Identities = 295/472 (62%), Positives = 381/472 (80%), Gaps = 6/472 (1%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
S+L +YEVG+ LGQG FAKVYYAR++ T Q+VA+K+I+KDK+M+VGL +QIKREIS+MR
Sbjct: 6 SILMGRYEVGKQLGQGTFAKVYYARNLTTGQAVAIKMINKDKVMKVGLMEQIKREISIMR 65
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDF 128
+V+HPN++QL+EVMA+KSKI+FV+EYAKGGELFNK+AK GKL ED+ARRYF QLINAVD+
Sbjct: 66 LVKHPNVLQLFEVMASKSKIYFVLEYAKGGELFNKIAKEGKLSEDSARRYFHQLINAVDY 125
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
CHSRGVYHRD+KPENLLLDENENLK+SDFGLSALA+ K QDGLLHTTCGTPAYVAPEV++
Sbjct: 126 CHSRGVYHRDLKPENLLLDENENLKVSDFGLSALAESKRQDGLLHTTCGTPAYVAPEVLS 185
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248
RKGYDG K D+WSCGV+LFVL+AGYLPFHD NLIEMYRKI +A+F+CP +F E++ L+
Sbjct: 186 RKGYDGAKADVWSCGVILFVLVAGYLPFHDPNLIEMYRKICRADFRCPRYFSAELKDLIH 245
Query: 249 KILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIA-AE 307
KILD +PSTRIS+ +I+ S+W+RK + K +E+ S +G + GS+ + +E
Sbjct: 246 KILDSDPSTRISIPRIKRSTWYRKPVEINAKN--SEAATTNSISSGVATTSGSAECSTSE 303
Query: 308 IKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAKSL 367
Q LPNLNAFDIISLS GF+LSGFF++ +E RFT+++P + ++ KL+E+AK L
Sbjct: 304 ENQGSLSLPNLNAFDIISLSTGFNLSGFFEDTHGHQEERFTTRQPVTTVLGKLKELAKRL 363
Query: 368 RLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKDD 427
+LK+ KKD G+L+ KEG+KG + +DAEIF++TP+F LVE+KK+NGDT+EY+KL+K+D
Sbjct: 364 KLKVKKKDNGVLRLAAPKEGKKGFLELDAEIFEVTPSFLLVELKKTNGDTMEYRKLVKED 423
Query: 428 IRPALQDIVWVWQGEQQQPLQQQLELQQQQDQRPQPQELWHHQEAQEQQQQQ 479
IRPAL+DIVWVWQG++ L Q LQ +Q Q P P EL Q QQ+
Sbjct: 424 IRPALKDIVWVWQGDEH--LNSQSILQGEQQQSPLPPELPQDQLQPSLPQQE 473
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10LQ2|CIPKA_ORYSJ CBL-interacting protein kinase 10 OS=Oryza sativa subsp. japonica GN=CIPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 600 bits (1547), Expect = e-171, Method: Compositional matrix adjust.
Identities = 291/445 (65%), Positives = 359/445 (80%), Gaps = 3/445 (0%)
Query: 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR 63
M K ++L ++YE+G+LLGQG+FAKVY+ R+I+ +QSVA+KVIDK+KI++ L DQI+R
Sbjct: 1 MVEQKGNILMKRYEIGKLLGQGSFAKVYHGRNIKNSQSVAIKVIDKEKILKCELMDQIRR 60
Query: 64 EISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI 123
EISVM +VRHP IVQLYEVMATK+KI+F++EY KGGELFNKV +G+LKE+ AR+YFQQLI
Sbjct: 61 EISVMNLVRHPCIVQLYEVMATKTKIYFILEYVKGGELFNKVRRGRLKEEVARKYFQQLI 120
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+A+DFCHSRGVYHRD+KPENLLLDEN NLKISDFGLSALA+CK QDGLLHTTCGTPAYVA
Sbjct: 121 SAIDFCHSRGVYHRDLKPENLLLDENRNLKISDFGLSALAECKRQDGLLHTTCGTPAYVA 180
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV 243
PEVINRKGYDG K D+W+CGV+L+VLLAGYLPF D N+I MY+KI KAEFK P+WF ++
Sbjct: 181 PEVINRKGYDGAKADVWACGVILYVLLAGYLPFQDKNVINMYKKICKAEFKWPSWFSSDI 240
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKV--TESKDAASQDAGASAPQGS 301
RKLL +ILDPNP+TRIS+++I E WFR G+N K T+ D S
Sbjct: 241 RKLLRRILDPNPATRISVSEIMEDPWFRVGLNSDLLNKTIPTDKVDKVVHVDMDSTFGNL 300
Query: 302 SSIAAEIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLE 361
S+ E KQE L +LNAFDIISLS+GFDLS F++ E++FTS A+ I KLE
Sbjct: 301 SNNINEGKQEAENLTSLNAFDIISLSSGFDLSAMFEDENSKEESKFTSTNTATTITKKLE 360
Query: 362 EIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYK 421
++AK+LRLK +KK+GGLLK EG K GRKG++S++AEIFQITP+FHLVE K NGDTLEY+
Sbjct: 361 DVAKNLRLKFLKKNGGLLKMEGSKPGRKGVMSINAEIFQITPDFHLVEFTKINGDTLEYQ 420
Query: 422 KLLKDDIRPALQDIVWVWQGEQQQP 446
K +K ++RPAL+DIVW WQGEQ QP
Sbjct: 421 K-VKQEMRPALKDIVWAWQGEQPQP 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6H7U5|CIPKQ_ORYSJ CBL-interacting protein kinase 26 OS=Oryza sativa subsp. japonica GN=CIPK26 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 592 bits (1526), Expect = e-168, Method: Compositional matrix adjust.
Identities = 287/490 (58%), Positives = 375/490 (76%), Gaps = 32/490 (6%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
++ ++L ++YE+GR LGQG FAKVYYAR++ + Q+VA+K+IDK+K+ RVGL QIKREIS
Sbjct: 3 DRRTILMDRYEIGRQLGQGNFAKVYYARNLTSGQAVAIKMIDKEKVTRVGLMVQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
+MR+V+HPNI+QL+EVMA+KSKI+FV+EYAKGGELF K++KGK ED ARRYF QLI+ +
Sbjct: 63 IMRLVKHPNILQLFEVMASKSKIYFVLEYAKGGELFKKISKGKFSEDVARRYFHQLISGI 122
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
D+CHSRGVYHRD+KPENLLLDENE+LK+SDFGLSAL++ K DGLLHTTCGTPAYVAPEV
Sbjct: 123 DYCHSRGVYHRDLKPENLLLDENESLKVSDFGLSALSESKRHDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
++R+GYDG K DIWSCGV+LFVL++GYLPFHD+NLIEMYRKI KAE+KCP F E++ L
Sbjct: 183 LSRRGYDGAKADIWSCGVILFVLVSGYLPFHDTNLIEMYRKIAKAEYKCPRSFSAELKDL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKD------------------- 287
L KILDP+PSTRIS+ KI+ S+W+RK + + E+ D
Sbjct: 243 LYKILDPDPSTRISIPKIKRSAWYRKSSDVNALKSKHETGDKVYKGEATTSDTTECSIFE 302
Query: 288 ---AASQDAGASAPQGSSSIAAEIKQELGQ-----LPNLNAFDIISLSAGFDLSGFFDEN 339
A+S+D + + ++S + E G+ LPNLNAFDIISLS GFDLS F+E
Sbjct: 303 GNRASSRDKVYTNGEATTSDSPECSNSDGKQASLSLPNLNAFDIISLSTGFDLSNLFEER 362
Query: 340 PLIREARFTSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIF 399
RE RFT+++PA+ I +KL E+A+ +LK+ KK+ G+L+ KEG KG++ +DAE+F
Sbjct: 363 YGRREERFTTRQPAAAIFAKLNELARRFKLKIKKKENGVLRLVAPKEGIKGLLELDAEVF 422
Query: 400 QITPNFHLVEMKKSNGDTLEYKKLLKDDIRPALQDIVWVWQGEQ-QQPLQ--QQLELQQQ 456
++ P+FHLVE KKSNGDT+EY+KL+K+DIRPAL+DIVW WQG Q QQP Q Q ++ +QQ
Sbjct: 423 ELAPSFHLVEFKKSNGDTIEYQKLMKEDIRPALKDIVWAWQGGQHQQPEQSMQGMQGEQQ 482
Query: 457 QDQRP--QPQ 464
+ P QPQ
Sbjct: 483 PSRLPSQQPQ 492
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A3B529|CIPKS_ORYSJ CBL-interacting protein kinase 28 OS=Oryza sativa subsp. japonica GN=CIPK28 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 583 bits (1502), Expect = e-165, Method: Compositional matrix adjust.
Identities = 269/435 (61%), Positives = 353/435 (81%), Gaps = 4/435 (0%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
SVL E+Y +GR LGQG F KVYYAR++ + QSVA+K+IDK+KI++VGL +QIKREIS+MR
Sbjct: 5 SVLMERYVIGRQLGQGTFGKVYYARNLSSGQSVAIKMIDKEKILKVGLMEQIKREISIMR 64
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFC 129
+VRHPN++QL+EVMATKS I+F +EYAKGGELF+K+A+ KL E++AR YFQQLI+A+D+C
Sbjct: 65 LVRHPNVLQLFEVMATKSNIYFALEYAKGGELFHKMARAKLNEESARNYFQQLISAMDYC 124
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
HSRGVYHRD+KPENLLLDENE LK+SDFGLSALA+ + QDGLLHT CGTPAYVAPEV++R
Sbjct: 125 HSRGVYHRDLKPENLLLDENETLKVSDFGLSALAESRRQDGLLHTACGTPAYVAPEVLSR 184
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCK 249
KGY G K D+WSCGV+LFVL+A YLPFHD N+I+MYRKI KAE++CP F E+++LL
Sbjct: 185 KGYSGSKADVWSCGVILFVLVANYLPFHDRNIIQMYRKIAKAEYRCPRHFSAELKELLYG 244
Query: 250 ILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAAEIK 309
ILDP+PSTR+S+++I+ S+W+RK + T K + + +A S P + I++E
Sbjct: 245 ILDPDPSTRMSISRIKRSAWYRKPIAISALNNET-GKKSCTSEAPFSGP--TICISSERN 301
Query: 310 QELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAKSLRL 369
QE L NLNAFDIISLS GFDLSG F E RE+ FTS++PA+ ++ KL+E+AK+L L
Sbjct: 302 QEPPNLHNLNAFDIISLSTGFDLSGLFGERYGRRESLFTSRKPAAAVLVKLKELAKALNL 361
Query: 370 KMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKDDIR 429
K+ K D G+LK KEGRKG + +DAE+ ++ P F LVE+KK+NGDTLEY++++K+DIR
Sbjct: 362 KVTKTDNGVLKLATTKEGRKGRLELDAEVSEVAP-FLLVELKKTNGDTLEYQRMMKEDIR 420
Query: 430 PALQDIVWVWQGEQQ 444
P+L+DI+W WQG+QQ
Sbjct: 421 PSLKDIIWTWQGDQQ 435
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LWM4|CIPK5_ORYSJ CBL-interacting protein kinase 5 OS=Oryza sativa subsp. japonica GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 570 bits (1470), Expect = e-162, Method: Compositional matrix adjust.
Identities = 276/460 (60%), Positives = 358/460 (77%), Gaps = 24/460 (5%)
Query: 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV 67
K S+L +YE+GR+LGQG FAKVY+AR++ +NQSVA+KVIDK+K++RVG+ DQIKREIS+
Sbjct: 4 KASILMNRYELGRMLGQGTFAKVYHARNLASNQSVAIKVIDKEKVLRVGMIDQIKREISI 63
Query: 68 MRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVD 127
MR+VRHPNIVQL+EVMA+KSKI+F MEY +GGELF++VA+G+LKEDAAR+YFQQLI AVD
Sbjct: 64 MRLVRHPNIVQLHEVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIGAVD 123
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
FCHSRGVYHRD+KPENLL+DEN NLK+SDFGLSA +C+ QDGLLHTTCGTPAYVAPE+I
Sbjct: 124 FCHSRGVYHRDLKPENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAPEII 183
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLL 247
N++GYDG K DIWSCGV+LFVLLAGYLPFHDSNL+EMYRKI K + K P WF +VR+LL
Sbjct: 184 NKRGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVRRLL 243
Query: 248 CKILDPNPSTRISMAKIRESSWFRKGM---------NQKQKQK-VTESKDAASQDAGASA 297
++LDPNP+ RI++ K+ E WF+KG N+ K V + A +D A
Sbjct: 244 SRLLDPNPNIRITVEKLVEHPWFKKGYKPAVMLSQPNESNNLKDVHTAFSADHKDNEGKA 303
Query: 298 PQGSSSIAAEIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIR-EARFTSKRPASVI 356
+ +SS+ + +LNAFDIISLS GFDLSG F+ + + ++RF +++PAS I
Sbjct: 304 KEPASSL---------KPVSLNAFDIISLSKGFDLSGLFENDKEQKADSRFMTQKPASAI 354
Query: 357 ISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGD 416
+SKLE+IA++ K+ K+D GL+K +G KEGRKG +++DAEIF++TP+F +VE+KKS GD
Sbjct: 355 VSKLEQIAETESFKVKKQD-GLVKLQGSKEGRKGQLAIDAEIFEVTPSFFVVEVKKSAGD 413
Query: 417 TLEYKKLLKDDIRPALQDIVWVWQGEQQQP-LQQQLELQQ 455
TLEY+K +RP+L+DI W G+ + P L Q L Q
Sbjct: 414 TLEYEKFCNKGLRPSLRDI--CWDGQSEHPSLAQSSTLTQ 451
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJ54|CIPKK_ARATH CBL-interacting serine/threonine-protein kinase 20 OS=Arabidopsis thaliana GN=CIPK20 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 563 bits (1452), Expect = e-160, Method: Compositional matrix adjust.
Identities = 276/453 (60%), Positives = 348/453 (76%), Gaps = 19/453 (4%)
Query: 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR 63
MD N VL KYE+GRLLGQG FAKVY+AR+I+T +SVA+KVIDK K+ +VGL DQIKR
Sbjct: 1 MDKN-GIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKR 59
Query: 64 EISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI 123
EISVMR+VRHP++V L+EVMA+K+KI+F MEY KGGELF+KV+KGKLKE+ AR+YFQQLI
Sbjct: 60 EISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLI 119
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
A+D+CHSRGVYHRD+KPENLLLDEN +LKISDFGLSAL + K QDGLLHTTCGTPAYVA
Sbjct: 120 GAIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVA 179
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV 243
PEVI +KGYDG K D+WSCGVVL+VLLAG+LPFH+ NL+EMYRKI K EFKCPNWFPPEV
Sbjct: 180 PEVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEV 239
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSS 303
+KLL +ILDPNP++RI + KI E+SWF+KG + + K ES S
Sbjct: 240 KKLLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQI-------------DS 286
Query: 304 IAAEIKQELGQLP-NLNAFDII-SLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLE 361
+ +++ P + NAFD+I SLS GFDLSG F++ E++FT+K+ A I+SK E
Sbjct: 287 LISDVHAAFSVKPMSYNAFDLISSLSQGFDLSGLFEKEER-SESKFTTKKDAKEIVSKFE 345
Query: 362 EIAKSL-RLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEY 420
EIA S R + K D G +K E +EGRKG +++D EIF++T +FH+VE KKS GDT+EY
Sbjct: 346 EIATSSERFNLTKSDVG-VKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEY 404
Query: 421 KKLLKDDIRPALQDIVWVWQGEQQQPLQQQLEL 453
K+ ++RP+L+DIVW WQG +++E+
Sbjct: 405 KQFCDRELRPSLKDIVWKWQGNNNNSNNEKIEV 437
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner (By similarity). Required for the abscisic acid-mediated (ABA) signaling pathway involved in seed germination and growth elongation inhibition. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 479 | ||||||
| 255553349 | 457 | CBL-interacting serine/threonine-protein | 0.908 | 0.951 | 0.791 | 0.0 | |
| 224146636 | 464 | predicted protein [Populus trichocarpa] | 0.914 | 0.943 | 0.758 | 0.0 | |
| 224126941 | 450 | predicted protein [Populus trichocarpa] | 0.903 | 0.962 | 0.780 | 0.0 | |
| 359478333 | 437 | PREDICTED: CBL-interacting serine/threon | 0.883 | 0.967 | 0.750 | 0.0 | |
| 8777339 | 464 | serine/threonine protein kinase [Arabido | 0.908 | 0.937 | 0.738 | 0.0 | |
| 116265946 | 438 | CBL-interacting protein kinase 14 [Popul | 0.878 | 0.961 | 0.769 | 0.0 | |
| 297796751 | 462 | cbl-interacting protein kinase 10 [Arabi | 0.918 | 0.952 | 0.731 | 0.0 | |
| 18424099 | 479 | CBL-interacting serine/threonine-protein | 0.912 | 0.912 | 0.721 | 0.0 | |
| 225439641 | 462 | PREDICTED: CBL-interacting protein kinas | 0.899 | 0.932 | 0.729 | 0.0 | |
| 449463306 | 471 | PREDICTED: CBL-interacting serine/threon | 0.910 | 0.925 | 0.717 | 0.0 |
| >gi|255553349|ref|XP_002517716.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223543114|gb|EEF44648.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/436 (79%), Positives = 391/436 (89%), Gaps = 1/436 (0%)
Query: 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR 63
MDH K SVLT+KYE GRLLGQG FAKVYYARSIRTNQSVA+KVIDK+KI+RVGL +QIKR
Sbjct: 1 MDH-KSSVLTQKYETGRLLGQGTFAKVYYARSIRTNQSVAIKVIDKEKILRVGLVEQIKR 59
Query: 64 EISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI 123
EISVMRIVRHPN+VQLYEV+ATKSKI+FVMEY KGGELFNKVAKGKLKE+AAR+YFQQLI
Sbjct: 60 EISVMRIVRHPNVVQLYEVLATKSKIYFVMEYCKGGELFNKVAKGKLKEEAARKYFQQLI 119
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
NAVDFCHSRGVYHRDIKPENLLLDENENLKI+DFGLSALA CKHQDGLLHTTCGTPAYVA
Sbjct: 120 NAVDFCHSRGVYHRDIKPENLLLDENENLKITDFGLSALADCKHQDGLLHTTCGTPAYVA 179
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV 243
PEVINR+GYDG K DIWSCGVVL+VLLAGYLPFHDSNL+EMYRKIG+AEFKCPNWFP +
Sbjct: 180 PEVINRRGYDGAKADIWSCGVVLYVLLAGYLPFHDSNLMEMYRKIGRAEFKCPNWFPQDA 239
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSS 303
R+L+ K+LDPNP+TRIS+AKI+ESSWF+KG+N KQ + E++D + + S P +S
Sbjct: 240 RRLVFKMLDPNPNTRISIAKIKESSWFKKGLNSKQNKTEAETRDISHLERNRSGPSEINS 299
Query: 304 IAAEIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEI 363
+++E KQE P LNAFDIISLSAGFDLSG FDENP +REARFTS +PASVIISKLEEI
Sbjct: 300 VSSEAKQESVNPPKLNAFDIISLSAGFDLSGLFDENPQLREARFTSMQPASVIISKLEEI 359
Query: 364 AKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKL 423
AK LRLK+ KKD GLLK E L+EGRKG++S+DAEIF++TPNFHLVE+KKSNGD EY+K+
Sbjct: 360 AKRLRLKITKKDAGLLKMEALEEGRKGLLSIDAEIFEVTPNFHLVEVKKSNGDLYEYQKI 419
Query: 424 LKDDIRPALQDIVWVW 439
LKDDI+PAL DIV VW
Sbjct: 420 LKDDIQPALHDIVCVW 435
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224146636|ref|XP_002326078.1| predicted protein [Populus trichocarpa] gi|116265924|gb|ABJ91210.1| CBL-interacting protein kinase 2 [Populus trichocarpa] gi|222862953|gb|EEF00460.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1834), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/439 (75%), Positives = 391/439 (89%), Gaps = 1/439 (0%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
NKPSVLT+KYEVGRLLGQG FAKVY+AR+I+TNQSVA+K+I+K+K++RVGL DQIKREI
Sbjct: 3 NKPSVLTQKYEVGRLLGQGTFAKVYFARNIKTNQSVAIKLIEKEKVLRVGLVDQIKREIY 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VMR+VRHPNI++LYEV+ATKSKI+FVMEYAKGGELFNKV+KG+LKED A +YFQQLINAV
Sbjct: 63 VMRLVRHPNIIKLYEVLATKSKIYFVMEYAKGGELFNKVSKGRLKEDVAWKYFQQLINAV 122
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSR VYHRDIKPENLLLDENENLKISDFGLSALA+ K QDGLLHTTCGTPAYVAPEV
Sbjct: 123 DFCHSRDVYHRDIKPENLLLDENENLKISDFGLSALAESKRQDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
I RKGYDG K DIWSCGVVLFVLLAGYLPFHD+NL+EMYRKI KAEFKCPNWFP + RKL
Sbjct: 183 IKRKGYDGAKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIDKAEFKCPNWFPTDARKL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAA 306
L KILDPNP+TRIS+A+I+ESSWFRKG+ ++ K + T ++AA+ S P +SS+A
Sbjct: 243 LRKILDPNPNTRISIAEIKESSWFRKGLPRQSKTE-TVGREAAALGRNGSGPSENSSVAC 301
Query: 307 EIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAKS 366
E KQE + P LNAFDIISLSAGFDLSG FD+ REARFTS +PASV+ISKLE+I+K
Sbjct: 302 EAKQESAKPPYLNAFDIISLSAGFDLSGLFDDKYPNREARFTSAQPASVVISKLEDISKC 361
Query: 367 LRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKD 426
L+LK+MKKD GLLK EG+KEGRKG++++DAEIF++TPNFHLVE+KK+NGDTLEY+K+L +
Sbjct: 362 LKLKVMKKDAGLLKMEGMKEGRKGLLAIDAEIFELTPNFHLVELKKTNGDTLEYQKMLNE 421
Query: 427 DIRPALQDIVWVWQGEQQQ 445
DIRPAL+DIVW+WQG +
Sbjct: 422 DIRPALKDIVWLWQGSKNH 440
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126941|ref|XP_002319966.1| predicted protein [Populus trichocarpa] gi|222858342|gb|EEE95889.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1825), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/433 (78%), Positives = 388/433 (89%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
NKPSVLT+ YEVGRLLGQG FAKVY+ARSIRTN SVA+KVIDK+K+++VGL +QIKREIS
Sbjct: 3 NKPSVLTKNYEVGRLLGQGTFAKVYFARSIRTNLSVAIKVIDKEKVLKVGLVNQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VMR+VRHPNIVQLYEV+ATKSKI+FVMEYAKGGELF+KVAKG+LKED A++YFQQLINAV
Sbjct: 63 VMRLVRHPNIVQLYEVLATKSKIYFVMEYAKGGELFDKVAKGRLKEDVAQKYFQQLINAV 122
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL + K QDGLLHTTCGTPAYVAPEV
Sbjct: 123 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALTESKQQDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
INRKGYDG K DIWSCGVVLFVLL+GYLPFHDSNL+EMYRKIG+AEFKCPNWFP + R+L
Sbjct: 183 INRKGYDGTKADIWSCGVVLFVLLSGYLPFHDSNLMEMYRKIGRAEFKCPNWFPTDARRL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAA 306
L KILDPNPSTRISMA+I+ESSWFRKG+N KQ + T+SK+ A+ D S +SS+A+
Sbjct: 243 LRKILDPNPSTRISMAEIKESSWFRKGLNSKQIKTGTKSKEVAALDWNGSGSSENSSVAS 302
Query: 307 EIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAKS 366
E KQE + P+LNAFDIISLSAGFDLSG F+EN REARFTS +PASVIISKLE+IAK
Sbjct: 303 EAKQESAKPPSLNAFDIISLSAGFDLSGLFEENYQKREARFTSIQPASVIISKLEDIAKR 362
Query: 367 LRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKD 426
+LK++KKD GLLK EG++EGRKG +S+DAEIF++TPN H VE+KKSNGDTLEY+K+L++
Sbjct: 363 QKLKVIKKDAGLLKLEGMEEGRKGPLSVDAEIFEVTPNIHFVEVKKSNGDTLEYQKILEE 422
Query: 427 DIRPALQDIVWVW 439
IRPAL DIV VW
Sbjct: 423 AIRPALNDIVCVW 435
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478333|ref|XP_002269410.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 10 isoform 3 [Vitis vinifera] gi|229609823|gb|ACQ83527.1| CBL-interacting protein kinase 11 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/433 (75%), Positives = 380/433 (87%), Gaps = 10/433 (2%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
+K +VL +YE+GRLLGQG FAKVYYAR+++T QSVA+KVIDK+K+++VGL DQIKREIS
Sbjct: 3 SKGAVLMNRYELGRLLGQGTFAKVYYARNLKTGQSVAIKVIDKEKVVKVGLKDQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VM++ RHPN++QLYEVMATKSKI+FVMEYAKGGELF KVAKGKLKE+ A +YF+QLI+AV
Sbjct: 63 VMKLARHPNVLQLYEVMATKSKIYFVMEYAKGGELFKKVAKGKLKEEVAWKYFRQLIDAV 122
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSRGVYHRD+KPENLLLDEN+NLK+SDFGLSA+A+CKHQDGLLHTTCGTP YVAPEV
Sbjct: 123 DFCHSRGVYHRDLKPENLLLDENDNLKVSDFGLSAMAECKHQDGLLHTTCGTPTYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
IN+KGYDG K DIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI KAEFKCPNWF P+VR+L
Sbjct: 183 INKKGYDGAKADIWSCGVVLFVLLAGYLPFHDSNLIEMYRKISKAEFKCPNWFSPDVRRL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAA 306
L KILDPNP+TRIS+AKI+ESSWFR+G+ KQ + T SKD A D AA
Sbjct: 243 LQKILDPNPNTRISIAKIKESSWFRRGLKSKQIKSETGSKDMAPLDTD----------AA 292
Query: 307 EIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAKS 366
KQEL + NLNAFDIIS+SAGFDLSG F+E ++A FT ++PA+VIIS+LEEIAK
Sbjct: 293 SAKQELAKPTNLNAFDIISISAGFDLSGLFEEPCQKKKAIFTFRKPAAVIISRLEEIAKH 352
Query: 367 LRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKD 426
LRLK+MKKD G +KFEGLKEG+KGI+S+DAEIF++TP+FHLVE+KKSNGDTLEY+KLLK+
Sbjct: 353 LRLKVMKKDAGFMKFEGLKEGKKGILSIDAEIFEVTPSFHLVEVKKSNGDTLEYQKLLKE 412
Query: 427 DIRPALQDIVWVW 439
DIRPALQDIVW W
Sbjct: 413 DIRPALQDIVWTW 425
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|8777339|dbj|BAA96929.1| serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1778), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/440 (73%), Positives = 384/440 (87%), Gaps = 5/440 (1%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
NKPSVLT+KY+VGRLLGQG FAKVYY RSI TNQSVA+K+IDK+K+M+VGL +QIKREIS
Sbjct: 3 NKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VMRI RHPN+V+LYEVMATK++I+FVMEY KGGELFNKVAKGKL++D A +YF QLINAV
Sbjct: 63 VMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINAV 122
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSR VYHRDIKPENLLLD+NENLK+SDFGLSALA CK QDGLLHTTCGTPAYVAPEV
Sbjct: 123 DFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
INRKGYDG K DIWSCGVVLFVLLAGYLPFHDSNL+EMYRKIGKA+FK P+WF PEVR+L
Sbjct: 183 INRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRRL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAA 306
LCK+LDPNP TRI++A+IRESSWFRKG++ KQK+ K+ S +AG + + + +
Sbjct: 243 LCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAGPS 302
Query: 307 EIKQELGQLPNLNAFDIISLSAGFDLSGFF-DENPLIREARFTSKRPASVIISKLEEIAK 365
E + + NLNAFD+I+LSAGFDL+G F D+N RE+RFTS++PASVIISKLEE+A+
Sbjct: 303 ENGAD--EPTNLNAFDLIALSAGFDLAGLFGDDNK--RESRFTSQKPASVIISKLEEVAQ 358
Query: 366 SLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLK 425
L+L + K++ GL K E LKEGRKGI+SMDAEIFQ+TPNFHLVE+KKSNGDTLEY+KL+
Sbjct: 359 RLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEVKKSNGDTLEYQKLVA 418
Query: 426 DDIRPALQDIVWVWQGEQQQ 445
+D+RPAL DIVWVWQGE+ +
Sbjct: 419 EDLRPALSDIVWVWQGEKDE 438
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116265946|gb|ABJ91221.1| CBL-interacting protein kinase 14 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1778), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/433 (76%), Positives = 380/433 (87%), Gaps = 12/433 (2%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
NKPSVLT+ YEVGRLLGQG FAKVY+ARSIRTN SVA+KVIDK+K+++VGL +QIKREIS
Sbjct: 3 NKPSVLTKNYEVGRLLGQGTFAKVYFARSIRTNLSVAIKVIDKEKVLKVGLVNQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VMR+VRHPNIVQLYEV+ATKSKI+FVMEYAKGGELF+KVAKG+LKED A++YFQQLINAV
Sbjct: 63 VMRLVRHPNIVQLYEVLATKSKIYFVMEYAKGGELFDKVAKGRLKEDVAQKYFQQLINAV 122
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL + K QDGLLHTTCGTPAYVAPEV
Sbjct: 123 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALTESKQQDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
INRKGYDG K DIWSCGVVLFVLL+GYLPFHDSNL+EMYRKIG+AEFKCPNWFP + R+L
Sbjct: 183 INRKGYDGTKADIWSCGVVLFVLLSGYLPFHDSNLMEMYRKIGRAEFKCPNWFPTDARRL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAA 306
L KILDPNPSTRISMA+I+ESSWFRKG K+ A+ D S +SS+A+
Sbjct: 243 LRKILDPNPSTRISMAEIKESSWFRKG------------KEVAALDWNGSGSSENSSVAS 290
Query: 307 EIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAKS 366
E KQE + P+LNAFDIISLSAGFDLSG F+EN REARFTS +PASVIISKLE+IAK
Sbjct: 291 EAKQESAKPPSLNAFDIISLSAGFDLSGLFEENYQKREARFTSIQPASVIISKLEDIAKR 350
Query: 367 LRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKD 426
+LK++KKD GLLK EG++EGRKG +S+DAEIF++TPN H VE+KKSNGDTLEY+K+L++
Sbjct: 351 QKLKVIKKDAGLLKLEGMEEGRKGPLSVDAEIFEVTPNIHFVEVKKSNGDTLEYQKILEE 410
Query: 427 DIRPALQDIVWVW 439
IRPAL DIV VW
Sbjct: 411 AIRPALNDIVCVW 423
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297796751|ref|XP_002866260.1| cbl-interacting protein kinase 10 [Arabidopsis lyrata subsp. lyrata] gi|297312095|gb|EFH42519.1| cbl-interacting protein kinase 10 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1774), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/447 (73%), Positives = 385/447 (86%), Gaps = 7/447 (1%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
NKPSVLT+KY+VGRLLGQG FAKVYY RSI TNQSVA+K+IDK+K+M+VGL +QIKREIS
Sbjct: 3 NKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VMRI RHPN+V+LYEVMATK++I+FVMEY KGGELFNKVAKGKL++D A +YF QLINAV
Sbjct: 63 VMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINAV 122
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSR VYHRDIKPENLLLD+NENLK+SDFGLSALA CK QDGLLHTTCGTPAYVAPEV
Sbjct: 123 DFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
INRKGYDG K DIWSCGVVLFVLLAGYLPFHDSNL+EMYRKIGKA+FK P+WF PEVR+L
Sbjct: 183 INRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRRL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAG-ASAPQGSSSIA 305
LCK+LDPNP TRI++A+IRESSWFRKG++ KQK+ K+ S +AG A P + +
Sbjct: 243 LCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEMNSVEAGVAGGPNENGAGP 302
Query: 306 AE-----IKQELGQLP-NLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISK 359
+E I++ P NLNAFD+I+LSAGFDL+G F + RE+RFTS++PASVIISK
Sbjct: 303 SENGDRVIEENQTDEPTNLNAFDLIALSAGFDLAGLFGDVFNKRESRFTSQKPASVIISK 362
Query: 360 LEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLE 419
LEE+A+ L+L + K++ GL K E LKEGRKGI+SMDAEIFQ+TP FHLVE+KKSNGDTLE
Sbjct: 363 LEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPTFHLVEVKKSNGDTLE 422
Query: 420 YKKLLKDDIRPALQDIVWVWQGEQQQP 446
Y+KL+ +D+RPAL DIVWVWQGE+ +P
Sbjct: 423 YQKLVAEDLRPALSDIVWVWQGEKDEP 449
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18424099|ref|NP_568878.1| CBL-interacting serine/threonine-protein kinase 10 [Arabidopsis thaliana] gi|75333352|sp|Q9C562.1|CIPKA_ARATH RecName: Full=CBL-interacting serine/threonine-protein kinase 10; AltName: Full=SNF1-related kinase 3.8; AltName: Full=SOS2-like protein kinase PKS2; AltName: Full=SOS3-interacting protein 1 gi|13249119|gb|AAK16685.1|AF295665_1 CBL-interacting protein kinase 10 [Arabidopsis thaliana] gi|13448029|gb|AAK26841.1|AF339143_1 SOS2-like protein kinase PKS2 [Arabidopsis thaliana] gi|20453092|gb|AAM19789.1| AT5g07070/T28J14_10 [Arabidopsis thaliana] gi|21703141|gb|AAM74510.1| AT5g07070/T28J14_10 [Arabidopsis thaliana] gi|21928023|gb|AAM78040.1| AT5g07070/T28J14_10 [Arabidopsis thaliana] gi|110742161|dbj|BAE99008.1| SOS2-like protein kinase PKS2 [Arabidopsis thaliana] gi|332009663|gb|AED97046.1| CBL-interacting serine/threonine-protein kinase 10 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1770), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/453 (72%), Positives = 384/453 (84%), Gaps = 16/453 (3%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
NKPSVLT+KY+VGRLLGQG FAKVYY RSI TNQSVA+K+IDK+K+M+VGL +QIKREIS
Sbjct: 3 NKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VMRI RHPN+V+LYEVMATK++I+FVMEY KGGELFNKVAKGKL++D A +YF QLINAV
Sbjct: 63 VMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINAV 122
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSR VYHRDIKPENLLLD+NENLK+SDFGLSALA CK QDGLLHTTCGTPAYVAPEV
Sbjct: 123 DFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
INRKGYDG K DIWSCGVVLFVLLAGYLPFHDSNL+EMYRKIGKA+FK P+WF PEVR+L
Sbjct: 183 INRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRRL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQ------- 299
LCK+LDPNP TRI++A+IRESSWFRKG++ KQK+ K+ S +AG +
Sbjct: 243 LCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAGPS 302
Query: 300 ----GSSSIAAEIKQE--LGQLPNLNAFDIISLSAGFDLSGFF-DENPLIREARFTSKRP 352
G S + +E + NLNAFD+I+LSAGFDL+G F D+N RE+RFTS++P
Sbjct: 303 ENGAGPSENGDRVTEENHTDEPTNLNAFDLIALSAGFDLAGLFGDDNK--RESRFTSQKP 360
Query: 353 ASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKK 412
ASVIISKLEE+A+ L+L + K++ GL K E LKEGRKGI+SMDAEIFQ+TPNFHLVE+KK
Sbjct: 361 ASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEVKK 420
Query: 413 SNGDTLEYKKLLKDDIRPALQDIVWVWQGEQQQ 445
SNGDTLEY+KL+ +D+RPAL DIVWVWQGE+ +
Sbjct: 421 SNGDTLEYQKLVAEDLRPALSDIVWVWQGEKDE 453
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439641|ref|XP_002269189.1| PREDICTED: CBL-interacting protein kinase 18 isoform 1 [Vitis vinifera] gi|147843535|emb|CAN81218.1| hypothetical protein VITISV_040419 [Vitis vinifera] gi|229609815|gb|ACQ83523.1| CBL-interacting protein kinase 07 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 678 bits (1749), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/436 (72%), Positives = 379/436 (86%), Gaps = 5/436 (1%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
N S+L ++YE+G+LLGQG FAKV++AR+++T SVA+K+IDK+KI++VG+ DQIKREIS
Sbjct: 3 NNGSILMQRYELGKLLGQGTFAKVHHARNLKTGTSVAIKIIDKEKILKVGMVDQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VMR+VRHPN+V+LYEVMA+K+KI+FVMEYAKGGELFNKVAKGKLKED AR+YFQQLI+AV
Sbjct: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYAKGGELFNKVAKGKLKEDVARKYFQQLISAV 122
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSRGVYHRD+KPENLLLDEN NLK+SDFGLSALA+ KHQDGLLHTTCGTPAYVAPEV
Sbjct: 123 DFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
INRKGYDG K DIWSCGVVLFVLLAGYLPFHDSNL+E+YRKIGKAE++ PNWFP EVR+L
Sbjct: 183 INRKGYDGAKADIWSCGVVLFVLLAGYLPFHDSNLMELYRKIGKAEYRFPNWFPSEVRRL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQG---SSS 303
L KILDPNP TRIS+ KI E+SWF+KG++ ++TE+ + D A G S+S
Sbjct: 243 LSKILDPNPKTRISITKIMENSWFQKGLD--PVLRITETGEKEPADLEVEAVFGSNESAS 300
Query: 304 IAAEIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEI 363
AE KQEL L NLNAFDIIS SAGFDLSG F+EN +E RFTS++PAS IISKLE+I
Sbjct: 301 TTAEAKQELATLSNLNAFDIISFSAGFDLSGLFEENKQKKEVRFTSRQPASAIISKLEDI 360
Query: 364 AKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKL 423
AK L LK+ KKDGGLLK EG KEGRKG++S+DAEIF++TP+FHLVE+KKS+GDTLEY+K+
Sbjct: 361 AKRLMLKVKKKDGGLLKMEGSKEGRKGVLSIDAEIFEVTPSFHLVEVKKSSGDTLEYQKI 420
Query: 424 LKDDIRPALQDIVWVW 439
+K +IRPAL+DIVW W
Sbjct: 421 VKQEIRPALKDIVWAW 436
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463306|ref|XP_004149375.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 10-like [Cucumis sativus] gi|449526279|ref|XP_004170141.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 10-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 673 bits (1736), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/436 (71%), Positives = 375/436 (86%)
Query: 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREI 65
NK SV+ ++YE+GRLLGQG FAKVYYAR+ +NQSVA+KVIDK+KI + L DQIKREI
Sbjct: 2 ENKASVMVQRYELGRLLGQGTFAKVYYARNTGSNQSVAIKVIDKEKITKASLIDQIKREI 61
Query: 66 SVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINA 125
S+MR+VRHPNI++LYEVMATK+KI+FV+EYAKGGELF+KVAKGKLKED A +YF QLINA
Sbjct: 62 SIMRLVRHPNILRLYEVMATKTKIYFVLEYAKGGELFDKVAKGKLKEDVAWKYFYQLINA 121
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
VDFCHSRGVYHRDIKPENLLLDENENLK+SDFGLSALA+ K QDGLLHTTCGTPAYVAPE
Sbjct: 122 VDFCHSRGVYHRDIKPENLLLDENENLKVSDFGLSALAESKRQDGLLHTTCGTPAYVAPE 181
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRK 245
VINRKGYDG K DIWSCGVVLFVLLAGYLPFH+SNL+EMYRKIGKAE+KCP+WFP EVR+
Sbjct: 182 VINRKGYDGAKADIWSCGVVLFVLLAGYLPFHNSNLMEMYRKIGKAEYKCPSWFPREVRR 241
Query: 246 LLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIA 305
LL ++LDP+P+TR S+A IR+SSWF+KG+ K + ES A +DA A + S+A
Sbjct: 242 LLSRMLDPDPNTRTSIALIRQSSWFKKGLRSKNARSGVESNAVAPEDATAGSGPSEGSVA 301
Query: 306 AEIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAK 365
A+ QE + P LNAFDIISLSAGF+LS F++N +E FT ++PASVI+SKLEE+AK
Sbjct: 302 ADGNQEPDRPPTLNAFDIISLSAGFNLSSLFEDNSKKKETLFTCRKPASVILSKLEEMAK 361
Query: 366 SLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLK 425
LR ++ KK+ GLLKFE L EG+KG +S+D EIF++TP+F+LVEMKKSNGDTLEY+K+LK
Sbjct: 362 LLRFRVQKKEAGLLKFEALTEGKKGALSIDTEIFEVTPSFYLVEMKKSNGDTLEYQKVLK 421
Query: 426 DDIRPALQDIVWVWQG 441
+DIRPAL+DIVWVW+G
Sbjct: 422 EDIRPALKDIVWVWRG 437
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 479 | ||||||
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.899 | 0.899 | 0.673 | 1.3e-157 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.903 | 0.949 | 0.660 | 1.2e-152 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.881 | 0.961 | 0.583 | 7.1e-132 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.870 | 0.990 | 0.583 | 5.7e-130 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.868 | 0.943 | 0.531 | 4.2e-118 | |
| TAIR|locus:2124072 | 489 | CIPK12 "CBL-interacting protei | 0.891 | 0.873 | 0.515 | 3.1e-115 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.883 | 0.866 | 0.519 | 8.2e-115 | |
| UNIPROTKB|Q84XC0 | 516 | Q84XC0 "Calcineurin B-like-int | 0.563 | 0.523 | 0.627 | 8.7e-115 | |
| TAIR|locus:2152370 | 483 | CIPK19 "CBL-interacting protei | 0.887 | 0.879 | 0.5 | 1.5e-113 | |
| TAIR|locus:2029974 | 520 | CIPK18 "CBL-interacting protei | 0.887 | 0.817 | 0.5 | 1.6e-111 |
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1536 (545.8 bits), Expect = 1.3e-157, P = 1.3e-157
Identities = 301/447 (67%), Positives = 351/447 (78%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
NKPSVLT+KY+VGRLLGQG FAKVYY RSI TNQSVA+K+IDK+K+M+VGL +QIKREIS
Sbjct: 3 NKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VMRI RHPN+V+LYEVMATK++I+FVMEY KGGELFNKVAKGKL++D A +YF QLINAV
Sbjct: 63 VMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINAV 122
Query: 127 DFCHSRGVYHRDIKPXXXXXXXXXXXKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSR VYHRDIKP K+SDFGLSALA CK QDGLLHTTCGTPAYVAPEV
Sbjct: 123 DFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
INRKGYDG K DIWSCGVVLFVLLAGYLPFHDSNL+EMYRKIGKA+FK P+WF PEVR+L
Sbjct: 183 INRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRRL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASA-------PQ 299
LCK+LDPNP TRI++A+IRESSWFRKG++ KQK+ K+ S +AG + P
Sbjct: 243 LCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAGPS 302
Query: 300 ----GSSSIAAEIKQE--LGQLPNLNAFDIISLSAGFDLSGFF-DENPLIREARFTSKRP 352
G S + +E + NLNAFD+I+LSAGFDL+G F D+N RE+RFTS++P
Sbjct: 303 ENGAGPSENGDRVTEENHTDEPTNLNAFDLIALSAGFDLAGLFGDDNK--RESRFTSQKP 360
Query: 353 ASVIISKLEEIAKSXXXXXXXXXXXXXXXXXXXXXXXXIVSMDAEIFQITPNFHLVEMKK 412
ASVIISKLEE+A+ I+SMDAEIFQ+TPNFHLVE+KK
Sbjct: 361 ASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEVKK 420
Query: 413 SNGDTLEYKKLLKDDIRPALQDIVWVW 439
SNGDTLEY+KL+ +D+RPAL DIVWVW
Sbjct: 421 SNGDTLEYQKLVAEDLRPALSDIVWVW 447
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1489 (529.2 bits), Expect = 1.2e-152, P = 1.2e-152
Identities = 286/433 (66%), Positives = 335/433 (77%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
NKPSVLTE+YEVGRLLGQG FAKVY+ RS TN+SVA+K+IDKDK+MRVGL+ QIKREIS
Sbjct: 3 NKPSVLTERYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKREIS 62
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
VMRI +HPN+V+LYEVMATKS+I+FV+EY KGGELFNKVAKGKLKED A +YF QLI+AV
Sbjct: 63 VMRIAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLISAV 122
Query: 127 DFCHSRGVYHRDIKPXXXXXXXXXXXKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
DFCHSRGVYHRDIKP K+SDFGLSALA CK QDGLLHTTCGTPAYVAPEV
Sbjct: 123 DFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEV 182
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
INRKGY+G K DIWSCGVVLFVLLAGYLPFHD+NL+EMYRKIGKA+FKCP+WF PEV++L
Sbjct: 183 INRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVKRL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAA 306
LCK+LDPN TRI++AKI+ESSWFRKG++ KQK+ K + GS
Sbjct: 243 LCKMLDPNHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNPMEAGGSGQNEN 302
Query: 307 EIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAKS 366
E +L LNAFDII+LS GF L+G F + RE+RF S++PAS IISKL E+AK
Sbjct: 303 GENHEPPRLATLNAFDIIALSTGFGLAGLFGDVYDKRESRFASQKPASEIISKLVEVAKC 362
Query: 367 XXXXXXXXXXXXXXXXXXXXXXXXIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKD 426
I++MDAEIFQ+TP FHLVE+KK NGDT+EY+KL+++
Sbjct: 363 LKLKIRKQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGDTMEYQKLVEE 422
Query: 427 DIRPALQDIVWVW 439
D+RPAL DIVWVW
Sbjct: 423 DLRPALADIVWVW 435
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1293 (460.2 bits), Expect = 7.1e-132, P = 7.1e-132
Identities = 255/437 (58%), Positives = 317/437 (72%)
Query: 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR 63
MD N VL KYE+GRLLGQG FAKVY+AR+I+T +SVA+KVIDK K+ +VGL DQIKR
Sbjct: 1 MDKNG-IVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKR 59
Query: 64 EISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI 123
EISVMR+VRHP++V L+EVMA+K+KI+F MEY KGGELF+KV+KGKLKE+ AR+YFQQLI
Sbjct: 60 EISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLI 119
Query: 124 NAVDFCHSRGVYHRDIKPXXXXXXXXXXXKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
A+D+CHSRGVYHRD+KP KISDFGLSAL + K QDGLLHTTCGTPAYVA
Sbjct: 120 GAIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVA 179
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV 243
PEVI +KGYDG K D+WSCGVVL+VLLAG+LPFH+ NL+EMYRKI K EFKCPNWFPPEV
Sbjct: 180 PEVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEV 239
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSS 303
+KLL +ILDPNP++RI + KI E+SWF+KG + + K ES S + A
Sbjct: 240 KKLLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHA------ 293
Query: 304 IAAEIKQELGQLPNLNAFDIIS-LSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEE 362
A +K + NAFD+IS LS GFDLSG F++ E++FT+K+ A I+SK EE
Sbjct: 294 -AFSVKPM-----SYNAFDLISSLSQGFDLSGLFEKEER-SESKFTTKKDAKEIVSKFEE 346
Query: 363 IAKSXXXXXXXXXXXXXXXXXXXXXXXXIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKK 422
IA S +++D EIF++T +FH+VE KKS GDT+EYK+
Sbjct: 347 IATSSERFNLTKSDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQ 406
Query: 423 LLKDDIRPALQDIVWVW 439
++RP+L+DIVW W
Sbjct: 407 FCDRELRPSLKDIVWKW 423
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1275 (453.9 bits), Expect = 5.7e-130, P = 5.7e-130
Identities = 252/432 (58%), Positives = 314/432 (72%)
Query: 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV 67
K SVL +YEVG+ LGQG FAKVY+AR ++T SVA+KVIDK++I++VG+ +QIKREIS
Sbjct: 4 KGSVLMLRYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKREISA 63
Query: 68 MRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVD 127
MR++RHPNIV+L+EVMATKSKI+FVME+ KGGELFNKV+ GKL+ED AR+YFQQL+ AVD
Sbjct: 64 MRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNKVSTGKLREDVARKYFQQLVRAVD 123
Query: 128 FCHSRGVYHRDIKPXXXXXXXXXXXKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
FCHSRGV HRD+KP KISDFGLSAL+ + QDGLLHTTCGTPAYVAPEVI
Sbjct: 124 FCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAPEVI 183
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLL 247
+R GYDG K D+WSCGV+LFVLLAGYLPF DSNL+E+Y+KIGKAE K PNW P ++LL
Sbjct: 184 SRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAKRLL 243
Query: 248 CKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAAE 307
+ILDPNP+TR+S KI +SSWFRKG+ ++ K+ V E + DA A +G++S E
Sbjct: 244 KRILDPNPNTRVSTEKIMKSSWFRKGLQEEVKESVEEETEV---DAEA---EGNASAEKE 297
Query: 308 IKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAKSX 367
K+ + NLNAF+IISLS GFDLSG F++ E RFTS R AS I KL EI K
Sbjct: 298 KKRCI----NLNAFEIISLSTGFDLSGLFEKGEEKEEMRFTSNREASEITEKLVEIGKDL 353
Query: 368 XXXXXXXXXXXXXXXXXXXXXXXIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKDD 427
++AE+F+I P++H+V +KKS GDT EYK+++K+
Sbjct: 354 KMKVRKKEHEWRVKMSAEATV-----VEAEVFEIAPSYHMVVLKKSGGDTAEYKRVMKES 408
Query: 428 IRPALQDIVWVW 439
IRPAL D V W
Sbjct: 409 IRPALIDFVLAW 420
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1163 (414.5 bits), Expect = 4.2e-118, P = 4.2e-118
Identities = 228/429 (53%), Positives = 296/429 (68%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
+L +YE+GRLLG G FAKVY+AR+I+T +SVA+KV+ K+K+++VG+ DQIKREISVMR+
Sbjct: 19 LLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRM 78
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH 130
V+HPNIV+L+EVMA+KSKI+F ME +GGELF KVAKG+L+ED AR YFQQLI+AVDFCH
Sbjct: 79 VKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFCH 138
Query: 131 SRGVYHRDIKPXXXXXXXXXXXKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
SRGVYHRD+KP K++DFGLSA + QDGLLHTTCGTPAYVAPEVI +K
Sbjct: 139 SRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKK 198
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250
GYDG K D+WSCGV+LFVLLAGYLPF D NL+ MYRKI + +FKCP W + R+L+ K+
Sbjct: 199 GYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKL 258
Query: 251 LDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAAEIKQ 310
LDPNP+TRI++ K+ +S WF+K + + + V + +D + + K+
Sbjct: 259 LDPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDV--------DFLVHKSKE 310
Query: 311 ELGQLPNLNAFDIISLSAGFDLSGFFDENPLI--REARFTSKRPASVIISKLEEIAKSXX 368
E LNAF II+LS GFDLS F+E RE RF + RPAS +IS LEE A+
Sbjct: 311 ET---ETLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAARVGN 367
Query: 369 XXXXXXXXXXXXXXXXXXXXXXIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKDDI 428
++++AEIF + P+F +VE+KK +GDTLEY +
Sbjct: 368 KFDVRKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTAL 427
Query: 429 RPALQDIVW 437
RPAL+DI W
Sbjct: 428 RPALKDIFW 436
|
|
| TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1136 (405.0 bits), Expect = 3.1e-115, P = 3.1e-115
Identities = 230/446 (51%), Positives = 304/446 (68%)
Query: 5 DHNKPSVLT-EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR 63
+ + P L +YE+G+LLG G FAKVY AR+++TN+SVA+KVIDK+K+++ GL IKR
Sbjct: 14 ERSSPQALILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKR 73
Query: 64 EISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI 123
EIS++R VRHPNIVQL+EVMATK+KI+FVMEY +GGELFNKVAKG+LKE+ AR+YFQQLI
Sbjct: 74 EISILRRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLI 133
Query: 124 NAVDFCHSRGVYHRDIKPXXXXXXXXXXXKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+AV FCH+RGVYHRD+KP K+SDFGLSA++ QDGL HT CGTPAYVA
Sbjct: 134 SAVTFCHARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 193
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV 243
PEV+ RKGYD KVDIWSCGV+LFVL+AGYLPFHD N++ MY+KI + EF+CP WF E+
Sbjct: 194 PEVLARKGYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTEL 253
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESK------DAASQDAGASA 297
+LL K+L+ NP R + +I E+SWF+KG K V + K D + +
Sbjct: 254 TRLLSKLLETNPEKRFTFPEIMENSWFKKGFKHI-KFYVEDDKLCNVVDDDELESDSVES 312
Query: 298 PQGSSSIAAEI-----KQELGQLP---NLNAFDIISLSAGFDLSGFFDENPLIREARFTS 349
+ S++ +EI ++ +G LP +LNAFDIIS S GFDLSG FD++ +RF S
Sbjct: 313 DRDSAASESEIEYLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGLFDDDG--EGSRFVS 370
Query: 350 KRPASVIISKLEEIAKSXXXXXXXXXXXXXXXXXXXXXXXXIVSMDAEIFQITPNFHLVE 409
P S IISKLEEIAK + ++ AEIF++TP+ +VE
Sbjct: 371 GAPVSKIISKLEEIAKVVSFTVRKKDCRVSLEGSRQGVKGPL-TIAAEIFELTPSLVVVE 429
Query: 410 MKKSNGDTLEYKKLLKDDIRPALQDI 435
+KK GD EY+ ++++P LQ++
Sbjct: 430 VKKKGGDKTEYEDFCNNELKPKLQNL 455
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1132 (403.5 bits), Expect = 8.2e-115, P = 8.2e-115
Identities = 224/431 (51%), Positives = 297/431 (68%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
VL KYE+GRLLG+G F KVYY + I T +SVA+K+I+KD++ R G+ +QIKREIS+MR+
Sbjct: 38 VLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIKREISIMRL 97
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH 130
VRHPNIV+L EVMATK+KIFF+MEY KGGELF+K+ KGKLKED+AR+YFQQLI+AVDFCH
Sbjct: 98 VRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIVKGKLKEDSARKYFQQLISAVDFCH 157
Query: 131 SRGVYHRDIKPXXXXXXXXXXXKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
SRGV HRD+KP K+SDFGLSAL + QDGLLHT CGTPAYVAPEV+ +K
Sbjct: 158 SRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAYVAPEVLRKK 217
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250
GYDG K DIWSCG++L+VLLAG+LPF D NL++MYRKI K+EF+ P WF PE ++L+ K+
Sbjct: 218 GYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSPESKRLISKL 277
Query: 251 LDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAAEIKQ 310
L +P+ RIS+ I + WFRK +N + K+ E + +D P +++ A
Sbjct: 278 LVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVED---ETPTTTATTATTTTT 334
Query: 311 ELGQLPNL-NAFDIIS-LSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAKSXX 368
+ P NAF+ IS +S+GFDLS F+ +R + FTS+ AS I+ KLE I K
Sbjct: 335 PVS--PKFFNAFEFISSMSSGFDLSSLFESKRKLR-SMFTSRWSASEIMGKLEGIGKEMN 391
Query: 369 XXXXXXXXXXXXXXXXXXXXXXIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKDDI 428
+++ AE+F++ P +VE+ KS GDTLEY +L ++ +
Sbjct: 392 MKVKRTKDFKVKLFGKTEGRKGQIAVTAEVFEVAPEVAVVELCKSAGDTLEYNRLYEEHV 451
Query: 429 RPALQDIVWVW 439
RPAL++IVW W
Sbjct: 452 RPALEEIVWSW 462
|
|
| UNIPROTKB|Q84XC0 Q84XC0 "Calcineurin B-like-interacting protein kinase" [Pisum sativum (taxid:3888)] | Back alignment and assigned GO terms |
|---|
Score = 933 (333.5 bits), Expect = 8.7e-115, Sum P(2) = 8.7e-115
Identities = 170/271 (62%), Positives = 219/271 (80%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
+ P++L ++E+G+LLG G FAKV+ A++I+T ++VA+K+I KDKI++ GL IKREIS
Sbjct: 17 DNPNLLLGRFELGKLLGHGTFAKVHLAKNIKTGEAVAIKIISKDKILKSGLVSHIKREIS 76
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
++R VRHPNIVQL+EVMATK+KI+FVMEY +GGELFNKVAKG+LKE+ AR+YFQQLI AV
Sbjct: 77 ILRRVRHPNIVQLFEVMATKTKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLICAV 136
Query: 127 DFCHSRGVYHRDIKPXXXXXXXXXXXKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
+FCH+RGV+HRDIKP K+SDFGLSA++ QDGL HT CGTPAYVAPEV
Sbjct: 137 EFCHARGVFHRDIKPENLLLDENGNLKVSDFGLSAVSDEIKQDGLFHTFCGTPAYVAPEV 196
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKIGKAEFKCPNWFPPEVRK 245
++RKGYDG KVDIWSCGVVLFVL+AGYLPFHD +N++ MY+KI K +F+CP WF PE+
Sbjct: 197 LSRKGYDGGKVDIWSCGVVLFVLMAGYLPFHDPNNVMVMYKKIYKGDFRCPRWFSPELVN 256
Query: 246 LLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276
LL ++LD P TRIS+ +I E+ WF+ G +
Sbjct: 257 LLTRLLDTKPQTRISIPEIMENRWFKIGFKR 287
|
|
| TAIR|locus:2152370 CIPK19 "CBL-interacting protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1120 (399.3 bits), Expect = 1.5e-113, P = 1.5e-113
Identities = 223/446 (50%), Positives = 296/446 (66%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
N +++ KYE+GRLLG G FAKVY AR+ ++ +SVA+KVIDK+K+++ GL IKREIS
Sbjct: 19 NHQALILGKYEMGRLLGHGTFAKVYLARNAQSGESVAIKVIDKEKVLKSGLIAHIKREIS 78
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
++R VRHPNIVQL+EVMATKSKI+FVMEY KGGELFNKVAKG+LKE+ AR+YFQQLI+AV
Sbjct: 79 ILRRVRHPNIVQLFEVMATKSKIYFVMEYVKGGELFNKVAKGRLKEEMARKYFQQLISAV 138
Query: 127 DFCHSRGVYHRDIKPXXXXXXXXXXXKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
FCH RGVYHRD+KP K+SDFGLSA++ QDGL HT CGTPAYVAPEV
Sbjct: 139 SFCHFRGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV 198
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
+ RKGYDG KVDIWSCGV+LFVL+AG+LPFHD N++ MY+KI + +F+CP WFP E+ +L
Sbjct: 199 LARKGYDGAKVDIWSCGVILFVLMAGFLPFHDRNVMAMYKKIYRGDFRCPRWFPVEINRL 258
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGM--------------NQKQKQKVTESKDAASQD 292
L ++L+ P R +M I E+SWF+KG N ++ + + +
Sbjct: 259 LIRMLETKPERRFTMPDIMETSWFKKGFKHIKFYVEDDHQLCNVADDDEIESIESVSGRS 318
Query: 293 AGASAPQGSSSIAAEIKQELGQLP---NLNAFDIISLSAGFDLSGFFDENPLIREARFTS 349
+ S P+ S ++ G +P +LNAFD+IS S GFDLSG F+++ +RF S
Sbjct: 319 STVSEPEDFESFDG--RRRGGSMPRPASLNAFDLISFSPGFDLSGLFEDDG--EGSRFVS 374
Query: 350 KRPASVIISKLEEIAKSXXXXXXXXXXXXXXXXXXXXXXXXIVSMDAEIFQITPNFHLVE 409
P IISKLEEIA+ +S+ AEIF++TP +VE
Sbjct: 375 GAPVGQIISKLEEIARIVSFTVRKKDCKVSLEGSREGSMKGPLSIAAEIFELTPALVVVE 434
Query: 410 MKKSNGDTLEYKKLLKDDIRPALQDI 435
+KK GD +EY + +++P LQ++
Sbjct: 435 VKKKGGDKMEYDEFCNKELKPKLQNL 460
|
|
| TAIR|locus:2029974 CIPK18 "CBL-interacting protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1101 (392.6 bits), Expect = 1.6e-111, P = 1.6e-111
Identities = 219/438 (50%), Positives = 295/438 (67%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
++L KYE+G+LLG G FAKVY A++I++ VA+KVIDK+KIM+ GL IKREIS++R
Sbjct: 68 NILMGKYELGKLLGHGTFAKVYLAQNIKSGDKVAIKVIDKEKIMKSGLVAHIKREISILR 127
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFC 129
VRHP IV L+EVMATKSKI+FVMEY GGELFN VAKG+L E+ ARRYFQQLI++V FC
Sbjct: 128 RVRHPYIVHLFEVMATKSKIYFVMEYVGGGELFNTVAKGRLPEETARRYFQQLISSVSFC 187
Query: 130 HSRGVYHRDIKPXXXXXXXXXXXKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
H RGVYHRD+KP K+SDFGLSA+A+ QDGL HT CGTPAY+APEV+ R
Sbjct: 188 HGRGVYHRDLKPENLLLDNKGNLKVSDFGLSAVAEQLRQDGLCHTFCGTPAYIAPEVLTR 247
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCK 249
KGYD K D+WSCGV+LFVL+AG++PF+D N++ MY+KI K EF+CP WF ++ +LL +
Sbjct: 248 KGYDAAKADVWSCGVILFVLMAGHIPFYDKNIMVMYKKIYKGEFRCPRWFSSDLVRLLTR 307
Query: 250 ILDPNPSTRISMAKIRESSWFRKGMNQK----QKQKVT---ESKDAASQDAGASAPQGSS 302
+LD NP TRI++ +I ++ WF+KG + K+ E ++ + +G S+ S
Sbjct: 308 LLDTNPDTRITIPEIMKNRWFKKGFKHVKFYIEDDKLCREDEDEEEEASSSGRSSTVSES 367
Query: 303 SIAAEIKQE-LGQLP---NLNAFDIISLSAGFDLSGFFDENPLIREARFTSKRPASVIIS 358
++K+ +G +P +LNAFDIIS S+GFDLSG F+E RF S P S IIS
Sbjct: 368 DAEFDVKRMGIGSMPRPSSLNAFDIISFSSGFDLSGLFEEEGG-EGTRFVSGAPVSKIIS 426
Query: 359 KLEEIAKSXXXXXXXXXXXXXXXXXXXXXXXXIVSMDAEIFQITPNFHLVEMKKSNGDTL 418
KLEEIAK + ++ AEIF++TP+ +VE+KK GD
Sbjct: 427 KLEEIAKIVSFTVRKKEWSLRLEGCREGAKGPL-TIAAEIFELTPSLVVVEVKKKGGDRE 485
Query: 419 EYKKLLKDDIRPALQDIV 436
EY++ ++RP L+ ++
Sbjct: 486 EYEEFCNKELRPELEKLI 503
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9C562 | CIPKA_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7218 | 0.9123 | 0.9123 | yes | no |
| Q7X996 | CIPK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6880 | 0.8977 | 0.9706 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CIPK14 | hypothetical protein (444 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 479 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-106 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-93 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-79 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-73 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-73 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-69 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-68 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-64 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-63 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-58 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-56 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-55 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-54 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-53 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 1e-51 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-50 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-49 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-49 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-48 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-47 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-47 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-47 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-47 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-46 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-46 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-46 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-46 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-45 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-45 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-45 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-44 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-43 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-43 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-42 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-42 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-42 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-42 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-42 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-42 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-41 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-41 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-41 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-40 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-40 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-40 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-40 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-39 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-39 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-39 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-39 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-39 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-39 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-39 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-38 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-38 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-38 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-38 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-38 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-38 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-37 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-37 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-37 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-37 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-37 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-37 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-36 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-36 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-36 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-36 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-36 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-36 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-36 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-35 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-35 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-35 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-34 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-34 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-34 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-34 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-34 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-34 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-33 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-33 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-33 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-32 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-32 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-32 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-32 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-32 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-31 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-31 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-31 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-31 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-31 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-31 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-31 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-31 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-30 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-30 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-30 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-30 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-30 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-30 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-29 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-29 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-29 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-29 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-29 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-29 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-29 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-28 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-27 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-27 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-26 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-26 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-26 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-26 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-26 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-25 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 3e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-24 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-23 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-23 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-22 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-22 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-20 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-20 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-20 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-19 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-17 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-17 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 7e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 316 bits (813), Expect = e-106
Identities = 111/260 (42%), Positives = 169/260 (65%), Gaps = 11/260 (4%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
YE+ LG+G+F KVY AR +T + VA+KVI K KI ++I REI +++ ++HPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
IV+LY+V + K++ VMEY +GG+LF+ +G+L ED AR Y +Q+++A+++ HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDG 194
HRD+KPEN+LLDE+ ++K++DFGL+ L T GTP Y+APEV+ KGY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 195 EKVDIWSCGVVLFVLLAGYLPF-HDSNLIEMYRKIGKAEFKCPNW---FPPEVRKLLCKI 250
VDIWS GV+L+ LL G PF D L+E+++KIGK + P PE + L+ K+
Sbjct: 176 -AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 251 LDPNPSTRISMAKIRESSWF 270
L +P R++ + + +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 281 bits (722), Expect = 7e-93
Identities = 98/263 (37%), Positives = 147/263 (55%), Gaps = 11/263 (4%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
YE+ R LG G+F VY A+ T + VAVK++ K +REI ++R + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKS-KKDQTARREIRILRRLSHPN 59
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
IV+L + K ++ VMEY +GG+LF+ G L ED A++ Q++ +++ HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDG 194
HRD+KPEN+LLDEN +KI+DFGL+ L T GTP Y+APEV+ G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 195 EKVDIWSCGVVLFVLLAGYLPF---HDSNLIEMYRKIGKAEFKCPNWF----PPEVRKLL 247
KVD+WS GV+L+ LL G PF + + +++ R+I + E + L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 248 CKILDPNPSTRISMAKIRESSWF 270
K L+ +PS R + +I + WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 1e-79
Identities = 95/253 (37%), Positives = 155/253 (61%), Gaps = 7/253 (2%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG+G+F KV R T + A+KV+ K KI++ + E +++ + HP IV+L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIK 140
T+ K++ V+EYA GGELF+ ++K G+ E+ AR Y +++ A+++ HS G+ +RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 141 PENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIW 200
PEN+LLD + ++K++DFGL+ + +T CGTP Y+APEV+ KGY G+ VD W
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 201 SCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRI- 259
S GV+L+ +L G PF+ + E+Y KI K + P + PE R L+ +L +P+ R+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 260 --SMAKIRESSWF 270
+I+ +F
Sbjct: 238 SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 2e-73
Identities = 94/249 (37%), Positives = 138/249 (55%), Gaps = 38/249 (15%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG+G F VY AR +T + VA+K+I K+ L +++ REI +++ + HPNIV+LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYG 58
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDI 139
V ++ ++ VMEY +GG L + + + GKL ED R Q++ +++ HS G+ HRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 140 KPENLLLDENE-NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVD 198
KPEN+LLD + +K++DFGLS LL T GTPAY+APEV+ KGY EK D
Sbjct: 119 KPENILLDSDNGKVKLADFGLS--KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 199 IWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTR 258
IWS GV+L+ L PE++ L+ K+L +P R
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 259 ISMAKIRES 267
S +I E
Sbjct: 206 PSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 5e-73
Identities = 96/262 (36%), Positives = 156/262 (59%), Gaps = 12/262 (4%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+E + LG G+F +V R + + A+K++ K KI+++ + + E +++ +RHP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGV 134
+V LY S ++ VMEY GGELF+ + K G+ E AR Y Q++ A+++ HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDG 194
+RD+KPENLLLD + +KI+DFG K G +T CGTP Y+APE+I KGY G
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGF-----AKRVKGRTYTLCGTPEYLAPEIILSKGY-G 176
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
+ VD W+ G++++ +LAGY PF D N I++Y KI + + + P++F P+ + L+ +L +
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 255 PSTRISMAK-----IRESSWFR 271
+ R+ K I+ WF
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 220 bits (564), Expect = 7e-69
Identities = 87/279 (31%), Positives = 156/279 (55%), Gaps = 25/279 (8%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHP 74
++ G+++G+G+F+ V A+ TN+ A+K++DK ++++ +K E V+ R+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRG 133
I++LY + ++FV+EYA GEL + K G L E R Y +++ A+++ HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSAL-------AQCKHQDGLLHTT----------- 175
+ HRD+KPEN+LLD++ ++KI+DFG + + K + +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC 235
GT YV+PE++N K G+ D+W+ G +++ +L G PF SN ++KI K E+
Sbjct: 183 VGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 236 PNWFPPEVRKLLCKILDPNPSTRI----SMAKIRESSWF 270
P FPP+ + L+ K+L +P R+ +++ +F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 6e-68
Identities = 93/256 (36%), Positives = 139/256 (54%), Gaps = 10/256 (3%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
KYE+ + +G+G+F KVY R + +K ID M + E+ +++ + HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHP 59
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK-----LKEDAARRYFQQLINAVDFC 129
NI++ YE K K+ VMEYA GG+L K+ K K E+ +F QL A+ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
HSR + HRDIKP+N+ L N +K+ DFG+S + L T GTP Y++PE+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STVDLAKTVVGTPYYLSPELCQN 177
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-CPNWFPPEVRKLLC 248
K Y+ K DIWS G VL+ L PF NL+E+ KI K ++ P+ + E+R L+
Sbjct: 178 KPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236
Query: 249 KILDPNPSTRISMAKI 264
+L +P R S+A+I
Sbjct: 237 SLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 5e-64
Identities = 90/254 (35%), Positives = 139/254 (54%), Gaps = 10/254 (3%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
+ +GA+ +V+ A+ T A+KVI K ++R DQ+ E ++ + P +V+LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIK 140
K ++ VMEY GG+L + + G L ED AR Y +++ A+++ HS G+ HRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 141 PENLLLDENENLKISDFGLSALA----QCKHQDGLLHT--TCGTPAYVAPEVINRKGYDG 194
P+N+L+D N +LK++DFGLS + Q D GTP Y+APEVI +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFPPEVRKLLCKILD 252
+ VD WS G +L+ L G PFH E+++ I GK E+ E L+ K+L
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 253 PNPSTRISMAKIRE 266
P+P R+ I E
Sbjct: 240 PDPEKRLGAKSIEE 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 3e-63
Identities = 79/264 (29%), Positives = 132/264 (50%), Gaps = 12/264 (4%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
++ G LLG+G+F VY A T + +AVK ++ + ++REI ++ ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG-DSEEELEALEREIRILSSLQHP 59
Query: 75 NIVQLYEVMATKSKIFF--VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS 131
NIV+ Y + K +EY GG L + + K GKL E R+Y +Q++ + + HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
G+ HRDIK N+L+D + +K++DFG + + GTP ++APEVI +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSN--LIEMYRKIGKAEFKCPN---WFPPEVRKL 246
Y G DIWS G + + G P+ + + +Y KIG + + P E +
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-KIGSSG-EPPEIPEHLSEEAKDF 236
Query: 247 LCKILDPNPSTRISMAKIRESSWF 270
L K L +P R + ++ + +
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 193 bits (494), Expect = 1e-58
Identities = 96/261 (36%), Positives = 141/261 (54%), Gaps = 18/261 (6%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG G F +V + N++ A+K + K I+ G + I E ++ HP IV+LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 82 VMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIK 140
K I+ +MEY GGEL+ + +G E AR Y ++ A ++ H+RG+ +RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 141 PENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIW 200
PENLLLD N +K+ DFG + + + T CGTP YVAPE+I KGYD VD W
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKT---WTFCGTPEYVAPEIILNKGYD-FSVDYW 176
Query: 201 SCGVVLFVLLAGYLPFHDSNL--IEMYRKI----GKAEFKCPNWFPPEVRKLLCKILDPN 254
S G++L+ LL G PF + + +E+Y I GK EF PN+ + L+ ++L N
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRN 234
Query: 255 PSTRISMAK-----IRESSWF 270
P R+ K I++ WF
Sbjct: 235 PEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-56
Identities = 84/251 (33%), Positives = 124/251 (49%), Gaps = 16/251 (6%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVID--KDKIMRVGLADQIKREISVMRIVR 72
+E+ +G+G F +VY AR RT + VA+KVI + +I EI +++ +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE-----KIINEIQILKKCK 55
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCH 130
HPNIV+ Y K +++ VME+ GG L + K L E ++L+ +++ H
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
S G+ HRDIK N+LL + +K+ DFGLSA +T GTP ++APEVIN K
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKIGKAEFKCPNWFPPEVRKLL 247
YD K DIWS G+ L G P+ + + G + P + E + L
Sbjct: 173 PYDY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFL 231
Query: 248 CKILDPNPSTR 258
K L NP R
Sbjct: 232 KKCLQKNPEKR 242
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 5e-55
Identities = 89/249 (35%), Positives = 144/249 (57%), Gaps = 7/249 (2%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+E+G LG G+F +V A+ T + A+K + K +I+++ + +E S++ + HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGV 134
IV + +++++F++E+ GGELF + K G+ D A+ Y +L+ A ++ HS+ +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDG 194
+RD+KPENLLLD ++K++DFG + K T CGTP Y+APEVI KG+ G
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFA-----KKVPDRTFTLCGTPEYLAPEVIQSKGH-G 193
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
+ VD W+ GV+L+ +AGY PF D +Y KI K PNWF R L+ +L +
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTD 253
Query: 255 PSTRISMAK 263
+ R+ K
Sbjct: 254 HTKRLGTLK 262
|
Length = 329 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 2e-54
Identities = 86/263 (32%), Positives = 140/263 (53%), Gaps = 17/263 (6%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
YEV +G+G+F V R + + K ID M Q+ E++++R ++HP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHP 59
Query: 75 NIVQLY--EVMATKSKIFFVMEYAKGGELFNKVAKGK-----LKEDAARRYFQQLINAVD 127
NIV+ Y + + ++ VMEY +GG+L + K K ++E+ R QL+ A+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 128 FCHSRG-----VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV 182
CH+R V HRD+KP N+ LD N N+K+ DFGL+ + H T GTP Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG--HDSSFAKTYVGTPYYM 177
Query: 183 APEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC-PNWFPP 241
+PE +N YD EK DIWS G +++ L A PF N +++ KI + +F+ P +
Sbjct: 178 SPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236
Query: 242 EVRKLLCKILDPNPSTRISMAKI 264
E+ +++ +L+ +P R S ++
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 1e-53
Identities = 91/282 (32%), Positives = 134/282 (47%), Gaps = 28/282 (9%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
Y + R LG+G+F +VY AR + VA+KV+ K + ++ REI ++ + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 75 -NIVQLYEVMATKSKIFFVMEYAKGGELF----NKVAKGKLKEDAARRYFQQLINAVDFC 129
NIV+LY+ + ++ VMEY GG L KG L E A Q+++A+++
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 130 HSRGVYHRDIKPENLLLDENEN-LKISDFGLSALA----QCKHQDGLLHTTCGTPAYVAP 184
HS+G+ HRDIKPEN+LLD + +K+ DFGL+ L L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 185 EVI--NRKGYDGEKVDIWSCGVVLFVLLAGYLPFH----DSNLIEMYRKIGKAEFKC--- 235
EV+ Y DIWS G+ L+ LL G PF S + + I +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 236 ------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFR 271
P LL K+L +P R+S +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-51
Identities = 64/116 (55%), Positives = 84/116 (72%), Gaps = 1/116 (0%)
Query: 319 NAFDIISLSAGFDLSGFFDENPLI-REARFTSKRPASVIISKLEEIAKSLRLKMMKKDGG 377
NAFD+ISLS+G DLSG F+E + RE RFTS++PA II KLEE AK L ++ KK G
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 378 LLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKDDIRPALQ 433
+K EG K GRKG +++ E+F++TP+ +VE+KKS GDTLEY K KD +RP L+
Sbjct: 61 GVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 3e-50
Identities = 83/267 (31%), Positives = 144/267 (53%), Gaps = 16/267 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ E + +G G F +V+ R + A+KV+ +++R+ + E V++ V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCHSR 132
P I++L+ + ++ +MEY GGELF+ + G+ Y +++ A+++ HS+
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
+ +RD+KPEN+LLD+ ++K++DFG + K T CGTP Y+APEVI KG+
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFA-----KKLRDRTWTLCGTPEYLAPEVIQSKGH 175
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFPPEVRKLLCKI 250
+ VD W+ G++++ +L GY PF D N +Y KI GK EF P + L+ K+
Sbjct: 176 -NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF--PRHLDLYAKDLIKKL 232
Query: 251 LDPNPSTRISMAK-----IRESSWFRK 272
L + + R+ K ++ WF+
Sbjct: 233 LVVDRTRRLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-49
Identities = 79/254 (31%), Positives = 131/254 (51%), Gaps = 14/254 (5%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVID-KDKIMRVGLADQIKREISVMRIV 71
E Y+ +G+GA +VY A T + VA+K + + + + I EI +M+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL-----IINEILIMKDC 72
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVA--KGKLKEDAARRYFQQLINAVDFC 129
+HPNIV Y+ +++ VMEY GG L + + ++ E ++++ +++
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
HS+ V HRDIK +N+LL ++ ++K++DFG + AQ + ++ GTP ++APEVI R
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFA--AQLTKEKSKRNSVVGTPYWMAPEVIKR 190
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLP-FHDSNLIEMY--RKIGKAEFKCPNWFPPEVRKL 246
K Y KVDIWS G++ + G P + L ++ G K P + PE +
Sbjct: 191 KDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249
Query: 247 LCKILDPNPSTRIS 260
L K L +P R S
Sbjct: 250 LNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 78/261 (29%), Positives = 141/261 (54%), Gaps = 10/261 (3%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+E+ R++G+GAF KV + T + A+K ++K K + G + E +++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
+V L+ + ++ V++ GG+L ++ K K E+ + + +++ A+++ HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDG 194
HRDIKP+N+LLDE ++ I+DF ++ D L +T GTP Y+APEV+ R+GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATK---VTPDTLTTSTSGTPGYMAPEVLCRQGYSV 178
Query: 195 EKVDIWSCGVVLFVLLAGYLPF--HDSNLIEMYR-KIGKAEFKCPNWFPPEVRKLLCKIL 251
VD WS GV + L G P+ H + + R K A+ P + E + K+L
Sbjct: 179 A-VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 252 DPNPSTRIS--MAKIRESSWF 270
+ +P R+ + ++ +F
Sbjct: 238 ERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 8e-48
Identities = 94/264 (35%), Positives = 149/264 (56%), Gaps = 20/264 (7%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQ 78
++LG+G+F KV A T++ AVKV+ KD I++ + E V+ + +HP + Q
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 79 LYEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ TK ++FFVMEY GG+L F+ G+ E AR Y +++ + F H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH-----TTCGTPAYVAPEVINRKGY 192
D+K +N+LLD ++KI+DFG+ CK +G+L T CGTP Y+APE+++ + Y
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGM-----CK--EGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
G VD W+ GV+L+ +LAG PF + E+++ I + E + P W E + +L L
Sbjct: 174 -GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLT 232
Query: 253 PNPSTRI-----SMAKIRESSWFR 271
NP R+ I+ +FR
Sbjct: 233 KNPEKRLGCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 87/258 (33%), Positives = 135/258 (52%), Gaps = 18/258 (6%)
Query: 24 QGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH-PNIVQLYEV 82
+GAF VY A+ T A+KV+ K ++ +K E ++M I P + +LY
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 83 MATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKP 141
+K ++ VMEY GG+ + + G L ED A++Y +++ V+ H RG+ HRDIKP
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKP 125
Query: 142 ENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPAYVAPEVINRKGYDGEKVDIW 200
ENLL+D+ +LK++DFGLS ++GL + GTP Y+APE I G D + D W
Sbjct: 126 ENLLIDQTGHLKLTDFGLS-------RNGLENKKFVGTPDYLAPETILGVG-DDKMSDWW 177
Query: 201 SCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPPEVRKLLCKILDPNPS 256
S G V+F L GY PFH ++ I P + PE L+ ++L +P+
Sbjct: 178 SLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237
Query: 257 TRIS---MAKIRESSWFR 271
R+ +I+ +F+
Sbjct: 238 KRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 83/262 (31%), Positives = 129/262 (49%), Gaps = 14/262 (5%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQ 78
G +G G F KVY A ++ T + +AVK I +I E+ V+ +++HPN+V+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHR 137
Y V + K++ MEY GG L + G+ L E R Y QL+ + + HS G+ HR
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQD---GLLHTTCGTPAYVAPEVINRKGYDG 194
DIKP N+ LD N +K+ DFG A+ + + + GTPAY+APEVI G
Sbjct: 124 DIKPANIFLDHNGVIKLGDFG-CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 195 E--KVDIWSCGVVLFVLLAGYLPFH--DSNLIEMYRKIG---KAEFKCPNWFPPEVRKLL 247
DIWS G V+ + G P+ D+ M+ +G K PE + L
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-HVGAGHKPPIPDSLQLSPEGKDFL 241
Query: 248 CKILDPNPSTRISMAKIRESSW 269
+ L+ +P R + +++ + +
Sbjct: 242 DRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-47
Identities = 78/258 (30%), Positives = 133/258 (51%), Gaps = 6/258 (2%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
Y++G L+G+GAF VY ++ T VA+K I +KI L I +EI +++ ++HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRG 133
NIV+ + T ++ ++EYA+ G L + K G E Y Q++ + + H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD 193
V HRDIK N+L ++ +K++DFG++ + + GTP ++APEVI G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 194 GEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
DIWS G + LL G P++D N + ++R + P PE++ L +
Sbjct: 178 -TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236
Query: 253 PNPSTRISMAKIRESSWF 270
+P+ R + ++ + W
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-47
Identities = 96/266 (36%), Positives = 150/266 (56%), Gaps = 21/266 (7%)
Query: 20 RLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIMRVGLAD--QIKREISVMRIVRHP 74
++LG+G + KV+ R + T + A+KV+ K I+R D K E +++ V+HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVKHP 60
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRG 133
IV L T K++ ++EY GGELF + + G ED A Y ++ A++ H +G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRK 190
+ +RD+KPEN+LLD ++K++DFGL CK H+ + HT CGT Y+APE++ R
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGL-----CKESIHEGTVTHTFCGTIEYMAPEILMRS 175
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250
G+ G+ VD WS G +++ +L G PF N + KI K + P + PE R LL K+
Sbjct: 176 GH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKL 234
Query: 251 LDPNPSTRI-----SMAKIRESSWFR 271
L NPS+R+ A+++ +FR
Sbjct: 235 LKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-47
Identities = 89/292 (30%), Positives = 142/292 (48%), Gaps = 35/292 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ +EV +++G+GAF +V+ R T Q A+KV+ K +++ ++ E ++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSR 132
P IV+LY + ++ VMEY GG+L N + K E+ AR Y +L+ A+D H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL-------------------- 172
G HRDIKP+N+L+D + ++K++DFGL
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 173 -------HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMY 225
++T GTP Y+APEV+ Y E D WS GV+L+ +L G+ PF+ L E Y
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 226 RKI--GKAEFKCP--NWFPPEVRKLLCKILDPNPSTRISMAK-IRESSWFRK 272
KI K + P PE L+C++L P R+ + I+ +F+
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 1e-46
Identities = 88/244 (36%), Positives = 145/244 (59%), Gaps = 8/244 (3%)
Query: 20 RLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
++LGQG+F KV+ R I Q A+KV+ K ++V + K E ++ V HP I
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKK-ATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKL-KEDAARRYFQQLINAVDFCHSRGVY 135
V+L+ T+ K++ ++++ +GG+LF +++K + E+ + Y +L A+D HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGE 195
+RD+KPEN+LLDE ++K++DFGLS + + ++ CGT Y+APEV+NR+G+ +
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-Q 177
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNP 255
D WS GV++F +L G LPF + E I KA+ P + PE + LL + NP
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237
Query: 256 STRI 259
+ R+
Sbjct: 238 ANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 1e-46
Identities = 107/328 (32%), Positives = 164/328 (50%), Gaps = 34/328 (10%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
+LLG+G F KV R T + A+K++ K+ I+ E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAKGKL-KEDAARRYFQQLINAVDFCHSRGVYHRD 138
T ++ FVMEYA GGELF +++ ++ E+ AR Y ++++A+++ HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKH---QDGLLHTTCGTPAYVAPEVINRKGYDGE 195
IK ENL+LD++ ++KI+DFGL CK + T CGTP Y+APEV+ Y G
Sbjct: 121 IKLENLMLDKDGHIKITDFGL-----CKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 174
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNP 255
VD W GVV++ ++ G LPF++ + ++ I E + P PE + LL +L +P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234
Query: 256 STRI----SMAKIRESSWFRKGMN-----QKQ-----KQKVTESKDA-------ASQDAG 294
R+ S AK F +N QK+ K +VT D +Q
Sbjct: 235 KQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSIT 294
Query: 295 ASAPQGSSSIAAEIKQELGQLPNLNAFD 322
+ P S+ EL Q + F
Sbjct: 295 ITPPDRYDSLGLL---ELDQRTHFPQFS 319
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 90/244 (36%), Positives = 138/244 (56%), Gaps = 10/244 (4%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
+LLG+G F KV R T + A+K++ K+ I+ E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
T ++ FVMEYA GGELF +++ ED AR Y ++++A+ + HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKH--QDG-LLHTTCGTPAYVAPEVINRKGYDGE 195
+K ENL+LD++ ++KI+DFGL CK DG + T CGTP Y+APEV+ Y G
Sbjct: 121 LKLENLMLDKDGHIKITDFGL-----CKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 174
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNP 255
VD W GVV++ ++ G LPF++ + +++ I E + P PE + LL +L +P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234
Query: 256 STRI 259
R+
Sbjct: 235 KQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 7e-46
Identities = 90/258 (34%), Positives = 145/258 (56%), Gaps = 12/258 (4%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQ 78
++LG+G+F KV A TN+ A+K + KD ++ + E V+ + HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 79 LYEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ TK +FFVMEY GG+L F+ + G+ E AR Y ++I + F H +G+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQ---DGLLHTTCGTPAYVAPEVINRKGYDG 194
D+K +N+LLD++ ++KI+DFG+ CK +G T CGTP Y+APE++ + Y+
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGM-----CKENMNGEGKASTFCGTPDYIAPEILKGQKYN- 174
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
E VD WS GV+L+ +L G PFH + E++ I P W E + L K+ + +
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD 234
Query: 255 PSTRISMA-KIRESSWFR 271
P+ R+ + IR+ +FR
Sbjct: 235 PTKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 2e-45
Identities = 85/245 (34%), Positives = 136/245 (55%), Gaps = 11/245 (4%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQ 78
R+LG+G+F KV AR + + AVKV+ KD I++ + E ++ + R HP + Q
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHR 137
LY T ++FFVME+ GG+L + K + E AR Y ++ +A+ F H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQ--DGLLHTT-CGTPAYVAPEVINRKGYDG 194
D+K +N+LLD + K++DFG+ CK +G +T CGTP Y+APE++ Y G
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM-----CKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-G 174
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
VD W+ GV+L+ +L G+ PF N +++ I E P W + +L + N
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKN 234
Query: 255 PSTRI 259
P+ R+
Sbjct: 235 PTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 22/264 (8%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR-----EISVMRI 70
++V + LG+G++ VY + + NQ A+K +D +G Q +R EI ++
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD------LGSMSQKEREDAVNEIRILAS 55
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK-----LKEDAARRYFQQLINA 125
V HPNI+ E +K+ VMEYA G+L ++K K + E R F QL+
Sbjct: 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
+ H + + HRD+K N+LL N+ +KI D G+S + + + T GTP Y+APE
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPE 171
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEVR 244
V + Y K DIWS G +L+ + PF ++ ++ K+ + ++ P + +++
Sbjct: 172 VWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230
Query: 245 KLLCKILDPNPSTRISMAKIRESS 268
+ +L P R + KI S
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 87/294 (29%), Positives = 133/294 (45%), Gaps = 46/294 (15%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
YE +G+G + +VY AR+ +T + VA+K I + + G REI +++ +RHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPN 59
Query: 76 IVQLYEVMATKSK--IFFVMEYAK---GGELFNKVAKGKLKEDAARRYFQQLINAVDFCH 130
IV+L E++ +K K I+ V EY G L + + K E + Y +QL+ + + H
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLH 117
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI-NR 189
S G+ HRDIK N+L++ + LK++DFGL A K T Y PE++
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRPPELLLGA 176
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------------ 231
Y G +VD+WS G +L L G F S +E KI +
Sbjct: 177 TRY-GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235
Query: 232 ---------------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270
FK + P LL K+L +P RIS + + +F
Sbjct: 236 ENLKPKKPYKRRLREFFK--HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 6e-45
Identities = 89/308 (28%), Positives = 140/308 (45%), Gaps = 79/308 (25%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI--DKDKIMRVGLADQIK----REISVMR 69
YE LG+G + VY AR +T + VA+K I D ++ + I REIS+++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-------EGIPSTALREISLLK 53
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYA----KGGELFNKVAKGKLKEDAARRYFQQLINA 125
++HPNIV+L +V+ T+ K++ V EY K + G L + + QL+
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKK---YLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA----- 180
+ +CHS + HRD+KP+N+L++ + LK++DFGL+ G P
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-------------RAFGIPLRTYTH 157
Query: 181 ------YVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFH-DSN---LIEMYRKIG 229
Y APE++ K Y VDIWS G + ++ G F DS L ++++ +G
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG 216
Query: 230 ----------------KAEFKCPNW--------FP---PEVRKLLCKILDPNPSTRISMA 262
K F P + P PE LL K+L NP+ RIS
Sbjct: 217 TPTEESWPGVTKLPDYKPTF--PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK 274
Query: 263 KIRESSWF 270
+ + +F
Sbjct: 275 EALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 7e-44
Identities = 88/275 (32%), Positives = 148/275 (53%), Gaps = 18/275 (6%)
Query: 16 YEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIM-RVGLADQIKREISVMRIV 71
+E+ R+LG GA+ KV+ R + + A+KV+ K I+ + A+ + E V+ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 72 RH-PNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFC 129
R P +V L+ T +K+ +++Y GGELF + + E R Y +++ A+D
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
H G+ +RDIK EN+LLD ++ ++DFGLS + ++ ++ CGT Y+APEVI
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRG 180
Query: 190 K--GYDGEKVDIWSCGVVLFVLLAGYLPF----HDSNLIEMYRKIGKAEFKCPNWFPPEV 243
G+D + VD WS GV+ F LL G PF ++ E+ R+I K++ P E
Sbjct: 181 GSGGHD-KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239
Query: 244 RKLLCKILDPNPSTRI---SMAKIRESSWFRKGMN 275
R + K+L+ +P R+ +I+ +F +G++
Sbjct: 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFF-QGID 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 85/239 (35%), Positives = 132/239 (55%), Gaps = 4/239 (1%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
+G+G+F KV R T + A+K I K I+ E +V+ V P IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIK 140
+ K++ V+ + GGELF+ + + G+ AR Y +L+ A++ H V +RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 141 PENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIW 200
PEN+LLD ++ + DFGL L D +T CGTP Y+APE++ GY + VD W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 201 SCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRI 259
+ GV+L+ +L G PF+D N+ EMYRKI + + P+ F + + LL +L +P+ R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 3e-43
Identities = 90/245 (36%), Positives = 143/245 (58%), Gaps = 11/245 (4%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
+LLG+G F KV + T + A+K++ K+ I+ E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAKGKL-KEDAARRYFQQLINAVDFCHS-RGVYHR 137
T ++ FVMEYA GGELF +++ ++ ED AR Y ++++A+D+ HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKH--QDG-LLHTTCGTPAYVAPEVINRKGYDG 194
D+K ENL+LD++ ++KI+DFGL CK +DG + T CGTP Y+APEV+ Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGL-----CKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-G 174
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
VD W GVV++ ++ G LPF++ + +++ I E + P PE + LL +L +
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKD 234
Query: 255 PSTRI 259
P R+
Sbjct: 235 PKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 84/270 (31%), Positives = 127/270 (47%), Gaps = 26/270 (9%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVI--DKDKIMRVGLADQIKREISVMRIVRHP 74
E ++LGQG+ VY R T + A+K I D D+ R Q+ RE+ +R P
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR----KQLLRELKTLRSCESP 59
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS-R 132
+V+ Y + +I V+EY GG L + + K GK+ E +Q++ +D+ H+ R
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSA-----LAQCKHQDGLLHTTCGTPAYVAPEVI 187
+ HRDIKP NLL++ +KI+DFG+S L QC +T GT Y++PE I
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-------NTFVGTVTYMSPERI 172
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKI--GKAEFKCPNWFPPE 242
+ DIWS G+ L G PF E+ + I G F PE
Sbjct: 173 QGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE 231
Query: 243 VRKLLCKILDPNPSTRISMAKIRESSWFRK 272
R + L +P R S A++ + + +K
Sbjct: 232 FRDFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 18/259 (6%)
Query: 19 GRLLGQGAFAKVYYARSIRTN----QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
G+ LG+GAF +VY + VAVK + +D + + RE +MR + HP
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEE-FLREARIMRKLDHP 61
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
N+V+L V + ++ VMEY +GG+L + + + KL + Q+ +++ S+
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV---APEVINR 189
HRD+ N L+ EN +KISDFGLS D + G + APE +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLS----RDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 190 KGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEVRKLL 247
+ K D+WS GV+L+ + G P+ + E+ + P PPE+ L+
Sbjct: 178 GKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLM 236
Query: 248 CKILDPNPSTRISMAKIRE 266
+ +P R + +++ E
Sbjct: 237 LQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 82/263 (31%), Positives = 133/263 (50%), Gaps = 21/263 (7%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
+GQG + +V+ A+ T + VA+K + K + ++ + E ++ + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 82 VMATKSKIFFVMEYAKGGE---LFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
++ MEY GG+ L N G L ED AR Y ++ AVD H G HRD
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVD 198
+KPEN L+D + ++K++DFGLS ++ G+P Y+APEV+ KGYD VD
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIV-----TYANSVVGSPDYMAPEVLRGKGYDFT-VD 180
Query: 199 IWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG--KAEFKCPNWFPP------EVRKLLCKI 250
WS G +L+ L G+ PF S E + + K + P + P E L+ K+
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL 240
Query: 251 LDPNPSTRI-SMAKIRESSWFRK 272
++ +PS R S+ I+ +F++
Sbjct: 241 IN-DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 85/261 (32%), Positives = 136/261 (52%), Gaps = 15/261 (5%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
+++G+G+F KV A+ + AVKV+ K I++ I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T K++FV++Y GGELF + + + E AR Y ++ +A+ + HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKH---QDGLLHTTCGTPAYVAPEVINRKGYDG 194
D+KPEN+LLD ++ ++DFGL CK T CGTP Y+APEV+ ++ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL-----CKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD- 174
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
VD W G VL+ +L G PF+ + EMY I + R LL +L +
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234
Query: 255 PSTRISMAK----IRESSWFR 271
+ R+ I+ +F
Sbjct: 235 RTKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 6e-42
Identities = 86/313 (27%), Positives = 138/313 (44%), Gaps = 68/313 (21%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ +E +++G+GAF +V + T A+K + K +++ ++ E ++ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSR 132
P +V+LY ++ ++ +MEY GG++ + K E+ R Y + I A+D H
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKH------------------------- 167
G HRDIKP+NLLLD ++K+SDFGL + H
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 168 QDGLLHT-----------TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF 216
T T GTP Y+APEV + GY ++ D WS GV+++ +L GY PF
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239
Query: 217 HDSNLIEMYRKIGKAEFKCPNW-----FPPEV----------RKLLCKILDPNPSTRI-- 259
N E YRKI NW FP EV ++L C R+
Sbjct: 240 CSDNPQETYRKI-------INWKETLQFPDEVPLSPEAKDLIKRLCC-----EAERRLGN 287
Query: 260 -SMAKIRESSWFR 271
+ +I+ +F+
Sbjct: 288 NGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 6e-42
Identities = 84/244 (34%), Positives = 138/244 (56%), Gaps = 10/244 (4%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
+LLG+G F KV R + + A+K++ K+ I+ E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAKGKL-KEDAARRYFQQLINAVDFCHSRGVYHRD 138
TK ++ FVMEY GGELF +++ ++ ED R Y ++++A+D+ HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKH---QDGLLHTTCGTPAYVAPEVINRKGYDGE 195
+K ENL+LD++ ++KI+DFGL CK + T CGTP Y+APEV+ Y G
Sbjct: 121 LKLENLMLDKDGHIKITDFGL-----CKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GR 174
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNP 255
VD W GVV++ ++ G LPF++ + +++ I + K P + + LL +L +P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP 234
Query: 256 STRI 259
+ R+
Sbjct: 235 NKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 9e-42
Identities = 85/292 (29%), Positives = 142/292 (48%), Gaps = 45/292 (15%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
+LLG+G +V+ R T + A+KV+DK ++++ ++ E ++ + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 80 YEVMATKSKIFFVMEYAKGGELF---NKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYH 136
Y T++ + VM+Y GGELF + L E+ AR Y +++ A+++ H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 137 RDIKPENLLLDENENLKISDFGLSALAQC---------------KHQDGLLHTT------ 175
RD+KPEN+LL E+ ++ +SDF LS + + + T
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 176 ------CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG 229
GT Y+APEVI+ G+ VD W+ G++L+ +L G PF SN E + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 230 KAEFKCPNWFPPEV------RKLLCKILDPNPSTRISMAK----IRESSWFR 271
K E FP R L+ K+L +PS R+ + I++ +FR
Sbjct: 246 KKEVT----FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 90/262 (34%), Positives = 143/262 (54%), Gaps = 18/262 (6%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV----RHPN 75
++LG+G+F KV+ A TNQ A+K + KD ++ + D ++ + R++ HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL---MDDDVECTMVEKRVLSLAWEHPF 57
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
+ LY TK +FFVMEY GG+L F+ + K A Y ++I + F HS+G+
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQ---DGLLHTTCGTPAYVAPEVINRKG 191
+RD+K +N+LLD + ++KI+DFG+ CK D T CGTP Y+APE++ +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGM-----CKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKIL 251
Y VD WS GV+L+ +L G PFH + E+++ I P W E + +L K+
Sbjct: 173 Y-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLF 231
Query: 252 DPNPSTRISM-AKIRESSWFRK 272
P R+ + IR+ +FR+
Sbjct: 232 VREPERRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 85/276 (30%), Positives = 144/276 (52%), Gaps = 22/276 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E ++V +++G+GAF +V R + Q A+K++ K ++++ + E +M
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRG 133
IVQL+ ++ VMEY GG+L N ++ + E AR Y +++ A+D HS G
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQC--KHQDGLLH--TTCGTPAYVAPEVINR 189
HRD+KP+N+LLD++ +LK++DFG C +G++ T GTP Y++PEV+
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFG-----TCMKMDANGMVRCDTAVGTPDYISPEVLKS 217
Query: 190 KGYDGE---KVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV--- 243
+G DG + D WS GV L+ +L G PF+ +L+ Y KI + K FP ++
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI--MDHKNSLTFPDDIEIS 275
Query: 244 ---RKLLCKILDPNPST--RISMAKIRESSWFRKGM 274
+ L+C L R + +I+ +F+
Sbjct: 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 5e-41
Identities = 86/255 (33%), Positives = 130/255 (50%), Gaps = 19/255 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVID----KDKIMRVGLADQIKREISVMR 69
E + + +G+G+F +VY A RTNQ VA+KVID +D+I + I++EI +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI------EDIQQEIQFLS 54
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFC 129
R P I + Y SK++ +MEY GG + + GKL E ++++ +++
Sbjct: 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYL 114
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
H G HRDIK N+LL E ++K++DFG+S Q +T GTP ++APEVI +
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPPEVRK 245
GYD EK DIWS G+ L G P D + + + I K P N F +
Sbjct: 173 SGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PPSLEGNKFSKPFKD 229
Query: 246 LLCKILDPNPSTRIS 260
+ L+ +P R S
Sbjct: 230 FVSLCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 8e-41
Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 25/263 (9%)
Query: 19 GRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIK---REISVMRIV 71
G+ LG+GAF +VY VAVK + +D QI+ RE +MR +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASE-----QQIEEFLREARIMRKL 58
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGK-LKEDAARRYFQQLINAVDF 128
HPNIV+L V + + VMEY GG+L + + + K L + Q+ +++
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV---APE 185
S+ HRD+ N L+ EN +KISDFGLS D + G + APE
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLS----RDLYDDDYYKVKGGKLPIRWMAPE 174
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEV 243
+ + K D+WS GV+L+ + G P+ + E+ + K P PPE+
Sbjct: 175 SLKEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL 233
Query: 244 RKLLCKILDPNPSTRISMAKIRE 266
KL+ + +P R + +++ E
Sbjct: 234 YKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 85/285 (29%), Positives = 145/285 (50%), Gaps = 35/285 (12%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +E +L+ GA+ VY R T Q A+K I+K ++ Q+ E ++ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSR 132
P +V ++ TK + VMEY +GG+ + G L D AR YF + + A+++ H+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT----------------- 175
G+ HRD+KP+NLL+ ++K++DFGLS + GL+ T
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKI-------GLMSLTTNLYEGHIEKDTREFLD 173
Query: 176 ---CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE 232
CGTP Y+APEVI R+GY G+ VD W+ G++L+ L G +PF E++ ++ +
Sbjct: 174 KQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232
Query: 233 FKCP---NWFPPEVRKLLCKILDPNPSTRI---SMAKIRESSWFR 271
+ P P + + L+ ++L NP R+ ++++ +F
Sbjct: 233 IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 84/274 (30%), Positives = 136/274 (49%), Gaps = 24/274 (8%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ YE+ ++G GA A VY A + N+ VA+K ID +K + + D++++E+ M H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSV-DELRKEVQAMSQCNH 58
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN----KVAKGKLKEDAARRYFQQLINAVDFC 129
PN+V+ Y +++ VM Y GG L + +G L E ++++ +++
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSA-LAQ-CKHQDGLLHTTCGTPAYVAPEVI 187
HS G HRDIK N+LL E+ ++KI+DFG+SA LA + T GTP ++APEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 188 N-RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI----------GKAEFKCP 236
GYD K DIWS G+ L G P+ +++ G K
Sbjct: 179 EQVHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237
Query: 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270
F RK++ L +PS R + ++ + +F
Sbjct: 238 KSF----RKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 85/265 (32%), Positives = 142/265 (53%), Gaps = 18/265 (6%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQ 78
++LG+G+F KV A T++ A+KV+ KD I++ D E ++ + HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ TK ++FFVMEY GG+L ++ + K E +R Y ++ A+ F H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKH--QDGLLHTT-CGTPAYVAPEVINRKGYDG 194
D+K +N+LLD + K++DFG+ CK +G+ TT CGTP Y+APE++ Y G
Sbjct: 121 DLKLDNILLDAEGHCKLADFGM-----CKEGILNGVTTTTFCGTPDYIAPEILQELEY-G 174
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
VD W+ GV+++ ++AG PF N +++ I + P W E +L + N
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKN 234
Query: 255 PSTRISMA-------KIRESSWFRK 272
P+ R+ I++ +F++
Sbjct: 235 PNKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 82/253 (32%), Positives = 130/253 (51%), Gaps = 9/253 (3%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVI--DKDKIMRVGLADQIKREISVMRIVRHPNI 76
G+LLGQGAF +VY + T + +AVK + D D + ++ EI +++ ++H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCHSRGVY 135
VQ Y + + MEY GG + +++ A G L E R+Y +Q++ V++ HS +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQ--CKHQDGLLHTTCGTPAYVAPEVINRKGYD 193
HRDIK N+L D N+K+ DFG S Q C G+ T GTP +++PEVI+ +GY
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPEVISGEGY- 184
Query: 194 GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK--AEFKCPNWFPPEVRKLLCKIL 251
G K D+WS G + +L P+ + + KI + P+ P+ R L +
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTF 244
Query: 252 DPNPSTRISMAKI 264
N R S ++
Sbjct: 245 VENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 8e-40
Identities = 73/234 (31%), Positives = 115/234 (49%), Gaps = 17/234 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +++ LG+G++ VY A T Q VA+KV+ + +I +EIS+++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDS 57
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHS 131
P IV+ Y + ++ VMEY G + + K+ L E+ Q + +++ HS
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
HRDIK N+LL+E K++DFG+S Q +T GTP ++APEVI G
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRK 245
Y+ K DIWS G+ + G P+ D + + +A F PN PP +
Sbjct: 176 YN-NKADIWSLGITAIEMAEGKPPYSDIHPM-------RAIFMIPNKPPPTLSD 221
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 86/245 (35%), Positives = 135/245 (55%), Gaps = 11/245 (4%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
+++G+G+F KV AR + AVKV+ K I++ I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T K++FV++Y GGELF + + + E AR Y ++ +A+ + HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQ---DGLLHTTCGTPAYVAPEVINRKGYDG 194
D+KPEN+LLD ++ ++DFGL CK +G T CGTP Y+APEV++++ YD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGL-----CKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD- 174
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
VD W G VL+ +L G PF+ N EMY I + R LL +L +
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 234
Query: 255 PSTRI 259
+ R+
Sbjct: 235 RTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 2e-39
Identities = 84/291 (28%), Positives = 139/291 (47%), Gaps = 41/291 (14%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
+Y++ +G+GA V+ A+ T ++VA+K + ++ G+ +Q REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHP 59
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK--LKEDAARRYFQQLINAVDFCHSR 132
+V+L +V S VMEY +L + + L E + Y + L+ V + H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHT-TCGTPAYVAPEVI--NR 189
G+ HRD+KP NLL+ + LKI+DFGL+ L ++ L++ T Y APE++ R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLF--SEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE----MYRKIGKAEFKC-------PNW 238
K YD VD+W+ G + LL G F N IE ++R +G + P++
Sbjct: 177 K-YDPG-VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234
Query: 239 ----FPPEVRK---------------LLCKILDPNPSTRISMAKIRESSWF 270
FP LL +L +PS R+S A+ +F
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 87/244 (35%), Positives = 136/244 (55%), Gaps = 9/244 (3%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVG-LADQI-KREISVMRIVRH-PNIVQ 78
+G+G F +VY R T + A+KV+ K +I+ +A I +R I V ++ P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L T S ++ V +Y GGELF + K G+ ED A+ Y +L+ A++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV-INRKGYDGEK 196
D+KPEN+LLD ++ + DFGLS + +T CGT Y+APEV ++ KGY +
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 197 VDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP-NWFPPEVRKLLCKILDPNP 255
VD WS GV++F + G+ PF+ + +MYR I + + P N E R+ + +L+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 256 STRI 259
R+
Sbjct: 238 QHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 91/277 (32%), Positives = 156/277 (56%), Gaps = 21/277 (7%)
Query: 16 YEVGRLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIM-RVGLADQIKREISVMRIV 71
+E+ ++LG GA+ KV+ R + T + A+KV+ K ++ + + + E +V+ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 72 RH-PNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFC 129
R P +V L+ T++K+ +++Y GGE+F + + ED R Y ++I A++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSA--LAQCKHQDGLLHTTCGTPAYVAPEVI 187
H G+ +RDIK EN+LLD ++ ++DFGLS L++ K + ++ CGT Y+APE+I
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT---YSFCGTIEYMAPEII 178
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPF----HDSNLIEMYRKIGKAEFKCPNWFPPEV 243
KG G+ VD WS G+++F LL G PF + E+ R+I K + P++ PE
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 244 RKLLCKILDPNPSTRISMA-----KIRESSWFRKGMN 275
+ LL K+L +P R+ +I+E +F KG++
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF-KGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 3e-39
Identities = 84/255 (32%), Positives = 140/255 (54%), Gaps = 10/255 (3%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
KYE R++G+GAF V+ R + V +K I ++ M + E V++++ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ-MTKDERLAAQNECQVLKLLSHP 59
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGG---ELFNKVAKGKLKEDAARRYFQQLINAVDFCHS 131
NI++ YE + VMEYA GG E K L ED +F Q++ A+ H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 132 RGVYHRDIKPENLLLDENEN-LKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
+ + HRD+K +N+LLD+++ +KI DFG+S + K + +T GTP Y++PE+ K
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGK 176
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-CPNWFPPEVRKLLCK 249
Y+ +K DIW+ G VL+ L + F +NL + KI F + + P++R+L+
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235
Query: 250 ILDPNPSTRISMAKI 264
+L+ +PS R +++I
Sbjct: 236 MLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 3e-39
Identities = 77/244 (31%), Positives = 119/244 (48%), Gaps = 12/244 (4%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV---RHPNIVQ 78
LG+G F KV A +T + A+K + K I+ + + E + RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
L+ T+ + FVMEYA GG+L + E A Y ++ + + H + +RD
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRD 126
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT---CGTPAYVAPEVINRKGYDGE 195
+K +NLLLD +KI+DFGL CK G T CGTP ++APEV+ Y
Sbjct: 127 LKLDNLLLDTEGFVKIADFGL-----CKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TR 180
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNP 255
VD W GV+++ +L G PF + E++ I E + P + E ++ ++L NP
Sbjct: 181 AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNP 240
Query: 256 STRI 259
R+
Sbjct: 241 ERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 9e-39
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 4/198 (2%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
Y+ +G+G + VY AR T + VA+K I K + G+ REI +++ + HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 76 IVQLYEVMATKSKIFFVMEYAKGG-ELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
I++L +V K ++ V E+ K + L E + Y QL+ + FCHS G+
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDG 194
HRD+KPENLL++ LK++DFGL+ T Y APE++
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 195 EKVDIWSCGVVLFVLLAG 212
VDIWS G + LL+
Sbjct: 178 TPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 85/316 (26%), Positives = 138/316 (43%), Gaps = 73/316 (23%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+ + +G GAF +V R + TN A+K + K ++ A +K E ++ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
+V+LY K ++FVM+Y GG++ + + G +ED AR Y +L A++ H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 135 YHRDIKPENLLLDENENLKISDFGL------------------------------SALAQ 164
HRDIKP+N+L+D + ++K++DFGL S + +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 165 C-----------KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGY 213
C +HQ L H+ GTP Y+APEV+ R GY + D WS GV+L+ +L G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 241
Query: 214 LPFHDSNLIEMYRKIGKAEFKCPNW-----FPPE----------VRKLLCKILDPNPSTR 258
PF E K+ NW P + + +L C R
Sbjct: 242 PPFLADTPAETQLKV-------INWETTLHIPSQAKLSREASDLILRLCC-----GAEDR 289
Query: 259 I---SMAKIRESSWFR 271
+ +I+ +F+
Sbjct: 290 LGKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 75/256 (29%), Positives = 127/256 (49%), Gaps = 10/256 (3%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVK---VIDKDKIMRVGLADQIKREISVMRIV 71
++ G LLG G+F VY ++ AVK + D + + + Q+++EI+++ +
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK-QLEQEIALLSKL 59
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCH 130
+HPNIVQ + ++ +E GG L + K G E R Y +Q++ +++ H
Sbjct: 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
R HRDIK N+L+D N +K++DFG++ Q + G+P ++APEVI ++
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMA--KQVVEFSFAK-SFKGSPYWMAPEVIAQQ 176
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG--KAEFKCPNWFPPEVRKLLC 248
G G DIWS G + + G P+ + KIG K P+ E + +
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236
Query: 249 KILDPNPSTRISMAKI 264
K L +PS R + A++
Sbjct: 237 KCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 73/261 (27%), Positives = 120/261 (45%), Gaps = 17/261 (6%)
Query: 17 EVGRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
E+G+ LG+GAF +VY T VAVK + K+ + E S+M+ +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREE-FLEEASIMKKLS 59
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCH 130
HPNIV+L V ++ V EY GG+L F + KL + Q+ +++
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP---AYVAPEVI 187
S+ HRD+ N L+ EN +KISDFGLS ++D G ++APE +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRD---IYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRK 245
+ K D+WS GV+L+ + G P+ + E+ + P P E+ +
Sbjct: 177 KDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYE 235
Query: 246 LLCKILDPNPSTRISMAKIRE 266
L+ + +P R + +++ E
Sbjct: 236 LMLQCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 4e-38
Identities = 77/222 (34%), Positives = 126/222 (56%), Gaps = 11/222 (4%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
+++G+G+F KV A+ AVKV+ K I++ + I E +V+ + ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T K++FV++Y GGELF + + + E AR Y ++ +A+ + HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRKGYDG 194
D+KPEN+LLD ++ ++DFGL CK + T CGTP Y+APEV+ ++ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL-----CKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD- 174
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP 236
VD W G VL+ +L G PF+ ++ +MY I + P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-38
Identities = 91/295 (30%), Positives = 136/295 (46%), Gaps = 47/295 (15%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI--DKDKIMRVGLADQIKREISVMRIVR 72
+YE G+ LG+G +A VY AR T + VA+K I + K + G+ REI +++ ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQLINAVDFC 129
HPNI+ L +V KS I V E+ +L KV K K L + Y + +++
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFM-ETDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG--TPAYVAPEVI 187
HS + HRD+KP NLL+ + LK++DFGL+ T T Y APE++
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLA----RSFGSPNRKMTHQVVTRWYRAPELL 174
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAG--YLPFHDSNLIEMYRKIGKAEFKCP---NW---- 238
+ G VD+WS G + LL +LP + I+ KI +A P NW
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLLRVPFLP--GDSDIDQLGKIFEA-LGTPTEENWPGVT 231
Query: 239 ----------FPPEVRK------------LLCKILDPNPSTRISMAKIRESSWFR 271
FPP K LL ++L NP+ RI+ + E +F
Sbjct: 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 4e-38
Identities = 72/204 (35%), Positives = 108/204 (52%), Gaps = 11/204 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVK---VIDKDKIMRVGLADQIKREISVMRI 70
KYEV ++G+GA+ V R+ T + VA+K + D+ ++ RE+ V+R
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK----KTALREVKVLRQ 56
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGG--ELFNKVAKGKLKEDAARRYFQQLINAVDF 128
+RH NIV L E K +++ V EY + EL G L DA R Y QL+ A+ +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSYIWQLLQAIAY 115
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
CHS + HRDIKPEN+L+ E+ LK+ DFG + + + L T Y APE++
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT-DYVATRWYRAPELLV 174
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAG 212
G+ VD+W+ G ++ LL G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 7e-38
Identities = 88/268 (32%), Positives = 133/268 (49%), Gaps = 30/268 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI---DKDKIMRVGLADQIKREISVMRI 70
E YE+ + +G G + VY AR I T + VA+KVI D + I++EIS+++
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF------EIIQQEISMLKE 56
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDF 128
RHPNIV + + K++ VMEY GG L + +V +G L E ++ + + +
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
H G HRDIK N+LL E+ ++K++DFG+S AQ + GTP ++APEV
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 189 ---RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP------NW- 238
+ GYDG K DIW+ G+ L P D + + I K+ F P W
Sbjct: 175 VERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233
Query: 239 --FPPEVRKLLCKILDPNPSTRISMAKI 264
F ++K L K +P R + K+
Sbjct: 234 PVFHDFIKKCLTK----DPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 8e-38
Identities = 83/247 (33%), Positives = 135/247 (54%), Gaps = 12/247 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E YEV +++G+GAF +V R T + A+K++ K ++++ + E +M
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRG 133
P +VQL+ ++ VMEY GG+L N ++ + E AR Y +++ A+D HS G
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH--TTCGTPAYVAPEVINRK- 190
HRD+KP+N+LLD++ +LK++DFG +++G++ T GTP Y++PEV+ +
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 191 --GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI----GKAEFKCPNWFPPEVR 244
GY G + D WS GV L+ +L G PF+ +L+ Y KI F N E +
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279
Query: 245 KLLCKIL 251
L+C L
Sbjct: 280 NLICAFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 84/261 (32%), Positives = 140/261 (53%), Gaps = 18/261 (6%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV----RHPN 75
++LG+G+F KV A + AVK + KD ++ + D ++ + R++ +P
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL---IDDDVECTMVEKRVLALAWENPF 57
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
+ LY TK +FFVME+ GG+L F+ KG+ A Y +++ + F HS+G+
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQ---DGLLHTTCGTPAYVAPEVINRKG 191
+RD+K +N++LD + ++KI+DFG+ CK D T CGTP Y+APE++
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGM-----CKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKIL 251
Y VD WS GV+L+ +L G PFH + E++ I P W E + +L K+
Sbjct: 173 YTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLF 231
Query: 252 DPNPSTRISM-AKIRESSWFR 271
+ +P+ R+ + IR +F+
Sbjct: 232 ERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 84/251 (33%), Positives = 138/251 (54%), Gaps = 20/251 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E Y+V +++G+GAF +V R + + A+K++ K ++++ + E +M
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRG 133
P +VQL+ ++ VMEY GG+L N ++ + E A+ Y +++ A+D HS G
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD--GLLH--TTCGTPAYVAPEVINR 189
+ HRD+KP+N+LLD++ +LK++DFG C D G++ T GTP Y++PEV+
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFG-----TCMKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 190 K---GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV--- 243
+ GY G + D WS GV LF +L G PF+ +L+ Y KI + K FP +V
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI--MDHKNSLNFPEDVEIS 275
Query: 244 ---RKLLCKIL 251
+ L+C L
Sbjct: 276 KHAKNLICAFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 24/263 (9%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR---EISVMRIVRHPNIVQ 78
LG GAF KVY A+ T A K+I + ++++ EI ++ +HPNIV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQ------IESEEELEDFMVEIDILSECKHPNIVG 66
Query: 79 LYEVMATKSKIFFVMEYAKGGELFN---KVAKGKLKEDAARRYFQQLINAVDFCHSRGVY 135
LYE ++K++ ++E+ GG L + ++ +G L E R +Q++ A++F HS V
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVI 125
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN-----RK 190
HRD+K N+LL + ++K++DFG+SA K T GTP ++APEV+
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKN--KSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPPEVRKLL 247
YD K DIWS G+ L L P H+ N + + KI K+E P+ + L
Sbjct: 184 PYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFL 242
Query: 248 CKILDPNPSTRISMAKIRESSWF 270
L +P R + A++ + +
Sbjct: 243 KSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 78/214 (36%), Positives = 123/214 (57%), Gaps = 11/214 (5%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
+++G+G+F KV A+ + AVKV+ K ++ I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T K++FV+++ GGELF + + + E AR Y ++ +A+ + HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT---CGTPAYVAPEVINRKGYDG 194
D+KPEN+LLD ++ ++DFGL CK TT CGTP Y+APEVI ++ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL-----CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD- 174
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
VD W G VL+ +L G PF+ ++ EMY I
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 78/254 (30%), Positives = 135/254 (53%), Gaps = 9/254 (3%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
+G+G+ V A T + VAVK +D K R L + E+ +MR +HPNIV++Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL---LFNEVVIMRDYQHPNIVEMYS 83
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKP 141
+++ VME+ +GG L + V ++ E+ ++ A+ F H++GV HRDIK
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143
Query: 142 ENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWS 201
+++LL + +K+SDFG AQ + + GTP ++APEVI+R Y E VDIWS
Sbjct: 144 DSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE-VDIWS 200
Query: 202 CGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPPEVRKLLCKILDPNPSTR 258
G+++ ++ G P+ + ++ ++I K + P +R L ++L +P+ R
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR 260
Query: 259 ISMAKIRESSWFRK 272
+ A++ + K
Sbjct: 261 ATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 27/275 (9%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
++V L+G+G F +V R T A+KV+ K ++ + E ++ I P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRG 133
I QL K ++ VMEY GG+L + + + + ED A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSA-LAQCKHQDGLLHTTCGTPAYVAPEVI----- 187
HRDIKPEN+L+D ++K++DFG +A L K + L GTP Y+APEV+
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL--PVGTPDYIAPEVLTTMNG 180
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVR--- 244
+ KG G + D WS GV+ + ++ G PFH+ + Y I F+ FP + +
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI--MNFQRFLKFPEDPKVSS 238
Query: 245 -------KLLCKILDPNPSTRISMAKIRESSWFRK 272
LLC R+ + +F K
Sbjct: 239 DFLDLIQSLLC-----GQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 73/242 (30%), Positives = 126/242 (52%), Gaps = 13/242 (5%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVK-------VIDKDKIMRVGLADQIKREISVMRIV 71
G L+G+G + +VY A ++ T + +AVK + + + + ++ EI ++ +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCH 130
H NIVQ T+ + +EY GG + + + G+ +E R + +Q++ + + H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN-- 188
S+G+ HRD+K +NLL+D + KISDFG+S + + + + G+ ++APEVI+
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248
+GY KVDIWS G V+ + AG P+ D I K+G P PP+V L
Sbjct: 186 SQGYSA-KVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP--IPPDVSMNLS 242
Query: 249 KI 250
+
Sbjct: 243 PV 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 74/202 (36%), Positives = 123/202 (60%), Gaps = 11/202 (5%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQ 78
R++G+G++AKV +T + A+KVI K+ + D ++ E V HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 79 LYEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T+S++FFV+E+ GG+L F+ + KL E+ AR Y ++ A++F H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKH--QDGLLHTT-CGTPAYVAPEVINRKGYDG 194
D+K +N+LLD ++K++D+G+ CK + G +T CGTP Y+APE++ + Y G
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGM-----CKEGIRPGDTTSTFCGTPNYIAPEILRGEDY-G 174
Query: 195 EKVDIWSCGVVLFVLLAGYLPF 216
VD W+ GV++F ++AG PF
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-36
Identities = 85/261 (32%), Positives = 140/261 (53%), Gaps = 16/261 (6%)
Query: 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN-IVQL 79
+LG+G+F KV A T++ A+K++ KD I++ + E V+ + P + QL
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
+ T +++FVMEY GG+L + + GK KE A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQ---DGLLHTTCGTPAYVAPEVINRKGYDGE 195
+K +N++LD ++KI+DFG+ CK T CGTP Y+APE+I + Y G+
Sbjct: 127 LKLDNVMLDAEGHIKIADFGM-----CKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GK 180
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNP 255
VD W+ GV+L+ +LAG PF + E+++ I + P E + +L +P
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP 240
Query: 256 STRISMA-----KIRESSWFR 271
+ R+ IRE ++FR
Sbjct: 241 AKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 86/291 (29%), Positives = 131/291 (45%), Gaps = 54/291 (18%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI---DKDKIMRVGLADQIKREISVMRIV 71
+YE+ + +G GA+ V A RT + VA+K I D I A +I REI ++R +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI----DAKRILREIKLLRHL 56
Query: 72 RHPNIVQLYEVMATKSK-----IFFVMEYAKGGELFNKV--AKGKLKEDAARRYFQQLIN 124
RH NI+ L +++ S ++ V E +L +KV + L +D + + Q++
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDL-HKVIKSPQPLTDDHIQYFLYQILR 114
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG--TPAYV 182
+ + HS V HRD+KP N+L++ N +LKI DFGL A +D T T Y
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL-ARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 183 APEVI-NRKGYDGEKVDIWSCGVVLFVLLAG--YLPFHDS----NLI---------EMYR 226
APE++ + Y + +DIWS G + LL P D NLI E +
Sbjct: 174 APELLLSSSRYT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232
Query: 227 KIGKAEFK-----------------CPNWFPPEVRKLLCKILDPNPSTRIS 260
I + + P PE LL K+L +P RI+
Sbjct: 233 FITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRIT 282
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 82/256 (32%), Positives = 138/256 (53%), Gaps = 11/256 (4%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
+YE+ + +G+G+F K+Y A++ ++ +K ID K M V + K+E+ ++ ++HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHP 59
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQLINAVDFCHS 131
NIV + ++F VMEY GG+L ++ + + ED +F Q+ + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 132 RGVYHRDIKPENLLLDENENL-KISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
R + HRDIK +N+ L +N + K+ DFG++ Q L +T GTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIA--RQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK--CPNWFPPEVRKLLC 248
Y+ K DIWS G VL+ L PF +NL ++ KI + F PN F ++R L+
Sbjct: 178 PYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN-FSRDLRSLIS 235
Query: 249 KILDPNPSTRISMAKI 264
++ +P R S+ I
Sbjct: 236 QLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 4e-36
Identities = 86/255 (33%), Positives = 128/255 (50%), Gaps = 19/255 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKRE-----ISVM 68
+KY +GQGA VY A + T Q VA+K ++ L Q K+E I VM
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVM 70
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDF 128
R +HPNIV + +++ VMEY GG L + V + + E ++ + A++F
Sbjct: 71 RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 130
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
HS V HRDIK +N+LL + ++K++DFG AQ + T GTP ++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI---GKAEFKCPNWFPPEVRK 245
RK Y G KVDIWS G++ ++ G P+ + N + I G E + P R
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247
Query: 246 LLCKILDPNPSTRIS 260
L + L+ + R S
Sbjct: 248 FLNRCLEMDVEKRGS 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 5e-36
Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDK-----DKIMRVGLADQIKREI-SVMR 69
Y+V + LG G F VY AR+ T + VA+K + K ++ M + RE+ S+ +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-------REVKSLRK 53
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGG--ELFNKVAKGKLKEDAARRYFQQLINAVD 127
+ HPNIV+L EV +++FV EY +G +L E R Q++ +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPAYVAPEV 186
H G +HRD+KPENLL+ E +KI+DFGL+ + + +T T Y APE+
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEI 169
Query: 187 INRKGYDGEKVDIWSCGVVLF 207
+ R VDIW+ G ++
Sbjct: 170 LLRSTSYSSPVDIWALGCIMA 190
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 77/264 (29%), Positives = 136/264 (51%), Gaps = 13/264 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTN-QSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
E + R LG G+F +V A + VA+K +K KI++ D + E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHS 131
HP V LY +S ++ V+E+ GGE F + + K D Y Q++ ++ S
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
+ +RD+KPENLLLD++ +K++DFG + + + +T CGTP Y+APE++ G
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVG 204
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKIL 251
+ G+ D W+ G+ ++ +L G PF+ + + +Y+KI + P + + L+ K+L
Sbjct: 205 H-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLL 263
Query: 252 DPNPSTRISMAK-----IRESSWF 270
+ + R K ++E WF
Sbjct: 264 SHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 83/264 (31%), Positives = 146/264 (55%), Gaps = 22/264 (8%)
Query: 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV----RHPNI 76
+LG+G+F KV A T++ A+K++ KD +++ D ++ + R++ + P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALSGKPPFL 63
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVY 135
QL+ T +++FVMEY GG+L ++ + G+ KE A Y ++ + F HS+G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQ--DGLLHTT-CGTPAYVAPEVINRKGY 192
+RD+K +N++LD ++KI+DFG+ CK DG+ T CGTP Y+APE+I + Y
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGM-----CKENMWDGVTTKTFCGTPDYIAPEIIAYQPY 178
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
G+ VD W+ GV+L+ +LAG PF + E+++ I + P E + ++
Sbjct: 179 -GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237
Query: 253 PNPSTRISMA-----KIRESSWFR 271
+P R+ I+E ++FR
Sbjct: 238 KHPGKRLGCGPEGERDIKEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 74/255 (29%), Positives = 131/255 (51%), Gaps = 12/255 (4%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+++ + +G+G F+ VY A + + VA+K + ++M +EI +++ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGEL---FNKVAKGK--LKEDAARRYFQQLINAVD 127
HPN+++ +++ V+E A G+L K K + E +YF QL +A++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
HS+ + HRDIKP N+ + +K+ D GL K H+ GTP Y++PE I
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERI 178
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS--NLIEMYRKIGKAEFK-CPN-WFPPEV 243
+ GY+ K DIWS G +L+ + A PF+ NL + +KI K ++ P + E+
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237
Query: 244 RKLLCKILDPNPSTR 258
R L+ + ++P+P R
Sbjct: 238 RDLVSRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 86/265 (32%), Positives = 146/265 (55%), Gaps = 22/265 (8%)
Query: 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV----RHPNI 76
+LG+G+F KV A T++ A+K++ KD +++ D ++ + R++ + P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALQDKPPFL 63
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVY 135
QL+ T +++FVMEY GG+L + + GK KE A Y ++ + F H RG+
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQ--DGL-LHTTCGTPAYVAPEVINRKGY 192
+RD+K +N++LD ++KI+DFG+ CK DG+ T CGTP Y+APE+I + Y
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGM-----CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
G+ VD W+ GV+L+ +LAG PF + E+++ I + P E + ++
Sbjct: 179 -GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237
Query: 253 PNPSTRISMAK-----IRESSWFRK 272
+PS R+ IRE ++FR+
Sbjct: 238 KHPSKRLGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 4e-35
Identities = 76/247 (30%), Positives = 123/247 (49%), Gaps = 8/247 (3%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+E+ +G+G+F V+ + A+K ID K+ R + I E V+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSY 60
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQLINAVDFCHSR 132
I++ YE K K+ VMEYA+ G+L + + L ED R+F Q++ + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
+ HRDIK NL LD +N+KI D G++ L +T GTP Y++PE+ K Y
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-CPNWFPPEVRKLLCKIL 251
+ EK D+W+ GVVL+ G PF +N + KI + F + ++ +L+ + L
Sbjct: 179 N-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237
Query: 252 DPNPSTR 258
+ R
Sbjct: 238 TKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-35
Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 20 RLLGQGAFAKVYYAR-SIRTNQS--VAVKVI--DKDKIMRVGLADQIKREISVMRIVRHP 74
+ LG+GAF +VY + + ++ VAVK + D + R +E VM+ + HP
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER----KDFLKEARVMKKLGHP 56
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGEL----------FNKVAKGKLKEDAARRYFQQLIN 124
N+V+L V + ++ V+EY +GG+L F K L + Q+
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS-----ALAQCKHQDGLLHTTCGTP 179
+++ S+ HRD+ N L+ E+ +KISDFGLS K G L
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI----- 171
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVL---FVLLAGYLPFHDSNLIEMYRKIGKAEF-KC 235
++APE + + K D+WS GV+L F L G P+ + E+ + K
Sbjct: 172 RWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTL--GATPYPGLSNEEVLEYLRKGYRLPK 228
Query: 236 PNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
P + P E+ +L+ +P R + +++ E
Sbjct: 229 PEYCPDELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 84/269 (31%), Positives = 144/269 (53%), Gaps = 20/269 (7%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
L ++ E L+G+GA+ VY + + T + VA+K+I+ D ++D I+RE++++ +
Sbjct: 2 LYQRLE---LIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSD-IQREVALLSQL 56
Query: 72 RH---PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDF 128
R PNI + Y +++ +MEYA+GG + + G + E ++++ A+ +
Sbjct: 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPAYVAPEVI 187
H GV HRDIK N+L+ N+K+ DFG++AL Q+ +T GTP ++APEVI
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVI 173
Query: 188 NR-KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPPE 242
K YD K DIWS G+ ++ + G P+ D + I K+ K P N +
Sbjct: 174 TEGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKL 230
Query: 243 VRKLLCKILDPNPSTRISMAKIRESSWFR 271
+R+ + LD P R+S ++ +S W +
Sbjct: 231 LREFVAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 5e-34
Identities = 90/283 (31%), Positives = 153/283 (54%), Gaps = 30/283 (10%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
R++G+G++AKV R +T + A+KV+ K+ + D ++ E V + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 79 LYEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T+S++FFV+EY GG+L F+ + KL E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT---CGTPAYVAPEVINRKGYDG 194
D+K +N+LLD ++K++D+G+ CK TT CGTP Y+APE++ + Y G
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM-----CKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-G 174
Query: 195 EKVDIWSCGVVLFVLLAGYLPFH--------DSNLIE-MYRKIGKAEFKCPNWFPPEVRK 245
VD W+ GV++F ++AG PF D N + +++ I + + + P +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 234
Query: 246 LLCKILDPNPSTRI------SMAKIRESSWFRK----GMNQKQ 278
+L L+ +P R+ A I+ +FR M QKQ
Sbjct: 235 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQ 277
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 88/283 (31%), Positives = 157/283 (55%), Gaps = 25/283 (8%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
R++G+G++AKV R + +Q A+KV+ K+ + D ++ E V + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 79 LYEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T S++F V+EY GG+L F+ + KL E+ AR Y ++ A++F H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT---CGTPAYVAPEVINRKGYDG 194
D+K +N+LLD + ++K++D+G+ CK G TT CGTP Y+APE++ + Y G
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM-----CKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-G 174
Query: 195 EKVDIWSCGVVLFVLLAGYLPFH------DSNLIE-MYRKIGKAEFKCPNWFPPEVRKLL 247
VD W+ GV++F ++AG PF D N + +++ I + + P + + +L
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234
Query: 248 CKILDPNPSTRI------SMAKIRESSWFRK-GMNQKQKQKVT 283
L+ +P R+ + I+ ++FR + +K++VT
Sbjct: 235 KGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVT 277
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 84/293 (28%), Positives = 135/293 (46%), Gaps = 60/293 (20%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVI---DKDKIMRVGLADQIKREISVMRIVRHPNIVQ 78
+G+G + VY AR T + VA+K I +D+ G+ REIS+++ + HPNIV+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDE----GVPSTAIREISLLKELNHPNIVR 62
Query: 79 LYEVMATKSKIFFVMEYA----KGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
L +V+ +++K++ V E+ K + + L + Y QL+ + +CHS V
Sbjct: 63 LLDVVHSENKLYLVFEFLDLDLK--KYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120
Query: 135 YHRDIKPENLLLDENENLKISDFGLS-----ALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
HRD+KP+NLL+D LK++DFGL+ + H+ T Y APE++
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE-------VVTLWYRAPEILLG 173
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLP-FH-DSNLIEMY---RKIG--------------- 229
VDIWS G + F + P F DS + +++ R +G
Sbjct: 174 SRQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232
Query: 230 -KAEFKCPNWFPPEVRK-----------LLCKILDPNPSTRISMAKIRESSWF 270
K F P W ++ K LL K+L +P+ RIS + +F
Sbjct: 233 YKPTF--PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-34
Identities = 75/223 (33%), Positives = 115/223 (51%), Gaps = 24/223 (10%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR-IV 71
T +E+ ++G+G + KVY AR +T Q VA+K++D + ++IK E +++R
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYS 60
Query: 72 RHPNIVQLYEVMATKS------KIFFVMEYAKGG---ELFNKV-AKGK-LKEDAARRYFQ 120
HPNI Y K+ +++ VME GG +L + KGK LKE+ +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180
+ + + + H V HRDIK +N+LL +N +K+ DFG+S AQ G +T GTP
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS--AQLDSTLGRRNTFIGTPY 178
Query: 181 YVAPEVIN-----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHD 218
++APEVI YD + D+WS G+ L G P D
Sbjct: 179 WMAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 9e-34
Identities = 75/259 (28%), Positives = 134/259 (51%), Gaps = 10/259 (3%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
KY + +G+G+F K +S + +K I+ K M ++ ++E++V+ ++HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQLINAVDFCHS 131
NIVQ E ++ VM+Y +GG+L+ K+ + ED +F Q+ A+ H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC-GTPAYVAPEVINRK 190
R + HRDIK +N+ L ++ +K+ DFG +A+ + L TC GTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFG---IARVLNSTVELARTCIGTPYYLSPEICENR 176
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEVRKLLCK 249
Y+ K DIW+ G VL+ + F N+ + KI + + + + ++R L+ +
Sbjct: 177 PYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235
Query: 250 ILDPNPSTRISMAKIRESS 268
+ NP R S+ I E +
Sbjct: 236 LFKRNPRDRPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 79/260 (30%), Positives = 135/260 (51%), Gaps = 21/260 (8%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQS-VAVKVID-------KDKIMRVGLADQIKREISV 67
Y V LG GAF VY R Q+ +A+K I+ KDK R I E+++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 68 MR-IVRHPNIVQLYEVMATKSKIFFVMEYAKG---GELFN--KVAKGKLKEDAARRYFQQ 121
++ +RHPNIV+ Y+ +++ VM+ +G GE FN K K + E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 122 LINAVDFCH-SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180
++ A+ + H + + HRD+ P N++L E++ + I+DFG LA+ K + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG---LAKQKQPESKLTSVVGTIL 178
Query: 181 YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN--W 238
Y PE++ + Y GEK D+W+ G +L+ + PF+ +N++ + KI +A ++
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 239 FPPEVRKLLCKILDPNPSTR 258
+ +V ++ L P+ R
Sbjct: 238 YSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-33
Identities = 79/254 (31%), Positives = 129/254 (50%), Gaps = 9/254 (3%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
+Y V R++G+G+F + + + ++Q A+K I K + ++E ++ ++HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA--VEDSRKEAVLLAKMKHP 58
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVA--KGKL-KEDAARRYFQQLINAVDFCHS 131
NIV E ++ VMEY GG+L K+ +GKL ED ++F Q+ V H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
+ V HRDIK +N+ L +N +K+ DFG + L T GTP YV PE+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--LTSPGAYACTYVGTPYYVPPEIWENMP 176
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-CPNWFPPEVRKLLCKI 250
Y+ K DIWS G +L+ L PF ++ + K+ + +K P+ + E+R L+ ++
Sbjct: 177 YN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 251 LDPNPSTRISMAKI 264
NP +R S I
Sbjct: 236 FKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-33
Identities = 86/261 (32%), Positives = 133/261 (50%), Gaps = 9/261 (3%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+KY +GQGA VY A I T Q VA+K ++ + + L I EI VMR ++
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKN 75
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRG 133
PNIV + +++ VMEY GG L + V + + E ++ + A+DF HS
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD 193
V HRDIK +N+LL + ++K++DFG AQ + T GTP ++APEV+ RK Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 194 GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI---GKAEFKCPNWFPPEVRKLLCKI 250
G KVDIWS G++ ++ G P+ + N + I G E + P R L +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252
Query: 251 LDPNPSTRISMAKIRESSWFR 271
L+ + R S ++ + + +
Sbjct: 253 LEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 9/261 (3%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+KY +GQGA V+ A + T Q VA+K I+ K + L I EI VM+ +++
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMKELKN 75
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRG 133
PNIV + ++F VMEY GG L + V + + E ++ + A++F H+
Sbjct: 76 PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD 193
V HRDIK +N+LL + ++K++DFG AQ + T GTP ++APEV+ RK Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 194 GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI---GKAEFKCPNWFPPEVRKLLCKI 250
G KVDIWS G++ ++ G P+ + N + I G E + P P R L +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252
Query: 251 LDPNPSTRISMAKIRESSWFR 271
L+ + R S ++ + + +
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 74/257 (28%), Positives = 129/257 (50%), Gaps = 16/257 (6%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVID----KDKIMRVGLADQIKREISVMRIV 71
Y R+LG+GAF + R + V K ++ +K R L EI ++ ++
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-----NEIVILSLL 56
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQLINAVDF 128
+HPNI+ Y + + MEYA GG L++K+ + K +E+ Y Q+++AV +
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
H G+ HRDIK N+ L + +K+ DFG+S + ++ + T GTP Y++PE+
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQ 174
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-CPNWFPPEVRKLL 247
Y+ K DIW+ G VL+ LL F +N + + KI + + + + E+ L+
Sbjct: 175 GVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV 233
Query: 248 CKILDPNPSTRISMAKI 264
+L +P R + ++
Sbjct: 234 HSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 84/292 (28%), Positives = 137/292 (46%), Gaps = 59/292 (20%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK--REISVMRIVR-HPNIVQ 78
+G+G F++V A+S +T + A+K + K + +Q+ REI +R + HPNI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSL---EQVNNLREIQALRRLSPHPNILR 62
Query: 79 LYEVMATK-----SKIFFVM-----EYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDF 128
L EV+ + + +F +M E KG K L E + Y QL+ ++D
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKG-------RKRPLPEKRVKSYMYQLLKSLDH 115
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPAYVAPEVI 187
H G++HRDIKPEN+L+ ++ LK++DFG S +T T Y APE +
Sbjct: 116 MHRNGIFHRDIKPENILIK-DDILKLADFG-SCRGIYSKPP---YTEYISTRWYRAPECL 170
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPF------------HD------SNLIEMYRKIG 229
GY G K+DIW+ G V F +L+ + F HD + +++ +RK
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230
Query: 230 KAEFKCPNWFPPEVRKLL-----------CKILDPNPSTRISMAKIRESSWF 270
+ P+ +RKLL K+L +P RI+ + +F
Sbjct: 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 85/292 (29%), Positives = 133/292 (45%), Gaps = 58/292 (19%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG+G +A VY R+ T + VA+K I D G REIS+M+ ++H NIV+L++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 82 VMATKSKIFFVMEYAKGG---ELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
V+ T++K+ V EY + +G L + + + QL+ + FCH V HRD
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA-----------YVAPEVI 187
+KP+NLL+++ LK++DFGL+ G P Y AP+V+
Sbjct: 126 LKPQNLLINKRGELKLADFGLA-------------RAFGIPVNTFSNEVVTLWYRAPDVL 172
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN----LIEMYRKIG-------------- 229
+DIWS G ++ ++ G F +N L++++R +G
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232
Query: 230 --KAEF-KCP-----NWFP---PEVRKLLCKILDPNPSTRISMAKIRESSWF 270
K F + P FP P LL ++L NP RIS + WF
Sbjct: 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 27/210 (12%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQ-----IKREISVMRI 70
YE +G+GA+ VY AR + T + VA+K + RV L+++ REI++++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV------RVPLSEEGIPLSTLREIALLKQ 54
Query: 71 VR---HPNIVQLYEVMATKS-----KIFFVMEYAKG--GELFNKVAKGKLKEDAARRYFQ 120
+ HPNIV+L +V K+ V E+ +K K L + + +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR 114
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC-GTP 179
QL+ VDF HS + HRD+KP+N+L+ + +KI+DFGL+ + + T+ T
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR----IYSFEMALTSVVVTL 170
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVLFVL 209
Y APEV+ + Y VD+WS G + L
Sbjct: 171 WYRAPEVLLQSSY-ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 5e-32
Identities = 72/257 (28%), Positives = 127/257 (49%), Gaps = 23/257 (8%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVI--------DKDKIMRVGLADQIKREISVMRI 70
G+ LG GAF+ Y AR ++T +AVK + ++++++ + +++EI +M
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVV-----EALRKEIRLMAR 59
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFC 129
+ HP+I+++ S +E+ GG + + ++K G KE Y +QL+ + +
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL 119
Query: 130 HSRGVYHRDIKPENLLLDEN-ENLKISDFGLSA--LAQCKHQDGLLHTTCGTPAYVAPEV 186
H + HRD+K NLL+D + L+I+DFG +A A+ GT A++APEV
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD---SNLIEMYRKIGKAEF--KCPNWFPP 241
+ + Y G D+WS G V+ + P++ SN + + KI A P P
Sbjct: 180 LRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 242 EVRKLLCKILDPNPSTR 258
+R + + L+ P R
Sbjct: 239 GLRDVTLRCLELQPEDR 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 89/287 (31%), Positives = 145/287 (50%), Gaps = 23/287 (8%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +E+ LG GAF KVY A++ T A KVI+ L D + EI ++ H
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMV-EIEILATCNH 68
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGE---LFNKVAKGKLKEDAARRYFQQLINAVDFCH 130
P IV+L K++ ++E+ GG + ++ +G L E + +Q++ A+ + H
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLH 127
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSA--LAQCKHQDGLLHTTCGTPAYVAPEVI- 187
S + HRD+K N+LL + ++K++DFG+SA + + +D + GTP ++APEV+
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVM 183
Query: 188 ----NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFP 240
YD K DIWS G+ L + P H+ N + + KI K+E P+ +
Sbjct: 184 CETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242
Query: 241 PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM-NQKQKQKVTESK 286
E R L LD +P TR S A++ E + N+ ++ V E+K
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELVAEAK 289
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-32
Identities = 77/269 (28%), Positives = 132/269 (49%), Gaps = 25/269 (9%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI------MRVGLADQIKREISVMRIVR 72
G L+G G+F VY + + + +AVK ++ + + + D + REI++++ ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGE---LFNKVAKGKLKEDAARRYFQQLINAVDFC 129
H NIVQ + +EY GG L N G +E R + +Q++ +++
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYL 122
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT--PA------Y 181
H+RG+ HRDIK N+L+D +KISDFG+S K + L T P+ +
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISK----KLEANSLSTKTNGARPSLQGSVFW 178
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG-KAEFKCPNWFP 240
+APEV+ + Y K DIWS G ++ +L G PF D ++ KIG A + P+
Sbjct: 179 MAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS 237
Query: 241 PEVRKLLCKILDPNPSTRISMAKIRESSW 269
E L K + + + R + A++ + +
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 8e-32
Identities = 72/200 (36%), Positives = 112/200 (56%), Gaps = 9/200 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI--DKDKIMRVGLADQIKREISVMRIV 71
+ +G+LLG+GAF +VY T + +AVK + D D + ++ EI +++ +
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 72 RHPNIVQLYEVM--ATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDF 128
RH IVQ Y + + K+ +EY GG + +++ A G L E+ RRY +Q++ V +
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL-LHTTCGTPAYVAPEVI 187
HS + HRDIK N+L D N+K+ DFG S Q G + + GTP +++PEVI
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 188 NRKGYDGEKVDIWS--CGVV 205
+ +GY G K D+WS C VV
Sbjct: 182 SGEGY-GRKADVWSVACTVV 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 9e-32
Identities = 78/256 (30%), Positives = 141/256 (55%), Gaps = 28/256 (10%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +E+ +++G+GAF +V + ++ A+K+++K ++++ + E V+ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHS 131
I L+ ++ ++ VM+Y GG+L ++K +L ED AR Y +++ A+D H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT--CGTPAYVAPEVI-- 187
HRDIKP+N+L+D N +++++DFG S L +DG + ++ GTP Y++PE++
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLM--EDGTVQSSVAVGTPDYISPEILQA 177
Query: 188 --NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFPPEV 243
+ KG G + D WS GV ++ +L G PF+ +L+E Y KI K F+ FP +V
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ----FPAQV 233
Query: 244 -----------RKLLC 248
R+L+C
Sbjct: 234 TDVSEDAKDLIRRLIC 249
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 82/256 (32%), Positives = 141/256 (55%), Gaps = 28/256 (10%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ +E+ +++G+GAF +V + T Q A+K+++K ++++ + E V+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHS 131
I L+ ++ ++ VM+Y GG+L ++K +L ED AR Y +++ A+D H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT--CGTPAYVAPEVI-- 187
G HRDIKP+N+LLD+N +++++DFG S L DG + + GTP Y++PE++
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLA--DGTVQSNVAVGTPDYISPEILQA 177
Query: 188 --NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFPPEV 243
+ KG G + D WS GV ++ +L G PF+ +L+E Y KI K F+ FPP+V
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ----FPPDV 233
Query: 244 -----------RKLLC 248
R+L+C
Sbjct: 234 TDVSEEAKDLIRRLIC 249
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 93/340 (27%), Positives = 145/340 (42%), Gaps = 75/340 (22%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
+ LG GAF +V AR + T A+K + K ++ +K E ++ + +V+L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
Y K ++FVM+Y GG++ + + + G ED AR Y +L AV+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 139 IKPENLLLDENENLKISDFGL--------------------------------SALAQC- 165
IKP+N+L+D + ++K++DFGL A +C
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 166 ------------KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGY 213
+HQ L H+ GTP Y+APEV+ R GY + D WS GV+L+ +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 214 LPFHDSNLIEMYRKIGKAEFKCPNW-----------FPPEVRKLLCKI-------LDPNP 255
PF +E + K NW PE L+ K+ L N
Sbjct: 246 PPFLAQTPLE-------TQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNG 298
Query: 256 STRISMAKIRESSWFRKGMNQKQKQ---KVTESKDAASQD 292
+ I ++ F + Q+ K+T D ++ D
Sbjct: 299 ADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFD 338
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 2e-31
Identities = 84/261 (32%), Positives = 133/261 (50%), Gaps = 9/261 (3%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+KY +GQGA VY A + T Q VA++ ++ + + L I EI VMR ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKN 76
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRG 133
PNIV + +++ VMEY GG L + V + + E ++ + A++F HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD 193
V HRDIK +N+LL + ++K++DFG AQ + T GTP ++APEV+ RK Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 194 GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI---GKAEFKCPNWFPPEVRKLLCKI 250
G KVDIWS G++ ++ G P+ + N + I G E + P R L +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 251 LDPNPSTRISMAKIRESSWFR 271
LD + R S ++ + + +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 79/265 (29%), Positives = 128/265 (48%), Gaps = 20/265 (7%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKI-MRVGLADQIKREISVMRIVRHPNIVQLY 80
LG+G F +V + T + A K +DK ++ R G + + + + V IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEK-VSSRFIVSLA 59
Query: 81 EVMATKSKIFFVMEYAKGGEL---FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
TK + VM GG+L V + E A Y Q+I ++ H R + +R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGL-LHTTCGTPAYVAPEVINRKGYDGEK 196
D+KPEN+LLD++ N++ISD GL+ + + G + GTP Y+APEV+ + YD
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLA----VELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FS 174
Query: 197 VDIWSCGVVLFVLLAGYLPFHDSNLI----EMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
VD ++ G L+ ++AG PF E+ R+ + + P+ F PE + L +L
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234
Query: 253 PNPSTRI-----SMAKIRESSWFRK 272
+P R+ S ++RE F+
Sbjct: 235 KDPEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-31
Identities = 86/277 (31%), Positives = 135/277 (48%), Gaps = 16/277 (5%)
Query: 2 FGMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQI 61
F D +KY + R+LG GA V A+ + + AVKV+D + M ++
Sbjct: 20 FAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-MSEADKNRA 78
Query: 62 KREISVMRIVRHPNIVQLYEVMATK--------SKIFFVMEYAKGGELFNKV-----AKG 108
+ E+ + +IV+ +E A K I V++YA G+L ++
Sbjct: 79 QAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNR 138
Query: 109 KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168
+E A F Q++ AV HS+ + HRDIK N+LL N +K+ DFG S +
Sbjct: 139 TFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS 198
Query: 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
D + T CGTP YVAPE+ RK Y +K D++S GV+L+ LL PF N+ E+ K
Sbjct: 199 DDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257
Query: 229 GKAEFK-CPNWFPPEVRKLLCKILDPNPSTRISMAKI 264
+ P PE+++++ +L +P R S +K+
Sbjct: 258 LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 74/252 (29%), Positives = 130/252 (51%), Gaps = 12/252 (4%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+ + + +G+G F++VY A + VA+K + +M +EI +++ + HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK-----LKEDAARRYFQQLINAVDFCH 130
+++ Y +++ V+E A G+L + K + E +YF QL +A++ H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
SR V HRDIKP N+ + +K+ D GL K H+ GTP Y++PE I+
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHEN 181
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDS--NLIEMYRKIGKAEFK--CPNWFPPEVRKL 246
GY+ K DIWS G +L+ + A PF+ NL + +KI + ++ + + E+R+L
Sbjct: 182 GYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 240
Query: 247 LCKILDPNPSTR 258
+ ++P+P R
Sbjct: 241 VNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-31
Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 24/258 (9%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+++ + +G+G F++VY A + + VA+K + ++M +EI +++ + HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGEL-----FNKVAKGKLKEDAARRYFQQLINAVDFCH 130
+++ + +++ V+E A G+L + K K + E +YF QL +AV+ H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
SR V HRDIKP N+ + +K+ D GL K H+ GTP Y++PE I+
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHEN 181
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDS--NLIEMYRKIGKAEFKCPNWFPP------- 241
GY+ K DIWS G +L+ + A PF+ NL + +KI + + +PP
Sbjct: 182 GYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD------YPPLPTEHYS 234
Query: 242 -EVRKLLCKILDPNPSTR 258
++R+L+ + P+P R
Sbjct: 235 EKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 77/213 (36%), Positives = 113/213 (53%), Gaps = 29/213 (13%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVI---DKDKIMRVGLADQIKREISVMRIVRH 73
E +G GA VY T + A+KVI +D + R QI REI ++R V H
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNH 131
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN-KVAKGKLKEDAARRYFQQLINAVDFCHSR 132
PN+V+ +++ +I ++E+ GG L +A + D AR Q+++ + + H R
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRR 187
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLS-ALAQ----CKHQDGLLHTTCGTPAYVAPEVI 187
+ HRDIKP NLL++ +N+KI+DFG+S LAQ C +++ GT AY++PE I
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC-------NSSVGTIAYMSPERI 240
Query: 188 N---RKG-YDGEKVDIWSCGVVLFVLLAGYLPF 216
N G YDG DIWS GV + G PF
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-31
Identities = 82/272 (30%), Positives = 127/272 (46%), Gaps = 38/272 (13%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
+G+G + VY AR+ T + VA+K I D G+ REIS+++ + HPNIV+L +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 66
Query: 82 VMATKSKIFFVMEYAKGG--ELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDI 139
V+ T++K++ V E+ + + + + Y QL+ + FCHS V HRD+
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126
Query: 140 KPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDI 199
KP+NLL++ +K++DFGL A A H T Y APE++ Y VDI
Sbjct: 127 KPQNLLINTEGAIKLADFGL-ARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDI 184
Query: 200 WSCGVVLFVLLAGYLPF-HDS---NLIEMYRKIG----------------KAEFKCPNWF 239
WS G + ++ F DS L ++R +G K F P W
Sbjct: 185 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF--PKWA 242
Query: 240 P-----------PEVRKLLCKILDPNPSTRIS 260
+ R LL ++L +P+ RIS
Sbjct: 243 RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 72/263 (27%), Positives = 117/263 (44%), Gaps = 21/263 (7%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVI--DKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
LG G V T + +AVK I + ++ ++ QI RE+ ++ P IV
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ----KQILRELDILHKCNSPYIVGF 64
Query: 80 YEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHS-RGVYH 136
Y I MEY GG L K +G++ E + ++ + + H + H
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124
Query: 137 RDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEK 196
RD+KP N+L++ +K+ DFG+S + + L T GT +Y+APE I Y K
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGNDY-SVK 179
Query: 197 VDIWSCGVVLFVLLAGYLPFHDSN-----LIEMYRKIGKAEF-KCPN-WFPPEVRKLLCK 249
DIWS G+ L L G P+ N + E+ + I + P+ F P+ + +
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNL 239
Query: 250 ILDPNPSTRISMAKIRESSWFRK 272
L +P R S ++ E + +K
Sbjct: 240 CLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 73/234 (31%), Positives = 133/234 (56%), Gaps = 13/234 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ +E+ +++G+GAF +V + T + A+K+++K ++++ + E +V+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHS 131
I L+ ++ ++ VM+Y GG+L ++K +L ED AR Y +++ A+ H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT--CGTPAYVAPEVI-- 187
HRDIKP+N+LLD N +++++DFG S L +QDG + ++ GTP Y++PE++
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKM--NQDGTVQSSVAVGTPDYISPEILQA 177
Query: 188 --NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--FKCPN 237
+ G G + D WS GV ++ +L G PF+ +L+E Y KI E F+ P+
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 84/264 (31%), Positives = 140/264 (53%), Gaps = 12/264 (4%)
Query: 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR 63
+D P L E Y +G+G+ V AR + + VAVK++D K R L +
Sbjct: 14 VDQGDPRSLLENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL---LFN 67
Query: 64 EISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI 123
E+ +MR +H N+V++Y+ +++ +ME+ +GG L + V++ +L E+ + ++
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVL 127
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
A+ + HS+GV HRDIK +++LL + +K+SDFG AQ + GTP ++A
Sbjct: 128 QALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMA 185
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLP-FHDSNLIEMYRKIGKAEFKCPNW--FP 240
PEVI+R Y G +VDIWS G+++ ++ G P F DS + M R K N
Sbjct: 186 PEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKIS 244
Query: 241 PEVRKLLCKILDPNPSTRISMAKI 264
P +R L ++L P R + ++
Sbjct: 245 PVLRDFLERMLTREPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-30
Identities = 71/208 (34%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI--DKDKIMRVGLADQIKREISVMRIVRH 73
+ +G+LLGQGAF +VY T + +AVK + D + + ++ EI +++ + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 74 PNIVQLYEVM--ATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCH 130
IVQ Y + + + ME+ GG + +++ + G L E+ R+Y +Q++ V + H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQ--CKHQDGLLHTTCGTPAYVAPEVIN 188
S + HRDIK N+L D N+K+ DFG S Q C G+ T GTP +++PEVI+
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSPEVIS 182
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPF 216
+GY G K DIWS G + +L P+
Sbjct: 183 GEGY-GRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 5e-30
Identities = 80/274 (29%), Positives = 149/274 (54%), Gaps = 19/274 (6%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQS---VAVKVIDKDKIM-RVGLADQIKREISVMRIV 71
+E+ ++LG GA+ KV+ R + + S A+KV+ K I+ + + + E V+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 72 RH-PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVA-KGKLKEDAARRYFQQLINAVDFC 129
R P +V L+ T +K+ +++Y GGELF ++ + + KE + Y +++ A++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI-- 187
H G+ +RDIK EN+LLD N ++ ++DFGLS + ++ CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRG 180
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPF----HDSNLIEMYRKIGKAEFKCPNWFPPEV 243
G+D + VD WS GV+++ LL G PF ++ E+ R+I K+E P
Sbjct: 181 GDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 244 RKLLCKILDPNPSTRISMA-----KIRESSWFRK 272
+ ++ ++L +P R+ +I++ +F+K
Sbjct: 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 80/276 (28%), Positives = 125/276 (45%), Gaps = 59/276 (21%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
+ LG GAF +V A + T+ A+K + K ++ +K E ++ + +V+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
Y K ++FVM+Y GG++ + + + E AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 139 IKPENLLLDENENLKISDFGLSA------------------------------LAQCK-- 166
IKP+N+L+D + ++K++DFGL ++ C+
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 167 -------------HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGY 213
HQ L H+ GTP Y+APEV+ RKGY + D WS GV+LF +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 214 LPFHDSNLIEMYRKIGKAEFKCPNW-----FPPEVR 244
PF E + K NW PP+V+
Sbjct: 246 PPFLAPTPTE-------TQLKVINWENTLHIPPQVK 274
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-30
Identities = 79/269 (29%), Positives = 128/269 (47%), Gaps = 47/269 (17%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ +E +++G+GAF +V + T A+K++ K ++ I+ E ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCHSR 132
+V+++ K ++ +ME+ GG++ + K L E+A + Y + + A+D H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 133 GVYHRDIKPENLLLDENENLKISDFGL--------------------------------- 159
G HRDIKP+NLLLD ++K+SDFGL
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS 219
A K++ L ++T GTP Y+APEV + GY+ + D WS GV+++ +L GY PF
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 220 NLIEMYRKIGKAEFKCPNW-----FPPEV 243
E YRK+ NW FPPEV
Sbjct: 240 TPQETYRKV-------MNWKETLVFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 83/270 (30%), Positives = 141/270 (52%), Gaps = 17/270 (6%)
Query: 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI-MRVG--LADQIKREISVMRIVRHPNIV 77
++G+G F +VY R T + A+K +DK +I M+ G LA + +S++ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 78 QLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYH 136
+ T K+ F+++ GG+L +++ G E R Y ++I ++ H+R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 137 RDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEK 196
RD+KP N+LLDE+ +++ISD GL+ C H + GT Y+APEV+ +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSS 176
Query: 197 VDIWSCGVVLFVLLAGYLPFHD---SNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDP 253
D +S G +LF LL G+ PF + E+ R + P+ F PE++ LL +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236
Query: 254 NPSTRI-----SMAKIRESSWFRKGMNQKQ 278
+ S R+ +++E +F KG++ +Q
Sbjct: 237 DVSKRLGCLGRGAQEVKEHVFF-KGIDWQQ 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 47/269 (17%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +E +++G+GAF +V + T A+K++ K ++ I+ E ++
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCHSR 132
+V+++ K ++ +ME+ GG++ + K L E+ + Y + + A+D H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD----------------------- 169
G HRDIKP+NLLLD ++K+SDFGL + H+
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 170 ----------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS 219
L +T GTP Y+APEV + GY+ + D WS GV+++ +L GY PF
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 220 NLIEMYRKIGKAEFKCPNW-----FPPEV 243
E Y+K+ NW FPPEV
Sbjct: 240 TPQETYKKV-------MNWKETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 72/218 (33%), Positives = 117/218 (53%), Gaps = 9/218 (4%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVI--DKDKIMRVGLADQIKREISVMRIVRHPNI 76
G+LLGQGAF +VY + T + +A K + D + ++ EI +++ ++H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 77 VQLYEVMATKSK--IFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCHSRG 133
VQ Y + +++ + MEY GG + +++ A G L E R+Y +Q++ + + HS
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQ--CKHQDGLLHTTCGTPAYVAPEVINRKG 191
+ HRDIK N+L D N+K+ DFG S Q C G+ T GTP +++PEVI+ +G
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSPEVISGEG 185
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG 229
Y G K D+WS G + +L P+ + + KI
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 87/298 (29%), Positives = 138/298 (46%), Gaps = 69/298 (23%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVI---DKDKIMRVGLADQIKREISVMRIVRHPNIVQ 78
+G+G + VY R+ +T Q VA+K I +++ G+ REIS+++ ++HPNIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE----GVPSTAIREISLLKELQHPNIVC 63
Query: 79 LYEVMATKSKIFFVMEYAKGG--ELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVY 135
L +V+ +S+++ + E+ + + + KG+ + + + Y Q++ + FCHSR V
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVL 123
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA-----------YVAP 184
HRD+KP+NLL+D +K++DFGL+ G P Y AP
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLA-------------RAFGIPVRVYTHEVVTLWYRAP 170
Query: 185 EVINRKGYDGEKVDIWSCGVVLFVLLAGYLP-FH-DS---NLIEMYRKIG---------- 229
EV+ VDIWS G + F +A P FH DS L ++R +G
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229
Query: 230 ------KAEFKCPNWFPPEVRK-----------LLCKILDPNPSTRISMAKIRESSWF 270
K F P W +R LL K+L +P+ RIS K +F
Sbjct: 230 TSLPDYKNTF--PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR----VGLADQIKREISV 67
+T +Y + +G GAF V AR T Q+VA+K KIM+ LA + RE+ +
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-----KIMKPFSTPVLAKRTYRELKL 62
Query: 68 MRIVRHPNIVQLYEVMATKSK-IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
++ +RH NI+ L ++ + + I+FV E G +L + L++ + + Q++ +
Sbjct: 63 LKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGL 121
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
+ HS GV HRD+KP N+L++EN +LKI DFGL+ + QD + T Y APE+
Sbjct: 122 KYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAPEI 176
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAG 212
+ +VDIWS G + +L G
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 47/261 (18%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E + +++G+GAF +V + T + A+K + K ++ + +K E V+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKL-KEDAARRYFQQLINAVDFCHSR 132
P +V LY ++ +ME+ GG+L + K ED R Y + + A++ H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG---------------------- 170
G HRDIKP+N+L+D ++K+SDFGLS +H
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 171 -----------------------LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLF 207
+ ++T GTP Y+APE+ ++GY G++ D WS G ++F
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239
Query: 208 VLLAGYLPFHDSNLIEMYRKI 228
L G+ PF N E YRKI
Sbjct: 240 ECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 75/244 (30%), Positives = 124/244 (50%), Gaps = 22/244 (9%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI----DKDKIMRVGLADQIKREISVMR 69
EKYE L+G+G++ V + T Q VA+K D + ++ + REI +++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-----REIRMLK 55
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN-KVAKGKLKEDAARRYFQQLINAVDF 128
+RH N+V L EV K +++ V E+ L + + L E R+Y Q++ ++F
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPAYVAPEVI 187
CHS + HRDIKPEN+L+ ++ +K+ DFG A+ G ++T T Y APE++
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFG---FARTLAAPGEVYTDYVATRWYRAPELL 172
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAG--YLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRK 245
G VDIW+ G ++ +L G P DS++ ++Y I KC P ++
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYHII-----KCLGNLIPRHQE 226
Query: 246 LLCK 249
+ K
Sbjct: 227 IFQK 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 84/266 (31%), Positives = 139/266 (52%), Gaps = 22/266 (8%)
Query: 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI-MRVG--LADQIKREISVMRIVRHPNIV 77
++G+G F +VY R T + A+K +DK +I M+ G LA + +S++ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 78 QLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYH 136
+ T K+ F+++ GG+L +++ G E R Y ++I ++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 137 RDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK-GYDGE 195
RD+KP N+LLDE+ +++ISD GL+ C H + GT Y+APEV+ + YD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYD-S 175
Query: 196 KVDIWSCGVVLFVLLAGYLPFH-----DSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250
D +S G +LF LL G+ PF D + I+ R + P+ F PE+R LL +
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTLTMAVELPDSFSPELRSLLEGL 233
Query: 251 LDPNPSTRI-----SMAKIRESSWFR 271
L + + R+ +++E +FR
Sbjct: 234 LQRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 76/263 (28%), Positives = 127/263 (48%), Gaps = 22/263 (8%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLAD-----QIKREISVMR 69
+Y + + LG+G+F VY + + +KV+ K + VG + Q +E ++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVL---KEIPVGELNPNETVQANQEAQLLS 57
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-----AKGKLKEDAARRYFQQLIN 124
+ HP IV+ + + + EY +G +L K+ L E+ +F QL+
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL--AQCKHQDGLLHTTCGTPAYV 182
V + H R + HRD+K +N+ L N LKI DFG+S L C L T GTP Y+
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD----LATTFTGTPYYM 172
Query: 183 APEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPP 241
+PE + +GYD K DIWS G +L+ + F N + + +I + P +
Sbjct: 173 SPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSR 231
Query: 242 EVRKLLCKILDPNPSTRISMAKI 264
++ ++ +L+ +PS R S A+I
Sbjct: 232 QLNSIMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-28
Identities = 70/225 (31%), Positives = 118/225 (52%), Gaps = 13/225 (5%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
+G+G+ V A T + VAVK +D K R L + E+ +MR H N+V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRDYHHENVVDMYN 86
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKP 141
+++ VME+ +GG L + V ++ E+ ++ A+ + H++GV HRDIK
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 142 ENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWS 201
+++LL + +K+SDFG AQ + + GTP ++APEVI+R Y G +VDIWS
Sbjct: 147 DSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203
Query: 202 CGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
G+++ ++ G P+ + ++ R+I PP V+
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-------LPPRVKDS 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 68/201 (33%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVID----KDKIMRVGLADQIKREISVMRIVRHPNIV 77
+G+G+F +VY RT + VA+K+ID +D+I + I++EI+V+ P I
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEI------EDIQQEITVLSQCDSPYIT 65
Query: 78 QLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
+ Y +K++ +MEY GG + + G L+E ++++ +D+ HS HR
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKV 197
DIK N+LL E ++K++DFG++ Q +T GTP ++APEVI + YD K
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF-KA 182
Query: 198 DIWSCGVVLFVLLAGYLPFHD 218
DIWS G+ L G P D
Sbjct: 183 DIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 76/260 (29%), Positives = 122/260 (46%), Gaps = 25/260 (9%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
++G +G+G F V Q VAVK + D A E SVM +RHPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDD----STAAQAFLAEASVMTTLRHPNL 62
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFC------H 130
VQL V+ + ++ V EY G L + + + + A QQL A+D C
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA-YVAPEVINR 189
+ HRD+ N+L+ E+ K+SDFGL+ A G L P + APE + R
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTAPEAL-R 172
Query: 190 KGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLL 247
+ K D+WS G++L+ + + G +P+ L ++ + K + P PPEV K++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232
Query: 248 CKILDPNPSTRISMAKIRES 267
+ +P+ R + ++RE
Sbjct: 233 KDCWELDPAKRPTFKQLREQ 252
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
+G+G + VY AR + + VA+K + D R G+ REI+++ +RHPNIV+L E
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 82 VMATKS--KIFFVMEYAKG--GELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
V+ K IF VMEY + L + + E + QL+ + + H + HR
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHR 132
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI-NRKGYDGEK 196
D+K NLLL + LKI+DFGL+ + T Y APE++ Y
Sbjct: 133 DLKVSNLLLTDKGCLKIADFGLARTYG--LPAKPMTPKVVTLWYRAPELLLGCTTYT-TA 189
Query: 197 VDIWSCGVVLFVLLAG 212
+D+W+ G +L LLA
Sbjct: 190 IDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 73/255 (28%), Positives = 135/255 (52%), Gaps = 9/255 (3%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
+G+G+ V A + + VAVK +D K R L + E+ +MR +H N+V++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 84
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKP 141
+++ VME+ +GG L + V ++ E+ ++ A+ H++GV HRDIK
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 142 ENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWS 201
+++LL + +K+SDFG AQ + + GTP ++APE+I+R Y G +VDIWS
Sbjct: 145 DSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 202 CGVVLFVLLAGYLPFHDS---NLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTR 258
G+++ ++ G P+ + ++M R + K + P ++ L ++L +P+ R
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261
Query: 259 ISMAKIRESSWFRKG 273
+ A++ + + K
Sbjct: 262 ATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 75/217 (34%), Positives = 117/217 (53%), Gaps = 32/217 (14%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI------DKDKIMRVGLADQIKREISV 67
KYE+ + LG+GA+ V+ A RT + VA+K I D A + REI
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD-------AQRTFREIMF 59
Query: 68 MRIVR-HPNIVQLYEVM-ATKSK-IFFVMEYAKGGELFNKVAKGKLKEDAARRY-FQQLI 123
++ + HPNIV+L V+ A K I+ V EY + + V + + ED +RY QL+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD--LHAVIRANILEDVHKRYIMYQLL 117
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS-ALAQCK--HQDGLLHTTCGTPA 180
A+ + HS V HRD+KP N+LL+ + +K++DFGL+ +L++ + ++ +L T
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 181 YVAPEVI---NR--KGYDGEKVDIWSCGVVLFVLLAG 212
Y APE++ R KG VD+WS G +L +L G
Sbjct: 178 YRAPEILLGSTRYTKG-----VDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 80/273 (29%), Positives = 135/273 (49%), Gaps = 20/273 (7%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVID----KDKIMRVGLADQIKREISVMRIVRHPNIV 77
+G+G+F +V+ RT Q VA+K+ID +D+I + I++EI+V+ P +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI------EDIQQEITVLSQCDSPYVT 65
Query: 78 QLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
+ Y +K++ +MEY GG + + G E ++++ +D+ HS HR
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 125
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKV 197
DIK N+LL E ++K++DFG++ Q +T GTP ++APEVI + YD K
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKA 182
Query: 198 DIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNW---FPPEVRKLLCKILDPN 254
DIWS G+ L G P D + + + I K P F ++ + L+ +
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNPPTLTGEFSKPFKEFIDACLNKD 240
Query: 255 PSTRISMAKIRESSWFRKGMNQKQKQKVTESKD 287
PS R + ++ + + K N K+ +TE D
Sbjct: 241 PSFRPTAKELLKHKFIVK--NAKKTSYLTELID 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQ---IKREISVMRIVRHPN 75
G +LG+GA+ VY Q +AVK ++ D + + ++ E+ +++ ++H N
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGV 134
IVQ + I ME+ GG + + + + G L E +Y +Q+++ V + H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 135 YHRDIKPENLLLDENENLKISDFGLS-----ALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
HRDIK N++L N +K+ DFG + H + +L + GTP ++APEVIN
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN-MLKSMHGTPYWMAPEVINE 182
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPF 216
GY G K DIWS G +F + G P
Sbjct: 183 SGY-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 81/291 (27%), Positives = 123/291 (42%), Gaps = 56/291 (19%)
Query: 24 QGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83
+G + VY AR +T + VA+K + +K G REI+++ ++HPNIV + EV+
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVV 73
Query: 84 --ATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ--------QLINAVDFCHSRG 133
+ KI+ VMEY + +L K L E + + Q QL++ V H
Sbjct: 74 VGSNLDKIYMVMEYVEH-DL-----KS-LMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW 126
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG--TPAYVAPEVINRKG 191
+ HRD+K NLLL+ LKI DFGL+ ++ L T T Y APE++
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGLAR----EYGSPLKPYTQLVVTLWYRAPELLLGAK 182
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA----------EF-KCPNW-- 238
+D+WS G + LL F + I+ KI K F + P
Sbjct: 183 EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242
Query: 239 --------------FPPEVR-----KLLCKILDPNPSTRISMAKIRESSWF 270
FP LL ++L +P+ RIS + +F
Sbjct: 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 76/235 (32%), Positives = 114/235 (48%), Gaps = 10/235 (4%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
K+EV ++G+GA+ V R T + VA+K KD + + RE+ ++R ++
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGG--ELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
NIV+L E + K++ V EY + EL ++ G + R Y QLI A+ +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHWCHKN 119
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
+ HRDIKPENLL+ N+ LK+ DFG A + + T Y +PE++ Y
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGF-ARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLL 247
G+ VD+WS G +L L G F + I+ I K P E KL
Sbjct: 179 -GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL----GPLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI----DKDKIMRVGLADQIKREISVMR 69
EKYE +G+G++ V+ R+ T Q VA+K D I ++ L REI +++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL-----REIRMLK 55
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVD 127
++HPN+V L EV K K+ V EY L K +G + E ++ Q + AV+
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVN 114
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
FCH HRD+KPEN+L+ + +K+ DFG + + T Y APE++
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILT--GPGDDYTDYVATRWYRAPELL 172
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAG 212
G VD+W+ G V LL G
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 75/243 (30%), Positives = 121/243 (49%), Gaps = 27/243 (11%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR-IVRHP 74
+E+ ++G G + +VY R ++T Q A+KV+D + ++IK EI++++ H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73
Query: 75 NIVQLYEVMATKS------KIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQLINA 125
NI Y KS +++ VME+ G + + V K LKED ++++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
+ H+ V HRDIK +N+LL EN +K+ DFG+S AQ G +T GTP ++APE
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPE 191
Query: 186 VI----NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPP 241
VI N + DIWS G+ + G P D + + +A F P PP
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPRNPPP 244
Query: 242 EVR 244
+++
Sbjct: 245 KLK 247
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 4e-26
Identities = 81/285 (28%), Positives = 143/285 (50%), Gaps = 20/285 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +E+ LG GAF KVY A++ T A KVID L D + EI ++ H
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMV-EIDILASCDH 61
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK--LKEDAARRYFQQLINAVDFCHS 131
PNIV+L + ++ ++ ++E+ GG + + + + L E R +Q + A+++ H
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSA--LAQCKHQDGLLHTTCGTPAYVAPEVI-- 187
+ HRD+K N+L + ++K++DFG+SA + +D + GTP ++APEV+
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMC 177
Query: 188 ---NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPP 241
+ YD K D+WS G+ L + P H+ N + + KI K+E P+ +
Sbjct: 178 ETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 236
Query: 242 EVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESK 286
E + L K L+ N R + ++ + + N+ ++ + E+K
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEAK 281
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 69/226 (30%), Positives = 116/226 (51%), Gaps = 8/226 (3%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +E+ + +G G + VY AR++ T + A+KVI K+ +++EI +M+ +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKH 65
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCHSR 132
NIV + + K++ ME+ GG L + G L E ++ + + + HS+
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV--INRK 190
G HRDIK N+LL +N ++K++DFG+S AQ + GTP ++APEV + RK
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP 236
G + DIW+ G+ L P D + + + K+ F+ P
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 86/308 (27%), Positives = 131/308 (42%), Gaps = 65/308 (21%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVK----VIDKDKIMRVGLADQIKREISVMR 69
+ YE +G+G + KVY AR T + VA+K +D++ I L REIS+++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-----REISLLQ 55
Query: 70 IVRH-PNIVQLYEVMATKSK-----IFFVMEY-----AKGGELFNKVAKGKLKEDAARRY 118
++ IV+L +V + K ++ V EY K + + L + +
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 119 FQQLINAVDFCHSRGVYHRDIKPENLLLDENEN-LKISDFGLS-----ALAQCKHQDGLL 172
QL+ V CH GV HRD+KP+NLL+D+ + LKI+D GL + H+
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE---- 171
Query: 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF-HDS---NLIEMYRKI 228
T Y APEV+ + VDIWS G + + F DS L+ +++ +
Sbjct: 172 ---IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228
Query: 229 GKA---------------EFKCPNWFP-----------PEVRKLLCKILDPNPSTRISMA 262
G EF P W P PE LL K+L +P+ RIS
Sbjct: 229 GTPTEQVWPGVSKLRDWHEF--PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286
Query: 263 KIRESSWF 270
+F
Sbjct: 287 AALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 81/278 (29%), Positives = 135/278 (48%), Gaps = 30/278 (10%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVID----KDKIMRVGLADQIKREISVMRIVRHPNIV 77
+G+G+F +V+ RT + VA+K+ID +D+I + I++EI+V+ P +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI------EDIQQEITVLSQCDSPYVT 65
Query: 78 QLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
+ Y +K++ +MEY GG + + G L E ++++ +D+ HS HR
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKV 197
DIK N+LL E+ +K++DFG++ Q +T GTP ++APEVI + YD K
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKA 182
Query: 198 DIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPE--------VRKLLCK 249
DIWS G+ L G P S L M K F P PP +++ +
Sbjct: 183 DIWSLGITAIELAKGEPP--HSELHPM-----KVLFLIPKNNPPTLEGNYSKPLKEFVEA 235
Query: 250 ILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKD 287
L+ PS R + ++ + + + K+ +TE D
Sbjct: 236 CLNKEPSFRPTAKELLKHKFIVR--FAKKTSYLTELID 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 66/225 (29%), Positives = 113/225 (50%), Gaps = 21/225 (9%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR----VGLADQIKREISVMR 69
++Y+ +G GA+ +V A +T + VA+K K+ R A + RE+ +++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK-----KLSRPFQSAIHAKRTYRELRLLK 69
Query: 70 IVRHPNIVQLYEVMATKS------KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI 123
+ H N++ L +V S ++ V G +L N V KL +D + Q++
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL 128
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+ + HS G+ HRD+KP N+ ++E+ LKI DFGL+ +H D + T Y A
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRA 183
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
PE++ + + VDIWS G ++ LL G F S+ I+ ++I
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 69/213 (32%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKD---KIMRVGLADQIKREISVMRI 70
EK LG+GA V R T A+K I D + + QI RE+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK-----QILRELEINKS 55
Query: 71 VRHPNIVQLYEVMATK--SKIFFVMEYAKGGEL---FNKVAK--GKLKEDAARRYFQQLI 123
+ P IV+ Y + S I MEY +GG L + KV K G++ E + + ++
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+ + HSR + HRDIKP N+LL +K+ DFG+S L T GT Y+A
Sbjct: 116 KGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS----LAGTFTGTSFYMA 171
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF 216
PE I K Y D+WS G+ L + PF
Sbjct: 172 PERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 87/297 (29%), Positives = 139/297 (46%), Gaps = 49/297 (16%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++YE +G+G + VY AR TN+++A+K I ++ G+ REIS+++ ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
Query: 74 PNIVQLYEVMATKSKIFFVMEY--------AKGGELFNKVAKGKLKEDAARRYFQQLINA 125
NIV+L +V+ ++ +++ V EY F K + + Y Q++
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR------LIKTYLYQILRG 114
Query: 126 VDFCHSRGVYHRDIKPENLLLDENEN-LKISDFGLSALAQCKHQDGLLHTTCGTPAYVAP 184
+ +CHS V HRD+KP+NLL+D N LK++DFGL A A H T Y AP
Sbjct: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGL-ARAFGIPVRTFTHEVV-TLWYRAP 172
Query: 185 EVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH--DSNLIEMY---RKIGK--------- 230
E++ + VDIWS G + F + P DS + E++ R +G
Sbjct: 173 EILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231
Query: 231 ---AEFKC--PNWFP-----------PEVRKLLCKILDPNPSTRISMAKIRESSWFR 271
++K P W P P LL K+L +PS RI+ E +F+
Sbjct: 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 62/189 (32%), Positives = 96/189 (50%), Gaps = 11/189 (5%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
R +G G+F VY+AR +RTN+ VA+K + I +E+ ++ +RHPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 80 YEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
+ + VMEY G +V K L+E + + + HS HRD
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI---NRKGYDGE 195
IK N+LL E +K++DFG ++L ++ GTP ++APEVI + YDG
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDG- 193
Query: 196 KVDIWSCGV 204
KVD+WS G+
Sbjct: 194 KVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 3e-25
Identities = 37/58 (63%), Positives = 44/58 (75%), Gaps = 2/58 (3%)
Query: 318 LNAFDIISLSAGFDLSGFFDE--NPLIREARFTSKRPASVIISKLEEIAKSLRLKMMK 373
LNAFD+ISLS+G DLSG F+E +E RFTS++PAS IISKLEEIAK L K+ K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 78/303 (25%), Positives = 127/303 (41%), Gaps = 66/303 (21%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI---DKDKIMRVGLADQIKREISVMRIV 71
KYE +G+G + V+ A++ T++ VA+K + D D+ G+ REI +++ +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE----GVPSSALREICLLKEL 56
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGG-ELFNKVAKGKLKEDAARRYFQQLINAVDFCH 130
+H NIV+LY+V+ + K+ V EY + + G + + + + QL+ + FCH
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA---------- 180
S V HRD+KP+NLL+++N LK++DFGL+ G P
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLA-------------RAFGIPVRCYSAEVVTL 163
Query: 181 -YVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE--------------- 223
Y P+V+ K Y +D+WS G + L P N ++
Sbjct: 164 WYRPPDVLFGAKLYS-TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 222
Query: 224 ----------------MYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
MY P R LL +L NP RIS + +
Sbjct: 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLN-STGRDLLQNLLVCNPVQRISAEEALQH 281
Query: 268 SWF 270
+F
Sbjct: 282 PYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+K+++ +G+G + +VY AR T + VA+K + D + G REI ++R + H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLNH 65
Query: 74 PNIVQLYEVMATKSK----------IFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQ 121
NIV L E++ K + V EY +L + G ED + + +Q
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPA 180
L+ +++CH + HRDIK N+LL+ +K++DFGL+ L ++ +T T
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPYTNKVITLW 182
Query: 181 YVAPEVINRKGYDGEKVDIWSCGVVLFVL---------------------LAGY------ 213
Y PE++ + G +D+WSCG +L L L G
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 214 -----LP-FHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
LP F+ + YR+ + EF ++ P LL +L +PS R + + S
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEF---SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 268 SW 269
W
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 9e-25
Identities = 78/259 (30%), Positives = 125/259 (48%), Gaps = 22/259 (8%)
Query: 62 KREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKED------AA 115
+ E+ + H IV+ ++ + K+ +MEY GG+L NK K +LKE
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL-NKQIKQRLKEHLPFQEYEV 171
Query: 116 RRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT 175
F Q++ A+D HSR + HRD+K N+ L +K+ DFG S + +
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAE- 232
CGTP Y+APE+ RK Y +K D+WS GV+L+ LL + PF + E+ +++ GK +
Sbjct: 232 CGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290
Query: 233 FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQK----QKVTESKDA 288
F CP ++ LL +L NP+ R + ++ + + + N Q + D
Sbjct: 291 FPCP--VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDR 348
Query: 289 AS-----QDAGASAPQGSS 302
Q++G AP SS
Sbjct: 349 EEILRQLQESGERAPPPSS 367
|
Length = 478 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 18/206 (8%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
KYE +GQG F +V+ AR +T Q VA+K + + + G REI ++++++H
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKHE 71
Query: 75 NIVQLYEVMATKSK--------IFFVMEYAK---GGELFNKVAKGKLKEDAARRYFQQLI 123
N+V L E+ TK+ + V E+ + G L NK K L E ++ + L+
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE--IKKVMKMLL 129
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS-ALAQCKHQDGLLHTT-CGTPAY 181
N + + H + HRD+K N+L+ ++ LK++DFGL+ A + K+ +T T Y
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 182 VAPEV-INRKGYDGEKVDIWSCGVVL 206
PE+ + + Y G +D+W G ++
Sbjct: 190 RPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDK-DKIMRVGLADQIKREISVMRIVR 72
+Y+ +G+GA+ V A T VA+K I + + REI ++R +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKILRRFK 61
Query: 73 HPNIVQLYEVMATKS-----KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVD 127
H NI+ + +++ S ++ V E + +L+ + L D + + Q++ +
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH-QDGLLHTTCGTPAYVAPEV 186
+ HS V HRD+KP NLLL+ N +LKI DFGL+ +A +H G L T Y APE+
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 187 -INRKGYDGEKVDIWSCGVVLFVLLAG 212
+N KGY + +DIWS G +L +L+
Sbjct: 181 MLNSKGYT-KAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 34/265 (12%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR----EISVMRIVRHPN 75
+G+G F VY ++ N VAVK R L +KR E +++ HPN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTC------RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI-------NAVDF 128
IV+L V K I+ VME GG L L++ R ++L+ +++
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTF-----LRKKKNRLTVKKLLQMSLDAAAGMEY 108
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP----AYVAP 184
S+ HRD+ N L+ EN LKISDFG+S + + G+ + G + AP
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAP 164
Query: 185 EVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPE 242
E +N Y E D+WS G++L+ G P+ + + +I P P E
Sbjct: 165 EALNYGRYTSES-DVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEE 223
Query: 243 VRKLLCKILDPNPSTRISMAKIRES 267
+ +L+ + +P R S ++I
Sbjct: 224 IYRLMLQCWAYDPENRPSFSEIYNE 248
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR----VGLADQIKREISV 67
+ +Y+ +G GA+ V A R+ + VA+K KI LA + RE+ +
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKI 57
Query: 68 MRIVRHPNIVQLYEVMATKSK----IFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQL 122
+R +H NI+ + +++ ++ VM+ +L + + + L E+ R + QL
Sbjct: 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQL 116
Query: 123 INAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT--CGTPA 180
+ + + HS V HRD+KP NLL++E+ L+I DFG++ + T T
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 181 YVAPEVINRKGYDGEKVDIWSCGVVL 206
Y APE++ +D+WS G +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 62/258 (24%), Positives = 122/258 (47%), Gaps = 12/258 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E++ + R LG G F +V+ + VA+K++ D +++ ++E+ ++ +RH
Sbjct: 6 EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLK---QQDFQKEVQALKRLRH 61
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQ-QLINAVDFCH 130
+++ L+ V + ++ + E + G L F + +G++ A+ Q+ + +
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
+ HRD+ N+L+ E+ K++DFGL+ L K L + APE +
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHG 179
Query: 191 GYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLC 248
+ K D+WS G++L+ + G +P+ N E+Y +I CP P E+ K++
Sbjct: 180 TFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML 238
Query: 249 KILDPNPSTRISMAKIRE 266
+ P R S +RE
Sbjct: 239 ECWAAEPEDRPSFKALRE 256
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM----RVGLADQIKREISVM 68
YE+ LG+G F +VY AR I+T + VA+K KI+ + G REI ++
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKIL 61
Query: 69 RIVRHPNIVQLYEVMATKSK-----------IFFVMEYAKGGELFNKVAKGKLKEDAARR 117
+ ++HPN+V L ++ + + M++ G L N KL E +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--SVKLTESQIKC 119
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS-----ALAQCKHQDGLL 172
Y QL+ +++ H + HRDIK N+L+D LKI+DFGL+ K G
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 173 ---HTTC-GTPAYVAPE-VINRKGYDGEKVDIWSCGVVL 206
+T T Y PE ++ + Y VDIW G V
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 56/153 (36%), Positives = 84/153 (54%), Gaps = 13/153 (8%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV----GLADQIKREISVMR 69
E Y+ LG+G++A VY RS T Q VA+K I R+ G RE S+++
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLK 58
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVD 127
++H NIV L++++ TK + V EY +L + G L R + QL+ +
Sbjct: 59 DLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160
+CH R V HRD+KP+NLL+ E LK++DFGL+
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-23
Identities = 73/239 (30%), Positives = 123/239 (51%), Gaps = 38/239 (15%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
+YEV + +G G F +V+ + RT + K I + ++ Q+ E++VMR ++H
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMRELKHK 72
Query: 75 NIVQLYEVMATKS--KIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVD 127
NIV+ + K+ K++ +ME+ G+L + K GK++E A +QL++A+
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 128 FCHS-------RGVYHRDIKPENLLLD-----------ENENL------KISDFGLSALA 163
+CH+ V HRD+KP+N+ L + NL KI DFGLS
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 164 QCKHQDGLLHTTCGTPAYVAPEVI--NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN 220
+ + H+ GTP Y +PE++ K YD +K D+W+ G +++ L +G PFH +N
Sbjct: 193 GI---ESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 72/265 (27%), Positives = 121/265 (45%), Gaps = 23/265 (8%)
Query: 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV--RH--PNI 76
+G G +VY R +T +AVK ++ R G ++ KR + + +V H P I
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDVVLKSHDCPYI 76
Query: 77 VQLYEVMATKSKIFFVME-YAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR-GV 134
V+ Y T S +F ME + + K +G + ED + ++ A+ + + GV
Sbjct: 77 VKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHT-TCGTPAYVAPEVINRKGYD 193
HRD+KP N+LLD + N+K+ DFG+S + D T + G AY+APE I+ +
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISG----RLVDSKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 194 GE---KVDIWSCGVVLFVLLAGYLPFHDSNL-IEMYRKIGKAEFKCPNW---FPPEVRKL 246
+ + D+WS G+ L L G P+ + E+ KI + E F P+
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSF 252
Query: 247 LCKILDPNPSTRISMAKIRESSWFR 271
+ L + R ++ + + R
Sbjct: 253 VDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 5e-23
Identities = 75/258 (29%), Positives = 118/258 (45%), Gaps = 24/258 (9%)
Query: 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLY 80
+LG+G + VY AR + T +A+K I ++ R + EI++ ++H NIVQ
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRY--VQPLHEEIALHSYLKHRNIVQYL 71
Query: 81 EVMATKSKIFFVMEYAKGGELF----NKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYH 136
+ ME GG L +K K E Y +Q++ + + H + H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 137 RDIKPENLLLDENEN-LKISDFGLSALAQCKHQDGL---LHTTCGTPAYVAPEVINR--K 190
RDIK +N+L++ +KISDFG K G+ T GT Y+APEVI++ +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFG-----TSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHD--SNLIEMYRKIG--KAEFKCPNWFPPEVRKL 246
GY G DIWS G + + G PF + M+ K+G K + P E +
Sbjct: 187 GY-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFKIHPEIPESLSAEAKNF 244
Query: 247 LCKILDPNPSTRISMAKI 264
+ + +P+P R S +
Sbjct: 245 ILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 49/153 (32%), Positives = 91/153 (59%), Gaps = 3/153 (1%)
Query: 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
PS+ E++ + + + +GAF KVY R ++ AVKV+ K ++ + Q++ E +
Sbjct: 1 PSI--EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL 58
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVA-KGKLKEDAARRYFQQLINAVD 127
+ + P IV LY + + + ++ VMEY GG++ + + G E+ A +Y ++ A+D
Sbjct: 59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD 118
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160
+ H G+ HRD+KP+N+L+ ++K++DFGLS
Sbjct: 119 YLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 9e-23
Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 20/217 (9%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR-IVRHP 74
+E+ L+G G + +VY R ++T Q A+KV+D + ++IK+EI++++ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 75 NIVQLYEVMATKS------KIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQLINA 125
NI Y K+ +++ VME+ G + + + K LKE+ ++++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
+ H V HRDIK +N+LL EN +K+ DFG+S AQ G +T GTP ++APE
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPE 181
Query: 186 VI----NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD 218
VI N K D+WS G+ + G P D
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 70/254 (27%), Positives = 122/254 (48%), Gaps = 17/254 (6%)
Query: 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLY 80
LLG+G F +V+ +++ VAVK +D + L + E +++ HPNIV+L
Sbjct: 2 LLGKGNFGEVFKG-TLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 81 EVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
V + I+ VME GG+ F + K +LK ++ + + S+ HRD
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP----AYVAPEVINRKGYDG 194
+ N L+ EN LKISDFG+S + +D ++++ G + APE +N Y
Sbjct: 119 LAARNCLVGENNVLKISDFGMS-----RQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 195 EKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILD 252
E D+WS G++L+ + G P+ + ++ K CP P +V K++ + D
Sbjct: 174 ES-DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD 232
Query: 253 PNPSTRISMAKIRE 266
P R +++++
Sbjct: 233 YKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 67/226 (29%), Positives = 116/226 (51%), Gaps = 12/226 (5%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
YE+ + +G G + VY AR++ T + AVK+I + L I++EI +++ +H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKHCN 67
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCHSRGV 134
IV + ++ K++ MEY GG L + G L E ++ + + + HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 135 YHRDIKPENLLLDENENLKISDFGLSA--LAQCKHQDGLLHTTCGTPAYVAPEV--INRK 190
HRDIK N+LL +N ++K++DFG++A A + + GTP ++APEV + +
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI----GTPYWMAPEVAAVEKN 183
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP 236
G + DIW+ G+ L P D + + + K+ F+ P
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 63/220 (28%), Positives = 112/220 (50%), Gaps = 11/220 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E+Y+ +G GA+ V A R Q VAVK + + + A + RE+ +++ ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKH 73
Query: 74 PNIVQLYEVMATKSKI-----FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDF 128
N++ L +V + I +++ G +L N V KL ++ + QL+ + +
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
HS G+ HRD+KP N+ ++E+ L+I DFGL+ + D + T Y APE++
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLA-----RQADDEMTGYVATRWYRAPEIML 188
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
+ + VDIWS G ++ LL G F ++ I+ ++I
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
+Y++ ++G+G++ V A T + VA+K I D V A +I REI ++R++RHP
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 59
Query: 75 NIVQLYEVMATKSK-----IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ----QLINA 125
+IV++ +M S+ I+ V E +L + K +D + Q QL+ A
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVI---KANDDLTPEHHQFFLYQLLRA 115
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPAYVAP 184
+ + H+ V+HRD+KP+N+L + + LKI DFGL+ +A + T T Y AP
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 185 EVINR--KGYDGEKVDIWSCGVVLFVLLAG 212
E+ Y +DIWS G + +L G
Sbjct: 176 ELCGSFFSKYT-PAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 11/220 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E+Y+ +G GA+ V A +T VAVK + + + A + RE+ +++ ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 75
Query: 74 PNIVQLYEVM--ATKSKIF---FVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDF 128
N++ L +V A + F +++ + G +L N V KL +D + Q++ + +
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
HS + HRD+KP NL ++E+ LKI DFGL+ +H D + T Y APE++
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIML 190
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
+ + VDIWS G ++ LL G F ++ I+ + I
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 8e-22
Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 11/217 (5%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
R +G G+F VY+AR +RTN+ VA+K + I +E+ ++ ++HPN ++
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 80 YEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
+ + VMEY G +V K L+E + + + HS + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI---NRKGYDGE 195
IK N+LL E +K++DFG +++A ++ GTP ++APEVI + YDG
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDG- 203
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE 232
KVD+WS G+ L P + N + I + E
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 240
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 26/223 (11%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVI---DKDKIMRVGLADQIKREISVMRIVRHPNI 76
R LG G+ V+ A ++ VAVK I D + REI ++R + H NI
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV------KHALREIKIIRRLDHDNI 64
Query: 77 VQLYEVMATKSK--------------IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQL 122
V++YEV+ ++ V EY + +L N + +G L E+ AR + QL
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQL 123
Query: 123 INAVDFCHSRGVYHRDIKPENLLLD-ENENLKISDFGLSALAQCKHQ-DGLLHTTCGTPA 180
+ + + HS V HRD+KP N+ ++ E+ LKI DFGL+ + + G L T
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 181 YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE 223
Y +P ++ + +D+W+ G + +L G F ++ +E
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-21
Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-- 72
+YE +G GA+ VY AR + VA+K + + + GL RE+++++ +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 73 -HPNIVQLYEVMAT-----KSKIFFVMEYAKGG--ELFNKVAKGKLKEDAARRYFQQLIN 124
HPNIV+L +V AT ++K+ V E+ +KV L + + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAP 184
+DF H+ + HRD+KPEN+L+ +K++DFGL+ + C+ L T Y AP
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAP 176
Query: 185 EVINRKGYDGEKVDIWSCGVVL 206
EV+ + Y VD+WS G +
Sbjct: 177 EVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 70/271 (25%), Positives = 115/271 (42%), Gaps = 30/271 (11%)
Query: 20 RLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+ LG+G F KV R T + VAVK ++ + +D +REI ++R + H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH-RSD-FEREIEILRTLDHEN 67
Query: 76 IVQLYEVM--ATKSKIFFVMEYAKGGELFNKVAKGKLKEDAAR--RYFQQLINAVDFCHS 131
IV+ V + +MEY G L + + + + + + R + Q+ +D+ S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA-YVAPEVINRK 190
+ HRD+ N+L++ + +KISDFGL+ + + +P + APE +
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK---------------- 234
+ D+WS GV L+ L P S E R IG A+ +
Sbjct: 188 KFSSAS-DVWSFGVTLYELFTYGDPSQ-SPPAEFLRMIGIAQGQMIVTRLLELLKEGERL 245
Query: 235 -CPNWFPPEVRKLLCKILDPNPSTRISMAKI 264
P P EV L+ + P R S A +
Sbjct: 246 PRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 16/163 (9%)
Query: 64 EISVMRIVR-HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQ 121
E V ++++ +PN ++LY + T +M+Y K G+LF+ + +GKL E ++ +Q
Sbjct: 58 EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ 117
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENEN-LKISDFGLSALAQCKHQDGLLHTTC---G 177
L+ A++ H + H DIK EN+L D ++ + + D+GL CK + T G
Sbjct: 118 LVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-----CKI----IGTPSCYDG 168
Query: 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN 220
T Y +PE I YD D W+ GV+ + LL G PF +
Sbjct: 169 TLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-21
Identities = 71/252 (28%), Positives = 125/252 (49%), Gaps = 13/252 (5%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG G + +VY + + +VAVK + +D M V ++ +E +VM+ ++HPN+VQL
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEV---EEFLKEAAVMKEIKHPNLVQLLG 69
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ---QLINAVDFCHSRGVYHRD 138
V + + + E+ G L + + + +E A Q+ +A+++ + HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP-AYVAPEVINRKGYDGEKV 197
+ N L+ EN +K++DFGLS L H P + APE + + K
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPESLAYNKFS-IKS 186
Query: 198 DIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNP 255
D+W+ GV+L+ + G P+ +L ++Y + K + P PP+V +L+ NP
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNP 246
Query: 256 STRISMAKIRES 267
S R S A+I ++
Sbjct: 247 SDRPSFAEIHQA 258
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 70/253 (27%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
+G+G F +V+ R N VAVK + + L + +E +++ HPNIV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRE--TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 82 VMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDI 139
V K I+ VME +GG+ F + +LK + + +++ S+ HRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 140 KPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP----AYVAPEVINRKGYDGE 195
N L+ E LKISDFG+S + +DG+ +T G + APE +N Y E
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 196 KVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDP 253
D+WS G++L+ + G +P+ + + + I + CP P V +L+ + +
Sbjct: 177 S-DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 254 NPSTRISMAKIRE 266
+P R S + + +
Sbjct: 236 DPGQRPSFSTVHQ 248
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 11/217 (5%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
R +G G+F VY+AR +R ++ VA+K + I +E+ ++ +RHPN +Q
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 80 YEVMATKSKIFFVMEYAKG-GELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
+ + VMEY G +V K L+E + + + HS + HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI---NRKGYDGE 195
+K N+LL E +K+ DFG +++ + GTP ++APEVI + YDG
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDG- 193
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE 232
KVD+WS G+ L P + N + I + E
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 70/257 (27%), Positives = 117/257 (45%), Gaps = 16/257 (6%)
Query: 21 LLGQGAFAKVYYARSIRTNQ---SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIV 77
LG G+F V + VAVK + DK+ + D +E ++M + H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLI 59
Query: 78 QLYEVMATKSKIFFVMEYAKGGELFN---KVAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
+LY V+ T + V E A G L + K A G Y Q+ N + + S+
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 135 YHRDIKPENLLLDENENLKISDFGLS-ALAQCKHQDGLLHTTCGTP-AYVAPEVINRKGY 192
HRD+ N+LL ++ +KI DFGL AL Q ++ P A+ APE + + +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQ-NEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 193 DGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA--EFKCPNWFPPEVRKLLCK 249
D+W GV L+ + G P+ + ++ +KI K + P P ++ ++ +
Sbjct: 178 S-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236
Query: 250 ILDPNPSTRISMAKIRE 266
NP+ R + A +RE
Sbjct: 237 CWAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 71/270 (26%), Positives = 127/270 (47%), Gaps = 42/270 (15%)
Query: 1 MFGMDHNKPSVL--------TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI 52
++G+ S+L T+ +E+ +G+G + KVY + + AVK++D
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 53 MRVGLADQIKREISVMR-IVRHPNIVQLYEVMATKSK-----IFFVMEYAKGGELFNKVA 106
+ ++I+ E ++++ + HPN+V+ Y + K ++ V+E GG + ++
Sbjct: 61 VD----EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELV 115
Query: 107 KGKLKEDAARRYFQQLINAVDF--------CHSRGVYHRDIKPENLLLDENENLKISDFG 158
KG L +R + +I+ + + H+ + HRD+K N+LL +K+ DFG
Sbjct: 116 KGLLI--CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173
Query: 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVIN-RKGYDGE---KVDIWSCGVVLFVLLAGYL 214
+S AQ +T+ GTP ++APEVI + YD + D+WS G+ L G
Sbjct: 174 VS--AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
Query: 215 PFHDSNLIEMYRKIGKAEFKCPNWFPPEVR 244
P D + + K FK P PP +
Sbjct: 232 PLFDMHPV-------KTLFKIPRNPPPTLL 254
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 76/263 (28%), Positives = 122/263 (46%), Gaps = 16/263 (6%)
Query: 14 EKYEVGRLLGQGAFAKVY---YARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
E +GR +G+G F VY Y +VAVK V ++ +E +MR
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV--REKFLQEAYIMRQ 63
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDF 128
HP+IV+L V+ T++ ++ VME A GEL + +V K L + Y QL A+ +
Sbjct: 64 FDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT-P-AYVAPEV 186
S+ HRDI N+L+ + +K+ DFGLS + + G P ++APE
Sbjct: 123 LESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMAPES 179
Query: 187 INRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVR 244
IN + + D+W GV ++ +L+ G PF ++ +I E P PP +
Sbjct: 180 INFRRFTSAS-DVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238
Query: 245 KLLCKILDPNPSTRISMAKIRES 267
L+ K +PS R +++
Sbjct: 239 SLMTKCWAYDPSKRPRFTELKAQ 261
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 14/225 (6%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
L E+Y + +G GA+ V A RT + VA+K + + + A + RE+++++ +
Sbjct: 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHM 71
Query: 72 RHPNIVQLYEVMATKS------KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINA 125
+H N++ L +V + + VM Y + K+ L ED + Q++
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
+ + HS G+ HRD+KP NL ++E+ LKI DFGL+ +H D + T Y APE
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRWYRAPE 184
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK 230
VI + + VDIWS G ++ +L G F + ++ +I K
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 76/316 (24%), Positives = 125/316 (39%), Gaps = 62/316 (19%)
Query: 12 LTEKYE-VGRLLGQGAFAKVYYARSIRTNQSVAVKVI-----------DKDKIMRVGLAD 59
++E+Y G LG+G + KV A T + VA+K + D+ + G+
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65
Query: 60 QIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKG--GELFNKVAKGKLKEDAARR 117
RE+ +M ++H NI+ L +V I VM+ ++ + K +L E +
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD--RKIRLTESQVKC 123
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS----------ALAQCKH 167
Q++N ++ H HRD+ P N+ ++ KI+DFGL+ L++ +
Sbjct: 124 ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 168 QDGLLHTTCG--TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMY 225
T T Y APE++ VD+WS G + LL G F N I+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 226 RKIGKAEFKCP---NWFPPEVRK----------------------------LLCKILDPN 254
+I + P NW P+ +K LL +L N
Sbjct: 244 GRIFEL-LGTPNEDNW--PQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLN 300
Query: 255 PSTRISMAKIRESSWF 270
P RIS + + +F
Sbjct: 301 PLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 65/272 (23%), Positives = 122/272 (44%), Gaps = 19/272 (6%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
R+LG+G F +V + T + A K ++K +I + E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 80 YEVMATKSKIFFVMEYAKGGEL---FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYH 136
TK + V+ GG+L + E+ A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 137 RDIKPENLLLDENENLKISDFGLSALAQCKHQDG-LLHTTCGTPAYVAPEVINRKGYDGE 195
RD+KPEN+LLD+ +++ISD GL+ + +G + GT Y+APEV+ + Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV----EIPEGETIRGRVGTVGYMAPEVVKNERY-TF 180
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDS----NLIEMYRKIGKAEFKCPNWFPPEVRKLLCKIL 251
D W G +++ ++ G PF E+ R++ + + + F R + ++L
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240
Query: 252 DPNPSTRI-----SMAKIRESSWFRKGMNQKQ 278
+P R+ +++ +FR N K+
Sbjct: 241 TKDPGFRLGCRGEGAEEVKAHPFFRT-ANFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 73/256 (28%), Positives = 113/256 (44%), Gaps = 17/256 (6%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQ 78
+ LG G F V+ + R VA+K+I ++ M D E VM + HPN+VQ
Sbjct: 9 LKELGSGQFGVVHLGK-WRGKIDVAIKMI-REGAMS---EDDFIEEAKVMMKLSHPNLVQ 63
Query: 79 LYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHSRGVYH 136
LY V + IF V EY G L N + KGKL + + A+++ S G H
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123
Query: 137 RDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP---AYVAPEVINRKGYD 193
RD+ N L+ E+ +K+SDFGL+ D ++ GT + PEV + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYV----LDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 194 GEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKIL 251
K D+WS GV+++ V G +P+ + E+ + P P EV ++
Sbjct: 180 -SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCW 238
Query: 252 DPNPSTRISMAKIRES 267
P R + K+
Sbjct: 239 HEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 14/217 (6%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG+G F +V + T + A K +DK ++ + E ++ V P IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 82 VMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAAR--RYFQQLINAVDFCHSRGVYHRD 138
+K+ + VM GG+L ++ G+ + R Y Q+ + HS + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPAYVAPEVINRKGYDGEKV 197
+KPEN+LLD+ N ++SD GL+ + +DG T GT Y+APE++ + Y V
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV----ELKDGKTITQRAGTNGYMAPEILKEEPYS-YPV 175
Query: 198 DIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK 234
D ++ G ++ ++AG PF D K+ K E K
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHK-----EKVAKEELK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 21/242 (8%)
Query: 38 TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLY-EVMATKSKIFFVMEYA 96
T VA+K++ D + +RE ++ + HPNIV L A +F V EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 97 KGGELFNKVA-KGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL---DENENL 152
G L +A G L R Q+++A+ H++G+ HRD+KP+N+++ +
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 153 KISDFGLSALAQCKHQDGLLHTT-----CGTPAYVAPEVINRKGYDGEKV----DIWSCG 203
K+ DFG+ L + T GTP Y APE + GE V D+++ G
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLR-----GEPVTPNSDLYAWG 176
Query: 204 VVLFVLLAGYLPFHDSNLIE-MYRKIGKAEFKCPNWFPPE-VRKLLCKILDPNPSTRISM 261
++ L G +++ E +Y+++ + P W + ++L K L+ +P R +
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAAS 236
Query: 262 AK 263
A
Sbjct: 237 AP 238
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 77/274 (28%), Positives = 118/274 (43%), Gaps = 40/274 (14%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG+G++A VY S Q VA+KVI G+ RE S+++ ++H NIV L++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDI 139
++ TK + FV EY +L + + G L R + QL+ + + H + + HRD+
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 140 KPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDI 199
KP+NLL+ LK++DFGL+ Q + T Y P+V+ +DI
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 200 WSCGVVLFVLLAGYLPFHD-SNLIEMYRKI---------------GKAEFKCPNWF---- 239
W G + +L G F S++ E KI K P WF
Sbjct: 188 WGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCK 247
Query: 240 -------------PPEVRKLLCKILDPNPSTRIS 260
PP+ L ++L P RIS
Sbjct: 248 PQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 84/292 (28%), Positives = 128/292 (43%), Gaps = 55/292 (18%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQS--VAVKVIDK--DKIMRVGLADQIKREISVMRIV 71
YE+ + LGQGA+ V AR+ T++ VA+K I K + LA + RE+ ++R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI---LAKRALRELKLLRHF 58
Query: 72 R-HPNIVQLYEV-MATKSKIFFV------MEYAKGGELFNKVAKGKLKEDAARRYF-QQL 122
R H NI LY++ + + ME +L + G+ DA + F Q+
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 123 INAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH--QDGLLHTTCGTPA 180
+ + + HS V HRD+KP NLL++ + LKI DFGL+ G + T
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 181 YVAPEV-INRKGYDGEKVDIWSCGVVLFVLLAGYLPF------HDSNLI---------EM 224
Y APE+ ++ + Y + +D+WS G +L LL F N I E
Sbjct: 175 YRAPEIMLSFQSYT-KAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233
Query: 225 YRKIGKAE-------------FKCPNWFP---PEVRKLLCKILDPNPSTRIS 260
+IG + + FP P LL K+L +P+ RIS
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDK--DKIMRVGLADQIKREISVMR 69
+ KY + +G+GA+ V A++ TN+ VA+K I D + A + REI ++R
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID---AKRTLREIKLLR 59
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV----------------AKGKLKED 113
+ H N++ + ++M + E FN V + L +D
Sbjct: 60 HLDHENVIAIKDIMPPPHR-----------EAFNDVYIVYELMDTDLHQIIRSSQTLSDD 108
Query: 114 AARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173
+ + QL+ + + HS V HRD+KP NLLL+ N +LKI DFGL+ K +
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMT 166
Query: 174 TTCGTPAYVAPEVI-NRKGYDGEKVDIWSCGVVLFVLL 210
T Y APE++ N Y +D+WS G + LL
Sbjct: 167 EYVVTRWYRAPELLLNCSEY-TTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 8e-20
Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 13/223 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++Y + +G GA+ V A RT VA+K + + + A + RE+ +++ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKH 73
Query: 74 PNIVQLYEVMATKSKI------FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVD 127
N++ L +V + + VM + G +L + KL ED + Q++ +
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
+ H+ G+ HRD+KP NL ++E+ LKI DFGL+ + D + T Y APEVI
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQTDSEMTGYVVTRWYRAPEVI 187
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK 230
+ + VDIWS G ++ +L G F + ++ +I K
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 66/251 (26%), Positives = 118/251 (47%), Gaps = 34/251 (13%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
++ +E+ +G+G + KV+ + + AVK++D + ++I+ E ++++ +
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALS 72
Query: 73 -HPNIVQLYEVMATKS-----KIFFVMEYAKGGELFNKVAKGKLK------EDAARRYFQ 120
HPN+V+ Y + K +++ V+E GG + + KG LK E
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGFLKRGERMEEPIIAYILH 131
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA-LAQCKHQDGLLHTTCGTP 179
+ + + H HRD+K N+LL +K+ DFG+SA L + + +T+ GTP
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR---NTSVGTP 188
Query: 180 AYVAPEVIN-----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK 234
++APEVI YD + D+WS G+ L G P D + + +A FK
Sbjct: 189 FWMAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPM-------RALFK 240
Query: 235 CPNWFPPEVRK 245
P PP + +
Sbjct: 241 IPRNPPPTLHQ 251
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 5/192 (2%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG+G +A V+ RS T VA+K I + G RE+S+++ ++H NIV L++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 82 VMATKSKIFFVMEYA-KGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIK 140
++ T + V EY K + + + + + Q++ + +CH R V HRD+K
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131
Query: 141 PENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIW 200
P+NLL++E LK++DFGL+ + T Y P+V+ ++D+W
Sbjct: 132 PQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMW 189
Query: 201 SCGVVLFVLLAG 212
G + F + +G
Sbjct: 190 GVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 13/216 (6%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVID-KDKIMRVGLADQIKREISVMRIVRHPNIVQLY 80
+G G+F VY+A + TN+ VAVK + K D IK E+ ++ ++HPN ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK-EVKFLQQLKHPNTIEYK 87
Query: 81 EVMATKSKIFFVMEYAKG-GELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDI 139
+ + VMEY G +V K L+E + + + HS + HRDI
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 140 KPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI---NRKGYDGEK 196
K N+LL E +K++DFG ++ + ++ GTP ++APEVI + YDG K
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDG-K 200
Query: 197 VDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE 232
VD+WS G+ L P + N + I + +
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 66/256 (25%), Positives = 131/256 (51%), Gaps = 11/256 (4%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVID-KDKIMRVGLADQIKREISVMRIVRHPNIVQ 78
R++G+G++ +V R + +K ++ ++ R A + +E ++ ++HPNIV
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIVA 63
Query: 79 LYEVM-ATKSKIFFVMEYAKGGELFNKVA--KGKL-KEDAARRYFQQLINAVDFCHSRGV 134
E ++ VM + +GG+L++K+ KGKL E+ +F Q+ A+ + H + +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDG 194
HRD+K +N+ L +K+ D G++ + + +Q + T GTP Y++PE+ + K Y+
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPYYMSPELFSNKPYN- 180
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEM-YRKIGKAEFKCPNWFPPEVRKLLCKILDP 253
K D+W+ G ++ + F+ ++ + YR I P + PE+ +L+ +L
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSK 240
Query: 254 NPSTRISMAKIRESSW 269
P R S+ I +
Sbjct: 241 RPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG+G F +V + T + A K ++K ++ + + E ++ V IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 82 VMATKSKIFFVMEYAKGGEL------FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVY 135
TK+ + VM GG+L ++ G E A Y Q+I+ ++ H R +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRII 119
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT--CGTPAYVAPEVINRKGYD 193
+RD+KPEN+LLD + N++ISD GL+ + +DG T GTP ++APE++ + YD
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAV----ELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 194 GEKVDIWSCGVVLFVLLAGYLPF----HDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCK 249
VD ++ GV L+ ++A PF E+ ++I P+ F P +
Sbjct: 176 -FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEA 234
Query: 250 ILDPNPSTRI-----SMAKIRESSWFRKGMNQKQ 278
+L +P R+ + +R FR +N +Q
Sbjct: 235 LLAKDPEKRLGFRDGNCDGLRTHPLFR-DLNWRQ 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 15 KYEVGRLLGQGAFAKVYYARSI--RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
KYE+ +G+G + +VY A+ + + A+K DK G++ REI+++R ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 73 HPNIVQLYEVMATKS--KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ---------Q 121
H N+V L EV + ++ + +YA+ +L+ + K A R Q
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQII---KFHRQAKRVSIPPSMVKSLLWQ 116
Query: 122 LINAVDFCHSRGVYHRDIKPENLLL----DENENLKISDFGL-----SALAQCKHQDGLL 172
++N V + HS V HRD+KP N+L+ E +KI D GL + L D ++
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 173 HTTCGTPAYVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFH 217
T Y APE++ + Y + +DIW+ G + LL F
Sbjct: 177 VTIW----YRAPELLLGARHYT-KAIDIWAIGCIFAELLTLEPIFK 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 5/203 (2%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG+G +A VY RS T+ VA+K I + G RE+S+++ ++H NIV L++
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 82 VMATKSKIFFVMEYA-KGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIK 140
++ T+ + V EY K + + + + + QL+ +++CH R V HRD+K
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 141 PENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIW 200
P+NLL++E LK++DFGL+ + T Y P+++ ++D+W
Sbjct: 132 PQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMW 189
Query: 201 SCGVVLFVLLAGYLPFHDSNLIE 223
G + + + G F S + E
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 21/224 (9%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR----VGLADQIKREISVMRI 70
+Y+ + +G GA V A T Q+VA+K K+ R V A + RE+ +M++
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK-----KLSRPFQNVTHAKRAYRELVLMKL 71
Query: 71 VRHPNIVQLYEV------MATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLIN 124
V H NI+ L V + ++ VME +V + L + Q++
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMSYLLYQMLC 129
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAP 184
+ HS G+ HRD+KP N+++ + LKI DFG LA+ ++ T Y AP
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAP 186
Query: 185 EVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
EVI GY E VDIWS G ++ ++ G + F ++ I+ + KI
Sbjct: 187 EVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 60/204 (29%), Positives = 109/204 (53%), Gaps = 16/204 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTN-QSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
++YE +G+GA+ KV+ AR ++ + VA+K + + + G+ RE++V+R +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 59
Query: 73 ---HPNIVQLYEVMAT-----KSKIFFVMEYAKGG--ELFNKVAKGKLKEDAARRYFQQL 122
HPN+V+L++V ++K+ V E+ +KV + + + + QL
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 123 INAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV 182
+ +DF HS V HRD+KP+N+L+ + +K++DFGL+ + + L + T Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYR 176
Query: 183 APEVINRKGYDGEKVDIWSCGVVL 206
APEV+ + Y VD+WS G +
Sbjct: 177 APEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 68/273 (24%), Positives = 117/273 (42%), Gaps = 28/273 (10%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLAD----QIKREISVMRIVRHPNIV 77
LG+G + VY T ++A+K I R+ L + QI E+ ++ P IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI------RLELDESKFNQIIMELDILHKAVSPYIV 62
Query: 78 QLYEVMATKSKIFFVMEYAKGGEL----FNKVAKGKLKEDAARRYFQQLINAVDFCHSR- 132
Y + ++ MEY G L VA + ED RR ++ + F
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
+ HRD+KP N+L++ N +K+ DFG+S L T G +Y+APE I G
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSG----NLVASLAKTNIGCQSYMAPERIKSGGP 178
Query: 193 DGE-----KVDIWSCGVVLFVLLAGYLPF----HDSNLIEMYRKIGKAEFKCPNWFPPEV 243
+ + D+WS G+ + + G P+ + + ++ + P+ + +
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276
+ + K L+ P+ R + A++ E W K N
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 13/208 (6%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ YE LG+G++A VY +S + VA+KVI + G RE S+++ ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHS 131
NIV L++++ TK + V EY +L + K G L + + + QL+ + + H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG---TPAYVAPEVIN 188
R + HRD+KP+NLL+ + LK++DFGL+ HT T Y P+V+
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-----HTYSNEVVTLWYRPPDVLL 176
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPF 216
+D+W G + ++ G F
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 74/290 (25%), Positives = 131/290 (45%), Gaps = 52/290 (17%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTN-----QSVAVKVIDKDKIMRVGLADQIKREISVM 68
++ +G+ LG+GAF +V A ++ + +VAVK++ KD L+D + E+ +M
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS-EMEMM 69
Query: 69 RIV-RHPNIVQLYEVMATKSKIFFVMEYAKGGEL-----------------FNKVAKGKL 110
+++ +H NI+ L V + ++ V+EYA G L + + L
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 111 KEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC----- 165
+ + Q+ ++F S+ HRD+ N+L+ E+ +KI+DFGL+
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 166 KHQDGLLHTTCGTPA-YVAPEVINRKGYDGEKVDIWSCGVVLF--VLLAG--Y--LPFHD 218
K +G L P ++APE + + Y + D+WS GV+L+ L G Y +P +
Sbjct: 190 KTTNGRL------PVKWMAPEALFDRVYTHQS-DVWSFGVLLWEIFTLGGSPYPGIPVEE 242
Query: 219 --SNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
L E YR + P E+ L+ PS R + ++ E
Sbjct: 243 LFKLLKEGYR------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 74/290 (25%), Positives = 132/290 (45%), Gaps = 56/290 (19%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++Y++ RL+G+G +VY A ++ VA+K I +D L + RE + + H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKG---GELFNKV-AKGKLKEDAAR--------RYFQQ 121
P IV +Y + + +++ M Y +G L V K L ++ A F +
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD---------GLL 172
+ +++ HS+GV HRD+KP+N+LL + I D+G + + + +D +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 173 HTT-------CGTPAYVAPEVINRKGYDG-EKVDIWSCGVVLFVLLAGYLPF-------- 216
+++ GTP Y+APE + G E DI++ GV+L+ +L P+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239
Query: 217 ----HDSNLIEM--YRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRIS 260
+ IE+ YR+I PP + ++ K L +P+ R S
Sbjct: 240 SYRDVILSPIEVAPYREI-----------PPFLSQIAMKALAVDPAERYS 278
|
Length = 932 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 71/251 (28%), Positives = 121/251 (48%), Gaps = 19/251 (7%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
+G+G F V VAVK I D + LA E SVM +RH N+VQL
Sbjct: 14 IGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQLLG 66
Query: 82 VMAT-KSKIFFVMEYAKGGELFNKV-AKGK--LKEDAARRYFQQLINAVDFCHSRGVYHR 137
V+ K ++ V EY G L + + ++G+ L D ++ + A+++ + HR
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKV 197
D+ N+L+ E+ K+SDFGL+ A G L + APE + K + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAPEALREKKFS-TKS 180
Query: 198 DIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNP 255
D+WS G++L+ + + G +P+ L ++ ++ K + P+ PP V ++ + +
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDA 240
Query: 256 STRISMAKIRE 266
+TR S ++RE
Sbjct: 241 ATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 9e-19
Identities = 71/269 (26%), Positives = 115/269 (42%), Gaps = 44/269 (16%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQ 78
R LG G F +V+ + VAVK + K M + +E +M+ +RH +VQ
Sbjct: 11 ERKLGAGQFGEVWMG-TWNGTTKVAVKTL-KPGTMSP---EAFLQEAQIMKKLRHDKLVQ 65
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARR-YFQQLI-------NAVDFCH 130
LY V + + I+ V EY G L + LK ++ QL+ + +
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLD-----FLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQ----CKHQDGLLHTTCGTP-AYVAPE 185
SR HRD+ N+L+ EN KI+DFGL+ L + + P + APE
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF------PIKWTAPE 174
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLA-GYLPF---HDSNLIEM----YRKIGKAEFKCPN 237
N G K D+WS G++L ++ G +P+ + ++E YR P
Sbjct: 175 AANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR------MPRPP 227
Query: 238 WFPPEVRKLLCKILDPNPSTRISMAKIRE 266
P E+ L+ + D +P R + ++
Sbjct: 228 NCPEELYDLMLQCWDKDPEERPTFEYLQS 256
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 11/214 (5%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG+G +A V+ RS T VA+K I + G RE+S+++ ++H NIV L++
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ-QLINAVDFCHSRGVYHRDIK 140
++ T+ + V EY G L + F QL+ + +CH R + HRD+K
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 141 PENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPAYVAPEVINRKGYDGEKVDI 199
P+NLL++E LK++DFG LA+ K ++ T Y P+V+ +D+
Sbjct: 131 PQNLLINEKGELKLADFG---LARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187
Query: 200 WSCGVVLFVLLAGYLPFHDSNLIE----MYRKIG 229
W G +L+ + G F S + E ++R +G
Sbjct: 188 WGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKV--IDKDKIMRVGLADQIKREISVMRIV 71
E E LG G V + I T +A KV I +R QI RE+ +M
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR----KQILRELQIMHEC 60
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFC 129
R P IV Y ++ I ME+ G L +++ K G + + + ++ + +
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYL 119
Query: 130 HSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
++ + HRDIKP N+L++ +K+ DFG+S + + + T GT Y++PE I
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG----ELINSIADTFVGTSTYMSPERIQ 175
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN 220
Y K D+WS G+ + L G PF SN
Sbjct: 176 GGKYT-VKSDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG G VY A + T + +AVKVI D + V L QI E+ ++ P I+ Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKP 141
+++I E+ GG L K+ E R ++ + + S + HRD+KP
Sbjct: 67 AFFVENRISICTEFMDGGSL---DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKP 123
Query: 142 ENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWS 201
N+L++ +K+ DFG+S + + + T GT AY+APE I+ + Y G D+WS
Sbjct: 124 SNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQY-GIHSDVWS 178
Query: 202 CGVVLFVLLAGYLPF 216
G+ L G P+
Sbjct: 179 LGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 66/265 (24%), Positives = 122/265 (46%), Gaps = 16/265 (6%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
R+LG+G F +V + T + A K ++K +I + E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 80 YEVMATKSKIFFVMEYAKGGEL---FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYH 136
TK + V+ GG+L + + +E A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 137 RDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEK 196
RD+KPEN+LLD++ +++ISD GL+ + + GT Y+APEV+ + Y
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMAPEVVKNERYTFSP 182
Query: 197 VDIWSCGVVLFVLLAGYLPFHDSNLI----EMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
D W+ G +L+ ++AG PF E+ R + + + + F P+ R L +L
Sbjct: 183 -DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 253 PNPSTRI-----SMAKIRESSWFRK 272
+P R+ +++E F++
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 20/266 (7%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
R+LG+G F +V + T + A K ++K +I + E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 80 YEVMATKSKIFFVMEYAKGGEL----FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVY 135
TK + V+ GG+L +N G +E+ A Y +++ ++ H
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLHRENTV 124
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDG-LLHTTCGTPAYVAPEVINRKGYDG 194
+RD+KPEN+LLD+ +++ISD GL+ K +G + GT Y+APEV+N + Y
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPEVLNNQRY-T 179
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDS----NLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250
D W G +++ ++ G PF E+ R++ + E F E + + +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239
Query: 251 LDPNPSTRI-----SMAKIRESSWFR 271
L +P R+ +++ +FR
Sbjct: 240 LTKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 70/263 (26%), Positives = 107/263 (40%), Gaps = 31/263 (11%)
Query: 22 LGQGAFAKVYYARSIRTN-----QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
LG+GAF KVY N SVA+K + ++ + + ++E +M ++HPNI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNI 70
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELF---------NKVAKGKLKEDAARRYFQ------- 120
V L V + + EY G+L + V E
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 121 -QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
Q+ +++ S HRD+ N L+ E +KISDFGLS + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVLFVL----LAGYLPFHDSNLIEMYRKIGKAEFKC 235
++ PE I + E DIWS GVVL+ + L Y F + +IEM R + C
Sbjct: 191 RWMPPEAILYGKFTTES-DIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS--RQLLPC 247
Query: 236 PNWFPPEVRKLLCKILDPNPSTR 258
P P V L+ + + P+ R
Sbjct: 248 PEDCPARVYALMIECWNEIPARR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 19/258 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+K +G ++G+G F V T Q VAVK I D + L E +VM + H
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLE-----ETAVMTKLHH 58
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAAR--RYFQQLINAVDFCH 130
N+V+L V+ ++ VME G L N + +G+ + ++ + +++
Sbjct: 59 KNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
S+ + HRD+ N+L+ E+ K+SDFGL+ + + L + APE + K
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-----WTAPEALKHK 172
Query: 191 GYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLC 248
+ K D+WS GV+L+ V G P+ +L E+ + K + P P +V L+
Sbjct: 173 KFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMT 231
Query: 249 KILDPNPSTRISMAKIRE 266
+ P R S K+RE
Sbjct: 232 SCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 79/284 (27%), Positives = 129/284 (45%), Gaps = 43/284 (15%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR-----EISVMRIVRHPNI 76
LG+GA+ V R + T +AVK I V +Q KR +IS MR V P
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR----ATVNSQEQ-KRLLMDLDIS-MRSVDCPYT 62
Query: 77 VQLYEVMATKSKIFFVMEYAKGG--ELFNKVAKGKL--KEDAARRYFQQLINAVDFCHSR 132
V Y + + ++ ME + + KV L ED + ++ A+++ HS+
Sbjct: 63 VTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122
Query: 133 -GVYHRDIKPENLLLDENENLKISDFGLS-----ALAQCKHQDGLLHTTCGTPAYVAPEV 186
V HRD+KP N+L++ N +K+ DFG+S ++A K D G Y+APE
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDA------GCKPYMAPER 174
Query: 187 IN----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP------ 236
IN +KGYD K D+WS G+ + L G P+ + ++++ K + P
Sbjct: 175 INPELNQKGYD-VKSDVWSLGITMIELATGRFPY--DSWKTPFQQL-KQVVEEPSPQLPA 230
Query: 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQ 280
F PE + + K L N R + ++ + +F +++
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDV 274
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
PS LT E LG G F V+ + R VA+K I++ + + E VM
Sbjct: 3 PSELTFMKE----LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSE----EDFIEEAKVM 53
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAV 126
+ HP +VQLY V + ++ V E+ + G L N + +GKL +D Q + +
Sbjct: 54 MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP---AYVA 183
++ HRD+ N L+ +K+SDFG++ D ++ G +
Sbjct: 114 EYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPVKWSP 169
Query: 184 PEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGK 230
PEV N Y K D+WS GV+++ V G +PF + E+ I +
Sbjct: 170 PEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 74/269 (27%), Positives = 118/269 (43%), Gaps = 34/269 (12%)
Query: 20 RLLGQGAFAKV----YYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
R LG+G F KV Y T + VAVK + + +K+EI ++R + H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHEN 67
Query: 76 IVQLYEVMATK---SKIFFVMEYAKGGELFNKVAKGKLKEDAAR--RYFQQLINAVDFCH 130
IV+ Y+ + T+ + I +ME+ G L + + K K + + +Y Q+ +D+
Sbjct: 68 IVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY-VAPE-VIN 188
SR HRD+ N+L++ +KI DFGL+ + + + +P + APE +I
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---------------- 232
K Y D+WS GV L+ LL Y S + + IG
Sbjct: 187 SKFYIAS--DVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243
Query: 233 -FKCPNWFPPEVRKLLCKILDPNPSTRIS 260
P P EV +L+ K + PS R +
Sbjct: 244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTT 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 11 VLTEKYEVGRLLGQGAFAKVY--YARSIRTNQS---VAVKVIDKDKIMRVGLADQIKREI 65
+ EK + R LGQG+F VY A+ + + VA+K ++++ MR + + E
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEA 60
Query: 66 SVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAAR--------R 117
SVM+ ++V+L V++T VME G+L + + + + + +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 118 YFQ---QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC-----KHQD 169
+ Q ++ + + + ++ HRD+ N ++ E+ +KI DFG++ K
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 170 GLLHTTCGTPA-YVAPEVINRKGYDGEKVDIWSCGVVLF 207
GLL P ++APE + + G K D+WS GVVL+
Sbjct: 181 GLL------PVRWMAPESL-KDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 66/246 (26%), Positives = 117/246 (47%), Gaps = 35/246 (14%)
Query: 25 GAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84
G KV RT Q+ +K + K + + I + V PN+V L++ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTI-IPHCV--PNMVCLHKYIV 55
Query: 85 TKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPEN 143
++ +F V+++A+GG+L++ ++K + E+ +R+ +++ A+D H G+ RD+ P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 144 LLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA----YVAPEV--INRKGYDGEKV 197
+LLD+ +++++ F + + +C A Y APEV I+ + E
Sbjct: 116 ILLDDRGHIQLTYFS---------RWSEVEDSCDGEAVENMYCAPEVGGISE---ETEAC 163
Query: 198 DIWSCGVVLFVLLAGYLPFHDSNLIEMYRK-IGK-AEFKCPNWFPPEVRKLLCKILDPNP 255
D WS G +LF LL G L+E + I P W E R LL ++L NP
Sbjct: 164 DWWSLGAILFELLTG------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNP 217
Query: 256 STRISM 261
+ R+
Sbjct: 218 TERLGA 223
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
Y V + L G+ +V+ A V +K+ K + + +++ V HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM---------LLQNVNHPS 118
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRG 133
++++ + + + + V+ + +L+ + K L D A +Q++ + + H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD 193
+ HRD+K EN+ +++ + + I D G AQ GT APEV+ R Y+
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLG---AAQFPVVAPAFLGLAGTVETNAPEVLARDKYN 234
Query: 194 GEKVDIWSCGVVLFVLLA 211
K DIWS G+VLF +LA
Sbjct: 235 -SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYA--RSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV 67
SV+ +Y + L G+ +V+ + V VK + K REI +
Sbjct: 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDI 139
Query: 68 MRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAV 126
++ + H I+ L KS + VM K +LF V G L + A ++L+ A+
Sbjct: 140 LKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEAL 198
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC----GTPAYV 182
+ H RG+ HRD+K EN+ LDE EN + DFG A CK C GT
Sbjct: 199 AYLHGRGIIHRDVKTENIFLDEPENAVLGDFG----AACKLDAHPDTPQCYGWSGTLETN 254
Query: 183 APEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF 216
+PE++ Y K DIWS G+VLF + +
Sbjct: 255 SPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 80/296 (27%), Positives = 126/296 (42%), Gaps = 55/296 (18%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++Y+ + +G GA V A +VAVK + + A + RE+ +++ V H
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVNH 79
Query: 74 PNIVQLYEVMATKSK------IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVD 127
NI+ L V + ++ VME +V +L + Q++ +
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIK 137
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
HS G+ HRD+KP N+++ + LKI DFG LA+ + ++ T Y APEVI
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTACTNFMMTPYVVTRYYRAPEVI 194
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI------GKAEFKC------ 235
GY E VDIWS G ++ L+ G + F ++ I+ + K+ AEF
Sbjct: 195 LGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253
Query: 236 -------------------PNW-FPPE----------VRKLLCKILDPNPSTRISM 261
P+W FP E R LL K+L +P RIS+
Sbjct: 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV 309
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 13/221 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++Y+ + +G GA V A ++VA+K + + A + RE+ +M+ V H
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 74 PNIVQLYEVMATKSK------IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVD 127
NI+ L V + ++ VME +V + +L + Q++ +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
HS G+ HRD+KP N+++ + LKI DFGL+ A ++ T Y APEVI
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 197
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
GY E VDIWS G ++ ++ G + F ++ I+ + K+
Sbjct: 198 LGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 67/241 (27%), Positives = 112/241 (46%), Gaps = 17/241 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++Y+ + +G GA V A +++VA+K + + A + RE+ +M+ V H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75
Query: 74 PNIVQLYEVMATK------SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVD 127
NI+ L V + ++ VME +V + +L + Q++ +
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
HS G+ HRD+KP N+++ + LKI DFGL+ A ++ T Y APEVI
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 190
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRK-IGKAEFKCPNW---FPPEV 243
GY E VDIWS G ++ ++ + F + I+ + K I + CP + P V
Sbjct: 191 LGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 244 R 244
R
Sbjct: 250 R 250
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDK--DKIMRVGLADQIKREISVMRIVRHPNIV 77
R +G GAF V+ R + VA+K + ++ ++ RE+ ++ +H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS---CKRVFRELKMLCFFKHDNVL 62
Query: 78 QLYEVMATKSKIFFVMEYAKGGELFNK------VAKGKLKEDAARRYFQQLINAVDFCHS 131
+++ F Y EL V+ L D + + Q++ + + HS
Sbjct: 63 SALDILQPPHIDPFEEIYVVT-ELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT--CGTPAYVAPEVINR 189
G+ HRDIKP NLL++ N LKI DFG LA+ + D H T T Y APE++
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFG---LARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE 223
+ VDIWS G + LL + F + I+
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
PS LT E +G G F V+ + VA+K I ++ M + E VM
Sbjct: 3 PSELTLVQE----IGSGQFGLVWLG-YWLEKRKVAIKTI-REGAMS---EEDFIEEAQVM 53
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAV 126
+ HP +VQLY V +S I V E+ + G L + + +GK ++ + +
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP---AYVA 183
+ S V HRD+ N L+ EN+ +K+SDFG++ D ++ GT + +
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV----LDDQYTSSTGTKFPVKWSS 169
Query: 184 PEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHD 218
PEV + Y K D+WS GV+++ V G P+ +
Sbjct: 170 PEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 16/221 (7%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+G+ V+ A+ TN VAVK I+ D + L +++EI R ++HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHPN 60
Query: 76 IVQLYEVMATKSKIFFV---MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
I+ S+++ V M Y +L L E A + ++NA+D+ HS+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 133 GVYHRDIKPENLLLDENENLKISDF--GLSALAQCKHQ----DGLLHTTCGTPAYVAPEV 186
G HR +K ++LL + + +S +S + K Q D + P +++PEV
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP-WLSPEV 179
Query: 187 I--NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMY 225
+ N +GY+ EK DI+S G+ L G++PF D +M
Sbjct: 180 LQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 66/218 (30%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG G F V Y + R VA+K+I K+ M D+ E VM + H +VQLY
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMS---EDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI-------NAVDFCHSRGV 134
V + I+ V EY G L N L+E R QL+ + + S+
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLN-----YLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV---APEVINRKG 191
HRD+ N L+D+ +K+SDFGLS D ++ G+ V PEV+
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 192 YDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKI 228
+ K D+W+ GV+++ V G +P+ N E K+
Sbjct: 178 FS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 27/231 (11%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+ Y++G ++G G+F VY A I T++ VA+K + +D + RE+ +M+ +
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK-------NRELLIMKNLN 117
Query: 73 HPNIVQLYEVMATKS------KIFF--VMEYAKGGELFNKVAKGKLKEDAA------RRY 118
H NI+ L + T+ IF VME+ + +K K + + A + Y
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFLVKLY 175
Query: 119 FQQLINAVDFCHSRGVYHRDIKPENLLLDEN-ENLKISDFGLSALAQCKHQDGLLHTTCG 177
QL A+ + HS+ + HRD+KP+NLL+D N LK+ DFG SA Q + +
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSYIC-- 232
Query: 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
+ Y APE++ +D+WS G ++ ++ GY F + ++ +I
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283
|
Length = 440 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 67/269 (24%), Positives = 110/269 (40%), Gaps = 25/269 (9%)
Query: 20 RLLGQGAFAKVYYA--RSIRTNQS---VAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
R LG+GAF KV+ + VAVK + K+ D +RE ++ +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKD-FEREAELLTNFQHE 68
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGEL---------------FNKVAKGKLKEDAARRYF 119
NIV+ Y V V EY + G+L G+L +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 120 QQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
Q+ + + + S+ HRD+ N L+ + +KI DFG+S + T
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA-EFKCPN 237
++ PE I + + E D+WS GVVL+ + G P++ + E+ I + + P
Sbjct: 189 RWMPPESIMYRKFTTES-DVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR 247
Query: 238 WFPPEVRKLLCKILDPNPSTRISMAKIRE 266
P EV ++ +P RI++ I E
Sbjct: 248 TCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 64/248 (25%), Positives = 112/248 (45%), Gaps = 13/248 (5%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
R+LG+G F +V + T + A K ++K +I + E ++ V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 80 YEVMATKSKIFFVMEYAKGGEL----FNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVY 135
TK + V+ GG+L +N G E A Y +L ++ +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGE 195
+RD+KPEN+LLD+ +++ISD GL+ + + GT Y+APEVIN + Y
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDS----NLIEMYRKIGKAEFKCPNWFPPEVRKLLCKIL 251
D W G +++ ++ G PF E+ R++ + + + F + + + +L
Sbjct: 182 P-DWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 252 DPNPSTRI 259
NP R+
Sbjct: 241 TKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 65/250 (26%), Positives = 108/250 (43%), Gaps = 24/250 (9%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
R LG G F +V+ T VAVK + K M E +M+ +RHP ++QL
Sbjct: 12 RKLGAGQFGEVWEGLWNNTT-PVAVKTL-KPGTMDP---KDFLAEAQIMKKLRHPKLIQL 66
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAKGK--------LKEDAARRYFQQLINAVDFCHS 131
Y V + I+ V E K G L + G L + AA Q+ + + + +
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA-----QVASGMAYLEA 121
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP-AYVAPEVINRK 190
+ HRD+ N+L+ EN K++DFGL+ + K P + APE
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARV--IKEDIYEAREGAKFPIKWTAPEAALYN 179
Query: 191 GYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLC 248
+ K D+WS G++L ++ G +P+ E+ +++ + CP P E+ ++
Sbjct: 180 RFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML 238
Query: 249 KILDPNPSTR 258
+P R
Sbjct: 239 DCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 5e-15
Identities = 68/248 (27%), Positives = 115/248 (46%), Gaps = 25/248 (10%)
Query: 22 LGQGAFAKV---YYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQ 78
LG G F +V YY + VA+K + K M + E ++M+ ++HP +V+
Sbjct: 14 LGAGQFGEVWMGYY----NGHTKVAIKSL-KQGSMSP---EAFLAEANLMKQLQHPRLVR 65
Query: 79 LYEVMATKSKIFFVMEYAKGGEL--FNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVY 135
LY V+ T+ I+ + EY + G L F K +G KL + Q+ + F +
Sbjct: 66 LYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKH---QDGLLHTTCGTPAYVAPEVINRKGY 192
HRD++ N+L+ E KI+DFGL+ L + ++G + APE IN G
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI----KWTAPEAINY-GT 179
Query: 193 DGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKI 250
K D+WS G++L ++ G +P+ E+ + + + P+ P E+ +L+
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLC 239
Query: 251 LDPNPSTR 258
P R
Sbjct: 240 WKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 57 LADQIKREISVMRIVRHPNIVQLYEV--------MATKSKIFFVMEYAKGGELFNKVAKG 108
A Q++ EI + + H NI+++ E+ M T+ F + + K +
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK-DRP 264
Query: 109 KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168
LK+ R +QL+ AV++ H + + HRDIK EN+ L+ + + + DFG +A+ K +
Sbjct: 265 LLKQ--TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKER 321
Query: 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDS--NLIEMY 225
+ + GT A +PE++ GY E DIWSCG++L +L+ + P D +
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380
Query: 226 RKIGKAEFKCPNWFP 240
KI + C FP
Sbjct: 381 LKIIDSLSVCDEEFP 395
|
Length = 501 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 40/225 (17%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVK-----VIDKDKIMRVGLADQIKREI- 65
L + E+GR GAF V + +AVK V +K++ ++ ++
Sbjct: 6 LKDLGEIGR----GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQK-------RLLMDLD 54
Query: 66 SVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGG-ELFNKVAKGKLKEDAARRYFQQLIN 124
VMR P IV+ Y + + + ME + F K LK ++++
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLK----SVIPEEILG 110
Query: 125 AVDFCHSRG---------VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT 175
+ + + HRD+KP N+LLD N N+K+ DFG+S + D + T
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG----QLVDSIAKTR 166
Query: 176 -CGTPAYVAPEVIN---RKGYDGEKVDIWSCGVVLFVLLAGYLPF 216
G Y+APE I+ R GYD + D+WS G+ L+ + G P+
Sbjct: 167 DAGCRPYMAPERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 33/276 (11%)
Query: 22 LGQGAFAKVYYARSIRT-----NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
LG+ F KVY T Q+VA+K + KDK L ++ K E + ++HPNI
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELF-----------------NKVAKGKLKEDAARRYF 119
V L V+ + + + Y +L +K K L+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 120 QQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
Q+ ++F S V H+D+ N+L+ + N+KISD GL L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVLFVL----LAGYLPFHDSNLIEMYRKIGKAEFKC 235
+++PE I + + DIWS GVVL+ + L Y + + ++IEM R + C
Sbjct: 191 RWMSPEAIMYGKFSIDS-DIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN--RQVLPC 247
Query: 236 PNWFPPEVRKLLCKILDPNPSTRISMAKI--RESSW 269
P+ P V L+ + + PS R I R +W
Sbjct: 248 PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 67/264 (25%), Positives = 110/264 (41%), Gaps = 30/264 (11%)
Query: 20 RLLGQGAFAKV----YYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
R+LG+G F KV Y + T + VAVK + ++ + K+EI++++ + H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ--NTSGWKKEINILKTLYHEN 67
Query: 76 IVQLYEVMATKSK--IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRG 133
IV+ + + + +MEY G L + + K KL + QQ+ + + HS+
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY-VAPEVINRKGY 192
HRD+ N+LLD + +KI DFGL+ H+ + +P + A E + +
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDS------------------NLIEMYRKIGKAEFK 234
D+WS GV L+ LL LIE+ +
Sbjct: 188 SYAS-DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER--GMRLP 244
Query: 235 CPNWFPPEVRKLLCKILDPNPSTR 258
CP P EV L+ + R
Sbjct: 245 CPKNCPQEVYILMKNCWETEAKFR 268
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG G V + + +A K+I + ++ + +QI RE+ V+ P IV Y
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRG-------- 133
+ +I ME+ GG L ++V LKE A+R ++++ V RG
Sbjct: 71 AFYSDGEISICMEHMDGGSL-DQV----LKE--AKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 134 -VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
+ HRD+KP N+L++ +K+ DFG+S + D + ++ GT +Y++PE + Y
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK 230
+ DIWS G+ L L G P + E+ G+
Sbjct: 180 SVQS-DIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR 216
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 74/276 (26%), Positives = 114/276 (41%), Gaps = 33/276 (11%)
Query: 22 LGQGAFAKVY----YARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIV 77
LG+ AF K+Y Y + Q VA+K + KD I + ++E S+M + HPNIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KD-INNPQQWGEFQQEASLMAELHHPNIV 70
Query: 78 QLYEVMATKSKIFFVMEYAKGGELF------------------NKVAKGKLKEDAARRYF 119
L V+ + + + EY G+L + K L
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 120 QQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
Q+ +++ S H+D+ N+L+ E ++KISD GLS + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVLFVL----LAGYLPFHDSNLIEMYRKIGKAEFKC 235
++ PE I + + DIWS GVVL+ + L Y F + +IEM RK + C
Sbjct: 191 RWMPPEAIMYGKFSSDS-DIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQLLPC 247
Query: 236 PNWFPPEVRKLLCKILDPNPSTRISMAKI--RESSW 269
PP + L+ + PS R I R SW
Sbjct: 248 SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 69/249 (27%), Positives = 110/249 (44%), Gaps = 9/249 (3%)
Query: 22 LGQGAFAKVY--YARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
LG G F V + ++ ++VAVK++ K+ L D++ RE +VM+ + +P IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHRD 138
+ +S VME A+ G L + K K + E Q+ + + HRD
Sbjct: 62 IGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA-YVAPEVINRKGYDGEKV 197
+ N+LL KISDFGLS T P + APE +N + K
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS-SKS 179
Query: 198 DIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCKILDPNP 255
D+WS GV+++ + G P+ E+ + I E +CP PPE+ L+
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239
Query: 256 STRISMAKI 264
R A +
Sbjct: 240 DERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 71/283 (25%), Positives = 134/283 (47%), Gaps = 36/283 (12%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQS-------VAVKVIDKDKIMRVGLADQIKREIS 66
++ +G+ LG+G F +V A + ++S VAVK++ KD LAD I E+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EME 69
Query: 67 VMRIV-RHPNIVQLYEVMATKSKIFFVMEYAKGGEL-----------------FNKVAKG 108
+M+++ +H NI+ L V + ++ ++EYA G L KV +
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 109 KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168
+L Q+ +++ SR HRD+ N+L+ E+ +KI+DFG LA+ H
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFG---LARGVHD 186
Query: 169 -DGLLHTTCG-TPA-YVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEM 224
D T+ G P ++APE + + Y + D+WS G++++ + G P+ + E+
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQS-DVWSFGILMWEIFTLGGSPYPGIPVEEL 245
Query: 225 YRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
++ + + P+ E+ L+ + P+ R + ++ E
Sbjct: 246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 15/216 (6%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQS----VAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
E ++LG GAF VY I + VA+KV+ +++ +I E VM V
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKA-NKEILDEAYVMASVD 67
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVA--KGKLKEDAARRYFQQLINAVDFCH 130
HP++V+L + + S++ + + G L + V K + + Q+ + +
Sbjct: 68 HPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG-TP-AYVAPEVIN 188
+ + HRD+ N+L+ +++KI+DFGL+ L + H G P ++A E I
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD--EKEYHAEGGKVPIKWMALESIL 184
Query: 189 RKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIE 223
+ Y K D+WS GV ++ L+ G P+ +E
Sbjct: 185 HRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 76/249 (30%), Positives = 104/249 (41%), Gaps = 27/249 (10%)
Query: 22 LGQGAFAKV---YYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQ 78
LG G F V Y VAVK + ++ I + RE SVM + HP IV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQLDHPCIVR 60
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKGK-------LKEDAARRYFQQLINAVDFCHS 131
L V + + VME A G L K K + LKE A Q+ + + S
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPL-LKYLKKRREIPVSDLKELA-----HQVAMGMAYLES 113
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT-P-AYVAPEVINR 189
+ HRD+ N+LL KISDFG+S A D TT G P + APE IN
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 190 KGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLL 247
+ K D+WS GV L+ + G P+ + E+ + E P P E+ ++
Sbjct: 173 GKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIM 231
Query: 248 --CKILDPN 254
C P
Sbjct: 232 LSCWKYRPE 240
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 65/267 (24%), Positives = 117/267 (43%), Gaps = 32/267 (11%)
Query: 21 LLGQGAFAKVYYARSIRTNQS-----VAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
LG+G F +V+ A++ + V VK + K K + +RE+ + R + H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE--FRRELDMFRKLSHKN 69
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHSRG 133
+V+L + + ++EY G+L F + K K ++ + A+ + G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 134 V--------YHRDIKPENLLLDENENLKISDFGLS----ALAQCKHQDGLLHTTCGTPA- 180
+ HRD+ N L+ +K+S LS K ++ L+ P
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI------PLR 183
Query: 181 YVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKI--GKAEFKCPN 237
++APE + + K D+WS GV+++ V G LPF+ + E+ ++ GK E P
Sbjct: 184 WLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE 242
Query: 238 WFPPEVRKLLCKILDPNPSTRISMAKI 264
P + KL+ + NP R S +++
Sbjct: 243 GCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 9/196 (4%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LG G V+ + +A K+I + ++ + +QI RE+ V+ P IV Y
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDI 139
+ +I ME+ GG L + K G++ E + +I + + + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 140 KPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDI 199
KP N+L++ +K+ DFG+S + D + ++ GT +Y++PE + Y + DI
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYSVQS-DI 185
Query: 200 WSCGVVLFVLLAGYLP 215
WS G+ L + G P
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 21/165 (12%)
Query: 60 QIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYF 119
QI RE+ V+ P IV Y + +I ME+ GG L ++V K A R
Sbjct: 45 QIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLK------KAGRIP 97
Query: 120 QQLINAVDFCHSRG---------VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170
+ ++ + RG + HRD+KP N+L++ +K+ DFG+S + D
Sbjct: 98 ENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDS 153
Query: 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLP 215
+ ++ GT +Y++PE + Y + DIWS G+ L + G P
Sbjct: 154 MANSFVGTRSYMSPERLQGTHYTVQS-DIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 65/272 (23%), Positives = 123/272 (45%), Gaps = 26/272 (9%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTN---QSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+ +GR+LG+G F V A+ + Q VAVK++ D + ++ RE + M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDI-EEFLREAACMKEFD 59
Query: 73 HPNIVQLYEV---MATKSKI---FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI--- 123
HPN+++L V K ++ ++ + K G+L + ++ E+ Q L+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 124 ----NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
+ +++ S+ HRD+ N +L+EN + ++DFGLS + + C +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCASK 176
Query: 180 ---AYVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRK-IGKAEFK 234
++A E + Y D+W+ GV ++ ++ G P+ E+Y I K
Sbjct: 177 LPVKWLALESLADNVYTTHS-DVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235
Query: 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
P +V +L+C+ P P R S +R+
Sbjct: 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 20 RLLGQGAFAKVYYAR-SIRTNQSVAVKVIDKDKIMRVGLADQIK----REISVMRIVRHP 74
+++G G F +V R + + + V + K ++ G +D+ + E S+M HP
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAI----KTLKAGSSDKQRLDFLTEASIMGQFDHP 65
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
NI++L V+ + + EY + G L F + GK + + + + +
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG-TPA-YVAPEVINRK 190
HRD+ N+L++ N K+SDFGLS + + T G P + APE I +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPIRWTAPEAIAYR 183
Query: 191 GYDGEKVDIWSCGVVLF-VLLAGYLPFHD 218
+ D+WS G+V++ V+ G P+ D
Sbjct: 184 KFTSAS-DVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 15 KYEVGRLLGQGAFAKVYYARSI--RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+YE G +G+G + VY A+ + + A+K I+ G++ REI+++R ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEG-----TGISMSACREIALLRELK 56
Query: 73 HPNIVQLYEVMATKS--KIFFVMEYAKGGEL----FNKVAKG-----KLKEDAARRYFQQ 121
HPN++ L +V + S K++ + +YA+ F++ +K +L + Q
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 122 LINAVDFCHSRGVYHRDIKPENLLL----DENENLKISDFGLSALAQCKHQD-GLLHTTC 176
+++ + + H+ V HRD+KP N+L+ E +KI+D G + L + L
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 177 GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH 217
T Y APE++ + + +DIW+ G + LL FH
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 52 IMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK---- 107
+++ G E ++R + HP ++ L +V V+ + +L+ +
Sbjct: 198 VVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRP 256
Query: 108 -GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166
G + A R QL++A+D+ H G+ HRDIK EN+L++ E++ + DFG + A+
Sbjct: 257 LGLAQVTAVAR---QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313
Query: 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLF 207
+ GT APEV+ Y VDIWS G+V+F
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 20 RLLGQGAFAKVYYAR-SIRTNQSVAVKVIDKDKIMRVGLADQIKR----EISVMRIVRHP 74
+++G G F +V R + + + V + K ++ G ++ +R E S+M HP
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAI----KTLKAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 75 NIVQLYEVMATKSK-IFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHS 131
NI+ L E + TKSK + V EY + G L F + G+ + + + + +
Sbjct: 66 NIIHL-EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD 124
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA---YVAPEVIN 188
G HRD+ N+L++ N K+SDFGLS + + + +TT G + APE I
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIPIRWTAPEAIA 182
Query: 189 RKGYDGEKVDIWSCGVVLF-VLLAGYLPFHD 218
+ + D+WS G+V++ V+ G P+ +
Sbjct: 183 YRKFTSAS-DVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 21 LLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQI---KREISVMRIVRH 73
LG+G F V R T + VAVK + A+ + +REI +++ ++H
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST------AEHLRDFEREIEILKSLQH 64
Query: 74 PNIVQLYEVM--ATKSKIFFVMEYAKGGELFNKVAKGKLKEDAAR--RYFQQLINAVDFC 129
NIV+ V A + + VMEY G L + + K + + D + Y Q+ +++
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY-VAPEVIN 188
S+ HRD+ N+L++ +KI DFGL+ + + + +P + APE +
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 189 RKGYDGEKVDIWSCGVVLFVL 209
+ D+WS GVVL+ L
Sbjct: 185 ESKFSVAS-DVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 57/221 (25%), Positives = 109/221 (49%), Gaps = 24/221 (10%)
Query: 15 KYEVGRLLGQGAFAKVYYARSI--RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+YE G +G+G + VY A+ + ++ A+K I+ G++ REI+++R ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEG-----TGISMSACREIALLRELK 56
Query: 73 HPNIVQLYEVMATKS--KIFFVMEYAKGGEL----FNKVAKG-----KLKEDAARRYFQQ 121
HPN++ L +V + + K++ + +YA+ F++ +K +L + Q
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 122 LINAVDFCHSRGVYHRDIKPENLLL----DENENLKISDFGLSALAQCKHQD-GLLHTTC 176
+++ + + H+ V HRD+KP N+L+ E +KI+D G + L + L
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 177 GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH 217
T Y APE++ + + +DIW+ G + LL FH
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 60/241 (24%), Positives = 115/241 (47%), Gaps = 33/241 (13%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQ-------SVAVKVIDKDKIMRVGLADQIKREIS 66
+K +G+ LG+G F +V A ++ ++ +VAVK++ KD L+D + E+
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EME 72
Query: 67 VMRIV-RHPNIVQLYEVMATKSKIFFVMEYAKGGEL-----------------FNKVAKG 108
+M+++ +H NI+ L ++ ++EYA G L +V
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132
Query: 109 KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168
++ Q+ +++ S+ HRD+ N+L+ EN +KI+DFGL+ +
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--RDVNNI 190
Query: 169 DGLLHTTCGT-PA-YVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMY 225
D TT G P ++APE + + Y + D+WS GV+++ + G P+ + E++
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
Query: 226 R 226
+
Sbjct: 250 K 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 74/285 (25%), Positives = 118/285 (41%), Gaps = 53/285 (18%)
Query: 20 RLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIK----REISVMRI 70
R +GQGAF +V+ AR+ VAVK +++ + ++ RE ++M
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVK------MLKEEASADMQADFQREAALMAE 64
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQ-------- 120
HPNIV+L V A + + EY G+L F + + + +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 121 -QLINAVDFCHSRGV------------YHRDIKPENLLLDENENLKISDFGLS----ALA 163
L C ++ V HRD+ N L+ EN +KI+DFGLS +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 164 QCK-HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNL 221
K ++ + ++ PE I Y E D+W+ GVVL+ + + G P++
Sbjct: 185 YYKASENDAIPIR-----WMPPESIFYNRYTTES-DVWAYGVVLWEIFSYGMQPYYGMAH 238
Query: 222 IEM--YRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKI 264
E+ Y + G CP+ P E+ L+ PS R S A I
Sbjct: 239 EEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 14 EKYEVGRLLGQGAFAKV---YYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
E ++ + LG G F +V YY S + VAVK + K M V E ++M+
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTK----VAVKTL-KPGTMSV---QAFLEEANLMKT 57
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV---AKGKLKEDAARRYFQQLINAVD 127
++H +V+LY V+ + I+ + EY G L + + GK+ + Q+ +
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP---AYVAP 184
+ + HRD++ N+L+ E+ KI+DFGL+ + +D G + AP
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI----EDNEYTAREGAKFPIKWTAP 173
Query: 185 EVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPF 216
E IN + K D+WS G++L+ ++ G +P+
Sbjct: 174 EAINFGSFT-IKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 19/253 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E ++ + LG G F +V+ + N VAVK + + + E +M+ +RH
Sbjct: 6 ESLQLIKKLGNGQFGEVWMG-TWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLRH 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQLINAVDFCH 130
+VQLY V+ ++ I+ V EY G L + + G+ LK Q+ + +
Sbjct: 61 DKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP---AYVAPEVI 187
HRD++ N+L+ + KI+DFGL+ L +D G + APE
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLI----EDNEYTARQGAKFPIKWTAPEAA 175
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRK 245
G K D+WS G++L L+ G +P+ N E+ ++ + CP P + +
Sbjct: 176 -LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 234
Query: 246 LLCKILDPNPSTR 258
L+ + +P R
Sbjct: 235 LMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 62/239 (25%), Positives = 113/239 (47%), Gaps = 37/239 (15%)
Query: 18 VGRLLGQGAFAKVYYARSIRTNQS-------VAVKVIDKDKIMRVGLADQIKREISVMRI 70
+G+ LG+G F +V A +I ++ VAVK++ D + L+D I E+ +M++
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDLIS-EMEMMKM 79
Query: 71 V-RHPNIVQLYEVMATKSKIFFVMEYAKGGEL-------------------FNKVAKGKL 110
+ +H NI+ L ++ ++EYA G L +
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 111 KEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170
K+ + Y Q+ +++ S+ HRD+ N+L+ E+ +KI+DFGL+ H D
Sbjct: 140 KDLVSCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA--RDIHHIDY 195
Query: 171 LLHTTCGT-PA-YVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYR 226
TT G P ++APE + + Y + D+WS GV+L+ + G P+ + E+++
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTN-----QSVAVKVIDKDKIMRVGLADQIKREISVMR 69
+G+ LG+G F KV A + R +VAVK++ K+ L D + E ++++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML-KENASSSELRDLLS-EFNLLK 58
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN------KVAKGKLKEDAARR------ 117
V HP++++LY + + ++EYAK G L + KV L D R
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 118 -------------YFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164
+ Q+ + + + HRD+ N+L+ E +KISDFGLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RD 176
Query: 165 CKHQDGLLHTTCG-TPA-YVAPEVINRKGYDGEKVDIWSCGVVLFVLL 210
+D + + G P ++A E + Y + D+WS GV+L+ ++
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 19/245 (7%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LGQG F +V+ T + VA+K + + + +E VM+ +RH +VQLY
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 82 VMATKSKIFFVMEYAKGGEL--FNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHRD 138
V+ ++ I+ V EY G L F K GK L+ Q+ + + + HRD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP---AYVAPEVINRKGYDGE 195
++ N+L+ EN K++DFGL+ L +D G + APE G
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWTAPEAA-LYGRFTI 182
Query: 196 KVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDP 253
K D+WS G++L L G +P+ E+ ++ + CP P + L+C+
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 242
Query: 254 NPSTR 258
P R
Sbjct: 243 EPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 68/293 (23%), Positives = 108/293 (36%), Gaps = 55/293 (18%)
Query: 9 PSVLTEKYEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIMRVGLADQIKREI 65
P V + + R LG GAF +VY + V V + E
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60
Query: 66 SVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLK-EDAARRYFQQLIN 124
+M H NIV+L V + F ++E GG+L + + + + + E + + L+
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 125 -AVDF---CH---SRGVYHRDIKPENLLLD---ENENLKISDFGLS-------------- 160
A D C HRDI N LL KI+DFG++
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDG---EKVDIWSCGVVLF-VLLAGYLPF 216
A+ K ++ PE DG K D+WS GV+L+ + GY+P+
Sbjct: 181 AMLPIK--------------WMPPEAF----LDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
Query: 217 ---HDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ ++E G+ + P P V +++ P R + A I E
Sbjct: 223 PGRTNQEVMEFVTGGGRLDP--PKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 19/237 (8%)
Query: 22 LGQGAFA----KVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIV 77
LG G F VY R + + ++ V + +K +R D++ RE +M + +P IV
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR----DEMMREAEIMHQLDNPYIV 58
Query: 78 QLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVD----FCHSRG 133
++ V ++ + VME A GG L NK GK K++ +L++ V + +
Sbjct: 59 RMIGVCEAEA-LMLVMEMASGGPL-NKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP-AYVAPEVINRKGY 192
HRD+ N+LL KISDFGLS + P + APE IN + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 193 DGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLL 247
+ D+WS G+ ++ + G P+ E+ I + + CP PPE+ L+
Sbjct: 176 S-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALM 231
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 19/252 (7%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
LGQG F +V+ T + VA+K + +M + +E +M+ +RH +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 82 VMATKSKIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQLINAVDFCHSRGVYHRD 138
V+ ++ I+ V E+ G L + + +G LK Q+ + + + HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP---AYVAPEVINRKGYDGE 195
++ N+L+ +N KI+DFGL+ L +D G + APE G
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI----EDNEYTARQGAKFPIKWTAPEAA-LYGRFTI 182
Query: 196 KVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDP 253
K D+WS G++L L+ G +P+ E+ ++ + CP P + +L+
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKK 242
Query: 254 NPSTRISMAKIR 265
+P R + I+
Sbjct: 243 DPDERPTFEYIQ 254
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 69/264 (26%), Positives = 114/264 (43%), Gaps = 21/264 (7%)
Query: 20 RLLGQGAFAKVYYAR--SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIV 77
R LG+GAF KV+ A ++ Q + + K RE ++ ++H +IV
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 78 QLYEVMATKSKIFFVMEYAKGGELFNK-----------VAKG----KLKEDAARRYFQQL 122
+ Y V + V EY K G+L NK +A+G +L + QQ+
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 123 INAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV 182
+ + S+ HRD+ N L+ EN +KI DFG+S + T ++
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 183 APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFP 240
PE I + + E D+WS GVVL+ + G P++ + E+ I + + P P
Sbjct: 190 PPESIMYRKFTTES-DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCP 248
Query: 241 PEVRKLLCKILDPNPSTRISMAKI 264
EV L+ P R+++ +I
Sbjct: 249 KEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 65/256 (25%), Positives = 122/256 (47%), Gaps = 27/256 (10%)
Query: 20 RLLGQGAFAKVYYARSIRTNQS---VAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
R++G+G F VY+ I ++ AVK +++ I + +Q +E +M+ HPN+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 77 VQLYEVMATKSKI-FFVMEYAKGGELFNKVAKGK----LKEDAARRYFQQLINAVDFCHS 131
+ L + V+ Y K G+L N + +K+ + Q+ +++ S
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG--FGLQVAKGMEYLAS 116
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL-HTTCGTPA-YVAPEVINR 189
+ HRD+ N +LDE+ +K++DFGL+ K + HT P ++A E +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 190 KGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNL--IEMY----RKIGKAEFKCPNWFPPE 242
+ + K D+WS GV+L+ L+ G P+ D + I +Y R++ + E+ CP+
Sbjct: 177 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY-CPD----P 230
Query: 243 VRKLLCKILDPNPSTR 258
+ +++ P P R
Sbjct: 231 LYEVMLSCWHPKPEMR 246
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 51/249 (20%)
Query: 15 KYEVGRLLGQGAFAKVYYARSI-----RTNQ--SVAVKVIDKDKIMRVGLADQIKREISV 67
+ +G+ LG+G F +V A +I + N+ +VAVK++ KD L+D + E+ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVS-EMEM 70
Query: 68 MRIV-RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKED-AARR-------- 117
M+++ +H NI+ L ++ ++EYA +KG L+E ARR
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYA---------SKGNLREYLRARRPPGMDYSF 121
Query: 118 ----------YFQQLIN-------AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160
F+ L++ +++ S+ HRD+ N+L+ E+ +KI+DFGL+
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 161 ALAQCKHQDGLLHTTCGT-PA-YVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFH 217
+ D TT G P ++APE + + Y + D+WS GV+L+ + G P+
Sbjct: 182 --RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLLWEIFTLGGSPYP 238
Query: 218 DSNLIEMYR 226
+ E+++
Sbjct: 239 GIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 21 LLGQGAFAKVYYAR---SIRTNQSVAVKVIDKDKIMRVGLADQIKR----EISVMRIVRH 73
++G G F +V R + VA+K ++ G ++ +R E S+M H
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKT------LKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHS 131
PNI+ L V+ + + E+ + G L F + G+ + + + +
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA---YVAPEVIN 188
HRD+ N+L++ N K+SDFGLS + D ++ G + APE I
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 189 RKGYDGEKVDIWSCGVVLF-VLLAGYLPFHD 218
+ + D+WS G+V++ V+ G P+ D
Sbjct: 185 YRKFTSAS-DVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 61/267 (22%), Positives = 111/267 (41%), Gaps = 20/267 (7%)
Query: 18 VGRLLGQGAFAKVYYAR---SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
+G++LG+G F V + + VAVK + D + + + E + M+ HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHP 61
Query: 75 NIVQLYEV---MATKSKI---FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLIN-AVD 127
N+++L V ++ KI ++ + K G+L + + +L + Q L+ VD
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 128 ------FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
+ +R HRD+ N +L E+ + ++DFGLS +
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRK-IGKAEFKCPNWF 239
+A E + + Y K D+W+ GV ++ + G P+ E+Y K P
Sbjct: 182 IAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC 240
Query: 240 PPEVRKLLCKILDPNPSTRISMAKIRE 266
E+ L+ +P R + K+RE
Sbjct: 241 LDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 72/269 (26%), Positives = 125/269 (46%), Gaps = 34/269 (12%)
Query: 21 LLGQGAFAKVYYARSIRTN---QSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNI 76
++G+G F +V AR I+ + A+K + K+ + D E+ V+ ++ HPNI
Sbjct: 14 VIGEGNFGQVLKAR-IKKDGLRMDAAIKRM-KEYASKDDHRD-FAGELEVLCKLGHHPNI 70
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKED----------AARRYFQQLIN-- 124
+ L + ++ +EYA G L + + K ++ E A+ QQL++
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 125 -----AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT- 178
+D+ + HRD+ N+L+ EN KI+DFGLS + Q+ + T G
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMGRL 185
Query: 179 PA-YVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKC 235
P ++A E +N Y D+WS GV+L+ +++ G P+ E+Y K+ + +
Sbjct: 186 PVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 244
Query: 236 PNWFPPEVRKLLCKILDPNPSTRISMAKI 264
P EV L+ + P R S A+I
Sbjct: 245 PLNCDDEVYDLMRQCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 70/272 (25%), Positives = 116/272 (42%), Gaps = 30/272 (11%)
Query: 20 RLLGQGAFAKVYYARSIRTNQS-----VAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
R LG+GAF KV+ A + + VAVK + KD + +RE ++ ++H
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAA--RKDFQREAELLTNLQHE 67
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKV------------------AKGKLKEDAAR 116
+IV+ Y V + V EY K G+L NK AKG+L
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 117 RYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC 176
Q+ + + + S+ HRD+ N L+ N +KI DFG+S + T
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 177 GTPAYVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FK 234
++ PE I + + E D+WS GV+L+ + G P+ + E+ I + +
Sbjct: 187 LPIRWMPPESIMYRKFTTES-DVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE 245
Query: 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
P P EV ++ P R+++ +I +
Sbjct: 246 RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 8e-11
Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 36/270 (13%)
Query: 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS-----VMRIVRHPN 75
++G+G F +V AR + + + K M+ + R+ + + ++ HPN
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAI----KRMKEYASKDDHRDFAGELEVLCKLGHHPN 57
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK-LKEDAA----------------RRY 118
I+ L + ++ +EYA G L + + K + L+ D A +
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 119 FQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT 178
+ +D+ + HRD+ N+L+ EN KI+DFGLS + Q+ + T G
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMGR 172
Query: 179 -PA-YVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFK 234
P ++A E +N Y D+WS GV+L+ +++ G P+ E+Y K+ + +
Sbjct: 173 LPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231
Query: 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKI 264
P EV L+ + P R S A+I
Sbjct: 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 64 EISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI 123
E ++R + HP+I+QL ++ K AK + + ++
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD---GLLHTTCGTPA 180
A+ + H + HRDIK EN+ ++ ++ + DFG A C D + GT A
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG----AACFPVDINANKYYGWAGTIA 248
Query: 181 YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS 219
APE++ R Y G VDIWS G+VLF + HDS
Sbjct: 249 TNAPELLARDPY-GPAVDIWSAGIVLFEMATC----HDS 282
|
Length = 391 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 24/225 (10%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E ++ + LG G F +V+ A + + VAVK + K M V + E +VM+ ++H
Sbjct: 6 ESLKLEKKLGAGQFGEVWMA-TYNKHTKVAVKTM-KPGSMSV---EAFLAEANVMKTLQH 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELF--------NKVAKGKLKEDAARRYFQQLINA 125
+V+L+ V+ TK I+ + E+ G L +K KL + +A Q+
Sbjct: 61 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-----QIAEG 114
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP-AYVAP 184
+ F R HRD++ N+L+ + KI+DFGL+ + + + P + AP
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAP 172
Query: 185 EVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKI 228
E IN + K D+WS G++L ++ G +P+ + E+ R +
Sbjct: 173 EAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 69/266 (25%), Positives = 117/266 (43%), Gaps = 21/266 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQS-VAVKVIDKDKIMRVGLADQIKRE--ISVMRI 70
G+ LG GAF KV A + ++S +KV K M A +RE +S ++I
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK---MLKPTAHSSEREALMSELKI 91
Query: 71 V----RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQLI 123
+ H NIV L I + EY G+L N + + + L + + Q+
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG-LLHTTCGTPA-Y 181
+ F S+ HRD+ N+LL + +KI DFGL+ + ++ P +
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA--RDIMNDSNYVVKGNARLPVKW 209
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAEFKC--PNW 238
+APE I Y E D+WS G++L+ + + G P+ + + K+ K ++ P
Sbjct: 210 MAPESIFNCVYTFES-DVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268
Query: 239 FPPEVRKLLCKILDPNPSTRISMAKI 264
P E+ ++ D +P R + +I
Sbjct: 269 APAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 66/270 (24%), Positives = 122/270 (45%), Gaps = 36/270 (13%)
Query: 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR----EISVM-RIVRHPN 75
++G+G F +V A + + + K+++ ++ R E+ V+ ++ HPN
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKED----------AARRYFQQLI-- 123
I+ L + ++ +EYA G L + + K ++ E A+ QQL+
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 124 -----NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT 178
+ + + HRD+ N+L+ EN KI+DFGLS + ++ + T G
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS-----RGEEVYVKKTMGR 179
Query: 179 -PA-YVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFK 234
P ++A E +N Y K D+WS GV+L+ +++ G P+ E+Y K+ + +
Sbjct: 180 LPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238
Query: 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKI 264
P EV +L+ + P R A+I
Sbjct: 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 22/222 (9%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
E+GR G VY AR T V V++ D + L ++ E+ + RHPNI
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 77 VQLYEVMATKSKIFFV---MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRG 133
+ + V T S ++ + M Y L + E + +++ H G
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH---------TTCGTPAYVAP 184
HR+IK ++L+ + + +S GLS L ++G +T P +++P
Sbjct: 122 YIHRNIKASHILISGDGLVSLS--GLSHL-YSLVRNGQKAKVVYDFPQFSTSVLP-WLSP 177
Query: 185 EVINRK--GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEM 224
E++ + GY+ K DI+S G+ L G +PF D +M
Sbjct: 178 ELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 23/264 (8%)
Query: 22 LGQGAFAKVYYAR--SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
LG+GAF KV+ A ++ Q + + K +RE ++ +++H +IV+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 80 YEVMATKSKIFFVMEYAKGGELFNK-----------------VAKGKLKEDAARRYFQQL 122
Y V + V EY + G+L N+ VA G+L Q+
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 123 INAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV 182
+ + + S HRD+ N L+ + +KI DFG+S + T ++
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 191
Query: 183 APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA-EFKCPNWFP 240
PE I + + E DIWS GVVL+ + G P++ + E I + E + P P
Sbjct: 192 PPESILYRKFTTES-DIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCP 250
Query: 241 PEVRKLLCKILDPNPSTRISMAKI 264
PEV ++ P R+ + I
Sbjct: 251 PEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREI----SVMRIVRHPN 75
++LG GAF VY I + V + V K +R + + +EI VM V +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPV--AIKELREATSPKANKEILDEAYVMASVDNPH 70
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ----QLINAVDFCHS 131
+ +L + T S + + + G L + V + K ++ +Y Q+ +++
Sbjct: 71 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG-TP-AYVAPEVINR 189
R + HRD+ N+L+ +++KI+DFGL+ L ++ H G P ++A E I
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE--YHAEGGKVPIKWMALESILH 185
Query: 190 KGYDGEKVDIWSCGVVLFVLLA-GYLPF 216
+ Y + D+WS GV ++ L+ G P+
Sbjct: 186 RIYTHQS-DVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 71/278 (25%), Positives = 119/278 (42%), Gaps = 44/278 (15%)
Query: 20 RLLGQGAFAKVYYARSI------RTNQSVAVKVIDKDKIMRVGLADQIK----REISVMR 69
LG GAF +VY + VAVK + K G DQ K +E +M
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK------GATDQEKKEFLKEAHLMS 54
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKL-KEDAARRYFQQLIN-AVD 127
HPNIV+L V + +ME +GG+L + + ++ + ++L++ +D
Sbjct: 55 NFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114
Query: 128 FCHSRGVY-------HRDIKPENLLLDENEN-----LKISDFGL-----SALAQCKHQDG 170
VY HRD+ N L+ E +KI DFGL + K +G
Sbjct: 115 VAKG-CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKI- 228
LL ++APE + + + D+WS GV+++ +L G P+ N E+ + +
Sbjct: 174 LLPVR-----WMAPESLLDGKFTTQS-DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227
Query: 229 GKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ P P ++ +L+ +PS R + +I+E
Sbjct: 228 AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 58/240 (24%), Positives = 109/240 (45%), Gaps = 25/240 (10%)
Query: 9 PSVLTEKYEVGRLLGQGAFAKVYYA---RSIRTNQSVAVKVIDKDKIMRVGLADQIKR-- 63
PS +T++ +++G G F +V+ R +VA+K ++ G ++ ++
Sbjct: 4 PSHITKQ----KVIGAGEFGEVFRGILKMPGRKEVAVAIKT------LKPGYTEKQRQDF 53
Query: 64 --EISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYF 119
E S+M H NI++L V+ + EY + G L + + G+
Sbjct: 54 LSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML 113
Query: 120 QQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
+ + + + HRD+ N+L++ N K+SDFGLS + + +G T+ G
Sbjct: 114 RGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKI 172
Query: 180 A--YVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAEFKCP 236
+ APE I + + D+WS G+V++ V+ G P+ D + E+ + I F+ P
Sbjct: 173 PIRWTAPEAIAYRKFTSAS-DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81
+G G F KV + R V V + +E+ R + HPN++Q
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 82 VMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQL----INAVDFCHSRGVY 135
V+E+ G+L N + +G + + A + Q++ + + + H
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI 122
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT--CGTP-AYVAPEVINRKGY 192
H D+ N L + ++KI D+G LA ++ + T P ++APE++ +G
Sbjct: 123 HSDLALRNCQLTADLSVKIGDYG---LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 193 DGEKVD------IWSCGVVLFVLL-AGYLPFHD 218
D D IWS GV ++ L A P+ D
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177
Y Q+ ++F SR HRD+ N+LL EN +KI DFGL A K D +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDAR 236
Query: 178 TP-AYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMY-RKIGKAEFK 234
P ++APE I K Y + D+WS GV+L+ + + G P+ + E + R++ +
Sbjct: 237 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 235 C-PNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
P + PE+ ++ NP R + +++ E
Sbjct: 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 6/153 (3%)
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177
Y Q+ ++F SR HRD+ N+LL EN +KI DFGL A K D + +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGSAR 237
Query: 178 TP-AYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK--AEF 233
P ++APE I K Y + D+WS GV+L+ + + G P+ + E + + K
Sbjct: 238 LPLKWMAPESIFDKVYTTQS-DVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 234 KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ P PE+ +++ +P R + + + E
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 30 VYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89
V AR T + V V+ I+ + + ++ E+ V ++ HPNIV +++
Sbjct: 16 VNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74
Query: 90 FFV---MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL 146
+ V M Y +L + E A Q ++ A+D+ H G HR +K ++L+
Sbjct: 75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134
Query: 147 DENENLKISDFGL-SALAQCKH-------QDGLLHTTCGTPAYVAPEVI--NRKGYDGEK 196
+ + +S GL S L+ H D ++ P +++PEV+ N +GYD K
Sbjct: 135 SVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDA-K 190
Query: 197 VDIWSCGVVLFVLLAGYLPFHDSNLIEM 224
DI+S G+ L G++PF D +M
Sbjct: 191 SDIYSVGITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177
Y Q+ ++F SR HRD+ N+LL EN +KI DFGL A K D +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDAR 242
Query: 178 TP-AYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMY-RKIGKA-EF 233
P ++APE I + Y + D+WS GV+L+ + + G P+ + E + R++ +
Sbjct: 243 LPLKWMAPETIFDRVYTIQS-DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 234 KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ P++ PE+ + + PS R + +++ E
Sbjct: 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 18/133 (13%)
Query: 42 VAVKVI--DKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGG 99
VAVK++ D +K R + +EI +M ++ PNI++L V T + + EY + G
Sbjct: 49 VAVKMLREDANKNAR----NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENG 104
Query: 100 ELFNKVAKGKLKEDAA------------RRYFQQLINAVDFCHSRGVYHRDIKPENLLLD 147
+L +++ + +E A Q+ + + + S HRD+ N L+
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164
Query: 148 ENENLKISDFGLS 160
+N +KI+DFG+S
Sbjct: 165 KNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 40/176 (22%), Positives = 67/176 (38%), Gaps = 30/176 (17%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQS----------------VAVKVIDKDKIMRVG 56
+ LG+G F +V+ + VAVKV+ D
Sbjct: 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN-A 62
Query: 57 LADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAAR 116
D +K E+ ++ + PNI +L V + +MEY + G+L + K +
Sbjct: 63 REDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 117 RY-----FQQLIN-------AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160
F L+ + + S HRD+ N L+ +N +KI+DFG+S
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 38/230 (16%)
Query: 21 LLGQGAFAKVYYARSIR----TNQSVAVK-VIDKDKIMRVGLADQIKREISVMRIVRHPN 75
LL +G F +++Y I + V VK V D ++V L Q E ++ + H N
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ---ESCLLYGLSHQN 69
Query: 76 IVQLYEVMATKSKIFFVME-YAKGGELFNKVAKGKLKEDAARRYFQ---------QLINA 125
I+ + V + FV+ Y G L + + +L E + Q+
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ--------CKHQDGLLHTTCG 177
+ + H RGV H+DI N ++DE +KI+D +AL++ C L
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDYHC------LGDNEN 180
Query: 178 TP-AYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMY 225
P ++A E + K Y D+WS GV+L+ L+ G P+ + + EM
Sbjct: 181 RPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 35/184 (19%)
Query: 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSI-------------RTNQSVAVKVIDKDKIMR 54
+PS + + +G+ LG+GAF VY A + + + AV++ +++ R
Sbjct: 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRR 185
Query: 55 V---GLADQI---------KREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELF 102
AD + K+E + R+ L ++M +K + V Y L
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPY-----LL 240
Query: 103 NKV---AKGKLKEDA-ARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISDF 157
KV KG +E+ + +Q++ A+D HS G+ HRD+KP+N++ E + KI D
Sbjct: 241 GKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDL 300
Query: 158 GLSA 161
G +A
Sbjct: 301 GAAA 304
|
Length = 566 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 53/218 (24%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 11 VLTEKYEVGRLLGQGAFAKVY--YARSIRTNQ---SVAVKVIDKDKIMRVGLADQIKREI 65
V EK + R LGQG+F VY A+ + ++ VA+K +++ MR + + E
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEA 60
Query: 66 SVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAA--------RR 117
SVM+ ++V+L V++ +ME G+L + + + + + ++
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 118 YFQ---QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS-----ALAQCKHQD 169
Q ++ + + + ++ HRD+ N ++ E+ +KI DFG++ K
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLF 207
GLL +++PE + + G D+WS GVVL+
Sbjct: 181 GLLPVR-----WMSPESL-KDGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 26/228 (11%)
Query: 18 VGRLLGQGAFAKVYYARSIRTNQ--SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+G+ LG+G F V + + + VAVK + R + D + E M+ HPN
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHPN 61
Query: 76 IVQLYEV--MATKSKIF----FVMEYAKGGELFNKVAKGKLKEDAARRYFQQLI------ 123
+++L V +S+ + ++ + K G+L + + +L + Q L+
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 124 -NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT---CGTP 179
+ +++ S+ HRD+ N +L+EN N+ ++DFGLS K +G + P
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK----KIYNGDYYRQGRIAKMP 177
Query: 180 A-YVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMY 225
++A E + + Y K D+WS GV ++ + G P+ E+Y
Sbjct: 178 VKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREI----SVMRIVRHPN 75
++LG GAF VY I ++V + V K++R + + +EI VM V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPV--AIKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVA--KGKLKEDAARRYFQQLINAVDFCHSRG 133
+ +L + T S + V + G L + V K ++ + Q+ + +
Sbjct: 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG-TP-AYVAPEVINRKG 191
+ HRD+ N+L+ ++KI+DFGL+ L + H G P ++A E I +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE--YHADGGKVPIKWMALESILHRR 187
Query: 192 YDGEKVDIWSCGVVLFVLLA-GYLPF 216
+ + D+WS GV ++ L+ G P+
Sbjct: 188 FTHQS-DVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 11 VLTEKYEVGRLLGQGAFAKVY--YARSI---RTNQSVAVKVIDKDKIMRVGLADQIKREI 65
V EK + R LGQG+F VY AR I VAVK +++ +R + + E
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEA 60
Query: 66 SVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARR------YF 119
SVM+ ++V+L V++ VME G+L K L+ +A
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL--KSYLRSLRPEAENNPGRPPPTL 118
Query: 120 QQLI-------NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS-----ALAQCKH 167
Q++I + + + +++ HRD+ N ++ + +KI DFG++ K
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLF 207
GLL ++APE + + G D+WS GVVL+
Sbjct: 179 GKGLLPVR-----WMAPESL-KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 32/132 (24%), Positives = 60/132 (45%), Gaps = 15/132 (11%)
Query: 42 VAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGG-- 99
VAVK++ D + + D +K EI +M +++PNI++L V + + + EY + G
Sbjct: 47 VAVKMLRAD-VTKTARNDFLK-EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 100 -------ELFNKVAKGKLKEDAARRYF----QQLINAVDFCHSRGVYHRDIKPENLLLDE 148
E+ + + Q+ + + + S HRD+ N L+
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 149 NENLKISDFGLS 160
+ +KI+DFG+S
Sbjct: 165 HYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 46/197 (23%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSV----AVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
++LG GAF VY + ++V A+K++++ + + + E +M + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK--LKEDAARRYFQQLINAVDFCHSRG 133
+V+L V + + I V + G L + V + K + + Q+ + + R
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD 193
+ HRD+ N+L+ ++KI+DFGL+ L + ++ ++A E I+ + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 194 GEKVDIWSCGVVLFVLL 210
+ D+WS GV ++ L+
Sbjct: 190 HQS-DVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 55/244 (22%), Positives = 101/244 (41%), Gaps = 30/244 (12%)
Query: 39 NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLY----EVMATKSKIFFVME 94
N+ V ++ K L D + EI +R + NI+++Y +++ ++ ++E
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 95 YAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVY---------HRDIKPENLL 145
Y G L + K K + +L A+D C +G+Y ++++ + L
Sbjct: 103 YCTRGYLREVLDKEK-----DLSFKTKLDMAIDCC--KGLYNLYKYTNKPYKNLTSVSFL 155
Query: 146 LDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR--KGYDGEKVDIWSCG 203
+ EN LKI GL K Y + +++N Y K DI+S G
Sbjct: 156 VTENYKLKIICHGLE-----KILSSPPFKNVNFMVYFSYKMLNDIFSEYT-IKDDIYSLG 209
Query: 204 VVLFVLLAGYLPFHDSNLIEMYRKIGK--AEFKCPNWFPPEVRKLLCKILDPNPSTRISM 261
VVL+ + G +PF + E+Y I K P P E++ ++ + R ++
Sbjct: 210 VVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
Query: 262 AKIR 265
+I
Sbjct: 270 KEIL 273
|
Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 55/257 (21%), Positives = 109/257 (42%), Gaps = 21/257 (8%)
Query: 20 RLLGQGAFAKVYYA-RSIRTNQSVAVKVIDKDKIMRVGLADQIKR----EISVMRIVRHP 74
R+LG G F ++ + + + + V + +R G +D+ +R E + H
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAI----HTLRAGCSDKQRRGFLAEALTLGQFDHS 66
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
NIV+L V+ + + V EY G L F + +G+L L + + +
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV---APEVINR 189
G H+ + +L++ + KIS F L + K + ++TT + V APE I +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSE--AIYTTMSGKSPVLWAAPEAI-Q 181
Query: 190 KGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLL 247
+ D+WS G+V++ +++ G P+ D + ++ + + P P + +L+
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLM 241
Query: 248 CKILDPNPSTRISMAKI 264
R ++I
Sbjct: 242 LDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 68/272 (25%), Positives = 104/272 (38%), Gaps = 49/272 (18%)
Query: 22 LGQGAFAKVYYARSIRTNQS------------VAVKVIDKDKIMRVGLADQIKREISVMR 69
LGQG F +Y + + QS V +KV+ D R LA S+M
Sbjct: 3 LGQGTFTNIY--KGVLRVQSDLDIVGPGQEVSVVLKVLGSDH--RDSLAFF--ETASLMS 56
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKL----KEDAARRYFQQLI 123
+ H ++V+LY V I V EY K G L F K + K D A +QL
Sbjct: 57 QLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVA----KQLA 111
Query: 124 NAVDFCHSRGVYHRDIKPENLLL---DENEN----LKISDFGLSALAQCKHQDGLLHTTC 176
+A+ + + + H ++ +N+L+ NE +K+SD G+ L
Sbjct: 112 SALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV-------LSREER 164
Query: 177 GTPA-YVAPEVI-NRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA-E 232
++APE I N + D WS G L + G P + E R
Sbjct: 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224
Query: 233 FKCPNWFPPEVRKLLCKILDPNPSTRISMAKI 264
P+ E+ L+ + +P+ R S I
Sbjct: 225 LPMPDC--AELANLINQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 41/270 (15%)
Query: 22 LGQGAFAKVYYARSIRTNQ---------SVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
LGQG F K++ + IR V +KV+DK ++ S+M +
Sbjct: 3 LGQGTFTKIF--KGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLS 57
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRY--FQQLINAVDFCH 130
H ++V Y V + V EY K G L + K K + + + +QL A+ F
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE 117
Query: 131 SRGVYHRDIKPENLLLDENEN--------LKISDFGLSALAQCKHQDGLLHTTCGTPAYV 182
+G+ H ++ +N+LL E+ +K+SD G+S K + LL +V
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK--EILLERI----PWV 171
Query: 183 APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKI----GKAEFKCPN 237
PE I D WS G L+ + G P + ++ +K+ + + P
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL---SALDSQKKLQFYEDRHQLPAPK 228
Query: 238 WFPPEVRKLLCKILDPNPSTRISM-AKIRE 266
W E+ L+ + +D P R S A IR+
Sbjct: 229 W--TELANLINQCMDYEPDFRPSFRAIIRD 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 10/83 (12%)
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGE 195
HR K N+LL + + G S + Q P ++APEVI + Y E
Sbjct: 34 HRQAKSGNILL--TWDGLLKLDG-SVAFKTPEQSR------PDPYFMAPEVIQGQSYT-E 83
Query: 196 KVDIWSCGVVLFVLLAGYLPFHD 218
K DI+S G+ L+ L LP+++
Sbjct: 84 KADIYSLGITLYEALDYELPYNE 106
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 28/202 (13%)
Query: 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQI-KREISVMRIVRHPNIVQL 79
++ +G Y +SI+ VK I+ + I EI+ M ++HPNIV+L
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEIND--------VNSIPSSEIADMGKLQHPNIVKL 748
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH---SRGVYH 136
+ ++ + + EY +G L ++V + L + R+ + A+ F H S V
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNL-SEVLRN-LSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 137 RDIKPENLLLD--ENENLKISDFGLSALAQCKHQDGLLHTTCG-TPAYVAPEVINRKGYD 193
++ PE +++D + +L++S GL C T C + AYVAPE K
Sbjct: 807 GNLSPEKIIIDGKDEPHLRLSLPGLL----C------TDTKCFISSAYVAPETRETKDIT 856
Query: 194 GEKVDIWSCGVVLFVLLAGYLP 215
EK DI+ G++L LL G P
Sbjct: 857 -EKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 27/137 (19%), Positives = 59/137 (43%), Gaps = 17/137 (12%)
Query: 37 RTNQSVAVKVIDKDKIMRVG----LADQIKREISVMRIVR-HPNIV-QLYEVMATKSKIF 90
TN+ + D+D ++++ +RE+++++++ V ++ + +
Sbjct: 10 LTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSY 69
Query: 91 FVMEYAKGGEL--FNKVAKGKLKEDAAR--RYFQQLINAVDFCHSRGVYHRDIKPENLLL 146
+ME+ +G L ++ K + E A QL V CH D+ P N+L+
Sbjct: 70 LLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV-LCH------GDLHPGNILV 122
Query: 147 DENENLKISDFGLSALA 163
D+ + L I D+ +
Sbjct: 123 DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 61/242 (25%), Positives = 103/242 (42%), Gaps = 50/242 (20%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI-DKDKIMRVGLADQIKREISVMR 69
V T+++++ LLG+G F KV A + + AVK++ + K R K EI M
Sbjct: 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTR-----DAKIEIQFME 180
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAK--------GGELFNKVAK-GKLKEDAARRYFQ 120
VR + + +M K + +F E G L + + K G R+
Sbjct: 181 KVRQADPADRFPLM--KIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH----RHLA 234
Query: 121 QLI----NAVDFCHSR-GVYHRDIKPENLLLDENEN----------------LKISDFGL 159
Q+I A+D+ H+ + H D+KPEN+L++ ++ ++I D G
Sbjct: 235 QIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG- 293
Query: 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF--H 217
C + T Y +PEV+ G+ D+WS G +++ L G L + H
Sbjct: 294 ----GCCDERHSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTH 348
Query: 218 DS 219
D+
Sbjct: 349 DN 350
|
Length = 467 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 21/42 (50%), Positives = 27/42 (64%), Gaps = 1/42 (2%)
Query: 177 GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD 218
GTP Y+APE++ K + G VD W+ GV LF L G PF+D
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFND 582
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG--LLHTTCGT 178
Q+ + F S+ HRD+ N+LL KI DFG LA+ D ++
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFG---LARDIRNDSNYVVKGNARL 278
Query: 179 PA-YVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAEFK-- 234
P ++APE I Y E D+WS G++L+ + + G P+ + + K+ K ++
Sbjct: 279 PVKWMAPESIFNCVYTFES-DVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337
Query: 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
P P E+ ++ D +P R + +I +
Sbjct: 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 39/177 (22%), Positives = 75/177 (42%), Gaps = 42/177 (23%)
Query: 22 LGQGAFAKVY--------------YARSIRTNQS--VAVKVI--DKDKIMRVGLADQIKR 63
LG+G F +V+ + ++R + VAVK++ D +K R + +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR----NDFLK 68
Query: 64 EISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAAR------- 116
E+ ++ ++ PNI++L V + + + EY + G+L ++ L +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 117 -------------RYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160
Q+ + + + S HRD+ N L+ EN +KI+DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 13/222 (5%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQS----VAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
+LLG G F V+ I S VA+K I +D+ R +I + M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTF-QEITDHMLAMGSLDHA 69
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVA--KGKLKEDAARRYFQQLINAVDFCHSR 132
IV+L + S + V + + G L + V + L + Q+ + +
Sbjct: 70 YIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP-AYVAPEVINRKG 191
+ HR++ N+LL + ++I+DFG++ L + ++ TP ++A E I
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK-YFYSEHKTPIKWMALESILFGR 187
Query: 192 YDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE 232
Y + D+WS GV ++ +++ G P+ E+ + K E
Sbjct: 188 YTHQS-DVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 16/155 (10%)
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH--TTCGT 178
Q+ ++F S+ HRD+ N+LL + + +KI DFGL+ H + +T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA--RDIMHDSNYVSKGSTFLP 302
Query: 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFH----DSNLIEMYRKIGKAEF 233
++APE I Y D+WS G++L+ + + G P+ DS Y KI K+ +
Sbjct: 303 VKWMAPESIFDNLYTTLS-DVWSYGILLWEIFSLGGTPYPGMIVDSTF---YNKI-KSGY 357
Query: 234 KC--PNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ P+ EV ++ K + P R S + +
Sbjct: 358 RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 6/152 (3%)
Query: 117 RYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC 176
R+ Q+ +DF S+ HRD+ N+LL + KI DFGL A + ++
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGL-ARDIMNDSNYVVKGNA 274
Query: 177 GTPA-YVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAEFK 234
P ++APE I Y + D+WS G++L+ + + G P+ + + K+ K ++
Sbjct: 275 RLPVKWMAPESIFDCVYTVQS-DVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333
Query: 235 --CPNWFPPEVRKLLCKILDPNPSTRISMAKI 264
P++ PPE+ ++ + P+ R + ++I
Sbjct: 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 60/260 (23%), Positives = 104/260 (40%), Gaps = 42/260 (16%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK--REISVMRIVRHPNIVQL 79
+G G F KV + + + A +V+ K+ + + +Q+K E R ++H N++Q
Sbjct: 3 IGNGWFGKVILGE-VNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAA------RRYFQQLINAVDFCHSRG 133
+ VME+ G+L + + E +R ++ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT--CGTP-AYVAPEVINRK 190
H D+ N LL + +KI D+GLS K+++ T P ++APE+++
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLS---HNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 191 GYDGEKVD------IWSCGVVLFVLLA-GYLPF-HDSN-------LIEMYRKIGKAEFKC 235
+ VD +WS GV ++ L G P+ H S+ + E K+ K K
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237
Query: 236 PN-----------WFPPEVR 244
P W PE R
Sbjct: 238 PLSDRWYEVMQFCWLQPEQR 257
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 20/46 (43%), Positives = 30/46 (65%), Gaps = 1/46 (2%)
Query: 120 QQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165
+Q++ + H G+ HRDIKPENLL+ + +KI DFG +A+ C
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG-AAVDMC 360
|
Length = 507 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 40/165 (24%), Positives = 83/165 (50%), Gaps = 19/165 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARS----IRTNQSVA-VKVIDKDKI-MRVGLADQI--KREI 65
+++++ +L+G G F VY + NQ+VA ++ ++ + I M + + I +I
Sbjct: 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKI 71
Query: 66 SV-MRI--VRHPNIVQLYEVMATKSKI----FFVME--YAKGGELFNKVAKGKLKEDAAR 116
++ I + H I + Y + K F ++E E+F ++ K K K+ +
Sbjct: 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKK-LIK 129
Query: 117 RYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161
+ ++ +++ H G+ H DIKPEN+++D N I D+G+++
Sbjct: 130 NIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 30/108 (27%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH--TTCGT 178
Q+ N ++F S+ HRD+ N+L+ E + +KI DFGL+ + +T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA--RDIMRDSNYISKGSTFLP 304
Query: 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMY 225
++APE I Y D+WS G++L+ + G P+ + + E +
Sbjct: 305 LKWMAPESIFNNLYTTLS-DVWSFGILLWEIFTLGGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 479 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.64 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.58 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.49 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.33 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.79 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.78 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.7 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.67 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.53 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.47 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.35 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.23 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.23 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.11 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.1 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.1 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.78 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.76 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.68 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.61 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.61 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.58 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.49 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.45 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.44 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.41 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.39 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.37 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.04 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.94 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.79 | |
| PLN02236 | 344 | choline kinase | 96.7 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.6 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.38 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.26 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.17 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.82 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.66 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.5 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.36 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.23 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.02 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.76 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.62 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-62 Score=492.54 Aligned_cols=341 Identities=49% Similarity=0.836 Sum_probs=275.9
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeC
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR--VGLADQIKREISVMRIVR-HPNIVQLYEVMATK 86 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~ 86 (479)
....++|++++.||+|+||+|++|.+..+|+.||||++++..... ....+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 477889999999999999999999999999999999887763321 145678889999999999 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC-CCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN-ENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~-g~vkl~DFGla~~~~ 164 (479)
+.+|+|||||.||+|++++.. +++.|.+++.+|+||++||+|||++||+||||||||||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999988 899999999999999999999999999999999999999999 999999999998764
Q ss_pred ccccCCCccccCCCCcccChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCC-CHH
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKG-YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWF-PPE 242 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~ 242 (479)
..+..+.+.||||.|+|||++.+.+ |++.++|||||||+||.|++|+.||++.+...++..|.++.+.+|.++ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 4567789999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhhc-ccchhh--hhhhhccccccccccCC-CCCCCCCch-HHHHHHhhCCCCC
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFRK-GMNQKQ--KQKVTESKDAASQDAGA-SAPQGSSSI-AAEIKQELGQLPN 317 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~~-~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~ 317 (479)
+.+|+.+||.+||.+|+|+.+|+.||||+. ...... ................. ......... .............
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQKENPLPSDELPSEVAPSAPSAPSAKDSVSPVETEDEKPLSPTSTPESLPLS 330 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhccCCCCCccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999997 322210 00000000000000000 000000000 0000000002456
Q ss_pred Ccccchhc-ccccc--CCCCCCCCCcccccceeEecCC
Q 011694 318 LNAFDIIS-LSAGF--DLSGFFDENPLIREARFTSKRP 352 (479)
Q Consensus 318 ~~~~~~is-~s~~~--~ls~~~~~~~~~r~trf~s~~~ 352 (479)
++++++++ ++.+. +++++++.....+..+|.+..+
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (370)
T KOG0583|consen 331 LNAYDLGSSLSTGINEALSGLFENEKEKEEPRFASLTS 368 (370)
T ss_pred cChhhhcccccccccccccccccccccchhhhhhhccc
Confidence 78888776 67777 7888888654455667766554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-62 Score=474.08 Aligned_cols=266 Identities=38% Similarity=0.686 Sum_probs=235.5
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchh----hHHHHHHHHHHHHhCCCCCcceeEE
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVG----LADQIKREISVMRIVRHPNIVQLYE 81 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~----~~~~l~~Ei~il~~l~hpnIv~l~~ 81 (479)
+..++.+.+.|.+.+.||+|+||.|.+|..+.||+.||||++++.+..... ....+.+|+.+|++|+|||||++++
T Consensus 164 ~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d 243 (475)
T KOG0615|consen 164 KVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKD 243 (475)
T ss_pred cCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEee
Confidence 345566889999999999999999999999999999999999987654422 2345789999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC---CCeEEeec
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN---ENLKISDF 157 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~---g~vkl~DF 157 (479)
+|+..+..||||||++||+|++++.. +.+.|+..+.+++||+.||.|||++||+||||||+|||+..+ ..+||+||
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999999999976 679999999999999999999999999999999999999765 67999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCC--CCCccchhhHHHHHHHHHhCCCCCCCChHHH-HHHHhccCcCC
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY--DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE-MYRKIGKAEFK 234 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~--~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~~~ 234 (479)
|+|.... ......|.||||.|+|||++.+.++ ++.++|+||+||+||.+|+|.+||.+..... +...|.++.+.
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 9998653 4567789999999999999987664 3458999999999999999999998876554 88888888765
Q ss_pred CC--CC--CCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 235 CP--NW--FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 235 ~~--~~--~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+- .| ++.++++||++||..||++|||++|+|+||||+...
T Consensus 401 f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 401 FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 43 33 789999999999999999999999999999998544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-61 Score=486.62 Aligned_cols=262 Identities=37% Similarity=0.714 Sum_probs=247.8
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
.+|+.++.||+|+|+.||.+++..+|+.||+|++.+....+....+.+.+||.|++.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 47999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|+|..++|..++++ +.++|.+|+.|++||+.||.|||++||+|||||..|+||+++-+|||+|||||+...... ...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc--ccc
Confidence 99999999999986 579999999999999999999999999999999999999999999999999999876443 335
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
.|.||||.|.||||+...++. ..+||||+||+||.||.|++||+..+..+.|.+|...++..|..++.++.+||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 789999999999999988885 9999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccCChhhhhcChhhhcccchhh
Q 011694 253 PNPSTRISMAKIRESSWFRKGMNQKQ 278 (479)
Q Consensus 253 ~dP~~Rpt~~eil~h~wf~~~~~~~~ 278 (479)
+||.+|||+++|+.|+||++++.+..
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 99999999999999999977665443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-61 Score=492.37 Aligned_cols=262 Identities=39% Similarity=0.770 Sum_probs=247.9
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
-.+-|+++++||.|+-|.|.+|++..||+.+|||++.+...........+.+||.+|+.+.||||+++|++++++.++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 35779999999999999999999999999999999998765555666889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|+||++||+||+++.. |+++|.++.++|+||+.||.|||..+|+||||||||+|||..+++||+|||+|.+- ..+.
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VPGK 166 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---cCCc
Confidence 9999999999999876 89999999999999999999999999999999999999999999999999999753 4567
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHh
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 250 (479)
.+.+.||+|.|.|||++.+.+|+|.++||||||||||.||+|++||++.|...++.++..+.+..|..+|+++++||++|
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRM 246 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHH
Confidence 88999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCChhhhhcChhhhcccch
Q 011694 251 LDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 251 L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
|+.||.+|+|.+||++|||+......
T Consensus 247 l~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred hccCccccccHHHHhhCchhhcCCCC
Confidence 99999999999999999999866543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=437.23 Aligned_cols=261 Identities=36% Similarity=0.684 Sum_probs=241.6
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+-.++|++.+.||+|+||+||+++.+.|++.+|+|++++..+......+.++.|..+|..++||+||+++..|.+.+++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44689999999999999999999999999999999999998877777889999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+|+||+.||+|+..+.+ +.++|+.++.|+..|+.||.|||++||+||||||||||||.+|+++|+||||++..- ...
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KDG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc--cCC
Confidence 99999999999999985 789999999999999999999999999999999999999999999999999997432 223
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCC-CCHHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNW-FPPEVRKLLC 248 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~li~ 248 (479)
...++.|||+.|||||++.+.+|+ .++|.||||+++|+||+|.+||.+.+...++.+|.......++. ++.+++++++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 345678999999999999999997 89999999999999999999999999999999999998555554 9999999999
Q ss_pred HhccCCccccC----ChhhhhcChhhhccc
Q 011694 249 KILDPNPSTRI----SMAKIRESSWFRKGM 274 (479)
Q Consensus 249 ~~L~~dP~~Rp----t~~eil~h~wf~~~~ 274 (479)
++|..||.+|. .+++|.+||||+...
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 99999999996 689999999997654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-57 Score=421.54 Aligned_cols=257 Identities=38% Similarity=0.736 Sum_probs=243.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
.-..+|++.++||.|+||.|.+++++.+|..+|+|++++....+....+...+|..+|+.+.||+++++++.+.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 55678999999999999999999999999999999999999888888899999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+||||++||+||.++++ +++++..++.|+.||+.||+|||+++|++|||||||||||.+|.+||+|||+|....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 99999999999999987 799999999999999999999999999999999999999999999999999996432
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 249 (479)
+...+.||||.|+|||++..++|. .++|-|||||++|||++|.+||.+.+...+|.+|..++..+|+.+++++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 336789999999999999999996 8999999999999999999999999999999999999999999999999999999
Q ss_pred hccCCccccC-----ChhhhhcChhhhcc
Q 011694 250 ILDPNPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 250 ~L~~dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
+|+.|-.+|. ..++|..||||+.-
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCcccccc
Confidence 9999999994 46799999999854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-56 Score=446.51 Aligned_cols=261 Identities=33% Similarity=0.665 Sum_probs=242.4
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 90 (479)
--.+|..++.||+|+|++|++|+++.+++.||||++++..+.++.-.+.+.+|-.+|.+| .||.|++|+-.|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346899999999999999999999999999999999999888888888999999999999 7999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+|+||+++|+|.++|.+ |.+++..++.|+.+|+.||+|||++|||||||||||||||.+|++||+|||-|..+......
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999999999998 89999999999999999999999999999999999999999999999999999875533211
Q ss_pred -----------CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCC
Q 011694 170 -----------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNW 238 (479)
Q Consensus 170 -----------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 238 (479)
....+.+||..|++||+|..... ++.+|||+||||||+|++|.+||.+.+....+++|....+.+|+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 11245789999999999987655 589999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+|+.+.+||+++|..||.+|+|+.+|.+||||..-
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 99999999999999999999999999999999753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-55 Score=423.80 Aligned_cols=258 Identities=31% Similarity=0.527 Sum_probs=232.5
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE-E
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK-I 89 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~-~ 89 (479)
+...+.+.++.||+|+.|+||+++|+.|++.+|+|++... .+....+++.+|+.+++..+|||||++|+.|..+.. +
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 3445788899999999999999999999999999999443 234667899999999999999999999999999994 9
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+|+||||+||+|.+.+.. ++++|.....++.++++||.|||+ ++|+||||||+|||++..|.|||||||.|.....
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn-- 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN-- 231 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh--
Confidence 999999999999999987 789999999999999999999995 9999999999999999999999999999986543
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-----hHHHHHHHhccC-cCCCCCC-CC
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS-----NLIEMYRKIGKA-EFKCPNW-FP 240 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~-~~~~~~~-~~ 240 (479)
....+.+||..|||||.+.+..|. .++||||||+.++|+.+|+.||... +..+++..|..+ ....|.. +|
T Consensus 232 --S~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 232 --SIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred --hhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence 256789999999999999999886 8999999999999999999999875 667888888774 4456665 99
Q ss_pred HHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
+++++||..||++||.+|||+.+++.|||+++...
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 99999999999999999999999999999987543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-55 Score=425.29 Aligned_cols=258 Identities=36% Similarity=0.673 Sum_probs=234.4
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
..++|.+.+.||+|+||.||+|+++.++..||||.+.+.+..+ ...+.+..||.+|+.++|||||+++++..+.+.+|+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~-k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK-KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH-HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 4678999999999999999999999999999999999886543 567888999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC------CCeEEeecCchhhhh
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN------ENLKISDFGLSALAQ 164 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~------g~vkl~DFGla~~~~ 164 (479)
|||||+||+|.+++.+ +.++|..++.++.||+.||++||+++|+||||||.||||+.+ -.+||+|||+|+...
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999999999987 589999999999999999999999999999999999999864 358999999998765
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC---CCCCCCCH
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF---KCPNWFPP 241 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~ 241 (479)
......+.||+|.|||||++....|+ .|+|+||+|+|||++++|+.||+..+..+++..+..+.. ..+.++++
T Consensus 167 ---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 167 ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred ---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence 44567889999999999999988898 799999999999999999999999999998888766543 34456788
Q ss_pred HHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
...+|+...|..+|..|.+..+-..|++.....
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 888999999999999999999999999886554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=426.08 Aligned_cols=261 Identities=41% Similarity=0.754 Sum_probs=246.3
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
..+..+|++.++||.|+||+|.+|+....|+.||||.|.++++.+..-.-.|++||.||..|+||||+.+|++|++.+++
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 45678999999999999999999999999999999999999998877788999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
.|||||+.+|+|+|++.. +.++|.+++.+|+||++|+.|||.++|+|||||.+|||+|.++++||+|||++.++. .
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---D 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---c
Confidence 999999999999999986 789999999999999999999999999999999999999999999999999998764 4
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 248 (479)
...+.+.||+|.|.+||++++.+|.++.+|-|||||+||-|..|.+||++.+...+.+.|.++.+.-|. -|.++.-||+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIR 284 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIR 284 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHH
Confidence 567889999999999999999999999999999999999999999999999999999999999887776 5788999999
Q ss_pred HhccCCccccCChhhhhcChhhhccc
Q 011694 249 KILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.||-.||.+|.|+++|..|=|..=++
T Consensus 285 wmLmVNP~RRATieDiAsHWWvNwgy 310 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWVNWGY 310 (668)
T ss_pred HHHhcCcccchhHHHHhhhheeeccc
Confidence 99999999999999999998875443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-54 Score=428.89 Aligned_cols=264 Identities=33% Similarity=0.629 Sum_probs=237.1
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
..++-.++|++++.||+|+||+||+|+-+.||+.+|+|++.+......+..+.++.|-.+|....+|+||++|..|.+..
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 44666789999999999999999999999999999999999988877777889999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
++||||||++||++..+|.+ +.|+|+.++.|+.+++.|+..||+.|++||||||+|+|||..|++||+||||++.....
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999999999876 78999999999999999999999999999999999999999999999999998643321
Q ss_pred cc--------------------CCC-------------------------ccccCCCCcccChhhhhcCCCCCCccchhh
Q 011694 167 HQ--------------------DGL-------------------------LHTTCGTPAYVAPEVINRKGYDGEKVDIWS 201 (479)
Q Consensus 167 ~~--------------------~~~-------------------------~~~~~gt~~y~aPEvl~~~~~~~~~~DvwS 201 (479)
.. +.. ..+.+|||-|+||||+.+.+|. ..+|.||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHH
Confidence 10 000 1123799999999999999985 8999999
Q ss_pred HHHHHHHHHhCCCCCCCChHHHHHHHhccCc--CCCCCC--CCHHHHHHHHHhccCCccccCC---hhhhhcChhhhcc
Q 011694 202 CGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--FKCPNW--FPPEVRKLLCKILDPNPSTRIS---MAKIRESSWFRKG 273 (479)
Q Consensus 202 lGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~--~~~~~~~li~~~L~~dP~~Rpt---~~eil~h~wf~~~ 273 (479)
||||+||||.|++||.+.++.+.+++|.+.. +.+|.. +++++.+||.+||. ||.+|.. ++||..||||+.-
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 9999999999999999999999999997654 555554 78999999999999 9999996 8999999999754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-55 Score=400.10 Aligned_cols=264 Identities=34% Similarity=0.666 Sum_probs=237.5
Q ss_pred CCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 5 ~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
+.+....+.+.|++-+.||+|.|+.||.+.+..||+.+|+|+++..+.... -.+.+.+|+.|-+.|+||||+++++.+.
T Consensus 2 ~~d~~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 2 MNDASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred CCccccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 344566788999999999999999999999999999999999998776654 4588999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec---CCCeEEeecCch
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---NENLKISDFGLS 160 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---~g~vkl~DFGla 160 (479)
+....|+|+|+++|++|+.-|.. --++|..+-.+++||++||+|||.+||+|||+||+|+|+.+ ...+||+|||+|
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceE
Confidence 99999999999999999766654 46899999999999999999999999999999999999964 345999999999
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCC---
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN--- 237 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--- 237 (479)
.... .........|||.|||||++...+|. .++|||+||||||.||.|++||.+.+...+|..|..+.+..|+
T Consensus 161 i~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w 236 (355)
T KOG0033|consen 161 IEVN---DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW 236 (355)
T ss_pred EEeC---CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc
Confidence 7544 34456778899999999999999986 8999999999999999999999999999999999888776554
Q ss_pred -CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 238 -WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 238 -~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+++++++|+++||..||.+|+|+.|+|+|||+++.
T Consensus 237 ~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 237 DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 388999999999999999999999999999999754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-53 Score=418.10 Aligned_cols=268 Identities=33% Similarity=0.620 Sum_probs=235.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch-----------hhHHHHHHHHHHHHhCCCCCc
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV-----------GLADQIKREISVMRIVRHPNI 76 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----------~~~~~l~~Ei~il~~l~hpnI 76 (479)
.+....+.|++++.||+|.||+|.+|++..+++.||||++++...... ...+.+.+||.+|+++.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 345566789999999999999999999999999999999987543321 123689999999999999999
Q ss_pred ceeEEEEEeC--CEEEEEEeccCCCChHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeE
Q 011694 77 VQLYEVMATK--SKIFFVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLK 153 (479)
Q Consensus 77 v~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vk 153 (479)
|+++++..+. +++|||+|||..|.+...-..+. +++.+++.|+++++.||.|||.+||+||||||.|+||+++|.+|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 9999999764 68999999999999876655555 99999999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhcc---ccCCCccccCCCCcccChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHH
Q 011694 154 ISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINR---KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRK 227 (479)
Q Consensus 154 l~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPEvl~~---~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 227 (479)
|+|||.+..+... ..+..+...+|||.|+|||.+.+ ..+++.+.||||+||+||.|+.|++||.+....+++.+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998755222 12223455789999999999976 56789999999999999999999999999999999999
Q ss_pred hccCcCCCCCC--CCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 228 IGKAEFKCPNW--FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 228 i~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
|.+..+.+|.. +.+++++||.+||.+||.+|+++.+|..|||......
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 99998888876 7899999999999999999999999999999876643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-53 Score=399.30 Aligned_cols=255 Identities=29% Similarity=0.481 Sum_probs=218.0
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|+.+.++|+|+||.||+|+++.||+.||||.+.-.. .+....+-..|||.+|++++|||+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 67999999999999999999999999999999995432 23344566679999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|||+.. +.+-++. .+++++.++.|++|++.|+.|||++|++|||||||||||+.+|.+||||||+|+.... ....
T Consensus 81 E~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~ 157 (396)
T KOG0593|consen 81 EYCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN 157 (396)
T ss_pred eecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence 999984 4455554 5799999999999999999999999999999999999999999999999999987653 3445
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------------c
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-------------------E 232 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 232 (479)
.+..+.|.+|+|||.+.+..-+|.++||||+||++.||++|.+.|++.+..+....|.+. .
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 677889999999999998666689999999999999999999999988765544433211 0
Q ss_pred CCCC------------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 233 FKCP------------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 233 ~~~~------------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
..+| +.++.-+.+|+++||..||.+|++.++++.||+|..
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 1111 124577899999999999999999999999999943
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-54 Score=400.07 Aligned_cols=249 Identities=32% Similarity=0.593 Sum_probs=223.1
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEE-EE-EeC
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE-VM-ATK 86 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~-~~-~~~ 86 (479)
+.--...|+|.++||+|+||+||++++..+|..||.|.+..... +......+..||.+|++|+|||||++++ .+ +++
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 34445679999999999999999999999999999999986544 4456688899999999999999999998 44 444
Q ss_pred CEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CC--CeeccCCCCCEEEecCCCeEEeec
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHS--RG--VYHRDIKPENLLLDENENLKISDF 157 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~--~g--ivHrDLkp~NILl~~~g~vkl~DF 157 (479)
..++||||||++|+|...|+. ..++|..+++++.||+.||..||+ .. |+||||||.||+|+.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 459999999999999998864 359999999999999999999999 45 999999999999999999999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC-CC
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-CP 236 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~ 236 (479)
||++.+.... ...++.+|||.||+||++.+.+|+ .++||||+||++|||++-.+||.+.+..++..+|..++++ +|
T Consensus 173 GL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 173 GLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 9999876443 345788999999999999999997 8999999999999999999999999999999999999886 66
Q ss_pred -CCCCHHHHHHHHHhccCCccccCCh
Q 011694 237 -NWFPPEVRKLLCKILDPNPSTRISM 261 (479)
Q Consensus 237 -~~~~~~~~~li~~~L~~dP~~Rpt~ 261 (479)
..+|.++..+|..|+.+||..||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 5589999999999999999999996
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-53 Score=423.13 Aligned_cols=260 Identities=32% Similarity=0.609 Sum_probs=242.1
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|.+.+.||+|+||.||+|+.+.|.+.||||.+++..... ...+.+.+|+.|++.++|||||.++++|++..++|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 68999999999999999999999999999999999876543 45678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|||.| +|+.++.. +.++|+.++.+..+|++||.|||+++|.|||+||.|||++.+|.+|+||||+|+.... ....+
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vl 157 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVL 157 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Cceee
Confidence 99988 99999987 6899999999999999999999999999999999999999999999999999986543 34456
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
....|||.|||||++.+.+|+ ..+|+||||||+||+.+|++||...+...+.+.|.......|...+.++.+|+..+|.
T Consensus 158 tsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~ 236 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLI 236 (808)
T ss_pred eeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhh
Confidence 777899999999999999997 8999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccCChhhhhcChhhhcccchhh
Q 011694 253 PNPSTRISMAKIRESSWFRKGMNQKQ 278 (479)
Q Consensus 253 ~dP~~Rpt~~eil~h~wf~~~~~~~~ 278 (479)
+||..|+|..+++.|||++......+
T Consensus 237 kdP~~RltW~~Ll~HpF~k~~~~~~~ 262 (808)
T KOG0597|consen 237 KDPAQRLTWTDLLGHPFWKGKINIAE 262 (808)
T ss_pred cChhhcccHHHHhcChHHhhhhhhhc
Confidence 99999999999999999987665443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-52 Score=425.46 Aligned_cols=262 Identities=32% Similarity=0.607 Sum_probs=245.4
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 88 (479)
.+-.++|.+++.||+|+||+|++|..+.+++.+|||++.+..+...+..+....|..|+.... ||.+++++.+|.++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 455689999999999999999999999999999999999999888788899999999999885 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 89 IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
+|+||||+.||++...+..+.+++..++.|+..++.||.|||++||+|||||.+|||||.+|.+||+|||++.-. ...
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~~ 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MGQ 521 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CCC
Confidence 999999999999877777799999999999999999999999999999999999999999999999999998632 234
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 248 (479)
.....|.||||.|+|||++.+..|. .++|-|||||+||+||.|..||.+.+..+++..|...+...|.|+|.++.++|+
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMR 600 (694)
T ss_pred CCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHH
Confidence 4567899999999999999999996 899999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCccccCCh-----hhhhcChhhhccc
Q 011694 249 KILDPNPSTRISM-----AKIRESSWFRKGM 274 (479)
Q Consensus 249 ~~L~~dP~~Rpt~-----~eil~h~wf~~~~ 274 (479)
++|.+||.+|..+ ++|..||||+...
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 9999999999975 7899999998654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-53 Score=383.77 Aligned_cols=260 Identities=37% Similarity=0.697 Sum_probs=244.7
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
...-.++|++++.||+|.||.||+|+.+.++-.||+|++.+..+...+...++.||+.|...|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 34556899999999999999999999999999999999999988888888999999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 89 IFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
+|+++||+..|+|+..+.. .++++..+..|+.|++.|+.|||.++|+||||||+|+|++..|.+||+|||-+....
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999999984 369999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRK 245 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (479)
.+.-.+.|||.-|.+||...+.+++ ..+|+|++|++.|+++.|.+||...+..+.|++|.+.++.+|..++.++.+
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD 251 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence 3334688999999999999999998 899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCccccCChhhhhcChhhhcc
Q 011694 246 LLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
||.+||..+|.+|.+..|++.|||....
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHhc
Confidence 9999999999999999999999998653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=406.96 Aligned_cols=260 Identities=34% Similarity=0.686 Sum_probs=235.2
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
......++|++.+.||+|+||.||+|++..+++.||||++.+.........+.+.+|+.+++.++||||+++++++.+++
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 34455689999999999999999999999999999999998765444445677899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.+|+||||+.||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 170 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD- 170 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence 99999999999999999876 5799999999999999999999999999999999999999999999999999864321
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 246 (479)
...+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+.......|.++++.+.+|
T Consensus 171 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 245 (329)
T PTZ00263 171 ----RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDL 245 (329)
T ss_pred ----CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHH
Confidence 22356899999999999888775 8999999999999999999999998888888888888888999999999999
Q ss_pred HHHhccCCccccCC-----hhhhhcChhhhcc
Q 011694 247 LCKILDPNPSTRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 247 i~~~L~~dP~~Rpt-----~~eil~h~wf~~~ 273 (479)
|.+||+.||.+||+ +++++.||||+..
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999999997 7999999999763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=409.20 Aligned_cols=258 Identities=33% Similarity=0.534 Sum_probs=227.3
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK--SKI 89 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 89 (479)
..+.|+.+++||+|+||.||+|++..||+.||+|.+..+... .+......|||.||++|+||||+++.+...+. ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 356799999999999999999999999999999999887543 46677788999999999999999999999876 689
Q ss_pred EEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
|+|+||++. +|.-++... +|++.+++-||+||+.||+|||++||+|||||..|||||.+|.+||+|||||+++....
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999999988 888888875 79999999999999999999999999999999999999999999999999999876544
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC----------cCCCC-
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA----------EFKCP- 236 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------~~~~~- 236 (479)
. ..++..+.|.+|.|||++.+..-++.++|+||+||||.||++|++.|.+.+..+....|.+. ....|
T Consensus 273 ~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 273 S-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred C-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3 33667789999999999998877789999999999999999999999999887777766321 01111
Q ss_pred ------------------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 237 ------------------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 237 ------------------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
..+|+.+.+|+..||..||.+|.|+.++|.++||..
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 125788999999999999999999999999999944
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=402.58 Aligned_cols=260 Identities=32% Similarity=0.589 Sum_probs=221.6
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--EEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS--KIF 90 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 90 (479)
..+|..++.||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|+.++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 356899999999999999999999999999999997763222 677999999999999999999999854444 799
Q ss_pred EEEeccCCCChHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-CCCeEEeecCchhhhhc-c
Q 011694 91 FVMEYAKGGELFNKVAK-G-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-NENLKISDFGLSALAQC-K 166 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-~g~vkl~DFGla~~~~~-~ 166 (479)
++|||++||+|.+++.+ + +++|..++.|.+|++.||+|||++||+||||||+|||++. +|.+||+|||++..... .
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999999997 3 6999999999999999999999999999999999999999 79999999999876543 1
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC-ChHHHHHHHhccCc--CCCCCCCCHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKIGKAE--FKCPNWFPPEV 243 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~ 243 (479)
..........|||.|||||++........++||||+||++.+|+||+.||.. .......-.+.... ...|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1222334578999999999998633333599999999999999999999987 44444444443332 46788899999
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
++||.+|+..||.+|||++++|+|||.+....
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999876543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=410.50 Aligned_cols=260 Identities=38% Similarity=0.717 Sum_probs=236.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 88 (479)
.-+...|++++.||+|.||.||.|+++.||+.+|+|++.+.........+.+.+|+.+|+.++ |||||.++++|++.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 456678999999999999999999999999999999999887765445678999999999998 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC----CCeEEeecCchhhhh
Q 011694 89 IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN----ENLKISDFGLSALAQ 164 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~----g~vkl~DFGla~~~~ 164 (479)
+|+|||+|.||+|++.+....++|..+..++.|++.++.|||+.||+||||||||+|+... +.+|++|||+|....
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999999987569999999999999999999999999999999999999633 579999999998654
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCC--CCC--CC
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC--PNW--FP 240 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~--~~ 240 (479)
. ....++.||||.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+....+..+..+++.+ +.| ++
T Consensus 191 ~---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 191 P---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred C---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 3 4567889999999999999988886 89999999999999999999999999888888887776543 344 78
Q ss_pred HHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..+.+||++||..||.+|+|+.++|+|||++..
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999999999998654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-52 Score=410.85 Aligned_cols=260 Identities=30% Similarity=0.516 Sum_probs=224.9
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC-
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKS- 87 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~- 87 (479)
.++.++|.++++||.|+||.||+|+.+.+|+.||||.+.+....- +.... .||+..|++++ |||||++++++.+.+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~n-LREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 457789999999999999999999999999999999997654332 22233 48999999998 999999999999888
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.+|+||||++. .|+.+++. ..+++..++.|+.||+.||+|+|.+|++||||||||||+..+..+||+|||+|+....
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999976 89999986 3699999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc----C----------
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK----A---------- 231 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~----~---------- 231 (479)
....+.++.|.+|+|||++...++++.+.|||++|||++|+.+-++.|.+.+..+..-+|.. .
T Consensus 163 ---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 ---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred ---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 34457789999999999999999888999999999999999999999998876655544421 1
Q ss_pred -----cCCCC-----------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 232 -----EFKCP-----------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 232 -----~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
.+.+| +..++++.+||.+||.+||.+|||+.++++||||+....
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 12222 125789999999999999999999999999999986543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=406.05 Aligned_cols=260 Identities=39% Similarity=0.716 Sum_probs=242.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
-+.+-|.+.++||+|-|+.|.+|++.-||+.||||++++.+.... ....+..|+..|+.++|||||++|++..+..++|
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 356789999999999999999999999999999999999877553 3467889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe-cCCCeEEeecCchhhhhccc
Q 011694 91 FVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD-ENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~-~~g~vkl~DFGla~~~~~~~ 167 (479)
+|+|+-+||+|+|+|-+ ..+.|+.+++||.||+.|+.|||+..|+||||||||+.+. .-|-|||+|||++..+..
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-- 171 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-- 171 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence 99999999999999986 4799999999999999999999999999999999998875 568999999999876543
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 247 (479)
...+.+.||+..|-|||++.+..|+.+++||||||||||-|.+|++||...+..+.+..|....+..|..++.++++||
T Consensus 172 -G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 172 -GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred -cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHH
Confidence 3457899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCccccCChhhhhcChhhhccc
Q 011694 248 CKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..||..||.+|.|.++|..++|++..-
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHHhcCchhhccHHHHhccccccCCC
Confidence 999999999999999999999997654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=396.80 Aligned_cols=254 Identities=30% Similarity=0.619 Sum_probs=230.2
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654433344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||+++|+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 99999999999876 5799999999999999999999999999999999999999999999999999875432 12
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+......+|..+++.+.+||++||.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 346799999999999887775 8999999999999999999999998888888888888888888899999999999999
Q ss_pred CCccccCC-----hhhhhcChhhhcc
Q 011694 253 PNPSTRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 253 ~dP~~Rpt-----~~eil~h~wf~~~ 273 (479)
.||.+||+ ++++++||||+..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccCC
Confidence 99999995 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=373.89 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=223.4
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
.+|...+.||+|+||.||+|++..||+.||||.+......+ +......|||+.|+.++|+||+.++++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 57899999999999999999999999999999998875443 45566779999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||++. +|...|+.. .++...++.|+.+++.||+|||++.|+||||||+|+|++++|.+||+|||+|+.+......
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 99976 899999874 5999999999999999999999999999999999999999999999999999987654433
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc----CcC--------------
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK----AEF-------------- 233 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~----~~~-------------- 233 (479)
....+-|.+|+|||.+.+...++..+||||.|||+.||+-|.+-|.+.+..+....|.. ...
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 33448899999999998877778999999999999999999999998887766555522 110
Q ss_pred ----CCC------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 234 ----KCP------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 234 ----~~~------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+.| +..++++.+|+.+||..||.+|+|+.|+++|+||+...
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 001 11457889999999999999999999999999998643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=388.71 Aligned_cols=270 Identities=30% Similarity=0.513 Sum_probs=234.9
Q ss_pred CCCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 011694 3 GMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEV 82 (479)
Q Consensus 3 ~~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~ 82 (479)
+..+..+.+-.+.|++...||.|.-+.||+|+...+++.||||+++.++.... .+.+.+|+..|+.++||||++++..
T Consensus 15 ~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 15 SSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred ccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEE
Confidence 34555667778999999999999999999999999999999999999877653 6899999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 83 MATKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
|..+..+|+||.|+.+|++++.++. ..++|..+..+.++++.||.|||.+|.+|||||+.||||+.+|.|||+|||.
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence 9999999999999999999999986 5799999999999999999999999999999999999999999999999999
Q ss_pred hhhhhccccCC-Cc-cccCCCCcccChhhhh--cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCC
Q 011694 160 SALAQCKHQDG-LL-HTTCGTPAYVAPEVIN--RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC 235 (479)
Q Consensus 160 a~~~~~~~~~~-~~-~~~~gt~~y~aPEvl~--~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 235 (479)
+......+... .- .+.+|||+|||||++. ..+|+ .|+||||+|++..||.+|..||....+..+...-..+..++
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT 251 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence 86544333211 11 6779999999999964 45776 89999999999999999999999887776555444444432
Q ss_pred CC----------CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 236 PN----------WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 236 ~~----------~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
+. .++..++.++..||.+||.+|||++++++|+||++...
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 21 25678999999999999999999999999999987654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=399.26 Aligned_cols=251 Identities=35% Similarity=0.626 Sum_probs=225.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGG 99 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (479)
+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444344567789999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCC
Q 011694 100 ELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT 178 (479)
Q Consensus 100 ~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 178 (479)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 99999876 5799999999999999999999999999999999999999999999999999864221 12223456899
Q ss_pred CcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCcccc
Q 011694 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTR 258 (479)
Q Consensus 179 ~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 258 (479)
+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+.......|..+++++.+||.+||..||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999887775 8999999999999999999999988888888888777888888999999999999999999999
Q ss_pred C-----ChhhhhcChhhhcc
Q 011694 259 I-----SMAKIRESSWFRKG 273 (479)
Q Consensus 259 p-----t~~eil~h~wf~~~ 273 (479)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=406.38 Aligned_cols=259 Identities=34% Similarity=0.575 Sum_probs=233.1
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
...|....+||+|+.|.||.|+...+++.||||.++.....+ .+.+.+|+.+|+..+|+|||++++.|.-.+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 467899999999999999999999999999999998876544 46789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|||++||+|.|.+....++|.++..+++.++.||+|||.+||+|||||.+|||++.+|.+||+|||+++.+..... .-
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KR 426 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cc
Confidence 9999999999999998999999999999999999999999999999999999999999999999999987654433 34
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHh---ccCcCCCCCCCCHHHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI---GKAEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~li~~ 249 (479)
.+.+|||+|||||++..+.|. +++||||||++++||+-|.+||-..+.......| +...+..|..+|+.+++||.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 577999999999999999985 9999999999999999999999877665544444 344667788899999999999
Q ss_pred hccCCccccCChhhhhcChhhhcccchh
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGMNQK 277 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~~~~ 277 (479)
||..||.+|+++.|+|+||||+......
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~a~p~s 533 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKMAKPES 533 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhhcCCHH
Confidence 9999999999999999999996554433
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=400.77 Aligned_cols=260 Identities=29% Similarity=0.570 Sum_probs=233.2
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTN-QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
+..+-.++|++.+.||+|+||.||+|.+..++ ..||+|++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 44566789999999999999999999976655 68999999776544445567788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
+.+|+||||+.||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999999999976 5799999999999999999999999999999999999999999999999999875421
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRK 245 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (479)
...+.+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+.......|..+++.+.+
T Consensus 184 -----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 257 (340)
T PTZ00426 184 -----RTYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKH 257 (340)
T ss_pred -----CcceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 23456899999999999877765 899999999999999999999999888888888888888889999999999
Q ss_pred HHHHhccCCccccC-----ChhhhhcChhhhcc
Q 011694 246 LLCKILDPNPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 246 li~~~L~~dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
+|++||+.||.+|+ |++++++||||+..
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999996 89999999999753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-51 Score=377.50 Aligned_cols=260 Identities=35% Similarity=0.675 Sum_probs=230.6
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHhC-CCCCcceeEEEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR-----VGLADQIKREISVMRIV-RHPNIVQLYEVMA 84 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-----~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~ 84 (479)
-+..+|+-.+.||+|..+.|..+.++.+|+.+|+|+++...... ..+.+.-.+|+.||+++ .||||+.+.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 35568889999999999999999999999999999997543221 23456778899999998 5999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
++..+|+|+|.|+.|+|||++... .++|.+.+++++||+.|+.|||.++|+||||||+|||++++-++||+|||+|+..
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 999999999999999999999885 6999999999999999999999999999999999999999999999999999866
Q ss_pred hccccCCCccccCCCCcccChhhhhcC------CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC--CC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRK------GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF--KC 235 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~------~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~~ 235 (479)
.. ...+...||||+|+|||.+... +| +..+|+|+||||||-||.|.+||......-+.+.|..+.+ ..
T Consensus 174 ~~---GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 174 EP---GEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred CC---chhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 43 3446788999999999998643 34 4689999999999999999999999988889999977765 45
Q ss_pred CCC--CCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 236 PNW--FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 236 ~~~--~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
|.| ++..+++||++||+.||.+|+|++|+|.||||....
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 666 789999999999999999999999999999996543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=392.05 Aligned_cols=249 Identities=35% Similarity=0.621 Sum_probs=223.8
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 011694 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL 101 (479)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (479)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999765444444556778999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCc
Q 011694 102 FNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180 (479)
Q Consensus 102 ~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 180 (479)
.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccccCCcc
Confidence 999875 57999999999999999999999999999999999999999999999999998643211 122345689999
Q ss_pred ccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccccC-
Q 011694 181 YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRI- 259 (479)
Q Consensus 181 y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp- 259 (479)
|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+......+|..+++++.+||.+||..||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999888775 89999999999999999999999988888888888888888999999999999999999999997
Q ss_pred --ChhhhhcChhhhcc
Q 011694 260 --SMAKIRESSWFRKG 273 (479)
Q Consensus 260 --t~~eil~h~wf~~~ 273 (479)
++.+++.||||...
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57899999999865
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=398.06 Aligned_cols=258 Identities=29% Similarity=0.543 Sum_probs=222.1
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc----
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ---- 168 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~---- 168 (479)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999976 6799999999999999999999999999999999999999999999999999865322110
Q ss_pred -----------------------------CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 011694 169 -----------------------------DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS 219 (479)
Q Consensus 169 -----------------------------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~ 219 (479)
.....+.+||+.|+|||++.+.+++ .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0112346899999999999888876 7999999999999999999999988
Q ss_pred hHHHHHHHhcc--CcCCCCCC--CCHHHHHHHHHhccCCcc---ccCChhhhhcChhhhcc
Q 011694 220 NLIEMYRKIGK--AEFKCPNW--FPPEVRKLLCKILDPNPS---TRISMAKIRESSWFRKG 273 (479)
Q Consensus 220 ~~~~~~~~i~~--~~~~~~~~--~~~~~~~li~~~L~~dP~---~Rpt~~eil~h~wf~~~ 273 (479)
+..+.+.++.. ....+|+. +++++.++|.+|+. +|. .||++++|++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 88777777754 23444543 68999999999775 444 46899999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=391.87 Aligned_cols=255 Identities=30% Similarity=0.553 Sum_probs=226.5
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH---HhCCCCCcceeEEEEEeCCEEEEE
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM---RIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876543334456777777665 456799999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|||++||+|...+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999764221 12223
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+.......|..+++++.++|.+||.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999887775 8999999999999999999999998888888888777788888899999999999999
Q ss_pred CCccccC-----ChhhhhcChhhhcc
Q 011694 253 PNPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 253 ~dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
.||.+|| ++.++++||||+..
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999 68999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=404.47 Aligned_cols=263 Identities=43% Similarity=0.764 Sum_probs=246.5
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
..-.+.|.+.++||+|.|++|.+|++..|+..||||++++........ ..+.+|+.+|+.++|||||+++.+.+....+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 345688999999999999999999999999999999999987765444 4488999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|+||||+.+|++++++.+ +++.+..++.+|.|+++|++|||+++|+|||||++||||+.+-++||+|||++..+. .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 999999999999999987 789999999999999999999999999999999999999999999999999998876 4
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 248 (479)
...+.+.||+|.|.|||++.+..|+++.+|+||+|++||.|+.|.+||++.+..++......+.+..|-.++.++.++|+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCccccCChhhhhcChhhhcccch
Q 011694 249 KILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
++|..+|.+|+++++|++|.|.......
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhhh
Confidence 9999999999999999999998765544
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=392.24 Aligned_cols=251 Identities=33% Similarity=0.613 Sum_probs=224.3
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGG 99 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (479)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445567889999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCC
Q 011694 100 ELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT 178 (479)
Q Consensus 100 ~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 178 (479)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 99998876 5799999999999999999999999999999999999999999999999999864221 12223456899
Q ss_pred CcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCcccc
Q 011694 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTR 258 (479)
Q Consensus 179 ~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 258 (479)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.......|..+++++.+||.+||.+||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 999999999877775 8999999999999999999999988887888888777788888999999999999999999999
Q ss_pred C-----ChhhhhcChhhhcc
Q 011694 259 I-----SMAKIRESSWFRKG 273 (479)
Q Consensus 259 p-----t~~eil~h~wf~~~ 273 (479)
+ ++.+|++||||...
T Consensus 238 ~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 7 89999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=380.32 Aligned_cols=264 Identities=28% Similarity=0.434 Sum_probs=222.9
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT----- 85 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~----- 85 (479)
.+..+|...+.||+|+||.|+.|.++.||+.||||.+... ....-..++..||+.+|+.++|+||+.+++++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 4566777789999999999999999999999999998643 2333456888899999999999999999999865
Q ss_pred CCEEEEEEeccCCCChHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
-+.+|+|+|++ +.+|...++.+. ++++.++.+++||++||.|+|+.||+||||||.|+|++.++.+||||||+|+...
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 35699999999 459999999976 9999999999999999999999999999999999999999999999999998775
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------- 231 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 231 (479)
.....+..+..+.|.+|.|||++.....++.+.||||+||||.|||+|++.|.+.+.......|..-
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 4434555677889999999999876555568999999999999999999999887654443333110
Q ss_pred ----------cCCCC--------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 232 ----------EFKCP--------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 232 ----------~~~~~--------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
....| +..++.+.+|+.+||..||.+|+|++|+|.|||+.....+
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 00111 2367999999999999999999999999999999776543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=391.85 Aligned_cols=254 Identities=30% Similarity=0.558 Sum_probs=223.8
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445577889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999976 5799999999999999999999999999999999999999999999999999875432 33
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCCC------CCCHHHH
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCPN------WFPPEVR 244 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~------~~~~~~~ 244 (479)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+... ....|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 456899999999999888775 8999999999999999999999988777666555432 122222 3589999
Q ss_pred HHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 245 KLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+||.+||..+|.+|||++++++||||...
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=381.17 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=220.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999987654433344567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 95 YAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 95 ~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 9999999887753 3689999999999999999999999999999999999999999999999999865321 112
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH----HHHHHHhccCcCCCCCCCCHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL----IEMYRKIGKAEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li 247 (479)
....+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+. ......+.......+..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 3456799999999999887775 899999999999999999999987543 23333344445566777899999999
Q ss_pred HHhccCCccccCC-----hhhhhcChhhhccc
Q 011694 248 CKILDPNPSTRIS-----MAKIRESSWFRKGM 274 (479)
Q Consensus 248 ~~~L~~dP~~Rpt-----~~eil~h~wf~~~~ 274 (479)
++||+.||.+||+ ++++++||||....
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 9999999999997 89999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=390.12 Aligned_cols=251 Identities=35% Similarity=0.634 Sum_probs=223.5
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGG 99 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (479)
+.||+|+||.||++++..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998754433344567778999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCC
Q 011694 100 ELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT 178 (479)
Q Consensus 100 ~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 178 (479)
+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 99988876 5799999999999999999999999999999999999999999999999999764211 11223456799
Q ss_pred CcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCcccc
Q 011694 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTR 258 (479)
Q Consensus 179 ~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 258 (479)
+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.......|..+++++.+||.+||..||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999877775 8999999999999999999999988888888887777778888899999999999999999999
Q ss_pred C-----ChhhhhcChhhhcc
Q 011694 259 I-----SMAKIRESSWFRKG 273 (479)
Q Consensus 259 p-----t~~eil~h~wf~~~ 273 (479)
+ ++.++++||||...
T Consensus 238 ~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 8 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=388.01 Aligned_cols=256 Identities=32% Similarity=0.574 Sum_probs=227.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC-CcceeEEEEEeCCEEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP-NIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~ 93 (479)
+|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+..|+.++..++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876543334456778899999999765 6889999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||++||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 99999999999876 5799999999999999999999999999999999999999999999999999763221 12223
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
...+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+....+..+.......|..+++++.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999887775 8999999999999999999999998888888888888888888899999999999999
Q ss_pred CCccccCCh-----hhhhcChhhhcc
Q 011694 253 PNPSTRISM-----AKIRESSWFRKG 273 (479)
Q Consensus 253 ~dP~~Rpt~-----~eil~h~wf~~~ 273 (479)
+||.+|+++ +++++||||+..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999987 899999999764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=395.39 Aligned_cols=258 Identities=32% Similarity=0.613 Sum_probs=222.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444445577889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC---
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD--- 169 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~--- 169 (479)
||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999876 57999999999999999999999999999999999999999999999999998643211100
Q ss_pred ---------------------------------CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCC
Q 011694 170 ---------------------------------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF 216 (479)
Q Consensus 170 ---------------------------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf 216 (479)
....+.+||+.|+|||++.+.++. .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011235799999999999888775 8999999999999999999999
Q ss_pred CCChHHHHHHHhccC--cCCCCC--CCCHHHHHHHHHhccCCccccCC---hhhhhcChhhhcc
Q 011694 217 HDSNLIEMYRKIGKA--EFKCPN--WFPPEVRKLLCKILDPNPSTRIS---MAKIRESSWFRKG 273 (479)
Q Consensus 217 ~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt---~~eil~h~wf~~~ 273 (479)
...+....+..+... .+..|. .+++++.+||.+||. +|.+|++ +++++.||||+..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 988877766666432 233343 368999999999997 9999998 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=389.00 Aligned_cols=251 Identities=33% Similarity=0.615 Sum_probs=223.4
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||.||+|.++.+++.||||++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876543334456677888888876 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 999998876 5799999999999999999999999999999999999999999999999999764221 1222345689
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 257 (479)
|+.|+|||++.+..+. .++||||+||++|+|++|..||...+....+..+.......|.++++++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999877775 799999999999999999999999988888888888888889999999999999999999999
Q ss_pred cCCh------hhhhcChhhhcc
Q 011694 258 RISM------AKIRESSWFRKG 273 (479)
Q Consensus 258 Rpt~------~eil~h~wf~~~ 273 (479)
||++ ++++.||||...
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCCC
Confidence 9998 899999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=396.33 Aligned_cols=258 Identities=31% Similarity=0.544 Sum_probs=220.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
.|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987655555556788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc-----
Q 011694 95 YAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ----- 168 (479)
Q Consensus 95 ~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~----- 168 (479)
|++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999876 5799999999999999999999999999999999999999999999999999753311000
Q ss_pred ----------------------------------------CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHH
Q 011694 169 ----------------------------------------DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFV 208 (479)
Q Consensus 169 ----------------------------------------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ 208 (479)
.....+.+||+.|+|||++.+..++ .++||||+||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 0011345799999999999888775 89999999999999
Q ss_pred HHhCCCCCCCChHHHHHHHhcc--CcCCCCC--CCCHHHHHHHHHhc--cCCccccCChhhhhcChhhhcc
Q 011694 209 LLAGYLPFHDSNLIEMYRKIGK--AEFKCPN--WFPPEVRKLLCKIL--DPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 209 ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~L--~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
|++|..||...+.......+.. .....|. .+++++.+||.+|| ..+|..|+++++++.||||...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999988776655555432 2334444 47899999999955 5566669999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=381.39 Aligned_cols=264 Identities=31% Similarity=0.509 Sum_probs=235.1
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
+.+-..+|++++.||.|.-|+||+|+.+.++..+|+|++++.......-..++..|-.||..++||.++.+|..|+++..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 33445789999999999999999999999999999999999887766667888899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 89 IFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.|++||||+||+|.....+ +.+++..++.|+..++.||+|||-.|||+||||||||||-++|++.|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999998876 3699999999999999999999999999999999999999999999999999753210
Q ss_pred ---------------------------------cccC---------------------CCccccCCCCcccChhhhhcCC
Q 011694 166 ---------------------------------KHQD---------------------GLLHTTCGTPAYVAPEVINRKG 191 (479)
Q Consensus 166 ---------------------------------~~~~---------------------~~~~~~~gt~~y~aPEvl~~~~ 191 (479)
.... ....+.+||-.|+|||++.+.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0000 0012346999999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCC--CCHHHHHHHHHhccCCccccCC----hhhhh
Q 011694 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNW--FPPEVRKLLCKILDPNPSTRIS----MAKIR 265 (479)
Q Consensus 192 ~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt----~~eil 265 (479)
+. .++|.|+|||+|||||.|..||.+.+..+.+.+|......+|.. ++..+++||+++|.+||.+|.. ++||.
T Consensus 312 Hg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 312 HG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 85 89999999999999999999999999999999998887777754 6799999999999999999999 99999
Q ss_pred cChhhhcc
Q 011694 266 ESSWFRKG 273 (479)
Q Consensus 266 ~h~wf~~~ 273 (479)
+||||+.-
T Consensus 391 ~HpFF~gV 398 (459)
T KOG0610|consen 391 RHPFFEGV 398 (459)
T ss_pred cCccccCC
Confidence 99999754
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=394.96 Aligned_cols=263 Identities=31% Similarity=0.548 Sum_probs=227.9
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+-.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 44567899999999999999999999999999999999765444334456678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 90 FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
|+||||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... .
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~ 197 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-M 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-c
Confidence 999999999999999988889999999999999999999999999999999999999999999999999986543211 1
Q ss_pred CCccccCCCCcccChhhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCCC--CCCHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKG---YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCPN--WFPPE 242 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~---~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~ 242 (479)
....+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+....+..+... ...+|. .+|.+
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence 1224568999999999987543 3458999999999999999999999998887777777543 244454 47899
Q ss_pred HHHHHHHhccCCccc--cCChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPST--RISMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~--Rpt~~eil~h~wf~~~ 273 (479)
+.+||++||..+|.+ |+|++++++||||+..
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 999999999999998 9999999999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=395.91 Aligned_cols=258 Identities=33% Similarity=0.603 Sum_probs=220.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
..|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765444455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc-----
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH----- 167 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~----- 167 (479)
|||+||+|.+.+.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999876 579999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHH
Q 011694 168 ----------------------------------------QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLF 207 (479)
Q Consensus 168 ----------------------------------------~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~ 207 (479)
......+.+||+.|+|||++.+.+|+ .++||||+||+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00011245799999999999888886 8999999999999
Q ss_pred HHHhCCCCCCCChHHHHHHHhcc--CcCCCC--CCCCHHHHHHHHHhccCCccccCC---hhhhhcChhhhcc
Q 011694 208 VLLAGYLPFHDSNLIEMYRKIGK--AEFKCP--NWFPPEVRKLLCKILDPNPSTRIS---MAKIRESSWFRKG 273 (479)
Q Consensus 208 ~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt---~~eil~h~wf~~~ 273 (479)
+|++|..||...+..+....+.. .....| ..+++++.++|.+|+ .+|.+|++ +++++.||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999998777665555543 223333 357899999999987 59999998 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=387.55 Aligned_cols=251 Identities=32% Similarity=0.597 Sum_probs=223.7
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||.||+|.+..+++.||||++.+...........+..|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444456677888888866 799999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 999988875 5799999999999999999999999999999999999999999999999999864321 1223345679
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 257 (479)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||...+....+..+.......|.++++++.++|.+||++||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999887775 899999999999999999999999988888888888888889999999999999999999999
Q ss_pred cC-------ChhhhhcChhhhcc
Q 011694 258 RI-------SMAKIRESSWFRKG 273 (479)
Q Consensus 258 Rp-------t~~eil~h~wf~~~ 273 (479)
|| +++++++||||...
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCCC
Confidence 99 89999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-49 Score=372.02 Aligned_cols=262 Identities=28% Similarity=0.395 Sum_probs=222.7
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT--KSKIF 90 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 90 (479)
.+.|+.+..|++|+||.||+|+++.|++.||+|.++.++ .+.++.-...|||.+|.+++|||||.+.++... -+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 457999999999999999999999999999999998765 344555556799999999999999999999864 45799
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 91 FVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
||||||+. +|...+.. .++...+++-++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+...
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-- 230 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-- 230 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC--
Confidence 99999988 89888886 47999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc----Cc------------
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK----AE------------ 232 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~----~~------------ 232 (479)
....+..+.|.+|+|||++.+..-++.+.|+||+|||+.+|+++++.|.+........+|.. ..
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 23356678899999999999887667899999999999999999999998876655555421 10
Q ss_pred ---CCCCC-----------C--CCHHHHHHHHHhccCCccccCChhhhhcChhhhcccchhh
Q 011694 233 ---FKCPN-----------W--FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQ 278 (479)
Q Consensus 233 ---~~~~~-----------~--~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~~~ 278 (479)
..++. + ++....+|++.+|..||.+|.|+++.|+|+||.....+..
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~ 372 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPID 372 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCC
Confidence 11110 1 3477889999999999999999999999999987554433
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=396.17 Aligned_cols=257 Identities=31% Similarity=0.585 Sum_probs=219.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997655444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC---
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD--- 169 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~--- 169 (479)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999876 57999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHH
Q 011694 170 ------------------------------------------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLF 207 (479)
Q Consensus 170 ------------------------------------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~ 207 (479)
......+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 001135799999999999887775 8999999999999
Q ss_pred HHHhCCCCCCCChHHHHHHHhcc--CcCCCCC--CCCHHHHHHHHHhccCCcccc---CChhhhhcChhhhc
Q 011694 208 VLLAGYLPFHDSNLIEMYRKIGK--AEFKCPN--WFPPEVRKLLCKILDPNPSTR---ISMAKIRESSWFRK 272 (479)
Q Consensus 208 ~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~L~~dP~~R---pt~~eil~h~wf~~ 272 (479)
+|++|..||...+....+..+.. .....|. .+++++.+||.+||. +|.+| +|+.+++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 99999999998877776666653 2334444 378999999999998 66665 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=394.29 Aligned_cols=263 Identities=31% Similarity=0.572 Sum_probs=226.2
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34568999999999999999999999999999999999765444334456688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 90 FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
|+||||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~- 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM- 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999875432111
Q ss_pred CCccccCCCCcccChhhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCCC--CCCHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKG---YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCPN--WFPPE 242 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~---~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~ 242 (479)
....+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||...+....+..+... ....|. .++..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 1224668999999999997643 3458999999999999999999999988877777777543 244444 46899
Q ss_pred HHHHHHHhccCCccc--cCChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPST--RISMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~--Rpt~~eil~h~wf~~~ 273 (479)
+.+++.+||..+|.+ |+|++++++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999866654 8999999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=388.95 Aligned_cols=252 Identities=35% Similarity=0.624 Sum_probs=223.9
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGG 99 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (479)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444344567788999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 100 ELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 100 ~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
+|...+.. +.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 99998876 579999999999999999999997 7999999999999999999999999999864221 1222345679
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 257 (479)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.......|..+++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999887775 899999999999999999999998888888888877778888889999999999999999999
Q ss_pred cC-----ChhhhhcChhhhccc
Q 011694 258 RI-----SMAKIRESSWFRKGM 274 (479)
Q Consensus 258 Rp-----t~~eil~h~wf~~~~ 274 (479)
|+ ++.++++||||....
T Consensus 238 R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCCCC
Confidence 97 899999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=391.98 Aligned_cols=258 Identities=33% Similarity=0.643 Sum_probs=226.2
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765444455677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc-----
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH----- 167 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~----- 167 (479)
||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999976 589999999999999999999999999999999999999999999999999987543322
Q ss_pred ----------------------cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHH
Q 011694 168 ----------------------QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMY 225 (479)
Q Consensus 168 ----------------------~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~ 225 (479)
.........||+.|+|||++.+..++ .++|||||||+||+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 01123355799999999999888775 8999999999999999999999988877777
Q ss_pred HHhcc--CcCCCCCC--CCHHHHHHHHHhccCCccccCC-hhhhhcChhhhcc
Q 011694 226 RKIGK--AEFKCPNW--FPPEVRKLLCKILDPNPSTRIS-MAKIRESSWFRKG 273 (479)
Q Consensus 226 ~~i~~--~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt-~~eil~h~wf~~~ 273 (479)
..+.. .....|.. +++++.+||.+||. ||.+||+ ++++++||||+..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 76655 34444443 59999999999997 9999999 9999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=378.03 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=212.5
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|+++.+++.||+|++....... ...+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 47999999999999999999999999999999997654322 34567789999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||++++.+..+... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 99999877665544 579999999999999999999999999999999999999999999999999987643221 1122
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------------cC
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-------------------EF 233 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~ 233 (479)
....||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+.......+... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 345799999999999887775 8999999999999999999999876543322221110 00
Q ss_pred CC-------------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 234 KC-------------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 234 ~~-------------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.. ...+|+++.+||++||++||.+|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01 11267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=384.14 Aligned_cols=251 Identities=32% Similarity=0.612 Sum_probs=220.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..++... +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999875433223345567788887754 899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|...+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 999998876 5799999999999999999999999999999999999999999999999999863211 1223346789
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 257 (479)
|+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+.......|.+++.++.+||.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 899999999999999999999998888888888777777788899999999999999999999
Q ss_pred cCCh-hhhhcChhhhcc
Q 011694 258 RISM-AKIRESSWFRKG 273 (479)
Q Consensus 258 Rpt~-~eil~h~wf~~~ 273 (479)
||++ +++++||||+..
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9998 589999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=384.13 Aligned_cols=251 Identities=35% Similarity=0.667 Sum_probs=219.6
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI-VRHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||.||+|.+..+++.||||++.+...........+..|..++.. .+||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999987644333344555667777765 4899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCccccccC
Confidence 999999876 57999999999999999999999999999999999999999999999999998643221 223345689
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 257 (479)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+.......|.+++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 899999999999999999999999888888888877777788889999999999999999999
Q ss_pred cCChh-hhhcChhhhcc
Q 011694 258 RISMA-KIRESSWFRKG 273 (479)
Q Consensus 258 Rpt~~-eil~h~wf~~~ 273 (479)
||++. ++++||||+..
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 238 RLGVDGDIRQHPFFRGI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99975 88999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=384.11 Aligned_cols=256 Identities=30% Similarity=0.566 Sum_probs=226.8
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
+|++.+.||+|+||+||+|++..+++.||||++.+...........+..|..++..+ .||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876543334445667788888777 5899999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||+++|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 99999999999876 6799999999999999999999999999999999999999999999999999864321 12223
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
...+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+....+..+.......|..+++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 456899999999999888775 8999999999999999999999998888888888888888888999999999999999
Q ss_pred CCccccCCh-----hhhhcChhhhcc
Q 011694 253 PNPSTRISM-----AKIRESSWFRKG 273 (479)
Q Consensus 253 ~dP~~Rpt~-----~eil~h~wf~~~ 273 (479)
.||.+|+++ .++++||||+..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 999999985 899999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=394.31 Aligned_cols=258 Identities=31% Similarity=0.570 Sum_probs=219.8
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
.+|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654433344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc-----
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH----- 167 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~----- 167 (479)
|||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999876 568999999999999999999999999999999999999999999999999975321100
Q ss_pred ------------------------------------cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh
Q 011694 168 ------------------------------------QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA 211 (479)
Q Consensus 168 ------------------------------------~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~ 211 (479)
........+||+.|+|||++.+..++ .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 00011235799999999999888775 89999999999999999
Q ss_pred CCCCCCCChHHHHHHHhccC--cCCCC--CCCCHHHHHHHHHhccCCccccC---ChhhhhcChhhhcc
Q 011694 212 GYLPFHDSNLIEMYRKIGKA--EFKCP--NWFPPEVRKLLCKILDPNPSTRI---SMAKIRESSWFRKG 273 (479)
Q Consensus 212 G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~L~~dP~~Rp---t~~eil~h~wf~~~ 273 (479)
|+.||.+.+..+....+... ....| ..+++++.++|.+|+ .+|.+|+ |+.++++||||+..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 99999988776655554332 22333 357899999999977 5999999 99999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=385.08 Aligned_cols=250 Identities=31% Similarity=0.581 Sum_probs=217.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554444556788999999988 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence 999988865 6899999999999999999999999999999999999999999999999999863211 1223345689
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---------hHHHHHHHhccCcCCCCCCCCHHHHHHHH
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS---------NLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 248 (479)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||... .....+..+.......|..+++++.++|+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887775 8999999999999999999999631 12234555666677888899999999999
Q ss_pred HhccCCccccCC------hhhhhcChhhhc
Q 011694 249 KILDPNPSTRIS------MAKIRESSWFRK 272 (479)
Q Consensus 249 ~~L~~dP~~Rpt------~~eil~h~wf~~ 272 (479)
+||..||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=377.25 Aligned_cols=253 Identities=27% Similarity=0.443 Sum_probs=211.2
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++.+.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 35799999999999999999999999999999999754322 2235677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+++ +|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--TK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--Cc
Confidence 999986 89888865 35899999999999999999999999999999999999999999999999998643221 22
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------------
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------------- 231 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 231 (479)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2345578999999999876444458999999999999999999999876654433322110
Q ss_pred cCCC-----------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 232 EFKC-----------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 232 ~~~~-----------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.... .+.+++++.+||++||..||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0011 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=382.70 Aligned_cols=252 Identities=36% Similarity=0.657 Sum_probs=222.0
Q ss_pred eeeeeecCCeEEEEEEEc---CCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 19 GRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIMR-VGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~-~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
++.||+|+||.||++++. .+++.||||++.+..... ......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 478999999997654322 2334567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcc
Q 011694 95 YAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 95 ~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
|++||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 9999999999976 5689999999999999999999999999999999999999999999999999863221 122334
Q ss_pred ccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccC
Q 011694 174 TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDP 253 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 253 (479)
..+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.......|+.+++++.+||.+||.+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 56899999999999887765 89999999999999999999999988888888888888888999999999999999999
Q ss_pred CccccC-----ChhhhhcChhhhcc
Q 011694 254 NPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 254 dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
||.+|| ++++++.||||+..
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=381.90 Aligned_cols=251 Identities=35% Similarity=0.657 Sum_probs=223.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444556777899999887 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 999998876 4799999999999999999999999999999999999999999999999999863221 1222345679
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 257 (479)
|+.|+|||++.+..++ .++||||+||++|+|++|..||...+....+..+.......|..+++++.+||.+||..||.+
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999888776 799999999999999999999998888888888877777888889999999999999999999
Q ss_pred cCCh-----hhhhcChhhhcc
Q 011694 258 RISM-----AKIRESSWFRKG 273 (479)
Q Consensus 258 Rpt~-----~eil~h~wf~~~ 273 (479)
|||+ .+++.||||+..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=389.57 Aligned_cols=258 Identities=30% Similarity=0.577 Sum_probs=222.6
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998655444455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc----
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ---- 168 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~---- 168 (479)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999876 5799999999999999999999999999999999999999999999999999864321110
Q ss_pred -----------------------------CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 011694 169 -----------------------------DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS 219 (479)
Q Consensus 169 -----------------------------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~ 219 (479)
.....+.+||+.|+|||++.+.+++ .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0112245799999999999888876 8999999999999999999999988
Q ss_pred hHHHHHHHhcc--CcCCCCCC--CCHHHHHHHHHhccCCccccCC---hhhhhcChhhhcc
Q 011694 220 NLIEMYRKIGK--AEFKCPNW--FPPEVRKLLCKILDPNPSTRIS---MAKIRESSWFRKG 273 (479)
Q Consensus 220 ~~~~~~~~i~~--~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt---~~eil~h~wf~~~ 273 (479)
+....+..+.. ....+|+. +++++.+||.+|+. ||.+|++ +++++.||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 87777776654 23334443 68999999999874 9999984 7999999999763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=377.80 Aligned_cols=256 Identities=28% Similarity=0.475 Sum_probs=209.2
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999999754322 2234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ..
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--Cc
Confidence 99996 578777765 56999999999999999999999999999999999999999999999999998643221 22
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-HHHHHh----ccC--------------
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI-EMYRKI----GKA-------------- 231 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i----~~~-------------- 231 (479)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.... .....+ ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2345678999999999876554458999999999999999999999864321 222111 000
Q ss_pred ---cCC--CC---------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 232 ---EFK--CP---------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 232 ---~~~--~~---------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+. .| ..+++++.+|+.+||+.||.+|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000 00 0135678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=388.63 Aligned_cols=264 Identities=32% Similarity=0.568 Sum_probs=225.9
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
..+-.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34456899999999999999999999999999999999976544333445667899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 89 IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
+|+||||++||+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~- 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG- 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCccccCCCCcccChhhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc--CCCC--CCCCH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKG---YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--FKCP--NWFPP 241 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~---~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~~~ 241 (479)
.....+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||...+....+..+.... ..+| ..++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 11224568999999999997543 24589999999999999999999999988877777775432 3333 35899
Q ss_pred HHHHHHHHhccCCccc--cCChhhhhcChhhhcc
Q 011694 242 EVRKLLCKILDPNPST--RISMAKIRESSWFRKG 273 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~--Rpt~~eil~h~wf~~~ 273 (479)
.+.++|.+||..++.+ |+++++|++||||+..
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 9999999999855543 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=382.05 Aligned_cols=258 Identities=34% Similarity=0.612 Sum_probs=220.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIM-RVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKI 89 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 89 (479)
+|++++.||+|+||.||++++. .+++.||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 47899999999765432 2234567889999999994 99999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 999999999999999876 5799999999999999999999999999999999999999999999999999875432221
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC----hHHHHHHHhccCcCCCCCCCCHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS----NLIEMYRKIGKAEFKCPNWFPPEVR 244 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (479)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+.......|..+++.+.
T Consensus 161 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 161 -ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred -CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 22335689999999999987654468999999999999999999999643 2334455555566677778999999
Q ss_pred HHHHHhccCCccccC-----ChhhhhcChhhhcc
Q 011694 245 KLLCKILDPNPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 245 ~li~~~L~~dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
++|.+||..||.+|| +++++++||||+..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 78899999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=382.46 Aligned_cols=251 Identities=33% Similarity=0.584 Sum_probs=219.5
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS-VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||+||+|.+..+|+.||||++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998754433333344555554 56889999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 999998876 5799999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 257 (479)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+.......++.+++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999887775 799999999999999999999999888888888877777788889999999999999999999
Q ss_pred cCCh----hhhhcChhhhcc
Q 011694 258 RISM----AKIRESSWFRKG 273 (479)
Q Consensus 258 Rpt~----~eil~h~wf~~~ 273 (479)
||++ .++++||||...
T Consensus 238 R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9998 599999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=387.88 Aligned_cols=257 Identities=30% Similarity=0.531 Sum_probs=228.0
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
...|+..+.||+|+||.||+|.+..+++.||||+++.+... ..++.+..|+.++..++++||.++|+.|-.+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 34677779999999999999999999999999999987654 3468899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 93 MEYAKGGELFNKVAKGKL-KEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l-~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||||.||++.+.++.+.+ .|..+.-++++++.||.|||+++.+|||||+.|||+..+|.+||+|||.+.........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-- 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-- 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc--
Confidence 999999999999999765 99999999999999999999999999999999999999999999999998765543333
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCCCCCHHHHHHHHHh
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~ 250 (479)
..+.+|||.||||||+.+.+|+ .|+||||||++.++|++|.+||.+..+....-.|.+... .....+++.+++|+..|
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 2788999999999999988997 799999999999999999999988877554444443322 22234789999999999
Q ss_pred ccCCccccCChhhhhcChhhhccc
Q 011694 251 LDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 251 L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
|++||+.|||+.++++|+|+++..
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhcC
Confidence 999999999999999999998754
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=380.15 Aligned_cols=251 Identities=35% Similarity=0.638 Sum_probs=219.6
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI-VRHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||+||+|++..+++.||||++................|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999987543322334556677777775 4899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 999999976 5799999999999999999999999999999999999999999999999999863221 1222345679
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 257 (479)
|+.|+|||++.+..++ .++||||+||++|+|++|..||...+....+..+.......|.+++.++.++|.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999887775 899999999999999999999998888788877776667788889999999999999999999
Q ss_pred cCChh-hhhcChhhhcc
Q 011694 258 RISMA-KIRESSWFRKG 273 (479)
Q Consensus 258 Rpt~~-eil~h~wf~~~ 273 (479)
||++. +++.||||+..
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 238 RLGVKGDIRQHPFFREI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99996 99999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=384.99 Aligned_cols=258 Identities=30% Similarity=0.518 Sum_probs=222.1
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 99999999999976 5799999999999999999999999999999999999999999999999999875432211 12
Q ss_pred ccccCCCCcccChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC----cCCCCCCCCHH
Q 011694 172 LHTTCGTPAYVAPEVINR-----KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA----EFKCPNWFPPE 242 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~-----~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~ 242 (479)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+..+... .++....++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 222347999999999999999999999988777766666432 12233457899
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+.+||.+||. +|.+|||+++++.||||...
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 9999999998 99999999999999999763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=369.43 Aligned_cols=265 Identities=34% Similarity=0.599 Sum_probs=243.1
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
.+.++-.++|+.++.||+|+||+|-+++.+.+|+.+|||++.++.+...+....-..|-.+|+..+||.+..+...|...
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 35567788999999999999999999999999999999999998776655566667899999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
+++|+||||+.||+|+-.+.+ ..++|+.++.|-..|++||.|||+++|+.||||.+|+|+|.+|++||+|||++.- .
T Consensus 241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~ 318 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--E 318 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--c
Confidence 999999999999999988876 5799999999999999999999999999999999999999999999999999753 2
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRK 245 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (479)
........+.||||.|+|||++....|. .++|-|.+||++|+|++|++||...+...++..|...++.+|..++++++.
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAkt 397 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKT 397 (516)
T ss_pred ccccceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHH
Confidence 2234456789999999999999888884 899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCccccCC-----hhhhhcChhhhccc
Q 011694 246 LLCKILDPNPSTRIS-----MAKIRESSWFRKGM 274 (479)
Q Consensus 246 li~~~L~~dP~~Rpt-----~~eil~h~wf~~~~ 274 (479)
|+..+|.+||.+|.. +.||.+|+||+.-.
T Consensus 398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred HHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 999999999999985 78999999997644
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=381.48 Aligned_cols=251 Identities=31% Similarity=0.585 Sum_probs=217.2
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445556788899988776 799999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 999988865 5799999999999999999999999999999999999999999999999999864221 1222345689
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC---------ChHHHHHHHhccCcCCCCCCCCHHHHHHHH
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD---------SNLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 248 (479)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.. .........+.......|..++..+.+||.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887775 899999999999999999999952 112234455566677788889999999999
Q ss_pred HhccCCccccCC------hhhhhcChhhhcc
Q 011694 249 KILDPNPSTRIS------MAKIRESSWFRKG 273 (479)
Q Consensus 249 ~~L~~dP~~Rpt------~~eil~h~wf~~~ 273 (479)
+||..||.+||| ++++++||||+..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999998 4799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=379.40 Aligned_cols=256 Identities=32% Similarity=0.572 Sum_probs=225.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 93 (479)
+|+..+.||+|+||.||+|.++.+|+.||||++.+.........+.+..|+.+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998765443344566778888988886 577889999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC--Cccc
Confidence 99999999999876 67999999999999999999999999999999999999999999999999998643211 1223
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
...+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+.......+.......|..+++++.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999887775 8999999999999999999999998888888888877788888899999999999999
Q ss_pred CCccccCCh-----hhhhcChhhhcc
Q 011694 253 PNPSTRISM-----AKIRESSWFRKG 273 (479)
Q Consensus 253 ~dP~~Rpt~-----~eil~h~wf~~~ 273 (479)
+||.+|+++ +++++||||+..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999984 789999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=382.21 Aligned_cols=252 Identities=32% Similarity=0.535 Sum_probs=217.5
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcE-EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQS-VAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~-vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
..+......+.+.||+|+||+||+|.+ .|+. ||||++......... .+.+.+|+.+|.+++|||||+++|++.+..
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 344456667788899999999999998 5556 999999876554433 679999999999999999999999999888
Q ss_pred -EEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CeeccCCCCCEEEecCC-CeEEeecCchh
Q 011694 88 -KIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRG-VYHRDIKPENLLLDENE-NLKISDFGLSA 161 (479)
Q Consensus 88 -~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~g-ivHrDLkp~NILl~~~g-~vkl~DFGla~ 161 (479)
..+|||||+++|+|.+++.. +.++...+..++.||+.|+.|||+++ |+||||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999965 57999999999999999999999999 99999999999999998 99999999997
Q ss_pred hhhccccCCCccccCCCCcccChhhhh--cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHh--ccCcCCCCC
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVIN--RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPN 237 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~--~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i--~~~~~~~~~ 237 (479)
...... .......||+.|||||++. ...|+ .|+||||+||+||||+||..||.+.........+ .......|.
T Consensus 193 ~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 193 EKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK 269 (362)
T ss_pred eecccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence 643321 2233368999999999999 55776 8999999999999999999999998875554444 334556677
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+++.+..||.+||..||..||++.+|+.
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 79999999999999999999999999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=367.76 Aligned_cols=258 Identities=31% Similarity=0.470 Sum_probs=219.8
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEEeCC----
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN-IVQLYEVMATKS---- 87 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 87 (479)
...|+.+++||+|+||+||+|+++.+|+.||+|.+..+... ++......||+.+++.++|+| ||++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45677888999999999999999999999999999876543 345566789999999999999 999999998887
Q ss_pred --EEEEEEeccCCCChHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 88 --KIFFVMEYAKGGELFNKVAKG-----KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 88 --~~~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
.+++|+||++. +|..++... .++...++.+++||+.||+|||++||+||||||.||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999976 899988762 4888899999999999999999999999999999999999999999999999
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhc----cC-----
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG----KA----- 231 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~----~~----- 231 (479)
+.+... .......++|.+|+|||++.+...++...||||+|||+++|++++..|.+.+.......|. ..
T Consensus 168 ra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 855422 2335677899999999999988666689999999999999999999999987766555542 11
Q ss_pred ---------cCCCCCC------------CCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 ---------EFKCPNW------------FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 ---------~~~~~~~------------~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
...++.| .+++..+++.+||+.+|.+|.|++.++.||||....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1122222 125789999999999999999999999999997654
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=369.38 Aligned_cols=248 Identities=28% Similarity=0.458 Sum_probs=213.6
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 011694 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL 101 (479)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (479)
||+|+||+||++.+..+|+.||+|.+.+.........+.+..|+.+++.++||||+++++++..++.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999766544434446678899999999999999999999999999999999999999
Q ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccC
Q 011694 102 FNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC 176 (479)
Q Consensus 102 ~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 176 (479)
...+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--ccccccC
Confidence 887732 469999999999999999999999999999999999999999999999999986543221 1233457
Q ss_pred CCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH----HHHHHHhccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 177 GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL----IEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 177 gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
||+.|+|||++.+..++ .++||||+||++|+|++|+.||..... ......+.......|..+++.+.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999888775 899999999999999999999976432 2334444455556677799999999999999
Q ss_pred CCccccC-----ChhhhhcChhhhc
Q 011694 253 PNPSTRI-----SMAKIRESSWFRK 272 (479)
Q Consensus 253 ~dP~~Rp-----t~~eil~h~wf~~ 272 (479)
.||.+|| |++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=378.10 Aligned_cols=256 Identities=28% Similarity=0.477 Sum_probs=207.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK-----SKI 89 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 89 (479)
+|++.+.||+|+||.||+|++..+|+.||||.+...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 699999999999999999999999999999998753222 22345678999999999999999999988543 358
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|+||||+. ++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 589888876 5799999999999999999999999999999999999999999999999999875432221
Q ss_pred -CCCccccCCCCcccChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHh-----------------
Q 011694 169 -DGLLHTTCGTPAYVAPEVINR--KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI----------------- 228 (479)
Q Consensus 169 -~~~~~~~~gt~~y~aPEvl~~--~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i----------------- 228 (479)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 112245679999999999865 344 48999999999999999999999776543221111
Q ss_pred ----------ccCc-CC---CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 229 ----------GKAE-FK---CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 229 ----------~~~~-~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.... .. ..+.+++++.++|.+||+.||.+|||++++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0000 00 012367889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=379.71 Aligned_cols=251 Identities=32% Similarity=0.570 Sum_probs=218.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS-VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433333445555654 56789999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 999988876 5799999999999999999999999999999999999999999999999999864221 1222345689
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 257 (479)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.......++..+..+.++|.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999888776 799999999999999999999999888888888877777777778999999999999999999
Q ss_pred cCCh----hhhhcChhhhcc
Q 011694 258 RISM----AKIRESSWFRKG 273 (479)
Q Consensus 258 Rpt~----~eil~h~wf~~~ 273 (479)
||++ .++++||||...
T Consensus 238 R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred cCCCCCCHHHHhcCCCcCCC
Confidence 9987 489999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=374.76 Aligned_cols=257 Identities=24% Similarity=0.420 Sum_probs=218.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+..++|++.+.||+|+||.||++++..+|..||+|++.... .......+.+|+.+++.++||||+++++++...+.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45689999999999999999999999999999999997642 2234577899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
+||||++||+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 99999999999999976 5699999999999999999999986 699999999999999999999999999864422
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc------------------
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK------------------ 230 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------ 230 (479)
......+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+..+....+..
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -cccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 223456799999999999887765 899999999999999999999976654433222111
Q ss_pred ----------------------------Cc-CC-CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 231 ----------------------------AE-FK-CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 231 ----------------------------~~-~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.. .. ....+++++.+||.+||..||++|||+.+|++||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 00 00 0113678999999999999999999999999999997643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=377.19 Aligned_cols=251 Identities=32% Similarity=0.575 Sum_probs=219.2
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS-VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998755433333445555554 67889999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 999988876 5799999999999999999999999999999999999999999999999999864211 1223345689
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 257 (479)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.......|+..+..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999887775 799999999999999999999999888888888877778888889999999999999999999
Q ss_pred cCCh----hhhhcChhhhcc
Q 011694 258 RISM----AKIRESSWFRKG 273 (479)
Q Consensus 258 Rpt~----~eil~h~wf~~~ 273 (479)
||++ .++++|+||...
T Consensus 238 R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred cCCCCCCHHHHhCCCCcCCC
Confidence 9986 499999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=376.58 Aligned_cols=251 Identities=31% Similarity=0.576 Sum_probs=218.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445567788999999888 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 999988875 5799999999999999999999999999999999999999999999999999863221 1223356789
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-------hHHHHHHHhccCcCCCCCCCCHHHHHHHHHh
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS-------NLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 250 (479)
|+.|+|||++.+..++ .++|||||||++|+|++|..||... .....+..+.......|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999887775 8999999999999999999999532 2234555556666778888999999999999
Q ss_pred ccCCccccCCh------hhhhcChhhhcc
Q 011694 251 LDPNPSTRISM------AKIRESSWFRKG 273 (479)
Q Consensus 251 L~~dP~~Rpt~------~eil~h~wf~~~ 273 (479)
|..||.+|+++ +++++||||+..
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999999984 699999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=376.79 Aligned_cols=251 Identities=34% Similarity=0.593 Sum_probs=217.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHH-HHHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREI-SVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999865433322333444444 457889999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 999999876 5799999999999999999999999999999999999999999999999999864321 2223446689
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 257 (479)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+.......++.+++.+.++|.+||++||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887775 899999999999999999999999888888888877777777789999999999999999999
Q ss_pred cCChh----hhhcChhhhcc
Q 011694 258 RISMA----KIRESSWFRKG 273 (479)
Q Consensus 258 Rpt~~----eil~h~wf~~~ 273 (479)
|+++. ++++|+||...
T Consensus 238 R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CCCCCCCHHHHhcCcccCCC
Confidence 99976 89999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=378.51 Aligned_cols=250 Identities=36% Similarity=0.647 Sum_probs=220.7
Q ss_pred eeeeecCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecc
Q 011694 20 RLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYA 96 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 96 (479)
+.||+|+||.||++++. .+|+.||+|++.+..... .....+.+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999863 578999999998654322 22356678999999999999999999999999999999999
Q ss_pred CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcccc
Q 011694 97 KGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT 175 (479)
Q Consensus 97 ~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~ 175 (479)
++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCceecc
Confidence 99999999976 57999999999999999999999999999999999999999999999999998653221 1223456
Q ss_pred CCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCc
Q 011694 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNP 255 (479)
Q Consensus 176 ~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP 255 (479)
+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+.......+.......|..+++++.+||++||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 899999999999887775 8999999999999999999999988888888888777788888899999999999999999
Q ss_pred cccCC-----hhhhhcChhhhcc
Q 011694 256 STRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 256 ~~Rpt-----~~eil~h~wf~~~ 273 (479)
.+||| +++++.||||...
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999 6779999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=381.11 Aligned_cols=250 Identities=32% Similarity=0.577 Sum_probs=215.2
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV---RHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
||+|+||+||+|++..+++.||||++.+..............|..++... .||||+++++++.+.+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443333334455666666655 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
|+|.+.+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 999988876 5799999999999999999999999999999999999999999999999999864321 1223446789
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCC-CCCHHHHHHHHHhccCCcc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN-WFPPEVRKLLCKILDPNPS 256 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~li~~~L~~dP~ 256 (479)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+.......|. .+++++.+||.+||.+||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999976543458999999999999999999999998888888888776666665 4789999999999999999
Q ss_pred ccC----ChhhhhcChhhhcc
Q 011694 257 TRI----SMAKIRESSWFRKG 273 (479)
Q Consensus 257 ~Rp----t~~eil~h~wf~~~ 273 (479)
+|| +++++++||||+..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HCCCCCCCHHHHhcCccccCC
Confidence 998 68999999999754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=394.23 Aligned_cols=267 Identities=31% Similarity=0.493 Sum_probs=230.2
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
....+...++|.+.+.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.++..++|+||+++++.+..
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 3445567799999999999999999999999999999999998765432 345678899999999999999999987754
Q ss_pred CC--------EEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCe
Q 011694 86 KS--------KIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENL 152 (479)
Q Consensus 86 ~~--------~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~v 152 (479)
.. .+++||||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCE
Confidence 32 47899999999999998864 358999999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc
Q 011694 153 KISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE 232 (479)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 232 (479)
||+|||++.............+.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....+..+....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 99999998765433333344567899999999999887775 89999999999999999999999888777776665443
Q ss_pred C-CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 233 F-KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 233 ~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
. ..|+.+++++.+++.+||..||.+|||+.+++.|||++...
T Consensus 262 ~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 262 YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 3 46777899999999999999999999999999999987543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=367.21 Aligned_cols=254 Identities=24% Similarity=0.424 Sum_probs=218.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
.|++.+.||+|+||+||++.+..+++.||||++.............+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976554433344567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 95 YAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 95 ~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|+.||+|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC---Cc
Confidence 9999999988754 36999999999999999999999999999999999999999999999999998654321 12
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHH----HHHHhccCcCCCCCCCCHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE----MYRKIGKAEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~li 247 (479)
....+|++.|+|||++.+..++ .++||||+||++|+|++|..||.+.+... ....+.......+..+++.+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 2345799999999999877765 78999999999999999999998765432 223333344455667899999999
Q ss_pred HHhccCCccccC-----ChhhhhcChhhhc
Q 011694 248 CKILDPNPSTRI-----SMAKIRESSWFRK 272 (479)
Q Consensus 248 ~~~L~~dP~~Rp-----t~~eil~h~wf~~ 272 (479)
.+||..||.+|| ++++++.||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=374.31 Aligned_cols=259 Identities=29% Similarity=0.539 Sum_probs=218.3
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||++++..+++.||+|++.+....+......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444445567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+.||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-cc
Confidence 99999999999975 4799999999999999999999999999999999999999999999999999864332111 11
Q ss_pred ccccCCCCcccChhhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCC---CCCCHH
Q 011694 172 LHTTCGTPAYVAPEVINR----KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCP---NWFPPE 242 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~----~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~---~~~~~~ 242 (479)
....+||+.|+|||++.. ....+.++||||+||++|+|++|+.||...+..+.+..+... .+..| ..+|++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223579999999999963 233457999999999999999999999988777766666432 22223 347899
Q ss_pred HHHHHHHhccCCccc--cCChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPST--RISMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~--Rpt~~eil~h~wf~~~ 273 (479)
+.+||++||..++.+ |++++++++||||...
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999988664444 8899999999999654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=359.14 Aligned_cols=255 Identities=35% Similarity=0.668 Sum_probs=220.6
Q ss_pred CCCccCCCeEEe-eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 011694 8 KPSVLTEKYEVG-RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMAT 85 (479)
Q Consensus 8 ~~~il~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (479)
+..-+.++|.+. ++||-|-.|+|-.+.++.||+.+|+|++... ...++|+.++-.. .|||||.++++|++
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 344577888885 4599999999999999999999999998543 3457899988776 59999999999865
Q ss_pred ----CCEEEEEEeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec---CCCeEEe
Q 011694 86 ----KSKIFFVMEYAKGGELFNKVAK-G--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---NENLKIS 155 (479)
Q Consensus 86 ----~~~~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---~g~vkl~ 155 (479)
...+.+|||.++||+||..|.. + .++|.++..|++||..|+.|||+.+|+||||||||+|+.. |..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 3568899999999999999986 3 4999999999999999999999999999999999999974 4569999
Q ss_pred ecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh----HHHHHHHhccC
Q 011694 156 DFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN----LIEMYRKIGKA 231 (479)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~ 231 (479)
|||+|.... ....+.+.|-||+|+|||++....|+ ..+|+||+||++|.||+|++||.... ...+.++|..+
T Consensus 207 DfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 207 DFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred ccccccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 999996432 34567899999999999999887887 89999999999999999999997643 35678888888
Q ss_pred cCCCC--CC--CCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 EFKCP--NW--FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 ~~~~~--~~--~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+.+| .| +|.+++++|+++|..+|.+|.|++++++|||+....
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 77665 44 789999999999999999999999999999996544
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=381.35 Aligned_cols=258 Identities=29% Similarity=0.530 Sum_probs=236.5
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE-EEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK-IFF 91 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~l 91 (479)
.++|+.++.+|+|+||.+++++++..++.+++|.+........ .......|+.+++++.|||||.+.+.|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4689999999999999999999999999999999988776543 33467899999999999999999999998887 999
Q ss_pred EEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 92 VMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
||+||+||+|.+.|.+. -++|+.+..||.|++.||.|||+++|+|||||+.||+++.++.|||+|||+|......
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 99999999999999863 4999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-CCCCCCCCHHHHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLL 247 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 247 (479)
.....+..|||.|++||++.+.+|. .|+|||||||++|+|++-+.+|...+...+..+|.... .+.|..++.+++.+|
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 2456788999999999999999996 99999999999999999999999999999999998776 577888999999999
Q ss_pred HHhccCCccccCChhhhhcChhhhccc
Q 011694 248 CKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+.||..+|..||++.++|.+|......
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 999999999999999999999887655
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=388.01 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=205.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK---- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (479)
...++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 44578999999999999999999999999999999886542 2335799999999999999999887432
Q ss_pred ----CEEEEEEeccCCCChHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-CeEEee
Q 011694 87 ----SKIFFVMEYAKGGELFNKVA-----KGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISD 156 (479)
Q Consensus 87 ----~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-~vkl~D 156 (479)
..+++||||+++ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 257899999986 6766654 24699999999999999999999999999999999999998665 699999
Q ss_pred cCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc------
Q 011694 157 FGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK------ 230 (479)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------ 230 (479)
||+|...... ......+||+.|+|||++.+....+.++|||||||+||+|++|.+||.+.+.......+..
T Consensus 215 FGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 215 FGSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred cccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9999754322 2223567899999999987654445899999999999999999999988765443332211
Q ss_pred -----------CcC------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 231 -----------AEF------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 231 -----------~~~------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
... .+|...|+++.+||.+||..||.+|||+.+++.||||...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 000 1234567899999999999999999999999999999754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=364.21 Aligned_cols=251 Identities=30% Similarity=0.481 Sum_probs=206.2
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEE-----
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIR-TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV---RHPNIVQLYEVMA----- 84 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l---~hpnIv~l~~~~~----- 84 (479)
.+|++.+.||+|+||+||+|.+.. +++.||+|.+....... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999865 56889999987654322 2334556788777766 6999999999985
Q ss_pred eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
....+++||||+.+ +|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 34579999999974 88888864 358999999999999999999999999999999999999999999999999986
Q ss_pred hhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-C-------
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-F------- 233 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~------- 233 (479)
..... .......||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+....+..+.... .
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 54322 233456799999999999877775 79999999999999999999998876655554442110 0
Q ss_pred -------------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 234 -------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 234 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
...+.+++.+.+|+.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=363.74 Aligned_cols=255 Identities=33% Similarity=0.523 Sum_probs=214.6
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC--C
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK--S 87 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~--~ 87 (479)
+...-.|.-.+.+|+|+||.||.|....+++.||||.+-.+...+ .+|+.+|+.++|||||++..+|... +
T Consensus 20 ~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 20 KKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred cceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 334557899999999999999999999999999999987665433 3799999999999999999988543 2
Q ss_pred ---EEEEEEeccCCCChHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC-CCeEEeecC
Q 011694 88 ---KIFFVMEYAKGGELFNKVA-----KGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN-ENLKISDFG 158 (479)
Q Consensus 88 ---~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~-g~vkl~DFG 158 (479)
...+||||++. +|...++ +.+++.-.++-|++||++||+|||+.||+||||||.|+|+|.+ |.+||||||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 35689999987 8998888 3579999999999999999999999999999999999999965 999999999
Q ss_pred chhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------
Q 011694 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------- 231 (479)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------- 231 (479)
-|........ ..+...|..|+|||.+.+...++.+.||||+||++.||+-|++-|.+.+.......|.+-
T Consensus 172 SAK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 172 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 9987653332 356778999999999988776679999999999999999999999988766555444210
Q ss_pred ----------cCCCC------------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 232 ----------EFKCP------------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 232 ----------~~~~~------------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
....| ...++++.+|+.++|..+|.+|.++.|++.||||.....
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11111 226799999999999999999999999999999976543
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=371.18 Aligned_cols=259 Identities=27% Similarity=0.512 Sum_probs=219.1
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444444566888999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-cce
Confidence 99999999999976 579999999999999999999999999999999999999999999999999986432111 112
Q ss_pred ccccCCCCcccChhhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc--CCCC---CCCCHH
Q 011694 172 LHTTCGTPAYVAPEVINR----KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--FKCP---NWFPPE 242 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~----~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~~~~ 242 (479)
....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+....+..+.... ...| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234579999999999863 2333589999999999999999999999888877777775432 2333 347899
Q ss_pred HHHHHHHhccCCccc--cCChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPST--RISMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~--Rpt~~eil~h~wf~~~ 273 (479)
+.+||++||..+|.+ |++++++++||||...
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 999999999665544 7899999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=368.93 Aligned_cols=257 Identities=24% Similarity=0.414 Sum_probs=216.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+..++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 56789999999999999999999999999999999987643 2234567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
+||||+.||+|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999999999876 5799999999999999999999985 7999999999999999999999999998654321
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHh--------------------
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI-------------------- 228 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i-------------------- 228 (479)
.....+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+.......+
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 22345799999999999877665 7999999999999999999999765433221111
Q ss_pred ------------------------ccC-cCCC-CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 229 ------------------------GKA-EFKC-PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 229 ------------------------~~~-~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
... .... ...++.++.+||.+||+.||.+|||+++++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 000 0011 113578899999999999999999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=386.24 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=223.0
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCC-CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRT-NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44599999999999999999998877 7889999875442 2334567889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 92 VMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
||||++||+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999887753 36899999999999999999999999999999999999999999999999999765433
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCCCCCHHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEVRK 245 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~ 245 (479)
.......+.+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+..+.. ..|..+++++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 222334567899999999999887775 899999999999999999999998887777776655443 355668999999
Q ss_pred HHHHhccCCccccCChhhhhcChhhhcc
Q 011694 246 LLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+|.+||..||.+|||+++++.|+|++..
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999999653
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=360.64 Aligned_cols=255 Identities=36% Similarity=0.731 Sum_probs=229.4
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||++.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765544455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||+++++|.+++.. +.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999876 57999999999999999999999999999999999999999999999999998754322 3
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
...+|++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+..+....|..+++.+.++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 455799999999999776654 8999999999999999999999888777777777777778888899999999999999
Q ss_pred CCccccC-----ChhhhhcChhhhccc
Q 011694 253 PNPSTRI-----SMAKIRESSWFRKGM 274 (479)
Q Consensus 253 ~dP~~Rp-----t~~eil~h~wf~~~~ 274 (479)
.||.+|+ +++++++||||+...
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999999 899999999996643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=370.40 Aligned_cols=259 Identities=27% Similarity=0.499 Sum_probs=219.0
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654433344566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+.||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-ee
Confidence 99999999999975 5799999999999999999999999999999999999999999999999999865432211 11
Q ss_pred ccccCCCCcccChhhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc--CCCCC---CCCHH
Q 011694 172 LHTTCGTPAYVAPEVINRK----GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--FKCPN---WFPPE 242 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~----~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~~~~ 242 (479)
....+||+.|+|||++.+. +..+.++||||+||+||+|++|+.||...+..+.+..+.... +..|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998752 223479999999999999999999999888777776665432 33333 36899
Q ss_pred HHHHHHHhccCCccc--cCChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPST--RISMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~--Rpt~~eil~h~wf~~~ 273 (479)
+.++|.+||..++.+ |++++++++||||+..
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 999999999876655 5789999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=356.48 Aligned_cols=252 Identities=38% Similarity=0.670 Sum_probs=213.3
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 95 (479)
|++++.||+|+||+||++.+..+++.||+|++......... .....+|+.+++.++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999887544322 23445699999999999999999999999999999999
Q ss_pred cCCCChHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccc
Q 011694 96 AKGGELFNKVA-KGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHT 174 (479)
Q Consensus 96 ~~gg~L~~~i~-~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~ 174 (479)
+.+++|.+++. .+.+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 99999999998 578999999999999999999999999999999999999999999999999998643 122233456
Q ss_pred cCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---hHHHHHHHhccCcCCCCC----CCCHHHHHHH
Q 011694 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS---NLIEMYRKIGKAEFKCPN----WFPPEVRKLL 247 (479)
Q Consensus 175 ~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~----~~~~~~~~li 247 (479)
.++++.|+|||++......+.++||||||+++|+|++|..||... +...............+. ..++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 778999999999983333458999999999999999999999987 333333333322221111 1238999999
Q ss_pred HHhccCCccccCChhhhhcChhh
Q 011694 248 CKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+||+.||.+|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=373.19 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=211.0
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC---
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS--- 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~--- 87 (479)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 567899999999999999999999999999999999976532 2234567789999999999999999999986543
Q ss_pred ---EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 88 ---KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 88 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
.+|+||||+++ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999976 5666554 358999999999999999999999999999999999999999999999999986432
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhc---------------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG--------------- 229 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~--------------- 229 (479)
.........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+.
T Consensus 175 ---~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 ---TNFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ---cCccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 12223456789999999999888776 79999999999999999999998765433222110
Q ss_pred -------cCcCC---------CCC-----------CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 230 -------KAEFK---------CPN-----------WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 230 -------~~~~~---------~~~-----------~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
..... .+. ..++.+.+||.+||..||.+|||+.|++.||||...+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 00000 111 13578899999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=374.26 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=213.6
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
...+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3467999999999999999999999999999999996543 22345778999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 92 VMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||||+++|+|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 150 v~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DP 224 (353)
T ss_pred EEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cc
Confidence 9999999998653 246788889999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccCCCCcccChhhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCChH---HHHHHHh-ccCcCCCCCCCCHHH
Q 011694 172 LHTTCGTPAYVAPEVINR----KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL---IEMYRKI-GKAEFKCPNWFPPEV 243 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~----~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i-~~~~~~~~~~~~~~~ 243 (479)
.....||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||..... ......+ .......+..++.++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 345679999999999853 23455789999999999999999999974332 2222222 222334566789999
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+||.+||..||.+|||+.|+++||||.+..
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999999999999999999999997653
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=377.21 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=206.3
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+..++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++..+...+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 445789999999999999999999999999999996532 34578999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+|||++. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... ..
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~ 237 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NA 237 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-cc
Confidence 9999996 588888765 57999999999999999999999999999999999999999999999999998643221 11
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh-------HHHHHHHh--------------
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-------LIEMYRKI-------------- 228 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i-------------- 228 (479)
......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.... .......+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 223456899999999999887775 89999999999999999998874321 00000000
Q ss_pred ------------ccC----cCCCCC-----CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 229 ------------GKA----EFKCPN-----WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 229 ------------~~~----~~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
... ....|. .++.++.+||.+||+.||.+|||++|+++||||+..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 000 001111 246789999999999999999999999999999753
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=364.17 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=211.4
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|.+.+.||+|+||.||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 6799999999999999999999999999999999765422 22345678999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+++ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--TKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--ccc
Confidence 99986 78887764 35899999999999999999999999999999999999999999999999998643221 122
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc-------------------Cc
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK-------------------AE 232 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------------~~ 232 (479)
.....+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+.. ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 23456899999999987655445899999999999999999999987654333222210 00
Q ss_pred CCC-----------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 233 FKC-----------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 233 ~~~-----------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
... .+.+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 111 12367899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=371.72 Aligned_cols=255 Identities=28% Similarity=0.427 Sum_probs=211.7
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK----- 86 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (479)
+.++|.+.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 457899999999999999999999999999999998764322 12345677899999999999999999988543
Q ss_pred -CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 87 -SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
..+|++||++ |++|.+.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 4579999998 67999988888899999999999999999999999999999999999999999999999999875322
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-------------
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE------------- 232 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 232 (479)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 171 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 171 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred -----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 23456799999999999775444689999999999999999999998765443333221100
Q ss_pred ----------CCC--------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 233 ----------FKC--------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 233 ----------~~~--------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
... ....++.+.+||.+||..||.+|||+.+++.||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 000 11346778999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=352.12 Aligned_cols=256 Identities=30% Similarity=0.538 Sum_probs=219.1
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR--VGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
+.|++.+.||+|+||.||.|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56999999999999999999999999999999987653221 1234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|+||++|++|.+.+.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999876 578999999999999999999999999999999999999999999999999986543221111
Q ss_pred -CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc--CcCCCCCCCCHHHHHHH
Q 011694 171 -LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK--AEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 171 -~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li 247 (479)
......|++.|+|||++.+..++ .++||||+|+++|+|++|+.||.+.+.......+.. .....|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 11345688999999999887754 899999999999999999999987665544444332 23456667899999999
Q ss_pred HHhccCCccccCChhhhhcChhh
Q 011694 248 CKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=358.22 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=215.7
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
.|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999977654444444667789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 95 YAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 95 ~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|+.|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC---cc
Confidence 9999999988854 35999999999999999999999999999999999999999999999999998643211 12
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH---HHHHHh-ccCcCCCCCCCCHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI---EMYRKI-GKAEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i-~~~~~~~~~~~~~~~~~li 247 (479)
....+|++.|+|||++.+..++ .++||||+||++|+|++|..||...... ...... .......+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 2345799999999999887765 8999999999999999999999864321 111111 2222335566889999999
Q ss_pred HHhccCCccccCC-----hhhhhcChhhhc
Q 011694 248 CKILDPNPSTRIS-----MAKIRESSWFRK 272 (479)
Q Consensus 248 ~~~L~~dP~~Rpt-----~~eil~h~wf~~ 272 (479)
.+||+.||.+||| ++++++||||+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=374.50 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=212.2
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS-----KI 89 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 89 (479)
+|++++.||+|+||.||+|.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47899999999999999999999999999999865322 2233467889999999999999999999998776 89
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|+||||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~- 157 (372)
T cd07853 80 YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE- 157 (372)
T ss_pred EEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence 999999974 78877765 579999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc------------------
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK------------------ 230 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------ 230 (479)
........+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 12233456899999999998765445899999999999999999999987665443332211
Q ss_pred -----CcC---------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 231 -----AEF---------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 231 -----~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
... ......++++.+||.+||..||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 011 1223357899999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=368.25 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=207.2
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEV 82 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~ 82 (479)
+.+-.++|++.+.||+|+||.||+|.+. .+++.||||++..... ......+.+|+.+++.+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 4566789999999999999999999753 3457899999865422 23346788999999999 89999999998
Q ss_pred EEeC-CEEEEEEeccCCCChHHHHhcC-----------------------------------------------------
Q 011694 83 MATK-SKIFFVMEYAKGGELFNKVAKG----------------------------------------------------- 108 (479)
Q Consensus 83 ~~~~-~~~~lV~E~~~gg~L~~~i~~~----------------------------------------------------- 108 (479)
+... +.+|+||||+++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8754 4689999999999999988642
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCC
Q 011694 109 ----------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT 178 (479)
Q Consensus 109 ----------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 178 (479)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+..++
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 3777889999999999999999999999999999999999999999999998754322111112234467
Q ss_pred CcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHH-HHHHhcc-CcCCCCCCCCHHHHHHHHHhccCCc
Q 011694 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIE-MYRKIGK-AEFKCPNWFPPEVRKLLCKILDPNP 255 (479)
Q Consensus 179 ~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP 255 (479)
+.|+|||++.+..++ .++|||||||+||+|++ |..||.+..... ....+.. .....|..+++++.+++.+||..||
T Consensus 240 ~~y~aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 240 LKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred ccccCcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 889999999887775 89999999999999997 999998755433 2233322 2344566789999999999999999
Q ss_pred cccCChhhhhc
Q 011694 256 STRISMAKIRE 266 (479)
Q Consensus 256 ~~Rpt~~eil~ 266 (479)
.+|||+.+|++
T Consensus 319 ~~RPs~~el~~ 329 (338)
T cd05102 319 KERPTFSALVE 329 (338)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=358.03 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=204.8
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEEe-----C
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV---RHPNIVQLYEVMAT-----K 86 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 86 (479)
+|++.+.||+|+||.||+|.++.+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5999999999999999999999999999999987643222 2234456777777665 69999999999864 3
Q ss_pred CEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
..++++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999985 88888765 35899999999999999999999999999999999999999999999999998754
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC------------
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------ 231 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------ 231 (479)
... .......||+.|+|||++.+..++ .++||||+||++|+|++|.+||...+......++...
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SCQ---MALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cCc---ccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 322 222345789999999999877765 8999999999999999999999876554433332110
Q ss_pred ------cC---------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 232 ------EF---------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 232 ------~~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+ .+.+.++..+.++|.+||.+||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=354.96 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=207.5
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 011694 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL 101 (479)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (479)
||+|+||.||++.+..+|+.||+|.+.............+..|+.+++.++||||+++++++.++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443323334566799999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCC
Q 011694 102 FNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT 178 (479)
Q Consensus 102 ~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 178 (479)
.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeeccCCC
Confidence 888754 25899999999999999999999999999999999999999999999999998654321 122345799
Q ss_pred CcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH----HHHHHHhccCcCCCC-CCCCHHHHHHHHHhccC
Q 011694 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL----IEMYRKIGKAEFKCP-NWFPPEVRKLLCKILDP 253 (479)
Q Consensus 179 ~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~-~~~~~~~~~li~~~L~~ 253 (479)
+.|+|||++.+..++ .++||||+||++|+|++|..||..... ..............+ ..+++++.+||.+||++
T Consensus 158 ~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 999999999887765 899999999999999999999975422 233333333333222 35789999999999999
Q ss_pred CccccCCh----hhhhcChhhhcc
Q 011694 254 NPSTRISM----AKIRESSWFRKG 273 (479)
Q Consensus 254 dP~~Rpt~----~eil~h~wf~~~ 273 (479)
||.+||++ ++++.||||+..
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcCC
Confidence 99999999 678899999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=371.53 Aligned_cols=253 Identities=27% Similarity=0.464 Sum_probs=218.9
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
..++++-...+++++.||+|-||+||+|.+..+ ..||+|.+....... +.+.+|+++|++|+|+|||++++++..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 455666667778899999999999999999322 379999997754332 556699999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
+..+||||||++.|+|.++++. +.+...+...++.|||+|++||+++++|||||...|||++++..+||+|||||+.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 8899999999999999999986 4699999999999999999999999999999999999999999999999999984
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCC
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFP 240 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 240 (479)
.... .........-...|.|||.+....++ .||||||+||+||||+| |+.||...+..+....+.++ +.+.|+.||
T Consensus 353 ~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP 430 (468)
T KOG0197|consen 353 IGDD-EYTASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCP 430 (468)
T ss_pred cCCC-ceeecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCC
Confidence 3221 11111222235579999999988886 89999999999999998 99999999999999988765 678999999
Q ss_pred HHHHHHHHHhccCCccccCChhhhh
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIR 265 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil 265 (479)
+++.++|..||..+|++|||++.+.
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999999999998654
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=367.69 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=210.8
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK---- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (479)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 4678999999999999999999999999999999999764322 23456778999999999999999999998643
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 --SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
...|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 5666654 358999999999999999999999999999999999999999999999999987532
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc--------------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK-------------- 230 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 230 (479)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 1223456799999999999888776 799999999999999999999987654333221110
Q ss_pred --------C-----cC---------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 231 --------A-----EF---------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 231 --------~-----~~---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
. .. ..+...+.++.+||.+||..||.+|||+.|+++||||.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0 00 011123567899999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=382.87 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=202.0
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC------CCcceeEEEEEe
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH------PNIVQLYEVMAT 85 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h------pnIv~l~~~~~~ 85 (479)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 4578999999999999999999999999999999996532 223445667777777654 458899998876
Q ss_pred C-CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCC------------
Q 011694 86 K-SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENE------------ 150 (479)
Q Consensus 86 ~-~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g------------ 150 (479)
+ .++|+|||++ |++|.+++.. +.+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 5 5799999998 6688888765 689999999999999999999998 5999999999999998765
Q ss_pred ----CeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHH
Q 011694 151 ----NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYR 226 (479)
Q Consensus 151 ----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~ 226 (479)
.+||+|||++... .......+||+.|+|||++.+..|. .++|||||||++|+|++|++||.+.+..+...
T Consensus 282 ~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 4999999987532 1223456899999999999988886 89999999999999999999998766543332
Q ss_pred HhccCcCCC----------------------------CC--------------CCCHHHHHHHHHhccCCccccCChhhh
Q 011694 227 KIGKAEFKC----------------------------PN--------------WFPPEVRKLLCKILDPNPSTRISMAKI 264 (479)
Q Consensus 227 ~i~~~~~~~----------------------------~~--------------~~~~~~~~li~~~L~~dP~~Rpt~~ei 264 (479)
.+....... +. ..++.+.+||.+||..||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 221100000 00 013557799999999999999999999
Q ss_pred hcChhhhccc
Q 011694 265 RESSWFRKGM 274 (479)
Q Consensus 265 l~h~wf~~~~ 274 (479)
++||||.+..
T Consensus 436 L~Hp~~~~~~ 445 (467)
T PTZ00284 436 TTHPYVLKYY 445 (467)
T ss_pred hcCccccccC
Confidence 9999997654
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=369.87 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=211.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK---- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (479)
.+.++|++.+.||+|+||.||.|.+..+++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4568999999999999999999999999999999999764322 23346778999999999999999999987543
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 --SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 468999999976 67666643 58899999999999999999999999999999999999999999999999987542
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------- 231 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 231 (479)
. ........||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+...
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 1223456799999999999888775 7999999999999999999999876654444333210
Q ss_pred ---------cC--------------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 ---------EF--------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 ---------~~--------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.. ......+..+++||.+||..||.+|||+.++++||||....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 00 00011246789999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=353.55 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=219.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
.|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+.+++.+..++..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999977654443444567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 95 YAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 95 ~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---Cc
Confidence 9999999888754 36999999999999999999999999999999999999999999999999998643211 12
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHH----HHHHhccCcCCCCCCCCHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE----MYRKIGKAEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~li 247 (479)
.....|++.|+|||++.+..++ .++|+||+||++|+|++|..||....... ....+.......+..+++++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 2345799999999999877765 79999999999999999999998765432 233333444455667889999999
Q ss_pred HHhccCCccccCC-----hhhhhcChhhhcc
Q 011694 248 CKILDPNPSTRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 248 ~~~L~~dP~~Rpt-----~~eil~h~wf~~~ 273 (479)
.+||+.||.+||| +.+++.|+||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=355.01 Aligned_cols=256 Identities=31% Similarity=0.505 Sum_probs=220.6
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
...+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++.+......|+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 457999999999999999999999999999999999765432 24678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 92 VMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||||++|++|.+++..+.+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK 172 (296)
T ss_pred eecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cCCCCCCCCHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~ 248 (479)
.....|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+.......+... ....+..+++.+.+++.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred cCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 2345789999999999876664 8999999999999999999999877654333222221 22345568899999999
Q ss_pred HhccCCccccCChhhhhcChhhhcc
Q 011694 249 KILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+||.+||.+|||+.+++.||||...
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=356.39 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=212.8
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 46799999999999999999999999999999998754322 2234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+.+ +|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~ 159 (301)
T cd07873 83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 159 (301)
T ss_pred Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--CC
Confidence 999975 88888765 46899999999999999999999999999999999999999999999999998643221 12
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------------
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------------- 231 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 231 (479)
......+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 2234567899999999876554558999999999999999999999877654433222110
Q ss_pred cCCCC-----------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 232 EFKCP-----------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 232 ~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
....| ..+++++.+||.+||..||.+|||++++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00111 2467889999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=344.89 Aligned_cols=252 Identities=24% Similarity=0.503 Sum_probs=217.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT-KSKIFFVM 93 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~ 93 (479)
+|++.+.||+|+||.||.+.+..+++.||+|.+....... ...+.+.+|+.+++.++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5999999999999999999999999999999997654332 334668899999999999999999998864 45789999
Q ss_pred eccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 94 EYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 94 E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
||+++++|.+.+.. ..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--CC
Confidence 99999999998875 35899999999999999999999999999999999999999999999999998754322 22
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCCCCCHHHHHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEVRKLLCK 249 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 249 (479)
......+++.|+|||++.+..++ .++||||+||++|+|++|..||...+.......+..+.. ..+..+++.+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 33456789999999999877765 799999999999999999999988776655555544433 4556688999999999
Q ss_pred hccCCccccCChhhhhcChhh
Q 011694 250 ILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf 270 (479)
||+.||.+|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=374.77 Aligned_cols=255 Identities=29% Similarity=0.457 Sum_probs=216.0
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-C-----CCcceeEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-H-----PNIVQLYEV 82 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-h-----pnIv~l~~~ 82 (479)
...+..+|++.+.||+|+||.|-+|.+..|++.||||+++... ....+...|+.+|..++ | -|||+++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 3566679999999999999999999999999999999997654 45567778999999997 3 389999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec--CCCeEEeec
Q 011694 83 MATKSKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE--NENLKISDF 157 (479)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~--~g~vkl~DF 157 (479)
|...+++|||+|.++- +|+++++.+ +++...++.++.||+.||.+||+.||||+|||||||||.. ...|||+||
T Consensus 257 F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 257 FYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence 9999999999999965 999999974 6899999999999999999999999999999999999964 347999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC------
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------ 231 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------ 231 (479)
|.|+... ....+.+-+..|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|..-
T Consensus 336 GSSc~~~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 336 GSSCFES-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred ccccccC-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 9987532 223478899999999999999997 7999999999999999999999988766655544210
Q ss_pred ----------------------------------------------cCCCCCC-------C----CHHHHHHHHHhccCC
Q 011694 232 ----------------------------------------------EFKCPNW-------F----PPEVRKLLCKILDPN 254 (479)
Q Consensus 232 ----------------------------------------------~~~~~~~-------~----~~~~~~li~~~L~~d 254 (479)
....|+. + ...+.+||++||..|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 0001100 0 134689999999999
Q ss_pred ccccCChhhhhcChhhhccc
Q 011694 255 PSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 255 P~~Rpt~~eil~h~wf~~~~ 274 (479)
|.+|+|..++++||||....
T Consensus 490 P~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTGTS 509 (586)
T ss_pred chhcCCHHHHhcCccccccc
Confidence 99999999999999997543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=356.02 Aligned_cols=258 Identities=33% Similarity=0.578 Sum_probs=224.1
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765554345677899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC-
Q 011694 94 EYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD- 169 (479)
Q Consensus 94 E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~- 169 (479)
||+.|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999875 36999999999999999999999999999999999999999999999999998643321110
Q ss_pred --------------------------CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHH
Q 011694 170 --------------------------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE 223 (479)
Q Consensus 170 --------------------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~ 223 (479)
.......||..|+|||++.+..++ .++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC-chHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 011234688999999999877664 89999999999999999999999888777
Q ss_pred HHHHhccCcCCCCCC--CCHHHHHHHHHhccCCccccCC----hhhhhcChhhhc
Q 011694 224 MYRKIGKAEFKCPNW--FPPEVRKLLCKILDPNPSTRIS----MAKIRESSWFRK 272 (479)
Q Consensus 224 ~~~~i~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt----~~eil~h~wf~~ 272 (479)
.+..+.......+.. +++.+.++|.+||..||.+||| +++++.||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 676665555544444 6899999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=347.06 Aligned_cols=255 Identities=29% Similarity=0.543 Sum_probs=218.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc------hhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR------VGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~------~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
+|.++..||.|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999999999999999987643321 2344678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
.+++|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999976 578999999999999999999999999999999999999999999999999987654221
Q ss_pred cC----CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-cCCCCCCCCHH
Q 011694 168 QD----GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPE 242 (479)
Q Consensus 168 ~~----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 242 (479)
.. .......|++.|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 11 111234688999999999877765 7899999999999999999999877655444444332 33456668999
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhh
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
+.++|.+||++||.+||++.+|++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=351.18 Aligned_cols=252 Identities=30% Similarity=0.472 Sum_probs=208.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999998764322 2344678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 95 YAKGGELFNKVAK----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 95 ~~~gg~L~~~i~~----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 998 478887754 46899999999999999999999999999999999999999999999999998643221 12
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc----C---------------
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK----A--------------- 231 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~----~--------------- 231 (479)
......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 223446789999999987655445799999999999999999999986543322111100 0
Q ss_pred ----c------CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 232 ----E------FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 232 ----~------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
. ......+++++.++|.+||..||.+|||+.+|++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 00122368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=369.33 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=209.3
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSI--RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
...++..+|++++.||+|+||.||+|... .++..||+|.+.... ...+|+.+++.++||||+++++++..
T Consensus 86 ~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 86 PASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred cchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEee
Confidence 34466788999999999999999999764 356789999886532 34589999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
...+|++||++. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred CCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999999999996 588888864 579999999999999999999999999999999999999999999999999987544
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH---HHHHHHh----cc-------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL---IEMYRKI----GK------- 230 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i----~~------- 230 (479)
............||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+... ...+..+ ..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 33222223356799999999999888776 799999999999999999999965431 1111111 10
Q ss_pred ------------------CcCCCCC-----CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 231 ------------------AEFKCPN-----WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 231 ------------------~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..+..|. .++.++.+||++||..||.+|||+.+++.||||.+.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0111111 246788999999999999999999999999999764
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=353.49 Aligned_cols=253 Identities=25% Similarity=0.439 Sum_probs=213.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999987542 2234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||++|++|.+++.. +.+++..+..++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 99999999999976 679999999999999999999998 5999999999999999999999999999864322 22
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-------------------
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE------------------- 232 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------- 232 (479)
....+|++.|+|||++.+..+. .++|+||+||++|+|++|..||...+.......+....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 3456789999999998776664 89999999999999999999997655433322221110
Q ss_pred ------------------CCCC-CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 233 ------------------FKCP-NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 233 ------------------~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
...| ..+++++.+|+.+||..||++|||+.+++.||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0111 1257889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=376.56 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=226.2
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.+.|+|+..||.|+||+||+|.++.++-..|.|+|.... .+..+.+.-||.||..++||+||++++.|.-++++||+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 467899999999999999999999999999999997653 34457778899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
.|||.||-+...+.. ..++++++..+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.++...... .
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--q 185 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--Q 185 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH--h
Confidence 999999999887765 579999999999999999999999999999999999999999999999999986433222 2
Q ss_pred CccccCCCCcccChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC---CCCCCCHH
Q 011694 171 LLHTTCGTPAYVAPEVIN-----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK---CPNWFPPE 242 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~-----~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~ 242 (479)
.-.+..|||+|||||+.. ..+|+ +++||||||++|.+|..+.+|..+.++..+..+|.+...+ -|...+..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence 235678999999999974 56777 8999999999999999999999999999988888765433 45667899
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+.+|+++||.+||..||++++|++||||...
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9999999999999999999999999999843
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=346.62 Aligned_cols=252 Identities=29% Similarity=0.580 Sum_probs=222.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987665544556889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcc
Q 011694 95 YAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 95 ~~~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
|+.|++|.+++... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---ccc
Confidence 99999999999875 89999999999999999999999999999999999999999999999999986543221 234
Q ss_pred ccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH---HHHHHHhccCcCCCCCCCCHHHHHHHHHh
Q 011694 174 TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL---IEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 250 (479)
...|+..|+|||++.+..+. .++|+||+|+++|+|++|..||...+. ..............|..+|.++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCCC-CcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 56788999999999877654 899999999999999999999987663 33333333355667777899999999999
Q ss_pred ccCCccccCCh--hhhhcChhh
Q 011694 251 LDPNPSTRISM--AKIRESSWF 270 (479)
Q Consensus 251 L~~dP~~Rpt~--~eil~h~wf 270 (479)
|..||.+||++ .++++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=351.19 Aligned_cols=256 Identities=32% Similarity=0.524 Sum_probs=221.5
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
..+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 3579999999999999999999999999999999975432 2346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
+||+++++|..++..+.+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKR 172 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--ccC
Confidence 999999999999988889999999999999999999999999999999999999999999999999986543221 122
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cCCCCCCCCHHHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~~ 249 (479)
...++++.|+|||.+.+..+. .++||||+||++|+|++|..||...+.......+... ....+..+++.+.++|.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 345789999999999877665 7999999999999999999999887665444333222 234555688999999999
Q ss_pred hccCCccccCChhhhhcChhhhccc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
||..||.+|||+.+|+.||||+...
T Consensus 252 ~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 252 CLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=345.09 Aligned_cols=257 Identities=31% Similarity=0.610 Sum_probs=220.1
Q ss_pred CeEE-eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEE
Q 011694 15 KYEV-GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 15 ~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 92 (479)
-|++ .+.||+|+||.|--+.+..||..||||++++.. .....++.||+.++...+ |+||+.++++|++++++|+|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 3444 467999999999999999999999999998863 245688999999999985 99999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC---CeEEeecCchhhhhccc-
Q 011694 93 MEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE---NLKISDFGLSALAQCKH- 167 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g---~vkl~DFGla~~~~~~~- 167 (479)
||.+.||+|...|.+ ..++|.++.++.+.|+.||.|||.+||+||||||||||..... .||||||.+..-.....
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 999999999988876 5799999999999999999999999999999999999996554 48999999976433222
Q ss_pred ----cCCCccccCCCCcccChhhhh----cCCCCCCccchhhHHHHHHHHHhCCCCCCCC---------------hHHHH
Q 011694 168 ----QDGLLHTTCGTPAYVAPEVIN----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS---------------NLIEM 224 (479)
Q Consensus 168 ----~~~~~~~~~gt~~y~aPEvl~----~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~---------------~~~~~ 224 (479)
....+.+.||+..|||||+.. ...++..++|.||||||||.||+|++||.+. -...+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 223456789999999999973 2223348999999999999999999999642 13467
Q ss_pred HHHhccCcCCCCCC----CCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 225 YRKIGKAEFKCPNW----FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 225 ~~~i~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+..|..+.+.+|.. +|.++.++++.+|..|+..|.++.+++.|||++...
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 88888888888853 899999999999999999999999999999997654
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=342.85 Aligned_cols=255 Identities=30% Similarity=0.521 Sum_probs=218.4
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++++.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999999999999999997654332 4577899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 94 EYAKGGELFNKVAK----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 94 E~~~gg~L~~~i~~----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
|+++|++|.+.+.. +.+++..+..++.||+.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999875 35899999999999999999999999999999999999999999999999998765543322
Q ss_pred --CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCC-----CCCCH
Q 011694 170 --GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCP-----NWFPP 241 (479)
Q Consensus 170 --~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~-----~~~~~ 241 (479)
......+|++.|+|||++......+.++|+||+||++|+|++|+.||...+....+..+..... ..+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 1234457899999999997763445899999999999999999999987766555544433221 111 24678
Q ss_pred HHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+.+++.+||..||.+|||+++|++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=357.43 Aligned_cols=246 Identities=26% Similarity=0.444 Sum_probs=193.8
Q ss_pred eeeeeecCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEe
Q 011694 19 GRLLGQGAFAKVYYARSI--RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT--KSKIFFVME 94 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 94 (479)
+++||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999975 4678999999865432 2456789999999999999999999854 467899999
Q ss_pred ccCCCChHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE----ecCCCeEEeecCch
Q 011694 95 YAKGGELFNKVAK----------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL----DENENLKISDFGLS 160 (479)
Q Consensus 95 ~~~gg~L~~~i~~----------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl----~~~g~vkl~DFGla 160 (479)
|+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 78777652 248999999999999999999999999999999999999 45678999999999
Q ss_pred hhhhcccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH---------HHHHHHhcc
Q 011694 161 ALAQCKHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL---------IEMYRKIGK 230 (479)
Q Consensus 161 ~~~~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~---------~~~~~~i~~ 230 (479)
........ .......+||+.|+|||++.+....+.++||||+||++|+|++|.+||..... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 76533211 12234567899999999998765456899999999999999999999964321 011111100
Q ss_pred ----------------------------CcCCC----------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 231 ----------------------------AEFKC----------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 231 ----------------------------~~~~~----------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
..... ....++++.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 01124678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=389.37 Aligned_cols=267 Identities=27% Similarity=0.461 Sum_probs=220.8
Q ss_pred CCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 4 ~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
-....+.++.++|++++.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.+++.++|||||+++++|
T Consensus 3 ~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f 81 (1021)
T PTZ00266 3 GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRF 81 (1021)
T ss_pred ccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 355678888999999999999999999999999999999999997654332 3456788999999999999999999988
Q ss_pred Ee--CCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-------CCeeccCCCCCEEEecC
Q 011694 84 AT--KSKIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSR-------GVYHRDIKPENLLLDEN 149 (479)
Q Consensus 84 ~~--~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~-------givHrDLkp~NILl~~~ 149 (479)
.. ...+||||||+.+|+|.++|.. +.+++..++.|+.||+.||.|||+. +|+||||||+||||+.+
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 54 4679999999999999998864 4699999999999999999999995 49999999999999642
Q ss_pred -----------------CCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcC-CCCCCccchhhHHHHHHHHHh
Q 011694 150 -----------------ENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK-GYDGEKVDIWSCGVVLFVLLA 211 (479)
Q Consensus 150 -----------------g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-~~~~~~~DvwSlGvil~~ll~ 211 (479)
+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 3489999999875432 2223456799999999998643 223589999999999999999
Q ss_pred CCCCCCCChHH-HHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 212 GYLPFHDSNLI-EMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 212 G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
|..||...+.. .....+..........+++++.+||..||..+|.+|||+.+++.|||++...
T Consensus 239 Gk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 239 GKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 99999765543 3333333332222345789999999999999999999999999999997554
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=340.01 Aligned_cols=252 Identities=30% Similarity=0.495 Sum_probs=220.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|.+.+.||+|+||.||+|.+..+++.|++|.+....... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 5889999999999999999999999999999997654332 345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 95 YAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 95 ~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 9999999999876 36899999999999999999999999999999999999999999999999998654322 122
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC-CCCCCCHHHHHHHHHh
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-CPNWFPPEVRKLLCKI 250 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~ 250 (479)
....+|++.|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+...... .+..+++++.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3345789999999999887765 8999999999999999999999888776666666554433 3446789999999999
Q ss_pred ccCCccccCChhhhhcChhh
Q 011694 251 LDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 251 L~~dP~~Rpt~~eil~h~wf 270 (479)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=351.18 Aligned_cols=259 Identities=32% Similarity=0.632 Sum_probs=220.7
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997765433344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc----
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ---- 168 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~---- 168 (479)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999976 5799999999999999999999999999999999999999999999999998763211000
Q ss_pred ---------CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC---
Q 011694 169 ---------DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP--- 236 (479)
Q Consensus 169 ---------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--- 236 (479)
........+++.|+|||.+.+..+. .++|+|||||++|+|++|..||.+.+..+....+.......|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0011234678899999999877664 899999999999999999999988777776666655443333
Q ss_pred CCCCHHHHHHHHHhccCCccccCC---hhhhhcChhhhcc
Q 011694 237 NWFPPEVRKLLCKILDPNPSTRIS---MAKIRESSWFRKG 273 (479)
Q Consensus 237 ~~~~~~~~~li~~~L~~dP~~Rpt---~~eil~h~wf~~~ 273 (479)
..+|+++.++|.+||+.||.+||+ +.++++||||...
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 247899999999999999999998 7899999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=357.06 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=206.1
Q ss_pred Eeeeeeec--CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 011694 18 VGRLLGQG--AFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 18 i~~~LG~G--~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 95 (479)
++++||+| +|++||++.++.+|+.||+|.++..... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56889999 6899999999999999999999765432 24456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc----
Q 011694 96 AKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ---- 168 (479)
Q Consensus 96 ~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~---- 168 (479)
+++|+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999864 3599999999999999999999999999999999999999999999999986543211111
Q ss_pred -CCCccccCCCCcccChhhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC-----------
Q 011694 169 -DGLLHTTCGTPAYVAPEVINRK--GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK----------- 234 (479)
Q Consensus 169 -~~~~~~~~gt~~y~aPEvl~~~--~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~----------- 234 (479)
........++..|+|||++.+. .+ +.++||||+||++|+|++|..||.................+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0111234577889999999753 45 48999999999999999999999865433322221111100
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 235 -----------------------------------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 235 -----------------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
....+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 011246789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.28 Aligned_cols=257 Identities=32% Similarity=0.505 Sum_probs=220.2
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
...+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 458999999999999999999999999999999999764332 23667899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 92 VMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||||+++++|.+++....+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....... ..
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK 171 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--cC
Confidence 9999999999999988889999999999999999999999999999999999999999999999999986433221 12
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cCCCCCCCCHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~ 248 (479)
.....+++.|+|||.+.+..+. .++|+||+||++|+|++|..||...+.......+... ....|..+++.+.+|+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred cCcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 2345789999999999877664 8999999999999999999999876553332222221 22345567899999999
Q ss_pred HhccCCccccCChhhhhcChhhhccc
Q 011694 249 KILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+||..||.+|||++++++||||+...
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHccCChhhCcCHHHHhcCchhcccc
Confidence 99999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.98 Aligned_cols=256 Identities=31% Similarity=0.480 Sum_probs=219.7
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++.+......|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 467999999999999999999999899999999986542 23346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 999999999999875 469999999999999999999999999999999999999999999999999986543221 1
Q ss_pred CccccCCCCcccChhhhhcCC----CCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc---CCCCCCCCHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKG----YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPPEV 243 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~----~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~ 243 (479)
......+++.|+|||++.... ..+.++|+||+||++|+|++|..||...+.......+.... +..|..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 223456899999999985322 12368999999999999999999998877666555554432 33456688999
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.++|.+||..+|.+|||++++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=392.40 Aligned_cols=262 Identities=31% Similarity=0.533 Sum_probs=232.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+-.++|++++.||+|+||.|.+++++.|++.||+|++++-...+......+..|-.+|..-+.+.|+.++..|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34679999999999999999999999999999999998855544455577889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+||||++||+|..++.+ +++||+.++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||-+..+...+.
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~- 230 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT- 230 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc-
Confidence 99999999999999987 5799999999999999999999999999999999999999999999999997755442222
Q ss_pred CCccccCCCCcccChhhhh----cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCC--CCCCH
Q 011694 170 GLLHTTCGTPAYVAPEVIN----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCP--NWFPP 241 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~----~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~~~ 241 (479)
-...+.+|||-|.+||++. +.+.+|..+|-||+||++|+|+.|..||...+..+.|.+|.+- .+.+| ..+|+
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence 2345678999999999996 3355689999999999999999999999999999999999654 67788 45899
Q ss_pred HHHHHHHHhccCCccccCC---hhhhhcChhhhccc
Q 011694 242 EVRKLLCKILDPNPSTRIS---MAKIRESSWFRKGM 274 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt---~~eil~h~wf~~~~ 274 (479)
++++||++++. +|..|.. +++|..||||....
T Consensus 311 eakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 311 EAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred HHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 99999999886 5888888 99999999997643
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=346.26 Aligned_cols=256 Identities=32% Similarity=0.542 Sum_probs=221.6
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.++..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999976532 233466789999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcc
Q 011694 94 EYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 94 E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
||+++++|.+++..+++++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 99999999999998899999999999999999999999999999999999999999999999999987654321 1223
Q ss_pred ccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-CCCCCC-CCHHHHHHHHHhc
Q 011694 174 TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNW-FPPEVRKLLCKIL 251 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~-~~~~~~~li~~~L 251 (479)
...+++.|+|||.+.+..++ .++||||+||++|+|++|..||...+.......+.... ...+.. +++++.+++.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 45688999999999887765 89999999999999999999998776555544443332 223333 7899999999999
Q ss_pred cCCccccCChhhhhcChhhhccc
Q 011694 252 DPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 252 ~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..||.+|||++++++||||.+..
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCCC
Confidence 99999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=351.02 Aligned_cols=252 Identities=29% Similarity=0.509 Sum_probs=207.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+.+|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999999976432 22334567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 95 YAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 95 ~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|+++ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence 9975 77777654 57999999999999999999999999999999999999999999999999998754321 1222
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCC-CCChHHHHHHHhccC----------------c---
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF-HDSNLIEMYRKIGKA----------------E--- 232 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~----------------~--- 232 (479)
....+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+....+..+... .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877654458999999999999999998885 433333333222110 0
Q ss_pred C----------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 233 F----------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 233 ~----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
+ ...+.+++++.+||.+||..||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=347.24 Aligned_cols=254 Identities=30% Similarity=0.490 Sum_probs=214.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5999999999999999999999999999999997754322 345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 95 YAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 95 ~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|+ |++|.+.+.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999999864 4699999999999999999999999999999999999999999999999999876543221 223
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------------cC
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-------------------EF 233 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~ 233 (479)
....|++.|+|||.+.+....+.++||||+||++|+|++|.+||...+....+..+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 45678999999999876555568999999999999999999888776554433332110 00
Q ss_pred C-----------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhh
Q 011694 234 K-----------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 234 ~-----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
. ..+..+.++.+||.+||..||.+|||+++++.||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 1123568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=342.37 Aligned_cols=254 Identities=28% Similarity=0.493 Sum_probs=215.2
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc---chhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM---RVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~---~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
+|++++.||.|+||+||+|.+ .+++.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 58899999998754321 12334678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc---
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH--- 167 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~--- 167 (479)
+|||++|++|.+++.+ +.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999976 679999999999999999999999999999999999999999999999999987542211
Q ss_pred -cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cCCCCCCCCHHH
Q 011694 168 -QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEV 243 (479)
Q Consensus 168 -~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~ 243 (479)
.........|++.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11222345689999999999877765 8999999999999999999999876654433333222 224556688999
Q ss_pred HHHHHHhccCCccccCChhhhhcChhh
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.++|.+||..+|.+|||+.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=345.30 Aligned_cols=254 Identities=28% Similarity=0.436 Sum_probs=210.7
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.....+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 4799999999999999999999999999999998654322 123456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||++++.|...+.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence 99999888887765 5799999999999999999999999999999999999999999999999999875433221 12
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc---------------C----c-
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK---------------A----E- 232 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---------------~----~- 232 (479)
....++..|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.. . .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 3345788999999987654445899999999999999999999987654332222110 0 0
Q ss_pred -CCC----------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 233 -FKC----------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 233 -~~~----------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+. .+.++..+.+||.+||++||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 12357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.35 Aligned_cols=247 Identities=37% Similarity=0.700 Sum_probs=218.5
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 011694 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL 101 (479)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (479)
||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+++.+|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999876655445567899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCc
Q 011694 102 FNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180 (479)
Q Consensus 102 ~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 180 (479)
.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....++++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999976 468999999999999999999999999999999999999999999999999987553321 2234578999
Q ss_pred ccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh--HHHHHHHhc--cCcCCCCCCCCHHHHHHHHHhccCCcc
Q 011694 181 YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN--LIEMYRKIG--KAEFKCPNWFPPEVRKLLCKILDPNPS 256 (479)
Q Consensus 181 y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP~ 256 (479)
|+|||.+.+..++ .++|+||+|+++|+|++|..||.... ....+..+. ......|..+++++.++|.+||..||.
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998877765 79999999999999999999998766 556666655 445667777899999999999999999
Q ss_pred ccCC-----hhhhhcChhhhc
Q 011694 257 TRIS-----MAKIRESSWFRK 272 (479)
Q Consensus 257 ~Rpt-----~~eil~h~wf~~ 272 (479)
+||| ++|+++||||+.
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=370.13 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=204.6
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
....|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+++.++|||||++++++..++..++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 45689999999999999999999999999999996422 234689999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 92 VMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
|||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999996 588888765 46999999999999999999999999999999999999999999999999998765432222
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC--------hHHHHHHHhccCc---------
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS--------NLIEMYRKIGKAE--------- 232 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~--------~~~~~~~~i~~~~--------- 232 (479)
......+||+.|+|||++.+..++ .++|||||||+||+|++|..|+... ......+.+....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 223346799999999999888775 8999999999999999987655321 1112222211110
Q ss_pred --------------------CCCCCC-----CCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 233 --------------------FKCPNW-----FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 233 --------------------~~~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
...+.| +++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 011111 4568999999999999999999999999999964
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=347.51 Aligned_cols=261 Identities=31% Similarity=0.456 Sum_probs=220.0
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
++-...+.|++++.||.|+||.||+|.+..+++.|++|++.... ......+.+|+.+++.++||||+++++.+..++
T Consensus 6 ~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred cccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 44456688999999999999999999999999999999986542 234567888999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.+|+||||++|++|...+.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999999999999887754 4689999999999999999999999999999999999999999999999998764221
Q ss_pred cccCCCccccCCCCcccChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc---CCCCC
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINR-----KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPN 237 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~-----~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~ 237 (479)
. ........+++.|+|||++.+ ..+ +.++|||||||++|+|++|..||...+.......+.... ...+.
T Consensus 163 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06644 163 T--LQRRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS 239 (292)
T ss_pred c--ccccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCc
Confidence 1 111234568899999999853 233 478999999999999999999998776655555543332 23345
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.++.++.++|.+||..||.+||+++++++||||....
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 6788999999999999999999999999999996543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=344.42 Aligned_cols=252 Identities=28% Similarity=0.468 Sum_probs=211.0
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeC----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATK---- 86 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~---- 86 (479)
..+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4578999999999999999999999999999999997643 2235778999999998 699999999998653
Q ss_pred --CEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 87 --SKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
..+|++|||+.+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 568999999999999999875 358999999999999999999999999999999999999999999999999987
Q ss_pred hhhccccCCCccccCCCCcccChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc--CC
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINR-----KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--FK 234 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~-----~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~ 234 (479)
..... ........|++.|+|||++.+ ..+ +.++||||+||++|+|++|..||...........+.... ..
T Consensus 160 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 160 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred ecccc--cccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 54321 122345679999999999863 234 478999999999999999999997765444333332221 12
Q ss_pred CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 235 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+..++.++.+||.+||..||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 233478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=343.40 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=211.3
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
..++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..++.+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 45689999999999999999999999999999999975432 223567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
||||+++++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence 9999999999998865 579999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CccccCCCCcccChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCC-----CCCCCHH
Q 011694 171 LLHTTCGTPAYVAPEVINR---KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC-----PNWFPPE 242 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~---~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~ 242 (479)
......|++.|+|||.+.. ..+ +.++||||+||++|+|++|..||...+.......+....+.. +..++..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred ccCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 1234568999999999853 234 478999999999999999999997655443333332222222 2236789
Q ss_pred HHHHHHHhccCCccccCChhhhhcChh
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSW 269 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~w 269 (479)
+.+||++||..||.+|||+++|++|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=344.94 Aligned_cols=250 Identities=25% Similarity=0.427 Sum_probs=210.5
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 468899999999999999999999999999999976532 234467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcc
Q 011694 94 EYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 94 E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..... ....
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----cccc
Confidence 99999998654 3588999999999999999999999999999999999999999999999999864422 2234
Q ss_pred ccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH-------HHHHHHhccCc-CC-CCCCCCHHHH
Q 011694 174 TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-------IEMYRKIGKAE-FK-CPNWFPPEVR 244 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~-------~~~~~~i~~~~-~~-~~~~~~~~~~ 244 (479)
..+||+.|+|||++.+..+. .++|+||+||++|+|++|..||..... ......+.... .. .....++++.
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 56899999999999877765 899999999999999999999964321 12222222221 11 2234788999
Q ss_pred HHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 245 KLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+++.+||..||.+||+++++++||||...
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=345.73 Aligned_cols=239 Identities=21% Similarity=0.278 Sum_probs=207.7
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEec
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT----KSKIFFVMEY 95 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 95 (479)
..||+|++|.||+|.. +|+.||||.+...........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999998 899999999987654444456788899999999999999999999876 4578999999
Q ss_pred cCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcc
Q 011694 96 AKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 96 ~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
++||+|.+++.. +.+++.....++.|++.||.|||+. |++||||||+|||++.++.+||+|||++...... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cc
Confidence 999999999976 4689999999999999999999984 9999999999999999999999999998754321 23
Q ss_pred ccCCCCcccChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc--CcCCCCCCCCHHHHHHHHH
Q 011694 174 TTCGTPAYVAPEVINR--KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK--AEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~--~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~ 249 (479)
...|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+....+..+.. .....|..+|+.+.+++.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999976 455 4899999999999999999999998887777776633 3445565789999999999
Q ss_pred hccCCccccCChhhhhc
Q 011694 250 ILDPNPSTRISMAKIRE 266 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~ 266 (479)
||+.||.+|||+.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999975
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=339.15 Aligned_cols=252 Identities=29% Similarity=0.567 Sum_probs=219.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||+|+||.||++.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 6999999999999999999999999999999997654332 334678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 95 YAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 95 ~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 9999999998865 258999999999999999999999999999999999999999999999999986543221 11
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCCCCCHHHHHHHHHh
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~ 250 (479)
.....|++.|+|||++.+..+. .++|+||+||++|+|++|..||...+.......+..+.. ..+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 2234588999999999877664 799999999999999999999988777766666654443 35666889999999999
Q ss_pred ccCCccccCChhhhhcChhh
Q 011694 251 LDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 251 L~~dP~~Rpt~~eil~h~wf 270 (479)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=341.93 Aligned_cols=256 Identities=29% Similarity=0.499 Sum_probs=213.7
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc-------hhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR-------VGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-------~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6899999999999999999999999999999986432211 123457889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.+++||||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999876 67999999999999999999999999999999999999999999999999998654322
Q ss_pred ccCCCccccCCCCcccChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCCC----CC
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKG-YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCPN----WF 239 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~----~~ 239 (479)
..........|+..|+|||.+.... ..+.++|+||||+++|++++|..||...+.......+... ....+. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222233456899999999987654 2348999999999999999999999766554433333221 222222 35
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
+.++.++|.+||.++|.+|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=349.20 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=205.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcC----------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIR----------------TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hp 74 (479)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.+++.++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCC
Confidence 346789999999999999999998632 345799999876432 23456788999999999999
Q ss_pred CcceeEEEEEeCCEEEEEEeccCCCChHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011694 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKG--------------------KLKEDAARRYFQQLINAVDFCHSRGV 134 (479)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--------------------~l~e~~~~~i~~qll~aL~~LH~~gi 134 (479)
||+++++++.+.+..++||||+.+|+|.+++... .+++..+..++.||+.||.|||++||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999999999999999999999999988542 25777889999999999999999999
Q ss_pred eeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh--C
Q 011694 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA--G 212 (479)
Q Consensus 135 vHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~--G 212 (479)
+||||||+|||++.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ +
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccC
Confidence 99999999999999999999999998754322221222344568899999999877665 89999999999999986 6
Q ss_pred CCCCCCChHHHHHHHhc--------cCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhh
Q 011694 213 YLPFHDSNLIEMYRKIG--------KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIR 265 (479)
Q Consensus 213 ~~Pf~~~~~~~~~~~i~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil 265 (479)
..||...+.......+. ......|+.+|+.+.+|+.+||..||.+|||+++|.
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 78887765444333221 111234566889999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=342.66 Aligned_cols=256 Identities=27% Similarity=0.508 Sum_probs=215.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc---chhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM---RVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~---~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
+|+.++.||+|+||.||.|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488899999999999999999999999999999754322 12345788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-CeEEeecCchhhhhcccc-
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISDFGLSALAQCKHQ- 168 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-~vkl~DFGla~~~~~~~~- 168 (479)
||||+.|++|.+.+.. +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999999876 6799999999999999999999999999999999999998776 599999999865543211
Q ss_pred -CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHH---Hh--ccCcCCCCCCCCHH
Q 011694 169 -DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYR---KI--GKAEFKCPNWFPPE 242 (479)
Q Consensus 169 -~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i--~~~~~~~~~~~~~~ 242 (479)
........|+..|+|||.+.+..++ .++||||+|+++|+|++|..||...+...... .+ .......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1112234688999999999877665 89999999999999999999997544322222 21 12233455668899
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhh
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
+.+++.+||..+|.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=345.03 Aligned_cols=255 Identities=29% Similarity=0.474 Sum_probs=216.2
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
-|++.+.||+|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 4788999999999999999999999999999986543 2334677889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 95 YAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 95 ~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|+++++|...+.. +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 160 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 160 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence 9999999888754 56999999999999999999999999999999999999999999999999998643221 1222
Q ss_pred cccCCCCcccChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cCCCCCCCCHHHH
Q 011694 173 HTTCGTPAYVAPEVIN-----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVR 244 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~-----~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~ 244 (479)
....+++.|+|||++. +..+ +.++||||+||++|+|++|..||...+.......+... ....|..++.++.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred ccccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 3457899999999984 2233 47899999999999999999999887665554444332 2334556889999
Q ss_pred HHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 245 KLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
+||.+||..||.+|||++++++||||+....
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 9999999999999999999999999976543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=363.41 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=209.6
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTN-----QSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~ 81 (479)
.+....++|++++.||+|+||.||+|++..+| ..||||++...... .....+.+|+.+++.+ +||||+++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEee
Confidence 34556678999999999999999999875443 57999999765322 3356788999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc------------------------------------------------------
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAK------------------------------------------------------ 107 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~------------------------------------------------------ 107 (479)
++...+.+|+|||||++|+|.+++..
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 99999999999999999999988753
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 108 -----------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 108 -----------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 137788899999999999999999999999999999999999999999999986543221111
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC--cCCCCCCCCHHHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA--EFKCPNWFPPEVRKLL 247 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li 247 (479)
...+..+++.|+|||++.+..++ .++||||+||++|+|++ |+.||........+...... ....|..+|+++.+++
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 12223456789999999877765 89999999999999997 99999876544333332222 3456677899999999
Q ss_pred HHhccCCccccCChhhhhc
Q 011694 248 CKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~ 266 (479)
.+||+.||.+|||+.++++
T Consensus 349 ~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=346.85 Aligned_cols=255 Identities=27% Similarity=0.466 Sum_probs=216.1
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999999999999999986532 2233467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 94 EYAKGGELFNKVAKG----KLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 94 E~~~gg~L~~~i~~~----~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
||++|++|..++..+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999999888764 79999999999999999999997 599999999999999999999999999986432
Q ss_pred CCCccccCCCCcccChhhhhcCCC-----CCCccchhhHHHHHHHHHhCCCCCCCChHHHHHH---Hhcc-CcCCCCCCC
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGY-----DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYR---KIGK-AEFKCPNWF 239 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~-----~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i~~-~~~~~~~~~ 239 (479)
........+++.|+|||.+.+... .+.++|+||+||++|+|++|..||...+....+. .+.. .....|+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 122345578999999999865432 2478999999999999999999997654433332 2222 234456668
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
++++.+||.+||..+|.+||++++++.||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.43 Aligned_cols=253 Identities=28% Similarity=0.460 Sum_probs=211.5
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
.-.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+...+.+|
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 345689999999999999999999999999999999875532 22356788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...... .
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~ 160 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--I 160 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--c
Confidence 99999999999999875 67999999999999999999999999999999999999999999999999998644321 1
Q ss_pred CCccccCCCCcccChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCC-----CCCCCH
Q 011694 170 GLLHTTCGTPAYVAPEVIN---RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC-----PNWFPP 241 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~---~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~ 241 (479)
.......|++.|+|||++. ...+ +.++|+||+||++|+|++|..||................... ...++.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN 239 (267)
T ss_pred cccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence 1223457899999999984 3334 479999999999999999999997654433322222222221 123678
Q ss_pred HHHHHHHHhccCCccccCChhhhhcChh
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESSW 269 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~w 269 (479)
.+.++|.+||..+|.+|||+++|++|||
T Consensus 240 ~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 240 SFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 8999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=344.95 Aligned_cols=256 Identities=33% Similarity=0.679 Sum_probs=226.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 92 (479)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765544455577889999999998 99999999999999999999
Q ss_pred EeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC--
Q 011694 93 MEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD-- 169 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~-- 169 (479)
|||+.+++|.+.+... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999999999999874 7999999999999999999999999999999999999999999999999998755432211
Q ss_pred ----------------CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC
Q 011694 170 ----------------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF 233 (479)
Q Consensus 170 ----------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 233 (479)
.......++..|+|||++....+ +.++||||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 12233467899999999877665 4799999999999999999999998887777777766677
Q ss_pred CCCCCCCHHHHHHHHHhccCCccccCCh----hhhhcChhh
Q 011694 234 KCPNWFPPEVRKLLCKILDPNPSTRISM----AKIRESSWF 270 (479)
Q Consensus 234 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~eil~h~wf 270 (479)
..|..+++.+.++|.+||+.||.+|||+ ++++.||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 7888889999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=347.14 Aligned_cols=254 Identities=29% Similarity=0.455 Sum_probs=213.2
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999999999999987643322 34567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||+++++|...... +.+++..+..++.|++.||+|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence 99999999887765 469999999999999999999999999999999999999999999999999987543222 223
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------------cC
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-------------------EF 233 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~ 233 (479)
....+++.|+|||++.+....+.++||||+||++|+|++|.+||...+.......+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34568899999999976555568999999999999999999999765543332222110 00
Q ss_pred ------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 234 ------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 234 ------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
..++.++..+.+|+.+||..+|.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=360.24 Aligned_cols=249 Identities=33% Similarity=0.627 Sum_probs=219.7
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
-+.||+|.||+||-|+++++|+.||||+|++.+... ....++++|+.||..+.||.||.+--.|++.+.+|+|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 468999999999999999999999999999987765 3348999999999999999999999999999999999999987
Q ss_pred CChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC---CCeEEeecCchhhhhccccCCCcc
Q 011694 99 GELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN---ENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 99 g~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~---g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
.-|.-.+.. |++++...+.++.||+.||.|||-+||+|+||||||||+.+. -++||||||+|+..... ..-.
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---sFRr 724 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---SFRR 724 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh---hhhh
Confidence 555555543 799999999999999999999999999999999999999754 46999999999876433 3446
Q ss_pred ccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCC--C--CCHHHHHHHHH
Q 011694 174 TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN--W--FPPEVRKLLCK 249 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~~~~~~~li~~ 249 (479)
+.+|||.|+|||++.+++|. ..-|+||.|||+|.-|+|..||..... +-..|.+..+.+|+ | +++++.+||..
T Consensus 725 sVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 78999999999999999997 789999999999999999999986543 44556677776664 3 88999999999
Q ss_pred hccCCccccCChhhhhcChhhhccc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+|+..-.+|.|++..+.|||++...
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhcch
Confidence 9999999999999999999997653
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=354.21 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=230.8
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+-.+.|+..+.||+|+||+||-++.+.||+.+|+|.+++..+.+........+|-.+|.+++.+.||.+-..|++.+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 44577899999999999999999999999999999999887776666667789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 91 FVMEYAKGGELFNKVAK-G--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+||..++||+|.-.|-+ | .++|..++.|+.+|+.||.+||+.+||+|||||+|||||+.|+++|+|+|||.-+...
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g- 340 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG- 340 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC-
Confidence 99999999999877765 3 7999999999999999999999999999999999999999999999999999755322
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh----HHHHHHHhccCcCCCCCCCCHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN----LIEMYRKIGKAEFKCPNWFPPEV 243 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~ 243 (479)
......+||.+|||||++.+..|+ ...|-|||||+||+|+.|..||.... ..++-+.+.......|..+|+++
T Consensus 341 --~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 341 --KPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred --CccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 223445899999999999988876 89999999999999999999997543 23566677777788889999999
Q ss_pred HHHHHHhccCCccccCC-----hhhhhcChhhhcc
Q 011694 244 RKLLCKILDPNPSTRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt-----~~eil~h~wf~~~ 273 (479)
+++.+.+|.+||.+|.. ++++.+||||+..
T Consensus 418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 99999999999999985 5689999999874
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=343.92 Aligned_cols=250 Identities=30% Similarity=0.485 Sum_probs=204.4
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH---hCCCCCcceeEEEEEeCCEEEEEEeccC
Q 011694 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR---IVRHPNIVQLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 97 (479)
.||+|+||.||++.+..+++.||+|.+.+.............+|..+++ ...||||+.+++++..++..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997765433222233344544443 4479999999999999999999999999
Q ss_pred CCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccC
Q 011694 98 GGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC 176 (479)
Q Consensus 98 gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 176 (479)
||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999998875 57999999999999999999999999999999999999999999999999998643221 123457
Q ss_pred CCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh---HHHHHHHhccCcCCCCCCCCHHHHHHHHHhccC
Q 011694 177 GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDP 253 (479)
Q Consensus 177 gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 253 (479)
|++.|+|||.+......+.++||||+||++|+|++|..||.... ...............|..+++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998643333489999999999999999999997532 222222223334556777899999999999999
Q ss_pred CccccC-----ChhhhhcChhhhccc
Q 011694 254 NPSTRI-----SMAKIRESSWFRKGM 274 (479)
Q Consensus 254 dP~~Rp-----t~~eil~h~wf~~~~ 274 (479)
||.+|| |+.++++||||+...
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccCCC
Confidence 999999 699999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.52 Aligned_cols=252 Identities=28% Similarity=0.533 Sum_probs=220.8
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.+++.++|+||+++++++.+.+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999997654433 345677899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 95 YAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 95 ~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 99999999999763 58999999999999999999999999999999999999999999999999987543322 12
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC-CCCCCCHHHHHHHHHh
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-CPNWFPPEVRKLLCKI 250 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~ 250 (479)
.....|++.|+|||.+.+..++ .++||||+|+++|+|++|..||...+..+....+..+... .+..++.++.+++.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456789999999999877654 7999999999999999999999988777766666544333 3455789999999999
Q ss_pred ccCCccccCChhhhhcChhh
Q 011694 251 LDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 251 L~~dP~~Rpt~~eil~h~wf 270 (479)
|.++|.+|||+.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=342.27 Aligned_cols=256 Identities=30% Similarity=0.555 Sum_probs=217.8
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR---HPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 91 (479)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++ ||||+++++++..++..|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58889999999999999999999999999999875432 233467889999999986 9999999999999999999
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 92 VMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||||++|++|.+++..+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SK 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987554322 22
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCC-CCCHHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPN-WFPPEVRKLLCK 249 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~-~~~~~~~~li~~ 249 (479)
.....|++.|+|||.+.+....+.++|+||+||++|+|++|..||...+.......+..... ..+. .++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 23457899999999987654445899999999999999999999988766554443333221 2222 277899999999
Q ss_pred hccCCccccCChhhhhcChhhhccc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
||..||.+|||+.+++.|+||++..
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999999999999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=339.19 Aligned_cols=256 Identities=28% Similarity=0.499 Sum_probs=213.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM--RVGLADQIKREISVMRIVRHPNIVQLYEVMAT--KSKI 89 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 89 (479)
.+|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3689999999999999999999999999999998754322 12345678899999999999999999999875 4678
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc-
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH- 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~- 167 (479)
+++|||+++++|.+.+.. +.+++.....++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999999876 578999999999999999999999999999999999999999999999999986543211
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc--CcCCCCCCCCHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK--AEFKCPNWFPPEVRK 245 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ 245 (479)
.........++..|+|||.+.+..++ .++||||+||++|+|++|+.||...+.......... .....|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 11122335688999999999877665 799999999999999999999987665544443322 233456667889999
Q ss_pred HHHHhccCCccccCChhhhhcChhhh
Q 011694 246 LLCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
++ +||..+|.+|||+++|++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 57778999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=342.29 Aligned_cols=247 Identities=31% Similarity=0.513 Sum_probs=211.7
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 011694 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL 101 (479)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (479)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999875544334445667899999999999999999999999999999999999999
Q ss_pred HHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCC
Q 011694 102 FNKVAK-G--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT 178 (479)
Q Consensus 102 ~~~i~~-~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 178 (479)
.+++.. + .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 998865 3 699999999999999999999999999999999999999999999999999875432 2222345678
Q ss_pred CcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH----HHHHHHhccCcCCCCCCCCHHHHHHHHHhccCC
Q 011694 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL----IEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254 (479)
Q Consensus 179 ~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d 254 (479)
..|+|||++.+..++ .++||||+||++|+|++|+.||..... ......+.......|..+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 899999999877754 899999999999999999999976543 233333344445566678999999999999999
Q ss_pred ccccC-----ChhhhhcChhhhc
Q 011694 255 PSTRI-----SMAKIRESSWFRK 272 (479)
Q Consensus 255 P~~Rp-----t~~eil~h~wf~~ 272 (479)
|.+|| ++.+++.||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=347.85 Aligned_cols=258 Identities=30% Similarity=0.437 Sum_probs=212.3
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK--SKI 89 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 89 (479)
-.++|++.+.||+|+||.||+|.+..+|+.||+|.+....... +....+.+|+.+++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3568999999999999999999999999999999997543322 2234566899999999999999999998755 578
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
|+||||+.+ +|.+.+.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999975 78887765 569999999999999999999999999999999999999999999999999987543221
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC----------------
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---------------- 231 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 231 (479)
.......+++.|+|||++.+....+.++||||+||++|+|++|..||...+....+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 12223346888999999876544458999999999999999999999887766554443210
Q ss_pred ---cCCC-----------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 232 ---EFKC-----------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 232 ---~~~~-----------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+.. ..++++++.+||.+||..||.+|||+.+++.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0111 12357889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=342.20 Aligned_cols=250 Identities=31% Similarity=0.496 Sum_probs=207.2
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHH---HHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 011694 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKRE---ISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~E---i~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 97 (479)
.||+|+||.||+|.+..+++.||+|++.+..............| +.+++...||||+.+++++.+.+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987544322222222333 344555689999999999999999999999999
Q ss_pred CCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccC
Q 011694 98 GGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC 176 (479)
Q Consensus 98 gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 176 (479)
||+|..++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .....+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcC
Confidence 9999988865 57999999999999999999999999999999999999999999999999998644221 223557
Q ss_pred CCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---hHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccC
Q 011694 177 GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS---NLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDP 253 (479)
Q Consensus 177 gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 253 (479)
|++.|+|||++.+....+.++||||+||++|+|++|..||... ................|..+++++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999975433348999999999999999999999876 3333344444445566777899999999999999
Q ss_pred CccccC-----ChhhhhcChhhhccc
Q 011694 254 NPSTRI-----SMAKIRESSWFRKGM 274 (479)
Q Consensus 254 dP~~Rp-----t~~eil~h~wf~~~~ 274 (479)
+|.+|| ++.++++||||+...
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCCC
Confidence 999999 999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=337.31 Aligned_cols=256 Identities=29% Similarity=0.498 Sum_probs=213.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM--RVGLADQIKREISVMRIVRHPNIVQLYEVMAT--KSKI 89 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 89 (479)
.+|++++.||+|+||.||.|.+..+|+.||||.+...... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999999999999999998653321 22345688899999999999999999999876 3578
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|++|||++|++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999999876 5689999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCCCCCCHHHHH
Q 011694 169 -DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCPNWFPPEVRK 245 (479)
Q Consensus 169 -~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~ 245 (479)
........|+..|+|||++.+..++ .++||||+||++|+|++|+.||...+.......+... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 1122345689999999999877664 8999999999999999999999876554444443322 23345567788999
Q ss_pred HHHHhccCCccccCChhhhhcChhhh
Q 011694 246 LLCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
+|.+|+. +|.+|||+++|++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=359.92 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=209.1
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARS-----IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~ 81 (479)
+..+..++|++++.||+|+||.||+|.+ ..++..||||++...... ...+.+.+|+.+++.+ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 3445567899999999999999999974 346778999998654322 3346788999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC-----------------------------------------------------
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAKG----------------------------------------------------- 108 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------------------------------------------- 108 (479)
++.+.+..|+|||||+||+|.+++...
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 999999999999999999999888531
Q ss_pred -----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 109 -----------------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 109 -----------------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 367888999999999999999999999999999999999999999999999875432
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHH-HHHHhccC-cCCCCCCCCHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIE-MYRKIGKA-EFKCPNWFPPE 242 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~~~~ 242 (479)
...........+++.|+|||++.+..++ .++|||||||++|+|++ |..||....... ....+... ....|...+.+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 2221112233456789999999887775 89999999999999998 899998754433 33333322 23345667899
Q ss_pred HHHHHHHhccCCccccCChhhhhcC
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+.+|+.+||+.||.+|||+.+|++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=343.81 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=214.7
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTN-----QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 467999999999999999999986655 679999986543 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC
Q 011694 88 KIFFVMEYAKGGELFNKVAK-----------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE 150 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g 150 (479)
..|++|||+++|+|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999998864 3478889999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhc
Q 011694 151 NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIG 229 (479)
Q Consensus 151 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 229 (479)
.+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998654322222223345678899999999877765 89999999999999998 999999877777776665
Q ss_pred cCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 230 KAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 230 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
... ...|..+|+++.+|+.+||+.||.+|||+.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 443 34566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=335.50 Aligned_cols=251 Identities=32% Similarity=0.527 Sum_probs=215.5
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++.+.||.|+||.||+|.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++.+.+.+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999976532 2457888999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence 999999999998865 579999999999999999999999999999999999999999999999999987544321 1
Q ss_pred CccccCCCCcccChhhhhcC---CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC-----CCCCCCHH
Q 011694 171 LLHTTCGTPAYVAPEVINRK---GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-----CPNWFPPE 242 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~---~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~ 242 (479)
......++..|+|||.+.+. .++ .++|+||+||++|+|++|..||.+.+.......+....+. .+..++.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 22345788999999998765 555 7999999999999999999999877654444433333222 22335788
Q ss_pred HHHHHHHhccCCccccCChhhhhcChh
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSW 269 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~w 269 (479)
+.+++.+||..+|..|||+.+|+.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.16 Aligned_cols=252 Identities=19% Similarity=0.316 Sum_probs=211.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
+-..+|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.+++.++||||+++++++...+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34568999999999999999999875 4567899999976432 233467889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
..|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999999999875 4689999999999999999999999999999999999999999999999998754321
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEV 243 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 243 (479)
.... ......+++.|+|||++.+..++ .++||||+||++|++++ |..||.+.+.......+... ..+.|..+|..+
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd05064 160 EAIY-TTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL 237 (266)
T ss_pred cchh-cccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 1111 11123456789999999887775 89999999999999775 99999887776666665443 345667789999
Q ss_pred HHHHHHhccCCccccCChhhhhc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+++.+||+++|.+|||+++|++
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=334.36 Aligned_cols=251 Identities=33% Similarity=0.571 Sum_probs=218.2
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||+|+||.||+|.+..+++.+|||.+....... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 5999999999999999999999999999999998764433 345788899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-CeEEeecCchhhhhccccCC
Q 011694 95 YAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 95 ~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-~vkl~DFGla~~~~~~~~~~ 170 (479)
|++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 99999999999752 489999999999999999999999999999999999998654 5799999998754322 1
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-CCCCCCCCHHHHHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 249 (479)
......|++.|+|||.+.+..++ .++||||+|+++|+|++|..||...+.......+.... ...+..+++++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 22345689999999999876654 79999999999999999999998877766665554433 34566789999999999
Q ss_pred hccCCccccCChhhhhcChhh
Q 011694 250 ILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf 270 (479)
||..||.+|||+.+++.||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=342.05 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=220.0
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.+.|+..+.||.|+||.||.|.+..++..||||++..... ......+.+|+.+++.+.||||+++++++.+.+..|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4568889999999999999999999999999999875432 23457788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|||++|++|.+++..+++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 999999999999998899999999999999999999999999999999999999999999999999986543221 112
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHHhc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKIL 251 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L 251 (479)
....++..|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+... ....+..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 334688899999999877664 8999999999999999999999877655444443222 22333457789999999999
Q ss_pred cCCccccCChhhhhcChhhhccc
Q 011694 252 DPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 252 ~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..+|.+||++.+++.|+||.+..
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhcc
Confidence 99999999999999999996543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=354.03 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=212.8
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK---- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (479)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 467899999999999999999999999999999999865432 223446677899999999999999999998643
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 --SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
...|+||||+.+ +|.+.+... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 788877654 9999999999999999999999999999999999999999999999999986543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------- 231 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 231 (479)
. ........+++.|+|||.+.+..+. .++|||||||++|+|++|+.||...+....+..+...
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 1123345689999999999888775 8999999999999999999999876543333222110
Q ss_pred ---------cC--------------CC-------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 232 ---------EF--------------KC-------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 232 ---------~~--------------~~-------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
.. .. +...++.+.++|.+||..||.+|||+.+++.||||+.++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 00 00 11235678999999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=356.23 Aligned_cols=246 Identities=24% Similarity=0.391 Sum_probs=199.5
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
..+|++.+.||+|+||.||+|.+..+++.||+|+..... ...|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 457999999999999999999999999999999854332 24689999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 999965 78888764 4699999999999999999999999999999999999999999999999999864321 12
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC-CCCChHH----------HHH---HHhccCcCCCC
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLP-FHDSNLI----------EMY---RKIGKAEFKCP 236 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~P-f~~~~~~----------~~~---~~i~~~~~~~~ 236 (479)
......||+.|+|||++.+..+. .++||||+||++|+|+++..| |...... .+. .........+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 22345799999999999887775 899999999999999985544 4332110 011 11110000011
Q ss_pred ------------------------------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 237 ------------------------------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 237 ------------------------------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667788999999999999999999999999974
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=337.65 Aligned_cols=250 Identities=35% Similarity=0.672 Sum_probs=219.5
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 011694 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL 101 (479)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (479)
||.|+||.||++.+..+|+.|++|++.............+.+|+.+++.++||||+++++.+..++..|++|||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999776554445567889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc------CCCccc
Q 011694 102 FNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ------DGLLHT 174 (479)
Q Consensus 102 ~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~------~~~~~~ 174 (479)
.+++.+ +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999986 6799999999999999999999999999999999999999999999999999875432211 112234
Q ss_pred cCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCC--CHHHHHHHHHhcc
Q 011694 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWF--PPEVRKLLCKILD 252 (479)
Q Consensus 175 ~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~li~~~L~ 252 (479)
..+++.|+|||.+....+ +.++||||||+++|+|++|..||...+....+..+.......|... ++.+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568899999999977665 4899999999999999999999998888777777766666666655 8999999999999
Q ss_pred CCccccCCh---hhhhcChhhhc
Q 011694 253 PNPSTRISM---AKIRESSWFRK 272 (479)
Q Consensus 253 ~dP~~Rpt~---~eil~h~wf~~ 272 (479)
.+|.+|||+ .++++||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=351.88 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=211.5
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK----- 86 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (479)
+.++|++.+.||+|+||.||+|.+..+|+.||||.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4679999999999999999999999999999999986422 223446677899999999999999999987644
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 87 SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
..+|+++||+.+ +|.+.+..+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 358999999975 8888888888999999999999999999999999999999999999999999999999998754322
Q ss_pred cc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhc---------------c
Q 011694 167 HQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG---------------K 230 (479)
Q Consensus 167 ~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~---------------~ 230 (479)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+. .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 21 1122345789999999997654434589999999999999999999997654332221110 0
Q ss_pred C-----------cC-----CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 231 A-----------EF-----KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 231 ~-----------~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
. .. ...+..++++.++|.+||+.||.+|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 00 01123578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=334.22 Aligned_cols=253 Identities=29% Similarity=0.503 Sum_probs=216.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM--RVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
+|+..+.||+|+||+||+|.+..+++.|++|.+...... .......+.+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 588889999999999999999989999999998654321 223457789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 93 MEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
+||+++++|.+++.+ +.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999999999976 458999999999999999999999999999999999999999999999999986543222 2
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc--CcCCCCCCCCHHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK--AEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~ 249 (479)
.....|++.|+|||.+......+.++|+||+||++|+|++|..||...........+.. .....|..+++++.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999987655234899999999999999999999987664444333332 2234566788999999999
Q ss_pred hccCCccccCChhhhhcChhh
Q 011694 250 ILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf 270 (479)
||..+|.+|||+.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.64 Aligned_cols=250 Identities=30% Similarity=0.506 Sum_probs=216.2
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++.+.||+|+||.||+|.+..+++.|++|.+..... .+.+.+|+.+++.++||||+++++++.+....|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3689999999999999999999998999999999865421 57889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
+||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999864 4689999999999999999999999999999999999999999999999999875433221
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc---CcCCCCCCCCHHHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK---AEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~li 247 (479)
......++..|+|||++.+..++ .++||||+||++|+|++|+.||...+.......+.. .....+..++.++.++|
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred ccccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 22344588999999999887765 899999999999999999999987665443333322 22234445778999999
Q ss_pred HHhccCCccccCChhhhhcChhh
Q 011694 248 CKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+||+.||.+|||+.+++.||||
T Consensus 234 ~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=342.15 Aligned_cols=255 Identities=32% Similarity=0.512 Sum_probs=213.7
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++...+..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999876432 2244578899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||++++.+...... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99998777766655 5699999999999999999999999999999999999999999999999999876543322 123
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc----------------C-----
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK----------------A----- 231 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~----------------~----- 231 (479)
....+++.|+|||++.+....+.++||||+|+++|+|++|..||...+.......+.. .
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 4467889999999998773445899999999999999999999986654332221110 0
Q ss_pred c-----------CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 232 E-----------FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 232 ~-----------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
. ...+..+++++.+||++||..+|.+|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01233458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=334.01 Aligned_cols=247 Identities=30% Similarity=0.564 Sum_probs=214.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||+|+||.||++.+..+++.||+|.+...... ...+.+.+|+.+++.++||||+++++.+.+.+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 589999999999999999999999999999998754322 345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 95 YAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 95 ~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|+++++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--cc
Confidence 9999999998864 358999999999999999999999999999999999999999999999999986543221 12
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCCCCCHHHHHHHHHh
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~ 250 (479)
.....|++.|+|||++.+..++ .++|+||+|+++|+|++|..||...+.......+..+.. ..|..++..+.++|.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 2345689999999999877664 899999999999999999999998877666666544433 35566889999999999
Q ss_pred ccCCccccCChhhhhc
Q 011694 251 LDPNPSTRISMAKIRE 266 (479)
Q Consensus 251 L~~dP~~Rpt~~eil~ 266 (479)
|+.||.+|||+.+|+.
T Consensus 236 l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 236 FKRNPRSRPSATTILS 251 (255)
T ss_pred HhCCcccCCCHHHHhh
Confidence 9999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=344.44 Aligned_cols=257 Identities=30% Similarity=0.450 Sum_probs=213.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM--RVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
+|++.+.||+|+||.||+|.+..+|+.||||.+...... .......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765433 123446677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+ +|+|.+++... .+++..+..++.||+.||.|||++||+|+||+|+||+++.+|.++|+|||++....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--R 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--c
Confidence 9999 88999999774 59999999999999999999999999999999999999999999999999987543321 2
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc----------------C-
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE----------------F- 233 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------------~- 233 (479)
......+++.|+|||.+.+....+.++||||+||++|+|++|.+||...+....+..+.... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22334578899999998665444689999999999999999988887765544333321100 0
Q ss_pred -----------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 234 -----------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 234 -----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
......+..+.++|.+||.+||.+|||+.+++.||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 01123467899999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.48 Aligned_cols=252 Identities=28% Similarity=0.452 Sum_probs=209.9
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEE------
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMA------ 84 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~------ 84 (479)
..+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4578999999999999999999999999999999986643 2235678899999988 6999999999985
Q ss_pred eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
..+.+|++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 35679999999999999999875 358999999999999999999999999999999999999999999999999987
Q ss_pred hhhccccCCCccccCCCCcccChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC--C
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINR-----KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF--K 234 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~-----~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~ 234 (479)
..... ........|++.|+|||++.. ..+ +.++|||||||++|+|++|..||...........+..... .
T Consensus 170 ~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 54321 122345678999999999863 334 3789999999999999999999977654433333322211 1
Q ss_pred CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 235 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+..++.++.+||.+||..||.+|||+.+|++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 223478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=342.38 Aligned_cols=252 Identities=30% Similarity=0.482 Sum_probs=209.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||.|+||.||+|++..+|+.||||.+...... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 489999999999999999999999999999998755322 2334578899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 95 YAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 95 ~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|+. ++|.+++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 588888754 46899999999999999999999999999999999999999999999999998654321 122
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC------------------cC
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------------EF 233 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~ 233 (479)
.....+++.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 234467899999999876665568899999999999999999999776543322221100 00
Q ss_pred -----------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 234 -----------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 234 -----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
...+.+++++.++|.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=338.61 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=212.5
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeC---
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATK--- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~--- 86 (479)
-..++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 35789999999999999999999999999999999986542 2235677899999998 799999999998653
Q ss_pred --CEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 87 --SKIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
+..|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 468999999999999988752 4689999999999999999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCC----CCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---c
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY----DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---E 232 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~----~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~ 232 (479)
+........ ......|++.|+|||++..... .+.++||||+||++|+|++|+.||...+.......+... .
T Consensus 175 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd06639 175 SAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252 (291)
T ss_pred chhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 875432211 1234568999999999864321 247999999999999999999999877655444444332 2
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhh
Q 011694 233 FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 233 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
...+..++..+.+||.+||+.||.+||++.+|+.||||+
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 233445678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=346.54 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=219.2
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
..+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 3456666788999999999999999999999999986543 2335678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 92 VMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||||+++++|.+++..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 97 v~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 174 (292)
T cd06658 97 VMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PK 174 (292)
T ss_pred EEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999986543221 22
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc---CcCCCCCCCCHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK---AEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~li~ 248 (479)
.....|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+.......+.. ........++..+.+++.
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred CceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence 2345789999999999877765 799999999999999999999987766554444332 222233347889999999
Q ss_pred HhccCCccccCChhhhhcChhhhccc
Q 011694 249 KILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+||..||.+|||++++++||||+...
T Consensus 254 ~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 254 LMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHccCChhHCcCHHHHhhChhhhccC
Confidence 99999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=347.41 Aligned_cols=264 Identities=31% Similarity=0.561 Sum_probs=237.6
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATK 86 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (479)
...+-..+|..+..||.|+||+|-+|..+.|.+.+|||++.++.+...+-.+--..|-.+|... +-|.++.++.+|.+-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 3467778999999999999999999999999999999999988776554444445677777766 478999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
+.+|+||||+.||+|--.|.. |++.|..+..|+..|+-||-|||++||+.||||..|||||.+|++||+|||++.- .
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--n 500 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--N 500 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--c
Confidence 999999999999999888887 8999999999999999999999999999999999999999999999999999753 2
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRK 245 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (479)
...+....+.||||.|+|||++...+|. ..+|.||+||+|||||+|++||++.+..++++.|......+|..+|.++.+
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVA 579 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHH
Confidence 2234456789999999999999999985 899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCccccCCh-----hhhhcChhhhccc
Q 011694 246 LLCKILDPNPSTRISM-----AKIRESSWFRKGM 274 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~-----~eil~h~wf~~~~ 274 (479)
+++.+|.+.|.+|..+ .+|.+||||+..-
T Consensus 580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred HHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 9999999999999864 6899999998654
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=336.66 Aligned_cols=253 Identities=31% Similarity=0.508 Sum_probs=211.5
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC---
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKS--- 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~--- 87 (479)
..++|++.+.||+|+||.||+|.+..+++.+++|++..... ..+.+.+|+.+++.+ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 35899999999999999999999999999999999876542 346788999999998 6999999999997644
Q ss_pred ---EEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 88 ---KIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 88 ---~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
.+|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999988753 4699999999999999999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCC----CCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---c
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKG----YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---E 232 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~----~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~ 232 (479)
+....... .......|++.|+|||++.... ..+.++|||||||+||+|++|..||...+.......+... .
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 86543221 2223456899999999985422 2247899999999999999999999876554444444333 2
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 233 FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 233 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
...+..++.++.+||.+||..||.+|||+.++++|||+
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 22333467899999999999999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=343.46 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=206.0
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS---- 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (479)
..++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 346799999999999999999999999999999998654322 223345678999999999999999999986543
Q ss_pred ----EEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 88 ----KIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 88 ----~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
..|+||||+.+ +|.+.+... .+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 46999999975 787777653 69999999999999999999999999999999999999999999999999987
Q ss_pred hhhccccC--CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc--C------
Q 011694 162 LAQCKHQD--GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK--A------ 231 (479)
Q Consensus 162 ~~~~~~~~--~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~------ 231 (479)
........ .......++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+.. +
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 55332211 1223446788999999987654345799999999999999999999987654332222111 0
Q ss_pred -----------cCCCC-------------CCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 232 -----------EFKCP-------------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 232 -----------~~~~~-------------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
....| ...++.+.+||.+||..||.+|||++++++||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00011 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=340.82 Aligned_cols=253 Identities=31% Similarity=0.492 Sum_probs=205.7
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 37899999999999999999999999999999998764322 1224466899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+.+ +|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--K 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--c
Confidence 999985 89888865 468999999999999999999999999999999999999999999999999986432211 1
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh-HHHHHHHhcc----C--------------
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKIGK----A-------------- 231 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~----~-------------- 231 (479)
......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+ ..+....+.. .
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12234578899999998765434589999999999999999999997654 2221111100 0
Q ss_pred ---cCC---------CCCCCC--HHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 232 ---EFK---------CPNWFP--PEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 232 ---~~~---------~~~~~~--~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
... ....++ .++.+++.+||.+||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=338.94 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=212.3
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
+.+..++|++.+.||+|+||.||.|.+.. ++..||||++..... ......+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 45678899999999999999999998752 456799999865322 12345678999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCe
Q 011694 84 ATKSKIFFVMEYAKGGELFNKVAKG-----------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENL 152 (479)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~i~~~-----------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~v 152 (479)
...+..++||||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 9999999999999999999998642 24677889999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC
Q 011694 153 KISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA 231 (479)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 231 (479)
+|+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+...
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999998644322211112234567889999999877665 89999999999999998 79999887776666655443
Q ss_pred c-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 232 E-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 232 ~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
. ...+..+++.+.+++.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 34566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=346.66 Aligned_cols=247 Identities=26% Similarity=0.462 Sum_probs=192.6
Q ss_pred EeeeeeecCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCEEEEEE
Q 011694 18 VGRLLGQGAFAKVYYARSIR--TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA--TKSKIFFVM 93 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~ 93 (479)
.+.+||+|+||+||+|.+.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++. ....+|+||
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 35789999999999999754 66889999986543 2245678999999999999999999985 456789999
Q ss_pred eccCCCChHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE----ecCCCeEEeecCc
Q 011694 94 EYAKGGELFNKVAK----------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL----DENENLKISDFGL 159 (479)
Q Consensus 94 E~~~gg~L~~~i~~----------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl----~~~g~vkl~DFGl 159 (479)
||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99975 77777642 248899999999999999999999999999999999999 4567899999999
Q ss_pred hhhhhcccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH---------H----HH
Q 011694 160 SALAQCKHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI---------E----MY 225 (479)
Q Consensus 160 a~~~~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~---------~----~~ 225 (479)
+........ ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... . ..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 975533221 112334578999999999977554568999999999999999999999643210 0 00
Q ss_pred HHhc------------------------cCcC----------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 226 RKIG------------------------KAEF----------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 226 ~~i~------------------------~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
..+. .... ......+..+.+||.+||..||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 0000 0011124568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.97 Aligned_cols=258 Identities=24% Similarity=0.405 Sum_probs=212.8
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKI 89 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 89 (479)
|-+..|++++.||+||.++||++.....+ .||+|.+..... +.....-+.+||.+|.+|+ |.+||.++++-..++.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 44678999999999999999999875444 456665544322 3356788999999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
|+||||-+. +|...+..+ .++.-.++.|..|++.||.++|.+||||.||||.|+|+ ..|.+||+|||+|.......
T Consensus 436 YmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 436 YMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence 999998765 899999874 34545899999999999999999999999999999999 77999999999998776655
Q ss_pred cCCCccccCCCCcccChhhhhcCCCC----------CCccchhhHHHHHHHHHhCCCCCCCCh-HHHHHHHhccCc--CC
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYD----------GEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKIGKAE--FK 234 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~----------~~~~DvwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~--~~ 234 (479)
..-...+.+||+.||+||.+....+. +.++||||||||||+|+.|++||..-. ...-+..|...+ +.
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 55556778999999999999644332 578999999999999999999997643 444455554442 35
Q ss_pred CCCCCCHH-HHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 235 CPNWFPPE-VRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 235 ~~~~~~~~-~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
+|..-+.. +.++++.||..||++|||+.++|+|||...
T Consensus 594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 55543334 999999999999999999999999999865
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=338.39 Aligned_cols=254 Identities=24% Similarity=0.467 Sum_probs=211.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEE----
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMA---- 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~---- 84 (479)
....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 346789999999999999999999999999999999886532 2235678899999998 6999999999873
Q ss_pred -eCCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecC
Q 011694 85 -TKSKIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFG 158 (479)
Q Consensus 85 -~~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFG 158 (479)
.++.+|+||||++|++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 45679999999999999987642 468999999999999999999999999999999999999999999999999
Q ss_pred chhhhhccccCCCccccCCCCcccChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--
Q 011694 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINR-----KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-- 231 (479)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~-----~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-- 231 (479)
++...... ........|++.|+|||++.. ..+ +.++||||+||++|+|++|..||...+.......+...
T Consensus 170 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (286)
T cd06638 170 VSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP 246 (286)
T ss_pred ceeecccC--CCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence 98654321 112234568999999999853 224 47999999999999999999999876654444333222
Q ss_pred -cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 232 -EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 232 -~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
....|..++..+.++|.+||..||.+|||+.+|++|+||
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 222345567899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=343.72 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=218.5
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.+.|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 34577888999999999999999999999999998754322 3456789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|||+++++|.+++..+.+++..+..++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhh
Confidence 999999999999988889999999999999999999999999999999999999999999999999986543221 112
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-CCCCCCCCHHHHHHHHHhc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCKIL 251 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L 251 (479)
....|+..|+|||.+.+..++ .++||||+||++|+|++|..||...........+.... ...+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 234688999999999877765 79999999999999999999998665544443333222 2233447889999999999
Q ss_pred cCCccccCChhhhhcChhhhccc
Q 011694 252 DPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 252 ~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..+|.+|||+.+++.||||....
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHHh
Confidence 99999999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=337.45 Aligned_cols=255 Identities=27% Similarity=0.479 Sum_probs=219.7
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
+-|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++..++..|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 4578889999999999999999999999999998654322 33467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcc
Q 011694 94 EYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 94 E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
||+++++|.+++..+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06641 82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhc
Confidence 99999999999988889999999999999999999999999999999999999999999999999986443221 1123
Q ss_pred ccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHHhcc
Q 011694 174 TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~ 252 (479)
...++..|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+... ....+..++.++.+++.+||.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 45688999999999776664 7999999999999999999999876655555444333 223455688999999999999
Q ss_pred CCccccCChhhhhcChhhhcc
Q 011694 253 PNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 253 ~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+|.+||++.+++.||||.+.
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred CChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.78 Aligned_cols=253 Identities=28% Similarity=0.461 Sum_probs=216.6
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++.+...+..|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 4688999999999999999999999999999999765422 34567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
||+.+++|.+++.. ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 99999999999975 578999999999999999999999 9999999999999999999999999999875532221
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-----hHHHHHHHhccC-cCCCCCC-CCHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS-----NLIEMYRKIGKA-EFKCPNW-FPPEV 243 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~-~~~~~~~-~~~~~ 243 (479)
....+++.|+|||.+.+..++ .++||||+|+++|+|++|..||... ........+... ....+.. +++++
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred --hcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 126788999999999887765 8999999999999999999999764 223333333222 2233333 78899
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.++|.+||..||.+|||+.+++.||||++.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=332.61 Aligned_cols=252 Identities=33% Similarity=0.602 Sum_probs=218.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA--TKSKIFFV 92 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV 92 (479)
+|++.+.||.|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++.+. .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 5899999999999999999999999999999997654432 34567889999999999999999999875 34678999
Q ss_pred EeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-----HCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 93 MEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCH-----SRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH-----~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
|||+++++|.+++.. +.+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998864 46899999999999999999999 99999999999999999999999999999876
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCCCCCH
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPP 241 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~ 241 (479)
..... .......+++.|+|||++.+..++ .++|+||||+++|+|++|..||...+.......+..... ..+..++.
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 54322 113345789999999999877664 899999999999999999999998876666666655443 35556889
Q ss_pred HHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+.+++.+||..+|.+|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=331.55 Aligned_cols=255 Identities=31% Similarity=0.577 Sum_probs=215.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|.+.+.||+|+||.||.|.+..+++.||+|.+...... ......+.+|+.+++.++|+||++++++..+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999766433 3456789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC-C-
Q 011694 95 YAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG-L- 171 (479)
Q Consensus 95 ~~~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~-~- 171 (479)
|+++++|.+.+..+ .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999874 58999999999999999999999999999999999999999999999999987654322211 1
Q ss_pred ccccCCCCcccChhhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCChH-HHHHHHhc-cCcCCCCCCC--CHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKG--YDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-IEMYRKIG-KAEFKCPNWF--PPEVRK 245 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~--~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~-~~~~~~~~~~--~~~~~~ 245 (479)
.....+++.|+|||++.+.. ..+.++||||+|+++|++++|..||...+. ......+. ......|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999997654 134899999999999999999999976532 22222222 2233445544 899999
Q ss_pred HHHHhccCCccccCChhhhhcChhh
Q 011694 246 LLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
+|.+||+.+|.+|||+++++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=333.94 Aligned_cols=246 Identities=33% Similarity=0.601 Sum_probs=207.4
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV-MRIVRHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..+ ....+||||+++++++...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999976543322223334455444 4455899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 99 GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 99 g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++..... .....+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999999976 5799999999999999999999999999999999999999999999999998764321 234568
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC----CCCCCCHHHHHHHHHhccC
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK----CPNWFPPEVRKLLCKILDP 253 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~L~~ 253 (479)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+...... .+..+++++.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999987765 48999999999999999999999988777766666444332 2234789999999999999
Q ss_pred CccccCC---hhhhhcChhhhc
Q 011694 254 NPSTRIS---MAKIRESSWFRK 272 (479)
Q Consensus 254 dP~~Rpt---~~eil~h~wf~~ 272 (479)
||++||| ++|++.||||++
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 9999995 479999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=338.76 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=214.5
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
|++..++|++.+.||+|+||.||+|.++. .+..||+|.+...... .....+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 45677899999999999999999997653 3457999998654322 2234577899999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCe
Q 011694 84 ATKSKIFFVMEYAKGGELFNKVAK-----------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENL 152 (479)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~v 152 (479)
.+.+..|+||||+.+|+|.+++.. ..++...+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 999999999999999999999864 124567889999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC
Q 011694 153 KISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA 231 (479)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 231 (479)
+|+|||+++...............++..|+|||.+.+..++ .++||||+||++|+|++ |..||.+.+..+....+...
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999998744322211112233457789999999877665 89999999999999998 89999887776666655443
Q ss_pred -cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc------Chhhhc
Q 011694 232 -EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE------SSWFRK 272 (479)
Q Consensus 232 -~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~------h~wf~~ 272 (479)
....+..+++.+.+++.+||+.||.+|||+.++++ ||||+.
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 33455667899999999999999999999999986 788753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=347.63 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=214.1
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS---- 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (479)
+.++|++.+.||+|+||.||+|.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 67889999999999999999999999999999999865422 2234467889999999999999999999987654
Q ss_pred --EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 --KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 --~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.+++||||+ |++|.+.+....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 469999999 77999998888899999999999999999999999999999999999999999999999999864322
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC------------
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF------------ 233 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------ 233 (479)
......+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+....+..+.....
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 171 -----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred -----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 123346789999999997644446899999999999999999999987654433333211100
Q ss_pred -------------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 234 -------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 234 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
...+.+++.+.++|.+||..||.+|||+.+++.||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11235678899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=358.02 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=219.2
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
.|.=++.||+|+||.||.|++..+.+.||||.+........+-...|..|+..|++++|||+|.+.++|-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 45667899999999999999999999999999987765555556789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 95 YAKGGELFNKVA--KGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 95 ~~~gg~L~~~i~--~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||-| +-.|++. +.++.|.++..|..+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.... ..
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PA 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------PA 179 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------ch
Confidence 9976 6667765 3579999999999999999999999999999999999999999999999999887643 34
Q ss_pred cccCCCCcccChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-CCCC-CCCCHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVIN---RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-FKCP-NWFPPEVRKLL 247 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~---~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~-~~~~~~~~~li 247 (479)
.+.+|||+||||||+. ...|+ -++||||||++..+|.-.++|+...+....+..|..++ ...+ +..|..+.+|+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 5789999999999985 34566 69999999999999999999999988776555554333 2222 22578999999
Q ss_pred HHhccCCccccCChhhhhcChhhhcccc
Q 011694 248 CKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
..||++-|.+|||.++++.|+|......
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 9999999999999999999999876543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=343.17 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=220.4
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
+-|.++.+||+|+||.||+|.++.+|+.+|||.+..+. -..++..||.+|.+++.|+||++|+.|.....+||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 34678899999999999999999999999999987653 3467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|||..|++.|.++. ..++|+++..+++.-+.||.|||...-+|||||..|||++.+|..||+|||.|......- ..
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AK 185 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AK 185 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--Hh
Confidence 99999999999875 579999999999999999999999999999999999999999999999999986543221 12
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cCCCCCCCCHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~ 248 (479)
.++..|||.|||||++..-+|+ .++||||||++..+|..|++||.+-.+....-.|... .+.-|...|.++.+|++
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred hCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence 3578899999999999999998 7999999999999999999999876654333233221 22334446788999999
Q ss_pred HhccCCccccCChhhhhcChhhhcccc
Q 011694 249 KILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
.||-++|++|-|+-++++|||.+....
T Consensus 265 ~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred HHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 999999999999999999999987543
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=336.87 Aligned_cols=254 Identities=29% Similarity=0.500 Sum_probs=218.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
.|.-.+.||+|++|.||++.+..+++.+++|.++.... ...+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 45666899999999999999999999999999865432 234568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccc
Q 011694 95 YAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHT 174 (479)
Q Consensus 95 ~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~ 174 (479)
|++|++|.+.+..+++++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++....... .....
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~ 174 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKS 174 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccccc
Confidence 9999999999988889999999999999999999999999999999999999999999999999876443221 12234
Q ss_pred cCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC---CCCCCCCHHHHHHHHHhc
Q 011694 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF---KCPNWFPPEVRKLLCKIL 251 (479)
Q Consensus 175 ~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~L 251 (479)
..|++.|+|||.+.+..++ .++||||+||++|+|++|..||...+.......+..... ..+..+++.+.+++.+||
T Consensus 175 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 5689999999999877765 899999999999999999999988776666655544322 223337899999999999
Q ss_pred cCCccccCChhhhhcChhhhccc
Q 011694 252 DPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 252 ~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..+|.+|||+.++++||||++..
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ccChhhCcCHHHHccCcccccCC
Confidence 99999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=342.54 Aligned_cols=254 Identities=28% Similarity=0.506 Sum_probs=217.7
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
.|+....||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..|++||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 35556789999999999999999999999999965432 234668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccc
Q 011694 95 YAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHT 174 (479)
Q Consensus 95 ~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~ 174 (479)
|+++++|...+....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... .....
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~ 176 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKS 176 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccc
Confidence 9999999998888889999999999999999999999999999999999999999999999999986443221 12234
Q ss_pred cCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc---CCCCCCCCHHHHHHHHHhc
Q 011694 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPPEVRKLLCKIL 251 (479)
Q Consensus 175 ~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~L 251 (479)
.+|++.|+|||++.+..+. .++||||+||++|+|++|+.||...+.......+.... ...+..+++.+.++|.+||
T Consensus 177 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred eecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 6789999999999877764 89999999999999999999998776655555443322 2233457889999999999
Q ss_pred cCCccccCChhhhhcChhhhccc
Q 011694 252 DPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 252 ~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..+|.+||+++++++||||.+..
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred cCCcccCcCHHHHhhChhhccCC
Confidence 99999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=338.60 Aligned_cols=254 Identities=30% Similarity=0.442 Sum_probs=206.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCE----
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSK---- 88 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 88 (479)
++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 4799999999999999999999999999999998765322 233467788999999995 6999999999987665
Q ss_pred -EEEEEeccCCCChHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-CCCeEEeecCch
Q 011694 89 -IFFVMEYAKGGELFNKVAK------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-NENLKISDFGLS 160 (479)
Q Consensus 89 -~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-~g~vkl~DFGla 160 (479)
+|+||||+++ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 78887753 24799999999999999999999999999999999999998 899999999998
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC----c----
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA----E---- 232 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----~---- 232 (479)
...... ........+++.|+|||++.+....+.++||||+|+++|+|++|..||.+.+.......+... .
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 643221 112233467889999999876444458999999999999999999999876554433322110 0
Q ss_pred -----------C---------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhh
Q 011694 233 -----------F---------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 233 -----------~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
+ ...+.+++++.+||.+||.+||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 00123678899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=341.43 Aligned_cols=256 Identities=32% Similarity=0.511 Sum_probs=218.6
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 5799999999999999999999998999999999865432 2346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
+||+++++|.+++.+..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~~ 172 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 172 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--ccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999876443221 122
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc---CcCCCCCCCCHHHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK---AEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~li~~ 249 (479)
....|++.|+|||.+.+..++ .++|+||+||++|++++|..||...+.......+.. ..+..+..++..+.++|.+
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 345688999999999877664 799999999999999999999987655433322221 1222334467899999999
Q ss_pred hccCCccccCChhhhhcChhhhccc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
||..+|.+||++.+++.|+||+...
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=336.23 Aligned_cols=248 Identities=31% Similarity=0.520 Sum_probs=203.9
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeC--CEEEEE
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATK--SKIFFV 92 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lV 92 (479)
|++.+.||+|+||.||+|.+..+++.||+|.+....... .. ....+|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999999999999987543221 12 23347888888885 99999999999987 889999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+.+ +|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++. +.+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---P 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---C
Confidence 999975 78777765 46899999999999999999999999999999999999999 99999999998754322 1
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc------------------Cc
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK------------------AE 232 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------~~ 232 (479)
......+++.|+|||++....+.+.++||||+||++|+|++|..||.+.+..+....+.. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 223456889999999886655556899999999999999999999987765443333211 01
Q ss_pred CCCC-----------CCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 233 FKCP-----------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 233 ~~~~-----------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
+..| +.+|.++.++|.+||.+||.+|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=332.26 Aligned_cols=251 Identities=26% Similarity=0.445 Sum_probs=214.6
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+...+|.+.+.||+|+||.||+|.+..+++.||+|++..+. .....+.+|+.+++.++||||+++++++...+.+
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 345667999999999999999999999999999999986542 2245678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 90 FFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
+++|||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999999999865 25899999999999999999999999999999999999999999999999998754322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 244 (479)
... ......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+....+..+... ....|..+|+++.
T Consensus 158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (263)
T cd05052 158 TYT-AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVY 235 (263)
T ss_pred eee-ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 111 11122346689999999877765 79999999999999998 99999887777766666543 4456677899999
Q ss_pred HHHHHhccCCccccCChhhhhc
Q 011694 245 KLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.+||..||.+|||+.++++
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=332.53 Aligned_cols=251 Identities=28% Similarity=0.559 Sum_probs=211.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++.+.+..|++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999987654444455567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 94 EYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 94 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
||+++|+|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 99999999988752 348999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh--HHHHHHHhccCcCC-C-CCCCCHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN--LIEMYRKIGKAEFK-C-PNWFPPEVR 244 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~~-~-~~~~~~~~~ 244 (479)
.......|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.... .......+.....+ . +..++..+.
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 161 -TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred -HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 122345688999999999877765 79999999999999999999996543 23444444332221 1 234778999
Q ss_pred HHHHHhccCCccccCChhhhhcC
Q 011694 245 KLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h 267 (479)
++|.+||..+|.+|||+.++++.
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=336.66 Aligned_cols=251 Identities=32% Similarity=0.518 Sum_probs=209.8
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||.|++|.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999999765322 234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 95 YAKGGELFNKVAK----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 95 ~~~gg~L~~~i~~----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|+++ +|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++....... .
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--N 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--c
Confidence 9986 88887764 358999999999999999999999999999999999999999999999999986543221 1
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------------
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------------- 231 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 231 (479)
......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 2234567899999999876555568999999999999999999999877654443332110
Q ss_pred -cC---------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 232 -EF---------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 232 -~~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+ ...+.+++.+.++|.+||+.||.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 0112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=337.78 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=212.4
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.++|.+.+.||+|+||.||+|.+.. +++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998753 467899999865432 224578899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCe
Q 011694 88 KIFFVMEYAKGGELFNKVAK---------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENL 152 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~v 152 (479)
..|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999999864 237889999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC
Q 011694 153 KISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA 231 (479)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 231 (479)
||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999998643222211222344567899999999887775 79999999999999998 99999887777666666554
Q ss_pred cC-CCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 232 EF-KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 232 ~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.. ..+..++..+.+++.+||..||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 44 334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=341.09 Aligned_cols=253 Identities=30% Similarity=0.425 Sum_probs=210.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK--SKIFF 91 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~l 91 (479)
++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... +..|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 5799999999999999999999999999999999765433 23445667899999999999999999999877 89999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 92 VMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
||||+.+ +|.+.+.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-- 160 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--
Confidence 9999985 89888865 358999999999999999999999999999999999999999999999999987543321
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC------------------
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------------ 231 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 231 (479)
.......+++.|+|||.+.+....+.++|+||+|+++|+|++|..||...+......++...
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 22234567899999999876654458999999999999999999999876654443332110
Q ss_pred -------------cCCCCCC-CCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 232 -------------EFKCPNW-FPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 232 -------------~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
...++.. +++.+.++|.+||..||++|||+.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112222 57889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=330.51 Aligned_cols=252 Identities=31% Similarity=0.587 Sum_probs=216.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|.+.+.||+|+||.||++.+..+|..||+|.+....... ...+.+.+|+.+++.++||||+++++.+...+..|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5899999999999999999999999999999997754322 234677899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC-eEEeecCchhhhhccccCC
Q 011694 95 YAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN-LKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 95 ~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~-vkl~DFGla~~~~~~~~~~ 170 (479)
|+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++. +||+|||.+...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence 99999999998752 4899999999999999999999999999999999999998764 699999998755322 11
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCCCCCHHHHHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEVRKLLCK 249 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 249 (479)
......|++.|+|||++.+..+. .++|+||+||++|+|++|..||...+.......+..... ..++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 22344689999999999777665 899999999999999999999988776665555544332 3445578999999999
Q ss_pred hccCCccccCChhhhhcChhh
Q 011694 250 ILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf 270 (479)
||..+|++|||+.+++.||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=334.00 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=214.2
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRT-----NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
++..++|++.+.||+|+||.||+|.+... +..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 46678999999999999999999988654 47899999865432 123456789999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeE
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-----------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLK 153 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vk 153 (479)
.....|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 99999999999999999999864 1367889999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-
Q 011694 154 ISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA- 231 (479)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~- 231 (479)
|+|||++................++..|+|||.+.+..++ .++|||||||++|++++ |..||...+.......+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 9999998754432222223345578899999999776664 89999999999999998 99999887766666655533
Q ss_pred cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 232 EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 232 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
....|..++..+.+++.+||..+|.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 34567778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.82 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=215.9
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.....+|.+.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 44567899999999999999999999999999999999765444444556788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
|+||||+.| +|.+.+.. +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 999999975 67666653 5799999999999999999999999999999999999999999999999998864321
Q ss_pred cCCCccccCCCCcccChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-CC-CCCCCCHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINR--KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-FK-CPNWFPPEV 243 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~--~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~-~~~~~~~~~ 243 (479)
.....+++.|+|||++.+ ....+.++||||+|+++|+|++|..||...+.......+.... .. .+..++..+
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 234568899999999842 2223479999999999999999999998876655444433221 11 123367899
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.++|.+||..||.+|||+.+|+.||||....
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 9999999999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=308.55 Aligned_cols=255 Identities=30% Similarity=0.517 Sum_probs=215.8
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|.-.++||+|+||+||+|++..+++.||+|.+..+.. +++......+||.+++.++|.|||+++++..++.++.+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 56667899999999999999999999999999987643 33556677899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 95 YAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 95 ~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||+. +|..+... |.++.+.++.++.|++.||.|||++++.||||||.|+||+.+|.+|++|||+|+.+.... .-.
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rcy 158 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCY 158 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Eee
Confidence 9976 78888775 789999999999999999999999999999999999999999999999999998654332 123
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc----C---cC----CCCC---
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK----A---EF----KCPN--- 237 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~----~---~~----~~~~--- 237 (479)
+..+.|.+|.+|.++.+...++...|+||.|||+.|+.. |.+.|++.+......+|.. . .. ..|.
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 455689999999999887776789999999999999985 8888999887766665521 1 00 0111
Q ss_pred ---------------CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 238 ---------------WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 238 ---------------~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.++..-++|+.++|..+|..|++++.+++||||...
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 122345799999999999999999999999999653
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.57 Aligned_cols=252 Identities=37% Similarity=0.629 Sum_probs=221.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999999999999999765432 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 95 YAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 95 ~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
|+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999998875 569999999999999999999999999999999999999999999999999987654332
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-CCCCCCCCHHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLC 248 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~ 248 (479)
......+|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+............ ...|..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 233456789999999998877765 79999999999999999999998887666666554433 3445568899999999
Q ss_pred HhccCCccccCChhhhhcChhh
Q 011694 249 KILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf 270 (479)
+||..+|.+|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=347.83 Aligned_cols=258 Identities=29% Similarity=0.439 Sum_probs=210.2
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK----- 86 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (479)
+..+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 45899999999999999999999999999999999866543 3346788999999999999999999876544
Q ss_pred ---------CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-CCCeEEee
Q 011694 87 ---------SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-NENLKISD 156 (479)
Q Consensus 87 ---------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-~g~vkl~D 156 (479)
...|+||||+++ +|.+.+..+.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 358999999974 8999888888999999999999999999999999999999999999974 56789999
Q ss_pred cCchhhhhcccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC----
Q 011694 157 FGLSALAQCKHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---- 231 (479)
Q Consensus 157 FGla~~~~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---- 231 (479)
||++........ .+......+++.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999865432211 112233468899999998865444458999999999999999999999876543333222110
Q ss_pred ---------------------cC-----CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 232 ---------------------EF-----KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 232 ---------------------~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.. ...+.++.++.+||.+||..||.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 0123467889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=348.77 Aligned_cols=258 Identities=28% Similarity=0.416 Sum_probs=215.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE--
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK-- 88 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 88 (479)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 467789999999999999999999999999999999865422 22344667789999999999999999998866554
Q ss_pred ----EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 89 ----IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 89 ----~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
.|+|+||+ |++|.+++...++++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 5699999988889999999999999999999999999999999999999999999999999987542
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-----------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF----------- 233 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 233 (479)
. ......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+....-
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred c-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 2 134457889999999987644446899999999999999999999987765544443321100
Q ss_pred --------------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 234 --------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 234 --------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
.....+++.+.++|.+||..||.+|||+.+|+.||||.+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 011235789999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=333.41 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=211.5
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQ----SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT-KSK 88 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~-~~~ 88 (479)
..|++...||+|+||.||+|..+.++. .+|||.+...+.. .+......|||.+++.++||||+.+..+|-+ +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 579999999999999999997655433 6899999766432 3556677899999999999999999999977 788
Q ss_pred EEEEEeccCCCChHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC----CCeEEeecC
Q 011694 89 IFFVMEYAKGGELFNKVAK------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN----ENLKISDFG 158 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~----g~vkl~DFG 158 (479)
+++++||++. +|...|.- ..++...++.+++||+.|+.|||++=|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999988 88888863 358999999999999999999999999999999999999876 899999999
Q ss_pred chhhhhccccCC-CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH-------------HHH
Q 011694 159 LSALAQCKHQDG-LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-------------IEM 224 (479)
Q Consensus 159 la~~~~~~~~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~-------------~~~ 224 (479)
+|+.+...-..- .....+.|.+|.|||.+.+...++.+.|||+.|||+.|||+-.+.|.+... ..+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 999887554322 334567899999999999988888999999999999999998888864321 111
Q ss_pred HHHhccCc-------CCCCCC--------------------------CCHHHHHHHHHhccCCccccCChhhhhcChhhh
Q 011694 225 YRKIGKAE-------FKCPNW--------------------------FPPEVRKLLCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 225 ~~~i~~~~-------~~~~~~--------------------------~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
+.-++... ...|.+ -++...+|+.+||+.||.+|+|++++++|+||.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 11111110 011111 245688999999999999999999999999998
Q ss_pred cccc
Q 011694 272 KGMN 275 (479)
Q Consensus 272 ~~~~ 275 (479)
....
T Consensus 342 ~d~l 345 (438)
T KOG0666|consen 342 EDPL 345 (438)
T ss_pred cCCC
Confidence 7643
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=331.44 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=212.6
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRT---NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.++|++.+.||+|+||.||+|.+..+ ...||||++.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 36799999999999999999998654 4579999986543 223446778899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+++|||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999875 469999999999999999999999999999999999999999999999999998654211
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRK 245 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 245 (479)
.........+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...........+... ..+.+..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11111223456789999999877765 89999999999999998 99999877766666665443 33456668999999
Q ss_pred HHHHhccCCccccCChhhhhcC
Q 011694 246 LLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h 267 (479)
++.+||+.+|.+||++.+|+++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=341.70 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=205.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIR--TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK--SKIF 90 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 90 (479)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999999875433334456778999999999999999999999988 8899
Q ss_pred EEEeccCCCChHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec----CCCeEEeecCch
Q 011694 91 FVMEYAKGGELFNKVAK------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE----NENLKISDFGLS 160 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~----~g~vkl~DFGla 160 (479)
+||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999976 66666542 26899999999999999999999999999999999999998 899999999998
Q ss_pred hhhhcccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHH---------HHHHh--
Q 011694 161 ALAQCKHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE---------MYRKI-- 228 (479)
Q Consensus 161 ~~~~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~---------~~~~i-- 228 (479)
........ .......++++.|+|||++.+....+.++|||||||++|+|++|..||.+.+... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76533222 1122345789999999998765444589999999999999999999997543211 00000
Q ss_pred ------------------------ccCcCCCC-----------CCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 229 ------------------------GKAEFKCP-----------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 229 ------------------------~~~~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.......+ ...+..+.+++.+||..||.+|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000111 1356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.20 Aligned_cols=252 Identities=30% Similarity=0.438 Sum_probs=203.8
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|.+.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++|+||+++++++.++...|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 6899999999999999999999999999999999654322 22345678999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+. ++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QT 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--CC
Confidence 9996 577666643 468899999999999999999999999999999999999999999999999986432221 12
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-HHHHHhcc---------------C----
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI-EMYRKIGK---------------A---- 231 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~---------------~---- 231 (479)
.....+++.|+|||.+.+....+.++||||+||++|+|++|..||...+.. +....+.. .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 234567999999999876543347899999999999999999999765431 11111100 0
Q ss_pred -c---CCCCC---------CCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 232 -E---FKCPN---------WFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 232 -~---~~~~~---------~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
. ...+. ..++++.+++.+||..||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00000 125688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=337.22 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=215.5
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
..+|++.+.||+|+||+||++.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 367999999999999999999999999999999986543 224457889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+++++|.+++.. +.+++..+..++.+++.||.|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---- 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----
Confidence 999999999998876 579999999999999999999997 69999999999999999999999999997643221
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-----------HHHHHhccCc-CCCCCC
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI-----------EMYRKIGKAE-FKCPNW 238 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~-----------~~~~~i~~~~-~~~~~~ 238 (479)
.....+|+..|+|||++.+..++ .++||||+||++|+|++|..||...... .....+.... ...+..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred ccCccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 12345789999999999776664 7999999999999999999999864431 2223332221 222222
Q ss_pred -CCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 239 -FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 239 -~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
++.++.+|+.+||.+||.+|||+.++++|+||.+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 778999999999999999999999999999996644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=359.31 Aligned_cols=258 Identities=28% Similarity=0.475 Sum_probs=219.6
Q ss_pred ccCCCeEEe-----eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 11 VLTEKYEVG-----RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 11 il~~~y~i~-----~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
.+.-.|+.. -.||+|+||+||.|++..|....|||-+.... .....-+..||.+++.++|.|||+++|.+..
T Consensus 567 ~iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se 643 (1226)
T KOG4279|consen 567 KIEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSE 643 (1226)
T ss_pred ceEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCC
Confidence 344455543 36999999999999999999999999986543 2345778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe-cCCCeEEeecCch
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK--GKL--KEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD-ENENLKISDFGLS 160 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~--~~l--~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~-~~g~vkl~DFGla 160 (479)
++.+-|.||-++||+|.++++. |++ .|..+-.|.+||++||.|||++.|+|||||-+|+|++ -.|.+||+|||.+
T Consensus 644 nGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 644 NGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred CCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccc
Confidence 9999999999999999999987 777 8889999999999999999999999999999999997 5799999999988
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCChH--HHHHHH-hccCcCCCC
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKG-YDGEKVDIWSCGVVLFVLLAGYLPFHDSNL--IEMYRK-IGKAEFKCP 236 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~--~~~~~~-i~~~~~~~~ 236 (479)
.... +-.....+..||..|||||++...+ -+|.++|||||||++.||.||++||..... ..+++. +.+...+.|
T Consensus 724 KRLA--ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 724 KRLA--GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP 801 (1226)
T ss_pred hhhc--cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc
Confidence 6543 3344556788999999999996432 236899999999999999999999975432 233332 234456778
Q ss_pred CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 237 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..++.++++||.+|+.+||.+||++.++|.+||++..
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 8889999999999999999999999999999999866
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=347.09 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=212.1
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE----eCC
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA----TKS 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~----~~~ 87 (479)
+..+|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 45789999999999999999999999999999999976432 2234567788999999999999999999875 345
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.+|+||||+. ++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 7899999996 588888865 56999999999999999999999999999999999999999999999999998654322
Q ss_pred cc--CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc--------------
Q 011694 167 HQ--DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK-------------- 230 (479)
Q Consensus 167 ~~--~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 230 (479)
.. .......+|+..|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 11 11223457899999999987644445899999999999999999999987654322211100
Q ss_pred ----------Cc--CC-----CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 231 ----------AE--FK-----CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 231 ----------~~--~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.. .. ..+.+++++.++|.+||+.+|.+|||+++++.||||.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00 00 0133688999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.45 Aligned_cols=254 Identities=27% Similarity=0.464 Sum_probs=205.0
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV-MRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
++|++.+.||+|+||.||+|.+..+|+.||||.+....... ....+..|+.+ ++.++||||+++++++..++.+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999997653222 12344456554 6777899999999999999999999
Q ss_pred EeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 93 MEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
|||++| +|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999974 77666643 3689999999999999999999998 9999999999999999999999999998754221
Q ss_pred ccCCCccccCCCCcccChhhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCh-HHHHHHHh-ccCcCCCC-CCC
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINR----KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKI-GKAEFKCP-NWF 239 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~----~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i-~~~~~~~~-~~~ 239 (479)
.......|+..|+|||++.+ .++ +.++|+||+||++|+|++|..||.... ..+....+ .......| ..+
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred ---cccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 11223568899999999864 233 478999999999999999999997532 22222222 22223333 347
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
|.++.++|.+||..+|.+|||+.++++||||.+..
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 89999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=325.48 Aligned_cols=254 Identities=30% Similarity=0.523 Sum_probs=218.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK--SKIFFV 92 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV 92 (479)
+|.+.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... +.++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999999999999999766432 23457889999999999999999999999988 899999
Q ss_pred EeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 93 MEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
+||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9999999999999874 799999999999999999999999999999999999999999999999999876544332112
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh-HHHHHHHhc--cCcCCCCCCCCHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKIG--KAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~--~~~~~~~~~~~~~~~~li~ 248 (479)
.....++..|+|||.+.+..+ +.++||||+|+++|+|++|..||...+ .......+. ......|..++..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999977665 489999999999999999999998765 223333332 2334556667899999999
Q ss_pred HhccCCccccCChhhhhcChhh
Q 011694 249 KILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf 270 (479)
+||..||.+||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=341.94 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=209.4
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQS----VAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
..+|++.+.||+|+||.||+|.+..+++. ||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 46899999999999999999998766664 8999986432 223456788999999999999999999998765 5
Q ss_pred EEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 89 IFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.++++||+.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 78999999999999999763 5899999999999999999999999999999999999999999999999999765432
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc-CcCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK-AEFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~ 244 (479)
..........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+....+....+.. ...+.|..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 221112223456789999999887775 89999999999999997 9999988765554443332 23455677899999
Q ss_pred HHHHHhccCCccccCChhhhhcC
Q 011694 245 KLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+++.+||..||.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.39 Aligned_cols=256 Identities=29% Similarity=0.482 Sum_probs=209.2
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|++|.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999998665322 234467789999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-CCCeEEeecCchhhhhccccC
Q 011694 94 EYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-NENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 94 E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-~g~vkl~DFGla~~~~~~~~~ 169 (479)
||+++ +|.+.+... .+++..+..++.||+.||.|||++|++||||+|+||+++. ++.+||+|||++...... .
T Consensus 81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~ 157 (294)
T PLN00009 81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--V 157 (294)
T ss_pred ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--c
Confidence 99965 787777542 3688899999999999999999999999999999999985 557999999998643221 1
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc----C--------------
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK----A-------------- 231 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~----~-------------- 231 (479)
.......+++.|+|||.+.+....+.++||||+||++|+|++|..||...+..+...++.. .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 1223446789999999987654445899999999999999999999987655433332211 0
Q ss_pred -----cCC------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 232 -----EFK------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 232 -----~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
... ..+.+++++.+++.+||+.+|.+||++.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 000 123467889999999999999999999999999999754
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=328.38 Aligned_cols=255 Identities=31% Similarity=0.532 Sum_probs=219.5
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
.+|++.+.||+|++|.||+|.+..+++.|+||.+...... .....+.+|+..+..++||||+++++++...+..|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999999765432 34577889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+++++|.+++.. +.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++........ .
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--Q 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC--c
Confidence 99999999999976 689999999999999999999999 9999999999999999999999999999875432221 1
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh---HHHHHHHhccC-cCCCCCC-CCHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKIGKA-EFKCPNW-FPPEVRKL 246 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~-~~~~~~~-~~~~~~~l 246 (479)
.....++..|+|||.+....+ +.++|+||||+++|+|++|..||...+ .......+... ....+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 234568899999999977755 489999999999999999999997763 34444444332 2334444 78999999
Q ss_pred HHHhccCCccccCChhhhhcChhhhcc
Q 011694 247 LCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 247 i~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
|.+||.++|..|||+.++++||||+..
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=334.40 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=211.3
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
+-.++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 445789999999999999999999987 778899998865432 2234567889999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC---CeEE
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKG--------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE---NLKI 154 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g---~vkl 154 (479)
.+..|+||||+.|++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999999998652 488999999999999999999999999999999999998765 5999
Q ss_pred eecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc-Cc
Q 011694 155 SDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK-AE 232 (479)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~ 232 (479)
+|||++.................++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+.. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999998754222111111222345689999999877765 89999999999999997 9999988776665555533 34
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 233 FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 233 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
...|..+|..+.+++.+||..+|++|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 45567789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=329.39 Aligned_cols=244 Identities=26% Similarity=0.460 Sum_probs=203.4
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGG 99 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (479)
+.||+|+||.||+|.+..+++.||+|.+.... ..+....+.+|+.+++.++||||+++++++...+..|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999886432 2344567889999999999999999999999999999999999999
Q ss_pred ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 100 ELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 100 ~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999865 3589999999999999999999999999999999999999999999999999864322111111111123
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc-CcCCCCCCCCHHHHHHHHHhccCCc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK-AEFKCPNWFPPEVRKLLCKILDPNP 255 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP 255 (479)
+..|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+.. .....+..+|..+.+++.+||.+||
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 4579999999877765 79999999999999997 9999987665554444433 3445666788999999999999999
Q ss_pred cccCChhhhhc
Q 011694 256 STRISMAKIRE 266 (479)
Q Consensus 256 ~~Rpt~~eil~ 266 (479)
.+|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.52 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=211.1
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
-..+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3468999999999999999999853 345679999886542 23456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCe
Q 011694 87 SKIFFVMEYAKGGELFNKVAKG--------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENL 152 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~~--------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~v 152 (479)
+.+|+||||+++++|.+++... .+++..+..++.||+.||+|||++|++||||||+||+++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 9999999999999999998642 38999999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC
Q 011694 153 KISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA 231 (479)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 231 (479)
||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999998754322211122334567889999999877665 79999999999999998 99999887776666666555
Q ss_pred cC-CCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 232 EF-KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 232 ~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.. ..+..+++++.+|+.+||++||.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 43 345568899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=334.99 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=210.0
Q ss_pred CCeEEeeeeeecCCeEEEEEEEc----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSI----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+|++.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 57899999999999999999864 3567899999865322 23346788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC
Q 011694 90 FFVMEYAKGGELFNKVAK------------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN 151 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~------------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~ 151 (479)
|++|||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 999999999999998842 23788899999999999999999999999999999999999999
Q ss_pred eEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc
Q 011694 152 LKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK 230 (479)
Q Consensus 152 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 230 (479)
+||+|||++................++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+.......+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999998754332222223344567789999999877664 89999999999999998 9999987765555554433
Q ss_pred C-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 231 A-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 231 ~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
. ....+..+++.+.+++.+||++||.+||++.+|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2 345667789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.32 Aligned_cols=257 Identities=23% Similarity=0.406 Sum_probs=214.0
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCccee
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIR-------TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQL 79 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l 79 (479)
++++..++|.+++.||+|+||.||+|.+.. ++..+|+|.+..... ......+.+|+.+++.+ +||||+++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 567788999999999999999999998753 235699999976432 22346788899999999 79999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 011694 80 YEVMATKSKIFFVMEYAKGGELFNKVAKG-----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPE 142 (479)
Q Consensus 80 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~ 142 (479)
++++...+.+|+||||+.+|+|.+++... .++...+..++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 99999999999999999999999999642 3788999999999999999999999999999999
Q ss_pred CEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChH
Q 011694 143 NLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNL 221 (479)
Q Consensus 143 NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~ 221 (479)
||+++.++.+||+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999999999999999998654322111111222345789999999877664 89999999999999998 8999988777
Q ss_pred HHHHHHhccCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 222 IEMYRKIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 222 ~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
......+.... ...|..++.++.+++.+||..+|.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66666654443 35566788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=333.40 Aligned_cols=244 Identities=26% Similarity=0.439 Sum_probs=203.0
Q ss_pred CCCeEEeeee--eecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 011694 13 TEKYEVGRLL--GQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 13 ~~~y~i~~~L--G~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 89 (479)
.++|++.+.+ |+|+||.||++.++.++..+|+|++....... .|+.....+ +||||+++++.+...+..
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3567777776 99999999999999999999999987653221 122222222 699999999999999999
Q ss_pred EEEEeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-CeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-~vkl~DFGla~~~~~~~ 167 (479)
|+||||++|++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~-- 162 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT-- 162 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC--
Confidence 9999999999999999874 799999999999999999999999999999999999999888 999999999864321
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHH----HHHHhccCcCCCCCCCCHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE----MYRKIGKAEFKCPNWFPPEV 243 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~ 243 (479)
.....+++.|+|||++.+..+. .++||||+||++|+|++|..||....... .+..........++.+++.+
T Consensus 163 ----~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 163 ----PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred ----CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 1234689999999999887775 79999999999999999999997543221 12222233345556689999
Q ss_pred HHHHHHhccCCccccCC-hhhhhcChhhh
Q 011694 244 RKLLCKILDPNPSTRIS-MAKIRESSWFR 271 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt-~~eil~h~wf~ 271 (479)
.+||.+||++||.+||+ ++++++||||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 99999999999999996 69999999996
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=336.21 Aligned_cols=251 Identities=30% Similarity=0.465 Sum_probs=208.2
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 95 (479)
|++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999999765432 23345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 96 AKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 96 ~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
++ ++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 5899888763 5899999999999999999999999999999999999999999999999998643221 1122
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---------------------
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--------------------- 231 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------------- 231 (479)
....+++.|+|||++.+....+.++||||+||++|+|++|+.||...+.......+...
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 33457889999999876544457999999999999999999999876543322221110
Q ss_pred --------cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 232 --------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 232 --------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.....+.+++.+.++|.+||++||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 001123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=352.31 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=209.3
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRT-----NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~ 81 (479)
+.+.-.++|++++.||+|+||.||+|.+... +..||||++..... ....+.+.+|+.+++.+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4556678999999999999999999987543 34699999965432 234467889999999996 999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc------------------------------------------------------
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAK------------------------------------------------------ 107 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~------------------------------------------------------ 107 (479)
++.+.+.+|+|||||++|+|.+++..
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 99999999999999999999887753
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCE
Q 011694 108 -------------------------------------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENL 144 (479)
Q Consensus 108 -------------------------------------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NI 144 (479)
..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1367788899999999999999999999999999999
Q ss_pred EEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHH
Q 011694 145 LLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIE 223 (479)
Q Consensus 145 Ll~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~ 223 (479)
|++.++.+||+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||.......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999998754322222222334577889999999877765 89999999999999997 999998754332
Q ss_pred -HHHHhccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 224 -MYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 224 -~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+..+... ....+..+++++.+++.+||..||.+|||+.+|.+
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 33333322 33455668899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.69 Aligned_cols=245 Identities=27% Similarity=0.457 Sum_probs=213.0
Q ss_pred eeeeecCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecc
Q 011694 20 RLLGQGAFAKVYYARSIRT---NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYA 96 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 96 (479)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+.+++.++|+||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999999866 8899999997654322 4578899999999999999999999999999999999999
Q ss_pred CCCChHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 97 KGGELFNKVAK----------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 97 ~gg~L~~~i~~----------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999975 46899999999999999999999999999999999999999999999999998765433
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 244 (479)
..........+++.|+|||.+....++ .++|||||||++|+|++ |..||...+.......+... ....|..+|+++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 222223445678999999999877664 89999999999999999 69999988777777766543 4456777899999
Q ss_pred HHHHHhccCCccccCChhhhhcC
Q 011694 245 KLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+++.+||..||.+|||+.+++.+
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.26 Aligned_cols=246 Identities=38% Similarity=0.708 Sum_probs=220.4
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 011694 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL 101 (479)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (479)
||.|+||.||.+.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+..++.+|++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999877655545667889999999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCc
Q 011694 102 FNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180 (479)
Q Consensus 102 ~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 180 (479)
.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 9999874 78999999999999999999999999999999999999999999999999987543221 22345578899
Q ss_pred ccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccccCC
Q 011694 181 YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRIS 260 (479)
Q Consensus 181 y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 260 (479)
|+|||.+.+.... .++|+||||+++|++++|..||...+.......+.......|..++..+.++|.+||..||.+|||
T Consensus 159 ~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGYG-KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 9999999776654 799999999999999999999988777777777777777888888999999999999999999999
Q ss_pred h---hhhhcChhh
Q 011694 261 M---AKIRESSWF 270 (479)
Q Consensus 261 ~---~eil~h~wf 270 (479)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=324.63 Aligned_cols=252 Identities=31% Similarity=0.564 Sum_probs=219.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||+|++|.||++.+..+++.|++|.+...... ......+.+|+.+++.++|||++++++++.+.+..|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999876543 2345789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcc
Q 011694 95 YAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 95 ~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
|+++++|.+.+.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence 9999999999876 6899999999999999999999999999999999999999999999999999875543222 123
Q ss_pred ccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHh-ccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 174 TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI-GKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
...+++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+........ .......+..+++.+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4568999999999977665 48999999999999999999999876544333333 334445666788999999999999
Q ss_pred CCccccCChhhhhcChhh
Q 011694 253 PNPSTRISMAKIRESSWF 270 (479)
Q Consensus 253 ~dP~~Rpt~~eil~h~wf 270 (479)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=332.86 Aligned_cols=256 Identities=30% Similarity=0.461 Sum_probs=211.3
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT--KSKIFF 91 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 91 (479)
++|+..+.||.|++|.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+ .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 4799999999999999999999999999999999764321 345778899999999999999999998854 447999
Q ss_pred EEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 92 VMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
||||++|++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887642 45899999999999999999999999999999999999999999999999998643321
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh-----HHHHHHHhccCc-CCCC----
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-----LIEMYRKIGKAE-FKCP---- 236 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-----~~~~~~~i~~~~-~~~~---- 236 (479)
......++..|+|||.+.+..++ .++|||||||++|+|++|..||.... ..+....+.... ...+
T Consensus 159 ----~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 ----LAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ----ccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 12244678899999999877775 79999999999999999999998652 223333332211 1111
Q ss_pred --CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 237 --NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 237 --~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
..+++.+.++|.+||..||.+|||+.|+++||||++....
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 1245789999999999999999999999999999765543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=345.25 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=210.7
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK----- 86 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (479)
+..+|.+.+.||+|+||.||.|.+..+++.||||.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 4678999999999999999999999999999999987543222 2345677899999999999999999988654
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
..+|+++||+. ++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 588888876 5799999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc---------------
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK--------------- 230 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 230 (479)
.. .......++..|+|||.+......+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 21 2234457899999999987644345899999999999999999999977643222211100
Q ss_pred ------------C-c---CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 231 ------------A-E---FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 231 ------------~-~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
. . ....+.+++++.++|.+||+.||.+|||++++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 0 01123578899999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=331.40 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=208.0
Q ss_pred eEEeeeeeecCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE----
Q 011694 16 YEVGRLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK---- 88 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 88 (479)
|.+++.||+|+||.||.|.... ++..||||.+....... .....+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 6789999999999999998765 34789999987653332 334678899999999999999999998865543
Q ss_pred --EEEEEeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 89 --IFFVMEYAKGGELFNKVAK-------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 89 --~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
.+++|||+++|+|..++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 7999999999999888743 2589999999999999999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPN 237 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 237 (479)
+................++..|+|||.+.+..++ .++||||+||++|+|++ |..||.+.+..+.+..+... ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 8755433222222233456789999999776665 89999999999999999 99999887766666655433 445677
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+++++.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=346.13 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=208.0
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~ 81 (479)
+|.+-.++|++.+.||+|+||.||+|.+.. +++.||+|++..... ......+.+|+.+++.+ +||||+++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~ 78 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLG 78 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheee
Confidence 456677899999999999999999997543 457899999875432 22346678899999999 7999999999
Q ss_pred EEEe-CCEEEEEEeccCCCChHHHHhc-----------------------------------------------------
Q 011694 82 VMAT-KSKIFFVMEYAKGGELFNKVAK----------------------------------------------------- 107 (479)
Q Consensus 82 ~~~~-~~~~~lV~E~~~gg~L~~~i~~----------------------------------------------------- 107 (479)
++.. +..++++|||+++++|.+++..
T Consensus 79 ~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 79 ACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred eEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 8764 4678999999999999988753
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCC
Q 011694 108 ---------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT 178 (479)
Q Consensus 108 ---------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 178 (479)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++................++
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 25788999999999999999999999999999999999999999999999998764322211112234567
Q ss_pred CcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHH-HHhccC-cCCCCCCCCHHHHHHHHHhccCCc
Q 011694 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMY-RKIGKA-EFKCPNWFPPEVRKLLCKILDPNP 255 (479)
Q Consensus 179 ~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP 255 (479)
..|+|||++.+..++ .++|||||||++|+|++ |..||.+....+.+ ..+... ....|..+++++.+++.+||+.+|
T Consensus 239 ~~y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 239 LKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred ccccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCCh
Confidence 789999999888776 79999999999999998 99999765433322 222222 234455678999999999999999
Q ss_pred cccCChhhhhcC
Q 011694 256 STRISMAKIRES 267 (479)
Q Consensus 256 ~~Rpt~~eil~h 267 (479)
.+||++.++++|
T Consensus 318 ~~RPs~~ell~~ 329 (337)
T cd05054 318 EDRPTFSELVEI 329 (337)
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=356.55 Aligned_cols=244 Identities=35% Similarity=0.583 Sum_probs=216.5
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 90 (479)
..+.|++...+|.|+|+.|..+.+..+++.+++|++.+.... ..+|+.++... +||||+++++++.+..++|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceee
Confidence 578899999999999999999999999999999999876322 23566555444 7999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE-ecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL-DENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl-~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+|||++.|+.|.+.+...+....++..|+.+|+.|+.|||++||+||||||+|||+ +..|+++|+|||.+...+..
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 99999999999999988766668888999999999999999999999999999999 58899999999998754322
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH-HHHHHHhccCcCCCCCCCCHHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-IEMYRKIGKAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~li~ 248 (479)
..+.|-|..|+|||++...+|+ +++|+||||++||+||+|+.||..... .++...+..+.+. .++|..+++||.
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQ 544 (612)
T ss_pred --hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHH
Confidence 5567889999999999988887 999999999999999999999976544 4777777766555 889999999999
Q ss_pred HhccCCccccCChhhhhcChhh
Q 011694 249 KILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf 270 (479)
+||+.||.+|+++.+++.||||
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=337.81 Aligned_cols=259 Identities=27% Similarity=0.506 Sum_probs=212.6
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS- 87 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~- 87 (479)
+++..++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 5677889999999999999999999999999999999997653222 23356778999999999999999999987654
Q ss_pred ---------EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEee
Q 011694 88 ---------KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISD 156 (479)
Q Consensus 88 ---------~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~D 156 (479)
.+|+|+||+++ +|...+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 89999999987 67777765 3699999999999999999999999999999999999999999999999
Q ss_pred cCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cC
Q 011694 157 FGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EF 233 (479)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~ 233 (479)
||++........ .......+++.|+|||.+.+....+.++||||+||++|+|++|++||...+.......+... ..
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999875543221 12223356888999999876544458999999999999999999999876654444333211 00
Q ss_pred ---------------------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 234 ---------------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 234 ---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.....+|+.+.+++.+||..||.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0112368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=353.53 Aligned_cols=246 Identities=29% Similarity=0.470 Sum_probs=215.1
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.|+|..+....++-||.|+.|.||+|+. .++.||||.++.-+ ..+|+-|++|+||||+.|.|++....
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCc
Confidence 4556666666678899999999999998 78899999774322 45788999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.+|||||||..|.|...++.+ .++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.+......
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 999999999999999999985 7999999999999999999999999999999999999999999999999998754432
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 244 (479)
......+||..|||||++.+.+.. .|+||||+||+||+||||..||.+-+...+.--+..+ .++.|..+|..++
T Consensus 266 ---STkMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 266 ---STKMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFK 341 (904)
T ss_pred ---hhhhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHH
Confidence 345678999999999999988875 9999999999999999999999987765444333333 4567888999999
Q ss_pred HHHHHhccCCccccCChhhhhcChh
Q 011694 245 KLLCKILDPNPSTRISMAKIRESSW 269 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h~w 269 (479)
-||+.||.-.|..||++.+|+.|-=
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHHh
Confidence 9999999999999999999998843
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=343.99 Aligned_cols=258 Identities=28% Similarity=0.408 Sum_probs=211.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK---- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (479)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 3568999999999999999999999999999999999764322 22345678899999999999999999988643
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 --SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
+.+|++++++ |++|.+.+..+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478888887 7799998888889999999999999999999999999999999999999999999999999986432
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc------------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE------------ 232 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 232 (479)
.......+++.|+|||++.+....+.++||||+||++|+|++|+.||...+.......+....
T Consensus 172 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 172 -----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred -----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 122345789999999998764334579999999999999999999997655433322221100
Q ss_pred -----------CCC--------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 233 -----------FKC--------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 233 -----------~~~--------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
... ....++++.+||.+||..||.+|||+.+++.||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 000 1125788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=336.03 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=212.7
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRT-----NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
..+|++.+.||+|+||.||+|.+..+ ++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 35688899999999999999987543 5789999997543 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC
Q 011694 88 KIFFVMEYAKGGELFNKVAK-----------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE 150 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g 150 (479)
..++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 99999999999999998852 2478888999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhc
Q 011694 151 NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIG 229 (479)
Q Consensus 151 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 229 (479)
.+||+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998754322222223344567899999999877664 79999999999999998 889998877777777765
Q ss_pred cCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 230 KAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 230 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
... ...|..+++.+.+|+.+||+.+|.+||++.+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 544 34567799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=331.70 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=205.7
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC------C
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQ--SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK------S 87 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~------~ 87 (479)
|.+++.||+|+||.||+|.+..++. .||+|.+...... ......+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999987775 6999998764322 23456788999999999999999999986432 3
Q ss_pred EEEEEEeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 88 KIFFVMEYAKGGELFNKVAK-------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
..+++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57999999999999888742 24889999999999999999999999999999999999999999999999998
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccCc-CCCCCC
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNW 238 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~ 238 (479)
................+++.|+|||.+.+..+. .++||||+||++|+|++ |..||...+....+..+.... ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 764322211112233567789999999877665 89999999999999999 899998877666666665443 345667
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
++..+.++|.+||+.||.+|||+.+|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=327.11 Aligned_cols=255 Identities=29% Similarity=0.498 Sum_probs=215.2
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI--MRVGLADQIKREISVMRIVRHPNIVQLYEVMATK--SKI 89 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~--~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 89 (479)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 579999999999999999999999999999999864321 1223456888999999999999999999998764 568
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
+++|||+++++|.+.+.. +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999999876 5789999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCCCCCCHHHHH
Q 011694 169 -DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCPNWFPPEVRK 245 (479)
Q Consensus 169 -~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~ 245 (479)
........++..|+|||.+.+..++ .++|+||+||++|+|++|..||.+.........+... ....|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1112345689999999999877664 8999999999999999999999877655544444322 33467778999999
Q ss_pred HHHHhccCCccccCChhhhhcChhh
Q 011694 246 LLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
+|.+||. +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=365.17 Aligned_cols=248 Identities=29% Similarity=0.522 Sum_probs=207.4
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEE-EEe---C-
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEV-MAT---K- 86 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~-~~~---~- 86 (479)
..+++|.+.|.+|||+.||+|.+...|..||+|.+-.. ++...+.+++||.+|+.|+ |+|||.|++. ... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 45789999999999999999999888899999988654 3456788999999999997 9999999993 321 1
Q ss_pred --CEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCCEEEecCCCeEEeecCc
Q 011694 87 --SKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRG--VYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~g--ivHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
-.++|.||||.||.|-|++.. .+|+|.++++||.|+++||++||... |||||||-|||||+.+|++||||||-
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 247899999999999999974 47999999999999999999999998 99999999999999999999999998
Q ss_pred hhhhhccccCC--C--c---cccCCCCcccChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhc
Q 011694 160 SALAQCKHQDG--L--L---HTTCGTPAYVAPEVIN---RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG 229 (479)
Q Consensus 160 a~~~~~~~~~~--~--~---~~~~gt~~y~aPEvl~---~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~ 229 (479)
|+..-...... . . -...-|+.|+|||++. +.+. ++|+|||+|||+||-|+...+||++... ..|.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----laIl 267 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----LAIL 267 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEE
Confidence 86422111000 0 0 0124689999999984 5555 4999999999999999999999987642 3466
Q ss_pred cCcCCCCC--CCCHHHHHHHHHhccCCccccCChhhhhcCh
Q 011694 230 KAEFKCPN--WFPPEVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 230 ~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
++.+.+|+ .++..+.+||+.||++||.+||++.+++.+-
T Consensus 268 ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 268 NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 77787776 5889999999999999999999999987653
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=329.02 Aligned_cols=248 Identities=28% Similarity=0.460 Sum_probs=206.5
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 97 (479)
....||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++..++.+++|+||++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 34689999999999999999999999999865432 234678899999999999999999999999999999999999
Q ss_pred CCChHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-CCCeEEeecCchhhhhccccCCCc
Q 011694 98 GGELFNKVAK--GKL--KEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-NENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 98 gg~L~~~i~~--~~l--~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
+++|.+.+.. ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++...... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCcc
Confidence 9999999875 345 88899999999999999999999999999999999976 679999999998654321 1222
Q ss_pred cccCCCCcccChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCChHH--HHHHH-hccCcCCCCCCCCHHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVINRKG-YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI--EMYRK-IGKAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~-~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~--~~~~~-i~~~~~~~~~~~~~~~~~li~ 248 (479)
....|++.|+|||++.+.. ..+.++||||+|+++|+|++|..||...... ..+.. ........|..+++++.+++.
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence 3446899999999986543 2358999999999999999999999764322 22211 122334456778899999999
Q ss_pred HhccCCccccCChhhhhcChhh
Q 011694 249 KILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf 270 (479)
+||+.+|.+|||+.+++.||||
T Consensus 247 ~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=336.92 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=207.4
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcE--EEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQS--VAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSK 88 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (479)
-.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++..+ +||||+++++++...+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 346899999999999999999999888765 566665432 2223456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC
Q 011694 89 IFFVMEYAKGGELFNKVAKG-----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN 151 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~ 151 (479)
+|+||||+++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 99999999999999998642 4789999999999999999999999999999999999999999
Q ss_pred eEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc
Q 011694 152 LKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK 230 (479)
Q Consensus 152 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 230 (479)
+||+|||++........ .....++..|+|||.+.+..++ .++||||+||++|+|++ |..||...+..+....+..
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 163 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred EEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 99999999853211111 1112346679999999777664 89999999999999998 9999988776666665543
Q ss_pred C-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcCh
Q 011694 231 A-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 231 ~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
. ....+..+++++.+|+.+||+.+|.+||++++++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 3 2334555789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=370.44 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=207.5
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+|+.||||++...........+++.+|+.+++.++||||+++++++.+++..|++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999997654444445678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 94 EYAKGGELFNKVAK------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 94 E~~~gg~L~~~i~~------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
||++||+|.+.+.. ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999998853 134566788999999999999999999999999999999999999999999997
Q ss_pred hhhcccc----------------CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHH
Q 011694 162 LAQCKHQ----------------DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMY 225 (479)
Q Consensus 162 ~~~~~~~----------------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~ 225 (479)
....... .......+||+.|+|||++.+..++ .++||||+||++|+|++|..||...+.....
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 5521110 0011234799999999999887775 8999999999999999999999875543322
Q ss_pred HH-hccCc--CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 226 RK-IGKAE--FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 226 ~~-i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.. ..... ......+|+.+.+++.+||..||.+||+..+.+.+
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 21 11111 11123478999999999999999999887665543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=331.26 Aligned_cols=256 Identities=31% Similarity=0.538 Sum_probs=220.1
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
..+.|++.+.||+|+||.||.|.+..++..|++|++..... ....+.+|+.+++.++|+||+++++++...+..|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999998999999999976542 34678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 92 VMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
++||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 99999999999999875 79999999999999999999999999999999999999999999999999986543221
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc---CCCCCCCCHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPPEVRKL 246 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~l 246 (479)
.......+++.|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+.... ...+..++.++.++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 122344588999999999877765 89999999999999999999998776654444443222 22233378999999
Q ss_pred HHHhccCCccccCChhhhhcChhhhccc
Q 011694 247 LCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 247 i~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
|.+||+.+|.+|||+.++++|+||++..
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhccC
Confidence 9999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=333.49 Aligned_cols=257 Identities=24% Similarity=0.429 Sum_probs=214.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRT-----NQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~ 81 (479)
...+-.++|++.+.||+|+||.||++.+... ...+|+|.+..... ......+.+|+.+++.+ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3456678999999999999999999988644 37899999876432 22346688999999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCE
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAK-----------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENL 144 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NI 144 (479)
++...+.+|++|||+.+|+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 99999999999999999999999853 3588999999999999999999999999999999999
Q ss_pred EEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHH
Q 011694 145 LLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIE 223 (479)
Q Consensus 145 Ll~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~ 223 (479)
+++.++.+||+|||++................++..|+|||++.+..++ .++||||+||++|+|++ |..||...+...
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999998754432211112223356789999998777665 89999999999999997 999999887777
Q ss_pred HHHHhccCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 224 MYRKIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 224 ~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+..+.... ...|..++.++.+|+.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 666654432 34566688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=326.74 Aligned_cols=246 Identities=24% Similarity=0.424 Sum_probs=207.7
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 56899999999999999999875 4567999988654322 356788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 99999999999864 4689999999999999999999999999999999999999999999999998864321111 11
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccCc-CCCCCCCCHHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 249 (479)
.....++..|+|||++.+..+. .++||||+|+++|+|++ |+.||...+..+....+.... ...|...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1122355689999999877765 79999999999999999 999999887777666665442 33455578899999999
Q ss_pred hccCCccccCChhhhhc
Q 011694 250 ILDPNPSTRISMAKIRE 266 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~ 266 (479)
||..||.+|||++++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=334.23 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=209.4
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCC----------------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTN----------------QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~----------------~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnI 76 (479)
.++|++++.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876544 56899998765322 345788899999999999999
Q ss_pred ceeEEEEEeCCEEEEEEeccCCCChHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCE
Q 011694 77 VQLYEVMATKSKIFFVMEYAKGGELFNKVAKG------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENL 144 (479)
Q Consensus 77 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NI 144 (479)
+++++++..++..+++|||+.+++|.+++... .+++..++.++.|++.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 99999999999999999999999999998653 489999999999999999999999999999999999
Q ss_pred EEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh--CCCCCCCChHH
Q 011694 145 LLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA--GYLPFHDSNLI 222 (479)
Q Consensus 145 Ll~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~--G~~Pf~~~~~~ 222 (479)
+++.++.++|+|||++................+++.|+|||.+.+..+. .++||||+||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999998754332222223345577899999999876664 89999999999999998 78899876655
Q ss_pred HHHHHhccC--------cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 223 EMYRKIGKA--------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 223 ~~~~~i~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
..+...... ....+..+|.++.+++.+||+.||.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 544443211 12345567899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=325.26 Aligned_cols=250 Identities=28% Similarity=0.566 Sum_probs=212.0
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999997654444445678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 94 EYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 94 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999998853 35899999999999999999999999999999999999999999999999998654322
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh--HHHHHHHhccCcC-CCCC-CCCHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN--LIEMYRKIGKAEF-KCPN-WFPPEVR 244 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~~~~~~ 244 (479)
........+++.|+|||.+.+..++ .++|+||+||++|+|++|..||.... .......+..... +.|. .++..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 1222345689999999999877775 79999999999999999999996543 2233333333222 2333 5788999
Q ss_pred HHHHHhccCCccccCChhhhhc
Q 011694 245 KLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~ 266 (479)
++|.+||..+|.+|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.48 Aligned_cols=259 Identities=31% Similarity=0.562 Sum_probs=238.3
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+-..+.+++.+||-|+||.|=++........+|+|++++..+.+....+.+..|-.+|..++.|.||++|-.|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 44567788999999999999999886666669999999998888888899999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
++||-|-||+|+..++. +.+.+..++.|+..+++|++|||++||++|||||||++++.+|-+||.|||+|..... .
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---G 573 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc---C
Confidence 99999999999999986 7899999999999999999999999999999999999999999999999999986653 3
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCCCCCCHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCPNWFPPEVRKLL 247 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li 247 (479)
...-+.||||.|+|||++.+++++ .++|.||||+++||||+|.+||.+.++...|..|.++ ...+|..++..+.+||
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred CceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 345688999999999999999998 8999999999999999999999999999999999775 4678888999999999
Q ss_pred HHhccCCccccCC-----hhhhhcChhhhcc
Q 011694 248 CKILDPNPSTRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 248 ~~~L~~dP~~Rpt-----~~eil~h~wf~~~ 273 (479)
+++...+|.+|.. +.+|.+|.||..-
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 9999999999997 8999999999643
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=334.77 Aligned_cols=254 Identities=27% Similarity=0.476 Sum_probs=215.7
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 95 (479)
|.....||+|+||.||++.+..+|+.||||.+.... ......+.+|+.+++.++||||+++++.+...+..|++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 334578999999999999999999999999985432 23356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcccc
Q 011694 96 AKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT 175 (479)
Q Consensus 96 ~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~ 175 (479)
+++++|.+.+..+++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 999999999888889999999999999999999999999999999999999999999999999876433211 112345
Q ss_pred CCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc---CcCCCCCCCCHHHHHHHHHhcc
Q 011694 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK---AEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 176 ~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~li~~~L~ 252 (479)
.|++.|+|||.+.+..+. .++|+||+||++|+|++|..||...+.......+.. ........+++.+.+++.+||.
T Consensus 177 ~~~~~y~~pE~~~~~~~~-~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 689999999998776664 899999999999999999999987765544443322 2223344578999999999999
Q ss_pred CCccccCChhhhhcChhhhcccc
Q 011694 253 PNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 253 ~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
.||.+||++.+++.||||.+...
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCC
Confidence 99999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=329.47 Aligned_cols=250 Identities=28% Similarity=0.567 Sum_probs=211.6
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999987654444445577889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 94 EYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 94 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
||+.|++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 99999999998863 458999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH--HHHHHHhccCcCC--CCCCCCHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL--IEMYRKIGKAEFK--CPNWFPPEVR 244 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~~~~~~--~~~~~~~~~~ 244 (479)
......+|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||..... ......+...... .+..+++.+.
T Consensus 161 -~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 161 -TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred -cccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 223445789999999999877765 799999999999999999999975432 3333343332222 2245788999
Q ss_pred HHHHHhccCCccccCChhhhhc
Q 011694 245 KLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.+||..||.+|||+.+|++
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=327.90 Aligned_cols=249 Identities=25% Similarity=0.435 Sum_probs=208.4
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+..++|++.+.||+|+||.||+|.+..++ .||+|.+...... .+.+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 75 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCc
Confidence 466789999999999999999999886654 5999998764322 3567899999999999999999998754 568
Q ss_pred EEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 90 FFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999999999975 35899999999999999999999999999999999999999999999999998654322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 244 (479)
.. .......++..|+|||++.+..++ .++||||+||++|+|++ |..||.+.........+... ....+..++..+.
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 233 (262)
T cd05071 156 EY-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 233 (262)
T ss_pred cc-ccccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHH
Confidence 11 112234467789999999777765 89999999999999999 89999887766666555432 3445566889999
Q ss_pred HHHHHhccCCccccCChhhhhc
Q 011694 245 KLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.+||++||.+|||++++++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 234 DLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.63 Aligned_cols=249 Identities=24% Similarity=0.453 Sum_probs=213.5
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
.-..+|++++.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 345679999999999999999999977 88999999876532 23467889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 91 FVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999999999975 358999999999999999999999999999999999999999999999999987543211
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRK 245 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 245 (479)
. ......++..|+|||++.+..+. .++||||||+++|+|++ |..||...+..+.+..+... ..+.|..+++.+.+
T Consensus 159 ~--~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05148 159 Y--LSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYK 235 (261)
T ss_pred c--cccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHH
Confidence 1 11233456789999999877665 79999999999999998 89999887776666666533 34556678999999
Q ss_pred HHHHhccCCccccCChhhhhc
Q 011694 246 LLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~ 266 (479)
++.+||..||.+|||+.+|++
T Consensus 236 ~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 236 IMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=325.96 Aligned_cols=250 Identities=24% Similarity=0.420 Sum_probs=210.3
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
++..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ....+.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence 455678999999999999999999874 457899999875432 235678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 90 FFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
|++|||+.+++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999999999999752 5999999999999999999999999999999999999999999999999998765421
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 244 (479)
.... ......+..|+|||++.+..++ .++||||||+++|+|++ |..||.+.+.......+... ....+..++..+.
T Consensus 157 ~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05068 157 IYEA-REGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELY 234 (261)
T ss_pred cccc-cCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1110 1112234579999999876665 89999999999999999 99999887776666665433 3345666889999
Q ss_pred HHHHHhccCCccccCChhhhhc
Q 011694 245 KLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.+||+.+|.+||++.+|++
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.28 Aligned_cols=262 Identities=29% Similarity=0.416 Sum_probs=214.2
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeC--
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATK-- 86 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~-- 86 (479)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 356789999999999999999999999999999999986542222 2335677899999999 999999999998643
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 87 SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
...|+||||+.+ +|.+.+..+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 468999999975 9999998878899999999999999999999999999999999999999999999999998765432
Q ss_pred ccC---CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc-------------
Q 011694 167 HQD---GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK------------- 230 (479)
Q Consensus 167 ~~~---~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------- 230 (479)
... .......||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 211 2233456899999999987655455899999999999999999999976554333222110
Q ss_pred --------------CcC----CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 231 --------------AEF----KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 231 --------------~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
... ...+.++.++.++|.+||+.||.+|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000 0112368899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=319.72 Aligned_cols=248 Identities=33% Similarity=0.581 Sum_probs=213.2
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999998999999999976543 345788899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 95 YAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 95 ~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998774 799999999999999999999999999999999999999999999999999875433221 3
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cCCCCCCCCHHHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~~ 249 (479)
....++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+........... ....+..++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45578999999999987665 48999999999999999999999877443332222221 222233348999999999
Q ss_pred hccCCccccCChhhhhcChh
Q 011694 250 ILDPNPSTRISMAKIRESSW 269 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~w 269 (479)
||+.||.+|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=327.08 Aligned_cols=247 Identities=27% Similarity=0.455 Sum_probs=207.3
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
.+|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999885 5668999998654322 245778999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||++|++|.+++.. +.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 99999999999865 4689999999999999999999999999999999999999999999999999864321111 11
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~ 249 (479)
.....++..|+|||.+.+..+. .++||||+|+++|+|++ |..||...+..+....+... ....|..+|+.+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1112234579999999877765 79999999999999998 89999877666666555443 345566689999999999
Q ss_pred hccCCccccCChhhhhcC
Q 011694 250 ILDPNPSTRISMAKIRES 267 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h 267 (479)
||..+|.+|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=350.66 Aligned_cols=260 Identities=28% Similarity=0.444 Sum_probs=224.5
Q ss_pred CCCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCc---E-EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcce
Q 011694 3 GMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQ---S-VAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQ 78 (479)
Q Consensus 3 ~~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~-vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~ 78 (479)
|+.+.+|.+--++-.+.++||+|+||+||+|..+..+. . ||||...............+.+|.++|+.++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 67788888888999999999999999999998875432 3 8999987644344456788899999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEee
Q 011694 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISD 156 (479)
Q Consensus 79 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~D 156 (479)
+||+......+|+|||+|+||+|.++++.. .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCc
Confidence 999999999999999999999999999974 499999999999999999999999999999999999999999999999
Q ss_pred cCchhhhhccccCCCcc-ccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccCc--
Q 011694 157 FGLSALAQCKHQDGLLH-TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-- 232 (479)
Q Consensus 157 FGla~~~~~~~~~~~~~-~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-- 232 (479)
||+|+.... ..... ...-...|+|||.+...-|+ .++||||+||++||+.+ |..||.+....+...++....
T Consensus 306 FGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r 381 (474)
T KOG0194|consen 306 FGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR 381 (474)
T ss_pred cccccCCcc---eeeccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc
Confidence 999865331 11111 11256789999999888665 89999999999999998 899999999999999885443
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 233 FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 233 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+.|...|.++..++.+|+..||+.|||+.++.+
T Consensus 382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 3556667899999999999999999999999864
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=326.63 Aligned_cols=250 Identities=24% Similarity=0.423 Sum_probs=209.2
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
+.+..++|++.+.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.+++.++||||+++++++. .+.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEP 74 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence 3567789999999999999999999875 5667999998765432 256889999999999999999999885 456
Q ss_pred EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 89 IFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.|++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 8999999999999999865 3589999999999999999999999999999999999999999999999999865432
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEV 243 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 243 (479)
... .......++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+.+..+....+... ..+.+...+..+
T Consensus 155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05070 155 NEY-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL 232 (260)
T ss_pred ccc-ccccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 211 111222356689999998776664 89999999999999999 99999887766666666433 445666788999
Q ss_pred HHHHHHhccCCccccCChhhhhc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+|+.+||.+||.+|||++++.+
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=325.97 Aligned_cols=250 Identities=21% Similarity=0.405 Sum_probs=209.7
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+-.++|++.++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 455678999999999999999999864 566799998865432 246788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 90 FFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
|++|||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999999999864 46899999999999999999999999999999999999999999999999998754322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 244 (479)
.. .......++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+.......+... ..+.+..+|.++.
T Consensus 157 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05072 157 EY-TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELY 234 (261)
T ss_pred ce-eccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 111223456789999999877664 79999999999999998 99999887666655555433 2334455789999
Q ss_pred HHHHHhccCCccccCChhhhhc
Q 011694 245 KLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.+||..+|.+|||++++++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=330.81 Aligned_cols=259 Identities=30% Similarity=0.559 Sum_probs=216.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIM-RVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 89 (479)
.|++.+.||.|+||.||.|.+. .+|+.||+|++...... .....+.+.+|+.+++.+ +||||+.+++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 47899999999764332 223456788999999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 999999999999999876 5689999999999999999999999999999999999999999999999999875432211
Q ss_pred CCCccccCCCCcccChhhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCCh----HHHHHHHhccCcCCCCCCCCHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRK-GYDGEKVDIWSCGVVLFVLLAGYLPFHDSN----LIEMYRKIGKAEFKCPNWFPPEV 243 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~-~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~ 243 (479)
......+|+..|+|||.+.+. ...+.++||||+|+++|+|++|..||...+ .......+.......|..+++.+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 161 -ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred -cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 222346789999999998653 233578999999999999999999996432 23344444444556677789999
Q ss_pred HHHHHHhccCCccccC-----ChhhhhcChhhhccc
Q 011694 244 RKLLCKILDPNPSTRI-----SMAKIRESSWFRKGM 274 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rp-----t~~eil~h~wf~~~~ 274 (479)
.+++.+||..||.+|| ++++++.||||.+..
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999997 889999999997654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=385.15 Aligned_cols=261 Identities=32% Similarity=0.536 Sum_probs=224.6
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
-+.-+|.-+.+||.|.||.||.|.+..||+..|+|-+...... ......+.+|..++..++|||+|++|++-.+.+.++
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3556788899999999999999999999999999998765444 455688999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc--
Q 011694 91 FVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH-- 167 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~-- 167 (479)
|.||||+||+|.+.++.++ .+|...+.|..|++.|++|||++|||||||||+||+|+.+|-+|++|||.|.......
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999999999999875 6677778889999999999999999999999999999999999999999987654332
Q ss_pred cCCCccccCCCCcccChhhhhcCCC--CCCccchhhHHHHHHHHHhCCCCCCCChHH--HHHHHhccCcCCCCCCCCHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGY--DGEKVDIWSCGVVLFVLLAGYLPFHDSNLI--EMYRKIGKAEFKCPNWFPPEV 243 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~--~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 243 (479)
-.+.+....|||.|||||++.+..- .+-++|||||||+..||.||+.||...+.. -+|..-.......|..++++.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence 2334567789999999999975432 246899999999999999999999765432 344433444567888899999
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
++||.+||..||++|.++.||++|.|-+.
T Consensus 1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 99999999999999999999999997543
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=334.58 Aligned_cols=256 Identities=22% Similarity=0.400 Sum_probs=212.3
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCccee
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIR-------TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQL 79 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l 79 (479)
...+..++|.+++.||+|+||.||+|.+.. ....||+|.+..... ......+.+|+.+++.+ +||||+++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 445667899999999999999999998642 345799999875432 23346788999999999 69999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 011694 80 YEVMATKSKIFFVMEYAKGGELFNKVAK-----------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPE 142 (479)
Q Consensus 80 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~ 142 (479)
++++...+.+|++|||+.+|+|.+++.. ..++...+..++.||+.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 9999999999999999999999999864 24788899999999999999999999999999999
Q ss_pred CEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChH
Q 011694 143 NLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNL 221 (479)
Q Consensus 143 NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~ 221 (479)
|||++.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999998754322221112223345689999999877665 89999999999999999 8999988777
Q ss_pred HHHHHHhccCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 222 IEMYRKIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 222 ~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
...+..+.... ...|..++.++.+++.+||..||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 66666654432 3456678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.27 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=197.6
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCC-CcEEEEEEe--------------ecccccchhhHHHHHHHHHHHHhCCCC
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRT-NQSVAVKVI--------------DKDKIMRVGLADQIKREISVMRIVRHP 74 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vaiK~i--------------~~~~~~~~~~~~~l~~Ei~il~~l~hp 74 (479)
..+.++|++++.||+|+||+||+|..+.. +..+++|.+ .+...........+.+|+.+++.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 34567899999999999999999976543 222332311 111111223446788999999999999
Q ss_pred CcceeEEEEEeCCEEEEEEeccCCCChHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec
Q 011694 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKG------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE 148 (479)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~ 148 (479)
||+++++++...+..|+|+|++.+ +|.+++..+ ......++.++.||+.||.|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 999999999999999999999964 777776543 2346678899999999999999999999999999999999
Q ss_pred CCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCC-CCCCCh--HHHHH
Q 011694 149 NENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYL-PFHDSN--LIEMY 225 (479)
Q Consensus 149 ~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~-Pf~~~~--~~~~~ 225 (479)
+|.+||+|||++........ ......+||+.|+|||++.+..++ .++|||||||+||+|++|.. ||.... ....+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999875532211 122346799999999999888875 89999999999999999875 443221 11111
Q ss_pred HHhcc----CcCCCC----------------------------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 226 RKIGK----AEFKCP----------------------------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 226 ~~i~~----~~~~~~----------------------------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..+.. ....+| ..++.++.++|.+||..||.+|||+.|++.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 11100 000000 1245678889999999999999999999999999764
Q ss_pred c
Q 011694 274 M 274 (479)
Q Consensus 274 ~ 274 (479)
.
T Consensus 461 ~ 461 (501)
T PHA03210 461 E 461 (501)
T ss_pred C
Confidence 3
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=333.11 Aligned_cols=258 Identities=22% Similarity=0.405 Sum_probs=215.4
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEc-------CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcce
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSI-------RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQ 78 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~ 78 (479)
....+..++|.+.+.||+|+||.||+|++. ..+..||+|.+..... ......+.+|+.+++.+ +||||++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchh
Confidence 456777899999999999999999999753 2345799999865421 23346788999999999 7999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q 011694 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKG-----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKP 141 (479)
Q Consensus 79 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp 141 (479)
+++++......|++|||+.+|+|.+++... .++...+..++.||+.||.|||++||+||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999998642 367788999999999999999999999999999
Q ss_pred CCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCh
Q 011694 142 ENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSN 220 (479)
Q Consensus 142 ~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~ 220 (479)
+||+++.++.+||+|||++................+++.|+|||++.+..++ .++||||||+++|+|++ |..||...+
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999998754332222222334567889999999877765 79999999999999998 889998887
Q ss_pred HHHHHHHhccCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 221 LIEMYRKIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 221 ~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
..+....+.... ...+..++..+.+++.+||.++|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 777776664432 34556688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=330.51 Aligned_cols=252 Identities=32% Similarity=0.514 Sum_probs=209.9
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEE
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK--SKIFFVM 93 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 93 (479)
|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998764 2234456778999999999999999999999988 8999999
Q ss_pred eccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+++ +|.+.+... .+++..+..++.||+.||+|||++|++|+||+|+||++++++.+||+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 888888764 799999999999999999999999999999999999999999999999999875543221 12
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-------------------
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE------------------- 232 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------- 232 (479)
.....++..|+|||.+.+....+.++||||+|+++|+|++|+.||...+.......+....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 2344678899999987655444589999999999999999999998776544433332100
Q ss_pred ----CC--------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 233 ----FK--------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 233 ----~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.. ....+++.+.+++.+||..+|.+|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=340.75 Aligned_cols=262 Identities=27% Similarity=0.368 Sum_probs=212.7
Q ss_pred ccCCCeEE-eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch-----------hhHHHHHHHHHHHHhCCCCCcce
Q 011694 11 VLTEKYEV-GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV-----------GLADQIKREISVMRIVRHPNIVQ 78 (479)
Q Consensus 11 il~~~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----------~~~~~l~~Ei~il~~l~hpnIv~ 78 (479)
-+.++|.. .+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 35677864 5779999999999999999999999999865432210 01135778999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeec
Q 011694 79 LYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDF 157 (479)
Q Consensus 79 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DF 157 (479)
+++++..++..|+||||+. |+|.+.+.. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999997 489888876 57999999999999999999999999999999999999999999999999
Q ss_pred Cchhhhhccc------------cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHH
Q 011694 158 GLSALAQCKH------------QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMY 225 (479)
Q Consensus 158 Gla~~~~~~~------------~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~ 225 (479)
|++....... .........+++.|+|||.+.+....+.++|||||||++|+|++|..||...+....+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9987543111 0112233457889999999976554468999999999999999999999877655444
Q ss_pred HHhcc----Cc-C-----------------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 226 RKIGK----AE-F-----------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 226 ~~i~~----~~-~-----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..+.. .. . ...+..+.++.++|.+||+.+|.+|||+++++.||||+..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 33311 00 0 0112357889999999999999999999999999999755
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=330.34 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=210.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
+...+|.+.+.||+|+||.||++... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 44678999999999999999999743 356789999876432 2345678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKG----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN 149 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~ 149 (479)
.+..+++|||+.+++|.+++... .+++..+..++.||+.||+|||++|++||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 99999999999999999998652 37889999999999999999999999999999999999999
Q ss_pred CCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHh
Q 011694 150 ENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKI 228 (479)
Q Consensus 150 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i 228 (479)
+.+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...........+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999998644322211122233457889999999887775 89999999999999998 99999877665555555
Q ss_pred ccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 229 GKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 229 ~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
... ....|..+|+.+.++|.+||..||.+||++++|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 433 34556678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=322.59 Aligned_cols=250 Identities=30% Similarity=0.519 Sum_probs=218.8
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999997654332 334667789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 95 YAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 95 ~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998865 46899999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCCCCCHHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEVRKLLC 248 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~ 248 (479)
......+++.|+|||.+.+..++ .++|+||+|+++|+|++|+.||...+.......+....+ ..+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 23345689999999999877765 799999999999999999999998887666666554443 344557899999999
Q ss_pred HhccCCccccCChhhhhcChhh
Q 011694 249 KILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf 270 (479)
+||..+|.+|||+.+++.||+.
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999963
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=331.70 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=210.2
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.++|.+.+.||+|+||.||+|.+.. ++..+++|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4679999999999999999998643 456799998865432 23467889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC
Q 011694 88 KIFFVMEYAKGGELFNKVAK-----------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE 150 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g 150 (479)
..++||||+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999864 2378999999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhc
Q 011694 151 NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIG 229 (479)
Q Consensus 151 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 229 (479)
.++|+|||++................+++.|+|||.+.+..++ .++||||+||++|+|++ |..||...+.......+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999998654322222222345578899999999877765 79999999999999998 999998877766666665
Q ss_pred cCcC-CCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 230 KAEF-KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 230 ~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.... ..+..+|..+.+++.+||..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 4433 345557899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=324.94 Aligned_cols=250 Identities=24% Similarity=0.435 Sum_probs=209.6
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
+++..++|++++.||+|+||.||+|.+ .+++.||+|.+...... ...+.+|+.+++.++||||+++++++. .+.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 74 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEP 74 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCC
Confidence 467889999999999999999999986 46778999998765432 357789999999999999999999874 456
Q ss_pred EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 89 IFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.|++|||+.+++|.+.+.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 8999999999999998864 3689999999999999999999999999999999999999999999999999865432
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEV 243 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 243 (479)
... .......++..|+|||++....+. .++||||+|+++|++++ |++||.+.+.......+... ....+..++.++
T Consensus 155 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05067 155 NEY-TAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEEL 232 (260)
T ss_pred CCc-ccccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHH
Confidence 111 111223456789999999876664 89999999999999998 99999887766665555433 334556688999
Q ss_pred HHHHHHhccCCccccCChhhhhc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+++.+||..+|.+|||+++++.
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 233 YELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=317.78 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=211.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe----
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT---- 85 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~---- 85 (479)
.|-+++|++.+.||+|||+.||++.+..+++.+|+|.+..... +..+...+||...++++||||++++++...
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 3557899999999999999999999999999999999977653 345778899999999999999999887532
Q ss_pred -CCEEEEEEeccCCCChHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCCEEEecCCCeEEeec
Q 011694 86 -KSKIFFVMEYAKGGELFNKVAK----G-KLKEDAARRYFQQLINAVDFCHSRG--VYHRDIKPENLLLDENENLKISDF 157 (479)
Q Consensus 86 -~~~~~lV~E~~~gg~L~~~i~~----~-~l~e~~~~~i~~qll~aL~~LH~~g--ivHrDLkp~NILl~~~g~vkl~DF 157 (479)
....||++.|...|+|.+.+.. + -++|.++..||.+|++||.+||+.. ++||||||.|||+.+++..+|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 3459999999999999998875 2 5999999999999999999999999 999999999999999999999999
Q ss_pred CchhhhhccccCCC-------ccccCCCCcccChhhhhcCCCC--CCccchhhHHHHHHHHHhCCCCCCCChH--HHHHH
Q 011694 158 GLSALAQCKHQDGL-------LHTTCGTPAYVAPEVINRKGYD--GEKVDIWSCGVVLFVLLAGYLPFHDSNL--IEMYR 226 (479)
Q Consensus 158 Gla~~~~~~~~~~~-------~~~~~gt~~y~aPEvl~~~~~~--~~~~DvwSlGvil~~ll~G~~Pf~~~~~--~~~~~ 226 (479)
|-++........+. ......|..|+|||.+.-+.+. +.++|||||||+||.|+.|..||+..-. ..+.-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 99876543322211 1123478899999999765544 6899999999999999999999964221 11222
Q ss_pred HhccCcCCCCC--CCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 227 KIGKAEFKCPN--WFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 227 ~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+.++.+.+|. .+|+.+.++|+.||++||.+||++.+++.+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 34455555554 389999999999999999999999999864
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=332.00 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=213.5
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.+.|...+.||+|+||+||+|.+..+|+.|++|.+.............+.+|+.+++.++|||++++++++.+.+..|+|
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34577788999999999999999999999999999765544444556788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+.| +|.+.+.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++... .
T Consensus 100 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~------~ 172 (313)
T cd06633 100 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS------S 172 (313)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc------C
Confidence 999965 77777754 46899999999999999999999999999999999999999999999999987532 1
Q ss_pred CccccCCCCcccChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC--CCCCCCHHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVINR--KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK--CPNWFPPEVRKL 246 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~--~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~l 246 (479)
......|++.|+|||++.. ....+.++||||+||++|+|++|..||...+.......+.....+ ....++..+.+|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 2234578999999999842 222347899999999999999999999877655444444332221 223467889999
Q ss_pred HHHhccCCccccCChhhhhcChhhhcccc
Q 011694 247 LCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 247 i~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
+.+||+.+|.+||++.+++.||||+....
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 99999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=338.62 Aligned_cols=255 Identities=21% Similarity=0.351 Sum_probs=203.9
Q ss_pred eeeeec--CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 011694 20 RLLGQG--AFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 20 ~~LG~G--~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 97 (479)
..||+| +||+||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 99999999999999999999997654332 345788999999999999999999999999999999999999
Q ss_pred CCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC----
Q 011694 98 GGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG---- 170 (479)
Q Consensus 98 gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~---- 170 (479)
+++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999998875 358999999999999999999999999999999999999999999999998654322111110
Q ss_pred -CccccCCCCcccChhhhhcCCC-CCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC---------------
Q 011694 171 -LLHTTCGTPAYVAPEVINRKGY-DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF--------------- 233 (479)
Q Consensus 171 -~~~~~~gt~~y~aPEvl~~~~~-~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--------------- 233 (479)
......++..|+|||++.+... .+.++||||+||++|+|++|..||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 0111235677999999976421 25899999999999999999999987654333222211100
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 234 --------------------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 234 --------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
..+..+++.+.+||++||..||.+|||+.++++||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 011225678999999999999999999999999999976544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=331.61 Aligned_cols=248 Identities=24% Similarity=0.406 Sum_probs=206.7
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQ--SVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 90 (479)
++|++.+.||+|+||.||+|.+..++. .+++|.+.... .......+.+|+.++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999887765 46888775321 223346788999999999 7999999999999999999
Q ss_pred EEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeE
Q 011694 91 FVMEYAKGGELFNKVAKG-----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLK 153 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vk 153 (479)
++|||+++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999998642 488899999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-
Q 011694 154 ISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA- 231 (479)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~- 231 (479)
|+|||++........ ......+..|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+...
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999853221111 1112235579999999877765 89999999999999997 99999888777766666543
Q ss_pred cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 232 EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 232 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
....|..+++++.+|+.+||..+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 234556689999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=332.60 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=215.7
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
....|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.++|||++++++++.+.+..|+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 34558899999999999999999999999999999976644444556778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 92 VMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
||||+.| +|.+.+.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~----- 176 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS----- 176 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-----
Confidence 9999976 77776643 569999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccCCCCcccChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC--CCCCCCHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINR--KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK--CPNWFPPEVRK 245 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~--~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 245 (479)
......|++.|+|||.+.. ....+.++||||+||++|+|++|..||...+.......+...... .+..+++.+.+
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 177 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred -CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 1234578999999999842 222357999999999999999999999877665555555433322 22346789999
Q ss_pred HHHHhccCCccccCChhhhhcChhhhccc
Q 011694 246 LLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
++.+||+.+|.+||++.++++|+|+....
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 99999999999999999999999996544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=334.28 Aligned_cols=256 Identities=29% Similarity=0.459 Sum_probs=205.7
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC------
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK------ 86 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (479)
.++|++.+.||+|+||.||+|.+..+++.||||.+....... .......+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 589999999999999999999999999999999987543222 2234567899999999999999999987443
Q ss_pred --CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 87 --SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
..+|+||||+.+ +|...+.. ..+++..+..++.||+.||.|||++||+||||||+||++++++.+||+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999976 67666654 4799999999999999999999999999999999999999999999999999875
Q ss_pred hhccccC---------CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-
Q 011694 163 AQCKHQD---------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE- 232 (479)
Q Consensus 163 ~~~~~~~---------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~- 232 (479)
....... .......+++.|+|||.+.+....+.++||||+||++|+|++|++||.+.+.......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 4322211 111234578899999998765444589999999999999999999998776654443321100
Q ss_pred ----------------------CCCC-------CCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 233 ----------------------FKCP-------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 233 ----------------------~~~~-------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
...+ ..+++.+.++|.+||..||.+|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0001 1234678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=340.99 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=206.0
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEV 82 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~ 82 (479)
+..-.++|++.+.||+|+||.||+|.+. .+++.||||++...... .....+.+|+.++..+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 4455679999999999999999999853 46789999999754322 2346788999999999 68999999998
Q ss_pred EEe-CCEEEEEEeccCCCChHHHHhcC-----------------------------------------------------
Q 011694 83 MAT-KSKIFFVMEYAKGGELFNKVAKG----------------------------------------------------- 108 (479)
Q Consensus 83 ~~~-~~~~~lV~E~~~gg~L~~~i~~~----------------------------------------------------- 108 (479)
+.. +..++++||||++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 764 45689999999999999988531
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcc
Q 011694 109 ---------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 109 ---------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
.++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 25777888999999999999999999999999999999999999999999987542221111122
Q ss_pred ccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHH-HHHHhcc-CcCCCCCCCCHHHHHHHHHh
Q 011694 174 TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIE-MYRKIGK-AEFKCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~-~~~~~~~~~~~~~~~li~~~ 250 (479)
...+++.|+|||++.+..++ .++||||+|+++|+|++ |..||....... ....+.. .....|.++++++.+++.+|
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 33456789999999877765 89999999999999997 999997654322 2222222 23455667889999999999
Q ss_pred ccCCccccCChhhhhcC
Q 011694 251 LDPNPSTRISMAKIRES 267 (479)
Q Consensus 251 L~~dP~~Rpt~~eil~h 267 (479)
|..||.+|||+.+|++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=333.16 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=211.2
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~ 81 (479)
++++..++|.+.+.||+|+||.||+|.+. .++..||+|.+..... ....+.+.+|+.+++++ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 45677789999999999999999999753 3556899999875432 23456788999999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecC
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFG 158 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFG 158 (479)
++...+..|++|||+.+|+|.+++... .+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999999998752 38999999999999999999999999999999999999999999999999
Q ss_pred chhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC--cCCC
Q 011694 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA--EFKC 235 (479)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~ 235 (479)
++................+++.|+|||.+.+..++ .++||||+||++|+|++ |..||...+....+...... ....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 98754322111111223457889999999877765 89999999999999998 99999876654433333222 2234
Q ss_pred CCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 236 PNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 236 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+...++.+.+++.+||.++|.+|||+.++++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=330.84 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=206.1
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 92 (479)
++|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677788999999999999999999999999998765332 33467789999999986 99999999999999999999
Q ss_pred EeccCCCChHHH---Hh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 93 MEYAKGGELFNK---VA---KGKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 93 ~E~~~gg~L~~~---i~---~~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
|||+.+ +|.++ +. .+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999875 44433 22 25699999999999999999999985 999999999999999999999999999865432
Q ss_pred cccCCCccccCCCCcccChhhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCChH-HHHHHHhccCcC-C----CCC
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRK--GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-IEMYRKIGKAEF-K----CPN 237 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~--~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~-~----~~~ 237 (479)
. .......|++.|+|||++.+. ...+.++||||+||++|+|++|+.||...+. .+....+..... . .+.
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 S---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred C---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1 122344689999999999766 2334899999999999999999999976542 222233222211 1 122
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+++++.+||.+||.+||.+|||+++|+.||||+..
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 378899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=324.44 Aligned_cols=247 Identities=23% Similarity=0.398 Sum_probs=206.7
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||.||.|.+.. +..+|||.+...... .+.+.+|+.+++.++||||+++++++...+..|++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 579999999999999999998753 446999998654322 356789999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 99999999999875 3689999999999999999999999999999999999999999999999999864322111 01
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccCc-CCCCCCCCHHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 249 (479)
.....++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+.......+.... ...+...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1122355679999999877665 79999999999999998 999998777666655554432 33455578999999999
Q ss_pred hccCCccccCChhhhhcC
Q 011694 250 ILDPNPSTRISMAKIRES 267 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h 267 (479)
||..||.+|||+.+|+.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=327.14 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=208.3
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQ----SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
...+|++.+.||+|+||.||+|.+..+++ .||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 45789999999999999999999887776 489999865432 23456788999999999999999999998754
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
..++++||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999875 4699999999999999999999999999999999999999999999999999875532
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEV 243 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 243 (479)
...........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+... ..+.+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 2211111223356789999999877775 89999999999999998 99999876655554444332 334556688999
Q ss_pred HHHHHHhccCCccccCChhhhhc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+++.+||..||..|||+.+++.
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=324.05 Aligned_cols=244 Identities=26% Similarity=0.401 Sum_probs=203.0
Q ss_pred eeeeecCCeEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 011694 20 RLLGQGAFAKVYYARS--IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 97 (479)
+.||+|+||.||+|.+ ..++..+|+|++..... .....+.+.+|+.+++.++||||+++++++.. ...++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence 3689999999999965 45788999999865432 23456788899999999999999999998754 56789999999
Q ss_pred CCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC-CCcccc
Q 011694 98 GGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD-GLLHTT 175 (479)
Q Consensus 98 gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~ 175 (479)
+|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++......... ......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 9999999976 57999999999999999999999999999999999999999999999999998754322111 011223
Q ss_pred CCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHHhccC
Q 011694 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDP 253 (479)
Q Consensus 176 ~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~ 253 (479)
.+++.|+|||.+....++ .++|||||||++|+|++ |..||...+.......+... ....|..+++++.++|.+||+.
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~ 237 (257)
T cd05116 159 KWPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237 (257)
T ss_pred CCCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 346789999999766654 79999999999999998 99999887766666666543 3456777999999999999999
Q ss_pred CccccCChhhhhc
Q 011694 254 NPSTRISMAKIRE 266 (479)
Q Consensus 254 dP~~Rpt~~eil~ 266 (479)
||.+||++++|.+
T Consensus 238 ~p~~Rp~~~~i~~ 250 (257)
T cd05116 238 GVDERPGFAVVEL 250 (257)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=335.81 Aligned_cols=256 Identities=30% Similarity=0.447 Sum_probs=211.3
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT-KSKIF 90 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 90 (479)
+.++|++.+.||.|+||.||+|.+..+++.||||.+.+.... ......+.+|+.+++.++||||+++++++.. .+..|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 578899999999999999999999999999999998764322 2345678899999999999999999999865 56799
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 91 FVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
++|||+ +++|...+..+.+++..+..++.||+.||.|||++||+||||+|.||+++.++.+||+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred EEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 999999 56899888888899999999999999999999999999999999999999999999999999864321
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhc---------------------
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG--------------------- 229 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~--------------------- 229 (479)
......+++.|+|||++.+....+.++||||+||++|+|++|..||...+....+..+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 12345678899999998663334589999999999999999999997655422211110
Q ss_pred -----cCcCC-----CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 230 -----KAEFK-----CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 230 -----~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..... ..+.+++.+.++|.+||+.+|.+|||+++++.||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 00001 1134678999999999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=328.19 Aligned_cols=247 Identities=32% Similarity=0.531 Sum_probs=202.8
Q ss_pred EEeeeeeecCCeEEEEEEEc----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 17 EVGRLLGQGAFAKVYYARSI----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
++.+.||.|+||.||+|.+. ..+..|+||.+.... .....+.+.+|+..++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence 57899999999999999987 356789999995432 223467889999999999999999999999988889999
Q ss_pred EeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 93 MEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
|||+++|+|.+++... .+++..+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999874 7999999999999999999999999999999999999999999999999998755222111
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLL 247 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li 247 (479)
.......+...|+|||.+....++ .++||||||+++|++++ |..||.+.+.......+... ....|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 222334567889999999887764 89999999999999999 78999988777766666443 3455667899999999
Q ss_pred HHhccCCccccCChhhhhc
Q 011694 248 CKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~ 266 (479)
.+||..||.+|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=329.91 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=207.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998754 235689998865432 12346788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCE
Q 011694 90 FFVMEYAKGGELFNKVAK-------------------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENL 144 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NI 144 (479)
|++|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999998753 2478889999999999999999999999999999999
Q ss_pred EEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHH
Q 011694 145 LLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIE 223 (479)
Q Consensus 145 Ll~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~ 223 (479)
|++.++.+||+|||++...............+++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999998754322221112334567789999998776665 89999999999999998 999998877766
Q ss_pred HHHHhccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 224 MYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 224 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
....+... ....|..++.++.+++.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66555432 34456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=329.65 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=211.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
+-.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 345789999999999999999998753 678899999875432 2345678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKG-----------------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPE 142 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~-----------------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~ 142 (479)
....|++|||+++|+|.+++... .+++..+..++.||+.||.|||++|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 99999999999999999998632 3678889999999999999999999999999999
Q ss_pred CEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChH
Q 011694 143 NLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNL 221 (479)
Q Consensus 143 NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~ 221 (479)
||+++.++.++|+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999998643322111112233456789999999877765 79999999999999997 8899988777
Q ss_pred HHHHHHhccCcC-CCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 222 IEMYRKIGKAEF-KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 222 ~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+....+..... ..|..++.++.+|+.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 239 EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 666666654433 456678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=323.39 Aligned_cols=249 Identities=24% Similarity=0.437 Sum_probs=207.2
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
++..++|++.+.||+|+||.||+|.+..++ .+|+|.+..... ..+.+.+|+.+++.++||||+++++++.. +..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPI 75 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCc
Confidence 456788999999999999999999886554 599998865432 23567889999999999999999998854 568
Q ss_pred EEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 90 FFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
|++|||+.+++|.+++... .+++..+..++.||+.||.|||++|++||||||+||++++++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999999999752 4889999999999999999999999999999999999999999999999998654322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 244 (479)
.. .......++..|+|||.+.+..++ .++||||+||++|+|++ |..||.+.........+... ....+..++..+.
T Consensus 156 ~~-~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05069 156 EY-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLH 233 (260)
T ss_pred cc-cccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence 11 111223456789999998776664 89999999999999999 99999887766666655433 3345666889999
Q ss_pred HHHHHhccCCccccCChhhhhc
Q 011694 245 KLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.+||.+||.+||+++++++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=339.54 Aligned_cols=258 Identities=29% Similarity=0.434 Sum_probs=215.2
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS-----KI 89 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 89 (479)
+|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 69999999999999999999999999999999876432 2234567889999999999999999999988775 79
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|++|||+.+ +|.+.+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999985 89888876 4799999999999999999999999999999999999999999999999999876543321
Q ss_pred -CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC--------------
Q 011694 169 -DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-------------- 233 (479)
Q Consensus 169 -~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------------- 233 (479)
........+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 01234456899999999998773345899999999999999999999988776554444322100
Q ss_pred -----------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 234 -----------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 234 -----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
...+.+++++.++|.+||+.+|.+|||+++++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 01123678899999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.26 Aligned_cols=149 Identities=32% Similarity=0.643 Sum_probs=139.2
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|.+.+.||+|+||+||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999876555555667889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 93 MEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
|||+.|++|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999976 578999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=336.40 Aligned_cols=259 Identities=23% Similarity=0.395 Sum_probs=214.8
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcce
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRT-------NQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQ 78 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~ 78 (479)
.++++...+|++++.||+|+||.||+|.+... +..||+|++.... .......+.+|+.+++++ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 46677888999999999999999999987532 2368999886532 223456788999999999 7999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q 011694 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKG-----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKP 141 (479)
Q Consensus 79 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp 141 (479)
+++++...+.+|++|||+.+|+|.+++... .++...+..++.|++.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 999999999999999999999999998642 367788899999999999999999999999999
Q ss_pred CCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCh
Q 011694 142 ENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSN 220 (479)
Q Consensus 142 ~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~ 220 (479)
+|||++.++.+||+|||+++...............++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999998754322211112223345689999999877775 79999999999999998 899998887
Q ss_pred HHHHHHHhccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcCh
Q 011694 221 LIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 221 ~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
.......+... ....+..++.++.+++.+||..+|.+|||+.+++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 77777666543 2345666889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.85 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=212.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
++..++|++.+.||+|+||.||+|.+. .++.||||.+...... ...+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 567889999999999999999999975 5577999998764432 35688999999999999999999999998999
Q ss_pred EEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 90 FFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999999999975 36899999999999999999999999999999999999999999999999998654321
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 244 (479)
.. .......++..|+|||.+.+..+ +.++||||+||++|+|++ |+.||.+.+.......+... ....|..+|.++.
T Consensus 157 ~~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05034 157 EY-TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY 234 (261)
T ss_pred hh-hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 11112234578999999987665 489999999999999998 99999887776666666443 3455666789999
Q ss_pred HHHHHhccCCccccCChhhhhc
Q 011694 245 KLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.+||..+|.+||+++++++
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 235 DLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.36 Aligned_cols=251 Identities=21% Similarity=0.374 Sum_probs=210.1
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQ---SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
...|++.+.||+|+||.||+|.+..+++ .||||++.... .......+.+|+.+++.++||||+++++++.++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3569999999999999999999887665 59999986542 233457789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
++||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999875 468999999999999999999999999999999999999999999999999986543222
Q ss_pred cCCCccccC---CCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHH
Q 011694 168 QDGLLHTTC---GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPE 242 (479)
Q Consensus 168 ~~~~~~~~~---gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 242 (479)
......... .+..|+|||.+.+..++ .++||||+||++|++++ |..||...+.......+... ..+.+..+|..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111111 24579999999877775 79999999999999886 99999887766665555332 33455668899
Q ss_pred HHHHHHHhccCCccccCChhhhhc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+.+++.+||..+|.+||++++|+.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=330.58 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=204.1
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCC--------------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcce
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTN--------------QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQ 78 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--------------~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~ 78 (479)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+..... ......+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 3589999875422 234567889999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCChHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEE
Q 011694 79 LYEVMATKSKIFFVMEYAKGGELFNKVAKG-------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLL 145 (479)
Q Consensus 79 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NIL 145 (479)
+++++...+..++||||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 999999999999999999999999988542 3678889999999999999999999999999999999
Q ss_pred EecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh--CCCCCCCChHHH
Q 011694 146 LDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA--GYLPFHDSNLIE 223 (479)
Q Consensus 146 l~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~--G~~Pf~~~~~~~ 223 (479)
++.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999998654322211122233457789999999877664 89999999999999988 678888765544
Q ss_pred HHHHhcc--------CcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 224 MYRKIGK--------AEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 224 ~~~~i~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
....+.. .....++.+|+.+.+|+.+||+.||.+|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3333211 112335557899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=329.23 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=204.0
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcC----------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIR----------------TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnI 76 (479)
.++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999986532 34569999986542 22345678899999999999999
Q ss_pred ceeEEEEEeCCEEEEEEeccCCCChHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCE
Q 011694 77 VQLYEVMATKSKIFFVMEYAKGGELFNKVAKG------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENL 144 (479)
Q Consensus 77 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NI 144 (479)
+++++++...+..|++|||+++|+|.+++... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999988652 266778999999999999999999999999999999
Q ss_pred EEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh--CCCCCCCChHH
Q 011694 145 LLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA--GYLPFHDSNLI 222 (479)
Q Consensus 145 Ll~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~--G~~Pf~~~~~~ 222 (479)
|++.++.++|+|||++................+++.|+|||+..+..+. .++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999998754322211122233456789999998777664 89999999999999998 78999766544
Q ss_pred HHHHHhc--------cCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 223 EMYRKIG--------KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 223 ~~~~~i~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+...... ....+.+..+++.+.+|+.+||..||.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4333221 1123445668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.13 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=208.2
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK----- 86 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (479)
+..+|.+.+.||+|+||.||+|.+..+|+.||||.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 46789999999999999999999999999999999876432 223445678999999999999999999998754
Q ss_pred -CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 87 -SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
..+|+||||+.. +|...+ ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred CceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 357999999964 676654 34699999999999999999999999999999999999999999999999999864321
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--------------
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-------------- 231 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 231 (479)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 1234567899999999876443458999999999999999999999877654433322110
Q ss_pred ---------cCCC--------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 ---------EFKC--------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 ---------~~~~--------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
...+ .+..++++.+||.+||+.||.+|||+++++.||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 123567899999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.10 Aligned_cols=251 Identities=26% Similarity=0.373 Sum_probs=202.3
Q ss_pred CCCe-EEeeeeeecCCeEEEEEEE----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe--
Q 011694 13 TEKY-EVGRLLGQGAFAKVYYARS----IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT-- 85 (479)
Q Consensus 13 ~~~y-~i~~~LG~G~fg~Vy~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~-- 85 (479)
.++| ++.+.||+|+||+||++.. ..++..||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4566 9999999999999988653 35788999999875432 1234677899999999999999999998765
Q ss_pred CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
...+|++|||+++++|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 34689999999999999999888899999999999999999999999999999999999999999999999999875432
Q ss_pred cccC-CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH--HHH-------------HHh-
Q 011694 166 KHQD-GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI--EMY-------------RKI- 228 (479)
Q Consensus 166 ~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~--~~~-------------~~i- 228 (479)
.... .......++..|+|||.+.+..++ .++||||||+++|+|++|..||...... ... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 2211 111223456779999999776664 8999999999999999999998653311 100 000
Q ss_pred ccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 229 GKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 229 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.....+.|..++..+.+++.+||.+||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01122345667899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.98 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=211.1
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~ 81 (479)
++++-.++|.+++.||+|+||.||+|++. .+++.||+|++...... .....+.+|+.++..+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 56777889999999999999999999864 35568999999764322 33456889999999997 999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC-----------------------------------------------------
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAKG----------------------------------------------------- 108 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------------------------------------------- 108 (479)
++...+.+|+||||+.+|+|.+++...
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 999999999999999999999988542
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 011694 109 ----------------------------------------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPE 142 (479)
Q Consensus 109 ----------------------------------------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~ 142 (479)
.++...+..++.||+.||.|||++||+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2566778889999999999999999999999999
Q ss_pred CEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChH
Q 011694 143 NLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNL 221 (479)
Q Consensus 143 NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~ 221 (479)
|||++.++.+||+|||++................+++.|+|||.+.+..+. .++||||+||++|+|++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC-cHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999998754322211122334678899999999877664 89999999999999998 8999987554
Q ss_pred HHHH-HHhccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 222 IEMY-RKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 222 ~~~~-~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+.. ..+..+ ....|..++.++.+|+.+||..+|.+||++.+|+..
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4433 323222 344566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=346.61 Aligned_cols=256 Identities=24% Similarity=0.431 Sum_probs=219.3
Q ss_pred CCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 5 ~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
+.+-|.|..+...++..||+|+||+||+|++- | .||||+++.+....+ ..+.+++|+.++++-+|.||+-+.|++.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 34567888999999999999999999999983 3 499999998876654 6789999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
.... .||.-+|+|.+|+.++.- -++.....+.|++|++.|+.|||.++|+|||||..||+|.+++.|||+||||++.
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 8887 999999999999999864 4688899999999999999999999999999999999999999999999999986
Q ss_pred hhccccCCCccccCCCCcccChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-----C
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINR---KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-----K 234 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~---~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-----~ 234 (479)
...-.....+...-|...|||||++.. .+| ++.+||||+|+++|||++|.+||...+.....-.++.+.. .
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK 616 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence 544334445566678999999999963 345 4899999999999999999999996665555544554422 2
Q ss_pred CCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 235 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.-..++.++++|+..||..++++||++.+|+.
T Consensus 617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 22346789999999999999999999999976
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=323.10 Aligned_cols=251 Identities=22% Similarity=0.389 Sum_probs=209.0
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQ---SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999875543 799999865432 23456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999875 468999999999999999999999999999999999999999999999999987553322
Q ss_pred cCC-CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHH
Q 011694 168 QDG-LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244 (479)
Q Consensus 168 ~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 244 (479)
... ......++..|+|||.+.+..++ .++|+||+||++|++++ |..||.+.+..+....+... ..+.+..+|+.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 111 11112235689999999877664 89999999999999886 99999887666555555433 2344455789999
Q ss_pred HHHHHhccCCccccCChhhhhc
Q 011694 245 KLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.+||+++|.+|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.05 Aligned_cols=261 Identities=30% Similarity=0.541 Sum_probs=223.4
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+-..-|..++.||-|+||+|.+++...|...||+|.+.+...........++.|-.||....++.||+||..|.+++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34457889999999999999999999999999999999887766666788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+||||++||++-.++-+ +-++|+.++.|+..|.+|+++.|..|.|||||||+|||||.+|++||+||||++-++.....
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999999999888766 78999999999999999999999999999999999999999999999999998755422111
Q ss_pred C----------------------------------------CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHH
Q 011694 170 G----------------------------------------LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVL 209 (479)
Q Consensus 170 ~----------------------------------------~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~l 209 (479)
. +.+..+||+.|+|||++...+|. ..+|.||.|||||+|
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHH
Confidence 0 11223799999999999999996 899999999999999
Q ss_pred HhCCCCCCCChHHHHHHHhccC----cCCCCCCCCHHHHHHHHHhccCCccccCC---hhhhhcChhhhcc
Q 011694 210 LAGYLPFHDSNLIEMYRKIGKA----EFKCPNWFPPEVRKLLCKILDPNPSTRIS---MAKIRESSWFRKG 273 (479)
Q Consensus 210 l~G~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~eil~h~wf~~~ 273 (479)
+.|+.||.+.+..+...++.+- .+.....++.++.++|.++.. +++.|.. ++++..||||+..
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence 9999999888776555444332 334445689999999988654 5777775 6779999999754
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=319.78 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=202.3
Q ss_pred eeeeecCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecc
Q 011694 20 RLLGQGAFAKVYYARSIRTN---QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYA 96 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 96 (479)
+.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876554 78999999766443 34567889999999999999999999876 45689999999
Q ss_pred CCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC-Cccc
Q 011694 97 KGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG-LLHT 174 (479)
Q Consensus 97 ~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~-~~~~ 174 (479)
.+|+|.+++... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999874 59999999999999999999999999999999999999999999999999987543222110 0111
Q ss_pred cCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHHhcc
Q 011694 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 175 ~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~ 252 (479)
..++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+.......+... ....|..++..+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 1234679999999877765 89999999999999998 99999887766655555433 345667789999999999999
Q ss_pred CCccccCChhhhhc
Q 011694 253 PNPSTRISMAKIRE 266 (479)
Q Consensus 253 ~dP~~Rpt~~eil~ 266 (479)
++|.+|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=319.26 Aligned_cols=244 Identities=27% Similarity=0.502 Sum_probs=209.9
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+-.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ....+.+|+.+++.++|+||+++++++.+.+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 3457899999999999999999987 588999999976532 3567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 91 FVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999999999763 59999999999999999999999999999999999999999999999999987542111
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRK 245 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 245 (479)
....++..|+|||.+....+. .++||||||+++|++++ |..||...+.......+... ....|..+|+.+.+
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHH
Confidence 123456679999999766664 79999999999999997 99999887766655554433 33456668999999
Q ss_pred HHHHhccCCccccCChhhhhc
Q 011694 246 LLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~ 266 (479)
+|.+||..+|.+|||+.++++
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=327.73 Aligned_cols=251 Identities=31% Similarity=0.503 Sum_probs=210.0
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 95 (479)
|++.+.||+|++|.||+|.+..+++.+++|.+...... ......+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcc
Q 011694 96 AKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 96 ~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
+.+ +|.+.+.. +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 88887765 479999999999999999999999999999999999999999999999999986553322 1223
Q ss_pred ccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------------cCC
Q 011694 174 TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-------------------EFK 234 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~~ 234 (479)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+....+... ...
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 3458889999999977634458999999999999999999999877655443332110 000
Q ss_pred -----------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 235 -----------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 235 -----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
..+.++.++.++|.+||.+||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=324.60 Aligned_cols=250 Identities=21% Similarity=0.328 Sum_probs=205.6
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQS----VAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
.++|++.+.||+|+||+||+|.+..+++. |++|.+.... .......+..|+.+++.+.||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 46899999999999999999999877764 6677764321 12334677888889999999999999998754 55
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 89 IFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.++++||+.+|+|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999999999999965 46899999999999999999999999999999999999999999999999998754322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccCc-CCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 244 (479)
..........++..|+|||.+.+..++ .++||||+||++|+|++ |..||.+.........+..+. ...+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 222222344577889999999877765 89999999999999998 999998876555444443332 344556788999
Q ss_pred HHHHHhccCCccccCChhhhhc
Q 011694 245 KLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.+||..||.+|||+.++++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=323.01 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=211.5
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQ----SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
...+|++.+.||+|+||.||+|.+..+|+ .||+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45789999999999999999999877765 589998866532 2344678899999999999999999999987 7
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
..++||||+.+|+|.+.+.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 89999999999999999876 4699999999999999999999999999999999999999999999999999876542
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEV 243 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 243 (479)
...........++..|+|||.+....++ .++|+||+||++|++++ |..||......+....+... ....|..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2211111122345789999999776665 89999999999999998 99999988776666666543 345666788999
Q ss_pred HHHHHHhccCCccccCChhhhhc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+++.+||..||..|||+.++++
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=319.05 Aligned_cols=242 Identities=28% Similarity=0.487 Sum_probs=205.8
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE-EeCCEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM-ATKSKIF 90 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~ 90 (479)
-..+|++.+.||+|+||.||++.. .|..||+|.+.... ..+.+.+|+.+++.++||||+++++++ ..++..|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 346899999999999999999977 58889999986432 245688999999999999999999975 4567899
Q ss_pred EEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 91 FVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
++|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-- 154 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 154 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc--
Confidence 999999999999998753 388999999999999999999999999999999999999999999999999764321
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRK 245 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 245 (479)
......++..|+|||++.+..++ .++|||||||++|+|++ |+.||...+.......+... ....++.+|+.+.+
T Consensus 155 ---~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05082 155 ---TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYD 230 (256)
T ss_pred ---cCCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 11234456789999999877765 79999999999999997 99999887776666665443 33455678999999
Q ss_pred HHHHhccCCccccCChhhhhc
Q 011694 246 LLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~ 266 (479)
++.+||..+|.+|||+.++++
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=320.94 Aligned_cols=253 Identities=21% Similarity=0.364 Sum_probs=210.6
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQ---SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
|...+|+..+.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 445689999999999999999999876665 799999865432 233467889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
..|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999999865 4689999999999999999999999999999999999999999999999999865432
Q ss_pred cccCCCc-cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHH
Q 011694 166 KHQDGLL-HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPE 242 (479)
Q Consensus 166 ~~~~~~~-~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 242 (479)
....... .....++.|+|||++.+..++ .++||||+||++|+|++ |..||...+.......+... ..+.+..++.+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 238 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA 238 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2111111 112234579999999877765 89999999999999997 99999877766666666443 23334457899
Q ss_pred HHHHHHHhccCCccccCChhhhhc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+.+++.+||..+|.+||++.+|++
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=325.44 Aligned_cols=259 Identities=33% Similarity=0.571 Sum_probs=215.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIM-RVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 89 (479)
+|++.+.||+|+||.||++.+. .+++.||||++.+.... .......+.+|+.++..+ +||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999999764332 223456788999999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|+||||+.+|+|.+.+.. +.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 999999999999999875 5699999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCccccCCCCcccChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCh----HHHHHHHhccCcCCCCCCCCHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKG-YDGEKVDIWSCGVVLFVLLAGYLPFHDSN----LIEMYRKIGKAEFKCPNWFPPEV 243 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DvwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~ 243 (479)
......+|++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||...+ .......+.......|..+++++
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 161 -ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred -cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 1123356899999999986543 23579999999999999999999996432 23334444455566777789999
Q ss_pred HHHHHHhccCCccccCC---hhhhhcChhhhccc
Q 011694 244 RKLLCKILDPNPSTRIS---MAKIRESSWFRKGM 274 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt---~~eil~h~wf~~~~ 274 (479)
.++|.+||+.||++||| +.++++||||+...
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 99999999999999999 56779999997653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=321.17 Aligned_cols=263 Identities=30% Similarity=0.569 Sum_probs=233.6
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMAT 85 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (479)
.++.+-..+|.+++.||+|+|++|.+++++.|.+.+|+|++++.-.+..+-++.+..|-.+.... +||.+|.++.+|.+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 34556678999999999999999999999999999999999998877777778888888888766 69999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
+..+|+|.||++||+|--.+.+ .++||+.++.|...|+.||.|||++||+.||||..|+|+|..|++||+|+|++..
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke-- 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-- 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--
Confidence 9999999999999999655554 7899999999999999999999999999999999999999999999999999753
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC--------ChHHHHHHHhccCcCCCC
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD--------SNLIEMYRKIGKAEFKCP 236 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~--------~~~~~~~~~i~~~~~~~~ 236 (479)
.-......++.||||.|.|||++.+..| +..+|.|+|||++++|++|+.||+- .+..-+++-|....+..|
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip 479 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP 479 (593)
T ss_pred CCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc
Confidence 2234456788999999999999999888 5999999999999999999999962 223456777778888999
Q ss_pred CCCCHHHHHHHHHhccCCccccCC------hhhhhcChhhhc
Q 011694 237 NWFPPEVRKLLCKILDPNPSTRIS------MAKIRESSWFRK 272 (479)
Q Consensus 237 ~~~~~~~~~li~~~L~~dP~~Rpt------~~eil~h~wf~~ 272 (479)
..+|-.+..+++..|++||.+|.. ++++..|+||+.
T Consensus 480 rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 999999999999999999999985 678999999974
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=325.40 Aligned_cols=251 Identities=32% Similarity=0.514 Sum_probs=210.2
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 95 (479)
|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999998754 2223456778899999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcc
Q 011694 96 AKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 96 ~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
+.+ +|.+.+... .+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc--cccC
Confidence 985 899999874 79999999999999999999999999999999999999999999999999987543221 1223
Q ss_pred ccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC------------------cCCC
Q 011694 174 TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------------EFKC 235 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~~~ 235 (479)
...++..|+|||.+.+....+.++||||+||++|+|++|..||...+....+..+... ....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4456788999999976634458999999999999999999999877654443332110 0001
Q ss_pred -----------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 236 -----------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 236 -----------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+.++..+.++|.+||..||.+||++++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 11246789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=317.44 Aligned_cols=243 Identities=27% Similarity=0.422 Sum_probs=204.6
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGG 99 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (479)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++.+.+..|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999977 999999998765432 34567889999999999999999999999999999999999999
Q ss_pred ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 100 ELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 100 ~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
+|.+++.. ..+++..+..++.+++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999865 4689999999999999999999999999999999999999999999999999865432111111112234
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHHhccCCc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNP 255 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP 255 (479)
+..|+|||.+.+..+. .++|+|||||++|+|++ |..||...........+... ....|..+|..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 5679999999776664 89999999999999998 89999877765555555433 345566789999999999999999
Q ss_pred cccCChhhhhc
Q 011694 256 STRISMAKIRE 266 (479)
Q Consensus 256 ~~Rpt~~eil~ 266 (479)
.+|||+.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=328.89 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=212.4
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
....|...+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++|||++++++++...+..|+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 44568889999999999999999999999999999876443333445677889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 92 VMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
||||+.| +|.+.+.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 9999974 77776643 4689999999999999999999999999999999999999999999999998764321
Q ss_pred CCccccCCCCcccChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC--CCCCCCHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINR--KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK--CPNWFPPEVRK 245 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~--~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 245 (479)
.....+++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+...... .+..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 234568899999999853 222347999999999999999999999876654444333333221 23347889999
Q ss_pred HHHHhccCCccccCChhhhhcChhhhcc
Q 011694 246 LLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+|.+||..+|.+||++++++.|||+...
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=323.26 Aligned_cols=249 Identities=31% Similarity=0.453 Sum_probs=205.5
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEEeCCE----
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV---RHPNIVQLYEVMATKSK---- 88 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 88 (479)
|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 78999999999999999999889999999999754332 23345566788877766 59999999999988776
Q ss_pred -EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 89 -IFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 89 -~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
++++|||+.+ +|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999985 78888765 258999999999999999999999999999999999999999999999999986543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-----C------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-----F------ 233 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-----~------ 233 (479)
.. .......+++.|+|||++.+..+. .++|+||+||++|+|++|.+||.+.+..+...++.... .
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 22 222344578999999999877765 79999999999999999999998877655544442100 0
Q ss_pred ----------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 234 ----------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 234 ----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
...+.+++.+.++|.+||+.||.+||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0011245778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=318.70 Aligned_cols=242 Identities=26% Similarity=0.415 Sum_probs=200.3
Q ss_pred eeeecCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 21 LLGQGAFAKVYYARSI--RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 21 ~LG~G~fg~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999875 455679999986543 22345678899999999999999999998864 578999999999
Q ss_pred CChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC-CCcccc
Q 011694 99 GELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD-GLLHTT 175 (479)
Q Consensus 99 g~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~ 175 (479)
++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......... ......
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999864 57999999999999999999999999999999999999999999999999998754322111 111112
Q ss_pred CCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHHhccC
Q 011694 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDP 253 (479)
Q Consensus 176 ~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~ 253 (479)
.+++.|+|||.+....++ .++|||||||++|++++ |..||...........+..+ ...+|..+++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 335789999999876664 79999999999999996 99999887766666555433 3456777899999999999999
Q ss_pred CccccCChhhhhc
Q 011694 254 NPSTRISMAKIRE 266 (479)
Q Consensus 254 dP~~Rpt~~eil~ 266 (479)
||++||++.+|.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=321.64 Aligned_cols=252 Identities=28% Similarity=0.512 Sum_probs=211.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM--RVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
+|.+.+.||+|+||.||++.+..++..+++|++...... .......+.+|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888887888877543221 112234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 93 MEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
|||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++. +.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999988753 46999999999999999999999999999999999999964 67999999998654321
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-CCCCCCCCHHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKL 246 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 246 (479)
........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.+.+.......+.... ...+..++.++.++
T Consensus 159 -~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 159 -CDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred -cccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 1223345688999999999777765 78999999999999999999998777666555554332 33455688999999
Q ss_pred HHHhccCCccccCChhhhhcChhh
Q 011694 247 LCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 247 i~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
|.+||..||.+||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=317.78 Aligned_cols=243 Identities=26% Similarity=0.471 Sum_probs=204.7
Q ss_pred eeeeecCCeEEEEEEEcC-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecc
Q 011694 20 RLLGQGAFAKVYYARSIR-TNQ--SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYA 96 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 96 (479)
+.||+|+||.||+|.+.. +++ .||||.+...... ...+.+.+|+.+++.++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999776543 456788999999999999999999999988 8999999999
Q ss_pred CCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC-CCc
Q 011694 97 KGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD-GLL 172 (479)
Q Consensus 97 ~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~-~~~ 172 (479)
++++|.+.+... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 999999999763 5899999999999999999999999999999999999999999999999998765432111 111
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc--CcCCCCCCCCHHHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK--AEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~ 249 (479)
....++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+..+....+.. .....+..+|..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234577899999999877765 79999999999999998 9999987776665555542 2334455678999999999
Q ss_pred hccCCccccCChhhhhc
Q 011694 250 ILDPNPSTRISMAKIRE 266 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~ 266 (479)
||..+|.+|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=317.03 Aligned_cols=250 Identities=23% Similarity=0.407 Sum_probs=208.1
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
+++..++|++.+.||+|+||.||++.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 74 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP 74 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence 4678899999999999999999999864 45669999886542 224678899999999999999999999987 77
Q ss_pred EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 89 IFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.|++|||+++++|.+++.. ..++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 8999999999999999875 3578889999999999999999999999999999999999999999999999865432
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEV 243 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 243 (479)
... .......++..|+|||++....++ .++|+||+||++|++++ |..||...+.......+... ....+...+.++
T Consensus 155 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05073 155 NEY-TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 232 (260)
T ss_pred CCc-ccccCCcccccccCHhHhccCCcC-ccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHH
Confidence 111 111223456779999999776654 79999999999999998 99999887766655555433 234456688999
Q ss_pred HHHHHHhccCCccccCChhhhhc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+++.+||.++|.+||++.++++
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=322.03 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=209.9
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcC----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIR----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT- 85 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~- 85 (479)
+-.++|++.+.||+|+||.||.|.+.. ++..|++|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999876 35789999886432 23345778899999999999999999998765
Q ss_pred CCEEEEEEeccCCCChHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEee
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK---------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISD 156 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~D 156 (479)
....++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5778999999999999998864 3488999999999999999999999999999999999999999999999
Q ss_pred cCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCC
Q 011694 157 FGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFK 234 (479)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~ 234 (479)
||+++...............++..|+|||++.+..++ .++|||||||++|++++ |..||...+.......+... ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 9998754322111111233456789999999877665 89999999999999998 99999887766666555433 234
Q ss_pred CCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 235 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+..+|+++.+++.+||..||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 45567899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=330.09 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=199.5
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 97 (479)
+++.+|. +|.||.+++..+++.||||++....... .....+.+|+.+++.++||||+++++++.+.+..|++|||+.
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 3444444 4556666666799999999998753322 345789999999999999999999999999999999999999
Q ss_pred CCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc-----C
Q 011694 98 GGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ-----D 169 (479)
Q Consensus 98 gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~-----~ 169 (479)
+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||.+........ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999999875 4689999999999999999999999999999999999999999999999998764322111 1
Q ss_pred CCccccCCCCcccChhhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHH-HHhccC---------------
Q 011694 170 GLLHTTCGTPAYVAPEVINRK--GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMY-RKIGKA--------------- 231 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~--~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~-~~i~~~--------------- 231 (479)
.......++..|+|||++.+. .+ +.++||||+||++|+|++|..||......... ..+...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 112334578899999999653 35 47999999999999999999999865443222 111100
Q ss_pred ------------------cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 ------------------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 ------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
....+..++.++.+|+.+||..||.+|||++++++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000111346788999999999999999999999999997554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=330.99 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=205.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCC--CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEe----CC
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRT--NQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMAT----KS 87 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 87 (479)
+|++.+.||+|+||.||++.+..+ +..||||.+.... ........+.+|+.+++.+ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 9999999986532 1223346678899999999 59999999987543 25
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.+|++|||+. ++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6899999996 588888865 57999999999999999999999999999999999999999999999999998754322
Q ss_pred cc--CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc--------------
Q 011694 167 HQ--DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK-------------- 230 (479)
Q Consensus 167 ~~--~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 230 (479)
.. ........||+.|+|||++.+....+.++||||+||++|+|++|..||...+.......+..
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 11223457899999999986543334899999999999999999999987553322221100
Q ss_pred -------------C-cC---CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 231 -------------A-EF---KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 231 -------------~-~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
. .. ...+.++..+.+|+.+||+.||.+|||+.+++.||||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0 00 01123578899999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=323.99 Aligned_cols=266 Identities=26% Similarity=0.410 Sum_probs=213.2
Q ss_pred CCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEE
Q 011694 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEV 82 (479)
Q Consensus 4 ~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~ 82 (479)
++.....+-.++|++.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.++... .||||++++++
T Consensus 5 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 5 IDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred ecceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhhee
Confidence 34556677789999999999999999999999989999999999764322 2234556677766666 59999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 83 MATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
+.+....|++|||+.+ .|.+.+.. +.+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 83 FITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred eecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence 9999999999999854 67666654 569999999999999999999997 5999999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCChH-HHHHHHhccCc-CC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKG---YDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-IEMYRKIGKAE-FK 234 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~---~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~-~~ 234 (479)
+....... ......+++.|+|||.+.+.. ..+.++||||+|+++|+|++|+.||..... .+.+..+.... ..
T Consensus 162 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T cd06618 162 SGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238 (296)
T ss_pred chhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC
Confidence 86543211 122345788999999987543 124799999999999999999999976432 23333333222 12
Q ss_pred CC--CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 235 CP--NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 235 ~~--~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
.+ ..++.++.+|+.+||..||.+|||+++++.||||.....
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 22 236889999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=364.37 Aligned_cols=255 Identities=30% Similarity=0.548 Sum_probs=210.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE-------
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM------- 83 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~------- 83 (479)
-...+|+.++.||+||||.||+++++-+|+.||||.|.... .......+.+|+..+.+|+|||||+||..+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 35567999999999999999999999999999999998765 334567899999999999999999998200
Q ss_pred -----------------------------------------------------E------------------e-------
Q 011694 84 -----------------------------------------------------A------------------T------- 85 (479)
Q Consensus 84 -----------------------------------------------------~------------------~------- 85 (479)
. +
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0 0
Q ss_pred --------------------------C--------CEEEEEEeccCCCChHHHHhcCCCC--HHHHHHHHHHHHHHHHHH
Q 011694 86 --------------------------K--------SKIFFVMEYAKGGELFNKVAKGKLK--EDAARRYFQQLINAVDFC 129 (479)
Q Consensus 86 --------------------------~--------~~~~lV~E~~~gg~L~~~i~~~~l~--e~~~~~i~~qll~aL~~L 129 (479)
+ ..+||-||||+...|.+++..+.+. .+.++++|++|++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 2479999999998999999887664 889999999999999999
Q ss_pred HHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh----c------------cccCCCccccCCCCcccChhhhhcCC--
Q 011694 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ----C------------KHQDGLLHTTCGTPAYVAPEVINRKG-- 191 (479)
Q Consensus 130 H~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPEvl~~~~-- 191 (479)
|++||+||||||.||+++++++|||+|||+|+... . ....+..+..+||..|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999998622 0 11122345668999999999997765
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCCCC-hHHHHHHHhccCcCCCCCCCC----HHHHHHHHHhccCCccccCChhhhh
Q 011694 192 -YDGEKVDIWSCGVVLFVLLAGYLPFHDS-NLIEMYRKIGKAEFKCPNWFP----PEVRKLLCKILDPNPSTRISMAKIR 265 (479)
Q Consensus 192 -~~~~~~DvwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~eil 265 (479)
|+ .|+|+||||||||||+ .||... ........+.++.++.|..+. +.-..+|++||+.||.+|||+.|+|
T Consensus 794 ~Yn-~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 794 KYN-SKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccc-chhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 65 8999999999999998 467543 334556666666666663322 5677999999999999999999999
Q ss_pred cChhhh
Q 011694 266 ESSWFR 271 (479)
Q Consensus 266 ~h~wf~ 271 (479)
++.||-
T Consensus 870 ~s~llp 875 (1351)
T KOG1035|consen 870 NSELLP 875 (1351)
T ss_pred hccCCC
Confidence 999996
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=315.46 Aligned_cols=247 Identities=30% Similarity=0.474 Sum_probs=209.7
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTN----QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
+++.+.||.|+||.||.|.+..++ ..||+|++...... .....+..|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357899999999999999998766 89999999654321 245788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhcC-C--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 92 VMEYAKGGELFNKVAKG-K--LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~-~--l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
+|||+++++|.+.+... . +++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999999763 2 99999999999999999999999999999999999999999999999999875543311
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccCc-CCCCCCCCHHHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKL 246 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 246 (479)
... ....+++.|+|||.+.+..+ +.++||||+|+++|+|++ |..||...+.......+.... ...+..++.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 111 01236789999999966555 489999999999999998 899998877777666665433 34556689999999
Q ss_pred HHHhccCCccccCChhhhhc
Q 011694 247 LCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 247 i~~~L~~dP~~Rpt~~eil~ 266 (479)
+.+||..||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=316.03 Aligned_cols=247 Identities=25% Similarity=0.423 Sum_probs=208.0
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 47999999999999999999875 4678999998654332 356788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+++++|.+++.. +.++++.+..++.|++.|++|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 99999999999875 4689999999999999999999999999999999999999999999999999864322111 11
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~ 249 (479)
.....++..|+|||.+.+..+. .++||||||+++|+|++ |..||...........+..+ ....|...+..+.+|+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 1123356789999999877665 79999999999999998 99999887776666666443 233455578999999999
Q ss_pred hccCCccccCChhhhhcC
Q 011694 250 ILDPNPSTRISMAKIRES 267 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h 267 (479)
||..+|.+|||+.++++.
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HcccChhhCCCHHHHHHh
Confidence 999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=319.83 Aligned_cols=241 Identities=25% Similarity=0.417 Sum_probs=199.8
Q ss_pred eeeeecCCeEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecc
Q 011694 20 RLLGQGAFAKVYYARSIRTNQ--SVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIFFVMEYA 96 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 96 (479)
+.||+|+||.||+|.+..++. .+++|.+.... .......+.+|+.++.++ +||||+++++++...+..|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988876 46888776432 223446788999999999 7999999999999999999999999
Q ss_pred CCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 97 KGGELFNKVAKG-----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 97 ~gg~L~~~i~~~-----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
++|+|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999998642 378899999999999999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPN 237 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 237 (479)
+........ ......++.|+|||++....++ .++|||||||++|+|++ |..||.+.+....+..+... ....+.
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYVK---KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhhh---ccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 753221111 1122346679999999776665 89999999999999997 99999887766666665443 234455
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.++.++.+++.+||..||.+|||+.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 67899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=321.92 Aligned_cols=238 Identities=24% Similarity=0.325 Sum_probs=196.4
Q ss_pred eeeeecCCeEEEEEEEcCCCcE-------EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 20 RLLGQGAFAKVYYARSIRTNQS-------VAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~-------vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
+.||+|+||.||+|.+..++.. ||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4699999999999998765543 8888875432 23446778899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC--------eEEeecCchhh
Q 011694 93 MEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN--------LKISDFGLSAL 162 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~--------vkl~DFGla~~ 162 (479)
|||+++|+|..++... .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999999763 5899999999999999999999999999999999999987765 69999998754
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCChHHHHHHHhccCcCCCCCCCCH
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG-YLPFHDSNLIEMYRKIGKAEFKCPNWFPP 241 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (479)
.. ......+++.|+|||++.+....+.++||||+||++|+|++| ..||...+...... ........|...+.
T Consensus 158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWT 230 (258)
T ss_pred cC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcH
Confidence 32 123456889999999998755445899999999999999998 56766555443322 22334556666778
Q ss_pred HHHHHHHHhccCCccccCChhhhhcC
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
++.+||.+||+.||.+|||+++|++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=312.76 Aligned_cols=242 Identities=27% Similarity=0.475 Sum_probs=202.2
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGG 99 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (479)
+.||+|+||.||+|.. .++..||+|++..... ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4689999999999986 4688999999865432 233456889999999999999999999999999999999999999
Q ss_pred ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCC
Q 011694 100 ELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177 (479)
Q Consensus 100 ~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 177 (479)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ .......+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 99998865 3589999999999999999999999999999999999999999999999999864321111 11112344
Q ss_pred CCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHHhccCCc
Q 011694 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNP 255 (479)
Q Consensus 178 t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP 255 (479)
++.|+|||++.+..+. .++||||+|+++|++++ |..||...+.......+... ....+..++..+.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 6789999999776654 79999999999999998 99999887766555555433 335566789999999999999999
Q ss_pred cccCChhhhhc
Q 011694 256 STRISMAKIRE 266 (479)
Q Consensus 256 ~~Rpt~~eil~ 266 (479)
.+|||+.++++
T Consensus 236 ~~Rp~~~~l~~ 246 (250)
T cd05085 236 ENRPKFSELQK 246 (250)
T ss_pred ccCCCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=319.56 Aligned_cols=251 Identities=23% Similarity=0.390 Sum_probs=209.7
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.++|++.+.||+|+||+||+|+.+. +.+.|++|.+..... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 3789999999999999999999764 346799998865432 224577899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-C---------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeec
Q 011694 88 KIFFVMEYAKGGELFNKVAK-G---------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDF 157 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~---------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DF 157 (479)
..|+||||+++|+|.+++.. . .+++..+..++.||+.||.|||++||+||||||+||+++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999875 2 4899999999999999999999999999999999999999999999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccCc--CC
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE--FK 234 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~ 234 (479)
|++....... ........+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...........+.... ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 9975332111 1122334567789999998776664 79999999999999998 889998766666666554333 33
Q ss_pred CCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 235 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+..+|..+.+++.+||..||.+|||+.+++..
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=321.71 Aligned_cols=249 Identities=31% Similarity=0.494 Sum_probs=204.8
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEe
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 94 (479)
|.+.+.||+|+||+||+|.+..+++.|+||.+....... ......+|+..++.++ ||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 788999999999999999999999999999986543221 1223457899999999 9999999999999999999999
Q ss_pred ccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 95 YAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 95 ~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|+ +|+|.+.+... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---CC
Confidence 99 77898888752 6899999999999999999999999999999999999999999999999998754322 12
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------------c
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-------------------E 232 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 232 (479)
.....++..|+|||++.+....+.++|+||+|+++++|++|+.||...+....+..+... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999999865444458999999999999999999999776544333222110 0
Q ss_pred CC-----------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 233 FK-----------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 233 ~~-----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.. ..+..++++.++|++||..||.+|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=342.06 Aligned_cols=256 Identities=25% Similarity=0.494 Sum_probs=220.1
Q ss_pred ccCCCe-EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 11 VLTEKY-EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM-RVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 11 il~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
.-.++| +....||+|+|-+||+|.|..+|-.||.--+...... .....+++..|+.+|+.|+|||||++|+++.+..+
T Consensus 36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN 115 (632)
T ss_pred CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence 345566 4567799999999999999999999996655444433 33456899999999999999999999999987765
Q ss_pred --EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCCEEEec-CCCeEEeecCchhh
Q 011694 89 --IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRG--VYHRDIKPENLLLDE-NENLKISDFGLSAL 162 (479)
Q Consensus 89 --~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~g--ivHrDLkp~NILl~~-~g~vkl~DFGla~~ 162 (479)
+.+|+|.+.+|+|+.++++ +++....++.|++||+.||.|||++. |+|||||-+||+|+. .|.|||+|+|||++
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 8899999999999999998 78999999999999999999999995 999999999999984 59999999999998
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC-CChHHHHHHHhccCcCCC--CCCC
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH-DSNLIEMYRKIGKAEFKC--PNWF 239 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~-~~~~~~~~~~i~~~~~~~--~~~~ 239 (479)
.+... .....|||.|||||++. ..|+ ..+||||||++|.||.|+..||. ..+..++|+++..+..+- ..--
T Consensus 196 ~r~s~----aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 196 LRKSH----AKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred hhccc----cceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence 76433 23478999999999997 5676 89999999999999999999996 467789999987764321 1223
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.|++++||.+||.. ...|+|+.|+|.||||...
T Consensus 270 dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 58999999999999 9999999999999999875
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=317.13 Aligned_cols=252 Identities=27% Similarity=0.437 Sum_probs=208.3
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRT---NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
+-..+|.+.+.||+|+||.||+|.+... ...||||....... ....+.+.+|+.+++.++||||+++++++.+ +
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3456799999999999999999987544 34699998865432 2345678899999999999999999999876 4
Q ss_pred EEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
..|+||||+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 578999999999999999763 589999999999999999999999999999999999999999999999999865432
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEV 243 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 243 (479)
.... ......+++.|+|||.+....+. .++|||||||++|++++ |..||...+..+....+... ....|..+|+.+
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05056 160 ESYY-KASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 237 (270)
T ss_pred ccce-ecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 2111 11122345689999999777665 89999999999999986 99999887766655555443 345667789999
Q ss_pred HHHHHHhccCCccccCChhhhhcC
Q 011694 244 RKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+++.+||..+|.+|||+.+++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=316.10 Aligned_cols=228 Identities=27% Similarity=0.450 Sum_probs=193.1
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCChHHH
Q 011694 25 GAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK 104 (479)
Q Consensus 25 G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 104 (479)
|+||+||++++..+++.||+|.+..... ..+|...+....||||+++++++.+.+..|++|||++||+|.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976531 22344455556799999999999999999999999999999999
Q ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccC
Q 011694 105 VAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183 (479)
Q Consensus 105 i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 183 (479)
+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||++..... ......++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 876 5799999999999999999999999999999999999999999999999998754322 1233456788999
Q ss_pred hhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccccCCh--
Q 011694 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISM-- 261 (479)
Q Consensus 184 PEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-- 261 (479)
||.+.+..++ .++|+||+||++|+|++|..||....... ........|.++++.+.++|.+||+.||.+|||+
T Consensus 151 PE~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEET-EACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 9999776664 79999999999999999999886533211 0112345778899999999999999999999996
Q ss_pred ---hhhhcChhh
Q 011694 262 ---AKIRESSWF 270 (479)
Q Consensus 262 ---~eil~h~wf 270 (479)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=352.23 Aligned_cols=252 Identities=28% Similarity=0.426 Sum_probs=222.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
+-..+-+..+.||+|+||+||+|+... ....||||.++.... ......++||+.++..++|||||+++|++..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--NQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 445677788999999999999998643 345799999976542 2467899999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhcC-----------C----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKG-----------K----LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE 150 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~-----------~----l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g 150 (479)
++.+|+|+||+..|||..++... . ++..+...++.||+.|+.||-++..|||||-.+|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999998631 2 77889999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhc
Q 011694 151 NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIG 229 (479)
Q Consensus 151 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 229 (479)
.|||+||||++-....+.........-..+|||||.+....|+ .+|||||+||+|||+++ |+.||.+.+..+....+.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 9999999999876655555555455567899999999998886 79999999999999997 999999999888888886
Q ss_pred cCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhh
Q 011694 230 KAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIR 265 (479)
Q Consensus 230 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil 265 (479)
.+. +++|..+|.++.+||..||+.+|.+||++.||-
T Consensus 720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 720 AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 554 689999999999999999999999999999983
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=317.52 Aligned_cols=244 Identities=20% Similarity=0.302 Sum_probs=191.4
Q ss_pred eeeeecCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 011694 20 RLLGQGAFAKVYYARSIR--TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 97 (479)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 469999999999996533 44578888775432 22334567889999999999999999999999999999999999
Q ss_pred CCChHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 98 GGELFNKVAKG------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 98 gg~L~~~i~~~------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
+|+|.+++... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999998752 246788899999999999999999999999999999999999999999999854322111111
Q ss_pred ccccCCCCcccChhhhhcC------CCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHh-ccCcCC-----CCCC
Q 011694 172 LHTTCGTPAYVAPEVINRK------GYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKI-GKAEFK-----CPNW 238 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~------~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i-~~~~~~-----~~~~ 238 (479)
.....+++.|+|||++... ...+.++||||+||++|+|++ |..||............ ...... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 2234467789999998532 123579999999999999999 88999876655444433 222222 2334
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++...+++..|+ .||.+|||+++|++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7788899999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.57 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=202.5
Q ss_pred eeeeecCCeEEEEEEEcCCC------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 20 RLLGQGAFAKVYYARSIRTN------QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~------~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
+.||+|+||.||+|.+.... +.+|||.+..... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46999999999999986544 6899998865421 123467788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-----CeEEeecCch
Q 011694 94 EYAKGGELFNKVAK--------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-----NLKISDFGLS 160 (479)
Q Consensus 94 E~~~gg~L~~~i~~--------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-----~vkl~DFGla 160 (479)
||+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999999864 2378899999999999999999999999999999999999877 8999999998
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc-CcCCCCCC
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK-AEFKCPNW 238 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~ 238 (479)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+.. .....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 65432222122223456788999999987766 489999999999999998 9999987776666555543 23455667
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+|+.+.++|.+||..+|.+||++.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=322.83 Aligned_cols=251 Identities=21% Similarity=0.351 Sum_probs=206.1
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQ----SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
.++|++.+.||+|+||.||+|.+..+|+ .||+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4688999999999999999999988776 468888765432 22334678999999999999999999998754 4
Q ss_pred EEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 89 IFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.++++||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 67999999999999998763 6899999999999999999999999999999999999999999999999998765422
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc-CcCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK-AEFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~ 244 (479)
..........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.........+.. .....++.++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 221112234467789999999877765 89999999999999997 9999987655444333332 23445566789999
Q ss_pred HHHHHhccCCccccCChhhhhcC
Q 011694 245 KLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+++.+||..+|.+||+++++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=312.75 Aligned_cols=240 Identities=28% Similarity=0.486 Sum_probs=203.3
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++..+ ..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 36799999999999999999864 78899999986542 235678999999999999999999998765 47999
Q ss_pred EeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 93 MEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
|||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 9999999999998752 5899999999999999999999999999999999999999999999999998643211
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLL 247 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li 247 (479)
......+..|+|||.+.+..+. .++|+|||||++|+|++ |..||...+..+....+... ....+..+|+.+.+++
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence 1223346789999999776665 79999999999999997 99999888776666555443 2334556889999999
Q ss_pred HHhccCCccccCChhhhhc
Q 011694 248 CKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~ 266 (479)
.+||+.+|..||+++++++
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 231 TSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.99 Aligned_cols=237 Identities=24% Similarity=0.304 Sum_probs=192.3
Q ss_pred eeeecCCeEEEEEEEcCC------------------------CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc
Q 011694 21 LLGQGAFAKVYYARSIRT------------------------NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76 (479)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~------------------------~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnI 76 (479)
.||+|+||.||+|....+ ...|++|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975322 2358889886542 2334667889999999999999
Q ss_pred ceeEEEEEeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC----
Q 011694 77 VQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE---- 150 (479)
Q Consensus 77 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g---- 150 (479)
+++++++.+.+..|+||||+++|+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998864 5789999999999999999999999999999999999997654
Q ss_pred ---CeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHH-hCCCCCCCChHHHHHH
Q 011694 151 ---NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLL-AGYLPFHDSNLIEMYR 226 (479)
Q Consensus 151 ---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll-~G~~Pf~~~~~~~~~~ 226 (479)
.+|++|||++..... .....+++.|+|||.+.+....+.++||||+||++|+|+ +|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998753211 123457889999999876444458999999999999985 6999998765544322
Q ss_pred HhccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 227 KIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.. ......|...++.+.++|.+||+.+|.+|||+.+|+++
T Consensus 233 ~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FY-EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22 22334455567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.71 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=201.3
Q ss_pred CeEEeeeeeecCCeEEEEEEE----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CE
Q 011694 15 KYEVGRLLGQGAFAKVYYARS----IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK--SK 88 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 88 (479)
-|++.+.||+|+||.||+|.. ..++..||+|.+..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 468999999999999999974 45788999999865432 23456789999999999999999999998775 57
Q ss_pred EEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 89 IFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.++||||++|++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999998653 5899999999999999999999999999999999999999999999999998755322
Q ss_pred ccC-CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH---------------HHHHHHhc-
Q 011694 167 HQD-GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL---------------IEMYRKIG- 229 (479)
Q Consensus 167 ~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~---------------~~~~~~i~- 229 (479)
... .......++..|+|||++.+..+. .++||||+||++|+|+++..|+..... ......+.
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 211 112244567789999999877665 799999999999999998776532110 11111111
Q ss_pred cCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 230 KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 230 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
....+.+..+++.+.+|+.+||+.||.+|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 12234456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=317.14 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=199.9
Q ss_pred CCCeEEeeeeeecCCeEEEEEEE----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe--C
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARS----IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT--K 86 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~--~ 86 (479)
..+|++.+.||+|+||.||+|.. ..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 46899999999999999999974 4578899999986543 2334678899999999999999999998743 4
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
..+++||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 568999999999999999865 468999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCC-CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHH----------------HHHH
Q 011694 165 CKHQDG-LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE----------------MYRK 227 (479)
Q Consensus 165 ~~~~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~----------------~~~~ 227 (479)
...... ......++..|+|||++.+..+. .++||||+||++|+|++|..|+....... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 221110 11112244569999999877664 89999999999999999887765432110 0111
Q ss_pred hc-cCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 228 IG-KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 228 i~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+. ....+.+..++.++.+|+.+||..+|.+|||+.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 1123445568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=315.19 Aligned_cols=238 Identities=22% Similarity=0.303 Sum_probs=192.6
Q ss_pred eeeeecCCeEEEEEEEcC------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 20 RLLGQGAFAKVYYARSIR------------TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~------------~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
+.||+|+||.||+|.... ....|++|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 22358889876542 234467788999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC-------eEEeecC
Q 011694 88 KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN-------LKISDFG 158 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~-------vkl~DFG 158 (479)
..++||||+++|+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888864 46999999999999999999999999999999999999987664 8999999
Q ss_pred chhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHH-hCCCCCCCChHHHHHHHhccCcCCCCC
Q 011694 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLL-AGYLPFHDSNLIEMYRKIGKAEFKCPN 237 (479)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 237 (479)
++..... .....++..|+|||.+......+.++||||+||++|+|+ .|..||......+... ..........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCC
Confidence 8754321 123457889999999875444458999999999999998 5899988765443322 2222333333
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
..++++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 356889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=315.27 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=205.2
Q ss_pred eEEeeeeeecCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----
Q 011694 16 YEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS----- 87 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~----- 87 (479)
|++.+.||+|+||.||+|.+. .+++.||||++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999865 36789999999764332 234567889999999999999999999886532
Q ss_pred -EEEEEEeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 88 -KIFFVMEYAKGGELFNKVAK-------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 88 -~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
..++++||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 34789999999999887642 1478999999999999999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPN 237 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 237 (479)
+................+++.|++||.+....++ .++|||||||++|+|++ |..||...+....+..+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8754322211122233456789999999877765 79999999999999999 89999887776666655433 344556
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+++.+.+++.+||+.+|.+|||+.+++.+
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=313.83 Aligned_cols=244 Identities=19% Similarity=0.246 Sum_probs=192.0
Q ss_pred eeeeecCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 011694 20 RLLGQGAFAKVYYARSI--RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 97 (479)
+.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.++||||+++++++.+...+++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 35677999988655321 223567889999999999999999999999999999999999
Q ss_pred CCChHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 98 GGELFNKVAKG------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 98 gg~L~~~i~~~------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
+|+|.+++... ..++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999998642 356678889999999999999999999999999999999999999999999864322211111
Q ss_pred ccccCCCCcccChhhhhcCC------CCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHh-ccCcC--CCC---CC
Q 011694 172 LHTTCGTPAYVAPEVINRKG------YDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKI-GKAEF--KCP---NW 238 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~------~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i-~~~~~--~~~---~~ 238 (479)
.....+++.|+|||++.+.. ..+.++||||+||++|+|++ |..||...+..+..... ..... ..| ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22346788999999986432 12579999999999999996 99999876554433322 11111 112 23
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.++.+.+++.+|+ .+|.+|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 5788999999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=311.30 Aligned_cols=245 Identities=23% Similarity=0.391 Sum_probs=197.4
Q ss_pred eeeeecCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEEEEEEec
Q 011694 20 RLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA-TKSKIFFVMEY 95 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 95 (479)
+.||+|+||.||+|.+.. .+..||||.+.... .....+.+.+|+.+++.++||||+++++++. .++..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 34579999875432 2234567889999999999999999999765 45678999999
Q ss_pred cCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC--CC
Q 011694 96 AKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD--GL 171 (479)
Q Consensus 96 ~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~--~~ 171 (479)
+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999875 35678888999999999999999999999999999999999999999999998643321110 11
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~ 249 (479)
.....+++.|+|||.+.+..+. .++|||||||++|+|++ |.+||...+.......+... ....+..+|+.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1233467789999999877765 79999999999999999 56778776666555555443 233455678999999999
Q ss_pred hccCCccccCChhhhhcC
Q 011694 250 ILDPNPSTRISMAKIRES 267 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h 267 (479)
||.++|.+||++.+++..
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.23 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=208.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 93 (479)
+.+.+..||.|+.|.|++++.+.+|...|||.+..... .+..++|.+.+.++-+.. +|+||+.+|+|..+..++|.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 44567789999999999999999999999999977542 234567777787776654 899999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|.+.. -+..++++ ++++|..+-++...++.||.||.++ ||+|||+||+|||+|..|++|+||||+|...-.. .
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---k 246 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---K 246 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc---c
Confidence 99853 33444443 6799999999999999999999964 9999999999999999999999999998654321 1
Q ss_pred CccccCCCCcccChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCh-HHHHHHHhccCcCCCC---CCCCHHH
Q 011694 171 LLHTTCGTPAYVAPEVINR---KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKIGKAEFKCP---NWFPPEV 243 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~---~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~~~~---~~~~~~~ 243 (479)
.-....|.+.|||||.+.- ..|+ -.+||||||+.|++|.||..||.+.+ ..++..++.+...++- ..+|+.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence 2234579999999999853 3455 78999999999999999999998744 4577777766544322 2389999
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+|+..||.+|+.+||...++++|||+...-
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 9999999999999999999999999986543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=352.00 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=217.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQ-----SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
+-...-++.+.||+|+||.||.|....... .||||.+.+. .+.+....+.+|..+|+.++|||||+++|++-+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 335677899999999999999998765322 3888887654 344566888999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeec
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKG--------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDF 157 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DF 157 (479)
....+|++||++||+|..+|+.. .++..+...++.|++.|+.||++++.|||||..+|+||+....+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999863 3889999999999999999999999999999999999999999999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHH-HhccCcCCC
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYR-KIGKAEFKC 235 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~-~i~~~~~~~ 235 (479)
|+|+........+.-....-...|||||.+....+. .|+||||+||+|||+++ |..||.+.+..++.. ....+++..
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFt-skSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~ 925 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFT-SKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP 925 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccc-cccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence 999843322222221122334689999999987775 89999999999999998 999999998887777 445568889
Q ss_pred CCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 236 PNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 236 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
|..||..+.++|..||+.+|++||++..|++
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999999987
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=312.68 Aligned_cols=249 Identities=28% Similarity=0.557 Sum_probs=207.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEcC-CCcEEEEEEeecccc-------cchhhHHHHHHHHHHHHh-CCCCCcceeEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIR-TNQSVAVKVIDKDKI-------MRVGLADQIKREISVMRI-VRHPNIVQLYEVMAT 85 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~-------~~~~~~~~l~~Ei~il~~-l~hpnIv~l~~~~~~ 85 (479)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 788999998864321 122334566788888865 799999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
++..|++|||++|++|.+.+.. ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999888742 468999999999999999999996 7899999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCC-C-C
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC-P-N 237 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-~-~ 237 (479)
+....... ......|+..|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+....... + .
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 87543221 3345678999999999987666 489999999999999999999998877666665554443322 2 2
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+++++.++|.+||..||.+||++.++..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=322.96 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=208.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CC----CcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR--HP----NIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~--hp----nIv~l~~ 81 (479)
.+.++.++|++..+||+|+||+|-.+.+..++..||||++..-.. ..+..+-||.++.++. .| -+|.+.+
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 456789999999999999999999999999999999999965432 3345567899999984 33 3788889
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec----------
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---------- 148 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---------- 148 (479)
+|.-.++++||+|.+ |-++++++..+ +++.+.++.+.+||+.+++|||+.+++|.||||||||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999998 55999999984 5999999999999999999999999999999999999832
Q ss_pred ----------CCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 011694 149 ----------NENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD 218 (479)
Q Consensus 149 ----------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~ 218 (479)
+-.++|+|||-|+.-... -++.+.|..|.|||++.+-+++ .++||||+||||+|+.+|...|..
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceeccc
Confidence 224899999988753322 2567899999999999999997 899999999999999999999987
Q ss_pred ChHHH---HHHHhccC------------------cCCCCCC------------C-------------CHHHHHHHHHhcc
Q 011694 219 SNLIE---MYRKIGKA------------------EFKCPNW------------F-------------PPEVRKLLCKILD 252 (479)
Q Consensus 219 ~~~~~---~~~~i~~~------------------~~~~~~~------------~-------------~~~~~~li~~~L~ 252 (479)
.+..+ +...|... .+..|.. + -..+.+||++||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 65433 44333211 0110100 0 1347899999999
Q ss_pred CCccccCChhhhhcChhhhcc
Q 011694 253 PNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 253 ~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.||.+|+|+.|++.||||+..
T Consensus 392 fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFARL 412 (415)
T ss_pred cCccccccHHHHhcCHHhhcC
Confidence 999999999999999999754
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=314.65 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=204.5
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEc----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe--C
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSI----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT--K 86 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~--~ 86 (479)
...|++.+.||+|+||.||+|... .+++.||||++...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357888999999999999999864 35889999999765432 345788999999999999999999999877 5
Q ss_pred CEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
...+++|||+++++|.+++... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 6899999999999999999764 49999999999999999999999999999999999999999999999999987654
Q ss_pred ccccC-CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHH---------------HHHHh
Q 011694 165 CKHQD-GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE---------------MYRKI 228 (479)
Q Consensus 165 ~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~---------------~~~~i 228 (479)
..... .......++..|+|||.+.+..+. .++||||+|+++|+|++|..||....... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 22111 111123455679999999777664 89999999999999999999986542211 11111
Q ss_pred c-cCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 229 G-KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 229 ~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
. ....+.+..++.++.+++.+||.++|.+|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 1223445667899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=325.39 Aligned_cols=265 Identities=28% Similarity=0.453 Sum_probs=220.4
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc----hhhHHHHHHHHHHHHhCCCCCcceeEEEEE-
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR----VGLADQIKREISVMRIVRHPNIVQLYEVMA- 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~----~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~- 84 (479)
..+.++|-++++||+|+|++||+|.+....+.||||+-..++..+ +...+...+|..|++.|.||.||++|++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 467899999999999999999999999999999999986655433 234456779999999999999999999996
Q ss_pred eCCEEEEEEeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CCeeccCCCCCEEEe---cCCCeEEeecC
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSR--GVYHRDIKPENLLLD---ENENLKISDFG 158 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~--givHrDLkp~NILl~---~~g~vkl~DFG 158 (479)
+.+.+|-|+|||+|.+|.-+++.. -++|.+++.|+.||+.||.||.+. -|+|-||||.||||- ..|.+||+|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 556789999999999999999875 589999999999999999999976 599999999999994 35789999999
Q ss_pred chhhhhccccCC-----CccccCCCCcccChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-HH--HHH
Q 011694 159 LSALAQCKHQDG-----LLHTTCGTPAYVAPEVINR---KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI-EM--YRK 227 (479)
Q Consensus 159 la~~~~~~~~~~-----~~~~~~gt~~y~aPEvl~~---~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~-~~--~~~ 227 (479)
|+..++....+. +.....||.+|++||.+.- .+-.+.++||||.|||+|..+.|+.||...... .+ +..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 999877554432 2344579999999999842 334468999999999999999999999865332 22 222
Q ss_pred hcc-C--cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 228 IGK-A--EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 228 i~~-~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
|.+ . .++..+.+++++.+||++||++--++|..+.++..||+|....
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 322 2 3444456899999999999999999999999999999997654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=310.44 Aligned_cols=235 Identities=23% Similarity=0.283 Sum_probs=191.8
Q ss_pred eeeeecCCeEEEEEEEcCCC----------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 20 RLLGQGAFAKVYYARSIRTN----------QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~----------~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999998776 3477887654431 14678899999999999999999999888 778
Q ss_pred EEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-------CeEEeecCch
Q 011694 90 FFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-------NLKISDFGLS 160 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-------~vkl~DFGla 160 (479)
++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999999763 589999999999999999999999999999999999999887 7999999998
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcC-CCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccCcCCCCCC
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRK-GYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAEFKCPNW 238 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 238 (479)
..... .....++..|+|||++.+. ...+.++||||+||++|+|++ |..||...+.......... ....+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCCC
Confidence 65322 2234577889999999766 234589999999999999999 6888877654333222221 1222222
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
....+.++|.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3488999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.28 Aligned_cols=255 Identities=15% Similarity=0.218 Sum_probs=194.2
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCC---CcEEEEEEeecccccc--hhh------HHHHHHHHHHHHhCCCCCcc
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRT---NQSVAVKVIDKDKIMR--VGL------ADQIKREISVMRIVRHPNIV 77 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~--~~~------~~~l~~Ei~il~~l~hpnIv 77 (479)
..+..++|++.+.||+|+||+||+|.+..+ +..+|+|+........ ... ......++..+..+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 356778999999999999999999998877 6778888754332110 000 01122333455667899999
Q ss_pred eeEEEEEeCC----EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCe
Q 011694 78 QLYEVMATKS----KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENL 152 (479)
Q Consensus 78 ~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~v 152 (479)
+++++..... ..++++|++.. ++.+.+.. ...++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 9999876543 45788898754 56666655 347889999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhcccc-----CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH-H----
Q 011694 153 KISDFGLSALAQCKHQ-----DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-I---- 222 (479)
Q Consensus 153 kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~-~---- 222 (479)
+|+|||+|+....... ........||+.|+|||++.+..++ .++||||+||++|+|++|.+||...+. .
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999875532211 1112334799999999999887775 899999999999999999999976632 1
Q ss_pred ----HHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 223 ----EMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 223 ----~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+....+...... ++.+++.+.+++..|+..+|.+||++++|++
T Consensus 245 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 122333333333 3346899999999999999999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=309.57 Aligned_cols=267 Identities=24% Similarity=0.392 Sum_probs=216.6
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe--
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT-- 85 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~-- 85 (479)
+.-...+.|+-..+||+|.||+||+|+.+.+|+.||+|++-.+. .+.++.....+|+.+|..++|+|++.+++++..
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 44566788999999999999999999999999999998764432 233555566799999999999999999987743
Q ss_pred ------CCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeec
Q 011694 86 ------KSKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDF 157 (479)
Q Consensus 86 ------~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DF 157 (479)
...+|+||.+|+. +|+-.+... +++..++.+++++|++||.|+|.+.|+|||+||+|+||+.+|.+||+||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 2358999999987 888888763 7999999999999999999999999999999999999999999999999
Q ss_pred Cchhhhhcccc--CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhc--cCcC
Q 011694 158 GLSALAQCKHQ--DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG--KAEF 233 (479)
Q Consensus 158 Gla~~~~~~~~--~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~--~~~~ 233 (479)
|+++.+..... .......+.|.+|.+||.+.+...++++.|||+.|||+.+|++|.+-+.+.+.......|. .+.+
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99976543321 1223445679999999999988777899999999999999999999998766544433331 0100
Q ss_pred C--------------------CC-------------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 234 K--------------------CP-------------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 234 ~--------------------~~-------------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
. .| -.-.+++.+|+.++|..||.+|+++.+++.|.||.+...+
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 0 11 1123578899999999999999999999999999876543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.63 Aligned_cols=244 Identities=18% Similarity=0.282 Sum_probs=191.3
Q ss_pred eeeeecCCeEEEEEEEcCC--CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 011694 20 RLLGQGAFAKVYYARSIRT--NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 97 (479)
+.||+|+||+||+|..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 33566777655432 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 98 GGELFNKVAKG-----KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 98 gg~L~~~i~~~-----~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
+|+|.+++... .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999998752 3677788899999999999999999999999999999999999999999987532211111122
Q ss_pred cccCCCCcccChhhhhcCC------CCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccCc------CCCCCCC
Q 011694 173 HTTCGTPAYVAPEVINRKG------YDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE------FKCPNWF 239 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~------~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~------~~~~~~~ 239 (479)
...++++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+.... ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999985321 12478999999999999997 678997766655555443221 1223346
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
++.+.+++..|+ .+|.+|||+++|++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 788999999999 67999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.31 Aligned_cols=243 Identities=33% Similarity=0.532 Sum_probs=198.5
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS----- 87 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~----- 87 (479)
.+-|..-+.||+|+||.||+++++.||+.||||.+++.... ...+..-+|+.+|++++|||||+++++-++..
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 36688889999999999999999999999999999876533 34578889999999999999999999876554
Q ss_pred -EEEEEEeccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe--cCCC--eEEeecC
Q 011694 88 -KIFFVMEYAKGGELFNKVAK----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD--ENEN--LKISDFG 158 (479)
Q Consensus 88 -~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~--~~g~--vkl~DFG 158 (479)
...+|||||.||+|+..+.+ .+++|.+.+.++..+..||.|||++||+||||||+||++- .+|. .||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 46899999999999999986 3799999999999999999999999999999999999995 3343 7999999
Q ss_pred chhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH-----HHHHHHhccC--
Q 011694 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-----IEMYRKIGKA-- 231 (479)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~-----~~~~~~i~~~-- 231 (479)
.|+-.+ .+....+..||+.|.+||++....+++..+|.||+||++|++.||..||..... .-++..+.+.
T Consensus 170 ~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 997654 344677889999999999998655566899999999999999999999954321 1233322111
Q ss_pred ------------------cCCCCCCCCHH----HHHHHHHhccCCccccCC
Q 011694 232 ------------------EFKCPNWFPPE----VRKLLCKILDPNPSTRIS 260 (479)
Q Consensus 232 ------------------~~~~~~~~~~~----~~~li~~~L~~dP~~Rpt 260 (479)
.++.|..+++. +-.++..+|..+|.+|..
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 12233333433 456888899999999994
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=335.77 Aligned_cols=260 Identities=27% Similarity=0.501 Sum_probs=224.3
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEe---
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMAT--- 85 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~--- 85 (479)
.-..+.|++..+||.|.+|+||+++++++++.+|+|+.+... +..++++.|..+++.+. |||++.++++|.-
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 345788999999999999999999999999999999998764 34478889999999884 9999999999853
Q ss_pred --CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 86 --KSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 86 --~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
++.+|||||||.||+..|+++. +++.|+.+..|++.++.|+.+||.+.++|||||-.|||++.+|.|||+|||.+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 4689999999999999999986 57999999999999999999999999999999999999999999999999998
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcC-----CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc---
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRK-----GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--- 232 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-----~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--- 232 (479)
+..+.. .+.-.+..|||.|||||++... .|+ ..+|+||||++..||-.|.+|+-+..+...+-.|..+.
T Consensus 171 aQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 171 AQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeeecc--cccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 755433 3345678999999999999643 244 68999999999999999999999888776665554432
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 233 FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 233 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
+.-|...+.++.+||..||.+|-.+||+..++++|||.+....+
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~~e 291 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQPNE 291 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccccH
Confidence 22344467899999999999999999999999999999866543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=313.78 Aligned_cols=247 Identities=30% Similarity=0.484 Sum_probs=195.6
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-EEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS-KIFF 91 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~l 91 (479)
+++|.-.+.||+|+||.||+|... +|..||||.+....... ..++.+|+.++.+++|||+|+++|+|.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 467888899999999999999874 44899999876654321 345999999999999999999999999998 5999
Q ss_pred EEeccCCCChHHHHhc--C-CCCHHHHHHHHHHHHHHHHHHHHCC---CeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 92 VMEYAKGGELFNKVAK--G-KLKEDAARRYFQQLINAVDFCHSRG---VYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~--~-~l~e~~~~~i~~qll~aL~~LH~~g---ivHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
|+||++.|+|.+.+.. + .+++....+|+.+++.||+|||+.. |+||||||+|||||++.+.||+|||+|.....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999976 3 7899999999999999999999864 99999999999999999999999999964332
Q ss_pred cccCCCcccc-CCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh------HHHHHH-HhccCc---C-
Q 011694 166 KHQDGLLHTT-CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN------LIEMYR-KIGKAE---F- 233 (479)
Q Consensus 166 ~~~~~~~~~~-~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~------~~~~~~-~i~~~~---~- 233 (479)
. .....+. .||.+|+|||.+..... +.|+||||+||+|.||++|+.|.+... ...... .+.... +
T Consensus 230 ~--~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 230 G--DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred c--ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 1 2222222 89999999999976444 589999999999999999998887432 122111 111111 1
Q ss_pred --CCC-CCCC--HH---HHHHHHHhccCCccccCChhhhhc
Q 011694 234 --KCP-NWFP--PE---VRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 234 --~~~-~~~~--~~---~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
... ..++ .. +..+..+|++.+|..||++.++++
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111 1223 22 456778899999999999999743
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.50 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=179.7
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCC----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE---
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRT----NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEV--- 82 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~----~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~--- 82 (479)
..-.++|++.+.||+|+||.||+|.+..+ +..||||.+...... +....+ .++...+.++..+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 34567999999999999999999999988 999999987543211 111111 1122222233222221
Q ss_pred ---EEeCCEEEEEEeccCCCChHHHHhcCCC---------------------CHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 011694 83 ---MATKSKIFFVMEYAKGGELFNKVAKGKL---------------------KEDAARRYFQQLINAVDFCHSRGVYHRD 138 (479)
Q Consensus 83 ---~~~~~~~~lV~E~~~gg~L~~~i~~~~l---------------------~e~~~~~i~~qll~aL~~LH~~givHrD 138 (479)
......+++||||+.+++|.+++....+ .+..+..++.||+.||.|||++||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2456679999999999999998875322 2344678999999999999999999999
Q ss_pred CCCCCEEEec-CCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCC---------------------CCc
Q 011694 139 IKPENLLLDE-NENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD---------------------GEK 196 (479)
Q Consensus 139 Lkp~NILl~~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~---------------------~~~ 196 (479)
|||+|||++. ++.+||+|||+|+...... .......++|+.|+|||.+...... +.+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999999985 6899999999997543221 2233466899999999976432211 245
Q ss_pred cchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC---------------------CCCCCCCHHHHHHHHHhccCCc
Q 011694 197 VDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF---------------------KCPNWFPPEVRKLLCKILDPNP 255 (479)
Q Consensus 197 ~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------------------~~~~~~~~~~~~li~~~L~~dP 255 (479)
+||||+||+||+|+++..|++... ......+..... ......+....+||.+||++||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 699999999999999877765321 111111111111 0011112345689999999999
Q ss_pred cccCChhhhhcChhhhcc
Q 011694 256 STRISMAKIRESSWFRKG 273 (479)
Q Consensus 256 ~~Rpt~~eil~h~wf~~~ 273 (479)
.+|||+.++++||||...
T Consensus 439 ~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 439 RQRISAKAALAHPYFDRE 456 (566)
T ss_pred ccCCCHHHHhCCcCcCCC
Confidence 999999999999999653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.30 Aligned_cols=239 Identities=44% Similarity=0.812 Sum_probs=206.8
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCChHHHH
Q 011694 26 AFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV 105 (479)
Q Consensus 26 ~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 105 (479)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..++.++|+||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999999999999999976543321 578899999999999999999999999999999999999999999999
Q ss_pred hcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccCh
Q 011694 106 AKGK-LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAP 184 (479)
Q Consensus 106 ~~~~-l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 184 (479)
.... ++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||++....... ......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence 7754 8999999999999999999999999999999999999999999999999987543321 33456788999999
Q ss_pred hhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC-ChHHHHHHHhccCcCCCCCC---CCHHHHHHHHHhccCCccccCC
Q 011694 185 EVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKIGKAEFKCPNW---FPPEVRKLLCKILDPNPSTRIS 260 (479)
Q Consensus 185 Evl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rpt 260 (479)
|.+.+..++ .++||||+|+++|++++|..||.. .+.......+.......... ++.++.+++.+||..+|.+||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999877775 799999999999999999999987 55555555554444333222 8899999999999999999999
Q ss_pred hhhhhcChhh
Q 011694 261 MAKIRESSWF 270 (479)
Q Consensus 261 ~~eil~h~wf 270 (479)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=287.86 Aligned_cols=251 Identities=25% Similarity=0.496 Sum_probs=204.4
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC--EE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKS--KI 89 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~--~~ 89 (479)
.++|++.+++|+|.|++||.|++..+++.++||++..-+ .+.++||+.||..|. ||||++++++..+.. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 468999999999999999999999999999999986543 367899999999997 999999999997654 46
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-CCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-NENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-~g~vkl~DFGla~~~~~~~~ 168 (479)
.+|+||++..+...+. ..++.-.++.|+.+|+.||.|||++||+|||+||.|++||. ...++|+|+|+|.++...
T Consensus 111 aLiFE~v~n~Dfk~ly--~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-- 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY--PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-- 186 (338)
T ss_pred hhHhhhhccccHHHHh--hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC--
Confidence 7999999886654443 34888899999999999999999999999999999999985 567999999999765433
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC-CChHHHHHHHhc-------------cC---
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH-DSNLIEMYRKIG-------------KA--- 231 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~-~~~~~~~~~~i~-------------~~--- 231 (479)
...+..+.+..|--||.+..-......-|+||+||+|..|+..+-||. +.+......+|. +-
T Consensus 187 -~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 187 -KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred -ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 334566788899999999876655689999999999999999999984 332222222211 00
Q ss_pred ----------cCCCCCC-----------CCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 ----------EFKCPNW-----------FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 ----------~~~~~~~-----------~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..+..+| .++++.+|+.++|..|-.+|+|+.|++.||||..-.
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 1111111 469999999999999999999999999999997544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.31 Aligned_cols=251 Identities=28% Similarity=0.449 Sum_probs=210.9
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcC--CCc--EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIR--TNQ--SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~--~~~--~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
+-.+..++.+.||+|-||.||.|.... .|+ .||||+-+.+... +..+.+..|..+|+.++|||||+++|++.+.
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 344555667899999999999998643 233 5899988765432 3367888999999999999999999999865
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
.+|||||+++-|+|..+++. ..++......|..||+.||+|||+...+||||-..|||+.+..-|||+|||+++...
T Consensus 464 -P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred -ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 58999999999999999987 468899999999999999999999999999999999999999999999999999876
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc-CcCCCCCCCCHH
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK-AEFKCPNWFPPE 242 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~ 242 (479)
........ ...-..-|||||-++-..+. .++|||-+||++||++. |..||.+-...+..-.+.+ .++++|+.||+.
T Consensus 543 d~~yYkaS-~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~ 620 (974)
T KOG4257|consen 543 DDAYYKAS-RGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPA 620 (974)
T ss_pred ccchhhcc-ccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChH
Confidence 54433221 22234569999999888886 79999999999999886 9999998766665555544 468999999999
Q ss_pred HHHHHHHhccCCccccCChhhhhc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+..|+.+||+.||.+||++.+|..
T Consensus 621 LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHHH
Confidence 999999999999999999888743
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.22 Aligned_cols=258 Identities=25% Similarity=0.440 Sum_probs=221.9
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcC-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIR-TNQ--SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
|-.++..+.++||+|.||.|+.|.+.. +|+ .||||++..+.... ....+.+|+.+|.+|+|||++++||+..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 556778889999999999999998864 333 59999998776543 56788999999999999999999999988 7
Q ss_pred EEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 88 KIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
.+.+|||+|++|+|.+.+.. +.|.......|+.||+.|+.||.++++|||||-..|+||.....||||||||.+-..
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78999999999999999986 458889999999999999999999999999999999999999999999999987554
Q ss_pred cccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc-CcCCCCCCCCH
Q 011694 165 CKHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK-AEFKCPNWFPP 241 (479)
Q Consensus 165 ~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~ 241 (479)
.... ........-...|+|||.+....+. .++|||++||++|||++ |..||.+.+...++.+|.. ..++.|..||.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cse 342 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSE 342 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChH
Confidence 3221 1111122345679999999988886 89999999999999998 8999999999999888864 45788999999
Q ss_pred HHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
++.++++.||..+|.+|||+..|.+.-+...
T Consensus 343 dIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 9999999999999999999999987666543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=291.20 Aligned_cols=252 Identities=23% Similarity=0.387 Sum_probs=205.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH-hCCCCCcceeEEEEEeCCEEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR-IVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
+.+-...||.|+||+|++-.++.+|+..|||.|...... ....++..|..... .-++||||++||....++..||.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~--keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE--KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch--HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 344467899999999999999999999999999877653 33467777887554 457999999999999999999999
Q ss_pred eccCCCChHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 94 EYAKGGELFNKV------AKGKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 94 E~~~gg~L~~~i------~~~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
|+++- +|..+. .+..++|..+-.+..-.+.||.||... .|+|||+||+|||++..|.+||||||++......
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 99965 543332 235799999999999999999999965 8999999999999999999999999998654322
Q ss_pred ccCCCccccCCCCcccChhhhh--cCCCCCCccchhhHHHHHHHHHhCCCCCCCCh-HHHHHHHhccCcCCC---CCC--
Q 011694 167 HQDGLLHTTCGTPAYVAPEVIN--RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKIGKAEFKC---PNW-- 238 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~--~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~~~---~~~-- 238 (479)
- ..+...|...|||||.+. +.+|+ -++||||||++|||+.||..|+..-+ ..+....+..+.++. +..
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 1 123446889999999995 34676 89999999999999999999998754 456666665554432 222
Q ss_pred -CCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 239 -FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 239 -~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
++..+..+|..||.+|-..||...+++++||++..
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 78899999999999999999999999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=312.97 Aligned_cols=262 Identities=19% Similarity=0.296 Sum_probs=190.1
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEc----------------CCCcEEEEEEeecccccch-----------hhHHHHH
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSI----------------RTNQSVAVKVIDKDKIMRV-----------GLADQIK 62 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~~~~vaiK~i~~~~~~~~-----------~~~~~l~ 62 (479)
++-.++|++.++||+|+||.||+|... ..++.||||.+........ ...+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 455789999999999999999999752 2456799999865321100 0112233
Q ss_pred HHHHHHHhCCCCCc-----ceeEEEEEe--------CCEEEEEEeccCCCChHHHHhcC---------------------
Q 011694 63 REISVMRIVRHPNI-----VQLYEVMAT--------KSKIFFVMEYAKGGELFNKVAKG--------------------- 108 (479)
Q Consensus 63 ~Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~~--------------------- 108 (479)
.|+.++.+++|.++ +++++++.. .+..|+||||+++++|.+++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46667777766544 667776643 35689999999999998887531
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccCh
Q 011694 109 ----KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAP 184 (479)
Q Consensus 109 ----~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 184 (479)
.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ .......+||.|+||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 235567889999999999999999999999999999999999999999999864432111 111123458999999
Q ss_pred hhhhcCC--------------------CC-CCccchhhHHHHHHHHHhCCC-CCCCCh-----------HHHHHHHhccC
Q 011694 185 EVINRKG--------------------YD-GEKVDIWSCGVVLFVLLAGYL-PFHDSN-----------LIEMYRKIGKA 231 (479)
Q Consensus 185 Evl~~~~--------------------~~-~~~~DvwSlGvil~~ll~G~~-Pf~~~~-----------~~~~~~~i~~~ 231 (479)
|++.... |. ..+.||||+||++|+|++|.+ ||.+.. ....++.+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9985322 11 134799999999999999986 775421 11222223223
Q ss_pred cC--CCCCCCCHHHHHHHHHhccCCc---cccCChhhhhcChhhhc
Q 011694 232 EF--KCPNWFPPEVRKLLCKILDPNP---STRISMAKIRESSWFRK 272 (479)
Q Consensus 232 ~~--~~~~~~~~~~~~li~~~L~~dP---~~Rpt~~eil~h~wf~~ 272 (479)
.+ ...+..++...+|+.+||..+| .+|+|++|+|+||||..
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 33 3334578999999999999866 78999999999999964
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.14 Aligned_cols=250 Identities=26% Similarity=0.468 Sum_probs=220.3
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
.++|++-..+..+.++||-|.||.||.|.+++-.-.||||.+..+.. ..+++..|..+|+.++|||+|+++++|..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 35777777788889999999999999999999888999999865532 24778899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
+..+|||.||+..|.|.++++.. .++.-....++.||.+|+.||..++.|||||-..|+|+.++..|||+||||+++
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999999999862 477778888999999999999999999999999999999999999999999998
Q ss_pred hhccccCCCccccCC---CCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCC
Q 011694 163 AQCKHQDGLLHTTCG---TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPN 237 (479)
Q Consensus 163 ~~~~~~~~~~~~~~g---t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 237 (479)
+.... .....| ..-|.|||-+....+. .|+|||++||+||++.| |-.||.+-+....|..+.++ +..-|.
T Consensus 415 MtgDT----YTAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~Pe 489 (1157)
T KOG4278|consen 415 MTGDT----YTAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPE 489 (1157)
T ss_pred hcCCc----eecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCC
Confidence 65322 122223 4569999999877776 79999999999999997 89999999998888877655 456788
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhh
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKI 264 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~ei 264 (479)
.||+.+.+||+.||+++|.+||+++||
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 999999999999999999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=308.30 Aligned_cols=255 Identities=30% Similarity=0.475 Sum_probs=213.4
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC------CCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR------HPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~------hpnIv~l~~ 81 (479)
=|+++..+|.+....|+|-|++|..|.+...|..||||+|..+. -+.+.=.+|+.+|++|+ --|+++|+.
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 46789999999999999999999999999999999999997754 34455678999999996 248999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-CeEEee
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAK-G---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISD 156 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~-~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-~vkl~D 156 (479)
.|...+++|||+|-+.. .|.+.++. | +|....++.|++||+.||..|-..||+|.||||.|||++++. .+||||
T Consensus 502 ~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred HhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence 99999999999999865 78888876 3 588999999999999999999999999999999999998654 589999
Q ss_pred cCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC
Q 011694 157 FGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP 236 (479)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (479)
||-|..+. ......+..+..|.|||++.+.+|+ ...|+||.||+||+|.||+..|++.+...+++......-++|
T Consensus 581 fGSA~~~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 581 FGSASFAS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred Cccccccc----cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 99886542 2333445567789999999999998 899999999999999999999998776665544321111111
Q ss_pred C-----------------------------------------------------CCC-------HHHHHHHHHhccCCcc
Q 011694 237 N-----------------------------------------------------WFP-------PEVRKLLCKILDPNPS 256 (479)
Q Consensus 237 ~-----------------------------------------------------~~~-------~~~~~li~~~L~~dP~ 256 (479)
. .+| ..+.+||.+||..||.
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 0 011 3478999999999999
Q ss_pred ccCChhhhhcChhhhc
Q 011694 257 TRISMAKIRESSWFRK 272 (479)
Q Consensus 257 ~Rpt~~eil~h~wf~~ 272 (479)
+|.|+.++|.||||..
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999953
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.69 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=213.8
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
+.......++++||+|-||+|.+|.- ..+..||||+++..... .....+.+||++|.+++|||||++++++..++.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 34567788999999999999999986 33689999999876533 3457899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 90 FFVMEYAKGGELFNKVAKGKL---KEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~~l---~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
++|+||++.|+|..++..... .-....+++.||++|++||.+.+++||||.+.|+|++.++++||+|||+|+-....
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 999999999999999987532 34556779999999999999999999999999999999999999999999865544
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHH--hCCCCCCCChHHHHHHHhcc--------CcCCCC
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLL--AGYLPFHDSNLIEMYRKIGK--------AEFKCP 236 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll--~G~~Pf~~~~~~~~~~~i~~--------~~~~~~ 236 (479)
.........+-..+|||||.+....+. .++|+|++|++|||++ +...||...+......+... .-+..|
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 444444455667899999999888886 7999999999999876 58899988776655544321 124567
Q ss_pred CCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 237 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.-+|..+.++|.+|+..|-.+|||++++-.
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 789999999999999999999999999843
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=291.70 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=212.9
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK---- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (479)
++-.+|.-++.+|.|+- .|..|.+..++++||+|.+...... .....+..+|..++..++|+||++++.+|.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 44568988999999999 8999999999999999998776333 34457778999999999999999999998543
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 --SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
...|+||||+++ +|...+. -.++-+.+..++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 358999999976 7877776 457888999999999999999999999999999999999999999999999997533
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------- 231 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 231 (479)
.+-..+..+.|..|.|||++.+.+|. +.+||||+||++.+|++|...|.+.+....+.++...
T Consensus 170 ---~~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 ---TDFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ---cccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 22345677899999999999999975 8999999999999999999999877655554443110
Q ss_pred -----------c---CC----CCCC-----------CCHHHHHHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 232 -----------E---FK----CPNW-----------FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 232 -----------~---~~----~~~~-----------~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
+ +. +|+. -+..+++++.+||..||++|.+++++|.||||+-++..
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~ 319 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP 319 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc
Confidence 0 00 1111 12458899999999999999999999999999855433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=316.47 Aligned_cols=254 Identities=22% Similarity=0.397 Sum_probs=221.6
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQ---SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
+|-...-.|.+.||.|.||+|+.|+.+..|+ .||||.++..... .....+..|..||-+.+||||++|.|+....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte--kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH--HHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 3445566889999999999999999988774 5999999765433 4456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
..+.||.||++.|+|..+++. |.++..++..+++.|+.|+.||-+.|+|||||...|||++.+-.+|++||||+++..
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999999999986 679999999999999999999999999999999999999999999999999999775
Q ss_pred ccccCCCccccCC--CCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCC
Q 011694 165 CKHQDGLLHTTCG--TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFP 240 (479)
Q Consensus 165 ~~~~~~~~~~~~g--t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 240 (479)
... .....+.-| ..+|.|||.+....+. .++||||+||+|||.++ |.-||-+.+..+....|..+ +++.|..||
T Consensus 783 dd~-~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP 860 (996)
T KOG0196|consen 783 DDP-EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCP 860 (996)
T ss_pred cCC-CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCc
Confidence 443 222233323 4689999999988886 79999999999998775 99999998888888888654 567788899
Q ss_pred HHHHHHHHHhccCCccccCChhhhhcC
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
..+..|+..||++|-.+||++.+|+.+
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999999764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=300.31 Aligned_cols=200 Identities=30% Similarity=0.548 Sum_probs=180.5
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhH-----HHHHHHHHHHHhCC---CCCcceeEEEEEe
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLA-----DQIKREISVMRIVR---HPNIVQLYEVMAT 85 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~-----~~l~~Ei~il~~l~---hpnIv~l~~~~~~ 85 (479)
.+|..++.||+|+||.|++|.++.+...|+||.|.++++.-.... -.+-.||+||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 359999999999999999999999999999999988766433322 13567999999997 9999999999999
Q ss_pred CCEEEEEEecc-CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 86 KSKIFFVMEYA-KGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 86 ~~~~~lV~E~~-~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
++++||+||-- +|.+||++|+. .+++|.++..+|+|++.|+++||+.||+|||||-||+.++.+|-+||+|||-|...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 99999999976 45699999997 47999999999999999999999999999999999999999999999999998764
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH 217 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~ 217 (479)
..+...+.+||..|.|||++.+..|-|..-|||+||++||-+....-||.
T Consensus 721 ----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 ----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 34567788999999999999999999999999999999999998888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=307.29 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=221.9
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
-..++|+++..+|.|+||.||+|+++.+++..|+|+++...- ....-+..||-+++..+|||||.+++.+-.....|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 456899999999999999999999999999999999977643 23466788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
|.||||.||+|.+.-.- +.++|.++....+..+.|++|||+.|-+|||||-.|||+++.|.+|++|||.+..+...-
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-- 166 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-- 166 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh--
Confidence 99999999999987654 899999999999999999999999999999999999999999999999999986543222
Q ss_pred CCccccCCCCcccChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCC-----CCCH
Q 011694 170 GLLHTTCGTPAYVAPEVIN---RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN-----WFPP 241 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~---~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-----~~~~ 241 (479)
.......|||+|||||+-. ..+|. ..+|||++|+...++---.+|-.+...........+..+..|. ..++
T Consensus 167 ~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 2235678999999999963 45565 8999999999999998888887766666555555555555443 3678
Q ss_pred HHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+.+|++.+|.++|++|||++.+|.|||....
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 99999999999999999999999999998654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=281.96 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=207.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS-----KI 89 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 89 (479)
+.+--+.||-|+||.||.+.+..+|+.||+|.+..- ..+-...+++.+|+.++...+|.||+..+++..-.+ .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 345568899999999999999999999999988542 222234578899999999999999999999876543 36
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|++.|.+.. +|...|.. ..++.+.++-+.+||++||.|||+.||.||||||.|+|+++|..+||||||+|+.-+....
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 888998855 78887765 5799999999999999999999999999999999999999999999999999987554433
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHh--------------------
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI-------------------- 228 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i-------------------- 228 (479)
.. ....+.|-+|.|||++.+...++.+.||||.|||+.|||..+..|...++.+....|
T Consensus 212 ~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 212 LN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 32 334467889999999998877778999999999999999999999766554433332
Q ss_pred ---ccCcCCCCC-----------CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 229 ---GKAEFKCPN-----------WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 229 ---~~~~~~~~~-----------~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.++..+.|+ .-..+...++..+|..||++|++.++.+.|++..++
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111222222 122467889999999999999999999999997654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=331.73 Aligned_cols=237 Identities=24% Similarity=0.351 Sum_probs=187.8
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
..|...+.||+|+||.||+|.+..++..||||.+...... ...|+..+++++|||||++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3466678999999999999999999999999998653321 134688999999999999999999999999999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 94 EYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH---SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 94 E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH---~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
||+++|+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 763 Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------ 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------ 833 (968)
T ss_pred eCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence 99999999999964 899999999999999999999 6799999999999999988888776 66543221
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh-----HHHHHHHhcc---------CcC---
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-----LIEMYRKIGK---------AEF--- 233 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-----~~~~~~~i~~---------~~~--- 233 (479)
......||+.|+|||++.+..++ .++||||+||++|||++|+.||+... .....+.... ...
T Consensus 834 ~~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 834 TDTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred cCCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 11234688999999999887775 89999999999999999999995421 1111111100 000
Q ss_pred -CCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 234 -KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 234 -~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
..+.....++.+++.+||+.||.+|||++++++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000112356789999999999999999999764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=283.51 Aligned_cols=248 Identities=23% Similarity=0.473 Sum_probs=195.4
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH--hCCCCCcceeEEEEEeC--
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR--IVRHPNIVQLYEVMATK-- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~--~l~hpnIv~l~~~~~~~-- 86 (479)
.+..+-.+.+.||+|.||+||.|.+ .|+.||||+|.... .....||..|.. .|+|+||+.+++.-..+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 5677889999999999999999998 89999999997643 234556666665 56999999999876433
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCCEEEecCCCeEEee
Q 011694 87 --SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR--------GVYHRDIKPENLLLDENENLKISD 156 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~--------givHrDLkp~NILl~~~g~vkl~D 156 (479)
+.+|+|.+|.+.|+|+|++.+..++-+.+.+++..+++||++||.. .|+|||||..|||+.++|.+-|+|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 4699999999999999999999999999999999999999999953 599999999999999999999999
Q ss_pred cCchhhhhccc--cCCCccccCCCCcccChhhhhcCC----CCC-CccchhhHHHHHHHHHhC----------CCCCCC-
Q 011694 157 FGLSALAQCKH--QDGLLHTTCGTPAYVAPEVINRKG----YDG-EKVDIWSCGVVLFVLLAG----------YLPFHD- 218 (479)
Q Consensus 157 FGla~~~~~~~--~~~~~~~~~gt~~y~aPEvl~~~~----~~~-~~~DvwSlGvil~~ll~G----------~~Pf~~- 218 (479)
+|||....... -+-..+..+||.+|||||++...- +.+ ..+||||+|.++||+... .+||.+
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99997654332 123456789999999999996432 222 358999999999998752 578854
Q ss_pred ----ChHHHHHHHhccC--cCCCCC-CCC----HHHHHHHHHhccCCccccCChhhhhc
Q 011694 219 ----SNLIEMYRKIGKA--EFKCPN-WFP----PEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 219 ----~~~~~~~~~i~~~--~~~~~~-~~~----~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
++..++..-+... +...|. |-+ ..+..+|+.||..||.-|.|+-.|.+
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 3344444443322 233333 433 23567899999999999999877753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=287.54 Aligned_cols=256 Identities=30% Similarity=0.527 Sum_probs=205.1
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEe
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMAT 85 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~ 85 (479)
.-+.+.|.++++||+|+|+.||+|.+.. .++.||+|.+..... ..++.+|+.+|..+. +.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3456789999999999999999999887 788999999876532 367899999999985 9999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe-cCCCeEEeecCchhhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD-ENENLKISDFGLSALAQ 164 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~-~~g~vkl~DFGla~~~~ 164 (479)
++++.+||||.+..+..++... ++..+++.|++.++.||.++|.+||+||||||.|+|.+ ..+.-.|+|||+|...+
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 9999999999999888887765 67889999999999999999999999999999999998 46788999999997321
Q ss_pred ccc------c-------------------------CCCc-----------cccCCCCcccChhhhhcCCCCCCccchhhH
Q 011694 165 CKH------Q-------------------------DGLL-----------HTTCGTPAYVAPEVINRKGYDGEKVDIWSC 202 (479)
Q Consensus 165 ~~~------~-------------------------~~~~-----------~~~~gt~~y~aPEvl~~~~~~~~~~DvwSl 202 (479)
... . .+.. ....|||+|.|||++.+.+-.++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 110 0 0000 012599999999999988888899999999
Q ss_pred HHHHHHHHhCCCCCCCCh-----HHHHH--------HH----hcc------Cc-------------------CCCC----
Q 011694 203 GVVLFVLLAGYLPFHDSN-----LIEMY--------RK----IGK------AE-------------------FKCP---- 236 (479)
Q Consensus 203 Gvil~~ll~G~~Pf~~~~-----~~~~~--------~~----i~~------~~-------------------~~~~---- 236 (479)
|||+..++++..||.... ..++. ++ ... .. .++.
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 999999999999995211 00000 00 000 00 0000
Q ss_pred ------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 237 ------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 237 ------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
..++..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 113568999999999999999999999999999973
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=282.45 Aligned_cols=135 Identities=28% Similarity=0.488 Sum_probs=116.6
Q ss_pred CCCccC-CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----C---CCcce
Q 011694 8 KPSVLT-EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-----H---PNIVQ 78 (479)
Q Consensus 8 ~~~il~-~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-----h---pnIv~ 78 (479)
-|.++. ++|.+.++||.|-|++||+|.+..+.+.||+|+.+.... ..+....||.+|+.++ | .+||+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 355677 999999999999999999999999999999999976543 3456678999999884 3 36999
Q ss_pred eEEEEEe----CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEe
Q 011694 79 LYEVMAT----KSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLD 147 (479)
Q Consensus 79 l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~ 147 (479)
|++.|.. +.++++|+|++ |..|..+|.. ..++...++.|++|++.||.|||.. ||+|.||||||||+.
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9999954 56899999999 5578888875 4699999999999999999999975 999999999999983
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.94 Aligned_cols=255 Identities=25% Similarity=0.458 Sum_probs=213.2
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcC---C----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCccee
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIR---T----NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQL 79 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~---~----~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l 79 (479)
.+++..++..+.+.||+|+||.|++|.... . ...||||.+...... ...+.+..|+.+|+.+. ||||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence 566777777888899999999999997431 1 456999998765433 44678899999999985 9999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 011694 80 YEVMATKSKIFFVMEYAKGGELFNKVAKGK-----------------LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPE 142 (479)
Q Consensus 80 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~ 142 (479)
++++...+.+++|+|||..|+|.++++..+ ++..+...+..||+.|++||++..++||||-.+
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998766 999999999999999999999999999999999
Q ss_pred CEEEecCCCeEEeecCchhhhhccccCCCccccCC--CCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 011694 143 NLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG--TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDS 219 (479)
Q Consensus 143 NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~ 219 (479)
|||+..+..+||+|||+|+.......... ....| ...|||||.+....|+ .++||||+||+|||+++ |..||.+.
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999974332222111 11122 3359999999987665 89999999999999998 99999985
Q ss_pred h-HHHHHHHhccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 220 N-LIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 220 ~-~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
. ..+.+..+..+ +...|..+++++.++++.||+.+|.+||++.++.+
T Consensus 526 ~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 526 PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 4 44556655554 45788889999999999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=304.10 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=195.8
Q ss_pred EEeeeeeecCCeE-EEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEe
Q 011694 17 EVGRLLGQGAFAK-VYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 17 ~i~~~LG~G~fg~-Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 94 (479)
.-.+.+|.|+-|+ ||+|.. .|+.||||.+-. +......|||..|+.-+ |||||++|+.-.+....||..|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred ccHHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3346789999885 799988 888999998744 34467789999999984 9999999999999999999999
Q ss_pred ccCCCChHHHHhcC-C----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec---CC--CeEEeecCchhhhh
Q 011694 95 YAKGGELFNKVAKG-K----LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---NE--NLKISDFGLSALAQ 164 (479)
Q Consensus 95 ~~~gg~L~~~i~~~-~----l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---~g--~vkl~DFGla~~~~ 164 (479)
.|.. +|.++++.. . ......+....|+++||++||+.+|+||||||.||||+. ++ .++|+|||++....
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9976 999999873 1 111456889999999999999999999999999999975 33 68999999997654
Q ss_pred cccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCChHHHHHHHhccCcCCCCC---CC
Q 011694 165 CKHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG-YLPFHDSNLIEMYRKIGKAEFKCPN---WF 239 (479)
Q Consensus 165 ~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~~~---~~ 239 (479)
.... -....+..||-+|+|||++....-. .++||||+||++|+.++| .+||.+.-..+ .+|.++....-. .-
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLP 739 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCc
Confidence 3321 1224566799999999999876654 799999999999988885 99998764332 234444332111 11
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..++.+||.+||++||..||++.+++.||+|....
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence 12899999999999999999999999999997654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=264.90 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=203.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEE-EEeCC
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEV-MATKS 87 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~-~~~~~ 87 (479)
--+.+.|.|.+.||+|.||++.+|.++.+...+++|.+...... ...+.+|...--.|. |.||+.-|++ |.+.+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 34678999999999999999999999999999999999876533 466778877666664 8999998876 57778
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec--CCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE--NENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~--~g~vkl~DFGla~~~~~ 165 (479)
.++++||||+-|+|..-+...++.|.....++.||++|+.|||+++++|||||.+||||-. .-++||||||+++..
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~-- 173 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV-- 173 (378)
T ss_pred eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc--
Confidence 8999999999999999999989999999999999999999999999999999999999953 347999999987532
Q ss_pred cccCCCccccCCCCcccChhhhhcCC---C-CCCccchhhHHHHHHHHHhCCCCCCCChH----HHHHHHhcc-CcCCCC
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKG---Y-DGEKVDIWSCGVVLFVLLAGYLPFHDSNL----IEMYRKIGK-AEFKCP 236 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~---~-~~~~~DvwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~-~~~~~~ 236 (479)
+......--+..|.+||++.... + ..+.+|||.+|+++|.+|+|++||..... ...+.++.. .....|
T Consensus 174 ---g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 174 ---GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred ---CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 22223334566899999875322 1 24679999999999999999999974322 222333322 222334
Q ss_pred C---CCCHHHHHHHHHhccCCcccc---CChhhhhcChhhhcc
Q 011694 237 N---WFPPEVRKLLCKILDPNPSTR---ISMAKIRESSWFRKG 273 (479)
Q Consensus 237 ~---~~~~~~~~li~~~L~~dP~~R---pt~~eil~h~wf~~~ 273 (479)
. .+++.+..+.++-|.++|++| -++...+...|....
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 3 378999999999999999999 566677777786543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=280.39 Aligned_cols=244 Identities=23% Similarity=0.382 Sum_probs=195.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH--hCCCCCcceeEEEEEeCC----
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR--IVRHPNIVQLYEVMATKS---- 87 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~--~l~hpnIv~l~~~~~~~~---- 87 (479)
....+.+.||+|.||.||+|.. +++.||||++.... ...+.+|-.|.+ .++|+||+++++.-...+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 4567788999999999999988 77999999996543 345566666665 457999999999876665
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------CCCeeccCCCCCEEEecCCCeEEeecC
Q 011694 88 KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHS---------RGVYHRDIKPENLLLDENENLKISDFG 158 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~---------~givHrDLkp~NILl~~~g~vkl~DFG 158 (479)
.++||+||.+.|+|.++++.+.++.....+++..+++||+|||+ ..|+|||||..|||+.++++.-|+|||
T Consensus 282 eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 79999999999999999999999999999999999999999996 369999999999999999999999999
Q ss_pred chhhhhccccCCCccccCCCCcccChhhhhcCCCC-----CCccchhhHHHHHHHHHhCC------------CCCC----
Q 011694 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD-----GEKVDIWSCGVVLFVLLAGY------------LPFH---- 217 (479)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~-----~~~~DvwSlGvil~~ll~G~------------~Pf~---- 217 (479)
||..+......+.....+||.+|||||++.+.-.- -.+.||||+|.+|||+++.. +||.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99888766666666778999999999999654221 13589999999999999853 3443
Q ss_pred -CChHHHHHHHh--ccCcCCCCCC-----CCHHHHHHHHHhccCCccccCChhhhh
Q 011694 218 -DSNLIEMYRKI--GKAEFKCPNW-----FPPEVRKLLCKILDPNPSTRISMAKIR 265 (479)
Q Consensus 218 -~~~~~~~~~~i--~~~~~~~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~eil 265 (479)
.++..++...+ .+.+..+|.. -...+.+.+..||+.||+.|.|+.-+-
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 12333443333 2333333332 125678999999999999999987654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=250.14 Aligned_cols=213 Identities=28% Similarity=0.481 Sum_probs=174.2
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI-VRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~-l~hpnIv~l~~~~~~~~~~ 89 (479)
+-.+...-+..||+|+||.|=+-++..+|...|+|.+...-. ....+++.+|+.+..+ ..+|.+|.+||.+..+..+
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 334455557889999999999999999999999999976432 2345677788887655 4799999999999999999
Q ss_pred EEEEeccCCCChHHHHh----c-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 90 FFVMEYAKGGELFNKVA----K-GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~----~-~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
||.||.++- +|..+.+ . +.++|..+-+++..++.||.|||++ .|+|||+||+||||+.+|++|+||||++...
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999999965 6654433 3 4699999999999999999999987 8999999999999999999999999998654
Q ss_pred hccccCCCccc-cCCCCcccChhhhh----cCCCCCCccchhhHHHHHHHHHhCCCCCCC-ChHHHHHHHhccC
Q 011694 164 QCKHQDGLLHT-TCGTPAYVAPEVIN----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKIGKA 231 (479)
Q Consensus 164 ~~~~~~~~~~~-~~gt~~y~aPEvl~----~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~ 231 (479)
. ++...+ ..|...|||||.+. ..+|+ -++||||||+.++||.+++.||+. .+..+.+..+...
T Consensus 200 ~----dSiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 200 V----DSIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred h----hhhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 3 222233 56888999999985 34676 899999999999999999999975 4556666666543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=247.90 Aligned_cols=212 Identities=45% Similarity=0.806 Sum_probs=186.9
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 011694 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL 101 (479)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (479)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++|+++++++......+++|||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997664321 346789999999999999999999999999999999999999999
Q ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-CCCeEEeecCchhhhhccccCCCccccCCC
Q 011694 102 FNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-NENLKISDFGLSALAQCKHQDGLLHTTCGT 178 (479)
Q Consensus 102 ~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 178 (479)
.+++... .++...+..++.+++.++.+||++|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999875 7999999999999999999999999999999999999998 89999999999865432211 13345688
Q ss_pred CcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCcccc
Q 011694 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTR 258 (479)
Q Consensus 179 ~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 258 (479)
..|++||.+......+.++|+|++|++++++ ..+.+++.+|+..||.+|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999997762345899999999999998 688999999999999999
Q ss_pred CChhhhhcCh
Q 011694 259 ISMAKIRESS 268 (479)
Q Consensus 259 pt~~eil~h~ 268 (479)
|+++++++++
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=284.40 Aligned_cols=247 Identities=22% Similarity=0.350 Sum_probs=210.6
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQ----SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
.+..++||+|+||+||+|.+...|+ +||||++...... +...++.+|.-+|..++|||++++++++.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3456889999999999999876665 5888888655433 33577889999999999999999999998766 889
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 92 VMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
|++|+++|.|.|+++. +++.......|..||+.|+.|||++.++||||-.+|||+.+...+||.|||+|.........
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999986 57999999999999999999999999999999999999999999999999999876544332
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc-CcCCCCCCCCHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK-AEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~li 247 (479)
-......-.+.|||-|.+....|. .++||||+||++||++| |..|+++....++-..+.. .+++.|+.++-++.-++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 222222345679999999888886 89999999999999998 9999999887766655543 35889999999999999
Q ss_pred HHhccCCccccCChhhhhc
Q 011694 248 CKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~ 266 (479)
.+||-.|+..||+++++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999988753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-31 Score=247.60 Aligned_cols=218 Identities=43% Similarity=0.720 Sum_probs=185.4
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 95 (479)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+...+..++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999765432 2457888999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC-C-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcc
Q 011694 96 AKGGELFNKVAKG-K-LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 96 ~~gg~L~~~i~~~-~-l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
+++++|.+.+... . +++..+..++.+++.++.+||++|++|+||+|.||+++.++.++|+|||++........ ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 9999999999874 4 89999999999999999999999999999999999999999999999999876543221 1234
Q ss_pred ccCCCCcccChhhh-hcCCCCCCccchhhHHHHHHHHHhCCCCCCC-Ch-HHHHHHHhccCcCCCCC
Q 011694 174 TTCGTPAYVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD-SN-LIEMYRKIGKAEFKCPN 237 (479)
Q Consensus 174 ~~~gt~~y~aPEvl-~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~-~~-~~~~~~~i~~~~~~~~~ 237 (479)
...++..|++||.+ ....+. .++|+|+||+++++|++|+.||.. .+ ...+...+..+.....+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 55788899999998 555554 699999999999999999999987 34 44677777666544433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=294.74 Aligned_cols=260 Identities=30% Similarity=0.519 Sum_probs=212.6
Q ss_pred CCCe-EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecc---cccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 13 TEKY-EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKD---KIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 13 ~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~---~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
.+.| .....+|.|++|.|+.+......+.++.|.+... ..........+..|+.+-..+.|||++.....+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 3445 5678999999999999988777777777765421 11111222337778888889999999888877777666
Q ss_pred EEEEEeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 89 IFFVMEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
++-.||||++ +|+.++... .++..++.-+++||+.||.|||+.||.||||||+|++++.+|.+||+|||.+.++....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6666999999 999999986 89999999999999999999999999999999999999999999999999999887776
Q ss_pred cC--CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHH--HHHh-------ccCcCCCC
Q 011694 168 QD--GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEM--YRKI-------GKAEFKCP 236 (479)
Q Consensus 168 ~~--~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~--~~~i-------~~~~~~~~ 236 (479)
.. ......+|+.+|+|||++.+..|++...||||+|++++.|.+|+.||.-...... .... ..+.....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 65 5667789999999999999999999999999999999999999999975543211 1111 11112222
Q ss_pred CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 237 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..+|...+.+|.+||++||.+|.|+++|++++||+..
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 3478889999999999999999999999999999764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=293.89 Aligned_cols=199 Identities=17% Similarity=0.221 Sum_probs=146.8
Q ss_pred CCC-CCcceeEEEE-------EeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q 011694 71 VRH-PNIVQLYEVM-------ATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIK 140 (479)
Q Consensus 71 l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLk 140 (479)
++| +||+++++++ .....++++|||+ +++|++++.. +.+++.++..+++||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5788888877 2334678889987 5599999975 359999999999999999999999999999999
Q ss_pred CCCEEEecC-------------------CCeEEeecCchhhhhcccc---------C-----CCccccCCCCcccChhhh
Q 011694 141 PENLLLDEN-------------------ENLKISDFGLSALAQCKHQ---------D-----GLLHTTCGTPAYVAPEVI 187 (479)
Q Consensus 141 p~NILl~~~-------------------g~vkl~DFGla~~~~~~~~---------~-----~~~~~~~gt~~y~aPEvl 187 (479)
|+||||+.. +.+|++|||+++....... . ......+||+.|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999653 4566666666643211000 0 001124689999999999
Q ss_pred hcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC-CCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-CPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 188 ~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+..|. .++|||||||+||||++|..|+..... ....+.....+ .+....+...+++.+||.+||.+|||+.++++
T Consensus 188 ~~~~~~-~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSSN-CASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCCC-chhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 888885 899999999999999999998764322 11111111111 11112456789999999999999999999999
Q ss_pred Chhhhcc
Q 011694 267 SSWFRKG 273 (479)
Q Consensus 267 h~wf~~~ 273 (479)
||||...
T Consensus 265 h~~~~~~ 271 (793)
T PLN00181 265 SEFINEP 271 (793)
T ss_pred chhhhhh
Confidence 9999753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=242.22 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=208.4
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE-
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTN-----QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA- 84 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~- 84 (479)
+-..++++.-.+-+|+||.||.|.+++.. +.|-+|.+..... +-....+..|-.++..+.|||+..+.++..
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS--~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS--QIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc--HHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 33567888899999999999999876532 3466676643321 123466778888999999999999999874
Q ss_pred eCCEEEEEEeccCCCChHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEe
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK---------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKIS 155 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~ 155 (479)
+....++++.+..-|.|..++.. ..++..+...++.|++.|++|||++||+|.||-.+|++||+.-++||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 55678889999988999999872 136777888899999999999999999999999999999999999999
Q ss_pred ecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cC
Q 011694 156 DFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EF 233 (479)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~ 233 (479)
|=.+++-.-..+..-+.........||+||.+....|+ .++|+||+||+||||++ |+.|+.+-++.++...+..+ ++
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 99998755433333233333456789999999998887 79999999999999998 99999999999998888665 45
Q ss_pred CCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 234 KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 234 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.-|-+||+++..++..||+.+|++||+++++..
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 678889999999999999999999999999753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-27 Score=230.52 Aligned_cols=254 Identities=35% Similarity=0.581 Sum_probs=211.2
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC-CcceeEEEEEeCCEEEEEEe
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP-NIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~E 94 (479)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999986 88999999876655434567889999999999988 79999999988888999999
Q ss_pred ccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-CeEEeecCchhhhhccccC
Q 011694 95 YAKGGELFNKVAKG----KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 95 ~~~gg~L~~~i~~~----~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-~vkl~DFGla~~~~~~~~~ 169 (479)
++.++++.+.+... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999777764 699999999999999999999999999999999999999888 6999999998754433222
Q ss_pred C----CccccCCCCcccChhhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCChH----HHHHHHhccCcCC-CCCC
Q 011694 170 G----LLHTTCGTPAYVAPEVINRK--GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL----IEMYRKIGKAEFK-CPNW 238 (479)
Q Consensus 170 ~----~~~~~~gt~~y~aPEvl~~~--~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~-~~~~ 238 (479)
. .....+||+.|+|||.+.+. .+.....|+||+|++++++++|..||..... ......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 34677899999999999874 3455899999999999999999999887653 4444444433332 2222
Q ss_pred CC--------HHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 239 FP--------PEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 239 ~~--------~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
.. ..+.+++.+++..+|..|.+..+...+++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 22 47899999999999999999999988866644
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=243.81 Aligned_cols=176 Identities=19% Similarity=0.223 Sum_probs=139.6
Q ss_pred CCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcC-CCcEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCcce-e
Q 011694 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIR-TNQSVAVKVIDKDKI--MRVGLADQIKREISVMRIVRHPNIVQ-L 79 (479)
Q Consensus 4 ~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~--~~~~~~~~l~~Ei~il~~l~hpnIv~-l 79 (479)
+...+.+.+.++|.+.+.||+|+||+||+|++.. +++.||||++..... ........+.+|+.+|+.++|+||+. +
T Consensus 8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 3445667899999999999999999999999876 788889998753311 12234567999999999999999985 4
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCCEEEecCCCeEEeecC
Q 011694 80 YEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDI-KPENLLLDENENLKISDFG 158 (479)
Q Consensus 80 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDL-kp~NILl~~~g~vkl~DFG 158 (479)
++. +..|+||||++|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||
T Consensus 88 ~~~----~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 88 LAT----GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred EEc----CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 432 458999999999999732 21 11 1568899999999999999999999 9999999999999999999
Q ss_pred chhhhhccccCCC------ccccCCCCcccChhhhhc
Q 011694 159 LSALAQCKHQDGL------LHTTCGTPAYVAPEVINR 189 (479)
Q Consensus 159 la~~~~~~~~~~~------~~~~~gt~~y~aPEvl~~ 189 (479)
+|+.......... ..+.++++.|+|||.+..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9986654332111 245678999999999853
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=222.35 Aligned_cols=157 Identities=21% Similarity=0.240 Sum_probs=127.1
Q ss_pred CChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccC
Q 011694 99 GELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC 176 (479)
Q Consensus 99 g~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 176 (479)
|+|.+++.. +.+++..++.++.|++.||.|||++| ||+|||++.++.+|+ ||++..... ....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence 689999975 35999999999999999999999999 999999999999999 999865432 1236
Q ss_pred CCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-HHHHHhccCcCC-------CCCCCCH--HHHHH
Q 011694 177 GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI-EMYRKIGKAEFK-------CPNWFPP--EVRKL 246 (479)
Q Consensus 177 gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~-------~~~~~~~--~~~~l 246 (479)
||+.|+|||++.+..|+ .++||||+||++|+|++|..||...... .....+...... .+..++. ++.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999888875 8999999999999999999999765432 222222211111 1122333 69999
Q ss_pred HHHhccCCccccCChhhhhcChhhh
Q 011694 247 LCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 247 i~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
|.+||..||.+|||+.++++|+|+.
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-28 Score=250.89 Aligned_cols=239 Identities=33% Similarity=0.584 Sum_probs=207.3
Q ss_pred eeeecCCeEEEEEEE---cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecc
Q 011694 21 LLGQGAFAKVYYARS---IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFVMEYA 96 (479)
Q Consensus 21 ~LG~G~fg~Vy~a~~---~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 96 (479)
++|.|+||+|++++- ...|..+|+|+..+....... ......|-.++..++ ||.+|+++..+..++..|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc-ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998854 346788999998775543322 225556778888886 999999999999999999999999
Q ss_pred CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCcccc
Q 011694 97 KGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT 175 (479)
Q Consensus 97 ~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~ 175 (479)
.||+|+..+.. ..+.+.....+...++-+++++|+.||+|||+|++||+++.+|++++.|||++...-... ..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hc
Confidence 99999998876 468888999999999999999999999999999999999999999999999987543221 22
Q ss_pred CCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCc
Q 011694 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNP 255 (479)
Q Consensus 176 ~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP 255 (479)
|||..|||||+++ ++. .++|-||+|+++|+|++|..||.. +....|.+..+..|..++..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999998 454 789999999999999999999998 677888888999999999999999999999999
Q ss_pred cccCCh-----hhhhcChhhhcc
Q 011694 256 STRISM-----AKIRESSWFRKG 273 (479)
Q Consensus 256 ~~Rpt~-----~eil~h~wf~~~ 273 (479)
.+|.-. .+|++|++|...
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHhccCcchhHHHhccchheee
Confidence 999874 789999999754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-25 Score=222.42 Aligned_cols=248 Identities=26% Similarity=0.355 Sum_probs=193.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhCCC----CCcceeEEEE-EeCCE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTN-QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH----PNIVQLYEVM-ATKSK 88 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 88 (479)
+|++.+.||+|+||.||++.+..++ ..+|+|+......... ..+..|+.++..+.. +++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997775 6799998866532221 267789999988863 6899999999 58888
Q ss_pred EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC-----CCeEEeecCch
Q 011694 89 IFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN-----ENLKISDFGLS 160 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~-----g~vkl~DFGla 160 (479)
-|+||+.+ |.+|.++... ++++...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 6699987753 579999999999999999999999999999999999999754 35999999999
Q ss_pred hhhhccccCC-------C-ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH---HHHHHhc
Q 011694 161 ALAQCKHQDG-------L-LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI---EMYRKIG 229 (479)
Q Consensus 161 ~~~~~~~~~~-------~-~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~ 229 (479)
+........+ . .....||..|+++.+..+... +.+.|+||++.++.+++.|.+||...... ..+....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8333211111 1 123459999999999988776 48999999999999999999999765532 2222222
Q ss_pred cCcCC--CCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 230 KAEFK--CPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 230 ~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
..... .....+.++..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22111 233456778888887777899999998777654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-26 Score=247.44 Aligned_cols=259 Identities=32% Similarity=0.567 Sum_probs=222.2
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIR-TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (479)
...|.+.+.||+|+|+.|-++.+.. +...+|+|.+.... ........+..|..+.+.+. |+|++.+++...+....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 6789999999999999999998754 44457777776543 23345677888999999997 999999999999999999
Q ss_pred EEEeccCCCChHHHH-hcC--CCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCCEEEecCC-CeEEeecCchhhhhc
Q 011694 91 FVMEYAKGGELFNKV-AKG--KLKEDAARRYFQQLINAVDFCH-SRGVYHRDIKPENLLLDENE-NLKISDFGLSALAQC 165 (479)
Q Consensus 91 lV~E~~~gg~L~~~i-~~~--~l~e~~~~~i~~qll~aL~~LH-~~givHrDLkp~NILl~~~g-~vkl~DFGla~~~~~ 165 (479)
++++|..|+++++.+ ..+ ..+...+..++.|+..++.|+| ..|+.|||+||+|.+++.++ +++++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 654 6888999999999999999999 99999999999999999999 999999999998877
Q ss_pred -cccCCCccccCC-CCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHH-HHHHhccC----cCCCCCC
Q 011694 166 -KHQDGLLHTTCG-TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE-MYRKIGKA----EFKCPNW 238 (479)
Q Consensus 166 -~~~~~~~~~~~g-t~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~----~~~~~~~ 238 (479)
.+........|| ++.|+|||...+..|.+...|+||+|+++..+++|..||....... .+..+... .......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 566667778899 9999999999988898999999999999999999999998765432 22222222 2334445
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
++....+++.++|..+|..|.+.+++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7899999999999999999999999999999977
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=206.98 Aligned_cols=244 Identities=22% Similarity=0.370 Sum_probs=195.2
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 88 (479)
.++.-.|+++++||+|+||.+++|.+.-++++||||.=.... ...+++.|....+.|. .++|...|.+...+.+
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY 98 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence 477889999999999999999999999999999999754332 2467889999999885 7999999999888888
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-----CeEEeecCchh
Q 011694 89 IFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-----NLKISDFGLSA 161 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-----~vkl~DFGla~ 161 (479)
-.+|||++ |.+|.|+..- .+++...+.-++.|++.-++|+|++++|.|||||+|+||...+ .+-|+|||+|.
T Consensus 99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 89999998 6688888764 4799999999999999999999999999999999999997544 48999999998
Q ss_pred hhhccccC-----CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC---ChHHHHHHHhccCcC
Q 011694 162 LAQCKHQD-----GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD---SNLIEMYRKIGKAEF 233 (479)
Q Consensus 162 ~~~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~ 233 (479)
.+...... +.-.+..||.+||+--...+..-+ ...|+-|||-+++++|-|.+||.+ ++..+-|.+|....-
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 76544322 223455799999998888777664 889999999999999999999976 456677888865443
Q ss_pred CCC-----CCCCHHHHHHHHHhccCCccccCC
Q 011694 234 KCP-----NWFPPEVRKLLCKILDPNPSTRIS 260 (479)
Q Consensus 234 ~~~-----~~~~~~~~~li~~~L~~dP~~Rpt 260 (479)
..| ..+|.++..-|+-.-..+-.+-|.
T Consensus 257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 332 235666655555443333333343
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=206.31 Aligned_cols=176 Identities=16% Similarity=0.187 Sum_probs=139.5
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHH------HHHHHHHHHhCCCCCcceeEEEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQ------IKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~------l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
.++.++|++.+.||.|+||.||++.. ++..+|||++............. +.+|+..+.++.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 36889999999999999999999755 57789999997665444444333 68999999999999999999987
Q ss_pred EeC--------CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEe
Q 011694 84 ATK--------SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKIS 155 (479)
Q Consensus 84 ~~~--------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~ 155 (479)
... +..+++|||++|.+|.+... +++ ....+++.+|..||++|++|||+||+||+++++| ++|+
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 643 35799999999999977732 333 2456999999999999999999999999999888 9999
Q ss_pred ecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHH
Q 011694 156 DFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLL 210 (479)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll 210 (479)
|||.+........ ....+....|. .++|+||||+++..+.
T Consensus 177 Dfg~~~~~~e~~a--------------~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKA--------------KDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhh--------------HHHHHHHhHhc-ccccccceeEeehHHH
Confidence 9997653321110 11144556676 7999999999987664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=238.12 Aligned_cols=220 Identities=32% Similarity=0.656 Sum_probs=176.0
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
...+|+.+++|..|+||.||+++|+.+.+.+|+ .+++.... .|- ++....+|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li--------lRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI--------LRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccchh--------hhc--cccccCCccee--------------
Confidence 356899999999999999999999999999999 45554321 111 44444566655
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc---
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH--- 167 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~--- 167 (479)
|+-...++. +.++.+. +.+++|+|+.||+|||+||+|++|+.-|++|++|||++...-...
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 344444544 4566554 789999999999999999999999999999999999986321110
Q ss_pred ----------cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCC
Q 011694 168 ----------QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN 237 (479)
Q Consensus 168 ----------~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 237 (479)
..-.....||||.|.||||+...+| |..+|.|++|+|+|+.+.|..||.+++..+++..+.......|.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 0001234599999999999999998 58999999999999999999999999999999988777666554
Q ss_pred C---CCHHHHHHHHHhccCCccccCC---hhhhhcChhhhc
Q 011694 238 W---FPPEVRKLLCKILDPNPSTRIS---MAKIRESSWFRK 272 (479)
Q Consensus 238 ~---~~~~~~~li~~~L~~dP~~Rpt---~~eil~h~wf~~ 272 (479)
. ++++++++|.++|+.+|..|.- +-++.+|+||+.
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 3 7899999999999999999974 678899999964
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=195.83 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=194.5
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATK 86 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~ 86 (479)
+.-++.++|+++++||.|+||.+|+|.+..+|+.||||+=..... ..++..|..+.+.|+ ...|..+..+..+.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 345778999999999999999999999999999999998655432 245678889999887 46788888888888
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec---CCCeEEeecCchh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---NENLKISDFGLSA 161 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---~g~vkl~DFGla~ 161 (479)
.+-.+|||.+ |.+|.++..- ..++...+.-++-|++.-++|+|.++.+||||||+|+|..- ...+.++|||+|.
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 9999999998 6688888763 57999999999999999999999999999999999999863 3469999999998
Q ss_pred hhhccccC-----CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH---HHHHHHhccCcC
Q 011694 162 LAQCKHQD-----GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL---IEMYRKIGKAEF 233 (479)
Q Consensus 162 ~~~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~ 233 (479)
.+...... .......||.+|.+--...+..- +...|+-|+|.+|.++.-|.+||.+... .+-+.+|.....
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 66543221 12234579999999777665544 4789999999999999999999987543 345555654444
Q ss_pred CCC-----CCCCHHHHHHHHHhccCCccccCC
Q 011694 234 KCP-----NWFPPEVRKLLCKILDPNPSTRIS 260 (479)
Q Consensus 234 ~~~-----~~~~~~~~~li~~~L~~dP~~Rpt 260 (479)
+.| ..+|.++.-.+.-|-..--++-|.
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 433 447888888887776555555554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=207.72 Aligned_cols=233 Identities=27% Similarity=0.374 Sum_probs=154.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC----------CCcceeEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH----------PNIVQLYEVMA 84 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h----------pnIv~l~~~~~ 84 (479)
.+..++.||.|+++.||.+.+..||+.+|+|++...........+.+++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35678899999999999999999999999999976654444456778877765555322 23333333332
Q ss_pred e---------C---C-----EEEEEEeccCCCChHHHHhc----CC----CCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q 011694 85 T---------K---S-----KIFFVMEYAKGGELFNKVAK----GK----LKEDAARRYFQQLINAVDFCHSRGVYHRDI 139 (479)
Q Consensus 85 ~---------~---~-----~~~lV~E~~~gg~L~~~i~~----~~----l~e~~~~~i~~qll~aL~~LH~~givHrDL 139 (479)
- . + +.+++|+-+. ++|.+.+.. .. +.......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 2367888774 488777542 22 222333556689999999999999999999
Q ss_pred CCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcC--------CCCCCccchhhHHHHHHHHHh
Q 011694 140 KPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK--------GYDGEKVDIWSCGVVLFVLLA 211 (479)
Q Consensus 140 kp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~--------~~~~~~~DvwSlGvil~~ll~ 211 (479)
+|+|++++.+|.++|+||+......... .....+..|.+||..... .+ +.+.|.|+||+++|.|+|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~-t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPY-TFATDAWQLGITLYSLWC 245 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE--HHHHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCccccee-eeccCHHHHHHHHHHHHH
Confidence 9999999999999999998764322111 113455789999987543 23 478999999999999999
Q ss_pred CCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCcccc
Q 011694 212 GYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTR 258 (479)
Q Consensus 212 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 258 (479)
|..||+.......... .+.....+|+.++.||.++|++||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999987654321111 232222789999999999999999998
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=198.53 Aligned_cols=140 Identities=19% Similarity=0.257 Sum_probs=112.5
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchh-----------------------hHHHHHHHHHHHHhCCCCC
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVG-----------------------LADQIKREISVMRIVRHPN 75 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~-----------------------~~~~l~~Ei~il~~l~hpn 75 (479)
...||+|+||.||+|.+. +|+.||||++......... ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999765321111 0123456999999998887
Q ss_pred cceeEEEEEeCCEEEEEEeccCCCChHHH-HhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCCEEEecCCCeE
Q 011694 76 IVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFC-HSRGVYHRDIKPENLLLDENENLK 153 (479)
Q Consensus 76 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-i~~~~l~e~~~~~i~~qll~aL~~L-H~~givHrDLkp~NILl~~~g~vk 153 (479)
+.....+.... .+|||||++|+++... +..+.+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 75544433222 3899999999877655 4456899999999999999999999 799999999999999998 58899
Q ss_pred EeecCchhh
Q 011694 154 ISDFGLSAL 162 (479)
Q Consensus 154 l~DFGla~~ 162 (479)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=193.14 Aligned_cols=142 Identities=18% Similarity=0.236 Sum_probs=115.6
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch-----------------------hhHHHHHHHHHHHHhCCCC
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV-----------------------GLADQIKREISVMRIVRHP 74 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----------------------~~~~~l~~Ei~il~~l~hp 74 (479)
+.+.||+|+||.||+|.+. +|+.||||+++....... .......+|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999986531100 0123356899999999999
Q ss_pred CcceeEEEEEeCCEEEEEEeccCCCChHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCe
Q 011694 75 NIVQLYEVMATKSKIFFVMEYAKGGELFN-KVAKGKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENL 152 (479)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~v 152 (479)
+|.....+.... .|+||||++|+++.. .+...++++..+..++.|++.+|.++|+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 886555554433 489999999985543 4556778999999999999999999999 9999999999999998 8999
Q ss_pred EEeecCchhhh
Q 011694 153 KISDFGLSALA 163 (479)
Q Consensus 153 kl~DFGla~~~ 163 (479)
+|+|||+|...
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=185.87 Aligned_cols=132 Identities=18% Similarity=0.287 Sum_probs=109.1
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-----CCCCcceeEEEEEeCC---EEE
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-----RHPNIVQLYEVMATKS---KIF 90 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 90 (479)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 57899999999995 7667666 6999876432 2346789999999999 5799999999999874 444
Q ss_pred -EEEec--cCCCChHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCCeeccCCCCCEEEecC----CCeEEeecC
Q 011694 91 -FVMEY--AKGGELFNKVAKGKLKEDAARRYFQQLINAV-DFCHSRGVYHRDIKPENLLLDEN----ENLKISDFG 158 (479)
Q Consensus 91 -lV~E~--~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL-~~LH~~givHrDLkp~NILl~~~----g~vkl~DFG 158 (479)
+|||| +.+|+|.++++++.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 557999999988777776 36688888777 99999999999999999999743 379999955
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-22 Score=182.64 Aligned_cols=191 Identities=17% Similarity=0.234 Sum_probs=142.8
Q ss_pred EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchh-hHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEe
Q 011694 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVG-LADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~-~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 94 (479)
.+...|++|+||+||++.. .+..++.+.+......... ....+.+|+.+|+++. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678999999999997765 7778887777655432211 1235789999999995 5889999886 44799999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCCEEEecCCCeEEeecCchhhhhccccC----
Q 011694 95 YAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDI-KPENLLLDENENLKISDFGLSALAQCKHQD---- 169 (479)
Q Consensus 95 ~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDL-kp~NILl~~~g~vkl~DFGla~~~~~~~~~---- 169 (479)
|+.|.+|...+..+ ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 79 YLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 99999997654221 2357899999999999999999999 799999999999999999999744322110
Q ss_pred ---C----CccccCCCCcccChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 011694 170 ---G----LLHTTCGTPAYVAPEVINRKG-YDGEKVDIWSCGVVLFVLLAGYLPFHDS 219 (479)
Q Consensus 170 ---~----~~~~~~gt~~y~aPEvl~~~~-~~~~~~DvwSlGvil~~ll~G~~Pf~~~ 219 (479)
. ...-...++.|++|+...-.. .+-...+.++.|.-+|.++|+..|+-++
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 011123688899998754321 1114678889999999999999887544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-23 Score=222.30 Aligned_cols=239 Identities=26% Similarity=0.380 Sum_probs=180.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccc-ccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDK-IMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~-~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
.|...+.||++.|=+|.+|++. .|. |+||++-+.. ...-.-..+..+|++ ...+++||++.+.-+......-|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6888899999999999999883 454 8999996643 222222233335555 66678999999999988888899999
Q ss_pred eccCCCChHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC--
Q 011694 94 EYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG-- 170 (479)
Q Consensus 94 E~~~gg~L~~~i~~~~-l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~-- 170 (479)
+|... +|+|++..++ +..-+.+.|+.||+.||.-||..||+|+|||.|||||+.=.=+.|+||.--........+.
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99987 8999998765 7788899999999999999999999999999999999887778999997533211111111
Q ss_pred ---CccccCCCCcccChhhhhcCC----------CCCCccchhhHHHHHHHHHh-CCCCCCCChHH-----------HHH
Q 011694 171 ---LLHTTCGTPAYVAPEVINRKG----------YDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLI-----------EMY 225 (479)
Q Consensus 171 ---~~~~~~gt~~y~aPEvl~~~~----------~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~-----------~~~ 225 (479)
...|...-..|.|||.+.... .-+++.||||+||+++||++ |.+||.-.... ...
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~L 259 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLL 259 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHH
Confidence 112223344699999986422 12468999999999999998 78888633221 122
Q ss_pred HHhccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 226 RKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
++|. +..++.+|..|++.||.+|.++++.|+.
T Consensus 260 e~Ie----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 260 EKIE----------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhCc----------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 2211 3478999999999999999999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.7e-21 Score=181.88 Aligned_cols=143 Identities=17% Similarity=0.200 Sum_probs=114.6
Q ss_pred CeEEeeeeeecCCeEEEEEE-EcCCCcEEEEEEeecccccc---------------------hhhHHHHHHHHHHHHhCC
Q 011694 15 KYEVGRLLGQGAFAKVYYAR-SIRTNQSVAVKVIDKDKIMR---------------------VGLADQIKREISVMRIVR 72 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~-~~~~~~~vaiK~i~~~~~~~---------------------~~~~~~l~~Ei~il~~l~ 72 (479)
-|.+.+.||+|+||.||+|. +..+|+.||||++....... ......+.+|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 77899999999997543210 001234678999999997
Q ss_pred CC--CcceeEEEEEeCCEEEEEEeccCCCChHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeccCCCCCEEEec
Q 011694 73 HP--NIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCHSRG-VYHRDIKPENLLLDE 148 (479)
Q Consensus 73 hp--nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i-~~~~l~e~~~~~i~~qll~aL~~LH~~g-ivHrDLkp~NILl~~ 148 (479)
+. .+.++++. . ..|+||||++|++|.... ....+....+..++.|++.+|.+||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 23344432 2 358999999998887665 3355677778899999999999999999 99999999999999
Q ss_pred CCCeEEeecCchhh
Q 011694 149 NENLKISDFGLSAL 162 (479)
Q Consensus 149 ~g~vkl~DFGla~~ 162 (479)
++.++|+|||.|..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999998763
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=181.89 Aligned_cols=241 Identities=21% Similarity=0.363 Sum_probs=194.8
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.+...+..+|.+.-.|+.|+|++ .|..+++|+++...... .....+..|.-.++...||||+.+++.+....++.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 45566778899999999999998 55567778887654332 3446677888899999999999999999999999999
Q ss_pred EeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCCEEEecCCCeEEe--ecCchhhhhc
Q 011694 93 MEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRG--VYHRDIKPENLLLDENENLKIS--DFGLSALAQC 165 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~g--ivHrDLkp~NILl~~~g~vkl~--DFGla~~~~~ 165 (479)
..|++-|+|++.+..+ .++..++.+++.++++|++|||+.. |----|....+++|++-+.+|+ |--++- .
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--q- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q- 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--e-
Confidence 9999999999999874 3788899999999999999999874 4455688899999988766653 322210 0
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCC--CCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHh--ccCcCCCCCCCCH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYD--GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFPP 241 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~--~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~ 241 (479)
.....-.|.||+||.+..++.+ -.++|+||+.+++|+|.|...||.+-+..+.--++ ..-+..+|+.+++
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence 1123457899999999887765 35799999999999999999999987776654444 3445678999999
Q ss_pred HHHHHHHHhccCCccccCChhhhh
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIR 265 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil 265 (479)
.+..|++-|++.||.+||.+..|+
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999987764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=182.39 Aligned_cols=189 Identities=26% Similarity=0.433 Sum_probs=142.8
Q ss_pred CCCCcceeEEEEEe---------------------------CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHH
Q 011694 72 RHPNIVQLYEVMAT---------------------------KSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLIN 124 (479)
Q Consensus 72 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~ 124 (479)
+|||||++...|.+ +..+|+||...+. +|..++-....+....+-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 59999999876633 2358999998876 8999998888888899999999999
Q ss_pred HHHHHHHCCCeeccCCCCCEEEe--cCC--CeEEeecCchhhhhcccc----CCCccccCCCCcccChhhhhcCCC----
Q 011694 125 AVDFCHSRGVYHRDIKPENLLLD--ENE--NLKISDFGLSALAQCKHQ----DGLLHTTCGTPAYVAPEVINRKGY---- 192 (479)
Q Consensus 125 aL~~LH~~givHrDLkp~NILl~--~~g--~vkl~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPEvl~~~~~---- 192 (479)
|+.|||.+||+|||+|.+|||+. +++ .+.|+|||++--.+...- ..-.-..-|.-.-||||+....+-
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 99999999999999999999994 333 489999998642221110 001112347788999999864321
Q ss_pred -CCCccchhhHHHHHHHHHhCCCCCCCChHHH-HHHHhccC-cCCCCCCCCHHHHHHHHHhccCCccccCCh
Q 011694 193 -DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE-MYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISM 261 (479)
Q Consensus 193 -~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 261 (479)
+-.++|.|++|.+.||+++..-||....... ..+..... -...|..+|+.+++++..+|+.||++|++.
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 1258999999999999999999997633211 11111222 235677899999999999999999999995
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=200.93 Aligned_cols=236 Identities=22% Similarity=0.344 Sum_probs=179.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceeEEEEEeCC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR---HPNIVQLYEVMATKS 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~---hpnIv~l~~~~~~~~ 87 (479)
+-.++|.|.+.||+|+||+||.|.... |+.||+|+=.......--... +++.+|+ -+.|+.+...+.-.+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHccCC
Confidence 456799999999999999999999876 999999987655433211112 2333333 345666766666677
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-------CCCeEEeecCc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-------NENLKISDFGL 159 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-------~g~vkl~DFGl 159 (479)
.-++|+||.+-|+|.+++.. +.+++..+..+..|++..|+.||..||||+||||+|+||.. +-.++|+|||.
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 78999999999999999986 56999999999999999999999999999999999999942 34599999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-C----
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-K---- 234 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~---- 234 (479)
|.-+..-.........++|-.+-++|...+.++. +.+|.|.+.-+++.||.|+.- + ..++.. .
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~-------q----~~~g~~~~~~~~ 915 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM-------E----VKNGSSWMVKTN 915 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH-------H----hcCCcceecccc
Confidence 8655444344456778899999999999999996 999999999999999999532 1 222211 1
Q ss_pred CCCCCC-HHHHHHHHHhccCCccccCChhhhh
Q 011694 235 CPNWFP-PEVRKLLCKILDPNPSTRISMAKIR 265 (479)
Q Consensus 235 ~~~~~~-~~~~~li~~~L~~dP~~Rpt~~eil 265 (479)
++.... .-..+++..+|++|-..=|.+.+|+
T Consensus 916 ~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr 947 (974)
T KOG1166|consen 916 FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELR 947 (974)
T ss_pred chhhhhHHHHHHHHHHHhCcCcccchhHHHHH
Confidence 121112 3345788889986555555555553
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-19 Score=167.95 Aligned_cols=137 Identities=20% Similarity=0.321 Sum_probs=116.3
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV-----GLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
+.||+|++|.||+|.+ +|..|++|+......... .....+.+|+.++..+.|++|.....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 788899998754332211 122467889999999999999888888877888999999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 95 YAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 95 ~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999875322 7889999999999999999999999999999998 88999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=166.43 Aligned_cols=133 Identities=20% Similarity=0.299 Sum_probs=109.5
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 011694 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV-----GLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 95 (479)
.||+|+||.||+|.. +|..|++|+......... ....++.+|+.+++.+.|+++....-++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 778899998654322111 1236678999999999988766666566667778999999
Q ss_pred cCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 96 AKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 96 ~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988765321 7899999999999999999999999999998 89999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=166.06 Aligned_cols=138 Identities=19% Similarity=0.286 Sum_probs=109.6
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch-------------------hhHHHHHHHHHHHHhCCCCC-
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV-------------------GLADQIKREISVMRIVRHPN- 75 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-------------------~~~~~l~~Ei~il~~l~hpn- 75 (479)
|.+.+.||+|+||.||++.+. +|+.||||++........ .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999874 899999999875431000 01123678899999988774
Q ss_pred -cceeEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEE
Q 011694 76 -IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKI 154 (479)
Q Consensus 76 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl 154 (479)
+...++ ....++||||++|++|...... .....++.+++.++.++|+.||+||||||+||+++.++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2445899999999998765431 346678899999999999999999999999999999999999
Q ss_pred eecCchhhh
Q 011694 155 SDFGLSALA 163 (479)
Q Consensus 155 ~DFGla~~~ 163 (479)
+|||++...
T Consensus 167 iDfg~~~~~ 175 (198)
T cd05144 167 IDWPQMVST 175 (198)
T ss_pred EECCccccC
Confidence 999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-20 Score=186.56 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=170.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEE------
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRT---NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE------ 81 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~------ 81 (479)
.....+.+.+..+..+++.+....-..+ .+-+.-+..+.++ ........+++-.+....|-+..-+.+
T Consensus 241 ~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~ 317 (516)
T KOG1033|consen 241 EESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLF 317 (516)
T ss_pred cccccccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchh
Confidence 3445666677777777777765544333 3334434333332 122344556666666555443333322
Q ss_pred -EE-----EeCCEEEEEEeccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC
Q 011694 82 -VM-----ATKSKIFFVMEYAKGGELFNKVAKG----KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN 151 (479)
Q Consensus 82 -~~-----~~~~~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~ 151 (479)
.+ ....++||.|++|+..+|.+++... ..+......++.|+..|+.| +|.+|||+||.||+...++.
T Consensus 318 ~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 318 ESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred hhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh
Confidence 11 1123589999999999999999753 46677889999999999999 99999999999999999999
Q ss_pred eEEeecCchhhhhccc----cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHH
Q 011694 152 LKISDFGLSALAQCKH----QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYR 226 (479)
Q Consensus 152 vkl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~ 226 (479)
+||.|||+.+-..... .........||..||+||.+.+..|. .++||||||+||++|+. =..+|.. ...+.
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~ 470 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLT 470 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhh
Confidence 9999999986544332 01122456799999999999999886 99999999999999997 2333322 12223
Q ss_pred HhccCcCCCCCCC-CHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 227 KIGKAEFKCPNWF-PPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 227 ~i~~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+..+.++...+. -|.-..|+.+||.+.|..||++.+.--|+|.
T Consensus 471 d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 471 DIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 3333333211111 2456689999999999999988777666663
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=184.87 Aligned_cols=139 Identities=18% Similarity=0.268 Sum_probs=113.2
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM-----RVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
..|...+.||+|+||.||++.+. +..+++|+....... .....+.+.+|+.+++.++|++|+....+..+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44566899999999999999874 444555543222111 11223568899999999999999988887777778
Q ss_pred EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 89 IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
.++||||++|++|.+.+. ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998875 457799999999999999999999999999999 678999999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=178.27 Aligned_cols=199 Identities=24% Similarity=0.397 Sum_probs=155.2
Q ss_pred HHhCCCCCcceeEEEEEeCCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCC-eeccCCCCCE
Q 011694 68 MRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGV-YHRDIKPENL 144 (479)
Q Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~gi-vHrDLkp~NI 144 (479)
|+.+.|.|+.++++...+....++|.+||.-|+|.|.+... +++.--...++++|+.||.|+|+--| +|+.|++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45678999999999999999999999999999999999885 56777788899999999999998866 9999999999
Q ss_pred EEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCC------CCCccchhhHHHHHHHHHhCCCCCCC
Q 011694 145 LLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY------DGEKVDIWSCGVVLFVLLAGYLPFHD 218 (479)
Q Consensus 145 Ll~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~------~~~~~DvwSlGvil~~ll~G~~Pf~~ 218 (479)
++|....+||+|||+.................-...|.|||.+..... -+.+.||||+|++++++++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999765432111111112223456999999976422 24679999999999999999999976
Q ss_pred Ch----HHHHHHHhcc-CcC-CCCC-----CCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 219 SN----LIEMYRKIGK-AEF-KCPN-----WFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 219 ~~----~~~~~~~i~~-~~~-~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.. ..+....+.+ ... ..|. .+++++..++..|+..+|..||++++|..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2334444433 221 1121 24567999999999999999999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-18 Score=156.83 Aligned_cols=138 Identities=19% Similarity=0.295 Sum_probs=100.8
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHH---------------------HHHHHHHHHhCCCC--C
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQ---------------------IKREISVMRIVRHP--N 75 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~---------------------l~~Ei~il~~l~hp--n 75 (479)
++.||+|+||.||+|.+. +|+.||||++............. ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999986 89999999987643221111111 14566666666443 3
Q ss_pred cceeEEEEEeCCEEEEEEeccCCCChHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeE
Q 011694 76 IVQLYEVMATKSKIFFVMEYAKGGELFN-KVAKGKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLK 153 (479)
Q Consensus 76 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vk 153 (479)
+.+.+++ ...++||||++|+.+.. .+...... ..+..++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4455543 23589999999954321 12211111 6788999999999999999 9999999999999999 99999
Q ss_pred EeecCchhhh
Q 011694 154 ISDFGLSALA 163 (479)
Q Consensus 154 l~DFGla~~~ 163 (479)
|+|||.+...
T Consensus 155 liDfg~a~~~ 164 (187)
T cd05119 155 IIDVPQAVEI 164 (187)
T ss_pred EEECcccccc
Confidence 9999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.1e-17 Score=157.53 Aligned_cols=137 Identities=16% Similarity=0.301 Sum_probs=106.6
Q ss_pred eeee-ecCCeEEEEEEEcCCCcEEEEEEeecccc----c------chhhHHHHHHHHHHHHhCCCCCc--ceeEEEEEeC
Q 011694 20 RLLG-QGAFAKVYYARSIRTNQSVAVKVIDKDKI----M------RVGLADQIKREISVMRIVRHPNI--VQLYEVMATK 86 (479)
Q Consensus 20 ~~LG-~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~----~------~~~~~~~l~~Ei~il~~l~hpnI--v~l~~~~~~~ 86 (479)
..|| .|+.|+||.+.. .+..++||.+..... . .......+.+|+.++..+.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 778888888876 477899998864321 1 11223567899999999998774 6777764432
Q ss_pred -C---EEEEEEeccCC-CChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 87 -S---KIFFVMEYAKG-GELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 87 -~---~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
. ..++|||+++| .+|.+.+..+.+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 2 23599999998 6899988877777654 5789999999999999999999999999998999999999875
Q ss_pred h
Q 011694 162 L 162 (479)
Q Consensus 162 ~ 162 (479)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-17 Score=180.26 Aligned_cols=270 Identities=23% Similarity=0.393 Sum_probs=215.8
Q ss_pred CCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 4 ~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
++-.+.+.--+.+.+.+-+-+|+++.++.+.-..+|...++|+..+.........+.+..+-.++-...+|.+++....+
T Consensus 794 ~sp~~yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~ 873 (1205)
T KOG0606|consen 794 RSPTKYRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF 873 (1205)
T ss_pred CCcccccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC
Confidence 33333445567788899999999999999998888888888876544332222234444444455555678888777767
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 84 ATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
......+++++|+.|++|...+.. +..+++.++.+...+..+++|||+..+.|||++|.|+|+..+|..+++|||....
T Consensus 874 ~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 874 PCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccc
Confidence 777889999999999999999987 5688889999999999999999999999999999999999999999999984321
Q ss_pred hhcc---------------------cc--------CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCC
Q 011694 163 AQCK---------------------HQ--------DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGY 213 (479)
Q Consensus 163 ~~~~---------------------~~--------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~ 213 (479)
.... .. ........||+.|.+||.+.+.... ..+|.|+.|+++++.++|.
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg-s~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG-SAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC-CcchhhhhhhhhhhhhcCC
Confidence 1100 00 0112334689999999999888764 7999999999999999999
Q ss_pred CCCCCChHHHHHHHhccCcCCCCCC---CCHHHHHHHHHhccCCccccCChh---hhhcChhhhccc
Q 011694 214 LPFHDSNLIEMYRKIGKAEFKCPNW---FPPEVRKLLCKILDPNPSTRISMA---KIRESSWFRKGM 274 (479)
Q Consensus 214 ~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rpt~~---eil~h~wf~~~~ 274 (479)
+||........++.+.+...+.|.. .++++++++.++|..+|.+|..+. ++..|++|+...
T Consensus 1033 pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred CCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 9999999999999998877766543 689999999999999999999987 899999997543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=138.22 Aligned_cols=131 Identities=19% Similarity=0.332 Sum_probs=112.5
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeEEEEEeCCEEEEEEec
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH--PNIVQLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 95 (479)
+.+.||+|.++.||++... +..+++|.+..... ...+.+|+.+++.++| +++.+++.+....+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999984 47899999865432 3567899999999976 5899999998888899999999
Q ss_pred cCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 96 AKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR---GVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 96 ~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~---givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
+.|+++... +......++.+++.+++++|.. +++|+|++|+||+++..+.++++|||.+.
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 999877554 5566778899999999999985 79999999999999998999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-16 Score=117.90 Aligned_cols=59 Identities=66% Similarity=0.938 Sum_probs=47.9
Q ss_pred CCCCcccchhccccccCCCCCCCCCc---ccccceeEecCCHHHHHHHHHHHHHHcCcEEEe
Q 011694 315 LPNLNAFDIISLSAGFDLSGFFDENP---LIREARFTSKRPASVIISKLEEIAKSLRLKMMK 373 (479)
Q Consensus 315 ~~~~~~~~~is~s~~~~ls~~~~~~~---~~r~trf~s~~~~~~i~~~l~~~~~~l~~~~~~ 373 (479)
|..+||||+||+|+|||||+||+... .+|.+||+|+.|+++|+++||++|+.+||.|++
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 56799999999999999999998653 368999999999999999999999999999975
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.5e-16 Score=160.03 Aligned_cols=258 Identities=18% Similarity=0.220 Sum_probs=195.3
Q ss_pred CccCCCeEEeeeeee--cCCeEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEE
Q 011694 10 SVLTEKYEVGRLLGQ--GAFAKVYYARS--IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMA 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~--G~fg~Vy~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~ 84 (479)
+.+...+-+.+.+|. |.+|.||.+.. ..++..+|+|.-+...... .....=.+|+...+.++ |+|.++.+..++
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p-~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP-LDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc-cccccccchhhcccccCccccccccCcccc
Confidence 456677888899999 99999999998 8899999999743221111 11122246777777775 999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-C-CCCHHHHHHHHHHHHH----HHHHHHHCCCeeccCCCCCEEEecC-CCeEEeec
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-G-KLKEDAARRYFQQLIN----AVDFCHSRGVYHRDIKPENLLLDEN-ENLKISDF 157 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~qll~----aL~~LH~~givHrDLkp~NILl~~~-g~vkl~DF 157 (479)
..+..|+-+|+|. .+|..+... . -+++..++.++.+... ||.++|+.+++|-|+||.||+...+ ...+++||
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 9999999999996 578777765 3 4899999999999999 9999999999999999999999988 88999999
Q ss_pred CchhhhhccccCCCc---cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC--hHHHHHHHhccCc
Q 011694 158 GLSALAQCKHQDGLL---HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS--NLIEMYRKIGKAE 232 (479)
Q Consensus 158 Gla~~~~~~~~~~~~---~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~ 232 (479)
|+........-.... ....|...|++||.+.+. .+...|++++|.++.+..+|..++... +.-...+.+. ..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip 344 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IP 344 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cc
Confidence 998755433321111 223578899999998754 357999999999999888876665432 1111111111 11
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 233 FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 233 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
..+....+.++...+..|++.+|..|++++.++.|++...
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 1122224567777999999999999999999999998763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=151.63 Aligned_cols=141 Identities=22% Similarity=0.293 Sum_probs=96.3
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc-------------------------------hhhHH------HHH
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR-------------------------------VGLAD------QIK 62 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-------------------------------~~~~~------~l~ 62 (479)
+.||.|++|.||+|+. .+|+.||||+........ .+... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999987 489999999986532110 00111 133
Q ss_pred HHHHHHHhC----CCCCcceeEEEE-EeCCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHH-HHHHHHHCCC
Q 011694 63 REISVMRIV----RHPNIVQLYEVM-ATKSKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLIN-AVDFCHSRGV 134 (479)
Q Consensus 63 ~Ei~il~~l----~hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~-aL~~LH~~gi 134 (479)
+|...+.++ +|.+-+.+-.++ ...+..++||||++|++|.+..... ..+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 344444443 232222222222 2234579999999999998876532 222 3345556655 4788999999
Q ss_pred eeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 135 YHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 135 vHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
+|+|++|.||+++.+|.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-15 Score=160.02 Aligned_cols=144 Identities=23% Similarity=0.410 Sum_probs=101.2
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc--------------------------c-----hhhHHHH
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM--------------------------R-----VGLADQI 61 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--------------------------~-----~~~~~~l 61 (479)
...|+. +.||+|++|.||.|+.+.+|+.||||+.+..... + .+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 446776 8999999999999999888999999999754210 0 0223344
Q ss_pred HHHHHHHHhC----------CCCCcceeEEEEEe-CCEEEEEEeccCCCChHHH--Hhc-C----CCCHHHHHHHHHHHH
Q 011694 62 KREISVMRIV----------RHPNIVQLYEVMAT-KSKIFFVMEYAKGGELFNK--VAK-G----KLKEDAARRYFQQLI 123 (479)
Q Consensus 62 ~~Ei~il~~l----------~hpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--i~~-~----~l~e~~~~~i~~qll 123 (479)
.+|+.+++.. .+.+.+.+-.++.+ .+..++||||++|+.+.+. +.. + .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 4555444333 23333443344432 4456799999999999764 333 2 255556666677765
Q ss_pred HHHHHHHHCCCeeccCCCCCEEEecCC----CeEEeecCchhhhh
Q 011694 124 NAVDFCHSRGVYHRDIKPENLLLDENE----NLKISDFGLSALAQ 164 (479)
Q Consensus 124 ~aL~~LH~~givHrDLkp~NILl~~~g----~vkl~DFGla~~~~ 164 (479)
..|++|+|+||.||+++.+| .+++.|||++....
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 59999999999999999888 99999999986543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4e-13 Score=140.32 Aligned_cols=185 Identities=17% Similarity=0.303 Sum_probs=138.3
Q ss_pred CeEEeeeeeecCCeEEE-EEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 15 KYEVGRLLGQGAFAKVY-YARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy-~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
-|++ ...+-++.+ +| .|..+.++.+|.|.+.+.... .....+++-++-|+.++||||+++++.++.++.+|||+
T Consensus 14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvT 88 (690)
T KOG1243|consen 14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVT 88 (690)
T ss_pred Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEe
Confidence 3555 333333433 44 466678899999999876543 34567888899999999999999999999999999999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH-SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH-~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|.+. .|..+++. ++...+..-+.||+.||.||| +.+++|++|.-..|+++..|..||++|.++........ ..
T Consensus 89 ErV~--Pl~~~lk~--l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~ 162 (690)
T KOG1243|consen 89 ERVR--PLETVLKE--LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PA 162 (690)
T ss_pred eccc--cHHHHHHH--hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--cc
Confidence 9995 46666655 447778888999999999998 66899999999999999999999999998753322111 11
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCC
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGY 213 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~ 213 (479)
....---.|..|+.+.... -..|.|.|||++++++.|.
T Consensus 163 ~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcc
Confidence 1111222356666553322 3579999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.9e-13 Score=124.31 Aligned_cols=140 Identities=15% Similarity=0.206 Sum_probs=103.8
Q ss_pred eeeeeecCCeEEEEEEEcC------CCcEEEEEEeecccc-------------------cchhhHHHH----HHHHHHHH
Q 011694 19 GRLLGQGAFAKVYYARSIR------TNQSVAVKVIDKDKI-------------------MRVGLADQI----KREISVMR 69 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~------~~~~vaiK~i~~~~~-------------------~~~~~~~~l----~~Ei~il~ 69 (479)
...||.|.-+.||.|.... .+..+|||+...... .+......+ ++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998643 357899998753110 011122333 38999999
Q ss_pred hCC--CCCcceeEEEEEeCCEEEEEEeccCCCChH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCCEE
Q 011694 70 IVR--HPNIVQLYEVMATKSKIFFVMEYAKGGELF-NKVAKGKLKEDAARRYFQQLINAVDFC-HSRGVYHRDIKPENLL 145 (479)
Q Consensus 70 ~l~--hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~-~~i~~~~l~e~~~~~i~~qll~aL~~L-H~~givHrDLkp~NIL 145 (479)
++. .-++..++++ ..-+|||||+.++.+. ..++...+++..+..++.+++.+|..| |+.||+|+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 885 3466667765 4568999999875443 233444566777888899999999999 8999999999999999
Q ss_pred EecCCCeEEeecCchhhh
Q 011694 146 LDENENLKISDFGLSALA 163 (479)
Q Consensus 146 l~~~g~vkl~DFGla~~~ 163 (479)
++ +|.+.|+|||.|...
T Consensus 158 ~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EE-CCcEEEEECCCceeC
Confidence 96 578999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.5e-14 Score=146.77 Aligned_cols=255 Identities=18% Similarity=0.179 Sum_probs=191.2
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEc-CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSI-RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATK 86 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (479)
......+|-++..||.|.|+.|+..... .++..|++|-.........+-+.. ..|+.+...+ .|.++++++..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccc
Confidence 4566788999999999999999998755 677889999876654433222222 3566666666 499999999999988
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC-CCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN-ENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~-g~vkl~DFGla~~~~ 164 (479)
.+.|+-.|||+++++...+.- ..+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||+.+.+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 899999999999988766643 468899999999999999999999999999999999999876 788999999876321
Q ss_pred ccccCCCccccCCCCccc-ChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHH
Q 011694 165 CKHQDGLLHTTCGTPAYV-APEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV 243 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~-aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (479)
... ....+.-++. .+|++........++|++|||.-+++.++|...-... .....+..+..+..+..+..+
T Consensus 419 ~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~~~p~~~~~~~~~ 490 (524)
T KOG0601|consen 419 FSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSGDTPNLPGLKLQL 490 (524)
T ss_pred eec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc---ccceeeecccccCCCchHHhh
Confidence 110 1111233344 3555544433358999999999999999876432221 123334455555555566888
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
+.+.+.++.+++..|+.+.++..|+-|..
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhhh
Confidence 99999999999999999999988876643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.5e-13 Score=121.95 Aligned_cols=127 Identities=20% Similarity=0.301 Sum_probs=96.9
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc-eeEEEEEeCCEEEEEEeccC
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIV-QLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lV~E~~~ 97 (479)
++.|+.|.++.||.+.. .+..|++|+...... ....+.+|+.+++.+.+.+++ +++.... +..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999987 478899999765431 113457899999988655543 4555433 33589999999
Q ss_pred CCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eeccCCCCCEEEecCCCeEEeecCchh
Q 011694 98 GGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGV-----YHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 98 gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~gi-----vHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
|.++.+. ......++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11123467899999999999985 9999999999998 6789999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.5e-12 Score=125.36 Aligned_cols=199 Identities=17% Similarity=0.273 Sum_probs=140.9
Q ss_pred HHhCCCCCcceeEEEEEeC-----CEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--Ce
Q 011694 68 MRIVRHPNIVQLYEVMATK-----SKIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRG--VY 135 (479)
Q Consensus 68 l~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~g--iv 135 (479)
+-.+-|.|||+++.++.+. ..+.++.||+..|++..++++ ..+....-.+|+-||++||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 3345699999999988654 458899999999999999975 25888899999999999999999884 99
Q ss_pred eccCCCCCEEEecCCCeEEeecCchhhhhccc--cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCC
Q 011694 136 HRDIKPENLLLDENENLKISDFGLSALAQCKH--QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGY 213 (479)
Q Consensus 136 HrDLkp~NILl~~~g~vkl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~ 213 (479)
|+++....|++..+|-+|+.---......... .........+-++|.|||.=.-... +.++|||++|+...+|..|.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHhe
Confidence 99999999999999988885322211110000 0011123356789999997543333 36899999999999998876
Q ss_pred CCCC-CChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 214 LPFH-DSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 214 ~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.--. ..+....-..+.+.-+... .+--+.++.+||+..|..||++.+++.||..
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred eccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 5422 2221121122221111111 1233578999999999999999999999975
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.4e-11 Score=108.28 Aligned_cols=134 Identities=22% Similarity=0.310 Sum_probs=101.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhh-----HHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGL-----ADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~-----~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
..+++|+-+.+|.+.. -|..+++|.=.+........ ..+..+|..++.+++--.|.-..=+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4678999999999966 44456677543333222222 2556789999998875555555555566677789999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 95 YAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 95 ~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
|++|..|.+.+... ...++..+=.-+.-||..||+|+||.++||++.. +++.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~-~~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG-GRIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC-CcEEEEECCcccc
Confidence 99999999888765 2456777788888999999999999999999955 4599999999753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.6e-11 Score=112.55 Aligned_cols=139 Identities=19% Similarity=0.317 Sum_probs=108.9
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeEEEEEeC---CEEEEEEe
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH--PNIVQLYEVMATK---SKIFFVME 94 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lV~E 94 (479)
+.||.|.++.||++... +|+.+++|+....... .....+.+|..+++.+.+ .++.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999874 3688999998654321 123567899999999875 4467777776654 36789999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 011694 95 YAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHS------------------------------------------- 131 (479)
Q Consensus 95 ~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~------------------------------------------- 131 (479)
|++|.++.+.+..+.+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999988776644567788888888888888888884
Q ss_pred -------------CCCeeccCCCCCEEEec--CCCeEEeecCchh
Q 011694 132 -------------RGVYHRDIKPENLLLDE--NENLKISDFGLSA 161 (479)
Q Consensus 132 -------------~givHrDLkp~NILl~~--~g~vkl~DFGla~ 161 (479)
..++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23589999999999988 5668999999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.2e-10 Score=102.69 Aligned_cols=144 Identities=18% Similarity=0.219 Sum_probs=109.0
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV-----GLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
....|-+|+-+.|+.+.. .|+...||.=.......+ -...+.++|+.++.++.--.|.-..=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567899999999999987 888888885432222211 1236778999999988655555555566666777899
Q ss_pred EeccCC-CChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC---eEEeecCchhhh
Q 011694 93 MEYAKG-GELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN---LKISDFGLSALA 163 (479)
Q Consensus 93 ~E~~~g-g~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~---vkl~DFGla~~~ 163 (479)
|||++| .++.+++.. ..........++++|=+.+.-||.++|+|+||..+||++.++|+ +-++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999988 467777764 23333344789999999999999999999999999999976653 589999998643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.1e-09 Score=109.71 Aligned_cols=211 Identities=18% Similarity=0.243 Sum_probs=155.3
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEEEEEEeccCC-CC
Q 011694 26 AFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT----KSKIFFVMEYAKG-GE 100 (479)
Q Consensus 26 ~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~g-g~ 100 (479)
--.+.|++....+|..|++|.++..+..... ..-.-+.+++++.|+|||.+.++|.. +..+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 3467899999999999999999655433321 12234678999999999999999863 4579999999986 46
Q ss_pred hHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 101 LFNKVA----------------KGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 101 L~~~i~----------------~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
|.++-- ..+.+|..+|.|+.||..||.++|+.|++-+-|.|.+||++.+-+++|+..|+.-+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 765431 1247899999999999999999999999999999999999988899999888754332
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC-CCCChHHHH-HHHhccCcCCCCCCCCHH
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLP-FHDSNLIEM-YRKIGKAEFKCPNWFPPE 242 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~P-f~~~~~~~~-~~~i~~~~~~~~~~~~~~ 242 (479)
... + |.+... .+-|.=.||.+++.|.+|..- +........ ...| ...++.+
T Consensus 445 ~d~---------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D 497 (655)
T KOG3741|consen 445 EDP---------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTD 497 (655)
T ss_pred CCC---------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHH
Confidence 111 0 112211 356888999999999999644 222222221 2222 2336789
Q ss_pred HHHHHHHhccCCccccCChhhhhcC
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
++++|.-+...++++ -++.+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 999999999998887 788888765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.6e-09 Score=105.53 Aligned_cols=235 Identities=20% Similarity=0.261 Sum_probs=150.9
Q ss_pred EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE----E--EEeCC-E
Q 011694 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE----V--MATKS-K 88 (479)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~----~--~~~~~-~ 88 (479)
..++.||+|+-+.+|-.-. -+..|| |+++..... ...+ .+..|... .||-+-.=+. . ..+.. .
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VA-KIYh~Pppa---~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVA-KIYHAPPPA---AQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch--hhchhh-eeecCCCch---HHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 4578899999999996543 233344 888765321 1111 12233332 4553322111 1 12222 3
Q ss_pred EEEEEeccCCCC-hHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 89 IFFVMEYAKGGE-LFNKVAK-------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 89 ~~lV~E~~~gg~-L~~~i~~-------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
+-+.|..+.|.. +.++... ....++-+.+..+.|+.+.+.||+.|.+-+|++++|+|+++++.|.|.|-.--
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 788999998753 3333322 12677889999999999999999999999999999999999999999874422
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCCCC----CCccchhhHHHHHHHHHhC-CCCCCCC-------hHHHH--H-
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD----GEKVDIWSCGVVLFVLLAG-YLPFHDS-------NLIEM--Y- 225 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~----~~~~DvwSlGvil~~ll~G-~~Pf~~~-------~~~~~--~- 225 (479)
.+ ...+......+|.+.|.+||.-.-..+. +...|.|.|||++|++|.| .+||.+- +..+. .
T Consensus 165 qi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 21 1223334456799999999986522221 3678999999999999886 9999642 22221 0
Q ss_pred -----H-HhccCcCCCC---CC--CCHHHHHHHHHhccC--CccccCChhh
Q 011694 226 -----R-KIGKAEFKCP---NW--FPPEVRKLLCKILDP--NPSTRISMAK 263 (479)
Q Consensus 226 -----~-~i~~~~~~~~---~~--~~~~~~~li~~~L~~--dP~~Rpt~~e 263 (479)
. +-..+..+.| +| +++++..|..+|+.. ++.-|||++-
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 0 0011111111 22 689999999999875 3668999653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.8e-09 Score=101.16 Aligned_cols=134 Identities=14% Similarity=0.067 Sum_probs=94.1
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeeccccc---ch-----hhHHHHHHHHHHHHhCCCC--CcceeEEEEEe-----CCEEE
Q 011694 26 AFAKVYYARSIRTNQSVAVKVIDKDKIM---RV-----GLADQIKREISVMRIVRHP--NIVQLYEVMAT-----KSKIF 90 (479)
Q Consensus 26 ~fg~Vy~a~~~~~~~~vaiK~i~~~~~~---~~-----~~~~~l~~Ei~il~~l~hp--nIv~l~~~~~~-----~~~~~ 90 (479)
....|+.... .|+.|.||........ +. .-.....+|+..+..+..- .+..+..+.+. ...-+
T Consensus 34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 34 EGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 3334555544 6778999976432211 00 0011367888888777422 23344444433 23578
Q ss_pred EEEeccCCC-ChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-------CCCeEEeecCc
Q 011694 91 FVMEYAKGG-ELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-------NENLKISDFGL 159 (479)
Q Consensus 91 lV~E~~~gg-~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-------~g~vkl~DFGl 159 (479)
+|||++++. +|.+++.. ...++.....++.+++..+.-||..||+|+|+++.|||++. ++.+.++||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999999986 78888753 45677788899999999999999999999999999999975 46799999997
Q ss_pred hh
Q 011694 160 SA 161 (479)
Q Consensus 160 a~ 161 (479)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 64
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.9e-09 Score=99.29 Aligned_cols=127 Identities=23% Similarity=0.375 Sum_probs=84.7
Q ss_pred EEEEEEEcCCCcEEEEEEeecc---------------c--------ccchhhHHHHHHHHHHHHhCCCC--CcceeEEEE
Q 011694 29 KVYYARSIRTNQSVAVKVIDKD---------------K--------IMRVGLADQIKREISVMRIVRHP--NIVQLYEVM 83 (479)
Q Consensus 29 ~Vy~a~~~~~~~~vaiK~i~~~---------------~--------~~~~~~~~~l~~Ei~il~~l~hp--nIv~l~~~~ 83 (479)
.||.|.. ..|..+|||+.... . ....-.....++|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899987 57789999997531 0 00011235678999999999755 566776553
Q ss_pred EeCCEEEEEEeccC--CCChHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 84 ATKSKIFFVMEYAK--GGELFNKVAKGKLKEDAARRYFQQLINAVDF-CHSRGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 84 ~~~~~~~lV~E~~~--gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~-LH~~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
. -+|||||++ |..+.. +....++.+....++.+++..+.. +|+.||+|+||.+.|||++.+ .+.|+|||.|
T Consensus 80 --~--~~ivME~I~~~G~~~~~-l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPR-LKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp --T--TEEEEE--EETTEEGGC-HHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred --C--CEEEEEecCCCccchhh-HHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2 379999998 545533 443333355677788888886555 579999999999999999876 9999999987
Q ss_pred hh
Q 011694 161 AL 162 (479)
Q Consensus 161 ~~ 162 (479)
..
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 53
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.1e-10 Score=120.59 Aligned_cols=151 Identities=21% Similarity=0.367 Sum_probs=112.6
Q ss_pred HHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc------C-CCccccCCCCcccChhhhhcCCCC
Q 011694 122 LINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ------D-GLLHTTCGTPAYVAPEVINRKGYD 193 (479)
Q Consensus 122 ll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~------~-~~~~~~~gt~~y~aPEvl~~~~~~ 193 (479)
.+.|+.|+|.. ++||++|.|++|.++.+|..||+.|+++.-...... + ....-......|.|||++.+. ..
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~~ 186 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-TN 186 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-cc
Confidence 34899999965 899999999999999999999999998764332111 0 011111245679999999874 44
Q ss_pred CCccchhhHHHHHHHHH-hCCCCCCCChHHHHHHHh----ccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcCh
Q 011694 194 GEKVDIWSCGVVLFVLL-AGYLPFHDSNLIEMYRKI----GKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 194 ~~~~DvwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
+.++|++|+||++|.+. .|+.-+...+....+..- ....+.....+|+++++=|.++|..++.-||++..+...|
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence 68999999999999998 566555544332222211 1223344567899999999999999999999999999999
Q ss_pred hhhcc
Q 011694 269 WFRKG 273 (479)
Q Consensus 269 wf~~~ 273 (479)
||...
T Consensus 267 ff~D~ 271 (700)
T KOG2137|consen 267 FFSDP 271 (700)
T ss_pred ccCCc
Confidence 99754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.2e-08 Score=97.12 Aligned_cols=137 Identities=22% Similarity=0.314 Sum_probs=103.6
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccc-------ccc------------hhhHHHHHHHHHHHHhCCCC--
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDK-------IMR------------VGLADQIKREISVMRIVRHP-- 74 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~-------~~~------------~~~~~~l~~Ei~il~~l~hp-- 74 (479)
+.++..||.|.-|.||.|.+. .|..+|||.-.... ... .-......+|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 467899999999999999984 78899999743210 000 01123457899999998644
Q ss_pred CcceeEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEE
Q 011694 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKI 154 (479)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl 154 (479)
.|.+.+++ +...+||||++|-.|...- ++.+.+..++..|+.-+.-+-..||+|+|+++-||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 67777665 5568999999997775442 235556667777777777777999999999999999999999999
Q ss_pred eecCchh
Q 011694 155 SDFGLSA 161 (479)
Q Consensus 155 ~DFGla~ 161 (479)
+||--+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9998553
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.2e-07 Score=88.67 Aligned_cols=141 Identities=19% Similarity=0.281 Sum_probs=96.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhH------HHHHHHHHHHHhCC---CCCcceeE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLA------DQIKREISVMRIVR---HPNIVQLY 80 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~------~~l~~Ei~il~~l~---hpnIv~l~ 80 (479)
.++.++|++.+.+-......|.+..- .|+.+++|.........+... ....+.+..+..+. -.....++
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 36788999999999988888887765 788999998865432221111 11233444343332 33333333
Q ss_pred EEEEe-----CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEe
Q 011694 81 EVMAT-----KSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKIS 155 (479)
Q Consensus 81 ~~~~~-----~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~ 155 (479)
-+.+. ....+++|||++|.+|.+... +++ .+...|..++.-+|+.|++|+|..|.|++++. +.+++.
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iI 176 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRII 176 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEE
Confidence 33322 234568999999988866532 333 24456778899999999999999999999975 459999
Q ss_pred ecCch
Q 011694 156 DFGLS 160 (479)
Q Consensus 156 DFGla 160 (479)
||+..
T Consensus 177 D~~~k 181 (229)
T PF06176_consen 177 DTQGK 181 (229)
T ss_pred ECccc
Confidence 99864
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.4e-07 Score=88.65 Aligned_cols=103 Identities=19% Similarity=0.360 Sum_probs=82.0
Q ss_pred HHHHHHHHHHHhCC--CCCcceeEEEEEeC----CEEEEEEeccCCC-ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 011694 59 DQIKREISVMRIVR--HPNIVQLYEVMATK----SKIFFVMEYAKGG-ELFNKVAK-GKLKEDAARRYFQQLINAVDFCH 130 (479)
Q Consensus 59 ~~l~~Ei~il~~l~--hpnIv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH 130 (479)
....+|...+..+. .-.+.+.+++.+.. ...++|+|+++|. +|.+++.. ...+......++.++...++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 46678888777764 22344555555442 2468999999985 78888876 34777788899999999999999
Q ss_pred HCCCeeccCCCCCEEEecCC---CeEEeecCchh
Q 011694 131 SRGVYHRDIKPENLLLDENE---NLKISDFGLSA 161 (479)
Q Consensus 131 ~~givHrDLkp~NILl~~~g---~vkl~DFGla~ 161 (479)
++||+|+|++|.|||++.++ .+.++||+-+.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 99999999999999999887 79999999654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=3e-07 Score=85.57 Aligned_cols=138 Identities=13% Similarity=0.122 Sum_probs=99.0
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeecc--cccc-hhhHHHHHHHHHHHHhCCCC--CcceeEEE--EEeC--CEEEEE
Q 011694 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKD--KIMR-VGLADQIKREISVMRIVRHP--NIVQLYEV--MATK--SKIFFV 92 (479)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~--~~~~-~~~~~~l~~Ei~il~~l~hp--nIv~l~~~--~~~~--~~~~lV 92 (479)
-|+||-+.|+.... .|+.+-+|.-... .... .--...+.+|+..+..+..- .+.+.... .... -.-+||
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 36688889998765 4556888865311 0000 11236788999999888522 24444422 1122 246899
Q ss_pred EeccCC-CChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC--eEEeecCchh
Q 011694 93 MEYAKG-GELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN--LKISDFGLSA 161 (479)
Q Consensus 93 ~E~~~g-g~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~--vkl~DFGla~ 161 (479)
+|-++| -+|.+.+... +.++.....++.++...++-||+.|+.|+|+.+.||+++.+|. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998765 4888888764 4577778899999999999999999999999999999987777 9999998554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.8e-09 Score=111.15 Aligned_cols=240 Identities=21% Similarity=0.190 Sum_probs=169.0
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN-IVQLYEVMATKSKIFFV 92 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV 92 (479)
.-|...+-+++|+++++++.+...+...+ .+++... ....-++.+|.+++||| .+..++.+..++..+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34566778899999999999886665555 5665443 34456888999999999 88888888999999999
Q ss_pred EeccCCC-ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 93 MEYAKGG-ELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 93 ~E~~~gg-~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
|+++.++ +....+.. -.+.+-+...+.+.-..+++++|+--=+||| ||+..+ +..|..||+.........
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9999987 22222211 1234444555667778899999998878998 877744 788999999875433221
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc--CCC---CCCCCHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--FKC---PNWFPPEVR 244 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~---~~~~~~~~~ 244 (479)
...+..+|+.++|||+.....++ ...|.|++|+--.++--|-+|-..+.. ....+..+. ... ..|-+..-.
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~~~~~~ 461 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWSPVFHR 461 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcCccccc
Confidence 34567899999999999988887 789999999876777767666543211 111111111 000 112222223
Q ss_pred HHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 245 KLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
++...|+...|..|++...++.|.+|...
T Consensus 462 ~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 462 DFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred CCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 57788999999999999999999988643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.56 E-value=9.3e-07 Score=84.25 Aligned_cols=132 Identities=15% Similarity=0.169 Sum_probs=84.3
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceeEEEEEeCCEEEEEEeccC
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP--NIVQLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~lV~E~~~ 97 (479)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..- .+.+.+++.+..+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 25567789876432 234578999999988643 35778888888888899999999
Q ss_pred CCC-hHHHH--------------h-------c---CCCCHHH-HHHHHHH----------HHHH-HHHHH----HCCCee
Q 011694 98 GGE-LFNKV--------------A-------K---GKLKEDA-ARRYFQQ----------LINA-VDFCH----SRGVYH 136 (479)
Q Consensus 98 gg~-L~~~i--------------~-------~---~~l~e~~-~~~i~~q----------ll~a-L~~LH----~~givH 136 (479)
|.+ +...+ . . ...+... ...+..+ +... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11111 0 0 0011100 0011100 1111 12222 124789
Q ss_pred ccCCCCCEEEecCCCeEEeecCchh
Q 011694 137 RDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 137 rDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.9e-07 Score=97.16 Aligned_cols=137 Identities=18% Similarity=0.319 Sum_probs=90.2
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc---------------------------c----hhhHHHHHHHH---
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM---------------------------R----VGLADQIKREI--- 65 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~---------------------------~----~~~~~~l~~Ei--- 65 (479)
..|+.++-|.||.|+.. +|+.||||+....-.. - .+..+.+..|+
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67899999999999984 5999999997542100 0 11223333333
Q ss_pred ---HHHHhC----C-CCCcceeEEEEEeCCEEEEEEeccCCCChHHH--HhcCCCCHHH-----HHHHHHHHHHHHHHHH
Q 011694 66 ---SVMRIV----R-HPNIVQLYEVMATKSKIFFVMEYAKGGELFNK--VAKGKLKEDA-----ARRYFQQLINAVDFCH 130 (479)
Q Consensus 66 ---~il~~l----~-hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~--i~~~~l~e~~-----~~~i~~qll~aL~~LH 130 (479)
..+.++ + .|+|.-..=+.+-.+.-.++|||++|-.+.+. ++...++.+. +..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~------- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL------- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 333333 1 33333222233345567899999999988777 4444455333 333333333
Q ss_pred HCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 131 ~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
..|.+|.|..|.||+++.+|.+-+.|||+.....
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 4899999999999999999999999999976443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.7e-06 Score=81.85 Aligned_cols=139 Identities=16% Similarity=0.174 Sum_probs=98.6
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc--------------------h-hhHHHHHHHHHHHHhCC--CCC
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR--------------------V-GLADQIKREISVMRIVR--HPN 75 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~--------------------~-~~~~~l~~Ei~il~~l~--hpn 75 (479)
...|+.|.-+.||+|.. .++..||+|++......- . -......+|...|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677888889999976 578899999985432111 0 11133467777787774 444
Q ss_pred cceeEEEEEeCCEEEEEEeccCCCC-hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeE
Q 011694 76 IVQLYEVMATKSKIFFVMEYAKGGE-LFNKVAKGKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLK 153 (479)
Q Consensus 76 Iv~l~~~~~~~~~~~lV~E~~~gg~-L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vk 153 (479)
+.+.+.+.. -.+||||+.... -.-.++.-++..+++..+..+++..+.-|-. .|+||+||+.=|||+. +|.+.
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 555565543 369999996531 1122222345555789999999999988877 8999999999999998 88999
Q ss_pred EeecCchhhh
Q 011694 154 ISDFGLSALA 163 (479)
Q Consensus 154 l~DFGla~~~ 163 (479)
|+|||-|...
T Consensus 207 iID~~QaV~~ 216 (268)
T COG1718 207 IIDVSQAVTI 216 (268)
T ss_pred EEECcccccc
Confidence 9999987644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.7e-06 Score=80.37 Aligned_cols=136 Identities=20% Similarity=0.302 Sum_probs=82.2
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceeEEEE---EeCCEEEEEE
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP--NIVQLYEVM---ATKSKIFFVM 93 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lV~ 93 (479)
++.|+.|..+.||.+.... ..+++|+.... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4789999999999998844 58999997554 2346778888888887532 355666643 3344689999
Q ss_pred eccCCCChHH----------------HHhc---C-----CCCHHH---------HHHH------------HHHHHH-HHH
Q 011694 94 EYAKGGELFN----------------KVAK---G-----KLKEDA---------ARRY------------FQQLIN-AVD 127 (479)
Q Consensus 94 E~~~gg~L~~----------------~i~~---~-----~l~e~~---------~~~i------------~~qll~-aL~ 127 (479)
++++|..+.. .+.. - .+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 1110 0 001000 0000 111222 233
Q ss_pred HHHH-------CCCeeccCCCCCEEEe-cCCCeEEeecCchh
Q 011694 128 FCHS-------RGVYHRDIKPENLLLD-ENENLKISDFGLSA 161 (479)
Q Consensus 128 ~LH~-------~givHrDLkp~NILl~-~~g~vkl~DFGla~ 161 (479)
.+++ ..++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 4699999999999999 66667899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.6e-06 Score=96.43 Aligned_cols=203 Identities=18% Similarity=0.184 Sum_probs=143.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCE----EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011694 59 DQIKREISVMRIVRHPNIVQLYEVMATKSK----IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRG 133 (479)
Q Consensus 59 ~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~----~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~g 133 (479)
....-|+..+.++.|+|+++++.+...... ..+..|+|++-++...+.. +.++.+.++.+..++++|+.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 344556677788899999999998754432 3345689999999888876 78999999999999999999999997
Q ss_pred CeeccCCCC---CEEEecCCCeEEe--ecCchhhhhccccCCCccccCCCCcccChhhhhcCCCC-CCccchhhHHHHHH
Q 011694 134 VYHRDIKPE---NLLLDENENLKIS--DFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD-GEKVDIWSCGVVLF 207 (479)
Q Consensus 134 ivHrDLkp~---NILl~~~g~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~-~~~~DvwSlGvil~ 207 (479)
..|.-|... +-..+..+.+.++ ||+.+........ ......+..+.|||......+. +...|+|.+|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 666655555 3334455666766 8887654432222 2233456678889888766554 23369999999999
Q ss_pred HHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 208 VLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 208 ~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+..|..+-.-...... -.+........+++.+|+.-++++|+++.+++.|+|.+..
T Consensus 384 ~~~~~~~i~~~~~~~~~---------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVPVS---------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhcCcccccccchhh---------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 99887654221111000 0111122267889999999999999999999999987644
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.26 E-value=8.2e-06 Score=78.45 Aligned_cols=74 Identities=14% Similarity=0.217 Sum_probs=53.5
Q ss_pred eeeecCC-eEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 21 LLGQGAF-AKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 21 ~LG~G~f-g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
.|..|.. +.||++.. .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4555666 78899865 34678889875442 235678898888874 44466788887777778999999999
Q ss_pred CChH
Q 011694 99 GELF 102 (479)
Q Consensus 99 g~L~ 102 (479)
.+|.
T Consensus 77 ~~l~ 80 (244)
T cd05150 77 VPAA 80 (244)
T ss_pred ccHh
Confidence 7665
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.3e-05 Score=71.86 Aligned_cols=133 Identities=21% Similarity=0.322 Sum_probs=97.7
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccc-------------cchhhHHHHHHHHHHHHhCC------CCCccee
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI-------------MRVGLADQIKREISVMRIVR------HPNIVQL 79 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~-------------~~~~~~~~l~~Ei~il~~l~------hpnIv~l 79 (479)
...||+|+.-.||.-- .....+||++..... .......+..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3579999999999543 334468899877650 11122456677777666665 7899999
Q ss_pred EEEEEeCCEEEEEEeccCC------CChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC--C-
Q 011694 80 YEVMATKSKIFFVMEYAKG------GELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN--E- 150 (479)
Q Consensus 80 ~~~~~~~~~~~lV~E~~~g------g~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~--g- 150 (479)
+|+.+++.-.-+|+|.+.. -+|.+++..+.+++ .. ...|-.-..||-+++|+.+||+|.||++..+ |
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999998743 26889998888877 33 3344455678899999999999999999643 2
Q ss_pred -CeEEee-cC
Q 011694 151 -NLKISD-FG 158 (479)
Q Consensus 151 -~vkl~D-FG 158 (479)
.+.|+| ||
T Consensus 159 ~~lvlIDG~G 168 (199)
T PF10707_consen 159 FRLVLIDGLG 168 (199)
T ss_pred eEEEEEeCCC
Confidence 477777 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.5e-05 Score=90.08 Aligned_cols=81 Identities=19% Similarity=0.372 Sum_probs=58.2
Q ss_pred EeeeeeecCCeEEEEEEEcCCC--cEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCc--ceeEEEEEeC---CEE
Q 011694 18 VGRLLGQGAFAKVYYARSIRTN--QSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNI--VQLYEVMATK---SKI 89 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~--~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~ 89 (479)
-.+.|+.|.+..+|+......+ ..+++|+........ ....+.+|+.+++.+. |++| .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3578899999999998764432 467778765432211 2356889999999995 6654 7777777664 467
Q ss_pred EEEEeccCCCC
Q 011694 90 FFVMEYAKGGE 100 (479)
Q Consensus 90 ~lV~E~~~gg~ 100 (479)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 99999999864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.3e-07 Score=104.79 Aligned_cols=215 Identities=15% Similarity=0.115 Sum_probs=155.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEeccCCCChHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH
Q 011694 59 DQIKREISVMRIVRHPNIVQLYEVMAT--KSKIFFVMEYAKGGELFNKVAKG-----KLKEDAARRYFQQLINAVDFCHS 131 (479)
Q Consensus 59 ~~l~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~qll~aL~~LH~ 131 (479)
+.+..|..-.+...|+++...+.-... ....|..++||.+|.+++.|-+| .+.+..+.....+.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 334445556667789999887776643 34579999999999999999764 35555566666666888888886
Q ss_pred CC-----CeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHH
Q 011694 132 RG-----VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVL 206 (479)
Q Consensus 132 ~g-----ivHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil 206 (479)
.. .+|++||+-|.+|..+-++|+.++|+.+... ..........++|.|++|++.+.-.+. .++|+|..|+.+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSL 1430 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHH
Confidence 52 7899999999999999999999999987221 112233456789999999999888876 569999999999
Q ss_pred HHHHhCCCCCCCChHHHHHHHhccCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 207 FVLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 207 ~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
|....|..+|-.-....+...+.+.. ...+...|.++-.....+|-..-..||.-..++.-+.|.-....
T Consensus 1431 y~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~~~d 1501 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVGLRD 1501 (2724)
T ss_pred HHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccccccC
Confidence 99999988875444433333333332 34444456666666666666667789998888888887655443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2e-05 Score=83.15 Aligned_cols=139 Identities=21% Similarity=0.300 Sum_probs=88.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc----------------------------hhhHHHHHHHHHHH---
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR----------------------------VGLADQIKREISVM--- 68 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~----------------------------~~~~~~l~~Ei~il--- 68 (479)
+.||.-+.|.||.|+.+. |+.||||+=+..-... .++.+.+..|+...
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999865 9999999864321000 11223333333322
Q ss_pred -------HhCCCCC------cceeEEEEEeCCEEEEEEeccCCCChHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011694 69 -------RIVRHPN------IVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHSRG 133 (479)
Q Consensus 69 -------~~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~--~i~~~~l~e~~~~~i~~qll~aL~~LH~~g 133 (479)
+.+.|-+ |.++|-.+ .+...++|||++|..+.| .|++.+++...+...+.+... .-+=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 2233444 33333322 345789999999987654 455666777654433322221 2223578
Q ss_pred CeeccCCCCCEEEec----CCCeEEeecCchhhh
Q 011694 134 VYHRDIKPENLLLDE----NENLKISDFGLSALA 163 (479)
Q Consensus 134 ivHrDLkp~NILl~~----~g~vkl~DFGla~~~ 163 (479)
.+|+|-.|.||++.. ++.+.+-|||+....
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 999999999999984 567999999997643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.6e-05 Score=70.19 Aligned_cols=129 Identities=22% Similarity=0.343 Sum_probs=93.6
Q ss_pred EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc-eeEEEEEeCCEEEEEEec
Q 011694 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIV-QLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lV~E~ 95 (479)
...+.||+|++|.||++.+ .|..+|+|+-..+. ....+..|.+++..+...++- +++.+.+ .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 3467899999999999998 67799999876553 346788999999999876655 4444433 3456999
Q ss_pred cCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCC-CCCEEEecCCCeEEeecCchhh
Q 011694 96 AKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIK-PENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 96 ~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLk-p~NILl~~~g~vkl~DFGla~~ 162 (479)
+.|-.|.+.-..+ + ++-...+++.-.-|-..||-|..|. |...+|..++.+.|+||.-|+.
T Consensus 94 i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998876654322 2 2333456666566777899999997 5555555666999999998763
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00013 Score=67.41 Aligned_cols=98 Identities=17% Similarity=0.282 Sum_probs=80.8
Q ss_pred HHHHHHHHhCCC-CCcceeEEEEEeCCEEEEEEeccCCCChHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 011694 62 KREISVMRIVRH-PNIVQLYEVMATKSKIFFVMEYAKGGELFNK----VAKGKLKEDAARRYFQQLINAVDFCHS---RG 133 (479)
Q Consensus 62 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~----i~~~~l~e~~~~~i~~qll~aL~~LH~---~g 133 (479)
..|.-+++.+.+ +++.+++|.+.. ++|.||...+++... ..-...++....+++.+++..+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999876 699999999853 678999988766532 111346889999999999999999998 45
Q ss_pred CeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 134 VYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 134 ivHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
+.-.|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999976544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00014 Score=67.35 Aligned_cols=129 Identities=20% Similarity=0.290 Sum_probs=91.6
Q ss_pred CCCeEEeeeeeecCC-eEEEEEEEcCCCcEEEEEEeec---cc-------ccch--------hhHHHHHHHHHHHHhCC-
Q 011694 13 TEKYEVGRLLGQGAF-AKVYYARSIRTNQSVAVKVIDK---DK-------IMRV--------GLADQIKREISVMRIVR- 72 (479)
Q Consensus 13 ~~~y~i~~~LG~G~f-g~Vy~a~~~~~~~~vaiK~i~~---~~-------~~~~--------~~~~~l~~Ei~il~~l~- 72 (479)
..+++.++.||.|+- |.||++.. .|+.+|+|++.. .. .... ....-+..|..+..+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 478999999999999 99999988 888999999321 10 0000 12245667777666654
Q ss_pred --CCCc--ceeEEEEEeC------------------CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 011694 73 --HPNI--VQLYEVMATK------------------SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH 130 (479)
Q Consensus 73 --hpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH 130 (479)
+.++ |+.+|++.-. ...-||.||++... .++. .=+.+|.+-+..+|
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccch----hHHHHHHHHHHHHH
Confidence 5566 8999987321 12467888877643 1222 33567888888999
Q ss_pred HCCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 131 SRGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 131 ~~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
..||+-+|+++.|.. +-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999985 3389999853
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.6e-05 Score=72.93 Aligned_cols=72 Identities=10% Similarity=0.117 Sum_probs=45.8
Q ss_pred eeeeecCCe-EEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC---CcceeEEEEEeC---CEEEEE
Q 011694 20 RLLGQGAFA-KVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP---NIVQLYEVMATK---SKIFFV 92 (479)
Q Consensus 20 ~~LG~G~fg-~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~lV 92 (479)
+.|+.|+.. .||... ..+++|+..... ....+.+|..+++.+... .+.++++..... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 567777776 488752 357778754421 235788999999887532 344444443332 245899
Q ss_pred EeccCCCCh
Q 011694 93 MEYAKGGEL 101 (479)
Q Consensus 93 ~E~~~gg~L 101 (479)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00038 Score=69.13 Aligned_cols=78 Identities=9% Similarity=0.125 Sum_probs=55.6
Q ss_pred EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC---CCcceeEEEEEe---CCEEE
Q 011694 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH---PNIVQLYEVMAT---KSKIF 90 (479)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~ 90 (479)
.-.+.||.|..+.||.... ++..+.+|+... .. ....+.+|...++.+.. -.|.++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~-~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYD--SQGNPMPLMARS-FS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEc--CCCCEEEEEecc-cc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 4467899999999999865 223466777432 11 12577889999988853 367788877754 36689
Q ss_pred EEEeccCCCCh
Q 011694 91 FVMEYAKGGEL 101 (479)
Q Consensus 91 lV~E~~~gg~L 101 (479)
+|||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00052 Score=70.62 Aligned_cols=80 Identities=19% Similarity=0.179 Sum_probs=54.9
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccc-cch---hhHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEE
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI-MRV---GLADQIKREISVMRIVR---HPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~-~~~---~~~~~l~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 91 (479)
.+.||.|.+..||.+.+...++.|+||.-..... ... -..++...|...|+.+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4789999999999999854446899998532110 001 12356777888888763 3467777777 4455789
Q ss_pred EEeccCCCC
Q 011694 92 VMEYAKGGE 100 (479)
Q Consensus 92 V~E~~~gg~ 100 (479)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00037 Score=66.44 Aligned_cols=75 Identities=17% Similarity=0.271 Sum_probs=48.7
Q ss_pred eeeeeecCCeEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCEEEEEEecc
Q 011694 19 GRLLGQGAFAKVYYARSIR-TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN-IVQLYEVMATKSKIFFVMEYA 96 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~ 96 (479)
++.|..|-...+|++.... .++.|++|+...... ..-...+|+.+++.+...+ ..++++... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4678888889999987533 357888998754321 1123357888888885333 344544432 2 4799999
Q ss_pred CCCCh
Q 011694 97 KGGEL 101 (479)
Q Consensus 97 ~gg~L 101 (479)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.0002 Score=69.48 Aligned_cols=132 Identities=15% Similarity=0.185 Sum_probs=77.1
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEeccCCC
Q 011694 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI-VQLYEVMATKSKIFFVMEYAKGG 99 (479)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg 99 (479)
.+..|-...+|+... +++.+++|+...... ...-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 456678888998863 667888897644321 110124678888888864333 33444332 26899999986
Q ss_pred ChHH--------------HHhc-C-------CCCH-HHHHHHHHHH---------HHHHHHHHH--------CCCeeccC
Q 011694 100 ELFN--------------KVAK-G-------KLKE-DAARRYFQQL---------INAVDFCHS--------RGVYHRDI 139 (479)
Q Consensus 100 ~L~~--------------~i~~-~-------~l~e-~~~~~i~~ql---------l~aL~~LH~--------~givHrDL 139 (479)
.+.. .+.+ . +++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 1111 0 1111 1222332222 111222222 25899999
Q ss_pred CCCCEEEecCCCeEEeecCchhh
Q 011694 140 KPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 140 kp~NILl~~~g~vkl~DFGla~~ 162 (479)
.|.||+++.++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999998877 89999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00017 Score=50.49 Aligned_cols=42 Identities=26% Similarity=0.470 Sum_probs=35.5
Q ss_pred eeEEEEEEEEEec-CceEEEEEEecCCChHHHHHHHhhhhhhcc
Q 011694 390 GIVSMDAEIFQIT-PNFHLVEMKKSNGDTLEYKKLLKDDIRPAL 432 (479)
Q Consensus 390 g~l~~~~~v~~~~-~~~~lVe~~k~~Gd~le~~~~~~~~l~~~l 432 (479)
..+.|.+||+.+. ++++.|+|+|.+||...|+++|.+ |-..|
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~-il~~l 45 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSK-ILNEL 45 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHH-HHHHT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHH-HHHHc
Confidence 3588999999997 899999999999999999999998 54444
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0007 Score=66.95 Aligned_cols=135 Identities=16% Similarity=0.219 Sum_probs=82.9
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceeEE------EEEeCCEEE
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP--NIVQLYE------VMATKSKIF 90 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~ 90 (479)
.+.|..|....+|+... .+..+++|+.... ....+..|+.++..+.+. .+.+++. +...++..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56788888889998865 3457888987541 124567788888777432 2444443 223456779
Q ss_pred EEEeccCCCChHH-----------HHhc-----CCCCH--------HHHH------------HHHHHHHHHHHHHHH---
Q 011694 91 FVMEYAKGGELFN-----------KVAK-----GKLKE--------DAAR------------RYFQQLINAVDFCHS--- 131 (479)
Q Consensus 91 lV~E~~~gg~L~~-----------~i~~-----~~l~e--------~~~~------------~i~~qll~aL~~LH~--- 131 (479)
+|++|++|..+.. .+.+ ..+.. .... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876421 0000 00000 0000 011112233444443
Q ss_pred ----CCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 132 ----RGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 132 ----~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
.+++|+|+.|.||+++.++.+.|.||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999987777899999763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.58 E-value=5.2e-05 Score=74.31 Aligned_cols=135 Identities=15% Similarity=0.246 Sum_probs=96.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccc---------------cchhh--H--HHHHHHHHHHHhCCC--
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI---------------MRVGL--A--DQIKREISVMRIVRH-- 73 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~---------------~~~~~--~--~~l~~Ei~il~~l~h-- 73 (479)
-|.+++.||-|.-+-||.+-+ ..|.+.++|+-..... ....+ . -...+|...|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367899999999999999987 5688888886432110 00001 1 123578888888752
Q ss_pred CCcceeEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeE
Q 011694 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLK 153 (479)
Q Consensus 74 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vk 153 (479)
--|.+.+++ +..++|||++.|-.|...-. ...+..+...|+.-+--|-.+|+||+|..-=||++++++.++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 234455544 55789999999977754421 122345666777778889999999999999999999999999
Q ss_pred EeecCc
Q 011694 154 ISDFGL 159 (479)
Q Consensus 154 l~DFGl 159 (479)
++||.-
T Consensus 243 vIDFPQ 248 (465)
T KOG2268|consen 243 VIDFPQ 248 (465)
T ss_pred EeechH
Confidence 999974
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0013 Score=65.50 Aligned_cols=137 Identities=17% Similarity=0.229 Sum_probs=80.8
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceeEEE------EEeCCEE
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP--NIVQLYEV------MATKSKI 89 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hp--nIv~l~~~------~~~~~~~ 89 (479)
-.+.++.|....+|++.. .+| .+++|+...... ...+..|+.++..|... .+.+++.. ....+..
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~-----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVK-----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCCC-----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 356788888889998864 344 577898755311 23455667777666322 23444331 1234668
Q ss_pred EEEEeccCCCChH-----------HHHhc-----CCCC--------HHH----HH-----------HHHHHHHHHHHHHH
Q 011694 90 FFVMEYAKGGELF-----------NKVAK-----GKLK--------EDA----AR-----------RYFQQLINAVDFCH 130 (479)
Q Consensus 90 ~lV~E~~~gg~L~-----------~~i~~-----~~l~--------e~~----~~-----------~i~~qll~aL~~LH 130 (479)
++++||++|.++. ..+.. ..++ ... .. .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 9999999986431 00110 0110 000 00 00112233455554
Q ss_pred H-------CCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 131 S-------RGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 131 ~-------~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
. .+++|+|+.+.||+++.++.+.|.||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 689999999999999988777899999753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00099 Score=66.32 Aligned_cols=138 Identities=20% Similarity=0.291 Sum_probs=87.5
Q ss_pred EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeEEEEEeCC--EEEEE
Q 011694 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH--PNIVQLYEVMATKS--KIFFV 92 (479)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h--pnIv~l~~~~~~~~--~~~lV 92 (479)
.+++.+..|..-.+|.... +++.++++ ... ............+|..+++.+.- .-+.+.++++.++. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3444554454445666655 38888888 321 12222345677889998888753 23445556665554 67999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHH-HHHHHHHHHHH----------------------------------------
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQ-QLINAVDFCHS---------------------------------------- 131 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~-qll~aL~~LH~---------------------------------------- 131 (479)
|+|++|..+.+.......+ ..+.. .+...|+-||+
T Consensus 104 ~~~veGe~~~~~~~~~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 104 MEWVEGEVVWSALPPESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred EEEecceeccCcCCcccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 9999996443332221111 12222 55555555553
Q ss_pred ------------------CCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 132 ------------------RGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 132 ------------------~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
..++|+|+.+.|++++.++-+-|.||+++.+
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 2479999999999999988899999999865
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00049 Score=71.33 Aligned_cols=167 Identities=23% Similarity=0.249 Sum_probs=109.4
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeC-CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 011694 59 DQIKREISVMRIVRHPNIVQLYEVMATK-SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHR 137 (479)
Q Consensus 59 ~~l~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHr 137 (479)
.++.-...+++.+.|+|...++++.... ....+|||+++. +|.+.+..+.+-..... .+|+.|-
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~l~~~s~~--------------~~~~~~~ 91 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGNLKDESLL--------------AHGVLHL 91 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcccchhhhc--------------cccccee
Confidence 4566778899999999999999988654 357899999955 89998877543222111 2222221
Q ss_pred cCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 011694 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH 217 (479)
Q Consensus 138 DLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~ 217 (479)
| .++++| -+++ . | | ...++|+||||+|.++.++.-|...|.
T Consensus 92 -----~-------~~~~td-~~~t-------~-----------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 92 -----N-------IIYITD-HFLT-------K-----------Y--P------SPIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----h-------hhhccc-cccc-------c-----------C--C------CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 2 233444 1110 0 0 0 011249999999999999999988777
Q ss_pred CChHHHHHHHhccCcCCCC------------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccchhhh
Q 011694 218 DSNLIEMYRKIGKAEFKCP------------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQK 279 (479)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~------------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~~~~ 279 (479)
.....+....+.+-....- -.++.....+..+|+...|..||...++++++-|.........
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~~~t~ 206 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYKDLTV 206 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHhhhhH
Confidence 6655554444432211111 1145667789999999999999999999999999876544433
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0017 Score=64.95 Aligned_cols=141 Identities=20% Similarity=0.238 Sum_probs=98.5
Q ss_pred EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccc----------------------ccchhhH-HHHHHHHHHHHhCCC
Q 011694 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDK----------------------IMRVGLA-DQIKREISVMRIVRH 73 (479)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~----------------------~~~~~~~-~~l~~Ei~il~~l~h 73 (479)
+|-..|.-|.-+.||.|.. .+|..+|||++...- .+...+. -....|+.-|+++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4567788999999999876 678889999875321 1111222 234677888887765
Q ss_pred CCcceeEEEEEeCCEEEEEEeccCCC-ChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCCEEEecCCC
Q 011694 74 PNIVQLYEVMATKSKIFFVMEYAKGG-ELFNKVAKGKLKEDAARRYFQQLINAVDFCH-SRGVYHRDIKPENLLLDENEN 151 (479)
Q Consensus 74 pnIv~l~~~~~~~~~~~lV~E~~~gg-~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH-~~givHrDLkp~NILl~~~g~ 151 (479)
..|.-.--+.-. ...|||+|+... --.-.++.-.++...+..+..|++.-+.-|- ..++||.||.-=|+|+ .+|.
T Consensus 226 aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred cCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 443322222211 246899999642 2233444457888899999999998887764 5699999999999999 6789
Q ss_pred eEEeecCchh
Q 011694 152 LKISDFGLSA 161 (479)
Q Consensus 152 vkl~DFGla~ 161 (479)
+.|+|-+-|.
T Consensus 303 lyiIDVSQSV 312 (520)
T KOG2270|consen 303 LYIIDVSQSV 312 (520)
T ss_pred EEEEEccccc
Confidence 9999988664
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0013 Score=65.24 Aligned_cols=75 Identities=19% Similarity=0.186 Sum_probs=48.4
Q ss_pred eeeeeecCCeEEEEEEEcC------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCEEEE
Q 011694 19 GRLLGQGAFAKVYYARSIR------TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN-IVQLYEVMATKSKIFF 91 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~------~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~l 91 (479)
++.|..|--..||++.... +++.+++|+...... ......+|..+++.+...+ ..++++.+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3566777777899887543 267899999765421 1234568888888875333 3355555542 35
Q ss_pred EEeccCCCCh
Q 011694 92 VMEYAKGGEL 101 (479)
Q Consensus 92 V~E~~~gg~L 101 (479)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0044 Score=62.01 Aligned_cols=135 Identities=14% Similarity=0.218 Sum_probs=74.3
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeEE------EEEeCCEEE
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH--PNIVQLYE------VMATKSKIF 90 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h--pnIv~l~~------~~~~~~~~~ 90 (479)
.+.|+.|....+|.... ++..+++|++.. .. .+.+..|+.+++.|.. -.+.+++. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g~~vLK~~~~--~~----~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQGEYVLTLFER--LT----AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe--CCCcEEEEEecc--CC----hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 35577788889998875 233688898751 11 1334445555555421 11333332 223356789
Q ss_pred EEEeccCCCChH-----------HHHhc-----CCC--------C--H-HH-HH-----------HHHHH-HHHHHHHHH
Q 011694 91 FVMEYAKGGELF-----------NKVAK-----GKL--------K--E-DA-AR-----------RYFQQ-LINAVDFCH 130 (479)
Q Consensus 91 lV~E~~~gg~L~-----------~~i~~-----~~l--------~--e-~~-~~-----------~i~~q-ll~aL~~LH 130 (479)
+++||++|..+. ..+.+ ..+ . . .. .. ..+.+ +-..+..+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999997431 11110 001 0 0 00 00 11111 111122222
Q ss_pred -------HCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 131 -------SRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 131 -------~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
..|++|+|+.|.||+++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2489999999999999865556899999764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0081 Score=61.82 Aligned_cols=77 Identities=17% Similarity=0.144 Sum_probs=51.9
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccc-cch---hhHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEE
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI-MRV---GLADQIKREISVMRIVR---HPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~-~~~---~~~~~l~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 90 (479)
..+.||.|....||+..+ .+..|+||.-..... ... -...+...|...|+.+. ..++.+++.+..+ .-+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 367899999999999887 345688997652111 111 02344556677776654 2478888888773 457
Q ss_pred EEEeccCC
Q 011694 91 FVMEYAKG 98 (479)
Q Consensus 91 lV~E~~~g 98 (479)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999987
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0075 Score=61.01 Aligned_cols=85 Identities=14% Similarity=0.112 Sum_probs=51.8
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeecc-cccc---hhhHHHHHHHHHHHHhCC--CC-CcceeEEEEEeCCEEEEEE
Q 011694 21 LLGQGAFAKVYYARSIRTNQSVAVKVIDKD-KIMR---VGLADQIKREISVMRIVR--HP-NIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~-~~~~---~~~~~~l~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV~ 93 (479)
.||.|...-||++.+...++.|+||--..- +... .-..++..-|...|+... .| .+.++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998544468999964311 1000 112356667888887764 34 45555544 444556999
Q ss_pred eccCCC-ChHHHHhc
Q 011694 94 EYAKGG-ELFNKVAK 107 (479)
Q Consensus 94 E~~~gg-~L~~~i~~ 107 (479)
|+++.. .|...+-.
T Consensus 80 EdL~~~~ilR~~Li~ 94 (370)
T TIGR01767 80 EDLSHHKIARKGLIE 94 (370)
T ss_pred hhCccchHHHHHHHc
Confidence 999653 33333333
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.012 Score=57.85 Aligned_cols=30 Identities=23% Similarity=0.494 Sum_probs=25.1
Q ss_pred CCeeccCCCCCEEEecCCC-eEEeecCchhh
Q 011694 133 GVYHRDIKPENLLLDENEN-LKISDFGLSAL 162 (479)
Q Consensus 133 givHrDLkp~NILl~~~g~-vkl~DFGla~~ 162 (479)
.++|+|++|.||+++.++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987565 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.021 Score=57.94 Aligned_cols=138 Identities=17% Similarity=0.235 Sum_probs=81.1
Q ss_pred eEEeeeeeecCCeEEEEEEEcC----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc-eeEEEEEeCCEEE
Q 011694 16 YEVGRLLGQGAFAKVYYARSIR----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIV-QLYEVMATKSKIF 90 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~ 90 (479)
..-...|-.|-.-.+|++.... +++.|++|+..... ....++ .+|..+++.+..-++- ++++.+...
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g---- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG---- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----
Confidence 3344566668888999987532 34689999886532 122233 6788888888643333 455655432
Q ss_pred EEEeccCCCChHH----------H----Hhc-------C-C--CCHHHHHHHHHHH-----------------HHHHHHH
Q 011694 91 FVMEYAKGGELFN----------K----VAK-------G-K--LKEDAARRYFQQL-----------------INAVDFC 129 (479)
Q Consensus 91 lV~E~~~gg~L~~----------~----i~~-------~-~--l~e~~~~~i~~ql-----------------l~aL~~L 129 (479)
.|.||++|.+|.. . +++ + . ...+.+..+..++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 5789998766531 1 110 0 0 1112233333221 1111111
Q ss_pred ----H----HCCCeeccCCCCCEEEec-CCCeEEeecCchh
Q 011694 130 ----H----SRGVYHRDIKPENLLLDE-NENLKISDFGLSA 161 (479)
Q Consensus 130 ----H----~~givHrDLkp~NILl~~-~g~vkl~DFGla~ 161 (479)
. ...++|+|+++.|||++. ++.+.++||..|.
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 235899999999999986 4789999999764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.025 Score=56.12 Aligned_cols=28 Identities=32% Similarity=0.617 Sum_probs=25.1
Q ss_pred CCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 132 RGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 132 ~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
.+++|+|+.+.||+++. +.+.|.||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 58999999999999987 67899999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.014 Score=59.77 Aligned_cols=78 Identities=21% Similarity=0.235 Sum_probs=51.5
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCC--CC-CcceeEEEEEeCCEEEEE
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV---GLADQIKREISVMRIVR--HP-NIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~l~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV 92 (479)
.+.||.|.-.-||++.+...++.|+||--..--...+ --.++..-|..+|+... .| ++.++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6789999999999999844467899986421111111 12466777888888764 34 45556554 44456789
Q ss_pred EeccCC
Q 011694 93 MEYAKG 98 (479)
Q Consensus 93 ~E~~~g 98 (479)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.072 Score=53.11 Aligned_cols=29 Identities=17% Similarity=0.251 Sum_probs=26.9
Q ss_pred CCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 133 GVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 133 givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
+++|+|+.+.|+|++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.065 Score=54.05 Aligned_cols=135 Identities=15% Similarity=0.246 Sum_probs=77.7
Q ss_pred eeeeeecCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEe
Q 011694 19 GRLLGQGAFAKVYYARSIRT---NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI-VQLYEVMATKSKIFFVME 94 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E 94 (479)
++.|..|---.+|+...... +..|++|+...... ..++ -.+|..+++.+..-++ .++++++. ++ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 45565577788998875432 34788998754321 1112 2578888888865444 35555553 22 5889
Q ss_pred ccCCCChHH----------HH----hc---CCC-------CHHHHHHHHHHH----------------------HHHHHH
Q 011694 95 YAKGGELFN----------KV----AK---GKL-------KEDAARRYFQQL----------------------INAVDF 128 (479)
Q Consensus 95 ~~~gg~L~~----------~i----~~---~~l-------~e~~~~~i~~ql----------------------l~aL~~ 128 (479)
|++|..|.. .+ ++ .++ ....+..++.++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998765421 11 11 111 112233333222 111222
Q ss_pred HH----HCC----CeeccCCCCCEEEec-CCCeEEeecCchh
Q 011694 129 CH----SRG----VYHRDIKPENLLLDE-NENLKISDFGLSA 161 (479)
Q Consensus 129 LH----~~g----ivHrDLkp~NILl~~-~g~vkl~DFGla~ 161 (479)
+. +.+ .+|.|+.|.|||+++ ++.++++||..|.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 21 122 699999999999975 5789999999874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.052 Score=53.60 Aligned_cols=75 Identities=15% Similarity=0.171 Sum_probs=47.9
Q ss_pred EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEE
Q 011694 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR---HPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 93 (479)
+-.+.++-|....+|... .+++.+.||+-... ....+..|..-|+.|. .-.+.+++.+....+.-|+||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345679999999999887 58888999987622 1245677887777773 446778999988777789999
Q ss_pred eccCCC
Q 011694 94 EYAKGG 99 (479)
Q Consensus 94 E~~~gg 99 (479)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.023 Score=53.23 Aligned_cols=29 Identities=28% Similarity=0.636 Sum_probs=21.1
Q ss_pred CCeeccCCCCCEEE-ecCCCeEEeecCchh
Q 011694 133 GVYHRDIKPENLLL-DENENLKISDFGLSA 161 (479)
Q Consensus 133 givHrDLkp~NILl-~~~g~vkl~DFGla~ 161 (479)
.++|.|+.|.|||+ +.++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 889999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.14 Score=51.62 Aligned_cols=132 Identities=17% Similarity=0.290 Sum_probs=77.6
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC------cceeEE----EEEeCCEEEE
Q 011694 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN------IVQLYE----VMATKSKIFF 91 (479)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpn------Iv~l~~----~~~~~~~~~l 91 (479)
|.+ .-..||+... .+|+ +++|+.... .. ...+.-|+..+..|.-.+ +..+-| ......+.+-
T Consensus 34 l~s-~eN~~f~~~~-~~g~-~iLki~~~~-~~----~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 34 LNS-EENSNFRVQT-EDGR-YILKIYRPG-WT----RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccc-ccCceEEEEe-cCCC-eEEEEecCC-CC----HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 444 4456888876 3344 489998776 22 356677888887773111 222222 2222247889
Q ss_pred EEeccCCCChHH------------HHhc-----CC-----------CCHH----H---------HHHHHHHHHHHHHHHH
Q 011694 92 VMEYAKGGELFN------------KVAK-----GK-----------LKED----A---------ARRYFQQLINAVDFCH 130 (479)
Q Consensus 92 V~E~~~gg~L~~------------~i~~-----~~-----------l~e~----~---------~~~i~~qll~aL~~LH 130 (479)
+++|++|..+.. .+.+ .. ..+. . -.....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999977651 0000 00 1111 0 0112234444455554
Q ss_pred H-------C-C--CeeccCCCCCEEEecCCC-eEEeecCchh
Q 011694 131 S-------R-G--VYHRDIKPENLLLDENEN-LKISDFGLSA 161 (479)
Q Consensus 131 ~-------~-g--ivHrDLkp~NILl~~~g~-vkl~DFGla~ 161 (479)
+ . + +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 2 3 999999999999998775 8999999653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.47 Score=47.68 Aligned_cols=70 Identities=14% Similarity=0.104 Sum_probs=42.0
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeE---E--EEEeCCEEEEEEeccCC
Q 011694 26 AFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH--PNIVQLY---E--VMATKSKIFFVMEYAKG 98 (479)
Q Consensus 26 ~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h--pnIv~l~---~--~~~~~~~~~lV~E~~~g 98 (479)
.-..||.... .+|..+++|+....... ...+..|+..+..|.. -.|+... + +...++..+.++++++|
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~----~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWS----DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCC----HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 3456888764 45667999988644322 3556677777776631 1122211 1 22335678899999988
Q ss_pred CC
Q 011694 99 GE 100 (479)
Q Consensus 99 g~ 100 (479)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 64
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.18 Score=51.85 Aligned_cols=77 Identities=14% Similarity=0.235 Sum_probs=46.1
Q ss_pred EEeeeeeecCCeEEEEEEEcCC-CcE-----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEE
Q 011694 17 EVGRLLGQGAFAKVYYARSIRT-NQS-----VAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI-VQLYEVMATKSKI 89 (479)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~-~~~-----vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnI-v~l~~~~~~~~~~ 89 (479)
...+.|..|--..+|++..... +.. |.+++.... .+..-.-.+|+.+++.+...++ .++++.+..
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~---- 124 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD---- 124 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence 3446676688899999975432 122 444443211 1111122578999999875444 455666543
Q ss_pred EEEEeccCCCCh
Q 011694 90 FFVMEYAKGGEL 101 (479)
Q Consensus 90 ~lV~E~~~gg~L 101 (479)
+++.||++|.+|
T Consensus 125 g~l~efIeGr~l 136 (383)
T PTZ00384 125 FTIQEWVEGNTM 136 (383)
T ss_pred EEEEEEeccccC
Confidence 599999998765
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.1 Score=53.30 Aligned_cols=62 Identities=21% Similarity=0.257 Sum_probs=47.5
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCCEEEecC
Q 011694 88 KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFC-HSRGVYHRDIKPENLLLDEN 149 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~L-H~~givHrDLkp~NILl~~~ 149 (479)
...++-+|..|.++..+++....+|....++..--..|+--| --.|.+|.|+.|.||++--+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 346677888898999999887788877777776666665443 35689999999999999543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.095 Score=49.31 Aligned_cols=85 Identities=19% Similarity=0.169 Sum_probs=58.4
Q ss_pred HHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--CCCee
Q 011694 59 DQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHS--RGVYH 136 (479)
Q Consensus 59 ~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~--~givH 136 (479)
..++++.+++.++. .|+++..- +.-.+-+++|+|-.... ++ ..++.-=+.+|.-.|+ .+.+|
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--------~~----~N~i~agi~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--------NF----SNFITAGIKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc--------ch----hHHHHHhHHHHHHhhccCCCeec
Confidence 45577777877653 46777643 45568899999954211 00 1111122566777884 47999
Q ss_pred ccCCCCCEEEecCCCeEEeecCc
Q 011694 137 RDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 137 rDLkp~NILl~~~g~vkl~DFGl 159 (479)
+|-.|+||+-|..|.+||.|=+.
T Consensus 167 GD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 167 GDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999663
|
The function of this family is unknown. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.21 Score=49.21 Aligned_cols=75 Identities=17% Similarity=0.143 Sum_probs=44.7
Q ss_pred eecCCeEEEEEEEcC----CC----cEEEEEEeecccccch--hhHHHHHHHHHHHHhCC---------C----CCccee
Q 011694 23 GQGAFAKVYYARSIR----TN----QSVAVKVIDKDKIMRV--GLADQIKREISVMRIVR---------H----PNIVQL 79 (479)
Q Consensus 23 G~G~fg~Vy~a~~~~----~~----~~vaiK~i~~~~~~~~--~~~~~l~~Ei~il~~l~---------h----pnIv~l 79 (479)
|.|-.|.+|.+.-.. ++ ..++||.......... .....+.+|+.+.+.+- . ..+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 677788888876533 22 3588888763222111 12356778887766441 1 234555
Q ss_pred EEEEEeCCEEEEEEeccC
Q 011694 80 YEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 80 ~~~~~~~~~~~lV~E~~~ 97 (479)
+....+....+||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 665555557899998764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 479 | ||||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-58 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-58 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-57 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-56 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-56 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-56 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-56 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-56 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-54 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-53 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-53 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-53 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-53 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-53 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-52 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-52 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-52 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-51 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-50 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-50 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-50 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-49 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-49 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-47 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-46 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-46 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-46 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-46 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-46 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-46 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-45 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-45 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-45 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-45 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-45 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-45 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-45 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-45 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-45 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-45 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-45 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-45 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-45 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-45 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-45 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-45 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-45 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-45 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-45 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-45 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-45 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-45 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-45 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-45 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-45 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-44 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-44 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-44 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-43 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-42 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-42 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-42 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-42 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-42 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-41 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-41 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-41 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-41 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-41 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-41 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-41 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-41 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-41 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-41 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-41 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-41 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-41 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-40 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-40 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-40 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-40 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-40 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-40 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-40 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-40 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-40 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-40 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-40 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-40 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-40 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-40 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-39 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-39 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-38 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-38 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-38 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-38 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-38 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-38 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-37 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-37 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-37 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-36 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-36 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-36 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-36 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-36 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-36 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-36 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-36 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-36 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-36 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-36 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-36 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-36 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-36 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-36 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-36 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-36 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-35 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-35 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-35 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-35 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-35 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-35 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-35 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-35 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-35 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-35 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-35 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-35 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-35 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-35 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-35 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-35 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-35 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-35 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-35 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-35 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-35 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-35 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-35 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-35 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-35 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-35 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-35 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-35 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-35 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-35 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-35 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-35 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-35 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-35 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-35 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-35 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-35 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-35 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-35 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-35 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-35 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-35 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-35 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-35 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-34 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-34 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-34 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-34 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-34 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-34 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-34 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-34 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-34 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-34 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-34 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-34 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-34 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-34 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-34 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-34 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-34 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-34 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-34 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-34 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-34 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-34 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-34 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-34 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-34 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-33 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-33 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-33 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-33 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-33 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-33 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-33 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-33 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-33 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-33 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-33 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-33 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-33 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-33 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-33 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-33 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-33 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-33 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-33 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-33 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-33 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-33 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-33 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-33 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-33 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-33 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-33 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-33 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-33 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-32 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-32 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-32 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-32 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-32 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-32 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-32 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-32 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-32 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-32 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-32 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-32 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-32 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-31 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-31 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-31 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-31 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-31 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-31 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-31 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-31 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-31 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-31 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-31 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-30 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-30 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-30 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-30 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-29 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-29 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-29 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-29 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-29 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-29 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-29 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-29 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-29 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-29 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-29 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-29 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-29 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-29 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-29 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-29 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-29 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-29 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-29 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-28 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-28 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-28 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-28 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-28 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-28 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-28 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-28 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-28 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-28 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-27 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-27 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-27 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-27 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-27 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-27 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-27 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-27 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-27 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-26 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-26 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-26 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-26 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-26 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-26 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-26 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-25 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-25 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-25 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-25 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-24 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-24 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-24 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-24 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-24 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-24 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-24 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-24 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-24 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-24 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-24 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-24 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-24 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-24 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-24 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-24 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-24 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-24 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-24 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-23 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-23 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-23 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-23 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-23 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-23 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-23 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-23 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-23 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-23 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-23 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-23 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-22 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-22 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-22 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-22 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-22 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-22 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-22 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-22 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-22 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-22 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-22 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-22 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-22 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-22 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-22 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-22 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-22 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-22 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-22 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-22 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-22 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-21 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-20 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-20 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-20 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-19 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-19 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-18 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-18 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-18 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-18 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-18 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-18 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-18 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-18 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-18 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-18 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-18 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-18 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-18 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-18 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-18 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-18 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-18 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-18 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-18 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-18 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-18 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-18 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-18 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-18 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-18 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-18 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-18 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-18 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-18 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-18 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-18 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-18 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-18 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-18 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-18 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-18 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-18 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-18 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-17 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-17 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-17 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-16 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-16 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-13 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-09 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-08 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 |
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 496 bits (1278), Expect = e-174
Identities = 135/471 (28%), Positives = 222/471 (47%), Gaps = 59/471 (12%)
Query: 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREI 65
+ V Y +G LG G F KV + T VAVK++++ KI + + +I+REI
Sbjct: 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 66 SVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLIN 124
+++ RHP+I++LY+V++T S IF VMEY GGELF+ G+L E +RR FQQ+++
Sbjct: 68 QNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAP 184
VD+CH V HRD+KPEN+LLD + N KI+DFGLS + L T+CG+P Y AP
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTSCGSPNYAAP 184
Query: 185 EVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVR 244
EVI+ + Y G +VDIWS GV+L+ LL G LPF D ++ +++KI F P + P V
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244
Query: 245 KLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQ-------------------------- 278
LL +L +P R ++ IRE WF++ + +
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFEC 304
Query: 279 -KQKVTES------------------------KDAASQDAGASAPQGSSSIAAEIKQELG 313
+++V +A S P +
Sbjct: 305 SEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPE 364
Query: 314 QLPNLNAFDIISLSAGFDLSGFFDENPLIREAR----FTSKRPASVIISKLEEIAKSLRL 369
++P L A + +L+ ++ +R+A+ S+ + I++++ K L
Sbjct: 365 RVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDY 424
Query: 370 KMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEY 420
+ + L+ M +++Q+ +L++ + + + LE
Sbjct: 425 EWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 482 bits (1242), Expect = e-170
Identities = 105/303 (34%), Positives = 171/303 (56%), Gaps = 6/303 (1%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +++ + LG+GA+ +V A + T ++VAVK++D + + + IK+EI + +++ H
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 64
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSR 132
N+V+ Y + + +EY GGELF++ + E A+R+F QL+ V + H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
G+ HRDIKPENLLLDE +NLKISDFGL+ + + +++ LL+ CGT YVAPE++ R+ +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKIGKAEFKCPNW--FPPEVRKLLCK 249
E VD+WSCG+VL +LAG LP+ S+ + Y + + W LL K
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244
Query: 250 ILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAAEIK 309
IL NPS RI++ I++ W+ K + + K+ S + +G S S+ + +
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVN 304
Query: 310 QEL 312
Sbjct: 305 SAS 307
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 480 bits (1237), Expect = e-170
Identities = 101/271 (37%), Positives = 162/271 (59%), Gaps = 6/271 (2%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +++ + LG+GA+ +V A + T ++VAVK++D + + + IK+EI + +++ H
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 64
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSR 132
N+V+ Y + + +EY GGELF++ + E A+R+F QL+ V + H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
G+ HRDIKPENLLLDE +NLKISDFGL+ + + +++ LL+ CGT YVAPE++ R+ +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKIGKAEFKCPNW--FPPEVRKLLCK 249
E VD+WSCG+VL +LAG LP+ S+ + Y + + W LL K
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244
Query: 250 ILDPNPSTRISMAKIRESSWFRKGMNQKQKQ 280
IL NPS RI++ I++ W+ K + + K+
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 476 bits (1228), Expect = e-169
Identities = 115/271 (42%), Positives = 167/271 (61%), Gaps = 4/271 (1%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
+ V Y +G LG G F KV T VAVK++++ KI + + +IKREI
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINA 125
+++ RHP+I++LY+V++T + F VMEY GGELF+ G+++E ARR FQQ+++A
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
VD+CH V HRD+KPEN+LLD + N KI+DFGLS + L T+CG+P Y APE
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTSCGSPNYAAPE 180
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRK 245
VI+ + Y G +VDIWSCGV+L+ LL G LPF D ++ +++KI F P + V
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240
Query: 246 LLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276
LL +L +P R ++ IRE WF++ +
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-168
Identities = 98/265 (36%), Positives = 149/265 (56%), Gaps = 6/265 (2%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVG-LADQIKREISVMRIVRH 73
KY +G LLG+G++ KV T AVK++ K K+ R+ +K+EI ++R +RH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 74 PNIVQLYEVM--ATKSKIFFVMEYAKGG--ELFNKVAKGKLKEDAARRYFQQLINAVDFC 129
N++QL +V+ K K++ VMEY G E+ + V + + A YF QLI+ +++
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN- 188
HS+G+ H+DIKP NLLL LKIS G++ D T+ G+PA+ PE+ N
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248
+ G KVDIWS GV L+ + G PF N+ +++ IGK + P P + LL
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLK 245
Query: 249 KILDPNPSTRISMAKIRESSWFRKG 273
+L+ P+ R S+ +IR+ SWFRK
Sbjct: 246 GMLEYEPAKRFSIRQIRQHSWFRKK 270
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 476 bits (1228), Expect = e-168
Identities = 116/345 (33%), Positives = 173/345 (50%), Gaps = 20/345 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++Y+ + +G G F R T + VAVK I++ + + ++REI R +RH
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRH 75
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSR 132
PNIV+ EV+ T + + +MEYA GGEL+ + G+ ED AR +FQQL++ V +CHS
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 133 GVYHRDIKPENLLLDENE--NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
+ HRD+K EN LLD + LKI DFG S + +T GTPAY+APEV+ R+
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRK----IGKAEFKCPN--WFPPEVR 244
YDG+ D+WSCGV L+V+L G PF D YRK I ++ P+ PE
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252
Query: 245 KLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSI 304
L+ +I +P+TRIS+ +I+ SWF K + + + + I
Sbjct: 253 HLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQI 312
Query: 305 AAEIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTS 349
+E + L+ F ++ DL D+ E S
Sbjct: 313 ISEATIPAVRNRCLDDF----MTDNLDLDDDMDDFDSESEIDIDS 353
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 457 bits (1179), Expect = e-161
Identities = 83/261 (31%), Positives = 135/261 (51%), Gaps = 4/261 (1%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+Y GR LG+G FAK + T + A K++ K +++ +++ EIS+ R + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSR 132
++V + +F V+E + L + L E AR Y +Q++ + H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
V HRD+K NL L+E+ +KI DFGL+ + + CGTP Y+APEV+++KG+
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE--YDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
E VD+WS G +++ LL G PF S L E Y +I K E+ P P L+ K+L
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 251
Query: 253 PNPSTRISMAKIRESSWFRKG 273
+P+ R ++ ++ +F G
Sbjct: 252 TDPTARPTINELLNDEFFTSG 272
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 455 bits (1174), Expect = e-161
Identities = 87/270 (32%), Positives = 152/270 (56%), Gaps = 5/270 (1%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E ++VG LLG+G+FA VY A SI T VA+K+IDK + + G+ +++ E+ + ++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHS 131
P+I++LY + ++ V+E GE+ K E+ AR + Q+I + + HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
G+ HRD+ NLLL N N+KI+DFGL+ + +T CGTP Y++PE+ R
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK--MPHEKHYTLCGTPNYISPEIATRSA 188
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKIL 251
+ G + D+WS G + + LL G PF + K+ A+++ P++ E + L+ ++L
Sbjct: 189 H-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL 247
Query: 252 DPNPSTRISMAKIRESSWFRKGMNQKQKQK 281
NP+ R+S++ + + + + + K K +
Sbjct: 248 RRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 457 bits (1178), Expect = e-161
Identities = 115/312 (36%), Positives = 183/312 (58%), Gaps = 20/312 (6%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
Y + LG+G+F KV A +T Q VA+K I + + + + +++REIS ++++RHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSRG 133
+I++LY+V+ T + I V+EYA GGELF+ V K ++ ED RR+FQQ+I A+++CH
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD 193
+ HRD+KPENLLLD+N N+KI+DFGLS + L T+CG+P Y APEVIN K Y
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 194 GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDP 253
G +VD+WSCG+VL+V+L G LPF D + +++K+ + P++ P + L+ +++
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA 245
Query: 254 NPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAAEIKQELG 313
+P RI++ +IR WF + + S + I +LG
Sbjct: 246 DPMQRITIQEIRRDPWFNVNLPDYLR---------------PMEEVQGSYADSRIVSKLG 290
Query: 314 QLPNLNAFDIIS 325
+ + I+
Sbjct: 291 EAMGFSEDYIVE 302
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 455 bits (1174), Expect = e-160
Identities = 83/261 (31%), Positives = 135/261 (51%), Gaps = 4/261 (1%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+Y GR LG+G FAK + T + A K++ K +++ +++ EIS+ R + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSR 132
++V + +F V+E + L + L E AR Y +Q++ + H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
V HRD+K NL L+E+ +KI DFGL+ + + CGTP Y+APEV+++KG+
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE--YDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
E VD+WS G +++ LL G PF S L E Y +I K E+ P P L+ K+L
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277
Query: 253 PNPSTRISMAKIRESSWFRKG 273
+P+ R ++ ++ +F G
Sbjct: 278 TDPTARPTINELLNDEFFTSG 298
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 449 bits (1158), Expect = e-158
Identities = 90/297 (30%), Positives = 156/297 (52%), Gaps = 31/297 (10%)
Query: 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV--------- 55
+ V +Y + +G+G++ V A + N A+KV+ K K++R
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 56 --------------GLADQIKREISVMRIVRHPNIVQLYEVM--ATKSKIFFVMEYAKGG 99
G +Q+ +EI++++ + HPN+V+L EV+ + ++ V E G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 100 ELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159
+ L ED AR YFQ LI +++ H + + HRDIKP NLL+ E+ ++KI+DFG+
Sbjct: 124 PVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 160 SALAQCKHQDGLLHTTCGTPAYVAPEVIN--RKGYDGEKVDIWSCGVVLFVLLAGYLPFH 217
S K D LL T GTPA++APE ++ RK + G+ +D+W+ GV L+ + G PF
Sbjct: 184 SNE--FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
Query: 218 DSNLIEMYRKIGKAEFKCPNW--FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
D ++ ++ KI + P+ +++ L+ ++LD NP +RI + +I+ W +
Sbjct: 242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 448 bits (1155), Expect = e-158
Identities = 92/270 (34%), Positives = 151/270 (55%), Gaps = 6/270 (2%)
Query: 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV 67
K + +++GR LG+G F VY AR + +A+KV+ K ++ + G+ Q++REI +
Sbjct: 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 68 MRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAV 126
+RHPNI+++Y + +I+ ++E+A GEL+ ++ K G+ E + + ++L +A+
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
+CH R V HRDIKPENLL+ LKI+DFG S A T CGT Y+ PE+
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA----PSLRRRTMCGTLDYLPPEM 183
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246
I K +D EKVD+W GV+ + L G PF + E +R+I + K P + + L
Sbjct: 184 IEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQ 276
+ K+L +P R+ + + E W + +
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 442 bits (1138), Expect = e-155
Identities = 99/282 (35%), Positives = 155/282 (54%), Gaps = 6/282 (2%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
K E +E+GR LG+G F VY AR ++ +A+KV+ K ++ + G+ Q++RE+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINA 125
+ +RHPNI++LY ++++ ++EYA G ++ ++ K K E Y +L NA
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
+ +CHS+ V HRDIKPENLLL LKI+DFG S A CGT Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTDLCGTLDYLPPE 177
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRK 245
+I + +D EKVD+WS GV+ + L G PF + E Y++I + EF P++ R
Sbjct: 178 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 246 LLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKD 287
L+ ++L NPS R + ++ E W ++ + ES
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 417 bits (1074), Expect = e-145
Identities = 108/271 (39%), Positives = 169/271 (62%), Gaps = 5/271 (1%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
Y + + +G+G FAKV AR I T + VA+K+IDK ++ L ++ RE+ +M+I+ HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLFREVRIMKILNHP 74
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCHSRG 133
NIV+L+EV+ T+ ++ +MEYA GGE+F+ VA G++KE AR F+Q+++AV +CH +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD 193
+ HRD+K ENLLLD + N+KI+DFG S G L CG P Y APE+ K YD
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 194 GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDP 253
G +VD+WS GV+L+ L++G LPF NL E+ ++ + +++ P + + LL + L
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 251
Query: 254 NPSTRISMAKIRESSWFRKGMNQKQKQKVTE 284
NP R ++ +I + W G + + + E
Sbjct: 252 NPIKRGTLEQIMKDRWINAGHEEDELKPFVE 282
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 415 bits (1068), Expect = e-144
Identities = 82/279 (29%), Positives = 131/279 (46%), Gaps = 20/279 (7%)
Query: 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQ---IKRE 64
+Y +G LLG+G F V+ + VA+KVI +++++ E
Sbjct: 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 65 ISVMRIVR----HPNIVQLYEVMATKSKIFFVMEYA-KGGELFNK-VAKGKLKEDAARRY 118
++++ V HP +++L + T+ V+E +LF+ KG L E +R +
Sbjct: 85 VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF 144
Query: 119 FQQLINAVDFCHSRGVYHRDIKPENLLLD-ENENLKISDFGLSALAQCKHQDGLLHTTCG 177
F Q++ A+ CHSRGV HRDIK EN+L+D K+ DFG AL D G
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL----LHDEPYTDFDG 200
Query: 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN 237
T Y PE I+R Y +WS G++L+ ++ G +PF ++I +AE P
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPA 254
Query: 238 WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276
P+ L+ + L P PS+R S+ +I W +
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 413 bits (1063), Expect = e-143
Identities = 80/268 (29%), Positives = 134/268 (50%), Gaps = 16/268 (5%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLAD-----QIKREISVMR 69
KY LG GAF V+ A N+ V VK I K+K++ + ++ EI+++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 70 IVRHPNIVQLYEVMATKSKIFFVME-YAKGGELFNK-VAKGKLKEDAARRYFQQLINAVD 127
V H NI+++ ++ + VME + G +LF +L E A F+QL++AV
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
+ + + HRDIK EN+++ E+ +K+ DFG +A + + L +T CGT Y APEV+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLFYTFCGTIEYCAPEVL 201
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLL 247
Y G ++++WS GV L+ L+ PF + + +A P E+ L+
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLV 255
Query: 248 CKILDPNPSTRISMAKIRESSWFRKGMN 275
+L P P R ++ K+ W + +N
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWVTQPVN 283
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 407 bits (1047), Expect = e-141
Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 18/275 (6%)
Query: 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLAD---QIKRE 64
+ L +Y+VG LLG G F VY + N VA+K ++KD+I G ++ E
Sbjct: 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 96
Query: 65 ISVMRIVRH--PNIVQLYEVMATKSKIFFVMEYAKG-GELFNK-VAKGKLKEDAARRYFQ 120
+ +++ V +++L + ++E + +LF+ +G L+E+ AR +F
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 156
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISDFGLSALAQCKHQDGLLHTTCGTP 179
Q++ AV CH+ GV HRDIK EN+L+D N LK+ DFG AL +D + GT
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTR 212
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWF 239
Y PE I Y G +WS G++L+ ++ G +PF +I + +
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRV 266
Query: 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274
E + L+ L PS R + +I+ W + +
Sbjct: 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-133
Identities = 69/325 (21%), Positives = 130/325 (40%), Gaps = 51/325 (15%)
Query: 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDK--------------D 50
+ Y + R L QG F K+ + N+ A+K +K D
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 51 KIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN------- 103
KI D K E+ ++ +++ + ++ +++ + EY + +
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 104 --KVAKGKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLS 160
K + + + ++N+ + H+ + + HRD+KP N+L+D+N +K+SDFG S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKG-YDGEKVDIWSCGVVLFVLLAGYLPFHD- 218
D + + GT ++ PE + + Y+G KVDIWS G+ L+V+ +PF
Sbjct: 200 EYM----VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
Query: 219 SNLIEMYRKIGKAEFKCP-------------------NWFPPEVRKLLCKILDPNPSTRI 259
+L+E++ I + P N+ E L L NP+ RI
Sbjct: 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 260 SMAKIRESSWFRKGMNQKQKQKVTE 284
+ + W + ++ E
Sbjct: 316 TSEDALKHEWLADTNIEDLREFSKE 340
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 343 bits (883), Expect = e-116
Identities = 76/307 (24%), Positives = 137/307 (44%), Gaps = 37/307 (12%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
+E +LGQGAF +V AR+ ++ A+K I + I E+ ++
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL----STILSEVMLLA 57
Query: 70 IVRHPNIVQLYEV-------------MATKSKIFFVMEYAKGGELFNKVAKGKLK--EDA 114
+ H +V+ Y + KS +F MEY + G L++ + L D
Sbjct: 58 SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 115 ARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL------------ 162
R F+Q++ A+ + HS+G+ HRD+KP N+ +DE+ N+KI DFGL+
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI 222
L + GT YVA EV++ G+ EK+D++S G++ F ++ Y +
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERV 235
Query: 223 EMYRKIGKAEFKCPNWFP----PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQ 278
+ +K+ + P F +K++ ++D +P+ R + S W +
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV 295
Query: 279 KQKVTES 285
++ +S
Sbjct: 296 IKEALKS 302
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-107
Identities = 101/323 (31%), Positives = 165/323 (51%), Gaps = 23/323 (7%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGL-----ADQI 61
P L ++Y + + LG GA +V A +T + VA+K+I K K A +
Sbjct: 3 VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV 62
Query: 62 KREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQ 120
+ EI +++ + HP I+++ + + V+E +GGELF+K V +LKE + YF
Sbjct: 63 ETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCG 177
Q++ AV + H G+ HRD+KPEN+LL +E+ +KI+DFG S + + L+ T CG
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 178
Query: 178 TPAYVAPEVIN---RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-IEMYRKI--GKA 231
TP Y+APEV+ GY VD WS GV+LF+ L+GY PF + + + +I GK
Sbjct: 179 TPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 232 EFKCPNWFP--PEVRKLLCKILDPNPSTRISMAKIRESSWFR-KGMNQKQKQKVTESKDA 288
F W + L+ K+L +P R + + W + + M +K + ++E ++
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENES 297
Query: 289 ASQDAGASAPQGSSSIAAEIKQE 311
+ + P S E + E
Sbjct: 298 TALPQVLAQPSTSRKRPREGEAE 320
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-106
Identities = 96/296 (32%), Positives = 156/296 (52%), Gaps = 23/296 (7%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM-----RVGLADQI 61
P L ++Y + + LG GA +V A +T + VA+++I K K A +
Sbjct: 128 VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNV 187
Query: 62 KREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQ 120
+ EI +++ + HP I+++ + + V+E +GGELF+K V +LKE + YF
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCG 177
Q++ AV + H G+ HRD+KPEN+LL +E+ +KI+DFG S + + L+ T CG
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 303
Query: 178 TPAYVAPEVI---NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKI--GKA 231
TP Y+APEV+ GY VD WS GV+LF+ L+GY PF + + + +I GK
Sbjct: 304 TPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 232 EFKCPNWFP--PEVRKLLCKILDPNPSTRISMAKIRESSWFR-KGMNQKQKQKVTE 284
F W + L+ K+L +P R + + W + + M +K + ++E
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 418
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-103
Identities = 92/293 (31%), Positives = 143/293 (48%), Gaps = 22/293 (7%)
Query: 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV------GLA 58
+ E YE +LG+G + V T + AVK+ID L
Sbjct: 8 GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 67
Query: 59 DQIKREISVMRIV-RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAAR 116
+ +E+ ++R V HPNI+QL + T + F V + K GELF+ K L E R
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127
Query: 117 RYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC 176
+ + L+ + H + HRD+KPEN+LLD++ N+K++DFG S L C
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVC 184
Query: 177 GTPAYVAPEVI------NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI-- 228
GTP+Y+APE+I N GY G++VD+WS GV+++ LLAG PF + M R I
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 229 GKAEFKCPNWFP--PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQK 279
G +F P W V+ L+ + L P R + + +F++ + ++ +
Sbjct: 244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-103
Identities = 95/276 (34%), Positives = 146/276 (52%), Gaps = 16/276 (5%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
+ + Y + +G+G++ +V A T A K I K + V D+ K+EI +M+ +
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---DRFKQEIEIMKSL 63
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCH 130
HPNI++LYE + I+ VME GGELF + V K +E A R + +++AV +CH
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 131 SRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
V HRD+KPEN L + LK+ DFGL+A + ++ T GTP YV+P+V+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK---PGKMMRTKVGTPYYVSPQVL 180
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFP--PEV 243
Y G + D WS GV+++VLL GY PF E+ KI G F +W P+
Sbjct: 181 EGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQK 279
L+ ++L +P RI+ + E WF K ++ +
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-103
Identities = 91/270 (33%), Positives = 145/270 (53%), Gaps = 13/270 (4%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
++ Y+V LG+GAF+ V T A K+I+ K+ ++RE + R +
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKL 62
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCH 130
+HPNIV+L++ + +S + V + GGELF VA+ E A QQ++ ++ +CH
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 131 SRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
S G+ HR++KPENLLL + +K++DFGL+ H GTP Y++PEV+
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVL 179
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFP--PEV 243
+ Y + VDIW+CGV+L++LL GY PF D + +Y +I G ++ P W PE
Sbjct: 180 KKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKG 273
+ L+ +L NP RI+ + + W
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWICNR 268
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-103
Identities = 89/285 (31%), Positives = 144/285 (50%), Gaps = 21/285 (7%)
Query: 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV-----GLAD 59
D +KY+ ++G+G + V T AVK+++ + +
Sbjct: 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 60 QIKREISVMR-IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARR 117
+RE ++R + HP+I+ L + + S +F V + + GELF+ K L E R
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS 204
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177
+ L+ AV F H+ + HRD+KPEN+LLD+N +++SDFG S + L CG
Sbjct: 205 IMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE---PGEKLRELCG 261
Query: 178 TPAYVAPEVI------NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--G 229
TP Y+APE++ GY G++VD+W+CGV+LF LLAG PF I M R I G
Sbjct: 262 TPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 230 KAEFKCPNWFP--PEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
+ +F P W V+ L+ ++L +P R++ + + +F +
Sbjct: 321 QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-102
Identities = 93/276 (33%), Positives = 156/276 (56%), Gaps = 20/276 (7%)
Query: 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV 67
+ + + + + +LG GAF++V+ + T + A+K I K R ++ EI+V
Sbjct: 3 QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAV 59
Query: 68 MRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAV 126
++ ++H NIV L ++ + + + VM+ GGELF++ + +G E A QQ+++AV
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119
Query: 127 DFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+ H G+ HRD+KPENLL +EN + I+DFGLS + Q+G++ T CGTP YVA
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVA 175
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFPP 241
PEV+ +K Y + VD WS GV+ ++LL GY PF++ +++ KI G EF+ P W
Sbjct: 176 PEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW--D 232
Query: 242 EV----RKLLCKILDPNPSTRISMAKIRESSWFRKG 273
++ + +C +L+ +P+ R + K W
Sbjct: 233 DISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = e-101
Identities = 68/305 (22%), Positives = 132/305 (43%), Gaps = 25/305 (8%)
Query: 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR 63
+ SV Y + + +G G +KV+ + Q A+K ++ ++ L D +
Sbjct: 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL-DSYRN 75
Query: 64 EISVMRIVRHPN--IVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQ 120
EI+ + ++ + I++LY+ T I+ VME +L + K + + Y++
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWK 134
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180
++ AV H G+ H D+KP N L+ + LK+ DFG++ Q + + GT
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 181 YVAPEVINRKGYD----------GEKVDIWSCGVVLFVLLAGYLPFHD--SNLIEMYRKI 228
Y+ PE I K D+WS G +L+ + G PF + + +++ I
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 229 -GKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKD 287
E + P+ +++ +L L +P RIS+ ++ + Q Q V +
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV-----QIQTHPVNQMAK 308
Query: 288 AASQD 292
+++
Sbjct: 309 GTTEE 313
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-101
Identities = 89/273 (32%), Positives = 139/273 (50%), Gaps = 18/273 (6%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
+ + + R LG GAF V+ + +K I+KD+ +QI+ EI V++ +
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSL 77
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-----AKGKLKEDAARRYFQQLINAV 126
HPNI++++EV ++ VME +GGEL ++ L E +Q++NA+
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 127 DFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+ HS+ V H+D+KPEN+L + +KI DFGL+ L + D GT Y+A
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK---SDEHSTNAAGTALYMA 194
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-CPNWFP-- 240
PEV R K DIWS GVV++ LL G LPF ++L E+ +K E P
Sbjct: 195 PEVFKRD-V-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252
Query: 241 PEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273
P+ LL ++L +P R S A++ WF++
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-101
Identities = 92/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREI 65
N + ++ Y+V LG+GAF+ V T A K+I+ K+ ++RE
Sbjct: 21 MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREA 79
Query: 66 SVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLIN 124
+ R ++HPNIV+L++ + +S + V + GGELF VA+ E A QQ++
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 125 AVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
++ +CHS G+ HR++KPENLLL + +K++DFGL+ H GTP Y
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGY 196
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWF 239
++PEV+ + Y + VDIW+CGV+L++LL GY PF D + +Y +I G ++ P W
Sbjct: 197 LSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 255
Query: 240 P--PEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273
PE + L+ +L NP RI+ + + W
Sbjct: 256 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 302 bits (777), Expect = e-101
Identities = 92/281 (32%), Positives = 157/281 (55%), Gaps = 14/281 (4%)
Query: 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKRE 64
+ E+Y + +LG+G+F +V + T Q AVKVI+K + I RE
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILRE 71
Query: 65 ISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLI 123
+ +++ + HPNI++L+E++ S + V E GGELF++ + + + E A R +Q+
Sbjct: 72 VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 124 NAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180
+ + + H + HRD+KPEN+LL +++ ++KI DFGLS Q Q+ + GT
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAY 188
Query: 181 YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNW 238
Y+APEV+ Y EK D+WS GV+L++LL+G PF+ N ++ +++ GK F P W
Sbjct: 189 YIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246
Query: 239 FP--PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQK 277
+ + L+ K+L +PS RI+ + E W +K +++
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = e-100
Identities = 95/278 (34%), Positives = 154/278 (55%), Gaps = 12/278 (4%)
Query: 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR 63
M + TE+Y++ LG+GAF+ V + Q A +I+ K+ ++R
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LER 59
Query: 64 EISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQL 122
E + R+++HPNIV+L++ ++ + + + + GGELF VA+ E A QQ+
Sbjct: 60 EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI 119
Query: 123 INAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
+ AV CH GV HR++KPENLLL + +K++DFGL+ + + + GTP
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTP 177
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPN 237
Y++PEV+ + Y G+ VD+W+CGV+L++LL GY PF D + +Y++I G +F P
Sbjct: 178 GYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236
Query: 238 WFP--PEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273
W PE + L+ K+L NPS RI+ A+ + W
Sbjct: 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 1e-99
Identities = 65/312 (20%), Positives = 111/312 (35%), Gaps = 51/312 (16%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
S + + +LGQGA A V+ R +T A+KV + +R D RE V++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLK 62
Query: 70 IVRHPNIVQLYEVM--ATKSKIFFVMEYAKGGELFNKVAK----GKLKEDAARRYFQQLI 123
+ H NIV+L+ + T +ME+ G L+ + + L E + ++
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 124 NAVDFCHSRGVYHRDIKPENLLL----DENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
++ G+ HR+IKP N++ D K++DFG + + D + GT
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTE 179
Query: 180 AYVAPEVINRKGYD-------GEKVDIWSCGVVLFVLLAGYLPFHDS----NLIEMYRKI 228
Y+ P++ R G VD+WS GV + G LPF E+ KI
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 229 GKAEF-------------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAK 263
+ + +L IL+ + +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 264 IRESSWFRKGMN 275
+
Sbjct: 300 FFAETSDILHRG 311
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 4e-98
Identities = 92/320 (28%), Positives = 146/320 (45%), Gaps = 52/320 (16%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQ--IKREISVMR 69
L +KY + +GQG++ V A +T A+K+++K+KI ++ D IK E+ +M+
Sbjct: 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK---------------------- 107
+ HPNI +LYEV + I VME GG L +K+
Sbjct: 84 KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 108 -------------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL-- 146
+E +Q+ +A+ + H++G+ HRDIKPEN L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 147 DENENLKISDFGLSAL--AQCKHQDGLLHTTCGTPAYVAPEVINRKGYD-GEKVDIWSCG 203
+++ +K+ DFGLS + + T GTP +VAPEV+N G K D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 204 VVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNW--FPPEVRKLLCKILDPNPSTRI 259
V+L +LL G +PF N + ++ K F+ PN+ P R LL +L+ N R
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323
Query: 260 SMAKIRESSWFRKGMNQKQK 279
+ + W + ++ K
Sbjct: 324 DAMRALQHPWISQFSDKIYK 343
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 4e-97
Identities = 95/290 (32%), Positives = 140/290 (48%), Gaps = 27/290 (9%)
Query: 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREI 65
H T+ YEV +G G+++ TN AVK+IDK K EI
Sbjct: 14 HRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEI 66
Query: 66 SVM-RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLI 123
++ R +HPNI+ L +V ++ V E KGGEL +K + + E A +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 124 NAVDFCHSRGVYHRDIKPENLLL----DENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
V++ H++GV HRD+KP N+L E+++I DFG + Q + ++GLL T C T
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA--KQLRAENGLLMTPCYTA 184
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH---DSNLIEMYRKI--GKAEFK 234
+VAPEV+ R+GYD DIWS GV+L+ +L GY PF D E+ +I GK
Sbjct: 185 NFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243
Query: 235 CPNWFPPEV----RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQ 280
W V + L+ K+L +P R++ A + W Q Q
Sbjct: 244 GGYW--NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQ 291
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 292 bits (751), Expect = 6e-97
Identities = 84/288 (29%), Positives = 151/288 (52%), Gaps = 20/288 (6%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM---RVGLADQIKREIS 66
S++ + YE+G LG G FA V R T + A K I K ++ R ++I+RE++
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINA 125
++R +RHPNI+ L+++ K+ + ++E GGELF+ K L ED A ++ +Q+++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 126 VDFCHSRGVYHRDIKPENLLL----DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
V + HS+ + H D+KPEN++L N +K+ DFG++ + GTP +
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNIFGTPEF 177
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWF 239
VAPE++N + G + D+WS GV+ ++LL+G PF E I +F +
Sbjct: 178 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF- 235
Query: 240 PPEV----RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVT 283
+ + ++L +P R+++A+ E SW + + + + +
Sbjct: 236 -SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDS 282
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 1e-96
Identities = 75/330 (22%), Positives = 142/330 (43%), Gaps = 23/330 (6%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
SV Y + + +G G +KV+ + Q A+K ++ ++ L D + EI+ +
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL-DSYRNEIAYLN 62
Query: 70 IVRHPN--IVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAV 126
++ + I++LY+ T I+ VME +L + K + + Y++ ++ AV
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
H G+ H D+KP N L+ + LK+ DFG++ Q + + GT Y+ PE
Sbjct: 122 HTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 187 INRKGYD----------GEKVDIWSCGVVLFVLLAGYLPFHD--SNLIEMYRKI-GKAEF 233
I K D+WS G +L+ + G PF + + +++ I E
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240
Query: 234 KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG---MNQKQKQKVTESKDAAS 290
+ P+ +++ +L L +P RIS+ ++ + + +NQ K E K
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 300
Query: 291 QDAGASAPQGSSSIAAEIKQELGQLPNLNA 320
Q G ++P A + + + N+
Sbjct: 301 QLVGLNSPNSILKAAKTLYEHYSGGESHNS 330
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 2e-96
Identities = 65/323 (20%), Positives = 113/323 (34%), Gaps = 51/323 (15%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
S + + +LGQGA A V+ R +T A+KV + +R D RE V++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLK 62
Query: 70 IVRHPNIVQLYEVM--ATKSKIFFVMEYAKGGELFNKVAK----GKLKEDAARRYFQQLI 123
+ H NIV+L+ + T +ME+ G L+ + + L E + ++
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 124 NAVDFCHSRGVYHRDIKPENLLL----DENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
++ G+ HR+IKP N++ D K++DFG + + D + GT
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTE 179
Query: 180 AYVAPEVINRKGYD-------GEKVDIWSCGVVLFVLLAGYLPFHD----SNLIEMYRKI 228
Y+ P++ R G VD+WS GV + G LPF E+ KI
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 229 GKAEF-------------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAK 263
+ + +L IL+ + +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 264 IRESSWFRKGMNQKQKQKVTESK 286
+ + +
Sbjct: 300 FFAETSDILHRMVIHVFSLQQMT 322
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 2e-96
Identities = 80/276 (28%), Positives = 144/276 (52%), Gaps = 18/276 (6%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQ--IKREISVMR 69
+ YE+ ++G+G F+ V + T Q AVK++D K +KRE S+
Sbjct: 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLK----EDAARRYFQQLIN 124
+++HP+IV+L E ++ ++ V E+ G +L + V + E A Y +Q++
Sbjct: 82 MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 125 AVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
A+ +CH + HRD+KP +LL + + +K+ FG++ Q + GTP +
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHF 199
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWF 239
+APEV+ R+ Y G+ VD+W CGV+LF+LL+G LPF+ + ++ I GK + W
Sbjct: 200 MAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWS 257
Query: 240 P--PEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273
+ L+ ++L +P+ RI++ + W ++
Sbjct: 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 3e-95
Identities = 81/297 (27%), Positives = 143/297 (48%), Gaps = 20/297 (6%)
Query: 3 GMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM---RVGLAD 59
GM+ K + + Y++G LG G FA V R T A K I K + R +
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 60 QIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRY 118
+I+RE+S++R V H N++ L++V ++ + ++E GGELF+ K L E+ A +
Sbjct: 61 EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 119 FQQLINAVDFCHSRGVYHRDIKPENLLL----DENENLKISDFGLSALAQCKHQDGLLHT 174
+Q+++ V++ H++ + H D+KPEN++L ++K+ DFGL+ +
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKN 177
Query: 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAE 232
GTP +VAPE++N + G + D+WS GV+ ++LL+G PF E I +
Sbjct: 178 IFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236
Query: 233 FKCPNWFPPEV----RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTES 285
F + + + K+L R+++ + W NQ+ +
Sbjct: 237 FDEEFF--SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 4e-95
Identities = 96/279 (34%), Positives = 151/279 (54%), Gaps = 22/279 (7%)
Query: 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKRE 64
D + L++ +EV LG+GA + VY + T + A+KV+ K ++ E
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTE 98
Query: 65 ISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLI 123
I V+ + HPNI++L E+ T ++I V+E GGELF++ V KG E A +Q++
Sbjct: 99 IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158
Query: 124 NAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180
AV + H G+ HRD+KPENLL + LKI+DFGLS + + L+ T CGTP
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQVLMKTVCGTPG 215
Query: 181 YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKI--GKAEFKCPN 237
Y APE++ Y G +VD+WS G++ ++LL G+ PF+D M+R+I + F P
Sbjct: 216 YCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274
Query: 238 WFPPEV----RKLLCKILDPNPSTRISMAKIRESSWFRK 272
W EV + L+ K++ +P R++ + + W
Sbjct: 275 W--DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 5e-95
Identities = 74/334 (22%), Positives = 142/334 (42%), Gaps = 23/334 (6%)
Query: 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREI 65
+ SV Y + + +G G +KV+ + Q A+K ++ ++ L D + EI
Sbjct: 48 NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL-DSYRNEI 105
Query: 66 SVMRIVRHPN--IVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQL 122
+ + ++ + I++LY+ T I+ VME +L + K + + Y++ +
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM 164
Query: 123 INAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV 182
+ AV H G+ H D+KP N L+ + LK+ DFG++ Q + + G Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 183 APEVINRKGYD----------GEKVDIWSCGVVLFVLLAGYLPFHD--SNLIEMYRKI-G 229
PE I K D+WS G +L+ + G PF + + +++ I
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283
Query: 230 KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG---MNQKQKQKVTESK 286
E + P+ +++ +L L +P RIS+ ++ + + +NQ K E K
Sbjct: 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMK 343
Query: 287 DAASQDAGASAPQGSSSIAAEIKQELGQLPNLNA 320
Q G ++P A + + + N+
Sbjct: 344 YVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 377
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 300 bits (768), Expect = 9e-95
Identities = 85/470 (18%), Positives = 164/470 (34%), Gaps = 57/470 (12%)
Query: 3 GMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK 62
G + P+ +E+ LG G F V T + VA+K ++ + ++
Sbjct: 3 GRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWC 60
Query: 63 REISVMRIVRHPNIVQLYEVMATKSKI------FFVMEYAKGGELFNKVAK----GKLKE 112
EI +M+ + HPN+V EV K+ MEY +GG+L + + LKE
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 113 DAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN---LKISDFGLSALAQCKHQD 169
R + +A+ + H + HRD+KPEN++L KI D G + Q
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QG 177
Query: 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH-DSNLIEMYRKI 228
L GT Y+APE++ +K Y VD WS G + F + G+ PF + ++ + K+
Sbjct: 178 ELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236
Query: 229 GKAEFKCPNWFP-----------------------PEVRKLLCKILDPNPSTRISMAKIR 265
+ + + ++ + L +L + R + +
Sbjct: 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296
Query: 266 ESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSSSIAAEIKQELGQLPNLNAFDIIS 325
F+ + + ++ + + + P + +K L Q + +
Sbjct: 297 NVGCFQALDSILSLKLLSVMNMVSGRV--HTYPVTENENLQNLKSWLQQDTGIPEEEQEL 354
Query: 326 LSAGFDLSGFFDENPLIREARFTSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLK 385
L + A+ ++ + + L + +E
Sbjct: 355 L---------QASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRK---TVYEPQI 402
Query: 386 EGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKDDIRPALQDI 435
S+ + +++ G + + LK+D LQ
Sbjct: 403 SLPAHPESVSIVLQDPKRPLTYTHLRRVWGQIWQTIRALKEDCARLLQGQ 452
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 1e-94
Identities = 82/295 (27%), Positives = 143/295 (48%), Gaps = 16/295 (5%)
Query: 3 GMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM---RVGLAD 59
GM+ K + + Y++G LG G FA V R T A K I K + R +
Sbjct: 1 GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 60 QIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRY 118
+I+RE+S++R V HPNI+ L++V ++ + ++E GGELF+ K L E+ A +
Sbjct: 61 EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 119 FQQLINAVDFCHSRGVYHRDIKPENLLL----DENENLKISDFGLSALAQCKHQDGLLHT 174
+Q+++ V++ H++ + H D+KPEN++L ++K+ DFGL+ +
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKN 177
Query: 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAE 232
GTP +VAPE++N + G + D+WS GV+ ++LL+G PF E I +
Sbjct: 178 IFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236
Query: 233 FKCPNWFP--PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTES 285
F + + + K+L R+++ + W Q+ +
Sbjct: 237 FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 4e-94
Identities = 98/305 (32%), Positives = 155/305 (50%), Gaps = 28/305 (9%)
Query: 8 KPSVLTEKYEVG---RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKRE 64
K S + Y++ + LG+G+F+ ++NQ+ AVK+I K ++E
Sbjct: 2 KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKE 55
Query: 65 ISVMRIVR-HPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQL 122
I+ +++ HPNIV+L+EV + F VME GGELF + K E A ++L
Sbjct: 56 ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL 115
Query: 123 INAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
++AV H GV HRD+KPENLL ++N +KI DFG + + L T C T
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA--RLKPPDNQPLKTPCFTL 173
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-------LIEMYRKI--GK 230
Y APE++N+ GYD E D+WS GV+L+ +L+G +PF + +E+ +KI G
Sbjct: 174 HYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 231 AEFKCPNWFP--PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDA 288
F+ W E + L+ +L +P+ R+ M+ +R + W + G +T
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILG 292
Query: 289 ASQDA 293
+S A
Sbjct: 293 SSGAA 297
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 2e-93
Identities = 92/276 (33%), Positives = 155/276 (56%), Gaps = 14/276 (5%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
E+Y + +LG+G+F +V + T Q AVKVI+K + I RE+ +++ +
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKL 78
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCH 130
HPNI++L+E++ S + V E GGELF++ + + + E A R +Q+ + + + H
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 131 SRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
+ HRD+KPEN+LL +++ ++KI DFGLS Q Q+ + GT Y+APEV+
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEVL 195
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNW--FPPEV 243
Y EK D+WS GV+L++LL+G PF+ N ++ +++ GK F P W +
Sbjct: 196 RGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQK 279
+ L+ K+L +PS RI+ + E W +K ++
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 7e-93
Identities = 80/276 (28%), Positives = 135/276 (48%), Gaps = 20/276 (7%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI---MRVGLADQIKREISVM 68
+ + Y+ G LG G FA V R T A K I K + R + I+RE+S++
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVD 127
+ ++HPN++ L+EV K+ + ++E GGELF+ K L E+ A + +Q++N V
Sbjct: 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 128 FCHSRGVYHRDIKPENLLL----DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+ HS + H D+KPEN++L +KI DFGL+ GTP +VA
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVA 185
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFPP 241
PE++N + G + D+WS GV+ ++LL+G PF E + EF+ +
Sbjct: 186 PEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF--S 242
Query: 242 EV----RKLLCKILDPNPSTRISMAKIRESSWFRKG 273
+ + ++L +P R+++ + W +
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 1e-92
Identities = 93/285 (32%), Positives = 158/285 (55%), Gaps = 13/285 (4%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
+++Y+ R+LG+G+F +V + T Q AVKVI K ++ + + + RE+ +++ +
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCH 130
HPNI++LYE K + V E GGELF++ +++ + E A R +Q+++ + + H
Sbjct: 84 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH 143
Query: 131 SRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
+ HRD+KPENLLL ++ N++I DFGLS + + GT Y+APEV+
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAPEVL 200
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNW--FPPEV 243
+ Y EK D+WS GV+L++LL+G PF+ +N ++ +K+ GK F+ P W
Sbjct: 201 HGT-Y-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDA 288
+ L+ K+L PS RIS + W + ++ V +A
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA 303
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 2e-92
Identities = 51/304 (16%), Positives = 98/304 (32%), Gaps = 54/304 (17%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
G +LGQ A T +S V V + Q+K E+ +R++R
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 73 -------------------------HPNIVQLYEVMATKS--KIFFVMEYAK------GG 99
++++ FF+ + G
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 100 ELFNKVAKGKLKEDAARRY-FQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFG 158
L + + K AR Q+I + H G+ H ++P +++LD+ + ++ F
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVI----------NRKGYDGEKVDIWSCGVVLFV 208
+DG + + + PE+ +R+ D W+ G+V++
Sbjct: 252 HL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 209 LLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268
+ LP + I F+ P VR LL L R+ + E+
Sbjct: 306 IWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 361
Query: 269 WFRK 272
+ +
Sbjct: 362 EYEQ 365
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 1e-90
Identities = 94/286 (32%), Positives = 153/286 (53%), Gaps = 23/286 (8%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLA----------DQI 61
+ E Y R LG GA+ +V + + A+KVI K + + + ++I
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 62 KREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQ 120
EIS+++ + HPNI++L++V K + V E+ +GGELF + + + K E A +
Sbjct: 94 YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCG 177
Q+++ + + H + HRDIKPEN+LL + N+KI DFGLS+ +D L G
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKLRDRLG 210
Query: 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKC 235
T Y+APEV+ +K Y EK D+WSCGV++++LL GY PF N ++ +K+ GK F
Sbjct: 211 TAYYIAPEVLKKK-Y-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 236 PNW--FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQK 279
+W E ++L+ +L + + R + + S W +K N K
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK 314
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 2e-90
Identities = 97/277 (35%), Positives = 155/277 (55%), Gaps = 14/277 (5%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
L+E Y+ + LG GA+ +V R T+ A+K+I K + + + E++V++++
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLL 93
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLINAVDFCH 130
HPNI++LY+ K + VME KGGELF++ + + K E A +Q+++ V + H
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 131 SRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
+ HRD+KPENLLL +++ +KI DFGLSA+ + + GT Y+APEV+
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---NQKKMKERLGTAYYIAPEVL 210
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNW--FPPEV 243
+K Y EK D+WS GV+LF+LLAGY PF E+ RK+ GK F P W
Sbjct: 211 RKK-Y-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQ 280
+ L+ ++L + RIS + E W ++ ++K+
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESG 305
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 2e-89
Identities = 81/307 (26%), Positives = 144/307 (46%), Gaps = 43/307 (14%)
Query: 8 KPSVLTEKYEVGR-LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
+ Y++ +LG+GA A+V ++ T+Q AVK+I+K ++ RE+
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVE 62
Query: 67 VMRIVR-HPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKGKLKEDAARRYFQQLIN 124
++ + H N+++L E + + + V E +GG + + + E A Q + +
Sbjct: 63 MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 125 AVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSAL-----AQCKHQDGLLHTTC 176
A+DF H++G+ HRD+KPEN+L ++ +KI DF L + L T C
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 177 GTPAYVAPEVINR-----KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI--------- 222
G+ Y+APEV+ YD ++ D+WS GV+L++LL+GY PF
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 223 ------EMYRKI--GKAEFKCPNWFPPEV----RKLLCKILDPNPSTRISMAKIRESSWF 270
++ I GK EF +W + + L+ K+L + R+S A++ + W
Sbjct: 242 CPACQNMLFESIQEGKYEFPDKDW--AHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299
Query: 271 RKGMNQK 277
+ +
Sbjct: 300 QGCAPEN 306
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 3e-89
Identities = 85/295 (28%), Positives = 143/295 (48%), Gaps = 33/295 (11%)
Query: 6 HNKPSVLTEKYEVGR-LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKRE 64
K +T+ Y++ + +LG G KV RT Q A+K++ R +E
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR--------QE 71
Query: 65 ISVM-RIVRHPNIVQLYEV----MATKSKIFFVMEYAKGGELFNK-VAKGKLK--EDAAR 116
+ + P+IV + +V K + +ME +GGELF++ +G E A
Sbjct: 72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 131
Query: 117 RYFQQLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLH 173
+ + A+ F HS + HRD+KPENLL +++ LK++DFG + + L
Sbjct: 132 EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQ 187
Query: 174 TTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN----LIEMYRKI- 228
T C TP YVAPEV+ + YD + D+WS GV++++LL G+ PF+ + M R+I
Sbjct: 188 TPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 229 -GKAEFKCPNWFP--PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQ 280
G+ F P W + ++L+ +L +P+ R+++ + W + M Q
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 3e-89
Identities = 77/289 (26%), Positives = 127/289 (43%), Gaps = 29/289 (10%)
Query: 3 GMDHNKPSVLTEKYEV-GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQI 61
+ Y + + LG+G FA V S T Q A K + K + + A+ I
Sbjct: 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-I 75
Query: 62 KREISVMRIVRH-PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARR 117
EI+V+ + + P ++ L+EV S+I ++EYA GGE+F+ + E+ R
Sbjct: 76 LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR 135
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHT 174
+Q++ V + H + H D+KP+N+LL ++KI DFG+S L
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG---HACELRE 192
Query: 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAE 232
GTP Y+APE++N D+W+ G++ ++LL PF + E Y I +
Sbjct: 193 IMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251
Query: 233 FKCPNWFPPEV--------RKLLCKILDPNPSTRISMAKIRESSWFRKG 273
+ + V + LL K NP R + SW ++
Sbjct: 252 YSEETF--SSVSQLATDFIQSLLVK----NPEKRPTAEICLSHSWLQQW 294
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 3e-89
Identities = 81/351 (23%), Positives = 151/351 (43%), Gaps = 22/351 (6%)
Query: 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV 67
K + + Y++ LG GAF V+ T + K I+ + +K EIS+
Sbjct: 45 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISI 101
Query: 68 MRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKG-KLKEDAARRYFQQLINA 125
M + HP ++ L++ K ++ ++E+ GGELF++ A+ K+ E Y +Q
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 126 VDFCHSRGVYHRDIKPENLLL--DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+ H + H DIKPEN++ + ++KI DFGL+ D ++ T T + A
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN---PDEIVKVTTATAEFAA 218
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFP- 240
PE+++R+ G D+W+ GV+ +VLL+G PF + +E + + EF +
Sbjct: 219 PEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 277
Query: 241 -PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQ 299
PE + + +L P R+++ E W + + + + + Q
Sbjct: 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
Query: 300 GSSSIAAEIKQELGQLPNLNAFDIISLSAGFDLSGFFDENPLIREARFTSK 350
+ A +G++ N ++ +FD + RF +
Sbjct: 338 WPAPQPA-----IGRIANFSSLRKHRPQEYQIYDSYFDRKEAVP--RFKLR 381
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 9e-89
Identities = 65/285 (22%), Positives = 124/285 (43%), Gaps = 20/285 (7%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
L EKY + LG+G F V+ + ++ K + + +K+EIS++ I
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIA 58
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKG-KLKEDAARRYFQQLINAVDFC 129
RH NI+ L+E + ++ + E+ G ++F + +L E Y Q+ A+ F
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 130 HSRGVYHRDIKPENLLL--DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
HS + H DI+PEN++ + +KI +FG + + P Y APEV
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLFTAPEYYAPEVH 175
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFPPEV-- 243
D+WS G +++VLL+G PF ++ I + F + E+
Sbjct: 176 QHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--KEISI 232
Query: 244 --RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESK 286
+ ++L +R++ ++ + W ++ + + + + K
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLK 277
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 7e-87
Identities = 89/293 (30%), Positives = 144/293 (49%), Gaps = 32/293 (10%)
Query: 8 KPSVLTEKYEV-GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
K + + + Y+V ++LG G KV + RT + A+K++ R RE+
Sbjct: 55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--------REVE 106
Query: 67 VM-RIVRHPNIVQLYEV----MATKSKIFFVMEYAKGGELFNK-VAKGKLK--EDAARRY 118
+ R + P+IV++ +V A + + VME GGELF++ +G E A
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 119 FQQLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTT 175
+ + A+ + HS + HRD+KPENLL N LK++DFG + L T
Sbjct: 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTP 223
Query: 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI----EMYRKI--G 229
C TP YVAPEV+ + YD + D+WS GV++++LL GY PF+ ++ + M +I G
Sbjct: 224 CYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282
Query: 230 KAEFKCPNWFP--PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQ 280
+ EF P W EV+ L+ +L P+ R+++ + W + Q
Sbjct: 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 1e-86
Identities = 83/289 (28%), Positives = 138/289 (47%), Gaps = 20/289 (6%)
Query: 8 KPSVLTEKYEVGRL--LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREI 65
K + Y V + LG G F +V+ T +A K+I + +++K EI
Sbjct: 81 KQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEI 137
Query: 66 SVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNK-VAKG-KLKEDAARRYFQQLI 123
SVM + H N++QLY+ +K+ I VMEY GGELF++ + + L E + +Q+
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197
Query: 124 NAVDFCHSRGVYHRDIKPENLLL--DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
+ H + H D+KPEN+L + + +KI DFGL+ + L GTP +
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK---PREKLKVNFGTPEF 254
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWF 239
+APEV+N D+WS GV+ ++LL+G PF N E I + + + +
Sbjct: 255 LAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ 313
Query: 240 P--PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESK 286
E ++ + K+L S RIS ++ + W + K +++ K
Sbjct: 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLS---DHKLHSRLSAQK 359
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-86
Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 19/289 (6%)
Query: 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV 67
K + + Y++ LG GAF V+ T + A K + + +++EI
Sbjct: 151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQT 207
Query: 68 MRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVA--KGKLKEDAARRYFQQLINA 125
M ++RHP +V L++ +++ + E+ GGELF KVA K+ ED A Y +Q+
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267
Query: 126 VDFCHSRGVYHRDIKPENLLL--DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+ H H D+KPEN++ + LK+ DFGL+A + T GT + A
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEFAA 324
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNWFPP 241
PEV K G D+WS GV+ ++LL+G PF N E R + +
Sbjct: 325 PEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--S 381
Query: 242 EV----RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESK 286
+ + + K+L +P+TR+++ + E W G + ++ S+
Sbjct: 382 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSR 430
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 2e-85
Identities = 84/281 (29%), Positives = 154/281 (54%), Gaps = 13/281 (4%)
Query: 4 MDHNKPSVLTEKY-----EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLA 58
+ H +P K + G++LG+G+F+ V AR + T++ A+K+++K I++
Sbjct: 15 LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV 74
Query: 59 DQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARR 117
+ RE VM + HP V+LY K++F + YAK GEL + K G E R
Sbjct: 75 PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF 134
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177
Y ++++A+++ H +G+ HRD+KPEN+LL+E+ +++I+DFG + + + + ++ G
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN 237
T YV+PE++ K + D+W+ G +++ L+AG PF N +++KI K E+ P
Sbjct: 195 TAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 253
Query: 238 WFPPEVRKLLCKILDPNPSTRI------SMAKIRESSWFRK 272
F P+ R L+ K+L + + R+ ++ +F
Sbjct: 254 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 2e-85
Identities = 88/283 (31%), Positives = 144/283 (50%), Gaps = 18/283 (6%)
Query: 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
PS E YEV +G G++ + R + + K +D M + E++++
Sbjct: 2 PSRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLL 59
Query: 69 RIVRHPNIVQLYE--VMATKSKIFFVMEYAKGGELFNKVAKGK-----LKEDAARRYFQQ 121
R ++HPNIV+ Y+ + T + ++ VMEY +GG+L + + KG L E+ R Q
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 122 LINAVDFCHSRG-----VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC 176
L A+ CH R V HRD+KP N+ LD +N+K+ DFGL+ H T
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKTFV 177
Query: 177 GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC- 235
GTP Y++PE +NR Y+ EK DIWS G +L+ L A PF + E+ KI + +F+
Sbjct: 178 GTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236
Query: 236 PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQ 278
P + E+ +++ ++L+ R S+ +I E+ + +
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 1e-84
Identities = 76/318 (23%), Positives = 127/318 (39%), Gaps = 35/318 (11%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
+ + V R+L +G FA VY A+ + + + A+K + ++ + I +E+ M+
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMK 80
Query: 70 IVR-HPNIVQLY-------EVMATKSKIFFVMEYAKGGELF----NKVAKGKLKEDAARR 117
+ HPNIVQ E T F ++ G+L ++G L D +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 118 YFQQLINAVDFCHSRG--VYHRDIKPENLLLDENENLKISDFGLSA-------LAQCKHQ 168
F Q AV H + + HRD+K ENLLL +K+ DFG + + +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 169 DGLLH---TTCGTPAYVAPEVIN--RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE 223
L+ T TP Y PE+I+ GEK DIW+ G +L++L PF D
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-- 258
Query: 224 MYRKIGKAEFKCPNW--FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQK 281
+I ++ P L+ +L NP R+S+A++ +
Sbjct: 259 --LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316
Query: 282 VTESKDAASQDAGASAPQ 299
+ G++
Sbjct: 317 PITELLEQNGGYGSATLS 334
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 1e-84
Identities = 76/293 (25%), Positives = 139/293 (47%), Gaps = 8/293 (2%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
EKY + +G+G+F K +S + +K I+ + M ++ +RE++V+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKH 82
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQLINAVDFCH 130
PNIVQ E ++ VM+Y +GG+LF ++ K +ED +F Q+ A+ H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
R + HRDIK +N+ L ++ +++ DFG++ L GTP Y++PE+ K
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIA--RVLNSTVELARACIGTPYYLSPEICENK 200
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC-PNWFPPEVRKLLCK 249
Y+ K DIW+ G VL+ L F ++ + KI F + ++R L+ +
Sbjct: 201 PYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259
Query: 250 ILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSS 302
+ NP R S+ I E + K + + ++ + + + +
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPA 312
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 2e-82
Identities = 59/286 (20%), Positives = 111/286 (38%), Gaps = 24/286 (8%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ Y + LG+G F+ V + A+K I + ++ +RE + R+ H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNH 85
Query: 74 PNIVQLYEV----MATKSKIFFVMEYAKGGELFN-----KVAKGKLKEDAARRYFQQLIN 124
PNI++L K + + ++ + K G L+N K L ED +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD-------GLLHTTCG 177
++ H++G HRD+KP N+LL + + D G A +
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 178 TPAYVAPEVINRKGYD--GEKVDIWSCGVVLFVLLAGYLPFHDSNL-IEMYRKIGKAEFK 234
T +Y APE+ + + + E+ D+WS G VL+ ++ G P+ + + +
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 235 CPNW--FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQ 278
P + +LL ++ +P R + + + Q
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 2e-81
Identities = 64/291 (21%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
++ L+G G F +V+ A+ ++ +K + + ++ +RE+ +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALA 59
Query: 70 IVRHPNIVQLYE----------------VMATKSKIFFVMEYAKGGELFNKVAKGK---L 110
+ H NIV + +F ME+ G L + K + L
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 111 KEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170
+ A F+Q+ VD+ HS+ + +RD+KP N+ L + + +KI DFGL + DG
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDG 176
Query: 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK 230
+ GT Y++PE I+ + Y ++VD+++ G++L LL +++ + + +
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD 233
Query: 231 AEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQK 281
+ F + + LL K+L P R + ++I + K +K ++
Sbjct: 234 GII--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH 282
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 5e-81
Identities = 90/269 (33%), Positives = 162/269 (60%), Gaps = 12/269 (4%)
Query: 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
P + +++ R LG G+F +V+ RS + A+KV+ K+ ++R+ + E ++
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVD 127
IV HP I++++ +IF +M+Y +GGELF+ + K + A+ Y ++ A++
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
+ HS+ + +RD+KPEN+LLD+N ++KI+DFG K+ + +T CGTP Y+APEV+
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGF-----AKYVPDVTYTLCGTPDYIAPEVV 175
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLL 247
+ K Y + +D WS G++++ +LAGY PF+DSN ++ Y KI AE + P +F +V+ LL
Sbjct: 176 STKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 234
Query: 248 CKILDPNPSTRISMAK-----IRESSWFR 271
+++ + S R+ + ++ WF+
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFK 263
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 1e-79
Identities = 82/271 (30%), Positives = 147/271 (54%), Gaps = 12/271 (4%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
++ + ++++ + LG G+F +V + + A+K++DK K++++ + E
Sbjct: 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINA 125
+++ V P +V+L S ++ VMEY GGE+F+ + + G+ E AR Y Q++
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
++ HS + +RD+KPENLL+D+ ++++DFG K G T CGTP +APE
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWTLCGTPEALAPE 208
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRK 245
+I KGY + VD W+ GV+++ + AGY PF I++Y KI + + P+ F +++
Sbjct: 209 IILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267
Query: 246 LLCKILDPNPSTRISMAK-----IRESSWFR 271
LL +L + + R K I+ WF
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 3e-78
Identities = 67/279 (24%), Positives = 113/279 (40%), Gaps = 23/279 (8%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR-IVRH 73
+ +LG GA + Y R + N+ VAVK I + RE+ ++R H
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHS 131
PN+++ + + + +E L V + QQ + + HS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 132 RGVYHRDIKPENLLLDENEN-----LKISDFGLSA-LAQCKHQDGLLHTTCGTPAYVAPE 185
+ HRD+KP N+L+ ISDFGL LA +H GT ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 186 VINRKGYD--GEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAEFKCPNWFP-- 240
+++ + VDI+S G V + +++ G PF S + +G C +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256
Query: 241 -PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQ 278
R+L+ K++ +P R S + + +F Q Q
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQ 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 7e-78
Identities = 40/303 (13%), Positives = 86/303 (28%), Gaps = 48/303 (15%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
K ++ L G + V+ R + + A+KV +++ +
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 73 HPNIVQLYEVM--------------------------ATKSKIFFVMEYAKG-----GEL 101
+ + + + +M A
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 102 FNKV--AKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159
+ V +G A QLI S+G+ H P+NL + + L + D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD-GEKVDIWSCGVVLFVLLAGYLPFHD 218
+ Y E +N ++ W G+ ++ + +LPF
Sbjct: 241 L-----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 219 SN--LIEMYRKIGKAE-------FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSW 269
+ +++ F P V+ L+ + L+ + R+ + E+
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355
Query: 270 FRK 272
F +
Sbjct: 356 FLQ 358
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-77
Identities = 60/270 (22%), Positives = 104/270 (38%), Gaps = 11/270 (4%)
Query: 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREI 65
S + ++ LG G++ +V+ RS + AVK A ++
Sbjct: 49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108
Query: 66 SVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLI 123
S ++ +HP V+L + ++ E G L L E Y + +
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
A+ HS+G+ H D+KP N+ L K+ DFGL G G P Y+A
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMA 224
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGY-LPFHDSNLIEMYRKIGKAEFKCPNWFPPE 242
PE++ Y D++S G+ + + LP ++ + EF E
Sbjct: 225 PELLQ-GSYG-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSE 280
Query: 243 VRKLLCKILDPNPSTRISMAKIRESSWFRK 272
+R +L +L+P+P R + + R+
Sbjct: 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 2e-77
Identities = 71/308 (23%), Positives = 110/308 (35%), Gaps = 54/308 (17%)
Query: 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREI 65
N L ++LG G+ V + + VAVK + D D EI
Sbjct: 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFC------DIALMEI 59
Query: 66 SVMR-IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--------GKLKEDAAR 116
++ HPN+++ Y T ++ +E L + V KE
Sbjct: 60 KLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 117 RYFQQLINAVDFCHSRGVYHRDIKPENLLLD-------------ENENLKISDFGLSALA 163
+Q+ + V HS + HRD+KP+N+L+ EN + ISDFGL
Sbjct: 119 SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL---- 174
Query: 164 QCKHQDG-------LLHTTCGTPAYVAPEVINRKGYD------GEKVDIWSCGVVLFVLL 210
CK D L+ GT + APE++ +DI+S G V + +L
Sbjct: 175 -CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 211 -AGYLPFHDSNLIEMYRKIGKAEFKCPNWFP-----PEVRKLLCKILDPNPSTRISMAKI 264
G PF D E G E L+ +++D +P R + K+
Sbjct: 234 SKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
Query: 265 RESSWFRK 272
F
Sbjct: 294 LRHPLFWP 301
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 2e-77
Identities = 56/334 (16%), Positives = 105/334 (31%), Gaps = 46/334 (13%)
Query: 10 SVLTEKY---EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
S L E+ G +LGQ A T +S V V + Q+K E+
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 67 VMR----------------------IVRHPNIVQLYEVMATKSKI-----FFVMEYAKG- 98
+R +V+ P ++ V + + FF+ +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 99 -----GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENL 152
L + + L A + Q+I + H G+ H ++P +++LD+ +
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV 250
Query: 153 KISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD----GEKVDIWSCGVVLFV 208
++ F + P A ++ + D W+ G+ ++
Sbjct: 251 FLTGFEHLVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 209 LLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268
+ LP D + I F+ P VR LL L R+ + E+
Sbjct: 310 IWCADLPNTDDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 365
Query: 269 WFRKGMNQKQKQKVTESKDAASQDAGASAPQGSS 302
+ + + D G + P G+S
Sbjct: 366 EYEQLRTELSAALPLYQTDGEPTREGGAPPSGTS 399
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 1e-76
Identities = 73/268 (27%), Positives = 134/268 (50%), Gaps = 12/268 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ + + +G+G F++VY A + VA+K + +M +EI +++ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK-----LKEDAARRYFQQLINAVDF 128
PN+++ Y +++ V+E A G+L + K + E +YF QL +A++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
HSR V HRDIKP N+ + +K+ D GL + H+ GTP Y++PE I+
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLG--RFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFH--DSNLIEMYRKIGKAEFKC--PNWFPPEVR 244
GY+ K DIWS G +L+ + A PF+ NL + +KI + ++ + + E+R
Sbjct: 210 ENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 268
Query: 245 KLLCKILDPNPSTRISMAKIRESSWFRK 272
+L+ ++P+P R + + + +
Sbjct: 269 QLVNMCINPDPEKRPDVTYVYDVAKRMH 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 1e-75
Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 52/297 (17%)
Query: 3 GMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK 62
G+ K +++ + ++LG G KV + RT + A+K++ R
Sbjct: 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-------- 58
Query: 63 REISVM-RIVRHPNIVQLYEV----MATKSKIFFVMEYAKGGELFNK-VAKGKLK--EDA 114
RE+ + R + P+IV++ +V A + + VME GGELF++ +G E
Sbjct: 59 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118
Query: 115 ARRYFQQLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGL 171
A + + A+ + HS + HRD+KPENLL N LK++DFG
Sbjct: 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------ 166
Query: 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI----EMYRK 227
A E + YD + D+WS GV++++LL GY PF+ ++ + M +
Sbjct: 167 -----------AKETT-GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213
Query: 228 I--GKAEFKCPNWFP--PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQ 280
I G+ EF P W EV+ L+ +L P+ R+++ + W + Q
Sbjct: 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 235 bits (600), Expect = 2e-73
Identities = 48/292 (16%), Positives = 105/292 (35%), Gaps = 29/292 (9%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARS-----IRTNQSVAVKVIDKDKIMRVGLADQIKREISV 67
++ V LLG+GAFA+VY A + Q +KV + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---YIGTQLMER 120
Query: 68 MRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK------LKEDAARRYFQQ 121
++ ++ Y ++ V E G L N + K + + + +
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 122 LINAVDFCHSRGVYHRDIKPENLLL-----------DENENLKISDFGLSALAQCKHQDG 170
++ ++ H + H DIKP+N +L D + L + D G S + +
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG-YLPFHDSNLIEMYRKIG 229
+ C T + E+++ K ++ ++D + ++ +L G Y+ + +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 230 KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQK 281
+ W E ++ I D + + + + + F++ K +
Sbjct: 300 RRLPHLDMW--NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRAL 349
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 5e-73
Identities = 76/281 (27%), Positives = 139/281 (49%), Gaps = 23/281 (8%)
Query: 8 KPSVLTEKYEVG-------RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQ 60
P V E +V R +G+G+F KV + T + A+K ++K K +
Sbjct: 2 MPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN 61
Query: 61 IKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYF 119
+ +E+ +M+ + HP +V L+ + +F V++ GG+L + + KE+ + +
Sbjct: 62 VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI 121
Query: 120 QQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH--QDGLLHTTCG 177
+L+ A+D+ ++ + HRD+KP+N+LLDE+ ++ I+DF + ++ + T G
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI-----AAMLPRETQITTMAG 176
Query: 178 TPAYVAPEVINRK---GYDGEKVDIWSCGVVLFVLLAGYLPFH---DSNLIEMYRKIGKA 231
T Y+APE+ + + GY VD WS GV + LL G P+H ++ E+
Sbjct: 177 TKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT 235
Query: 232 EFKCPNWFPPEVRKLLCKILDPNPSTRISMAK-IRESSWFR 271
P+ + E+ LL K+L+PNP R S ++ +
Sbjct: 236 VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 1e-72
Identities = 65/287 (22%), Positives = 114/287 (39%), Gaps = 32/287 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+E + LG+G F V+ A++ + + A+K I +++ RE+ + + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEH 62
Query: 74 PNIVQLYEV------------MATKSKIFFVMEYAKGGELFNKVAKGKLK----EDAARR 117
P IV+ + + K ++ M+ + L + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL----------AQCKH 167
F Q+ AV+F HS+G+ HRD+KP N+ ++ +K+ DFGL
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRK 227
GT Y++PE I+ Y KVDI+S G++LF LL Y +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--YPFSTQMERVRTLTD 239
Query: 228 IGKAEF-KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273
+ +F P ++ +L P+P R I E++ F
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 7e-72
Identities = 88/266 (33%), Positives = 142/266 (53%), Gaps = 19/266 (7%)
Query: 20 RLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIM-RVGLADQIKREISVMRIVRHPN 75
R+LG+G + KV+ R + T + A+KV+ K I+ K E +++ V+HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGV 134
IV L T K++ ++EY GGELF ++ + G ED A Y ++ A+ H +G+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRKG 191
+RD+KPEN++L+ ++K++DFGL CK H + HT CGT Y+APE++ R G
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGL-----CKESIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKIL 251
+ VD WS G +++ +L G PF N + KI K + P + E R LL K+L
Sbjct: 198 H-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 256
Query: 252 DPNPSTRI-----SMAKIRESSWFRK 272
N ++R+ +++ +FR
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-71
Identities = 86/261 (32%), Positives = 136/261 (52%), Gaps = 15/261 (5%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
+++G+G+F KV AR AVKV+ K I++ I E +V+ + V+HP +V
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T K++FV++Y GGELF + + E AR Y ++ +A+ + HS + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRKGYDG 194
D+KPEN+LLD ++ ++DFGL CK + T CGTP Y+APEV++++ Y
Sbjct: 164 DLKPENILLDSQGHIVLTDFGL-----CKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-D 217
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
VD W G VL+ +L G PF+ N EMY I + R LL +L +
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 277
Query: 255 PSTRI----SMAKIRESSWFR 271
+ R+ +I+ +F
Sbjct: 278 RTKRLGAKDDFMEIKSHVFFS 298
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 2e-71
Identities = 91/261 (34%), Positives = 141/261 (54%), Gaps = 15/261 (5%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
+LLG+G F KV R T + A+K++ K+ I+ E V++ RHP + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138
T ++ FVMEYA GGELF +++ E+ AR Y ++++A+++ HSR V +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 139 IKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRKGYDGE 195
IK ENL+LD++ ++KI+DFGL CK + T CGTP Y+APEV+ Y G
Sbjct: 131 IKLENLMLDKDGHIKITDFGL-----CKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 184
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNP 255
VD W GVV++ ++ G LPF++ + ++ I E + P PE + LL +L +P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 256 STRISMAK-----IRESSWFR 271
R+ + E +F
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL 265
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-71
Identities = 88/258 (34%), Positives = 136/258 (52%), Gaps = 12/258 (4%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
++LG+G+F KV+ A +TNQ A+K + KD ++ + E V+ HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
++ TK +FFVMEY GG+L + K A Y ++I + F HS+G+ +R
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRKGYDG 194
D+K +N+LLD++ ++KI+DFG+ CK D +T CGTP Y+APE++ + Y
Sbjct: 143 DLKLDNILLDKDGHIKIADFGM-----CKENMLGDAKTNTFCGTPDYIAPEILLGQKY-N 196
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
VD WS GV+L+ +L G PFH + E++ I P W E + LL K+
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVRE 256
Query: 255 PSTRI-SMAKIRESSWFR 271
P R+ IR+ FR
Sbjct: 257 PEKRLGVRGDIRQHPLFR 274
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-70
Identities = 84/266 (31%), Positives = 140/266 (52%), Gaps = 12/266 (4%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
YEV +++G+GAF +V R T + A+K++ K ++++ + E +M P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVY 135
+VQL+ ++ VMEY GG+L N ++ + E AR Y +++ A+D HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD-- 193
HRD+KP+N+LLD++ +LK++DFG + T GTP Y++PEV+ +G D
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 194 -GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPN--WFPPEVRKLLC 248
G + D WS GV L+ +L G PF+ +L+ Y KI K P+ E + L+C
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309
Query: 249 KILDPNPSTRI---SMAKIRESSWFR 271
L + R+ + +I+ +F+
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFK 334
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-70
Identities = 90/267 (33%), Positives = 150/267 (56%), Gaps = 23/267 (8%)
Query: 20 RLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIMRVGLADQI--KREISVMRIVRHP 74
++LGQG+F KV+ + I Q A+KV+ K + D++ K E ++ V HP
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV---RDRVRTKMERDILVEVNHP 86
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRG 133
IV+L+ T+ K++ ++++ +GG+LF +++K E+ + Y +L A+D HS G
Sbjct: 87 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRK 190
+ +RD+KPEN+LLDE ++K++DFGL K + ++ CGT Y+APEV+NR+
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGL-----SKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250
G+ + D WS GV++F +L G LPF + E I KA+ P + PE + LL +
Sbjct: 202 GH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML 260
Query: 251 LDPNPSTRI-----SMAKIRESSWFRK 272
NP+ R+ + +I+ S+F
Sbjct: 261 FKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 5e-70
Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
+LG+G+F KV + T++ AVK++ KD +++ + E V+ + P + Q
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T +++FVMEY GG+L + + G+ KE A Y ++ + F S+G+ +R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRKGYDG 194
D+K +N++LD ++KI+DFG+ CK T CGTP Y+APE+I + Y G
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGM-----CKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-G 199
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
+ VD W+ GV+L+ +LAG PF + E+++ I + P E + ++ +
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 259
Query: 255 PSTRI-----SMAKIRESSWFR 271
P R+ I+E ++FR
Sbjct: 260 PGKRLGCGPEGERDIKEHAFFR 281
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 8e-70
Identities = 86/263 (32%), Positives = 135/263 (51%), Gaps = 17/263 (6%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
R+LG+G+F KV AR T AVKV+ KD I++ + E ++ HP + Q
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T ++FFVME+ GG+L + K + E AR Y ++I+A+ F H +G+ +R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRKGYDG 194
D+K +N+LLD + K++DFG+ CK T CGTP Y+APE++ Y G
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGM-----CKEGICNGVTTATFCGTPDYIAPEILQEMLY-G 202
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
VD W+ GV+L+ +L G+ PF N +++ I E P W + +L + N
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKN 262
Query: 255 PSTRI------SMAKIRESSWFR 271
P+ R+ I +F+
Sbjct: 263 PTMRLGSLTQGGEHAILRHPFFK 285
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-68
Identities = 90/262 (34%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
+LLG+G F KV + T + A+K++ K+ I+ E V++ RHP + L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 80 YEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS-RGVYHR 137
T ++ FVMEYA GGELF +++ ED AR Y ++++A+D+ HS + V +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRKGYDG 194
D+K ENL+LD++ ++KI+DFGL CK + T CGTP Y+APEV+ Y G
Sbjct: 274 DLKLENLMLDKDGHIKITDFGL-----CKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-G 327
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
VD W GVV++ ++ G LPF++ + +++ I E + P PE + LL +L +
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD 387
Query: 255 PSTRISMAK-----IRESSWFR 271
P R+ I + +F
Sbjct: 388 PKQRLGGGSEDAKEIMQHRFFA 409
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-68
Identities = 78/276 (28%), Positives = 135/276 (48%), Gaps = 26/276 (9%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+E+ +++G+GAF++V + +T Q A+K+++K +++ G + E V+
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRG 133
I QL+ ++ ++ VMEY GG+L ++K ++ + AR Y +++ A+D H G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCK--HQDGLL--HTTCGTPAYVAPEVINR 189
HRDIKP+N+LLD +++++DFG C DG + GTP Y++PE++
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGS-----CLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 190 KGYD------GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPN---W 238
G G + D W+ GV + + G PF+ + E Y KI K P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297
Query: 239 FPPEVRKLLCKILDPNPSTRI---SMAKIRESSWFR 271
P E R + ++L P TR+ R +F
Sbjct: 298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 4e-68
Identities = 82/272 (30%), Positives = 145/272 (53%), Gaps = 26/272 (9%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
R++G+G++AKV R +T++ A+KV+ K+ + D ++ E V + HP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T+S++FFV+EY GG+L + + KL E+ AR Y ++ A+++ H RG+ +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRKGYDG 194
D+K +N+LLD ++K++D+G+ CK T CGTP Y+APE++ + Y G
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGM-----CKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-G 188
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLI---------EMYRKIGKAEFKCPNWFPPEVRK 245
VD W+ GV++F ++AG PF +++ I + + + P +
Sbjct: 189 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 248
Query: 246 LLCKILDPNPSTRI------SMAKIRESSWFR 271
+L L+ +P R+ A I+ +FR
Sbjct: 249 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 4e-68
Identities = 70/271 (25%), Positives = 137/271 (50%), Gaps = 18/271 (6%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+E+ +++G+GAF +V + ++ A+K+++K ++++ + E V+
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRG 133
I L+ + ++ VM+Y GG+L ++K +L E+ AR Y +++ A+D H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN----- 188
HRDIKP+N+L+D N +++++DFG L + GTP Y++PE++
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSC-LKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNW---FPPEV 243
+ Y G + D WS GV ++ +L G PF+ +L+E Y KI K F+ P
Sbjct: 255 KGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 244 RKLLCKILDPNPSTRI---SMAKIRESSWFR 271
+ L+ +++ + R+ + ++ +F
Sbjct: 314 KDLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-67
Identities = 81/272 (29%), Positives = 145/272 (53%), Gaps = 26/272 (9%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
R++G+G++AKV R +T++ A++V+ K+ + D ++ E V + HP +V
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T+S++FFV+EY GG+L + + KL E+ AR Y ++ A+++ H RG+ +R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRKGYDG 194
D+K +N+LLD ++K++D+G+ CK T CGTP Y+APE++ + Y G
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGM-----CKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-G 231
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLI---------EMYRKIGKAEFKCPNWFPPEVRK 245
VD W+ GV++F ++AG PF +++ I + + + P +
Sbjct: 232 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 291
Query: 246 LLCKILDPNPSTRI------SMAKIRESSWFR 271
+L L+ +P R+ A I+ +FR
Sbjct: 292 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-66
Identities = 80/274 (29%), Positives = 144/274 (52%), Gaps = 27/274 (9%)
Query: 20 RLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIM-RVGLADQIKREISVM-RIVRHP 74
++LG GA+ KV+ R I T + A+KV+ K I+ + + + E V+ I + P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRG 133
+V L+ T++K+ +++Y GGELF +++ + E + Y +++ A++ H G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCK----HQDGLLHTTCGTPAYVAPEVI-- 187
+ +RDIK EN+LLD N ++ ++DFGL K + + CGT Y+AP+++
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGL-----SKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFH----DSNLIEMYRKIGKAEFKCPNWFPPEV 243
G+ + VD WS GV+++ LL G PF ++ E+ R+I K+E P
Sbjct: 235 GDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293
Query: 244 RKLLCKILDPNPSTRI-----SMAKIRESSWFRK 272
+ L+ ++L +P R+ +I+E +F+K
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-65
Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQ 78
+LG+G+F KV + T++ AVK++ KD +++ + E V+ + P + Q
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 79 LYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHR 137
L+ T +++FVMEY GG+L + + G+ KE A Y ++ + F S+G+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 138 DIKPENLLLDENENLKISDFGLSALAQCK---HQDGLLHTTCGTPAYVAPEVINRKGYDG 194
D+K +N++LD ++KI+DFG+ CK T CGTP Y+APE+I + Y G
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGM-----CKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-G 520
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPN 254
+ VD W+ GV+L+ +LAG PF + E+++ I + P E + ++ +
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 580
Query: 255 PSTRI-----SMAKIRESSWFR 271
P R+ I+E ++FR
Sbjct: 581 PGKRLGCGPEGERDIKEHAFFR 602
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-63
Identities = 68/269 (25%), Positives = 120/269 (44%), Gaps = 23/269 (8%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
R+LG+G F +V+ + T + A K ++K ++ + E ++ V IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80 YEVMATKSKIFFVMEYAKGGELF-----NKVAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
TK+ + VM GG++ +E A Y Q+++ ++ H R +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQCKH---QDGLLHTTCGTPAYVAPEVINRKG 191
+RD+KPEN+LLD++ N++ISD GL GTP ++APE++ +
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGL-----AVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSN----LIEMYRKIGKAEFKCPNWFPPEVRKLL 247
Y VD ++ GV L+ ++A PF E+ +++ + P+ F P +
Sbjct: 366 Y-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFC 424
Query: 248 CKILDPNPSTRI-----SMAKIRESSWFR 271
+L +P R+ S +R FR
Sbjct: 425 EALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-63
Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 20/266 (7%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQL 79
R+LG+G F +V + T + A K ++K +I + E ++ V +V L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 80 YEVMATKSKIFFVMEYAKGGELF---NKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYH 136
TK + V+ GG+L + + E A Y ++ ++ H + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 137 RDIKPENLLLDENENLKISDFGLSALAQCKH--QDGLLHTTCGTPAYVAPEVINRKGYDG 194
RD+KPEN+LLD++ +++ISD GL H + + GT Y+APEV+ + Y
Sbjct: 310 RDLKPENILLDDHGHIRISDLGL-----AVHVPEGQTIKGRVGTVGYMAPEVVKNERY-T 363
Query: 195 EKVDIWSCGVVLFVLLAGYLPFHDSN----LIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250
D W+ G +L+ ++AG PF E+ R + + + F P+ R L ++
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
Query: 251 LDPNPSTRI-----SMAKIRESSWFR 271
L +P+ R+ S +++E F+
Sbjct: 424 LCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 4e-61
Identities = 51/295 (17%), Positives = 95/295 (32%), Gaps = 34/295 (11%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
S T ++ +G G F V+ A+K K V + ++ +
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELF-----NKVAKGKLKEDAARRYFQQ 121
+ +H ++V+ + A + EY GG L N KE + Q
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENENL-------------------KISDFGLSAL 162
+ + + HS + H DIKP N+ + KI D G
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182
Query: 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI 222
+ G ++A EV+ K DI++ + + + +
Sbjct: 183 -----RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-- 235
Query: 223 EMYRKIGKAEF-KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276
+ +I + + P E +LL ++ P+P R S + + S +
Sbjct: 236 -QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 8e-61
Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 16/265 (6%)
Query: 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV---RHPNI 76
R++G+G F +VY R T + A+K +DK +I E ++ +V P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVY 135
V + T K+ F+++ GG+L +++ G E R Y ++I ++ H+R V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGE 195
+RD+KP N+LLDE+ +++ISD GL+ C H + GT Y+APEV+ +
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 196 KVDIWSCGVVLFVLLAGYLPFHDSNLI---EMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
D +S G +LF LL G+ PF E+ R + P+ F PE+R LL +L
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 430
Query: 253 PNPSTRI-----SMAKIRESSWFRK 272
+ + R+ +++ES +FR
Sbjct: 431 RDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-58
Identities = 66/333 (19%), Positives = 122/333 (36%), Gaps = 73/333 (21%)
Query: 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVID-------KDKIMR-VGLADQI 61
S +E + +G+G F V+ A++ + + A+K I ++K+MR V ++
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 62 K-----------------------------------------------REISVMRIVRHP 74
+ +I M
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK----LKEDAARRYFQQLINAVDFCH 130
N V + + K ++ M+ + L + + + + F Q+ AV+F H
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQ----------CKHQDGLLHTTCGTPA 180
S+G+ HRD+KP N+ ++ +K+ DFGL GT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 181 YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWF 239
Y++PE I+ Y KVDI+S G++LF LL + + + + +F
Sbjct: 242 YMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQM--ERVRIITDVRNLKFPLLFTQK 298
Query: 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
P+ ++ +L P+P+ R I E++ F
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-58
Identities = 63/256 (24%), Positives = 102/256 (39%), Gaps = 17/256 (6%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+G+G+F +V+ + +T AVK + L E+ +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLS 108
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS 131
P IV LY + + ME +GG L + + G L ED A Y Q + +++ H+
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 132 RGVYHRDIKPENLLLDEN-ENLKISDFGLSA---LAQCKHQDGLLHTTCGTPAYVAPEVI 187
R + H D+K +N+LL + + DFG + GT ++APEV+
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPPEVR 244
K D KVDIWS ++ +L G P+ + KI + P P
Sbjct: 229 MGKPCDA-KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 245 KLLCKILDPNPSTRIS 260
+ + + L P R S
Sbjct: 288 QAIQEGLRKEPVHRAS 303
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-57
Identities = 70/257 (27%), Positives = 121/257 (47%), Gaps = 16/257 (6%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
+ +G G+F V+ R+ VAVK++ + + + RE+++M+ +RHPNI
Sbjct: 40 NIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNI 96
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELF----NKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
V + + V EY G L+ A+ +L E + +++ H+R
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 133 G--VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPAYVAPEVINR 189
+ HR++K NLL+D+ +K+ DFGLS L K L + GTP ++APEV+
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK--CPNWFPPEVRKLL 247
+ + EK D++S GV+L+ L P+ + N ++ +G + P P+V ++
Sbjct: 214 EPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 248 CKILDPNPSTRISMAKI 264
P R S A I
Sbjct: 273 EGCWTNEPWKRPSFATI 289
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-56
Identities = 63/264 (23%), Positives = 122/264 (46%), Gaps = 15/264 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ VG+ +G G+F VY + + VAVK+++ K E+ V+R RH
Sbjct: 24 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRH 79
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHS 131
NI+ T ++ V ++ +G L++ ++ K + +Q +D+ H+
Sbjct: 80 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
+ + HRD+K N+ L E+ +KI DFGL+ G+ ++APEVI +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 192 YD--GEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKIGK-----AEFKCPNWFPPEV 243
+ + D+++ G+VL+ L+ G LP+ + +N ++ +G+ K + P +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 244 RKLLCKILDPNPSTRISMAKIRES 267
++L+ + L R S +I
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAE 282
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-55
Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 24/280 (8%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQ 78
+LG+G + VY R + +A+K I + + EI++ + ++H NIVQ
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHLKHKNIVQ 83
Query: 79 LYEVMATKSKIFFVMEYAKGGELF----NKVAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
+ I ME GG L +K K E Y +Q++ + + H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 135 YHRDIKPENLLLDENE-NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN--RKG 191
HRDIK +N+L++ LKISDFG S + + T GT Y+APE+I+ +G
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTS--KRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYR---KIGKAEF--KCPNWFPPEVRKL 246
Y DIWS G + + G PF++ L E K+G + + P E +
Sbjct: 202 YGK-AADIWSLGCTIIEMATGKPPFYE--LGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 247 LCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESK 286
+ K +P+P R + + + K+K T+ K
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEF----LKVSSKKKKTQPK 294
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 4e-55
Identities = 61/263 (23%), Positives = 116/263 (44%), Gaps = 20/263 (7%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
E+G L+G+G F +VY+ R + VA+++ID ++ L KRE+ R RH N+
Sbjct: 36 EIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKA-FKREVMAYRQTRHENV 91
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
V + + + KG L++ + AK L + R+ Q+++ + + H++G+
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 135 YHRDIKPENLLLDENENLKISDFGLS---ALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
H+D+K +N+ D + I+DFGL + Q ++ L G ++APE+I +
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 192 YDG--------EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--FKCPNWFPP 241
D + D+++ G + + L A PF + ++G
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270
Query: 242 EVRKLLCKILDPNPSTRISMAKI 264
E+ +L R + K+
Sbjct: 271 EISDILLFCWAFEQEERPTFTKL 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 5e-55
Identities = 74/264 (28%), Positives = 115/264 (43%), Gaps = 30/264 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++ EV ++G+GAF V ++ + VA+K I+ + E+ + V H
Sbjct: 8 KEIEVEEVVGRGAFGVVC--KAKWRAKDVAIKQIESESER-----KAFIVELRQLSRVNH 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELF----NKVAKGKLKEDAARRYFQQLINAVDFC 129
PNIV+LY A + + VMEYA+GG L+ A + Q V +
Sbjct: 61 PNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 130 HSR---GVYHRDIKPENLLLDEN-ENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
HS + HRD+KP NLLL LKI DFG + + G+ A++APE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPE 173
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC-----PNWFP 240
V Y EK D++S G++L+ ++ PF + +I A P
Sbjct: 174 VFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTRPPLIKNLP 230
Query: 241 PEVRKLLCKILDPNPSTRISMAKI 264
+ L+ + +PS R SM +I
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEI 254
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-54
Identities = 70/262 (26%), Positives = 124/262 (47%), Gaps = 21/262 (8%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI-MRVGLADQIKREISVMRIVRHPN 75
+ ++G G F KVY R+ VAVK D + +++E + +++HPN
Sbjct: 10 TLEEIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVY 135
I+ L V + + VME+A+GG L ++ ++ D + Q+ +++ H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 136 ---HRDIKPENLLLDE--------NENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAP 184
HRD+K N+L+ + N+ LKI+DFGL+ + + G A++AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAP 183
Query: 185 EVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF--KCPNWFPPE 242
EVI + + D+WS GV+L+ LL G +PF + + + + + P+ P
Sbjct: 184 EVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242
Query: 243 VRKLLCKILDPNPSTRISMAKI 264
KL+ +P+P +R S I
Sbjct: 243 FAKLMEDCWNPDPHSRPSFTNI 264
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-54
Identities = 60/271 (22%), Positives = 115/271 (42%), Gaps = 35/271 (12%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVI----DKDKIMRVGLADQIKREISVMRIVR 72
E + +G+G F V+ R ++ VA+K + + + + + +RE+ +M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFC--- 129
HPNIV+LY + VME+ G+L++++ + + L +D
Sbjct: 82 HPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK----LRLMLDIALGI 135
Query: 130 ---HSRG--VYHRDIKPENLLLDENE-----NLKISDFGLSALAQCKHQDGLLHTTCGTP 179
++ + HRD++ N+ L + K++DFGLS + + G
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGNF 190
Query: 180 AYVAPEVINRKG--YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK--- 234
++APE I + Y EK D +S ++L+ +L G PF + + ++ E
Sbjct: 191 QWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 235 -CPNWFPPEVRKLLCKILDPNPSTRISMAKI 264
P PP +R ++ +P R + I
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYI 280
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 7e-53
Identities = 71/251 (28%), Positives = 133/251 (52%), Gaps = 9/251 (3%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+ +G+G+ V AR + + VAVK++D K R + + E+ +MR +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ 100
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
H N+V++Y+ +++ +ME+ +GG L + V++ +L E+ + ++ A+ + H++
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
GV HRDIK +++LL + +K+SDFG AQ + GTP ++APEVI+R Y
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKIGKAEFKCPNWFPPEVRKLLCK 249
+VDIWS G+++ ++ G P+ + ++ R + K + P +R L +
Sbjct: 219 A-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER 277
Query: 250 ILDPNPSTRIS 260
+L +P R +
Sbjct: 278 MLVRDPQERAT 288
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 8e-53
Identities = 80/251 (31%), Positives = 127/251 (50%), Gaps = 9/251 (3%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+KY +GQGA VY A + T Q VA++ ++ + + + I EI VMR +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENK 75
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
+PNIV + +++ VMEY GG L + V + + E ++ + A++F HS
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
V HRDIK +N+LL + ++K++DFG AQ + T GTP ++APEV+ RK Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKIGKAEFKCPNWFPPEVRKLLCK 249
KVDIWS G++ ++ G P+ + N + + G E + P R L +
Sbjct: 194 GP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 250 ILDPNPSTRIS 260
L+ + R S
Sbjct: 253 CLEMDVEKRGS 263
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 64/265 (24%), Positives = 122/265 (46%), Gaps = 18/265 (6%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQ 78
+G+G+F VY T VA + K+ + + K E +++ ++HPNIV+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQHPNIVR 89
Query: 79 LY----EVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRG 133
Y + K I V E G L + + +K R + +Q++ + F H+R
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 134 --VYHRDIKPENLLLDENE-NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
+ HRD+K +N+ + ++KI D GL+ L + GTP ++APE+
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE- 204
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKI--GKAEFKCPNWFPPEVRKLL 247
YD E VD+++ G+ + + P+ + N ++YR++ G PEV++++
Sbjct: 205 KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263
Query: 248 CKILDPNPSTRISMAKIRESSWFRK 272
+ N R S+ + ++F++
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-52
Identities = 49/259 (18%), Positives = 98/259 (37%), Gaps = 21/259 (8%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
L + +++ + + VKV+ D E +RI HPN+
Sbjct: 13 NFLTKLNENHSGELW--KGRWQGNDIVVKVLKVRDWSTRKSRD-FNEECPRLRIFSHPNV 69
Query: 77 VQLYEVMAT--KSKIFFVMEYAKGGELFN---KVAKGKLKEDAARRYFQQLINAVDFCHS 131
+ + + + + G L+N + + + A ++ + + F H+
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 132 RG--VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
+ + ++++DE+ +IS + Q PA+VAPE + +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQK 182
Query: 190 KGYDG--EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF--KCPNWFPPEVRK 245
K D D+WS V+L+ L+ +PF D + +E+ K+ P P V K
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242
Query: 246 LLCKILDPNPSTRISMAKI 264
L+ ++ +P+ R I
Sbjct: 243 LMKICMNEDPAKRPKFDMI 261
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-51
Identities = 76/272 (27%), Positives = 129/272 (47%), Gaps = 28/272 (10%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVID----KDKIMRVGLADQIKREISVM 68
E + +G+G+F +V+ RT + VA+K+ID +D+I + I++EI+V+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI------EDIQQEITVL 74
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDF 128
P + + Y +K++ +MEY GG + + G L E ++++ +D+
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDY 134
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
HS HRDIK N+LL E+ +K++DFG++ Q +T GTP ++APEVI
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIK 192
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248
+ YD K DIWS G+ L G P + + + K F P PP +
Sbjct: 193 QSAYD-SKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPKNNPPTLEGNYS 244
Query: 249 KI--------LDPNPSTRISMAKIRESSWFRK 272
K L+ PS R + ++ + + +
Sbjct: 245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-50
Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 17/291 (5%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
E +E+ LG GAF KVY A++ T A KVI+ + + EI ++
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCD 74
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCH 130
HP IV+L K++ ++E+ GG + L E + +Q++ A++F H
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI--- 187
S+ + HRD+K N+L+ +++++DFG+S A+ + GTP ++APEV+
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 188 --NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPPE 242
YD K DIWS G+ L + P H+ N + + KI K++ P+ + E
Sbjct: 193 TMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251
Query: 243 VRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQ-KQKVTESKDAASQD 292
R L LD NP TR S A++ E + + K ++ V E+K ++
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE 302
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-50
Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 35/272 (12%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
G +LG+G F + T + + +K + + +E+ VMR + HPN+
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEHPNV 69
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLIN-AVDFC---- 129
++ V+ ++ F+ EY KGG L K + + Q ++ A D
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP-------WSQRVSFAKDIASGMA 122
Query: 130 --HSRGVYHRDIKPENLLLDENENLKISDFGLSAL------------AQCKHQDGLLHTT 175
HS + HRD+ N L+ EN+N+ ++DFGL+ L + K +T
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK- 234
G P ++APE+IN + YD EKVD++S G+VL ++ D M + F
Sbjct: 183 VGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 235 --CPNWFPPEVRKLLCKILDPNPSTRISMAKI 264
CP PP + + D +P R S K+
Sbjct: 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-49
Identities = 69/254 (27%), Positives = 118/254 (46%), Gaps = 15/254 (5%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVID-KDKIMRVGLADQIKREISVMRIV 71
E ++V LG+G++ VY A T Q VA+K + + + +I +EIS+M+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL------QEIIKEISIMQQC 81
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFC 129
P++V+ Y + ++ VMEY G + + ++ L ED Q + +++
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
H HRDIK N+LL+ + K++DFG++ Q +T GTP ++APEVI
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVRKL 246
GY+ DIWS G+ + G P+ D + + I F+ P +
Sbjct: 200 IGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258
Query: 247 LCKILDPNPSTRIS 260
+ + L +P R +
Sbjct: 259 VKQCLVKSPEQRAT 272
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-48
Identities = 42/132 (31%), Positives = 75/132 (56%), Gaps = 4/132 (3%)
Query: 316 PNLNAFDIISLSAGFDLSGFFDENPLI--REARFTSKRPASVIISKLEEIAKSLRLKMMK 373
+NAF++I+LS G +LS FD R+ RF S+R S II+ +E +A S+ K
Sbjct: 5 LMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHT 64
Query: 374 KDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKDDIRPALQ 433
++ + EGL + G +++ EI+++ P+ +V+++K+ G+TLEY K K + L+
Sbjct: 65 RNFKT-RLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYK-KLCSKLE 122
Query: 434 DIVWVWQGEQQQ 445
+I+W +
Sbjct: 123 NIIWRATEGIPK 134
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-47
Identities = 79/286 (27%), Positives = 132/286 (46%), Gaps = 34/286 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVID----KDKIMRVGLADQIKREISVMR 69
+ YE+ ++G GA A V A + VA+K I+ + + D++ +EI M
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM------DELLKEIQAMS 68
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN---------KVAKGKLKEDAARRYFQ 120
HPNIV Y K +++ VM+ GG + + + G L E +
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA-LAQCKHQDGLL--HTTCG 177
+++ +++ H G HRD+K N+LL E+ +++I+DFG+SA LA T G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 178 TPAYVAPEVINR-KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN------LIEMYR---- 226
TP ++APEV+ + +GYD K DIWS G+ L G P+H L
Sbjct: 189 TPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 227 KIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
+ G + + + RK++ L +P R + A++ +F+K
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-47
Identities = 43/123 (34%), Positives = 64/123 (52%), Gaps = 5/123 (4%)
Query: 316 PNLNAFDIISLSAGFDLSGFFDENP-LIREARFTSKRPASVIISKLEEIAKSLRLKMMKK 374
+NAFDIIS S GF+LSG F + R RF S A ++ +LEEI + L + KK
Sbjct: 4 RRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKK 63
Query: 375 DGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKDDIRPALQD 434
+ +K EG +KG +M EI Q+T ++E++K + L D +RP +
Sbjct: 64 ETWGMKIEG----QKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVE 119
Query: 435 IVW 437
+V
Sbjct: 120 LVH 122
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-47
Identities = 73/299 (24%), Positives = 123/299 (41%), Gaps = 53/299 (17%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
EKYE +G+G++ V+ R+ T Q VA+K + + REI +++ ++H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKG---GELFNKVAKGKLKEDAARRYFQQLINAVDFCH 130
PN+V L EV K ++ V EY EL + + E + Q + AV+FCH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV------AP 184
HRD+KPEN+L+ ++ +K+ DFG A+ + V +P
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFG---FARLLTGPSDYYDD-----EVATRWYRSP 171
Query: 185 EVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------ 231
E++ Y G VD+W+ G V LL+G + + ++ I K
Sbjct: 172 ELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230
Query: 232 -------EFKCPNWFPPEVRK------------LLCKILDPNPSTRISMAKIRESSWFR 271
K P+ E + LL L +P+ R++ ++ +F
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 79/312 (25%), Positives = 130/312 (41%), Gaps = 72/312 (23%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI--DKDKIMRVGLADQIKREISVMRIV 71
+++ LG G +A VY + T VA+K + D ++ G REIS+M+ +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE----GTPSTAIREISLMKEL 60
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYA----KG--GELFNKVAKGKLKEDAARRYFQQLINA 125
+H NIV+LY+V+ T++K+ V E+ K L+ + + + QL+
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA----- 180
+ FCH + HRD+KP+NLL+++ LK+ DFGL A+ G P
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL---ARAF----------GIPVNTFSS 167
Query: 181 ------YVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-- 231
Y AP+V+ + Y +DIWSCG +L ++ G F +N E + I
Sbjct: 168 EVVTLWYRAPDVLMGSRTY-STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG 226
Query: 232 --------------EFKC--PNWFPPEVRK----------------LLCKILDPNPSTRI 259
++ P ++R+ L +L NP R+
Sbjct: 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 260 SMAKIRESSWFR 271
S + WF
Sbjct: 287 SAKQALHHPWFA 298
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 73/296 (24%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK----REISVMR 69
EKYE L+G+G++ V R+ T + VA+K K + +K REI +++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLK 79
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKG---GELFNKVAKGKLKEDAARRYFQQLINAV 126
+RH N+V L EV K + + V E+ +L ++ L ++Y Q+IN +
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL--ELFPNGLDYQVVQKYLFQIINGI 137
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
FCHS + HRDIKPEN+L+ ++ +K+ DFG A + T Y APE+
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF-ARTLAAPGEVYDDEVA-TRWYRAPEL 195
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--------------- 231
+ G+ VD+W+ G ++ + G F + I+ I
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 232 ----EFKCPNWFPPEVRKLLCKILDP------------NPSTRISMAKIRESSWFR 271
+ P E + L +P R A++ +F+
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 2e-46
Identities = 74/308 (24%), Positives = 133/308 (43%), Gaps = 72/308 (23%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI----DKDKIMRVGLADQIKREISVMR 69
+KYE +G+G + V+ A++ T++ VA+K + D + + L REI +++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLK 56
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYA----KGGELFNKVAKGKLKEDAARRYFQQLINA 125
++H NIV+L++V+ + K+ V E+ K + G L + + + QL+
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA----- 180
+ FCHSR V HRD+KP+NLL++ N LK+++FGL+ G P
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA-------------RAFGIPVRCYSA 160
Query: 181 ------YVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLP-FHDSNLIEMYRKIGKA- 231
Y P+V+ K Y +D+WS G + L P F +++ + ++I +
Sbjct: 161 EVVTLWYRPPDVLFGAKLY-STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219
Query: 232 ---------------EFKC-PNWFPPEVRKLLCKILDP------------NPSTRISMAK 263
++K P + + L+ NP RIS +
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 264 IRESSWFR 271
+ +F
Sbjct: 280 ALQHPYFS 287
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 13 TEKYEVGRLLGQGA--FAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
YE+ ++G+G V AR T + V V+ I+ + + ++ E+ V ++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV-TFLQGELHVSKL 82
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGG---ELFNKVAKGKLKEDAARRYFQQLINAVD 127
HPNIV ++++ V + G +L + E A Q ++ A+D
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSA-LAQCKHQDGLLHTTC----GTPAYV 182
+ H G HR +K ++L+ + + +S + + + ++H ++
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 183 APEVI--NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD 218
+PEV+ N +GYD K DI+S G+ L G++PF D
Sbjct: 203 SPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 239
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-46
Identities = 82/309 (26%), Positives = 135/309 (43%), Gaps = 76/309 (24%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI----DKDKIMRVGLADQIKREISVMR 69
EKY +G+G + VY A++ ++ A+K I + + I + REIS+++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTI-----REISILK 55
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYA----KGGELFNKVAKGKLKEDAARRYFQQLINA 125
++H NIV+LY+V+ TK ++ V E+ K V +G L+ A+ + QL+N
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNG 112
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA----- 180
+ +CH R V HRD+KP+NLL++ LKI+DFGL+ G P
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA-------------RAFGIPVRKYTH 159
Query: 181 ------YVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI----G 229
Y AP+V+ K Y +DIWS G + ++ G F + + +I G
Sbjct: 160 EIVTLWYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218
Query: 230 ----------------KAEFKCPNWFPPEVRK-----------LLCKILDPNPSTRISMA 262
F + P LL K+L +P+ RI+
Sbjct: 219 TPNSKNWPNVTELPKYDPNF--TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276
Query: 263 KIRESSWFR 271
+ E ++F+
Sbjct: 277 QALEHAYFK 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-46
Identities = 76/310 (24%), Positives = 126/310 (40%), Gaps = 75/310 (24%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK--------REI 65
++YE LG+G FA VY AR TNQ VA+K KI ++G + K REI
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIK-----KI-KLGHRSEAKDGINRTALREI 63
Query: 66 SVMRIVRHPNIVQLYEVMATKSKIFFVMEYA----KGGELFNKVAKGKLKEDAARRYFQQ 121
+++ + HPNI+ L + KS I V ++ + K L + Y
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLM 120
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA- 180
+ +++ H + HRD+KP NLLLDEN LK++DFGL+ + G+P
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPNR 167
Query: 181 ----------YVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG 229
Y APE++ + Y VD+W+ G +L LL + ++ +I
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVG-VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226
Query: 230 KA----------------EFKC-PNWFPPEVRK-----------LLCKILDPNPSTRISM 261
+ ++ ++ + L+ + NP RI+
Sbjct: 227 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 286
Query: 262 AKIRESSWFR 271
+ + +F
Sbjct: 287 TQALKMKYFS 296
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-46
Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 15/255 (5%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+ + R +G G+F VY+AR +R ++ VA+K + I +E+ ++ +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHS 131
HPN +Q + + VMEY G +V K L+E + + + HS
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI---N 188
+ HRD+K N+LL E +K+ DFG ++ ++ GTP ++APEVI +
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAPEVILAMD 226
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVRK 245
YD KVD+WS G+ L P + N + I + + +W R
Sbjct: 227 EGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRN 284
Query: 246 LLCKILDPNPSTRIS 260
+ L P R +
Sbjct: 285 FVDSCLQKIPQDRPT 299
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 69/262 (26%), Positives = 120/262 (45%), Gaps = 24/262 (9%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQ------IKRE 64
++ E+Y++ LG G + VY A N VA+K + + ++ +RE
Sbjct: 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA------IFIPPREKEETLKRFERE 61
Query: 65 ISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVA-KGKLKEDAARRYFQQLI 123
+ + H NIV + +V + VMEY +G L + G L D A + Q++
Sbjct: 62 VHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQIL 121
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC--GTPAY 181
+ + H + HRDIKP+N+L+D N+ LKI DFG +A+ + L T GT Y
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFG---IAKALSETSLTQTNHVLGTVQY 178
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH-DSNLIEMYRKIGKAEFKCPNWF- 239
+PE + E DI+S G+VL+ +L G PF+ ++ + + I +
Sbjct: 179 FSPEQA-KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237
Query: 240 ---PPEVRKLLCKILDPNPSTR 258
P + ++ + + + + R
Sbjct: 238 KDIPQSLSNVILRATEKDKANR 259
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 82/296 (27%), Positives = 131/296 (44%), Gaps = 50/296 (16%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVID--KDKIMRVGLADQIKREISVMR- 69
+E+ L+G G + +VY R ++T Q A+KV+D D+ ++IK+EI++++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLKK 76
Query: 70 IVRHPNIVQLYE------VMATKSKIFFVMEYAKGG---ELFNKVAKGKLKEDAARRYFQ 120
H NI Y +++ VME+ G +L LKE+ +
Sbjct: 77 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180
+++ + H V HRDIK +N+LL EN +K+ DFG+S AQ G +T GTP
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPY 194
Query: 181 YVAPEVINRK-----GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC 235
++APEVI YD K D+WS G+ + G P D + M +A F
Sbjct: 195 WMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMH--PM-----RALFLI 246
Query: 236 PNWFPPE-------------VRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQ 278
P P + L K N S R + ++ + + R N++Q
Sbjct: 247 PRNPAPRLKSKKWSKKFQSFIESCLVK----NHSQRPATEQLMKHPFIRDQPNERQ 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 75/308 (24%), Positives = 121/308 (39%), Gaps = 73/308 (23%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI----DKDKIMRVGLADQIKREISVMR 69
EKY+ +G+G + VY A+ + VA+K I + + I + REIS+++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAI-----REISLLK 74
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYA----KGGELFNKVAKGKLKEDAARRYFQQLINA 125
+ HPNIV L +V+ ++ + V E+ K K L++ + Y QL+
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKK---VLDENKTGLQDSQIKIYLYQLLRG 131
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA----- 180
V CH + HRD+KP+NLL++ + LK++DFGL+ G P
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA-------------RAFGIPVRSYTH 178
Query: 181 ------YVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-- 231
Y AP+V+ K Y VDIWS G + ++ G F + KI
Sbjct: 179 EVVTLWYRAPDVLMGSKKY-STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237
Query: 232 -----------------EFKCPNWFPPEVRK-----------LLCKILDPNPSTRISMAK 263
+ + LL +L +P+ RIS
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297
Query: 264 IRESSWFR 271
+F+
Sbjct: 298 AMNHPYFK 305
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-45
Identities = 70/307 (22%), Positives = 122/307 (39%), Gaps = 71/307 (23%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI---DKDKIMRVGLADQIKREISVMRI 70
E Y LG+G +A VY +S T+ VA+K I ++ + RE+S+++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-----REVSLLKD 56
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYA----KGGELFNKVAKGKLKEDAARRYFQQLINAV 126
++H NIV L++++ T+ + V EY K + + + + QL+ +
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQ---YLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA------ 180
+CH + V HRD+KP+NLL++E LK++DFGL A+ K P
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGL---ARAK----------SIPTKTYDNE 160
Query: 181 -----YVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--- 231
Y P+++ Y ++D+W G + + + G F S + E I +
Sbjct: 161 VVTLWYRPPDILLGSTDY-STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219
Query: 232 ----------------EFKCPNWFPPEVRK-----------LLCKILDPNPSTRISMAKI 264
+ P + + LL K+L RIS
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279
Query: 265 RESSWFR 271
+ +F
Sbjct: 280 MKHPFFL 286
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-45
Identities = 80/313 (25%), Positives = 133/313 (42%), Gaps = 78/313 (24%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI----DKDKIMRVGLADQIKREISVMR 69
++Y LG+G + +VY A TN++VA+K I +++ + + RE+S+++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI-----REVSLLK 88
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYA----KGGELFNKVAKGKLKEDAARRYFQQLINA 125
++H NI++L V+ ++ + EYA K +K + + + QLIN
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAENDLKK--YMDK--NPDVSMRVIKSFLYQLING 144
Query: 126 VDFCHSRGVYHRDIKPENLLLDENE-----NLKISDFGLSALAQCKHQDGLLHTTCGTPA 180
V+FCHSR HRD+KP+NLLL ++ LKI DFGL A+ G P
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL---ARAF----------GIPI 191
Query: 181 -----------YVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
Y PE++ + Y VDIWS + +L F + I+ KI
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHY-STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250
Query: 229 GKA----------------EFKC--PNWFPPEVRKLLCKILDP------------NPSTR 258
+ ++K P + ++++L +LD +P R
Sbjct: 251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKR 310
Query: 259 ISMAKIRESSWFR 271
IS E +F
Sbjct: 311 ISAKNALEHPYFS 323
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 76/312 (24%), Positives = 122/312 (39%), Gaps = 71/312 (22%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI--DKDKIMRVGLADQIKREISVMR-- 69
+YE +G GA+ VY AR + VA+K + GL RE++++R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 70 -IVRHPNIVQLYEVMATKS-----KIFFVMEYA----KGGELFNKVAKGKLKEDAARRYF 119
HPN+V+L +V AT K+ V E+ + +K L + +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPGLPAETIKDLM 126
Query: 120 QQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP 179
+Q + +DF H+ + HRD+KPEN+L+ +K++DFGL+
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA-------------RIYSYQ 173
Query: 180 A----------YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI- 228
Y APEV+ + Y VD+WS G + + F ++ + KI
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232
Query: 229 ---G--------------KAEFKCPNWFPPEVRK-----------LLCKILDPNPSTRIS 260
G + F P P V+ LL ++L NP RIS
Sbjct: 233 DLIGLPPEDDWPRDVSLPRGAF--PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 261 MAKIRESSWFRK 272
+ + S+ K
Sbjct: 291 AFRALQHSYLHK 302
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 63/254 (24%), Positives = 109/254 (42%), Gaps = 11/254 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ +E LG G V+ + +A K+I + + +QI RE+ V+
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHECNS 90
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHS 131
P IV Y + +I ME+ GG L ++V K G++ E + +I + +
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 132 RG-VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
+ + HRD+KP N+L++ +K+ DFG+S + D + ++ GT +Y++PE +
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGT 205
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250
Y + DIWS G+ L + G P + E+ G PP R +
Sbjct: 206 HYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 251 LDPNPSTRISMAKI 264
+R MA
Sbjct: 265 NKFGMDSRPPMAIF 278
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-43
Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 28/281 (9%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV-MRIVR 72
E +G G +V+ R +T +AVK + + +I ++ V ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLKSHD 82
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGG-ELFNKVAKGKLKEDAARRYFQQLINAVDFCHS 131
P IVQ + T + +F ME E K +G + E + ++ A+ +
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 132 -RGVYHRDIKPENLLLDENENLKISDFGLSA-----LAQCKHQDGLLHTTCGTPAYVAPE 185
GV HRD+KP N+LLDE +K+ DFG+S A+ + G AY+APE
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD--------RSAGCAAYMAPE 194
Query: 186 VI-----NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKIGKAE---FKCP 236
I + YD + D+WS G+ L L G P+ + E+ K+ + E
Sbjct: 195 RIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253
Query: 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQK 277
F + + + L + R K+ E S+ ++ +
Sbjct: 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-43
Identities = 64/256 (25%), Positives = 112/256 (43%), Gaps = 24/256 (9%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLA-DQI-----KREISVMR 69
Y + RL+G+G VY A + VA+K+ M L+ D + +RE
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKL------MSETLSSDPVFRTRMQREARTAG 89
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDF 128
++ P++V +++ +++ M G +L + + G L A +Q+ +A+D
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHT--TCGTPAYVAPEV 186
H+ G HRD+KPEN+L+ ++ + DFG +A + L T GT Y+APE
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFG---IASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWF----PPE 242
+ + + DI++ VL+ L G P+ L M I P+ P
Sbjct: 207 F-SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVA 264
Query: 243 VRKLLCKILDPNPSTR 258
++ + + NP R
Sbjct: 265 FDAVIARGMAKNPEDR 280
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-43
Identities = 80/274 (29%), Positives = 128/274 (46%), Gaps = 27/274 (9%)
Query: 3 GMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLA-DQI 61
G PS L+++YE+G +LG G ++V+ AR +R ++ VAVKV +R LA D
Sbjct: 1 GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV------LRADLARDPS 54
Query: 62 -----KREISVMRIVRHPNIVQLYEV----MATKSKIFFVMEYAKGGELFNKVAK-GKLK 111
+RE + HP IV +Y+ + VMEY G L + V G +
Sbjct: 55 FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT 114
Query: 112 EDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171
A A++F H G+ HRD+KP N+++ +K+ DFG+ A A + +
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI-ARAIADSGNSV 173
Query: 172 LHTTC--GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH-DSNLIEMYRKI 228
T GT Y++PE R + D++S G VL+ +L G PF DS + Y+ +
Sbjct: 174 TQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232
Query: 229 GKAEFKCPN----WFPPEVRKLLCKILDPNPSTR 258
+ + P+ ++ ++ K L NP R
Sbjct: 233 -REDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 2e-42
Identities = 76/324 (23%), Positives = 133/324 (41%), Gaps = 79/324 (24%)
Query: 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIR-TNQSVAVKVI----DKDKIMRVGLA 58
M+ + ++YE +G+GA+ KV+ AR ++ + VA+K + ++ G+
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-----GMP 55
Query: 59 DQIKREISVMR---IVRHPNIVQLYEVMAT-----KSKIFFVMEYA----KGGELFNKVA 106
RE++V+R HPN+V+L++V ++K+ V E+ +KV
Sbjct: 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVP 113
Query: 107 KGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166
+ + + + QL+ +DF HS V HRD+KP+N+L+ + +K++DFGL+
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------ 167
Query: 167 HQDGLLHTTCGTPA----------YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF 216
Y APEV+ + Y VD+WS G + + F
Sbjct: 168 -------RIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLF 219
Query: 217 HDSNLIEMYRKI----G--------------KAEFKCPNWFPPEVRK-----------LL 247
S+ ++ KI G + F + + K LL
Sbjct: 220 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF--HSKSAQPIEKFVTDIDELGKDLL 277
Query: 248 CKILDPNPSTRISMAKIRESSWFR 271
K L NP+ RIS +F+
Sbjct: 278 LKCLTFNPAKRISAYSALSHPYFQ 301
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-42
Identities = 60/258 (23%), Positives = 102/258 (39%), Gaps = 32/258 (12%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIR-TNQSVAVKVI----DKDKIMRVGLADQIKREI 65
++ +YEV + G +Y A + V +K + D + E
Sbjct: 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMA------MAER 130
Query: 66 SVMRIVRHPNIVQLYEV-----MATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ 120
+ V HP+IVQ++ + VMEY G L + KL A Y
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKLPVAEAIAYLL 189
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180
+++ A+ + HS G+ + D+KPEN++L E + LK+ D G + G L GTP
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLG---AVSRINSFGYL---YGTPG 242
Query: 181 YVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFP 240
+ APE++ + DI++ G L L + + + +
Sbjct: 243 FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK------TY 294
Query: 241 PEVRKLLCKILDPNPSTR 258
+LL + +DP+P R
Sbjct: 295 DSYGRLLRRAIDPDPRQR 312
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-42
Identities = 57/292 (19%), Positives = 116/292 (39%), Gaps = 49/292 (16%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
+ +G+G + +V+ ++VAVK+ + + E+ ++RH NI
Sbjct: 11 TLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDE----KSWFRETELYNTVMLRHENI 64
Query: 77 VQLY----EVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
+ + ++++ + Y + G L++ + L + R + + + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 133 --------GVYHRDIKPENLLLDENENLKISDFGLSAL--AQCKHQDGLLHTTCGTPAYV 182
+ HRD+K +N+L+ +N I+D GL+ + D + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 183 APEVINRKGYDG-----EKVDIWSCGVVLFVLLAGY----------LPFHDSN-----LI 222
APEV++ ++VDIW+ G+VL+ + PF+D
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 223 EMYRKIGKA----EFKCPNWFPPEVRKLLCKIL----DPNPSTRISMAKIRE 266
+M + + WF L K++ NPS R++ +I++
Sbjct: 245 DMRKVVCVDQQRPNIP-NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-41
Identities = 63/224 (28%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+ Y++ R LG+G +++V+ A +I N+ V VK++ K +IKREI ++ +R
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLR 88
Query: 73 -HPNIVQLYEVM--ATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFC 129
PNI+ L +++ V E+ + K L + R Y +++ A+D+C
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKALDYC 146
Query: 130 HSRGVYHRDIKPENLLLD-ENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI- 187
HS G+ HRD+KP N+++D E+ L++ D+G LA+ H + + + PE++
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLP-FHDSNLIEMYRKIGK 230
+ + YD +D+WS G +L ++ P FH + + +I K
Sbjct: 204 DYQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-41
Identities = 80/290 (27%), Positives = 130/290 (44%), Gaps = 55/290 (18%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
Y +++G G+F V+ A+ + +++ VA+K + +DK RE+ +MRIV+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-------RFKNRELQIMRIVK 90
Query: 73 HPNIVQLYEVMATKS------KIFFVMEY-----AKGGELFNKVAKGKLKEDAARRYFQQ 121
HPN+V L + + V+EY + + K K + + Y Q
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQ 149
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENEN-LKISDFGLSALAQCKHQDGLLHTTCGTPA 180
L+ ++ + HS G+ HRDIKP+NLLLD LK+ DFG A + + C +
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS-AKILIAGEP-NVSYIC-SRY 206
Query: 181 YVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFH-DSN---LIEMYRKIG------ 229
Y APE+I Y +DIWS G V+ L+ G F +S L+E+ + +G
Sbjct: 207 YRAPELIFGATNYTT-NIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265
Query: 230 -------KAEFKCPNW------------FPPEVRKLLCKILDPNPSTRIS 260
E K P PP+ L+ ++L+ PS R++
Sbjct: 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-41
Identities = 82/298 (27%), Positives = 129/298 (43%), Gaps = 70/298 (23%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
Y +++G G+F VY A+ + + VA+K + +DK + RE+ +MR +
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 105
Query: 73 HPNIVQLYEVMATKS------KIFFVMEY-----AKGGELFNKVAKGKLKEDAARRYFQQ 121
H NIV+L + + V++Y + +++ AK L + Y Q
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMYQ 164
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDEN-ENLKISDFGLSALAQCKHQDGLLHTTCGTP- 179
L ++ + HS G+ HRDIKP+NLLLD + LK+ DFG + G P
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA-----------KQLVRGEPN 213
Query: 180 -AYV------APEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFH-DSN---LIEMYRK 227
+Y+ APE+I Y +D+WS G VL LL G F DS L+E+ +
Sbjct: 214 VSYICSRYYRAPELIFGATDYT-SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 228 IG-------------KAEFKCPNW------------FPPEVRKLLCKILDPNPSTRIS 260
+G EFK P PPE L ++L+ P+ R++
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-41
Identities = 69/311 (22%), Positives = 121/311 (38%), Gaps = 64/311 (20%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI--DKDK----IMRVGLADQIKREISV 67
KYE +GQG F +V+ AR +T Q VA+K + + +K I + REI +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-------REIKI 69
Query: 68 MRIVRHPNIVQLYEVMATKS--------KIFFVMEYA----KGGELFNKVAKGKLKEDAA 115
+++++H N+V L E+ TK+ I+ V ++ G L + V K
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV-LVKFTLSEI 126
Query: 116 RRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT 175
+R Q L+N + + H + HRD+K N+L+ + LK++DFGL+ T
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 176 CG--TPAYVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI---- 228
T Y PE++ + Y G +D+W G ++ + + I
Sbjct: 187 NRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 229 ---------------GKAEFKCPNWFPPEVRK-------------LLCKILDPNPSTRIS 260
+ + +V+ L+ K+L +P+ RI
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305
Query: 261 MAKIRESSWFR 271
+F
Sbjct: 306 SDDALNHDFFW 316
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-40
Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 33/286 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV-MRIVR 72
E + +G+GA+ V + Q +AVK I + Q+ ++ V MR
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE--QKQLLMDLDVVMRSSD 79
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGG-----ELFNKVAKGKLKEDAARRYFQQLINAVD 127
P IVQ Y + + + ME + V + E+ + + A++
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 128 FCHS-RGVYHRDIKPENLLLDENENLKISDFGLSA-----LAQCKHQDGLLHTTCGTPAY 181
+ HRDIKP N+LLD + N+K+ DFG+S +A+ G Y
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT--------RDAGCRPY 191
Query: 182 VAPEVI----NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKIGKAE---- 232
+APE I +R+GYD + D+WS G+ L+ L G P+ +++ + ++ K +
Sbjct: 192 MAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250
Query: 233 -FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQK 277
F P + L + S R ++ + + +
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-40
Identities = 65/296 (21%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+ ++ + +G F V+ A+ N+ VAVK+ ++ + Q + E+ + ++
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFP----IQDKQSWQNEYEVYSLPGMK 76
Query: 73 HPNIVQLY----EVMATKSKIFFVMEYAKGGELFNKVAKGKLK--------EDAAR--RY 118
H NI+Q + ++ + + + G L + + + E AR Y
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAY 136
Query: 119 FQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT 178
+ I + H + HRDIK +N+LL N I+DFGL+ + G H GT
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 179 PAYVAPEV----INRKGYDGEKVDIWSCGVVLFVLLAG-----------YLPFHDS---- 219
Y+APEV IN + ++D+++ G+VL+ L + LPF +
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256
Query: 220 -NLIEMYRKIGKAEFKCP---NWFPPEVRKLLCKIL----DPNPSTRISMAKIRES 267
+L +M + + + W +LC+ + D + R+S + E
Sbjct: 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 56/307 (18%), Positives = 131/307 (42%), Gaps = 49/307 (15%)
Query: 3 GMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK 62
G+ + ++ ++ + +G+G + +V+ + + VAVKV + + +
Sbjct: 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEA----SWFRE 79
Query: 63 REISVMRIVRHPNIVQLY----EVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRY 118
EI ++RH NI+ + + ++++ + +Y + G L++ + L + +
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKL 139
Query: 119 FQQLINAVDFCHSR--------GVYHRDIKPENLLLDENENLKISDFGLSAL--AQCKHQ 168
++ + H+ + HRD+K +N+L+ +N I+D GL+ +
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 169 DGLLHTTCGTPAYVAPEVI------NRKGYDGEKVDIWSCGVVL---------FVLLAGY 213
D +T GT Y+ PEV+ N D++S G++L ++ Y
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 214 -LPFH-----DSNLIEMYRKIGKAEFK---CPNWFPPEVRKLLCKIL----DPNPSTRIS 260
LP+H D + +M + + + W E + + K++ NP++R++
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 261 MAKIRES 267
+++++
Sbjct: 319 ALRVKKT 325
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 64/286 (22%), Positives = 118/286 (41%), Gaps = 37/286 (12%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVI----DKDKIMRVGLADQIKREISV-M 68
+ E LG+GA+ V R + + Q +AVK I + + ++ ++ + M
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ------KRLLMDLDISM 60
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGG--ELFNKVAK--GKLKEDAARRYFQQLIN 124
R V P V Y + + ++ ME + + +V + ED + ++
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 125 AVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLSA-----LAQCKHQDGLLHTTCGT 178
A++ HS V HRD+KP N+L++ +K+ DFG+S +A+ G
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD--------IDAGC 172
Query: 179 PAYVAPEVI----NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD-SNLIEMYRKIGKAE- 232
Y+APE I N+KGY K DIWS G+ + L P+ + +++ +
Sbjct: 173 KPYMAPERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231
Query: 233 -FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQK 277
+ F E + L N R + ++ + +F ++
Sbjct: 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-39
Identities = 38/263 (14%), Positives = 84/263 (31%), Gaps = 38/263 (14%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
+ +Y + G + + A ++ VA+ +D ++ + + +
Sbjct: 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR 87
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH 130
+ P + ++ +V+ T++ V E+ +GG L +VA A R Q L A D H
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSL-QEVADTSPSPVGAIRAMQSLAAAADAAH 146
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
GV P + + + ++ + PA +
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVL----------------------AYPATMPDA----- 179
Query: 191 GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN-------WFPPEV 243
+ DI G L+ LL P ++ + + P P ++
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236
Query: 244 RKLLCKILDPNPSTRISMAKIRE 266
+ + + + R + +
Sbjct: 237 SAVAARSVQGDGGIRSASTLLNL 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 57/292 (19%), Positives = 125/292 (42%), Gaps = 47/292 (16%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
+ +G+G F +V+ R + VAVK+ + + + EI ++RH NI
Sbjct: 45 VLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENI 98
Query: 77 VQLY----EVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
+ + T ++++ V +Y + G LF+ + + + + + + + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 133 --------GVYHRDIKPENLLLDENENLKISDFGLSAL--AQCKHQDGLLHTTCGTPAYV 182
+ HRD+K +N+L+ +N I+D GL+ + D + GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 183 APEVINRKGYDG-----EKVDIWSCGVVLFVLLAGY----------LPFH-----DSNLI 222
APEV++ ++ DI++ G+V + + LP++ D ++
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 223 EMYRKIGKAEFK---CPNWFPPEVRKLLCKIL----DPNPSTRISMAKIRES 267
EM + + + + + W E +++ KI+ N + R++ +I+++
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 55/291 (18%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV----GLADQIKREISV 67
L + Y +G GA+ V A R+ + VA+K K+ R A + RE+ +
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----KLSRPFQSEIFAKRAYRELLL 76
Query: 68 MRIVRHPNIVQLYEVMATKSK------IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQ 121
++ ++H N++ L +V S + VM + +L K+ K E+ + Q
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKFSEEKIQYLVYQ 134
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
++ + + HS GV HRD+KP NL ++E+ LKI DFGL+ +H D + T Y
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRWY 189
Query: 182 VAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI----GK--AEF- 233
APEVI + Y+ + VDIWS G ++ +L G F + ++ +I G EF
Sbjct: 190 RAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 234 -------------KCPNW--------FP---PEVRKLLCKILDPNPSTRIS 260
P FP P+ LL K+L+ + R++
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 66/335 (19%), Positives = 127/335 (37%), Gaps = 74/335 (22%)
Query: 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARS--IRTNQSVAVKVIDKDKIMRVGLADQI 61
+ + V G +G+G + VY A+ + ++ A+K I+ G++
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSA 65
Query: 62 KREISVMRIVRHPNIVQLYEVMATKS--KIFFVMEYA---------KGGELFNKVAKGKL 110
REI+++R ++HPN++ L +V + + K++ + +YA +L
Sbjct: 66 CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 125
Query: 111 KEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN----LKISDFGLSALAQCK 166
+ Q+++ + + H+ V HRD+KP N+L+ +KI+D G A
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNS 184
Query: 167 HQDGLLHTTCG--TPAYVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAG----------- 212
L T Y APE++ + Y + +DIW+ G + LL
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243
Query: 213 --YLPFHDSNLIEMYRKIG-------------------KAEFKCPNWFPPEVRK------ 245
P+H L ++ +G +F+ + + K
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 246 ---------LLCKILDPNPSTRISMAKIRESSWFR 271
LL K+L +P RI+ + + +F
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-36
Identities = 56/313 (17%), Positives = 110/313 (35%), Gaps = 62/313 (19%)
Query: 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
PS+ + ++ L+G+G + VY + VAVKV E ++
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR------QNFINEKNIY 59
Query: 69 RI--VRHPNIVQLY-----EVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQ 121
R+ + H NI + + + VMEY G L ++ ++ R
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHS 119
Query: 122 LINAVDFCHS---------RGVYHRDIKPENLLLDENENLKISDFGLS------ALAQCK 166
+ + + H+ + HRD+ N+L+ + ISDFGLS L +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 167 HQDGLLHTTCGTPAYVAPEVI------NRKGYDGEKVDIWSCGVVLFVLLAGY------- 213
+D + GT Y+APEV+ ++VD+++ G++ + +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 214 ------LPFHDS-----NLIEMYRKIGKAEFKCP---NWFP-PEVRKLLCKIL----DPN 254
+ F +M + + + + W + L + + D +
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 255 PSTRISMAKIRES 267
R++ E
Sbjct: 300 AEARLTAQXAEER 312
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 21/227 (9%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV----GLADQIKREISV 67
+ ++Y+ + +G GA V A +++VA+K K+ R A + RE+ +
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVL 114
Query: 68 MRIVRHPNIVQLYEVMATKSK------IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQ 121
M+ V H NI+ L V + ++ VME L +V + +L + Q
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQ 172
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
++ + HS G+ HRD+KP N+++ + LKI DFG LA+ ++ T Y
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYY 229
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
APEVI GY E VDIWS G ++ ++ + F + I+ + K+
Sbjct: 230 RAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 55/229 (24%), Positives = 102/229 (44%), Gaps = 45/229 (19%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV----GLADQIKREISV 67
+ ++YE+ L+G G++ V A + VA+K KI+RV +I REI++
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAI 105
Query: 68 MRIVRHPNIVQLYEVMATKS-----KIFFVMEYAKGGELFNKV--AKGKLKEDAARRYFQ 120
+ + H ++V++ +++ K +++ V+E A + K+ L E +
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTLLY 163
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180
L+ V + HS G+ HRD+KP N L++++ ++K+ DFGL+
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 181 -------------------YV------APEVI-NRKGYDGEKVDIWSCG 203
+V APE+I ++ Y E +D+WS G
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIG 271
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 21/227 (9%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV----GLADQIKREISV 67
+ ++Y+ + +G GA V A ++VA+K K+ R A + RE+ +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVL 77
Query: 68 MRIVRHPNIVQLYEVMATKSK------IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQ 121
M+ V H NI+ L V + ++ VME L +V + +L + Q
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQ 135
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
++ + HS G+ HRD+KP N+++ + LKI DFG LA+ ++ T Y
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYY 192
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
APEVI GY E VDIWS G ++ ++ G + F ++ I+ + K+
Sbjct: 193 RAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 238
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 15/261 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +G +G+G F +V+ R N VAVK ++ + A +E +++ H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAK-FLQEARILKQYSH 171
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHS 131
PNIV+L V K I+ VME +GG+ + +L+ + +++ S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY----VAPEVI 187
+ HRD+ N L+ E LKISDFG+S DG+ + G APE +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREE----ADGVYAASGGLRQVPVKWTAPEAL 287
Query: 188 NRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRK 245
N Y + D+WS G++L+ G P+ + + + + K CP P V +
Sbjct: 288 NYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346
Query: 246 LLCKILDPNPSTRISMAKIRE 266
L+ + P R S + I +
Sbjct: 347 LMEQCWAYEPGQRPSFSTIYQ 367
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 76/292 (26%), Positives = 125/292 (42%), Gaps = 56/292 (19%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV----GLADQIKREISV 67
+ E+Y+ +G GA+ V A +T VAVK K+ R A + RE+ +
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-----KLSRPFQSIIHAKRTYRELRL 81
Query: 68 MRIVRHPNIVQLYEVMATKSK------IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ- 120
++ ++H N++ L +V ++ V G +L N + K + D ++
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 139
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180
Q++ + + HS + HRD+KP NL ++E+ LKI DFGL+ +H + T
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTADEMTGYVATRW 194
Query: 181 YVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI----GK--AEF 233
Y APE++ N Y+ + VDIWS G ++ LL G F ++ I+ + I G AE
Sbjct: 195 YRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253
Query: 234 --------------KCPNW--------FP---PEVRKLLCKILDPNPSTRIS 260
F P LL K+L + RI+
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 54/291 (18%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV----GLADQIKREISV 67
+ Y + +G GA+ V A RT VA+K K+ R A + RE+ +
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYRELRL 77
Query: 68 MRIVRHPNIVQLYEVMATKSK------IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQ 121
++ +RH N++ L +V + VM + G +L + KL ED + Q
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
++ + + H+ G+ HRD+KP NL ++E+ LKI DFGL+ + D + T Y
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWY 191
Query: 182 VAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI----GK--AEF- 233
APEVI N Y + VDIWS G ++ ++ G F S+ ++ ++I G AEF
Sbjct: 192 RAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 234 -------------KCPNW--------FP---PEVRKLLCKILDPNPSTRIS 260
P P LL K+L + R++
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 301
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 60/300 (20%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVID--KDKIMRVGLADQIKREISVMR 69
++ +++ LLG+GA+ V A T + VA+K I+ + A + REI +++
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL----FALRTLREIKILK 64
Query: 70 IVRHPNIVQLYEVMATKSK-----IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ-QLI 123
+H NI+ ++ + S ++ + E +L ++V ++ D +YF Q +
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTL 122
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTP--AY 181
AV H V HRD+KP NLL++ N +LK+ DFGL+ + D T + +
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 182 V------APEVI-NRKGYDGEKVDIWSCGVVLFVLLAG--------YL------------ 214
V APEV+ Y +D+WSCG +L L Y
Sbjct: 183 VATRWYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 215 PFHDS-----------NLIEMYRKIGKAEFKCPNWFP---PEVRKLLCKILDPNPSTRIS 260
P D+ I+ A + FP P+ LL ++L +P+ RI+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLE--KMFPRVNPKGIDLLQRMLVFDPAKRIT 299
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDK-DKIMRVGLADQIKREISVMRI 70
+ +Y +G+GA+ V A VA+K I + + REI ++
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT---YCQRTLREIKILLR 81
Query: 71 VRHPNIVQLYEVMATKSK-----IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ-QLIN 124
RH NI+ + +++ + ++ V + +L K+ K + + YF Q++
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQILR 139
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV-- 182
+ + HS V HRD+KP NLLL+ +LKI DFGL+ +A H T YV
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE-----YVAT 194
Query: 183 ----APEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI----GK--A 231
APE++ N KGY + +DIWS G +L +L+ F + ++ I G
Sbjct: 195 RWYRAPEIMLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 232 EF--------------KCPNW--------FP---PEVRKLLCKILDPNPSTRIS 260
E P+ FP + LL K+L NP RI
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 72/296 (24%), Positives = 120/296 (40%), Gaps = 52/296 (17%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
L +Y + LG G V+ A ++ VA+K I REI ++R +
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRRL 65
Query: 72 RHPNIVQLYEVMATKSK--------------IFFVMEYAKGGELFNKVAKGKLKEDAARR 117
H NIV+++E++ ++ V EY +L N + +G L E+ AR
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARL 124
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLD-ENENLKISDFGLS-ALAQCKHQDGLLHTT 175
+ QL+ + + HS V HRD+KP NL ++ E+ LKI DFGL+ + G L
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 176 CGTPAYVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPF------HDSNLI------ 222
T Y +P ++ + Y + +D+W+ G + +L G F LI
Sbjct: 185 LVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243
Query: 223 ---EMYRKIGK--AEF--KCPNW--------FP---PEVRKLLCKILDPNPSTRIS 260
E +++ + P E L +IL +P R++
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 76/308 (24%), Positives = 113/308 (36%), Gaps = 81/308 (26%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI-- 70
++++V R+ GQG F V + T SVA+K + +D R RE+ +M+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLA 74
Query: 71 -VRHPNIVQLYEVMATKSKIFF-------VMEY--------AKGGELFNKVAKGKLKEDA 114
+ HPNIVQL T + VMEY + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCR----NYYRRQVAPPPIL 130
Query: 115 ARRYFQQLINAVDFCH--SRGVYHRDIKPENLLLD-ENENLKISDFGLSALAQCKHQDGL 171
+ + QLI ++ H S V HRDIKP N+L++ + LK+ DFG + K
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA-----KKLSPS 185
Query: 172 LHTTCGTPAYV------APEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---- 220
AY+ APE+I + Y VDIWS G + ++ G F N
Sbjct: 186 EPNV----AYICSRYYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240
Query: 221 LIEMYRKIG-------------KAEFKCPNW---------------FPPEVRKLLCKILD 252
L E+ R +G + N E LL +L
Sbjct: 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300
Query: 253 PNPSTRIS 260
P R+
Sbjct: 301 YLPEERMK 308
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-34
Identities = 54/232 (23%), Positives = 105/232 (45%), Gaps = 38/232 (16%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV----GLADQIKREISV 67
+ + Y + L+G+G++ VY A T ++VA+K K+ R+ +I REI++
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILREITI 78
Query: 68 MRIVRHPNIVQLYEVMATKSK-----IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ-Q 121
+ ++ I++LY+++ ++ V+E A +L + +
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA- 180
L+ +F H G+ HRD+KP N LL+++ ++K+ DFGL+ + +++
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 181 -------------YV------APEVI-NRKGYDGEKVDIWSCGVVLFVLLAG 212
+V APE+I ++ Y + +DIWS G + LL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 75/330 (22%), Positives = 122/330 (36%), Gaps = 98/330 (29%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
++KY +G+ LG G+F V I + + A+K + +D RE+ +M++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKV 56
Query: 71 VRHPNIVQLYEVMATKSK--------------------------------------IFFV 92
+ H NI++L + T + +
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 93 MEY-----AKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD 147
MEY K + F + + + + Y QL AV F HS G+ HRDIKP+NLL++
Sbjct: 117 MEYVPDTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175
Query: 148 -ENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV------APEVI-NRKGYDGEKVDI 199
++ LK+ DFG + K + AY+ APE++ Y +D+
Sbjct: 176 SKDNTLKLCDFGSA-----KKLIPSEPSV----AYICSRFYRAPELMLGATEYT-PSIDL 225
Query: 200 WSCGVVLFVLLAGYLPF----HDSNLIEMYRKIG-------------KAEFKCPNW---- 238
WS G V L+ G F L+ + + +G E + P
Sbjct: 226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKD 285
Query: 239 ----F----PPEVRKLLCKILDPNPSTRIS 260
P LL +IL P RI+
Sbjct: 286 WRKILPEGTPSLAIDLLEQILRYEPDLRIN 315
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 66/297 (22%), Positives = 107/297 (36%), Gaps = 54/297 (18%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVG--------LADQIKR 63
+ Y V R + G++ V VA+K + L ++ R
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 64 EISVMRIVRHPNIVQLYEVMATKSK-----IFFVMEYAKGGELFN--KVAKGKLKEDAAR 116
EI ++ HPNI+ L ++ + ++ V E +L + + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQ 137
Query: 117 RYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC 176
+ ++ + H GV HRD+ P N+LL +N ++ I DF LA+ D
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTADANKTHYV 194
Query: 177 GTPAYVAPEVI-NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI----GK- 230
Y APE++ KG+ + VD+WS G V+ + F S KI G
Sbjct: 195 THRWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 231 -----AEFKCPN-------------------WFP---PEVRKLLCKILDPNPSTRIS 260
F P+ P P L+ K+L+ NP RIS
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 36/229 (15%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV----GLADQIKREISV 67
+ KYE+ + LG+GA+ V+ + RT + VAVK KI A + REI +
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRTFREIMI 61
Query: 68 MRIVR-HPNIVQLYEVMATKSK--IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQ-QLI 123
+ + H NIV L V+ + ++ V +Y +L + V + + E ++Y QLI
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLI 119
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA--- 180
+ + HS G+ HRD+KP N+LL+ ++K++DFGLS +
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 181 ----------YV------APEVI-NRKGYDGEKVDIWSCGVVLFVLLAG 212
YV APE++ Y + +D+WS G +L +L G
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCG 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
+ +YEV +++G+G+F +V A + +Q VA+K++ +K Q EI ++
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEH 149
Query: 71 VRH------PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK---LKEDAARRYFQQ 121
+R N++ + E ++ I E L+ + K K R++
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENE--NLKISDFGLSALAQCKHQDGLLHTTCGTP 179
++ +D H + H D+KPEN+LL + +K+ DFG S C ++ ++T +
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----C-YEHQRVYTYIQSR 263
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
Y APEVI Y +D+WS G +L LL GY + + +
Sbjct: 264 FYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 64/277 (23%), Positives = 127/277 (45%), Gaps = 17/277 (6%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ LG G + +VY + + +VAVK + +D + ++ +E +VM+ ++H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKH 275
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN---KVAKGKLKEDAARRYFQQLINAVDFCH 130
PN+VQL V + + + E+ G L + + + ++ Q+ +A+++
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY--VAPEVIN 188
+ HR++ N L+ EN +K++DFG L++ D APE +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 189 RKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKL 246
+ K D+W+ GV+L+ + G P+ +L ++Y + K + P P +V +L
Sbjct: 393 YNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451
Query: 247 LCKILDPNPSTRISMAKIRE--SSWFRKGMNQKQKQK 281
+ NPS R S A+I + + F++ + +K
Sbjct: 452 MRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 488
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 25/264 (9%)
Query: 19 GRLLGQGAFAKVY---YARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
LG G+F V + SVAVK + D + + D RE++ M + H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLIN-AVDFC----- 129
+++LY V + V E A G L + +L++ L AV
Sbjct: 83 LIRLYGV-VLTPPMKMVTELAPLGSLLD-----RLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 130 -HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT--P-AYVAPE 185
S+ HRD+ NLLL + +KI DFGL D P A+ APE
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA--LPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 186 VINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAEF--KCPNWFPPE 242
+ + + D W GV L+ + G P+ N ++ KI K P P +
Sbjct: 195 SLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 243 VRKLLCKILDPNPSTRISMAKIRE 266
+ ++ + P R + +R+
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRD 277
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 63/267 (23%), Positives = 106/267 (39%), Gaps = 31/267 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E + LGQG F +V+ VA+K + + + +E VM+ +RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRH 238
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFC---- 129
+VQLY V ++ I+ V EY G L + LK + + +L VD
Sbjct: 239 EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDF-----LKGE--TGKYLRLPQLVDMAAQIA 290
Query: 130 ------HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY-- 181
HRD++ N+L+ EN K++DFG LA+ +
Sbjct: 291 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKW 347
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWF 239
APE + K D+WS G++L + G +P+ E+ ++ + CP
Sbjct: 348 TAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406
Query: 240 PPEVRKLLCKILDPNPSTRISMAKIRE 266
P + L+C+ P R + ++
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQA 433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-29
Identities = 63/267 (23%), Positives = 105/267 (39%), Gaps = 31/267 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E + LGQG F +V+ VA+K + + + +E VM+ +RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRH 321
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFC---- 129
+VQLY V ++ I+ V EY G L LK + + +L VD
Sbjct: 322 EKLVQLYAV-VSEEPIYIVTEYMSKGSL-----LDFLKGE--TGKYLRLPQLVDMAAQIA 373
Query: 130 ------HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY-- 181
HRD++ N+L+ EN K++DFG LA+ +
Sbjct: 374 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKW 430
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWF 239
APE + K D+WS G++L + G +P+ E+ ++ + CP
Sbjct: 431 TAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 489
Query: 240 PPEVRKLLCKILDPNPSTRISMAKIRE 266
P + L+C+ P R + ++
Sbjct: 490 PESLHDLMCQCWRKEPEERPTFEYLQA 516
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 58/234 (24%), Positives = 104/234 (44%), Gaps = 30/234 (12%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
++YE+ L+G+G+F +V A + VA+K+I K +Q + E+ ++ +
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL----NQAQIEVRLLEL 106
Query: 71 VRHP------NIVQLYEVMATKSKIFFVME------YAKGGELFNKVAKGKLKEDAARRY 118
+ IV L ++ + V E Y +L + + R++
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY----DLLRNTNFRGVSLNLTRKF 162
Query: 119 FQQLINAVDFCHSR--GVYHRDIKPENLLL--DENENLKISDFGLSALAQCKHQDGLLHT 174
QQ+ A+ F + + H D+KPEN+LL + +KI DFG S+ C ++
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SS---C-QLGQRIYQ 217
Query: 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI 228
+ Y +PEV+ YD +D+WS G +L + G F +N ++ KI
Sbjct: 218 YIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 23/280 (8%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ LG G + +VY + + +VAVK + K+ M V ++ +E +VM+ ++H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEV---EEFLKEAAVMKEIKH 68
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN---KVAKGKLKEDAARRYFQQLINAVDFCH 130
PN+VQL V + + + E+ G L + + + ++ Q+ +A+++
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQ----CKHQDGLLHTTCGTPA-YVAPE 185
+ HRD+ N L+ EN +K++DFGLS L H P + APE
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF------PIKWTAPE 182
Query: 186 VINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEV 243
+ + K D+W+ GV+L+ + G P+ +L ++Y + K + P P +V
Sbjct: 183 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241
Query: 244 RKLLCKILDPNPSTRISMAKIRE--SSWFRKGMNQKQKQK 281
+L+ NPS R S A+I + + F++ + +K
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 281
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 65/283 (22%), Positives = 112/283 (39%), Gaps = 33/283 (11%)
Query: 18 VGRLLGQGAFAKVYYA--RSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+ LG G F V + + ++VAVK++ K++ L D++ E +VM+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH----- 130
IV++ + VME A+ G L + + + + N ++ H
Sbjct: 80 IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMG 129
Query: 131 -----SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT--P-AYV 182
HRD+ N+LL KISDFGLS + + P +
Sbjct: 130 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR--ADENYYKAQTHGKWPVKWY 187
Query: 183 APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFP 240
APE IN + K D+WS GV+++ G P+ E+ + K E CP P
Sbjct: 188 APECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 246
Query: 241 PEVRKLLCKILDPNPSTRISMAKIRE--SSWFRKGMNQKQKQK 281
E+ L+ + R A + +++ +N+
Sbjct: 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHH 289
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 57/261 (21%), Positives = 107/261 (40%), Gaps = 38/261 (14%)
Query: 19 GRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
++LG GAF VY + VA+K + ++ + I E VM V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMASVDNP 77
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCH-- 130
++ +L + S + + + G L + + K + Q L +++C
Sbjct: 78 HVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIG-------SQYL---LNWCVQI 126
Query: 131 --------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT--P- 179
R + HRD+ N+L+ +++KI+DFGL+ L + + G P
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVPI 183
Query: 180 AYVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPN 237
++A E I + Y + D+WS GV ++ ++ G P+ E+ + K E P
Sbjct: 184 KWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242
Query: 238 WFPPEVRKLLCKILDPNPSTR 258
+V ++ K + +R
Sbjct: 243 ICTIDVYMIMRKCWMIDADSR 263
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 42/230 (18%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-- 72
+Y + R LG G F+ V+ A+ + N VA+K++ DK+ + + EI +++ V
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 75
Query: 73 ---------HPNIVQLYEVMATKSK----IFFVME------YAKGGELFNKVAKGKLKED 113
+I++L + K + V E L K +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLL----ALIKKYEHRGIPLI 131
Query: 114 AARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENE------NLKISDFGLSALAQCK 166
++ +QL+ +D+ H R G+ H DIKPEN+L++ + +KI+D G +
Sbjct: 132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----- 186
Query: 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF 216
D + T Y +PEV+ + DIWS ++F L+ G F
Sbjct: 187 WYDEHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLF 235
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 60/269 (22%), Positives = 106/269 (39%), Gaps = 27/269 (10%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK--REISVMRIVRHPNI 76
+ +G G F V+ VA+K I R G + E VM + HP +
Sbjct: 13 VQEIGSGQFGLVHLGY-WLNKDKVAIKTI------REGAMSEEDFIEEAEVMMKLSHPKL 65
Query: 77 VQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHSRGV 134
VQLY V ++ I V E+ + G L + + +G + + + + V
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 135 YHRDIKPENLLLDENENLKISDFGLSALAQ----CKHQDGLLHTTCGTPA-YVAPEVINR 189
HRD+ N L+ EN+ +K+SDFG++ P + +PEV +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------PVKWASPEVFSF 179
Query: 190 KGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLL 247
Y K D+WS GV+++ V G +P+ + + E+ I P V +++
Sbjct: 180 SRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 238
Query: 248 CKILDPNPSTRISMAKIRE--SSWFRKGM 274
P R + +++ + G+
Sbjct: 239 NHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 69/271 (25%), Positives = 112/271 (41%), Gaps = 41/271 (15%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++ ++ + +G+G F V VAVK I K+ E SVM +RH
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI-KNDATA----QAFLAEASVMTQLRH 73
Query: 74 PNIVQLYEVMATKSK--IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH- 130
N+VQL V + K ++ V EY G L + L+ R + F
Sbjct: 74 SNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDY-----LRSR--GRSVLGGDCLLKFSLD 125
Query: 131 ---------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
HRD+ N+L+ E+ K+SDFGL+ A G L P
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P-- 177
Query: 182 V---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCP 236
V APE + K + K D+WS G++L+ + G +P+ L ++ ++ K P
Sbjct: 178 VKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 236
Query: 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
+ PP V +++ + + R S ++RE
Sbjct: 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 267
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 57/254 (22%), Positives = 96/254 (37%), Gaps = 50/254 (19%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
+L + V R +G G F +V + I + AVKV+ K K E +++
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT----RSAKIEADILKK 87
Query: 71 VRH-----PNIVQLYEVMATKSKIFFVME------YAKGGELFNKVAKGKLKEDAARRYF 119
+++ NIV+ + + + E Y E+ + + + Y
Sbjct: 88 IQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY----EIITRNNYNGFHIEDIKLYC 143
Query: 120 QQLINAVDFCHSRGVYHRDIKPENLLLDENE-------------------------NLKI 154
+++ A+++ + H D+KPEN+LLD+ +K+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 155 SDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYL 214
DFG A + + T Y APEVI G+D D+WS G VL L G L
Sbjct: 204 IDFG-CA---T-FKSDYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSL 257
Query: 215 PFHDSNLIEMYRKI 228
F +E +
Sbjct: 258 LFRTHEHMEHLAMM 271
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 59/265 (22%), Positives = 107/265 (40%), Gaps = 25/265 (9%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK--REISVMRIV 71
E+ + + LG G F V + + VAVK+I + G + + +E M +
Sbjct: 8 EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMI------KEGSMSEDEFFQEAQTMMKL 60
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFC 129
HP +V+ Y V + + I+ V EY G L N + L+ + + F
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ----CKHQDGLLHTTCGTPA-YVAP 184
S HRD+ N L+D + +K+SDFG++ P + AP
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF------PVKWSAP 174
Query: 185 EVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPE 242
EV + Y K D+W+ G++++ V G +P+ E+ K+ + P+
Sbjct: 175 EVFHYFKYSS-KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT 233
Query: 243 VRKLLCKILDPNPSTRISMAKIRES 267
+ +++ P R + ++ S
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLLSS 258
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 56/250 (22%), Positives = 108/250 (43%), Gaps = 16/250 (6%)
Query: 19 GRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
++LG GAF VY + VA+K + ++ + I E VM V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMASVDNP 77
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHSR 132
++ +L + S + + + G L + + K + + Q+ +++ R
Sbjct: 78 HVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG-TP-AYVAPEVINRK 190
+ HRD+ N+L+ +++KI+DFGL+ L ++ H G P ++A E I +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHR 194
Query: 191 GYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLC 248
Y + D+WS GV ++ ++ G P+ E+ + K E P +V ++
Sbjct: 195 IYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMV 253
Query: 249 KILDPNPSTR 258
K + +R
Sbjct: 254 KCWMIDADSR 263
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 68/266 (25%), Positives = 109/266 (40%), Gaps = 37/266 (13%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI 76
++ + +G+G F V VAVK I K+ E SVM +RH N+
Sbjct: 196 KLLQTIGKGEFGDVMLGDY--RGNKVAVKCI-KNDATA----QAFLAEASVMTQLRHSNL 248
Query: 77 VQLYEVMATKSK--IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH---- 130
VQL V + K ++ V EY G L L+ R + F
Sbjct: 249 VQLLGV-IVEEKGGLYIVTEYMAKGSL-----VDYLRSR--GRSVLGGDCLLKFSLDVCE 300
Query: 131 ------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA-YVA 183
HRD+ N+L+ E+ K+SDFGL+ A G L P + A
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTA 354
Query: 184 PEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPP 241
PE + K + K D+WS G++L+ + G +P+ L ++ ++ K P+ PP
Sbjct: 355 PEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 413
Query: 242 EVRKLLCKILDPNPSTRISMAKIRES 267
V ++ + +TR + ++RE
Sbjct: 414 AVYDVMKNCWHLDAATRPTFLQLREQ 439
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 68/267 (25%), Positives = 109/267 (40%), Gaps = 31/267 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK--REISVMRIV 71
+ + LG G F V Y + R VA+K+I + G + + E VM +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI------KEGSMSEDEFIEEAKVMMNL 76
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLIN-AVDFCH 130
H +VQLY V + IF + EY G L N L+E R QQL+ D C
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLN-----YLREMRHRFQTQQLLEMCKDVCE 131
Query: 131 ------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT--PA-Y 181
S+ HRD+ N L+++ +K+SDFGLS D ++ G+ P +
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 187
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWF 239
PEV+ + K DIW+ GV+++ + G +P+ E I + P+
Sbjct: 188 SPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 246
Query: 240 PPEVRKLLCKILDPNPSTRISMAKIRE 266
+V ++ R + +
Sbjct: 247 SEKVYTIMYSCWHEKADERPTFKILLS 273
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 61/309 (19%), Positives = 118/309 (38%), Gaps = 30/309 (9%)
Query: 19 GRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
++LG G F V+ V +KVI +DK R + + + + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQA-VTDHMLAIGSLDHA 75
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLIN-AVDFCH--- 130
+IV+L + S + V +Y G L + +++ Q L+N V
Sbjct: 76 HIVRLLGL-CPGSSLQLVTQYLPLGSLLDH-----VRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 131 ---SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT--P-AYVAP 184
G+ HR++ N+LL ++++DFG++ L D P ++A
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL---PPDDKQLLYSEAKTPIKWMAL 186
Query: 185 EVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPE 242
E I+ Y + D+WS GV ++ ++ G P+ L E+ + K E P +
Sbjct: 187 ESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245
Query: 243 VRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQGSS 302
V ++ K + + R + ++ F + + V + + G ++
Sbjct: 246 VYMVMVKCWMIDENIRPTFKELANE--FTRMARDPPRYLVIKRESGPGIAPGPEPHGLTN 303
Query: 303 SIAAEIKQE 311
E++ E
Sbjct: 304 KKLEEVELE 312
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 69/351 (19%), Positives = 123/351 (35%), Gaps = 90/351 (25%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYAR-SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
L E+YE+ LG+G F KV R VA+K+I R + + EI+V++
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR----EAARLEINVLK 71
Query: 70 IVRHP------NIVQLYEVMATKSKIFFVME------YAKGGELFNKVAKGKLKEDAARR 117
++ V + + + E + E + R
Sbjct: 72 KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF----EFLKENNFQPYPLPHVRH 127
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN-------------------LKISDFG 158
QL +A+ F H + H D+KPEN+L +E ++++DFG
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF-- 216
SA T T Y PEVI G+ + D+WS G +LF G+ F
Sbjct: 188 -SA---T-FDHEHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQT 241
Query: 217 HDSN----LIE---------MYRKIGKAEF---KCPNWFPPEVRK--------------- 245
H++ ++E M + K ++ W
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 246 -----------LLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTES 285
L+ ++L+ +P+ RI++A+ +F +++ + +
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 58/282 (20%), Positives = 109/282 (38%), Gaps = 44/282 (15%)
Query: 19 GRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIK---REISVMRIV 71
+ LG+G F V R T + VAVK ++ + ++ REI +++ +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK------LQHSTEEHLRDFEREIEILKSL 68
Query: 72 RHPNIVQLYEV--MATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVD 127
+H NIV+ V A + + +MEY G L + + K ++ +Y Q+ ++
Sbjct: 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV----- 182
+ ++ HRD+ N+L++ +KI DFGL+ + P
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEFFKVKEPGESPIFWY 184
Query: 183 APEVINRKGYDGEKVDIWSCGVVL----------------FVLLAGYLPFHDSNLIEMYR 226
APE + + D+WS GVVL F+ + G + +
Sbjct: 185 APESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 227 KIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
+ P+ P E+ ++ + + N + R S +
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 76/338 (22%), Positives = 127/338 (37%), Gaps = 90/338 (26%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTN-QSVAVKVIDKDKIMRVGLADQIKREISVMR 69
VL+ +YE+ LG+GAF KV + + VAVK++ + + EI V+
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC----EAARSEIQVLE 66
Query: 70 IVRHP------NIVQLYEVMATKSKIFFVME------YAKGGELFNKVAKGKLKEDAARR 117
+ VQ+ E I V E Y + + + D R+
Sbjct: 67 HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY----DFIKENGFLPFRLDHIRK 122
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN-------------------LKISDFG 158
Q+ +V+F HS + H D+KPEN+L +++ +K+ DFG
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF-- 216
SA + D T T Y APEVI G+ + D+WS G +L G+ F
Sbjct: 183 -SA---T-YDDEHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPT 236
Query: 217 HDSN----LIE---------MYRKIGKAEF-----------------------------K 234
HDS ++E M +K K ++
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
+ + L+ K+L+ +P+ RI++ + + +F
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 66/286 (23%), Positives = 118/286 (41%), Gaps = 39/286 (13%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E ++ LG G F +V+ + VAVK + + + D E ++M+ ++H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQH 67
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH--- 130
+V+LY V T+ I+ + EY + G L + LK + +D
Sbjct: 68 QRLVRLYAV-VTQEPIYIITEYMENGSLVDF-----LKTP--SGIKLTINKLLDMAAQIA 119
Query: 131 -------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQ----CKHQDGLLHTTCGTP 179
R HRD++ N+L+ + + KI+DFGL+ L + + P
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF------P 173
Query: 180 A-YVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCP 236
+ APE IN + K D+WS G++L ++ G +P+ E+ + + + P
Sbjct: 174 IKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRES--SWFRKGMNQKQKQ 280
+ P E+ +L+ P R + +R +F Q Q Q
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQ 278
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 77/270 (28%), Positives = 125/270 (46%), Gaps = 30/270 (11%)
Query: 14 EKYEVGRLLGQGAFAKVY---YARSIRTNQSVAVKVIDKDKIMRVGLADQIK----REIS 66
E+ E+GR +G+G F V+ Y +VA+K + +D ++ +E
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT------CKNCTSDSVREKFLQEAL 68
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLIN 124
MR HP+IV+L V T++ ++ +ME GEL F +V K L + Y QL
Sbjct: 69 TMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ----CKHQDGLLHTTCGTPA 180
A+ + S+ HRDI N+L+ N+ +K+ DFGLS + K G L P
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL------PI 181
Query: 181 -YVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPN 237
++APE IN + + D+W GV ++ +L+ G PF ++ +I E P
Sbjct: 182 KWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 240
Query: 238 WFPPEVRKLLCKILDPNPSTRISMAKIRES 267
PP + L+ K +PS R +++
Sbjct: 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 66/280 (23%), Positives = 115/280 (41%), Gaps = 36/280 (12%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQS---VAVKVIDKDKIMRVGLADQIKREISVMRI 70
+++ +GR+LG+G F V A+ + + S VAVK++ K I+ ++ RE + M+
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKE 81
Query: 71 VRHPNIVQLYEV------MATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLIN 124
HP++ +L V ++ + K G+L + ++ E+ Q L+
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 125 -AVDFCH------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQ-----CKHQDGLL 172
VD SR HRD+ N +L E+ + ++DFGLS + L
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 173 HTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKI 228
P V A E + Y D+W+ GV ++ ++ G P+ E+Y +
Sbjct: 202 ------P--VKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
Query: 229 GKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
K P EV L+ + +P R S +R
Sbjct: 253 IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 58/281 (20%), Positives = 110/281 (39%), Gaps = 44/281 (15%)
Query: 19 GRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIK---REISVMRIV 71
+ LG+G F V R T + VAVK ++ + ++ REI +++ +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK------LQHSTEEHLRDFEREIEILKSL 99
Query: 72 RHPNIVQLYEV--MATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVD 127
+H NIV+ V A + + +MEY G L + + K ++ +Y Q+ ++
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV----- 182
+ ++ HRD+ N+L++ +KI DFGL+ + + P
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEYYKVKEPGESPIFWY 215
Query: 183 APEVINRKGYDGEKVDIWSCGVVL----------------FVLLAGYLPFHDSNLIEMYR 226
APE + + D+WS GVVL F+ + G + +
Sbjct: 216 APESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 227 KIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ P+ P E+ ++ + + N + R S +
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 66/274 (24%), Positives = 105/274 (38%), Gaps = 25/274 (9%)
Query: 22 LGQGAFAKVYYA--RSIRTNQSVAVKVIDKDKIMRVGLADQIK----REISVMRIVRHPN 75
LG G F V R + VA+KV ++ G RE +M + +P
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV------LKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 76 IVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHSRG 133
IV+L V + VME A GG L F + ++ Q+ + + +
Sbjct: 72 IVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT--P-AYVAPEVINRK 190
HRD+ N+LL KISDFGLS D P + APE IN +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 191 GYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLC 248
+ + D+WS GV ++ L G P+ E+ I + + +CP PPE+ L+
Sbjct: 189 KFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS 247
Query: 249 KILDPNPSTRISMAKIRE--SSWFRKGMNQKQKQ 280
R + + + + ++ +
Sbjct: 248 DCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 16/264 (6%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
+++G G F +VY S + VA+K + K D E +M
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVD-FLGEAGIMG 101
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVD 127
H NI++L V++ + + EY + G L F + G+ + + +
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV---AP 184
+ + HRD+ N+L++ N K+SDFGLS + + +TT G + AP
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWTAP 219
Query: 185 EVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPE 242
E I+ + + D+WS G+V++ V+ G P+ + + E+ + I P P
Sbjct: 220 EAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 278
Query: 243 VRKLLCKILDPNPSTRISMAKIRE 266
+ +L+ + + R A I
Sbjct: 279 IYQLMMQCWQQERARRPKFADIVS 302
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 65/270 (24%), Positives = 114/270 (42%), Gaps = 37/270 (13%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E ++ + LG G F +V+ A + VAVK + + + E +VM+ ++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSV----EAFLAEANVMKTLQH 242
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH--- 130
+V+L+ V TK I+ + E+ G L LK D Q L +DF
Sbjct: 243 DKLVKLHAV-VTKEPIYIITEFMAKGSL-----LDFLKSD--EGSKQPLPKLIDFSAQIA 294
Query: 131 -------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQ----CKHQDGLLHTTCGTP 179
R HRD++ N+L+ + KI+DFGL+ + + + P
Sbjct: 295 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF------P 348
Query: 180 A-YVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCP 236
+ APE IN + K D+WS G++L ++ G +P+ + E+ R + + P
Sbjct: 349 IKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 407
Query: 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
P E+ ++ + P R + I+
Sbjct: 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQS 437
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 15/260 (5%)
Query: 17 EVGRLLGQGAFAKVYYAR---SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ +++G G +V Y R + + VA+K + K D + E S+M H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFL-SEASIMGQFDH 109
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHS 131
PNI++L V+ V EY + G L + G+ + + + +
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV---APEVIN 188
G HRD+ N+L+D N K+SDFGLS + + +TT G + APE I
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 189 RKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKL 246
+ + D+WS GVV++ VL G P+ + ++ + + P P + +L
Sbjct: 228 FRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQL 286
Query: 247 LCKILDPNPSTRISMAKIRE 266
+ + + R ++I
Sbjct: 287 MLDCWHKDRAQRPRFSQIVS 306
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 62/276 (22%), Positives = 104/276 (37%), Gaps = 21/276 (7%)
Query: 22 LGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK----REISVMRIVRHPNIV 77
LG G F V + + V + K+++ G RE +M + +P IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAI----KVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 78 QLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHSRGVY 135
+L V + VME A GG L + ++ Q+ + + +
Sbjct: 400 RLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT--P-AYVAPEVINRKGY 192
HR++ N+LL KISDFGLS D P + APE IN + +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALG--ADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 193 DGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCKI 250
+ D+WS GV ++ L G P+ E+ I + + +CP PPE+ L+
Sbjct: 517 S-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 575
Query: 251 LDPNPSTRISMAKIRE--SSWFRKGMNQKQKQKVTE 284
R + + + + ++ + E
Sbjct: 576 WIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALE 611
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 29/277 (10%)
Query: 10 SVLTEKYEV-------GRLLGQGAFAKVY---YARSIRTNQSVAVKVIDKDKIMRVGLAD 59
S+ +Y + R+LG+G F +VY Y +VAVK KD + +
Sbjct: 1 SMGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN--KE 58
Query: 60 QIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARR 117
+ E +M+ + HP+IV+L ++ + + +ME GEL + + K LK
Sbjct: 59 KFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL 117
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ----CKHQDGLLH 173
Y Q+ A+ + S HRDI N+L+ E +K+ DFGLS + K L
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL- 176
Query: 174 TTCGTP-AYVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA 231
P +++PE IN + + D+W V ++ +L G PF ++ + K
Sbjct: 177 -----PIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
Query: 232 E-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
+ P+ PP + L+ + D +PS R ++ S
Sbjct: 231 DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 19 GRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
R LG+G F KV R T + VAVK + K + +AD +K+EI ++R + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIAD-LKKEIEILRNLYHE 83
Query: 75 NIVQLYEV--MATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCH 130
NIV+ + + I +ME+ G L + K K+ +Y Q+ +D+
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQ------CKHQDGLLHTTCGTP-AYVA 183
SR HRD+ N+L++ +KI DFGL+ + D P + A
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------PVFWYA 197
Query: 184 PEVINRKGYDGEKVDIWSCGVVL 206
PE + + + D+WS GV L
Sbjct: 198 PECLMQSKFY-IASDVWSFGVTL 219
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 57/277 (20%), Positives = 109/277 (39%), Gaps = 45/277 (16%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQS---VAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++G+G F VY+ + + AVK + ++ E +M+ H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQ-FLTEGIIMKDFSH 85
Query: 74 PNIVQLYEVMA-TKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH-- 130
PN++ L + ++ V+ Y K G+L + ++ + + LI F
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLI---GFGLQV 137
Query: 131 --------SRGVYHRDIKPENLLLDENENLKISDFGLSAL-------AQCKHQDGLLHTT 175
S+ HRD+ N +LDE +K++DFGL+ + L
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--- 194
Query: 176 CGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA 231
P V A E + + + K D+WS GV+L+ ++ G P+ D N ++ + +
Sbjct: 195 ---P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
Query: 232 E-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
P + P + +++ K P R S +++
Sbjct: 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 60/267 (22%), Positives = 115/267 (43%), Gaps = 23/267 (8%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR---SIRTNQSVAVKVIDKDKIMRVGLADQIKR----EIS 66
+ +++G G F +V R + SVA+K ++VG ++ +R E S
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT------LKVGYTEKQRRDFLGEAS 98
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLIN 124
+M HPNI++L V+ + V EY + G L F + + + + +
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYV-- 182
+ + G HRD+ N+L++ N K+SDFGL + + +TT G +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRW 216
Query: 183 -APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWF 239
+PE I + + D+WS G+VL+ V+ G P+ + + ++ + + + P
Sbjct: 217 TSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275
Query: 240 PPEVRKLLCKILDPNPSTRISMAKIRE 266
P + +L+ + + R +I
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVS 302
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 35/208 (16%)
Query: 19 GRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
LG+G F V R T VAVK + + +REI +++ +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSD 84
Query: 75 NIVQLYEV-MATKSK-IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLIN-AVDFC-- 129
IV+ V + + VMEY G L + L+ AR +L+ + C
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCL-----RDFLQRHRARLDASRLLLYSSQICKG 139
Query: 130 ----HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC------KHQDGLLHTTCGTP 179
SR HRD+ N+L++ ++KI+DFGL+ L + G P
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------P 193
Query: 180 -AYVAPEVINRKGYDGEKVDIWSCGVVL 206
+ APE ++ + + D+WS GVVL
Sbjct: 194 IFWYAPESLSDNIFS-RQSDVWSFGVVL 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 77/261 (29%), Positives = 122/261 (46%), Gaps = 30/261 (11%)
Query: 14 EKYEVGRLLGQGAFAKVY---YARSIRTNQSVAVKVIDKDKIMRVGLADQIK----REIS 66
E+ E+GR +G+G F V+ Y +VA+K + +D ++ +E
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT------CKNCTSDSVREKFLQEAL 443
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLIN 124
MR HP+IV+L V T++ ++ +ME GEL F +V K L + Y QL
Sbjct: 444 TMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ----CKHQDGLLHTTCGTPA 180
A+ + S+ HRDI N+L+ N+ +K+ DFGLS + K G L P
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL------PI 556
Query: 181 -YVAPEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPN 237
++APE IN + + D+W GV ++ +L+ G PF ++ +I E P
Sbjct: 557 KWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 615
Query: 238 WFPPEVRKLLCKILDPNPSTR 258
PP + L+ K +PS R
Sbjct: 616 NCPPTLYSLMTKCWAYDPSRR 636
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 73/265 (27%), Positives = 112/265 (42%), Gaps = 53/265 (20%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
T ++ L+G G F KVY +R VA+K + G+ ++ + EI + R
Sbjct: 38 TNNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPES--SQGI-EEFETEIETLSFCR 93
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGE----LFNKVAKGK-------LK--EDAARRYF 119
HP++V L ++++ + +Y + G L+ L+ AAR
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR--- 150
Query: 120 QQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT---C 176
+ + H+R + HRD+K N+LLDEN KI+DFG+S + H +
Sbjct: 151 -----GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG---TELDQTHLSTVVK 202
Query: 177 GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG------YLPFHDSNLIEMYRKIGK 230
GT Y+ PE + G EK D++S GVVLF +L LP NL E
Sbjct: 203 GTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE------- 254
Query: 231 AEFKCPNWFPPEVRK-LLCKILDPN 254
W L +I+DPN
Sbjct: 255 -------WAVESHNNGQLEQIVDPN 272
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 56/277 (20%), Positives = 112/277 (40%), Gaps = 45/277 (16%)
Query: 17 EVGRLLGQGAFAKVYYAR---SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
R++G+G F VY+ + A+K + + M+ + RE +MR + H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ--VEAFLREGLLMRGLNH 81
Query: 74 PNIVQLYEVMATKSKIFF-VMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH-- 130
PN++ L +M + ++ Y G+L ++ + LI F
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDL-----LQFIRSPQRNPTVKDLI---SFGLQV 133
Query: 131 --------SRGVYHRDIKPENLLLDENENLKISDFGLSAL-------AQCKHQDGLLHTT 175
+ HRD+ N +LDE+ +K++DFGL+ + +H+ L
Sbjct: 134 ARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--- 190
Query: 176 CGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA 231
P V A E + + K D+WS GV+L+ +L G P+ + ++ + +
Sbjct: 191 ---P--VKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
Query: 232 E-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
P + P + +++ + + +P+ R + +
Sbjct: 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 67/295 (22%), Positives = 108/295 (36%), Gaps = 57/295 (19%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
+ G+ LG GAF KV A +VAVK++ K + E+ V+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREA-LMSELKVL 80
Query: 69 -RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL------------FNKVAKGKLKEDAA 115
+ H NIV L + EY G+L +K + +++D
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 116 RRYFQQLINAVDFCH----------SRGVYHRDIKPENLLLDENENLKISDFGLS----- 160
+ L+ F + S+ HRD+ N+LL KI DFGL+
Sbjct: 141 ALDLEDLL---SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 161 ALAQCKHQDGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPF 216
+ L P V APE I Y + D+WS G+ L+ + G P+
Sbjct: 198 DSNYVVKGNARL------P--VKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPY 248
Query: 217 ----HDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
DS +M ++ + P P E+ ++ D +P R + +I +
Sbjct: 249 PGMPVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 59/279 (21%), Positives = 110/279 (39%), Gaps = 35/279 (12%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQS---VAVKVIDKDKIMRVGLADQIKREISVMRI 70
+G++LG+G F V + + + VAVK + K ++ E + M+
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKD 92
Query: 71 VRHPNIVQLYEV-----MATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLIN- 124
HPN+++L V K ++ + K G+L + +L+ Q L+
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 125 AVDFCH------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQ-----CKHQDGLLH 173
VD +R HRD+ N +L ++ + ++DFGLS + + +
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM- 211
Query: 174 TTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIG 229
P V A E + + Y K D+W+ GV ++ + G P+ EMY +
Sbjct: 212 -----P--VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 230 KAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
K P E+ +++ +P R + + +R
Sbjct: 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 62/280 (22%), Positives = 111/280 (39%), Gaps = 37/280 (13%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
EK + R LGQG+F VY VA+K + + + E SVM
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIE-FLNEASVM 82
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRY--FQQLIN 124
+ ++V+L V++ +ME G+L + + + + + ++I
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 125 -AVD------FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC-----KHQDGLL 172
A + + ++ HRD+ N ++ E+ +KI DFG++ K GLL
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 173 HTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKI 228
P V +PE + + D+WS GVVL+ + P+ + ++ R +
Sbjct: 203 ------P--VRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
Query: 229 GKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
+ P+ P + +L+ NP R S +I S
Sbjct: 254 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 67/291 (23%), Positives = 122/291 (41%), Gaps = 52/291 (17%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-------SIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
+K +G+ LG+G F +V A + +VAVK++ KD L+D + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEME 138
Query: 67 VM-RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL----------FNKVAKGKLKEDAA 115
+M I +H NI+ L ++ ++EYA G L + + +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 116 RRYFQQLINAVDFCH----------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165
+ F+ L+ + S+ HRD+ N+L+ EN +KI+DFGL+
Sbjct: 199 QMTFKDLV---SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255
Query: 166 -----KHQDGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPF 216
K +G L P V APE + + Y + D+WS GV+++ + G P+
Sbjct: 256 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPY 306
Query: 217 HDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ E+++ + + P E+ ++ PS R + ++ E
Sbjct: 307 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 64/277 (23%), Positives = 111/277 (40%), Gaps = 38/277 (13%)
Query: 19 GRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
R LG+G F KV + T + VAVK + K + K+EI ++R + H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSG-WKQEIDILRTLYHE 93
Query: 75 NIVQLYEV--MATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
+I++ A + + VMEY G L + + + + + QQ+ + + H++
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLS-ALAQ-----CKHQDGLLHTTCGTP-AYVAPE 185
HRD+ N+LLD + +KI DFGL+ A+ + +DG P + APE
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------PVFWYAPE 207
Query: 186 VINRKGYDGEKVDIWSCGVVL---------------FVLLAGYLPFHDSNLIEMYRKIGK 230
+ + D+WS GV L L + ++ + + +
Sbjct: 208 CLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266
Query: 231 AE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
E P+ P EV L+ + S R + +
Sbjct: 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/277 (20%), Positives = 109/277 (39%), Gaps = 45/277 (16%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQS---VAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++G+G F VY+ + + AVK + ++ E +M+ H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQ-FLTEGIIMKDFSH 149
Query: 74 PNIVQLYEVMA-TKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH-- 130
PN++ L + ++ V+ Y K G+L + ++ + + LI F
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLI---GFGLQV 201
Query: 131 --------SRGVYHRDIKPENLLLDENENLKISDFGLS-------ALAQCKHQDGLLHTT 175
S+ HRD+ N +LDE +K++DFGL+ + L
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL--- 258
Query: 176 CGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA 231
P V A E + + + K D+WS GV+L+ ++ G P+ D N ++ + +
Sbjct: 259 ---P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
Query: 232 E-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
P + P + +++ K P R S +++
Sbjct: 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 72/291 (24%), Positives = 107/291 (36%), Gaps = 74/291 (25%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKR----EISVMRIVRHP 74
G +G+G F VY + N +VAVK + + ++K+ EI VM +H
Sbjct: 36 GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHE 90
Query: 75 NIVQL-------------YEVMATKSKIFFVMEYAKGGELFNKVAKGKLK--------ED 113
N+V+L Y M S + L L +
Sbjct: 91 NLVELLGFSSDGDDLCLVYVYMPNGS-----LLDR----LSCLDGTPPLSWHMRCKIAQG 141
Query: 114 AARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLH 173
AA ++F H HRDIK N+LLDE KISDFGL+ ++ +
Sbjct: 142 AAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE---KFAQTV 190
Query: 174 TT---CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF----HDSNLIEMYR 226
T GT AY+APE + +G K DI+S GVVL ++ G L+++
Sbjct: 191 MTSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248
Query: 227 KIGKAEFKCP--------NWFPPEVRK-----LLCKILDPNPSTRISMAKI 264
+I E + V C L + R + K+
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQC--LHEKKNKRPDIKKV 297
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 44/284 (15%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR--SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RI 70
+ ++G+G F +V AR A+K + K+ + D E+ V+ ++
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRD-FAGELEVLCKL 82
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGEL----------FNKVAKGKLKEDAARRYFQ 120
HPNI+ L + ++ +EYA G L A A+ Q
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 121 QLINAVDFCH----------SRGVYHRDIKPENLLLDENENLKISDFGLS--ALAQCKHQ 168
QL + F + HRD+ N+L+ EN KI+DFGLS K
Sbjct: 143 QL---LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 199
Query: 169 DGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEM 224
G L P V A E +N Y D+WS GV+L+ ++ G P+ E+
Sbjct: 200 MGRL------P--VRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250
Query: 225 YRKIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
Y K+ + + P EV L+ + P R S A+I S
Sbjct: 251 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 58/270 (21%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
++ + +LG+G F KVY R + VAVK + +++ G Q + E+ ++ +
Sbjct: 29 SDNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAV 85
Query: 73 HPNIVQL-------------YEVMATKSKIFFVMEYAKGGELFN-----KVAKGKLKEDA 114
H N+++L Y MA S + E + + ++A G +
Sbjct: 86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG-----S 140
Query: 115 AR--RYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172
AR Y D C + + HRD+K N+LLDE + DFGL+ L
Sbjct: 141 ARGLAYLH------DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDT 189
Query: 173 HTT---CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG 229
H T GT ++APE ++ G EK D++ GV+L L+ G ++ R
Sbjct: 190 HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRA------FDLARLAN 242
Query: 230 KAEFKCPNWFPPEVRKLLCK-----ILDPN 254
+ +W V+ LL + ++D +
Sbjct: 243 DDDVMLLDW----VKGLLKEKKLEALVDVD 268
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 68/292 (23%), Positives = 123/292 (42%), Gaps = 52/292 (17%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-------SIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
+K +G+ LG+GAF +V A + +VAVK++ KD L+D + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEME 92
Query: 67 VM-RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL----------FNKVAKGKLKEDAA 115
+M I +H NI+ L ++ ++EYA G L + + +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 116 RRYFQQLINAVDFCH----------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165
+ F+ L+ + S+ HRD+ N+L+ EN +KI+DFGL+
Sbjct: 153 QMTFKDLV---SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 166 -----KHQDGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPF 216
K +G L P V APE + + Y + D+WS GV+++ + G P+
Sbjct: 210 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPY 260
Query: 217 HDSNLIEMYRKIGK-AEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
+ E+++ + + P E+ ++ PS R + ++ E
Sbjct: 261 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 71/288 (24%), Positives = 106/288 (36%), Gaps = 47/288 (16%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
LG+ F KVY Q+VA+K + KDK + + E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREE-FRHEAMLR 66
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN-------KVAKGKLKEDAARRYFQQ 121
++HPN+V L V+ + + Y G+L G +D + +
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 122 LINAVDFCH----------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQC-----K 166
+ V S V H+D+ N+L+ + N+KISD GL
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 167 HQDGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHD-SN- 220
+ LL P + APE I + DIWS GVVL+ V G P+ SN
Sbjct: 187 LGNSLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237
Query: 221 -LIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
++EM R CP+ P V L+ + + PS R I
Sbjct: 238 DVVEMIRNRQVLP--CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 66/292 (22%), Positives = 122/292 (41%), Gaps = 52/292 (17%)
Query: 14 EKYEVGRLLGQGAFAKVY--YARSIRTNQS-----VAVKVIDKDKIMRVGLADQIKREIS 66
++ +G+ LG+GAF +V A + ++ VAVK++ K L+D I E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEME 126
Query: 67 VM-RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL----------FNKVAKGKLKEDAA 115
+M I +H NI+ L ++ ++EYA G L + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 116 RRYFQQLINAVDFCH----------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165
+ + L+ + S+ HRD+ N+L+ E+ +KI+DFGL+
Sbjct: 187 QLSSKDLV---SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243
Query: 166 -----KHQDGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPF 216
K +G L P V APE + + Y + D+WS GV+L+ + G P+
Sbjct: 244 IDYYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPY 294
Query: 217 HDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
+ E+++ + + P+ E+ ++ PS R + ++ E
Sbjct: 295 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 65/296 (21%), Positives = 110/296 (37%), Gaps = 56/296 (18%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
E E G++LG GAF KV A + VAVK++ K+K + E+ +M
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREA-LMSELKMM 102
Query: 69 -RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL------------FNKVAKGKLKEDAA 115
++ H NIV L I+ + EY G+L +++ K
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 116 RRYFQQLINA--VDFCH----------SRGVYHRDIKPENLLLDENENLKISDFGLS--- 160
L + F + + HRD+ N+L+ + +KI DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 161 --ALAQCKHQDGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYL 214
+ L P V APE + Y K D+WS G++L+ + G
Sbjct: 223 MSDSNYVVRGNARL------P--VKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVN 273
Query: 215 PF----HDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
P+ D+N ++ + K + P + E+ ++ + R S +
Sbjct: 274 PYPGIPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 63/291 (21%), Positives = 100/291 (34%), Gaps = 55/291 (18%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
+ G+ LG GAF KV A + VAVK++ K + E+ +M
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIM 103
Query: 69 -RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN--------KVAKGKLKEDAARRYF 119
+ +H NIV L + + EY G+L N +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 120 QQLINAVDFCH----------SRGVYHRDIKPENLLLDENENLKISDFGLS-----ALAQ 164
+ L+ F S+ HRD+ N+LL KI DFGL+
Sbjct: 164 RDLL---HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 165 CKHQDGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF--VLLAG--YLPFH 217
+ L P V APE I Y + D+WS G++L+ L Y P
Sbjct: 221 IVKGNARL------P--VKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY-PGI 270
Query: 218 DSN--LIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
N ++ + + P + P + ++ P+ R + +I
Sbjct: 271 LVNSKFYKLVKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 68/296 (22%), Positives = 116/296 (39%), Gaps = 57/296 (19%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
+ +G+ LG+G F KV A +VAVK++ K+ L D + E +V+
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRD-LLSEFNVL 80
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL------------------FNKVAKGKL 110
+ V HP++++LY + + ++EYAK G L ++ +
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 111 KEDAARRYFQQLINAVDFCH----------SRGVYHRDIKPENLLLDENENLKISDFGLS 160
D LI F + HRD+ N+L+ E +KISDFGLS
Sbjct: 141 HPDERALTMGDLI---SFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 161 -----ALAQCKHQDGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLA 211
+ K G + P V A E + Y + D+WS GV+L+ ++
Sbjct: 198 RDVYEEDSYVKRSQGRI------P--VKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTL 248
Query: 212 GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
G P+ ++ + + P+ E+ +L+ + P R A I +
Sbjct: 249 GGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 50/290 (17%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
++ ++G+ LG+GAF +V A T ++VAVK++ K+ + E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA-LMSELKIL 84
Query: 69 -RIVRHPNIVQLYEV-MATKSKIFFVMEYAKGGELFN-------KVAKGKLKEDAARRYF 119
I H N+V L + ++E+ K G L + K+ + + F
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 120 QQLINAVDFCH----------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQC---- 165
L + + + SR HRD+ N+LL E +KI DFGL+
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 166 -KHQDGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPF---- 216
+ D L P + APE I + Y + D+WS GV+L+ + G P+
Sbjct: 205 VRKGDARL------P--LKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 217 HDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
D ++ + P++ PE+ + + PS R + +++ E
Sbjct: 256 IDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 59/277 (21%), Positives = 93/277 (33%), Gaps = 38/277 (13%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-------SIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
E LGQG F K++ V +KV+DK ++ S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY---SESFFEAAS 64
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLIN 124
+M + H ++V Y V + V E+ K G L + K K + +QL
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENL--------KISDFGLSALAQCKHQDGLLHTTC 176
A+ F + H ++ +N+LL E+ K+SD G+S +
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI---------TVLPKD 175
Query: 177 GTPAYV---APEVI-NRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKA 231
+ PE I N K + D WS G L+ + G P + +
Sbjct: 176 ILQERIPWVPPECIENPKNLN-LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
Query: 232 E-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
P E+ L+ +D P R S I
Sbjct: 235 HQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRD 269
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 6e-21
Identities = 75/382 (19%), Positives = 116/382 (30%), Gaps = 140/382 (36%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
+ +Y V R LG G F+ V+ + I+ + VA+KV+ + + EI +++
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT----ETALDEIRLLKS 89
Query: 71 VR-----HPN---IVQLYEVMATKSKIF-----------FVMEYAKGGE----LFNKVAK 107
VR PN +VQL + F V E G K
Sbjct: 90 VRNSDPNDPNREMVVQLLD-------DFKISGVNGTHICMVFEVL--GHHLLKWIIKSNY 140
Query: 108 GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLL-------------------- 146
L ++ QQ++ +D+ H++ + H DIKPEN+LL
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200
Query: 147 -----------------------------DENENLKISDFGLSALAQCKHQDGLLHTTCG 177
E +KI+D G + +
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQ 255
Query: 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF--HDSN--------LIEMYRK 227
T Y + EV+ GY+ DIWS + F L G F H + +
Sbjct: 256 TRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314
Query: 228 IGK------------AEF-----------KCPNWFPPEVR---------------KLLCK 249
+GK EF K W EV L
Sbjct: 315 LGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLP 374
Query: 250 ILDPNPSTRISMAKIRESSWFR 271
+L+ P R + A+ W
Sbjct: 375 MLELIPEKRATAAECLRHPWLN 396
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 67/289 (23%), Positives = 113/289 (39%), Gaps = 52/289 (17%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIK--REIS 66
+ R LG+GAF KV+ A + VAVK + KD + + RE
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLA----ARKDFQREAE 69
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL----------FNKVAKGKLKEDAAR 116
++ ++H +IV+ Y V + V EY K G+L + G+ ++
Sbjct: 70 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 117 RYFQQLIN-AVDFCH------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQC---- 165
Q+++ A S+ HRD+ N L+ N +KI DFG+S
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
Query: 166 -KHQDGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVL---FVLLAGYLPFHD 218
+L P + PE I + + + D+WS GV+L F G P+
Sbjct: 190 RVGGHTML------P--IRWMPPESIMYRKFT-TESDVWSFGVILWEIFTY--GKQPWFQ 238
Query: 219 SNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ E+ I + + P P EV ++ P R+++ +I +
Sbjct: 239 LSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 63/289 (21%), Positives = 111/289 (38%), Gaps = 38/289 (13%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+Y +GR +G G+F +Y I + VA+K+ Q+ E + ++++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQG 63
Query: 74 -PNIVQLYEVMATKSKIFFVMEYAKG---GELFNKVAKGKLKEDAARRYFQQLINAVDFC 129
I + A VME G +LFN ++ K Q+I+ +++
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYI 121
Query: 130 HSRGVYHRDIKPENLLLDENEN---LKISDFGLSALAQCKHQDGLLHTT-------CGTP 179
HS+ HRD+KP+N L+ + + I DFGL+ + + H GT
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA--KKYRDARTHQHIPYRENKNLTGTA 179
Query: 180 AYVAPEVINR-KGYD-GEKVDIWSCGVVLFVLLAGYLP---FHDSNLIEMYRKIGKAEFK 234
Y + IN G + + D+ S G VL G LP + + Y +I + +
Sbjct: 180 RYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236
Query: 235 CPNW-----FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQ 278
P +P E L + + +R FR +++
Sbjct: 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR--QLFRNLFHRQG 283
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 66/280 (23%), Positives = 103/280 (36%), Gaps = 37/280 (13%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
+ + R LG GAF +VY + + + VAVK + + D + E ++
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALII 87
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAV 126
H NIV+ V F +ME GG+L F + + + + ++ L A
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 127 DFCH------SRGVYHRDIKPENLLLD---ENENLKISDFGLSALAQC-----KHQDGLL 172
D HRDI N LL KI DFG++ K +L
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 173 HTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKI 228
P V PE + K D WS GV+L+ + GY+P+ + E+ +
Sbjct: 208 ------P--VKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258
Query: 229 GK-AEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
P P V +++ + P R + A I E
Sbjct: 259 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 70/297 (23%), Positives = 105/297 (35%), Gaps = 59/297 (19%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
E R +G+GAF +V+ AR VAVK++ K++ AD +RE ++M
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQAD-FQREAALM 104
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL------------FNKVAKGKLKEDAAR 116
+PNIV+L V A + + EY G+L +
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 117 RYFQQLINAVDFCH-------------SRGVYHRDIKPENLLLDENENLKISDFGLSALA 163
++ + R HRD+ N L+ EN +KI+DFGLS
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 164 QC-----KHQDGLLHTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVL---FVLLAG 212
+ + P + PE I Y + D+W+ GVVL F G
Sbjct: 225 YSADYYKADGNDAI------P--IRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSY--G 273
Query: 213 YLPF---HDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
P+ +I R CP P E+ L+ P+ R S I
Sbjct: 274 LQPYYGMAHEEVIYYVRDGNILA--CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 56/238 (23%), Positives = 96/238 (40%), Gaps = 35/238 (14%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH- 73
+ VG+ +G G F ++ +++ TN+ VA+K+ Q+ E + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-----QLHLEYRFYKQLGSG 64
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGG----ELFNKVAKGKLKEDAARRYFQQLINAVDFC 129
I Q+Y V+E G +LF+ + QLI+ +++
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDR-TFSLKTVLMIAIQLISRMEYV 121
Query: 130 HSRGVYHRDIKPENLLLDENENLK-----ISDFGLSALAQCKHQDGLLH-------TTCG 177
HS+ + +RD+KPEN L+ N I DF L+ + + H + G
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA--KEYIDPETKKHIPYREHKSLTG 179
Query: 178 TPAYVAPEVINR-KGYD-GEKVDIWSCGVVLFVLLAGYLP---FHDSNLIEMYRKIGK 230
T Y++ IN G + + D+ + G + L G LP L E Y+KIG
Sbjct: 180 TARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 53/245 (21%), Positives = 100/245 (40%), Gaps = 33/245 (13%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
+ +V+ Y+VGR +G+G+F ++ ++ NQ VA+K + Q++ E
Sbjct: 3 GQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYR 57
Query: 67 VMRIVRH-PNIVQLYEVMATKSKIFFVMEYAKG---GELFNKVAKGKLKEDAARRYFQQL 122
+++ I +Y V++ G +L + + K +Q+
Sbjct: 58 TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQM 115
Query: 123 INAVDFCHSRGVYHRDIKPENLLL----DENEN-LKISDFGLSALAQCKHQDGLLH---- 173
+ V H + + +RDIKP+N L+ +N N + + DFG+ + H
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV--KFYRDPVTKQHIPYR 173
Query: 174 ---TTCGTPAYVAPEVINR-KGYD-GEKVDIWSCGVVLFVLLAGYLP---FHDSNLIEMY 225
GT Y++ IN G + + D+ + G V L G LP + + Y
Sbjct: 174 EKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230
Query: 226 RKIGK 230
+IG+
Sbjct: 231 ERIGE 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 65/290 (22%), Positives = 106/290 (36%), Gaps = 53/290 (18%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
+ LG+GAF KV+ A + VAVK + K+ D +RE ++
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESA-RQD-FQREAELL 97
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL---------FNKVAKGKLKEDAARRYF 119
+++H +IV+ + V + V EY + G+L K+ G
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 120 QQLIN-AVDFCH------SRGVYHRDIKPENLLLDENENLKISDFGLSALAQC-----KH 167
QL+ A HRD+ N L+ + +KI DFG+S
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 168 QDGLLHTTCGTPAYV---APEVINRKGYDG---EKVDIWSCGVVLF-VLLAGYLPF---H 217
+L P + PE I + D+WS GVVL+ + G P+
Sbjct: 218 GRTML------P--IRWMPPESIL----YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
Query: 218 DSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
++ I+ + + E P PPEV ++ P R S+ +
Sbjct: 266 NTEAIDCITQGRELE--RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 65/280 (23%), Positives = 103/280 (36%), Gaps = 37/280 (13%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
+ + R LG GAF +VY + + + VAVK + + D + E ++
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALII 128
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAV 126
H NIV+ V F ++E GG+L F + + + + ++ L A
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 127 DFCH------SRGVYHRDIKPENLLLD---ENENLKISDFGLSALAQC-----KHQDGLL 172
D HRDI N LL KI DFG++ K +L
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 248
Query: 173 HTTCGTPAYV---APEVINRKGYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKI 228
P V PE + K D WS GV+L+ + GY+P+ + E+ +
Sbjct: 249 ------P--VKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299
Query: 229 GKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
P P V +++ + P R + A I E
Sbjct: 300 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 67/257 (26%), Positives = 107/257 (41%), Gaps = 38/257 (14%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR- 72
K+ +GR +G G+F ++Y +I+TN+ VA+K+ + Q+ E + RI++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIYRILQG 61
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKG---GELFNKVAKGKLKEDAARRYFQQLINAVDFC 129
I + VM+ G +LFN ++ KL Q+IN V+F
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFV 119
Query: 130 HSRGVYHRDIKPENLLLDENEN---LKISDFGLSALAQCKHQDGLLHTT-------CGTP 179
HS+ HRDIKP+N L+ + I DFGL+ + + H GT
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA--KKYRDTSTHQHIPYRENKNLTGTA 177
Query: 180 AYVAPEVINR-KGYD-GEKVDIWSCGVVLFVLLAGYLPFHD---SNLIEMYRKIGKAEFK 234
Y + +N G + + D+ S G VL L G LP+ + Y KI + +
Sbjct: 178 RYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234
Query: 235 CPNWFPPEVRKLLCKIL 251
E LC+
Sbjct: 235 T----SIEA---LCRGY 244
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 46/280 (16%), Positives = 96/280 (34%), Gaps = 62/280 (22%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
++ +G+ +G G F +Y A + A V+ K + G + E+ + V
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV-KVEYQENG---PLFSELKFYQRVAKK 93
Query: 75 NIVQLYEVMATKSKI-------------------FFVMEYAKG---GELFNKVAKGKLKE 112
+ ++ + + F VME G ++ + G K+
Sbjct: 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKK 150
Query: 113 DAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD-ENEN-LKISDFGLSALAQCKHQDG 170
+ ++++ +++ H H DIK NLLL +N + + ++D+GLS ++
Sbjct: 151 STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS----YRYCPN 206
Query: 171 LLHTT---------CGTPAYVAPEVINR-KGYD-GEKVDIWSCGVVLFVLLAGYLPFHD- 218
H GT + + ++ KG + D+ G + L G LP+
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263
Query: 219 -----SNLIEMYRKIG------KAEFKCPNWFPPEVRKLL 247
+ + + E+ + L
Sbjct: 264 LKDPVAVQTAKTNLLDELPQSVLKWAPSGS-SCCEIAQFL 302
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 40/283 (14%), Positives = 84/283 (29%), Gaps = 60/283 (21%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRT--------NQSVAVKVIDKDK--------IMRVGL 57
++++ + +Y A T Q ++K+ KD R
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 58 ADQIKREISVMRIVRHPNIVQLYEVMATKSKI-FFVMEYAKG---GELFNKVAKGKLKED 113
Q+ + + I + K F V+ G + K L E
Sbjct: 102 PLQVNKWKKLYST-PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159
Query: 114 AARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKI--SDFGLSAL-------AQ 164
+ + +L++A++F H H ++ EN+ +D + ++ + +G +
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219
Query: 165 CKHQDGLLHTTCGTPAYVAPEVIN--------RKGYDGEKVDIWSCGVVLFVLLAGYLP- 215
H G +++ ++ R+ D+ S G + L G+LP
Sbjct: 220 YVEGSRSPHE--GDLEFIS---MDLHKGCGPSRRS------DLQSLGYCMLKWLYGFLPW 268
Query: 216 --FHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPS 256
+ M +K + P C
Sbjct: 269 TNCLPNTEDIMKQKQKFVDKPGPF-------VGPCGHWIRPSE 304
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 54/284 (19%), Positives = 101/284 (35%), Gaps = 55/284 (19%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
++VG +GQG F +Y A + +++SV K+ + E+ + P
Sbjct: 36 AWKVGLPIGQGGFGCIYLAD-MNSSESVGSDAPCVVKVEPSD-NGPLFTELKFYQRAAKP 93
Query: 75 NIVQLYEVMATKSKI-------------------FFVMEYAKG---GELFNKVAKGKLKE 112
+Q + + F +M+ G +++ AK +
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK-RFSR 151
Query: 113 DAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD-ENEN-LKISDFGLS-------ALA 163
+ ++++ +++ H H DIK NLLL+ +N + + + D+GL+
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 164 QCKHQDGLLHTTCGTPAYVAPEVINR-KGYD-GEKVDIWSCGVVLFVLLAGYLPFHD--- 218
H GT + + I+ G + D+ G + L G+LP+ D
Sbjct: 212 AYAADPKRCHD--GTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266
Query: 219 SNLIEMYRKIGKA------EFKCPNW--FPPEVRKLL--CKILD 252
KI KC P E+ K + K+LD
Sbjct: 267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLD 310
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 77.6 bits (190), Expect = 9e-16
Identities = 35/193 (18%), Positives = 65/193 (33%), Gaps = 47/193 (24%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQ-----IKREISV 67
TEK + +G+G F +V+ ++I + VA+K+I + V + Q I EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVF--QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 68 MRIV---------RHPNIVQLYEV------------------------------MATKSK 88
+ + R + L V +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 89 IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLD 147
+F V+E+ GG ++ A+ QL ++ + HRD+ N+LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 148 ENENLKISDFGLS 160
+ K+
Sbjct: 197 KTSLKKLHYTLNG 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 121 QLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC-----KHQDGLLHTT 175
Q+ ++F SR HRD+ N+LL E +KI DFGL+ + D L
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--- 257
Query: 176 CGTPA-YVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPF----HDSNLIEMYRKIG 229
P ++APE I + Y + D+WS GV+L+ + + G P+ D ++
Sbjct: 258 ---PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 313
Query: 230 KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ P++ PE+ + + PS R + +++ E
Sbjct: 314 RMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 24/97 (24%), Positives = 45/97 (46%), Gaps = 9/97 (9%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
++ ++G+ LG+GAF +V A T ++VAVK++ K+ + E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA-LMSELKIL 79
Query: 69 -RIVRHPNIVQLYEVMATKSK-IFFVMEYAKGGELFN 103
I H N+V L + ++E+ K G L
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 7e-07
Identities = 64/494 (12%), Positives = 125/494 (25%), Gaps = 182/494 (36%)
Query: 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
+PS++T Y R R NQ V K + R+ ++++ +
Sbjct: 103 RQPSMMTRMYIEQR------------DRLYNDNQ-----VFAKYNVSRLQPYLKLRQALL 145
Query: 67 VMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK--LKEDAARRYFQQLIN 124
+R N++ + G GK + D Y
Sbjct: 146 ELR--PAKNVL--------------I--DGVLG-------SGKTWVALDVCLSY------ 174
Query: 125 AVDFCHSRGVY----HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPA 180
V ++ PE +L+ + L + + ++ H + A
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPE-TVLEMLQKL-LYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 181 YVAPEVINRKGY-------DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF 233
+ ++ K Y ++ ++
Sbjct: 233 ELR-RLLKSKPYENCLLVLL----NVQ-----------------NAKAWNA--------- 261
Query: 234 KCPNWFPPEVRKLLCKIL----DPNPSTRISMAKIRESSW--FRKGMNQKQKQKV----- 282
F L CKIL + +S A S + + + +
Sbjct: 262 -----F-----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 283 -TESKDAASQDAGASAPQGSSSIAAEIKQELGQLPN----------------LNAFDIIS 325
+D + + P+ S IA I+ L N LN +
Sbjct: 312 DCRPQDLPRE-VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE 370
Query: 326 LSAGFDLSGFFDENPLIREARFTSKRPASVIISKL---------EEIAKSLRLK-MMKKD 375
FD F + I P + +S + + L +++K
Sbjct: 371 YRKMFDRLSVFPPSAHI---------PTIL-LSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 376 GGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLL----------K 425
KE I P+ +L K + ++ ++
Sbjct: 421 P--------KESTISI-----------PSIYLELKVKLENEYALHRSIVDHYNIPKTFDS 461
Query: 426 DDIRPALQDIVWVW 439
DD+ P D +
Sbjct: 462 DDLIPPYLDQYFYS 475
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 32/168 (19%), Positives = 58/168 (34%), Gaps = 27/168 (16%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQ--SVAVKV-------IDKDKIMRVGLADQIKREIS 66
+G ++ G A V+YA + + ++AVK+ DK G R IS
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 67 VMRIVR------HPNIVQLYEVMATKSKIFF------VMEYAKGGELFN---KVAKGKLK 111
V N+ + E + + + +ME+ EL +LK
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 112 EDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFG 158
E F ++ V + + H D+ N++ + + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI--DKVYFIDMG 214
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 28/154 (18%), Positives = 53/154 (34%), Gaps = 19/154 (12%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKV-------IDKDKIMRVGLADQIKREISVM 68
+G+L+G+G + V+ S + + VK K K R
Sbjct: 92 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 69 RIVRHPNIVQLYEVMATKSKIFF----VMEYAKGGELFNKVAKGKLKEDAARRYFQQLIN 124
+ +L + K + +ME EL+ ++ + ++
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR------VRVENPDEVLDMILE 204
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFG 158
V + RG+ H D+ N+L+ E + I DF
Sbjct: 205 EVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 237
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 6e-05
Identities = 14/97 (14%), Positives = 40/97 (41%), Gaps = 7/97 (7%)
Query: 337 DENPLIREARF------TSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKG 390
++ R RF TS + ++ ++ ++ + +K+ LL +
Sbjct: 17 GKDSKPRSLRFTWSMKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDS 76
Query: 391 IVSMDAEIFQIT-PNFHLVEMKKSNGDTLEYKKLLKD 426
+V + E+ ++ + + V K+ +G ++ +K +
Sbjct: 77 LVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK 113
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 479 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.77 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.73 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.68 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.61 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.57 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.47 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.34 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.3 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.3 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.13 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 98.11 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.79 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.62 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.55 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.52 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.43 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.21 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.2 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.07 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.83 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.07 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.63 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.99 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.19 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.37 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.2 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-67 Score=520.21 Aligned_cols=260 Identities=32% Similarity=0.637 Sum_probs=242.0
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
.-++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|+.++|||||++++++.+++.+||
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34679999999999999999999999999999999988766555667889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||||+||+|++++.+ +.++|.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.........
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999976 789999999999999999999999999999999999999999999999999998765444445
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHh
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 250 (479)
...+.||||.|||||++.+.+|+ .++|||||||+||+|++|.+||.+.+..+++.++.+..+.+|..+|+++++||.+|
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l 268 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL 268 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH
Confidence 56788999999999999998886 89999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCChhh------hhcChhhhc
Q 011694 251 LDPNPSTRISMAK------IRESSWFRK 272 (479)
Q Consensus 251 L~~dP~~Rpt~~e------il~h~wf~~ 272 (479)
|.+||.+|||++| |++||||+.
T Consensus 269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 269 LVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999999999988 588999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-66 Score=506.55 Aligned_cols=257 Identities=44% Similarity=0.857 Sum_probs=222.7
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++++.||+|+||+||+|+++.+|+.||||++++....+......+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999999999999999999877666666788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||| +|+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~~ 168 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFL 168 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---CCcc
Confidence 999 6799999875 6899999999999999999999999999999999999999999999999999976432 2334
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
.+.+|||.|||||++.+.+|++.++|||||||+||+|++|+.||.+.+...++..+....+..|..+|+++.+||.+||+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLI 248 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSC
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 57899999999999999998888999999999999999999999999999999999988899999999999999999999
Q ss_pred CCccccCChhhhhcChhhhccc
Q 011694 253 PNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 253 ~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+||.+|||++|+++||||+...
T Consensus 249 ~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 249 VNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp SSGGGSCCHHHHHHCHHHHTTC
T ss_pred CChhHCcCHHHHHcCcccccCC
Confidence 9999999999999999997643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-64 Score=508.49 Aligned_cols=257 Identities=27% Similarity=0.469 Sum_probs=231.8
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.+.|++++.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999998654332 35678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||||+||+|++++..+++++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... .....
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCB
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999975432 22345
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc---CCCCCCCCHHHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~ 249 (479)
.+.||||.|||||++.+.+|+ .++|||||||+||+|++|.+||.+.+..+.+..+.... +..+..+|+++.+||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 678999999999999988885 89999999999999999999999988888887775542 33445589999999999
Q ss_pred hccCCccccCChhhhhcChhhhcccc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
||.+||.+|||++|+++||||++...
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99999999999999999999987643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-64 Score=508.65 Aligned_cols=258 Identities=29% Similarity=0.554 Sum_probs=227.6
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++++.||+|+||+||+|+++.+|+.||||++++..... ...+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 68999999999999999999999999999999998775543 44678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 94 EYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 94 E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+||+|++++.. ..++|..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...... .
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--E 180 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--H
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--c
Confidence 99999999999964 257999999999999999999999999999999999999999999999999997653221 1
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCCCCCHHHHHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFPPEVRKLLCK 249 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 249 (479)
...+.|||+.|||||++.+.+|+ .++|||||||+||+|++|+.||.+.+..+++.++..+.+ +.+..+|+++.+||.+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 23467899999999999998886 899999999999999999999999999888888877665 4566799999999999
Q ss_pred hccCCccccCChhhhhcChhhhcccc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
||++||.+|||++|+++||||++...
T Consensus 260 ~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HccCChhHCcCHHHHhcCHHhhcCCC
Confidence 99999999999999999999986543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-63 Score=510.02 Aligned_cols=257 Identities=27% Similarity=0.473 Sum_probs=232.6
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.+.|++++.||+|+||+||+|+++.+|+.||||+++...... .+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 467999999999999999999999999999999998764332 35678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||||+||+|++++..+++++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... .....
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 304 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCB
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999975432 22345
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cCCCCCCCCHHHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~~ 249 (479)
.+.|||+.|||||++.+.+|+ .++|||||||+||+|++|++||.+.+..+.+..+... .+..+..+|+++.+||.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 678999999999999988885 8999999999999999999999998888877777544 334556689999999999
Q ss_pred hccCCccccCChhhhhcChhhhcccc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
||..||.+|||++|+++||||++...
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 99999999999999999999987643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-64 Score=496.45 Aligned_cols=257 Identities=35% Similarity=0.638 Sum_probs=226.9
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
-++|++++.||+|+||+||+|++. .+++.||||++++....... ...+.+|+.+|+.++|||||++++++.+++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 368999999999999999999984 47889999999876543322 24678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|||||||+||+|++++.+ +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... .
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--H 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--C
Confidence 999999999999999986 6899999999999999999999999999999999999999999999999999975432 2
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 248 (479)
.....+.||||.|||||++.+.+|+ .++|||||||+||+|++|.+||.+.+..+.+..+.+..+.+|..+|+++.+||.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 2344678999999999999998886 899999999999999999999999999999999998889999999999999999
Q ss_pred HhccCCccccCCh-----hhhhcChhhhcc
Q 011694 249 KILDPNPSTRISM-----AKIRESSWFRKG 273 (479)
Q Consensus 249 ~~L~~dP~~Rpt~-----~eil~h~wf~~~ 273 (479)
+||++||.+|||+ +|+++||||+..
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 9999999999994 799999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-61 Score=506.57 Aligned_cols=413 Identities=31% Similarity=0.557 Sum_probs=315.9
Q ss_pred CCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 5 ~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
....+.+..++|.+++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp --CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34567788999999999999999999999999999999999998765444455678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
+.+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++...
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 99999999999999999999976 57999999999999999999999999999999999999999999999999998754
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHH
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV 243 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (479)
.. .....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+..+..+.+..|..+++++
T Consensus 167 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 243 (476)
T 2y94_A 167 SD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243 (476)
T ss_dssp CT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHH
T ss_pred cc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHH
Confidence 32 234567799999999999998888778999999999999999999999999888888898888888899999999
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhcccchhhhhhh-------------hccccc-cccccC--CC----CCCCC--
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKV-------------TESKDA-ASQDAG--AS----APQGS-- 301 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~~~~~~~-------------~~~~~~-~~~~~~--~~----~~~~~-- 301 (479)
.+||.+||..||.+|||+++|++||||+........... .+.... ...... .+ .....
T Consensus 244 ~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 323 (476)
T 2y94_A 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLA 323 (476)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC----------------------
T ss_pred HHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHH
Confidence 999999999999999999999999999865432111000 000000 000000 00 00000
Q ss_pred ----------------Cch-H-HHHHHhhCCC--CCCcccchhc--c--cc--ccCCCCCC-------CCCcccccceeE
Q 011694 302 ----------------SSI-A-AEIKQELGQL--PNLNAFDIIS--L--SA--GFDLSGFF-------DENPLIREARFT 348 (479)
Q Consensus 302 ----------------~~~-~-~~~~~~~~~~--~~~~~~~~is--~--s~--~~~ls~~~-------~~~~~~r~trf~ 348 (479)
... . .......... .......... . +. ...++.+. .....++++++.
T Consensus 324 ~~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~ 403 (476)
T 2y94_A 324 VAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIR 403 (476)
T ss_dssp ---------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEE
T ss_pred HHHHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCc
Confidence 000 0 0000000000 0000000000 0 00 00111110 012356889999
Q ss_pred ecCCHHHHHHHHHHHHHHcCcEEEeeCCceEEEEeeecCcceeEEEEEEEEEecCceEEEEEEecCCChHHH
Q 011694 349 SKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEY 420 (479)
Q Consensus 349 s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k~~Gd~le~ 420 (479)
|+.+|.+||.+|..+++.+||.|++.+...|++..........+.|.+++|++.++.+||||++..|+.++|
T Consensus 404 s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 404 SQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp ECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred cCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 999999999999999999999999988888998653333345678999999999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-62 Score=479.74 Aligned_cols=255 Identities=25% Similarity=0.500 Sum_probs=221.3
Q ss_pred ccCCCe-EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe----
Q 011694 11 VLTEKY-EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT---- 85 (479)
Q Consensus 11 il~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~---- 85 (479)
...++| ++.+.||+|+||+||+|.++.+++.||||++....... ...+.+.+|+.+|+.++|||||++++++.+
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 345676 78889999999999999999999999999998765443 345789999999999999999999999875
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCCEEEe-cCCCeEEeecCchh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRG--VYHRDIKPENLLLD-ENENLKISDFGLSA 161 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~g--ivHrDLkp~NILl~-~~g~vkl~DFGla~ 161 (479)
++.+|||||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++| |+||||||+||||+ .+|.+||+|||+|+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 3568999999999999999986 68999999999999999999999999 99999999999998 47999999999997
Q ss_pred hhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-hHHHHHHHhccCcC--CCCCC
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS-NLIEMYRKIGKAEF--KCPNW 238 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~--~~~~~ 238 (479)
... .....+.||||.|||||++.+ .|+ .++|||||||+||+|++|+.||.+. +...++..+..+.. ..+..
T Consensus 181 ~~~----~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 181 LKR----ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GCC----TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred eCC----CCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence 532 234567899999999999875 575 8999999999999999999999764 44556666655432 34556
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
+++++.+||.+||++||.+|||++|+++||||++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 8899999999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-62 Score=486.02 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=219.6
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.+.|++.++||+|+||+||+|+++.+|+.||||+++..... .+|+.+++.++|||||++++++.+++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35699999999999999999999999999999999875432 3799999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-CeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-~vkl~DFGla~~~~~~~~~~ 170 (479)
||||+||+|++++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+.........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999999976 7899999999999999999999999999999999999999988 59999999998654332211
Q ss_pred ---CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC---CCCCCCCHHHH
Q 011694 171 ---LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF---KCPNWFPPEVR 244 (479)
Q Consensus 171 ---~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~ 244 (479)
...+.||||.|||||++.+.+|+ .++|||||||+||+|++|++||.+.+...++..+..... ..|+.+|+++.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 22346899999999999998886 899999999999999999999988776666666655443 46778999999
Q ss_pred HHHHHhccCCccccCChhhh-------------hcChhhhcc
Q 011694 245 KLLCKILDPNPSTRISMAKI-------------RESSWFRKG 273 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~ei-------------l~h~wf~~~ 273 (479)
+||.+||++||.+|||+.|+ ++|||+.+.
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 99999999999999999997 567887543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-60 Score=483.69 Aligned_cols=261 Identities=27% Similarity=0.388 Sum_probs=223.5
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe------
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT------ 85 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~------ 85 (479)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 457899999999999999999999999999999999765433 2345678899999999999999999999864
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
.+.+|||||||+ |+|++++.. +++++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 367999999996 579999976 689999999999999999999999999999999999999999999999999997543
Q ss_pred cc--ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC--------
Q 011694 165 CK--HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-------- 234 (479)
Q Consensus 165 ~~--~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-------- 234 (479)
.. .......+.|||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+....+..|......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22 12334567899999999999988777679999999999999999999999998877776665322111
Q ss_pred ------------C-----------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 235 ------------C-----------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 235 ------------~-----------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
. .+.+++++.+||.+||..||.+|||++|+|+||||++..
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0 123688999999999999999999999999999998654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-59 Score=459.65 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=224.9
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
..|-.++|.+.+.||+|+||+||+|++. .++..||||+++... ....+.+.+|+.+|++++|||||++++++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 4566789999999999999999999875 367899999997542 24457899999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC
Q 011694 84 ATKSKIFFVMEYAKGGELFNKVAK--------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN 149 (479)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~i~~--------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~ 149 (479)
.+++.+|||||||+||+|.+++.. ..+++.++..++.||+.||.|||++||+||||||+||||+.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 999999999999999999999964 259999999999999999999999999999999999999999
Q ss_pred CCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHh
Q 011694 150 ENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKI 228 (479)
Q Consensus 150 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i 228 (479)
+.+||+|||+|+..............+||+.|||||++.+..|+ .++||||+||+||||+| |+.||.+.+..++...+
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999866544333333456799999999999998886 89999999999999998 99999998888888887
Q ss_pred ccCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 229 GKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 229 ~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
..+. ...|..+|+++.+||.+||+.||.+|||+++| ++|+++
T Consensus 244 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 244 TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 6654 56788899999999999999999999999999 567754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=496.03 Aligned_cols=258 Identities=31% Similarity=0.517 Sum_probs=227.0
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHH---HHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQI---KREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l---~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
+-.++|++++.||+|+||+||+|+++.+|+.||||++++...........+ ++++.+++.++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 345789999999999999999999999999999999987654433333333 34466777889999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.+|||||||+||+|++++.+ +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|....
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~-- 343 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-- 343 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC--
Confidence 99999999999999999976 789999999999999999999999999999999999999999999999999997543
Q ss_pred ccCCCccccCCCCcccChhhhhc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCh---HHHHHHHhccCcCCCCCCCCHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINR-KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKIGKAEFKCPNWFPPE 242 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~-~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~ 242 (479)
.....+.||||.|||||++.+ .+| +.++|+|||||+||+|++|.+||.+.+ ...+...+.......|..+|++
T Consensus 344 --~~~~~t~~GTp~YmAPEvl~~~~~y-~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 344 --KKKPHASVGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp --SCCCCSCCSCGGGCCHHHHSTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred --CCCCCCccCCcCccCHHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 233467899999999999975 456 489999999999999999999997643 4466777777888899999999
Q ss_pred HHHHHHHhccCCccccCC-----hhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPSTRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt-----~~eil~h~wf~~~ 273 (479)
+.+||.+||.+||.+|++ ++||++||||+..
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 999999999999999998 6999999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=457.81 Aligned_cols=254 Identities=26% Similarity=0.451 Sum_probs=202.0
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS------ 87 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~------ 87 (479)
++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 46999999999999999999999999999999997653 2344578899999999999999999999987544
Q ss_pred ------EEEEEEeccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeec
Q 011694 88 ------KIFFVMEYAKGGELFNKVAKG----KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDF 157 (479)
Q Consensus 88 ------~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DF 157 (479)
.+|||||||+||+|.+++... ..++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 479999999999999999863 2456778999999999999999999999999999999999999999999
Q ss_pred CchhhhhccccC----------CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH-HHHHH
Q 011694 158 GLSALAQCKHQD----------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-IEMYR 226 (479)
Q Consensus 158 Gla~~~~~~~~~----------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~-~~~~~ 226 (479)
|+|+........ ....+.||||.|||||++.+.+|+ .++|||||||+||+|++ ||..... .....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999865433221 112356899999999999998886 89999999999999995 8875432 23333
Q ss_pred HhccCcCC-CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 227 KIGKAEFK-CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 227 ~i~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+....++ .+...++.+.+||.+||++||.+|||++|+++||||+..
T Consensus 239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 33333221 112245778899999999999999999999999999753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-58 Score=467.00 Aligned_cols=254 Identities=25% Similarity=0.473 Sum_probs=209.5
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKS 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (479)
+.++|++++.||+|+||+||+|+++ .+++.||||.+.+.. ...++.+|+.+|+.+ +|||||++++++.+.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 6789999999999999999999875 467899999986543 235678999999988 6999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC-CCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN-ENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~-g~vkl~DFGla~~~~~~ 166 (479)
++|+|||||+||+|.+++. ++++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 94 ~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 9999999999999999984 59999999999999999999999999999999999999876 89999999999643221
Q ss_pred c--------------------------cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-
Q 011694 167 H--------------------------QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS- 219 (479)
Q Consensus 167 ~--------------------------~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~- 219 (479)
. ......+.|||+.|+|||++.+.++++.++||||+||++|+|++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1 1112345689999999999988765668999999999999999999999543
Q ss_pred hHHHHHHHhcc--------------------------------------Cc----------------CCCCCCCCHHHHH
Q 011694 220 NLIEMYRKIGK--------------------------------------AE----------------FKCPNWFPPEVRK 245 (479)
Q Consensus 220 ~~~~~~~~i~~--------------------------------------~~----------------~~~~~~~~~~~~~ 245 (479)
+.......|.. .. ......+|+++.+
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 32222222110 00 0112347899999
Q ss_pred HHHHhccCCccccCChhhhhcChhhhc
Q 011694 246 LLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
||.+||..||.+|||++|+++||||+.
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=455.27 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=215.1
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
.+-.++|.+.+.||+|+||+||+|++. .+++.||||+++... ....+.+.+|+.+|++++|||||++++++.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345678999999999999999999875 368899999997542 344578999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK----------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE 148 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~----------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~ 148 (479)
+.+.+|||||||++|+|.+++.. +++++.++..|+.|++.||.|||++||+||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 99999999999999999999864 35899999999999999999999999999999999999999
Q ss_pred CCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHH
Q 011694 149 NENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRK 227 (479)
Q Consensus 149 ~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~ 227 (479)
++.+||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..+....
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999866544433444567899999999999988886 89999999999999999 9999999888877777
Q ss_pred hccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 228 IGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 228 i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+..+ ....|..+|+++.+||.+||+.||.+|||++||+++
T Consensus 273 i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 7554 467788899999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=449.92 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=224.5
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
++-...+++.+.||+|+||+||+|... .+++.||||++.... .....+.+.+|+.++++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 466678999999999999999999864 467899999996543 2234578999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-----------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD 147 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~ 147 (479)
+.+.+|||||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 99999999999999999999953 3589999999999999999999999999999999999999
Q ss_pred cCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHH
Q 011694 148 ENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYR 226 (479)
Q Consensus 148 ~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~ 226 (479)
.++++||+|||+|+............+.+||+.|||||++.+..|+ .++||||+||+||||+| |..||.+.+..+...
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999876554444455677899999999999988886 89999999999999998 899999988888887
Q ss_pred HhccCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 227 KIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 227 ~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+..+. .+.|+.+|+++.+|+.+||+.||.+|||+.+|+++
T Consensus 259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 776553 56788899999999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=450.30 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=209.0
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.|+|-.+++++++.||+|+||+||+|++. ..||||+++..... ....+.+.+|+.+|++++|||||++++++.+ +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 46777889999999999999999999864 35999999765433 3456789999999999999999999998754 5
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.+|||||||+||+|.+++.. +++++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 68999999999999999964 5799999999999999999999999999999999999999999999999999986554
Q ss_pred cccCCCccccCCCCcccChhhhhcC---CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHH-HhccCc-----CCCC
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRK---GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYR-KIGKAE-----FKCP 236 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~---~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~-~i~~~~-----~~~~ 236 (479)
........+.+||+.|||||++.+. +| +.++|||||||+||||+||+.||.+.+...... .+..+. ...+
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y-~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 263 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPF-SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCC-CcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence 3334445677999999999999743 35 489999999999999999999998765543333 332221 1245
Q ss_pred CCCCHHHHHHHHHhccCCccccCChhhhhcCh
Q 011694 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 237 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
..+|+++.+||.+||+.||.+|||+.+|+++-
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 56899999999999999999999999987654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-57 Score=484.84 Aligned_cols=257 Identities=30% Similarity=0.551 Sum_probs=232.1
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 45789999999999999999999999999999999976542 234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC--CCeEEeecCchhhhhccc
Q 011694 92 VMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN--ENLKISDFGLSALAQCKH 167 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~--g~vkl~DFGla~~~~~~~ 167 (479)
|||||+||+|++++.. +.+++.+++.|+.||+.||.|||++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~--- 308 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 308 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC---
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc---
Confidence 9999999999999964 579999999999999999999999999999999999999854 899999999997653
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----CCCCHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPPEV 243 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~ 243 (479)
......+.|||+.|||||++.+.+|. .++|||||||+||+|++|.+||.+.+..+.+..+....+.++ ..+|+++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 23345677999999999999999885 899999999999999999999999999999988877765544 4589999
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
.+||.+||..||.+|||++|+++||||+....
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999999999999999999999986543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-55 Score=437.03 Aligned_cols=262 Identities=40% Similarity=0.769 Sum_probs=240.0
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
.....++|++.+.||+|+||.||+|.+..+|+.||||++.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 345568999999999999999999999999999999999876543 2445778899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+|+||||++||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 166 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-- 166 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence 9999999999999999875 7899999999999999999999999999999999999999999999999999975432
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 247 (479)
.......+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+.......+..+.+..|..+++++.+||
T Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 245 (328)
T 3fe3_A 167 -GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLL 245 (328)
T ss_dssp -SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred -CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 2345677999999999999998888789999999999999999999999999999999998888899999999999999
Q ss_pred HHhccCCccccCChhhhhcChhhhccc
Q 011694 248 CKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
++||..||.+|||++++++||||+...
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999997654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=449.17 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=219.0
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRT-----NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH-PNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h-pnIv~l~~ 81 (479)
++++-.++|++++.||+|+||+||+|.+..+ ++.||||.+...... ...+.+.+|+.+|+.++| ||||++++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 4567788999999999999999999998654 467999999765322 335678899999999975 89999999
Q ss_pred EEEe-CCEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCC
Q 011694 82 VMAT-KSKIFFVMEYAKGGELFNKVAK-----------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPEN 143 (479)
Q Consensus 82 ~~~~-~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~N 143 (479)
++.+ ++.+|||||||++|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 9865 4679999999999999999964 238999999999999999999999999999999999
Q ss_pred EEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHH
Q 011694 144 LLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLI 222 (479)
Q Consensus 144 ILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~ 222 (479)
||++.++.+||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999865433222233456899999999999998886 89999999999999998 99999886543
Q ss_pred -HHHHHhcc-CcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 223 -EMYRKIGK-AEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 223 -~~~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.....+.. .....|..+|+++.+||.+||+.||.+|||+.+|++|
T Consensus 295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 33444433 3467788899999999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-54 Score=434.03 Aligned_cols=261 Identities=33% Similarity=0.611 Sum_probs=231.7
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (479)
.+-.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45568999999999999999999999999999999999876554445567788999999988 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-- 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-- 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--
Confidence 9999999999999999976 6899999999999999999999999999999999999999999999999999864321
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 247 (479)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+......+|.++++++.+||
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 22234567899999999999888775 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCccccCCh------hhhhcChhhhcc
Q 011694 248 CKILDPNPSTRISM------AKIRESSWFRKG 273 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~------~eil~h~wf~~~ 273 (479)
++||..||.+||++ ++|++||||+..
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 99999999999999 899999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=427.82 Aligned_cols=260 Identities=34% Similarity=0.619 Sum_probs=236.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+-.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 34578999999999999999999999999999999998765433445677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+||||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 99999999999999976 6799999999999999999999999999999999999999999999999999864221 22
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 249 (479)
....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 334567899999999999888875 8999999999999999999999999888888888888888999999999999999
Q ss_pred hccCCccccC-----ChhhhhcChhhhcc
Q 011694 250 ILDPNPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 250 ~L~~dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
||..||.+|| ++++|++||||+..
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 9999999999 89999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=433.87 Aligned_cols=260 Identities=42% Similarity=0.848 Sum_probs=234.3
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
...++|++.+.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45688999999999999999999999999999999998765444444568899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+||||+ +|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~---~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---G 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---S
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---C
Confidence 999999 6789888865 7899999999999999999999999999999999999999999999999999876532 2
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 249 (479)
....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+......+..+.......|..+|+++.+||.+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 241 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR 241 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 33456789999999999998887678999999999999999999999988776666677777778888999999999999
Q ss_pred hccCCccccCChhhhhcChhhhccc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
||..||.+|||++|+++||||+...
T Consensus 242 ~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 242 MIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp TSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HcCCChhHCcCHHHHHhChhhccCC
Confidence 9999999999999999999997654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=422.00 Aligned_cols=258 Identities=34% Similarity=0.707 Sum_probs=236.3
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+-.++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34578999999999999999999999999999999998765444445677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~----- 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----
Confidence 99999999999999986 579999999999999999999999999999999999999999999999999987532
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 249 (479)
....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 158 DVTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp SCBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 223567899999999999988875 8999999999999999999999999988889888888888999999999999999
Q ss_pred hccCCccccC-----ChhhhhcChhhhccc
Q 011694 250 ILDPNPSTRI-----SMAKIRESSWFRKGM 274 (479)
Q Consensus 250 ~L~~dP~~Rp-----t~~eil~h~wf~~~~ 274 (479)
||..||.+|| ++++|++||||+...
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 9999999999 899999999997643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-53 Score=427.60 Aligned_cols=266 Identities=29% Similarity=0.539 Sum_probs=235.4
Q ss_pred CCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceeE
Q 011694 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV---GLADQIKREISVMRIVRHPNIVQLY 80 (479)
Q Consensus 4 ~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~l~~Ei~il~~l~hpnIv~l~ 80 (479)
|..-+...+.++|++++.||+|+||.||+|.++.+|+.||||++.+...... ...+.+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp --CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 4444566788999999999999999999999999999999999987643321 1357889999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC----CeEEe
Q 011694 81 EVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE----NLKIS 155 (479)
Q Consensus 81 ~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g----~vkl~ 155 (479)
+++.+.+.+|+||||++||+|++++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 999999999999999999999999976 5799999999999999999999999999999999999998776 79999
Q ss_pred ecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCC
Q 011694 156 DFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC 235 (479)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 235 (479)
|||++..... .......+||+.|+|||++.+.+|. .++|||||||++|+|++|..||.+.+..+.+..+....+.+
T Consensus 162 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 162 DFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237 (361)
T ss_dssp CCSSCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred ecCCceEcCC---CCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9999875432 2234567899999999999887775 89999999999999999999999998888888887776655
Q ss_pred C----CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 236 P----NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 236 ~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+ ..+|+++.+||.+||.+||.+|||++++++||||+..
T Consensus 238 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 4 4589999999999999999999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=427.34 Aligned_cols=261 Identities=33% Similarity=0.626 Sum_probs=235.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (479)
.+-.++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999999999999999999876543334456788899999876 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-- 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc--
Confidence 9999999999999999986 7899999999999999999999999999999999999999999999999999864321
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 247 (479)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+.......|.++++++.+||
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence 12234567999999999999988875 89999999999999999999999999888999988888888999999999999
Q ss_pred HHhccCCccccCChh-hhhcChhhhcc
Q 011694 248 CKILDPNPSTRISMA-KIRESSWFRKG 273 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~-eil~h~wf~~~ 273 (479)
.+||..||.+||++. +|++||||+..
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcCCHhHcCCChHHHHcCccccCC
Confidence 999999999999998 99999999764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=423.21 Aligned_cols=258 Identities=31% Similarity=0.643 Sum_probs=237.3
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
....++|++++.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45568999999999999999999999999999999999876554445567888999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 999999999999999986 7899999999999999999999999999999999999999999999999999875422
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 248 (479)
...+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+.......|..+++++.+||.
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 23467899999999999988875 899999999999999999999999998899999988888899999999999999
Q ss_pred HhccCCccccCC-----hhhhhcChhhhcc
Q 011694 249 KILDPNPSTRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 249 ~~L~~dP~~Rpt-----~~eil~h~wf~~~ 273 (479)
+||..||.+||+ +++|++||||+..
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 999999999999 9999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=411.81 Aligned_cols=257 Identities=31% Similarity=0.499 Sum_probs=227.9
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
..++|++.+.||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 567899999999999999999999999999999999765433 24678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 92 VMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||||++||+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 172 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--ccc
Confidence 999999999999999889999999999999999999999999999999999999999999999999998654322 223
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhc---cCcCCCCCCCCHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG---KAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~li~ 248 (479)
....+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+.......+. ......|..+++.+.+||.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 4456899999999999988875 89999999999999999999998877655444442 2344556778999999999
Q ss_pred HhccCCccccCChhhhhcChhhhccc
Q 011694 249 KILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+||+.||.+|||++++++||||+...
T Consensus 252 ~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHccCChhHCcCHHHHhhChhhcccC
Confidence 99999999999999999999997654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=429.97 Aligned_cols=261 Identities=30% Similarity=0.569 Sum_probs=229.6
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (479)
.+-.++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|..+++.+ +||||+++++++.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45567999999999999999999999999999999999887655444456788999999877 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+|+||||++||+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.... .
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~--~ 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--R 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--C
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc--c
Confidence 9999999999999999876 689999999999999999999999999999999999999999999999999986422 1
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---------hHHHHHHHhccCcCCCCCC
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS---------NLIEMYRKIGKAEFKCPNW 238 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~~ 238 (479)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|..||... .....+..+......+|..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred CCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 22345678999999999999988885 8999999999999999999999632 2344667777788889999
Q ss_pred CCHHHHHHHHHhccCCccccCCh------hhhhcChhhhcc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISM------AKIRESSWFRKG 273 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~------~eil~h~wf~~~ 273 (479)
+++++.+||++||+.||.+||++ ++|++||||+..
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 99999999999999999999995 799999999754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=423.73 Aligned_cols=262 Identities=29% Similarity=0.538 Sum_probs=235.1
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKS 87 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (479)
..+-.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 356678999999999999999999999999999999999876544444567788999999987 7999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 99999999999999999986 7899999999999999999999999999999999999999999999999999864221
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 246 (479)
......+.+||+.|+|||++.+.+|. .++|||||||++|+|++|..||.+.+....+..+......+|..+|+++.+|
T Consensus 174 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 174 -DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 22234567999999999999988885 8999999999999999999999999998999999888888999999999999
Q ss_pred HHHhccCCccccCC-----hhhhhcChhhhcc
Q 011694 247 LCKILDPNPSTRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 247 i~~~L~~dP~~Rpt-----~~eil~h~wf~~~ 273 (479)
|.+||..||.+||+ +++|++||||+..
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 99999999999995 6999999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=419.25 Aligned_cols=261 Identities=30% Similarity=0.566 Sum_probs=232.3
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (479)
.+-.++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 34567899999999999999999999999999999999887665556667889999999987 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 9999999999999999976 6899999999999999999999999999999999999999999999999999864221
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC---------ChHHHHHHHhccCcCCCCCC
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD---------SNLIEMYRKIGKAEFKCPNW 238 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~~~~ 238 (479)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.. .+....+..+.......|..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 22334567999999999999988875 899999999999999999999975 23345666777777888999
Q ss_pred CCHHHHHHHHHhccCCccccCCh------hhhhcChhhhcc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISM------AKIRESSWFRKG 273 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~------~eil~h~wf~~~ 273 (479)
+++++.+||.+||..||.+||++ ++|++||||+..
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 99999999999999999999996 799999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=419.29 Aligned_cols=261 Identities=38% Similarity=0.701 Sum_probs=224.3
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
+.++|++++.||+|+||+||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 568999999999999999999999999999999999765432 234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
||||++||+|.+++..+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999999999999874 79999999999999999999999999999999999999999999999999997654444444
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-HHHHHhccCcCCC--CCCCCHHHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI-EMYRKIGKAEFKC--PNWFPPEVRKLL 247 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~--~~~~~~~~~~li 247 (479)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+....... ...+++.+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 4556789999999999998887668999999999999999999999875542 3333333322222 245899999999
Q ss_pred HHhccCCccccCChhhhhcChhhhccc
Q 011694 248 CKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+||..||.+|||++|+++||||++..
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999998654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=417.67 Aligned_cols=249 Identities=20% Similarity=0.332 Sum_probs=196.3
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----E
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS----K 88 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 88 (479)
..+|.+.+.||+|+||+||+|++ +|+.||||+++.... .....+.|+..+..++|||||++++++.+++ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 46799999999999999999988 789999999965431 1223345777778899999999999997653 6
Q ss_pred EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 89 IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR--------GVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~--------givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
+|||||||+||+|.+++...+++++.+..++.|++.||+|||++ ||+||||||+||||+.++++||+|||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 89999999999999999999999999999999999999999987 9999999999999999999999999999
Q ss_pred hhhhcccc--CCCccccCCCCcccChhhhhcCCC-----CCCccchhhHHHHHHHHHhCCCCCCCC--------------
Q 011694 161 ALAQCKHQ--DGLLHTTCGTPAYVAPEVINRKGY-----DGEKVDIWSCGVVLFVLLAGYLPFHDS-------------- 219 (479)
Q Consensus 161 ~~~~~~~~--~~~~~~~~gt~~y~aPEvl~~~~~-----~~~~~DvwSlGvil~~ll~G~~Pf~~~-------------- 219 (479)
+....... .....+.+||+.|||||++.+... .+.++|||||||+||||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 76543221 112345689999999999976421 236899999999999999997765321
Q ss_pred -hHHHHHHHhccCcC--CCCCC-----CCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 220 -NLIEMYRKIGKAEF--KCPNW-----FPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 220 -~~~~~~~~i~~~~~--~~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
........+..... ..|.. ++..+.+|+.+||+.||.+|||+.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12233333333222 22322 22468899999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=433.03 Aligned_cols=263 Identities=33% Similarity=0.655 Sum_probs=230.4
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
-+...+.++|++++.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEE 82 (444)
T ss_dssp ---CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred cccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence 355677889999999999999999999999999999999998765433 3456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe---cCCCeEEeecCchhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD---ENENLKISDFGLSAL 162 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~---~~g~vkl~DFGla~~ 162 (479)
+..|+|||||+||+|++.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|..
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999999999876 5799999999999999999999999999999999999998 457899999999965
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCC----C
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN----W 238 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~ 238 (479)
.... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+..+.+..|. .
T Consensus 163 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (444)
T 3soa_A 163 VEGE--QQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239 (444)
T ss_dssp CCTT--CCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred ecCC--CceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccccc
Confidence 4322 2234567899999999999888775 8999999999999999999999999888888888776554442 4
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+|+++.+||.+||+.||.+|||++++++||||+..
T Consensus 240 ~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 240 VTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 79999999999999999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=413.05 Aligned_cols=255 Identities=25% Similarity=0.468 Sum_probs=228.5
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
-+.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 36789999999999999999999999999999999997543 23467889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec--CCCeEEeecCchhhhhcc
Q 011694 91 FVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE--NENLKISDFGLSALAQCK 166 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~--~g~vkl~DFGla~~~~~~ 166 (479)
+|||||+||+|++++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~- 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC-
Confidence 999999999999999763 6999999999999999999999999999999999999987 78999999999875432
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----CCCCHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPPE 242 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~ 242 (479)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.......+ +.+|++
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 157 --GDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred --CCccccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 2234556899999999999877664 899999999999999999999999888888888877666554 368999
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+.+||.+||..||.+|||+.++++||||++.
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999999999999999999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=419.80 Aligned_cols=260 Identities=33% Similarity=0.664 Sum_probs=230.3
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
....+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 44556788999999999999999999999999999999998765433 34577899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC---CCeEEeecCchhhh
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN---ENLKISDFGLSALA 163 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~---g~vkl~DFGla~~~ 163 (479)
..|+||||++||+|++.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999999999876 579999999999999999999999999999999999999865 45999999998754
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCC----CC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN----WF 239 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~ 239 (479)
.. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+..+.+..|. .+
T Consensus 182 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (362)
T 2bdw_A 182 ND---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 257 (362)
T ss_dssp TT---CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGS
T ss_pred cC---CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 32 2234567899999999999887775 8999999999999999999999998888888888766655443 37
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
|+++.+||.+||..||.+|||++++++||||..
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 899999999999999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=422.12 Aligned_cols=266 Identities=28% Similarity=0.539 Sum_probs=235.4
Q ss_pred CCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 5 ~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
-...+.+..++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 6 FDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp --CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cCCCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34566778899999999999999999999999999999999998765544455678899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
+.+.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 99999999999999999999987 47999999999999999999999999999999999999999999999999999754
Q ss_pred hccccCCCccccCCCCcccChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCC---hHHHHHHHhccCcCCCCC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINR---KGYDGEKVDIWSCGVVLFVLLAGYLPFHDS---NLIEMYRKIGKAEFKCPN 237 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~---~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~ 237 (479)
. ......+.+||+.|+|||++.+ .+| +.++|||||||++|+|++|..||... ........+.......|.
T Consensus 166 ~---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~ 241 (384)
T 4fr4_A 166 P---RETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241 (384)
T ss_dssp C---TTCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT
T ss_pred c---CCCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC
Confidence 3 2234467799999999999964 335 48999999999999999999999743 345666666777788899
Q ss_pred CCCHHHHHHHHHhccCCccccCC-hhhhhcChhhhccc
Q 011694 238 WFPPEVRKLLCKILDPNPSTRIS-MAKIRESSWFRKGM 274 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt-~~eil~h~wf~~~~ 274 (479)
.+++++.+||.+||..||.+||+ +++++.||||+...
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 99999999999999999999999 89999999997643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=431.20 Aligned_cols=262 Identities=32% Similarity=0.561 Sum_probs=229.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
+..++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 45679999999999999999999999999999999997754333333456789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 91 FVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|........ .
T Consensus 146 lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-V 224 (410)
T ss_dssp EEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-E
T ss_pred EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-c
Confidence 999999999999999988999999999999999999999999999999999999999999999999999865432211 1
Q ss_pred CccccCCCCcccChhhhhcCCC---CCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCC--CCCCHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGY---DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCP--NWFPPEV 243 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~---~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~ 243 (479)
...+.+||+.|+|||++.+.+. .+.++|||||||++|+|++|..||.+.+....+..+... .+.+| ..+|+++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 2346789999999999986651 348999999999999999999999999988888888653 23444 4689999
Q ss_pred HHHHHHhccCCccc--cCChhhhhcChhhhcc
Q 011694 244 RKLLCKILDPNPST--RISMAKIRESSWFRKG 273 (479)
Q Consensus 244 ~~li~~~L~~dP~~--Rpt~~eil~h~wf~~~ 273 (479)
.+||++||..+|.+ ||++++|++||||+..
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999998 9999999999999764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=420.88 Aligned_cols=261 Identities=33% Similarity=0.561 Sum_probs=227.1
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhCCCCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV-MRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~i-l~~l~hpnIv~l~~~~~~~~~ 88 (479)
.+..++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4556899999999999999999999999999999999988765544445666777776 577899999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 9999999999999999976 6799999999999999999999999999999999999999999999999999875322
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 247 (479)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+.......|+.+++++.+||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 22345677999999999999988875 89999999999999999999999999999999998888888999999999999
Q ss_pred HHhccCCccccCCh----hhhhcChhhhcc
Q 011694 248 CKILDPNPSTRISM----AKIRESSWFRKG 273 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~----~eil~h~wf~~~ 273 (479)
.+||..||.+||++ ++|++||||+..
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 99999999999997 699999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=407.53 Aligned_cols=262 Identities=33% Similarity=0.641 Sum_probs=221.9
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc-----------------------hhhHHHHHHHH
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR-----------------------VGLADQIKREI 65 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~l~~Ei 65 (479)
..+..++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+.+|+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 3466789999999999999999999999999999999997654321 11235688999
Q ss_pred HHHHhCCCCCcceeEEEEEe--CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCC
Q 011694 66 SVMRIVRHPNIVQLYEVMAT--KSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPEN 143 (479)
Q Consensus 66 ~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~N 143 (479)
.+++.++||||+++++++.+ .+.+|+||||+++++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999999987 6789999999999999998877889999999999999999999999999999999999
Q ss_pred EEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCC--CCCccchhhHHHHHHHHHhCCCCCCCChH
Q 011694 144 LLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY--DGEKVDIWSCGVVLFVLLAGYLPFHDSNL 221 (479)
Q Consensus 144 ILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~--~~~~~DvwSlGvil~~ll~G~~Pf~~~~~ 221 (479)
||++.++.+||+|||++...... .......+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+.
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999998754321 223345689999999999976542 35789999999999999999999998887
Q ss_pred HHHHHHhccCcCCCC--CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 222 IEMYRKIGKAEFKCP--NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 222 ~~~~~~i~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
......+.......| +.+++++.+||.+||+.||.+|||+.++++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 777666655544443 468999999999999999999999999999999963
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=410.68 Aligned_cols=265 Identities=33% Similarity=0.613 Sum_probs=224.4
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEc---CCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCcceeEE
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIMR-VGLADQIKREISVMRIVRHPNIVQLYE 81 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~-~~~~~~l~~Ei~il~~l~hpnIv~l~~ 81 (479)
..+..+..++|++.+.||+|+||.||+|++. .+|+.||||++.+..... ......+.+|+.+++.++||||+++++
T Consensus 9 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 9 RGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp ----CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeE
Confidence 3455677899999999999999999999985 689999999998764322 223466789999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
++.+.+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 89 AFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999999999976 67999999999999999999999999999999999999999999999999998
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCC
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFP 240 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (479)
...... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.......|+.++
T Consensus 169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 245 (327)
T 3a62_A 169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLT 245 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSC
T ss_pred cccccC--CccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence 643222 2234567899999999999887775 8999999999999999999999999888888888888888899999
Q ss_pred HHHHHHHHHhccCCccccC-----ChhhhhcChhhhcc
Q 011694 241 PEVRKLLCKILDPNPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
+++.+||.+||..||.+|| +++++++||||+..
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 9999999999999999999 88999999999754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=400.59 Aligned_cols=262 Identities=37% Similarity=0.710 Sum_probs=233.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
+.....++|++++.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 34566789999999999999999999999999999999997765544455678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
..|+||||+++|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 99999999999999999876 6899999999999999999999999999999999999999999999999998854322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 246 (479)
......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.......|..+++++.+|
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred ---ccccccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 223456799999999999877664 8999999999999999999999999888888888888888899999999999
Q ss_pred HHHhccCCccccCChhhhhcChhhhccc
Q 011694 247 LCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 247 i~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
|.+||+.||.+|||++++++||||+...
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCc
Confidence 9999999999999999999999997543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=410.01 Aligned_cols=261 Identities=29% Similarity=0.555 Sum_probs=230.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV---GLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4567889999999999999999999999999999999987543221 1357789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC----CeEEeecCchh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE----NLKISDFGLSA 161 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g----~vkl~DFGla~ 161 (479)
+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999999976 5799999999999999999999999999999999999998877 89999999987
Q ss_pred hhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----C
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----N 237 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~ 237 (479)
..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.......+ .
T Consensus 167 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 167 KIDFG---NEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp ECCTT---SCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred ECCCC---CccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 54322 233456899999999999887775 899999999999999999999998887777777665554443 4
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+|+.+.+||.+||..||.+|||++++++||||+...
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 5789999999999999999999999999999997644
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=398.91 Aligned_cols=266 Identities=44% Similarity=0.827 Sum_probs=229.7
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
...+.+..++|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp ----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 35678888999999999999999999999999999999999977654444556788999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
.+..|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999999999976 679999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHH
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVR 244 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (479)
.. ......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+.......|..+++.+.
T Consensus 163 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 239 (276)
T 2h6d_A 163 DG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHH
Confidence 22 223456799999999999887776689999999999999999999999988888888887777788888999999
Q ss_pred HHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 245 KLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
++|.+||+.||.+|||++++++||||++..
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 999999999999999999999999997654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=428.78 Aligned_cols=263 Identities=34% Similarity=0.604 Sum_probs=226.4
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
...+..++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 34456789999999999999999999999999999999998764444444567789999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999999999876 679999999999999999999998 9999999999999999999999999999874322
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRK 245 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (479)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+
T Consensus 302 --~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 378 (446)
T 4ejn_A 302 --DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 378 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred --CCcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence 22234567899999999999888875 899999999999999999999999998888888888888899999999999
Q ss_pred HHHHhccCCccccC-----ChhhhhcChhhhcc
Q 011694 246 LLCKILDPNPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 246 li~~~L~~dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
||.+||+.||.+|| |++++++||||+..
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999999 99999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=414.91 Aligned_cols=259 Identities=40% Similarity=0.737 Sum_probs=215.6
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
....++|++.+.||+|+||.||+|++..+++.||||++....... +.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 345689999999999999999999999999999999997654332 5678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC--eEEeecCchhhhhcc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN--LKISDFGLSALAQCK 166 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~--vkl~DFGla~~~~~~ 166 (479)
|+||||++||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|.....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~- 170 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence 999999999999999875 68999999999999999999999999999999999999987765 99999999864322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH----HHHHHHhccCcCCCCC--CCC
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL----IEMYRKIGKAEFKCPN--WFP 240 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~--~~~ 240 (479)
.......+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+. ......+.......|. .++
T Consensus 171 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 171 --HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred --cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 22234568999999999999888876669999999999999999999987543 3444555555555554 479
Q ss_pred HHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
+++.+||.+||..||.+|||++++++||||.+...
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 99999999999999999999999999999976543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=415.55 Aligned_cols=261 Identities=30% Similarity=0.626 Sum_probs=223.6
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch--hhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV--GLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
...++.++|++.+.||+|+||.||+|.++.+|+.||||++........ ...+.+.+|+.+++.++||||+++++++.+
T Consensus 18 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 18 DDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97 (351)
T ss_dssp --CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CCCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 445677899999999999999999999999999999999976443211 135778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC---eEEeec
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN---LKISDF 157 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~---vkl~DF 157 (479)
.+.+|+|||||+||+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999999999887754 24899999999999999999999999999999999999987655 999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC-
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP- 236 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~- 236 (479)
|++...... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+. ..+..+.......+
T Consensus 178 g~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 178 GVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNP 253 (351)
T ss_dssp TTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCH
T ss_pred cceeEecCC--CeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCc
Confidence 998754321 2223456899999999999888775 899999999999999999999988653 45555555544443
Q ss_pred ---CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 237 ---NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 237 ---~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
..+|+++.+||.+||..||.+|||+.++++||||+.
T Consensus 254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 458999999999999999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=398.43 Aligned_cols=256 Identities=28% Similarity=0.478 Sum_probs=215.7
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 6899999999999999999999999999999999876533 345577889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+++ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..... ....
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 157 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCSC
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--cccc
Confidence 99987 55555543 6799999999999999999999999999999999999999999999999999875432 2223
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC-CCCChHHHHHHHhccC-------------------
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLP-FHDSNLIEMYRKIGKA------------------- 231 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~P-f~~~~~~~~~~~i~~~------------------- 231 (479)
....+||+.|+|||++.+....+.++||||+||++|+|++|..| |.+.+.......+...
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 45568999999999998776556899999999999999988777 5555554444443210
Q ss_pred ----------cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 232 ----------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 232 ----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.....+.+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 001123478999999999999999999999999999999764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=405.37 Aligned_cols=265 Identities=28% Similarity=0.415 Sum_probs=216.4
Q ss_pred CCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 4 ~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
++...+..+.++|++++.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 88 (311)
T 3niz_A 11 RENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVI 88 (311)
T ss_dssp ----CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 445566788999999999999999999999984 699999999976533 234557788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 84 ATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
.+.+.+|+||||+++ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp CCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence 999999999999986 78887765 359999999999999999999999999999999999999999999999999997
Q ss_pred hhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc----CcC----
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK----AEF---- 233 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~----~~~---- 233 (479)
..... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.. ...
T Consensus 168 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 168 AFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp ETTSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred ecCCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 54322 22334568999999999998755446899999999999999999999987654443333311 000
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 234 ----------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 234 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
...+.+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0123367899999999999999999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=427.15 Aligned_cols=262 Identities=26% Similarity=0.501 Sum_probs=227.5
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+..++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.++..++||||+++++++.+.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 34568999999999999999999999999999999999875443333334578999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999999999999986 579999999999999999999999999999999999999999999999999986543211
Q ss_pred cCCCccccCCCCcccChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCCC---
Q 011694 168 QDGLLHTTCGTPAYVAPEVIN-----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCPN--- 237 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~-----~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--- 237 (479)
.......+||+.|+|||++. ...| +.++|||||||++|+|++|+.||.+.+..+.+..+... .+.+|.
T Consensus 230 -~~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 230 -TVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp -CEECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred -CcccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 11223468999999999997 2334 58999999999999999999999999888888887543 344554
Q ss_pred CCCHHHHHHHHHhccCCccc--cCChhhhhcChhhhcc
Q 011694 238 WFPPEVRKLLCKILDPNPST--RISMAKIRESSWFRKG 273 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~--Rpt~~eil~h~wf~~~ 273 (479)
.+|+++.+||++||..+|.+ |++++++++||||+..
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 48999999999999998888 9999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=417.66 Aligned_cols=264 Identities=29% Similarity=0.398 Sum_probs=212.3
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC-
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKS- 87 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~- 87 (479)
..+.++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 4567899999999999999999999999999999999965432 2344567889999999997 999999999997654
Q ss_pred -EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 -KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 -~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.+|+||||+++ +|...+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 84 RDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp SCEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred CEEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 79999999984 8999999889999999999999999999999999999999999999999999999999999754321
Q ss_pred -------------------ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHH
Q 011694 167 -------------------HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRK 227 (479)
Q Consensus 167 -------------------~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 227 (479)
.........+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1112234568999999999998754445899999999999999999999998876665555
Q ss_pred hccCc-----------------------------------------------CCCCCCCCHHHHHHHHHhccCCccccCC
Q 011694 228 IGKAE-----------------------------------------------FKCPNWFPPEVRKLLCKILDPNPSTRIS 260 (479)
Q Consensus 228 i~~~~-----------------------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt 260 (479)
+.... ...+..+++++.+||.+||..||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 42110 0112257899999999999999999999
Q ss_pred hhhhhcChhhhcccc
Q 011694 261 MAKIRESSWFRKGMN 275 (479)
Q Consensus 261 ~~eil~h~wf~~~~~ 275 (479)
++|+++||||+....
T Consensus 323 ~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 323 ANDALKHPFVSIFHN 337 (388)
T ss_dssp HHHHTTSTTTTTTCC
T ss_pred HHHHhCCHHHHHhcC
Confidence 999999999976543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=395.03 Aligned_cols=261 Identities=35% Similarity=0.706 Sum_probs=234.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
+..+..++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+.+
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 34556689999999999999999999999999999999997765444445678899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
..|+||||+++|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 99999999999999999876 6799999999999999999999999999999999999999999999999999864322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKL 246 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 246 (479)
......+||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+.......|..+++++.++
T Consensus 167 ---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 167 ---LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp ---SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred ---cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHH
Confidence 223456799999999999887775 8999999999999999999999998888888888777888889999999999
Q ss_pred HHHhccCCccccCChhhhhcChhhhcc
Q 011694 247 LCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 247 i~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
|.+||..||.+|||++++++||||+..
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 999999999999999999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=391.11 Aligned_cols=260 Identities=33% Similarity=0.664 Sum_probs=229.7
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
+.+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 457899999999999999999999999999999999998765433 3457788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC---eEEeecCchhhhhc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN---LKISDFGLSALAQC 165 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~---vkl~DFGla~~~~~ 165 (479)
|+||||++|++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999888875 67999999999999999999999999999999999999986655 99999999865432
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----CCCCH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPP 241 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 241 (479)
........||+.|+|||++.+..+. .++||||+|+++|+|++|..||.+.+.......+.......| ..+++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 161 ---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ---SCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ---CccccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 2233456899999999999888775 899999999999999999999999888877777766554443 35789
Q ss_pred HHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
++.+||.+||+.||.+|||++++++||||+...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 999999999999999999999999999997654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=413.43 Aligned_cols=261 Identities=22% Similarity=0.375 Sum_probs=218.9
Q ss_pred cCCCeEEeeeeeec--CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 12 LTEKYEVGRLLGQG--AFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 12 l~~~y~i~~~LG~G--~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
-.++|++++.||+| +||.||+|++..+|+.||||++...... ......+.+|+.+++.++||||+++++++.+.+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 45789999999999 9999999999999999999999876443 35567889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 90 FFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999999975 56999999999999999999999999999999999999999999999999987543221
Q ss_pred c-----cCCCccccCCCCcccChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-------
Q 011694 167 H-----QDGLLHTTCGTPAYVAPEVINR--KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE------- 232 (479)
Q Consensus 167 ~-----~~~~~~~~~gt~~y~aPEvl~~--~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------- 232 (479)
. ........+||+.|+|||++.+ ..|+ .++|||||||++|+|++|..||.+.+.......+....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBC-THHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 1 1122334589999999999987 4554 89999999999999999999998755443333222111
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 233 ---------------------------------------FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 233 ---------------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
...+..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 12344578999999999999999999999999999999765
Q ss_pred c
Q 011694 274 M 274 (479)
Q Consensus 274 ~ 274 (479)
.
T Consensus 341 ~ 341 (389)
T 3gni_B 341 K 341 (389)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=428.18 Aligned_cols=262 Identities=34% Similarity=0.655 Sum_probs=233.3
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.+.++.++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45678899999999999999999999999999999999998766554455678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE---ecCCCeEEeecCchhhh
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALA 163 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl---~~~g~vkl~DFGla~~~ 163 (479)
.+|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999999876 679999999999999999999999999999999999999 46789999999999765
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCC--C--CCC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC--P--NWF 239 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~--~~~ 239 (479)
.. .......+||+.|+|||++.+ .|+ .++|||||||++|+|++|.+||.+.+.......+....+.. | ..+
T Consensus 180 ~~---~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 180 EA---SKKMKDKIGTAYYIAPEVLHG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp CC---CCSHHHHTTGGGTCCHHHHHT-CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred cc---ccccccCCCCccccCceeecC-CCC-CcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 32 233456789999999999976 454 89999999999999999999999998888888887665443 3 348
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
|+++.+||.+||.+||.+|||++++++||||+...
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 99999999999999999999999999999997654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=395.66 Aligned_cols=254 Identities=30% Similarity=0.503 Sum_probs=213.2
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++++.||+|+||.||+|.+ .+|+.||||++...... ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 78999999999765432 233467789999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+++ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ...
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 156 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--ccc
Confidence 99986 89888875 57999999999999999999999999999999999999999999999999999765322 122
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC----c---------------
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA----E--------------- 232 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----~--------------- 232 (479)
....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 345679999999999977654468999999999999999999999987765544443210 0
Q ss_pred -C---------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 233 -F---------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 233 -~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
+ ..+..+++++.+||.+||..||.+|||++++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0 112347899999999999999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=419.96 Aligned_cols=261 Identities=28% Similarity=0.509 Sum_probs=225.8
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.++..++||||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34568999999999999999999999999999999999875443334445688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
|+||||++||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 999999999999999976 379999999999999999999999999999999999999999999999999987543211
Q ss_pred cCCCccccCCCCcccChhhhhc-------CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCC--
Q 011694 168 QDGLLHTTCGTPAYVAPEVINR-------KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCP-- 236 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~-------~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~-- 236 (479)
. ......+||+.|+|||++.. ..| +.++|||||||++|+|++|..||.+.+..+.+.++... ....|
T Consensus 217 ~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 217 T-VRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp C-EECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred c-cccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 1 11235689999999999973 334 48999999999999999999999999888888777543 23334
Q ss_pred -CCCCHHHHHHHHHhccCCcccc---CChhhhhcChhhhcc
Q 011694 237 -NWFPPEVRKLLCKILDPNPSTR---ISMAKIRESSWFRKG 273 (479)
Q Consensus 237 -~~~~~~~~~li~~~L~~dP~~R---pt~~eil~h~wf~~~ 273 (479)
..+|+++.+||++||. +|.+| |++++|++||||+..
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 5689999999999999 99998 599999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=401.42 Aligned_cols=261 Identities=31% Similarity=0.587 Sum_probs=237.0
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
..++|.+++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35689999999999999999999999999999999987765555667889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--cc
Confidence 9999999999999876 67999999999999999999999999999999999999999999999999998754322 12
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHh
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 250 (479)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+.......|..+++.+.+||.+|
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 23456799999999999887775 89999999999999999999999988888888887778888889999999999999
Q ss_pred ccCCccccCChhhhhcChhhhcccc
Q 011694 251 LDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 251 L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
|..||.+|||++++++||||.....
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ccCChhHCcCHHHHhcCccccCCCc
Confidence 9999999999999999999987653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=392.50 Aligned_cols=261 Identities=31% Similarity=0.588 Sum_probs=236.6
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
...++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45678999999999999999999999999999999998776555556688999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--c
Confidence 99999999999999876 67999999999999999999999999999999999999999999999999998754322 1
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 249 (479)
......+||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+..+.+..+.......|..+++.+.++|.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 223456799999999999887765 8999999999999999999999998888888888888888888999999999999
Q ss_pred hccCCccccCChhhhhcChhhhccc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
||..||.+|||++++++||||....
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HcccChhhCcCHHHHhhChheecCC
Confidence 9999999999999999999997654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=394.73 Aligned_cols=258 Identities=33% Similarity=0.668 Sum_probs=206.7
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999999999999999999876544445567889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--E 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--C
Confidence 999999999999986 469999999999999999999999999999999999999999999999999987543221 1
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHh
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 250 (479)
.....+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.......|..+++++.+||.+|
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHH
Confidence 22356799999999999877664 89999999999999999999999877766666666667778888999999999999
Q ss_pred ccCCccccCChhhhhcChhhhcc
Q 011694 251 LDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 251 L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
|..||.+|||++++++||||...
T Consensus 247 l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp SCSSGGGSCCHHHHTTSTTTC--
T ss_pred cccCHhhCCCHHHHhcCccccCC
Confidence 99999999999999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=406.17 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=221.6
Q ss_pred CCCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----CCCcc
Q 011694 3 GMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-----HPNIV 77 (479)
Q Consensus 3 ~~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-----hpnIv 77 (479)
.++...+.++.++|++.+.||+|+||+||+|++..+++.||||++.... .......+|+.+++.+. ||||+
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3567788999999999999999999999999999999999999997532 33466778999999986 99999
Q ss_pred eeEEEEEeCCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec------
Q 011694 78 QLYEVMATKSKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE------ 148 (479)
Q Consensus 78 ~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~------ 148 (479)
++++++...+..|+||||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999999 88999999864 4999999999999999999999999999999999999975
Q ss_pred -------------------CCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHH
Q 011694 149 -------------------NENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVL 209 (479)
Q Consensus 149 -------------------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~l 209 (479)
++.+||+|||+|.... ......+||+.|+|||++.+..++ .++|||||||++|+|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el 252 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS-----DYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT-----SCCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecC-----CCCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHH
Confidence 7899999999987532 223456899999999999988875 899999999999999
Q ss_pred HhCCCCCCCChHHHHHHHhccCcCCCC--------------------------C--------------------CCCHHH
Q 011694 210 LAGYLPFHDSNLIEMYRKIGKAEFKCP--------------------------N--------------------WFPPEV 243 (479)
Q Consensus 210 l~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~--------------------~~~~~~ 243 (479)
++|..||...+.......+.......| . ..++.+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 999999988776555544422111111 1 123678
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhh
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
.+||.+||+.||.+|||++|+++||||+
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 8999999999999999999999999995
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=403.45 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=205.8
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++++.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 46899999999999999999999999999999999765422 2336778999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 93 MEYAKGGELFNKVAK-------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
|||++| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999985 89988864 2599999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-------------
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE------------- 232 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 232 (479)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 161 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 P--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp C--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred C--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 2 2233456899999999999875444589999999999999999999999887665554442100
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 233 ---------------------FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 233 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
...+..+++++.+||.+||..||.+|||++++++||||++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 01122478899999999999999999999999999999876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=408.20 Aligned_cols=256 Identities=34% Similarity=0.621 Sum_probs=220.4
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATK 86 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (479)
....+.++|++.+.||+|+||+||+|.++.+|+.||||++.+.... ..+|+.++..+ +||||+++++++.+.
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp ---CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 3446778999999999999999999999999999999999876432 24688888777 799999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC-C---CeEEeecCchh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN-E---NLKISDFGLSA 161 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~-g---~vkl~DFGla~ 161 (479)
+.+|+|||||+||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||+..+ + .+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999999999999876 579999999999999999999999999999999999998533 3 49999999987
Q ss_pred hhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC---ChHHHHHHHhccCcCCCC--
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD---SNLIEMYRKIGKAEFKCP-- 236 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~~-- 236 (479)
.... ......+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.. .+..+....+..+.+..+
T Consensus 169 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 169 QLRA--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp ECBC--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred cCcC--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 5432 22345577899999999999887775 799999999999999999999975 345567777766655544
Q ss_pred --CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 237 --NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 237 --~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..+|+++.+||.+||..||.+|||++++++||||...
T Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 4589999999999999999999999999999999653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=398.86 Aligned_cols=267 Identities=28% Similarity=0.522 Sum_probs=233.4
Q ss_pred CCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceeE
Q 011694 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV---GLADQIKREISVMRIVRHPNIVQLY 80 (479)
Q Consensus 4 ~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~l~~Ei~il~~l~hpnIv~l~ 80 (479)
|..-+...+.++|++++.||+|+||.||+|.+..+|+.||||++........ ...+.+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp CCCCBCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 3334456678899999999999999999999999999999999986543221 1357789999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC----CeEEe
Q 011694 81 EVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE----NLKIS 155 (479)
Q Consensus 81 ~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g----~vkl~ 155 (479)
+++.+.+..|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 999999999999999999999999986 5799999999999999999999999999999999999999887 79999
Q ss_pred ecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCC
Q 011694 156 DFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC 235 (479)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 235 (479)
|||++..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.......
T Consensus 162 Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (321)
T 2a2a_A 162 DFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237 (321)
T ss_dssp CCTTCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred cCccceecCc---cccccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence 9999875432 2223456799999999999887775 89999999999999999999999988877777776655544
Q ss_pred C----CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 236 P----NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 236 ~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+ ..+++.+.+||.+||..||.+|||++++++||||....
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 238 DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 4 46889999999999999999999999999999997543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=430.01 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=231.7
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+..++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 46678899999999999999999999999999999999876554444557788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 90 FFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
|+||||++||+|.+++... .+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 9999999999999998762 499999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh----HHHHHHHhccCcCCCCCCCCHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN----LIEMYRKIGKAEFKCPNWFPPE 242 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 242 (479)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||...+ ...+...+.......|..+|++
T Consensus 339 --~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 339 --GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp --TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred --CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 2234556899999999999887775 89999999999999999999998753 3456666666667788889999
Q ss_pred HHHHHHHhccCCccccC-----ChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
+.+||.+||..||.+|| ++++|++||||+..
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 99999999999999999 78999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=388.93 Aligned_cols=256 Identities=36% Similarity=0.666 Sum_probs=228.5
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
.+.++|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 4677899999999999999999999999999999999765432 2467889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE---ecCCCeEEeecCchhhhhcc
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCK 166 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl---~~~g~vkl~DFGla~~~~~~ 166 (479)
+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~- 161 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP- 161 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT-
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC-
Confidence 99999999999998876 679999999999999999999999999999999999999 7889999999999865432
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCC----CCCHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN----WFPPE 242 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~ 242 (479)
.......+||+.|+|||++.+. + +.++||||||+++|+|++|..||...+.......+.......|. .+++.
T Consensus 162 --~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 162 --GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp --TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred --ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 2334566899999999998754 4 58999999999999999999999998888888887777666654 58999
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+.+||.+||+.||.+|||+.++++||||++..
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999999999997654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=423.19 Aligned_cols=262 Identities=34% Similarity=0.637 Sum_probs=227.9
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch----------hhHHHHHHHHHHHHhCCCCCcce
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV----------GLADQIKREISVMRIVRHPNIVQ 78 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~----------~~~~~l~~Ei~il~~l~hpnIv~ 78 (479)
...+.++|++++.||+|+||+||+|.+..+++.||||++.+...... ...+.+.+|+.+++.++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34578899999999999999999999999999999999987543321 34578899999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC---CeEE
Q 011694 79 LYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE---NLKI 154 (479)
Q Consensus 79 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g---~vkl 154 (479)
+++++.+...+|+|||||+||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999999998875 6899999999999999999999999999999999999998776 6999
Q ss_pred eecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC
Q 011694 155 SDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK 234 (479)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 234 (479)
+|||+|..... .......+||+.|+|||++.+ .|+ .++||||+||++|+|++|..||.+.+.......+..+.+.
T Consensus 191 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 191 VDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KYN-EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp CCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999875432 223456789999999999874 454 8999999999999999999999999988888888777665
Q ss_pred CC----CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 235 CP----NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 235 ~~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
.+ ..+|+++.+||++||.+||.+|||++++++||||++...
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 44 568999999999999999999999999999999987543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=397.08 Aligned_cols=260 Identities=29% Similarity=0.428 Sum_probs=212.9
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCC---CCCcceeEEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM--RVGLADQIKREISVMRIVR---HPNIVQLYEVM 83 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~l~~Ei~il~~l~---hpnIv~l~~~~ 83 (479)
+.++.++|++.+.||+|+||+||+|++..+|+.||||++...... .......+.+|+.+++.++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 567889999999999999999999999999999999999754321 1122345677888877764 99999999999
Q ss_pred EeCC-----EEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEe
Q 011694 84 ATKS-----KIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKIS 155 (479)
Q Consensus 84 ~~~~-----~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~ 155 (479)
.... .+++||||+.+ +|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 8765 68999999975 999999863 39999999999999999999999999999999999999999999999
Q ss_pred ecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC--
Q 011694 156 DFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-- 233 (479)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-- 233 (479)
|||+|..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.....
T Consensus 163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eCccccccCC---CcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999975432 2334567899999999999888875 899999999999999999999998877665555422100
Q ss_pred -------------------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 234 -------------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 234 -------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
...+.+++++.+||.+||+.||.+|||++++++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0113477899999999999999999999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=410.19 Aligned_cols=256 Identities=27% Similarity=0.533 Sum_probs=225.7
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 355789999999999999999999999999999999976532 22457889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec--CCCeEEeecCchhhhhcc
Q 011694 91 FVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE--NENLKISDFGLSALAQCK 166 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~--~g~vkl~DFGla~~~~~~ 166 (479)
+||||+.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|.....
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~- 203 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 203 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC-
Confidence 999999999999999763 6999999999999999999999999999999999999974 47799999999875432
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----CCCCHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPPE 242 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~ 242 (479)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.......+ ..+|++
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 204 --DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred --CcceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 2334556899999999999887775 899999999999999999999999887777777765544333 457999
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+.+||.+||..||.+|||+.++++||||+..
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 9999999999999999999999999999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=402.44 Aligned_cols=264 Identities=30% Similarity=0.444 Sum_probs=210.5
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
........++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+++.++||||+++++++.+
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (329)
T 3gbz_A 26 AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHH 104 (329)
T ss_dssp ------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred cCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence 345566778999999999999999999999999999999999765432 2344667799999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-----CCCeEEeecCc
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-----NENLKISDFGL 159 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-----~g~vkl~DFGl 159 (479)
.+.+|+||||++| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 105 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 105 NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred CCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999999999985 99999876 47999999999999999999999999999999999999954 44599999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-CC----
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-FK---- 234 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~---- 234 (479)
|...... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+.... .+
T Consensus 184 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 9765422 2233456789999999999876645689999999999999999999999877665554442210 00
Q ss_pred ------CC-------------------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 235 ------CP-------------------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 235 ------~~-------------------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+ ..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 01 1167899999999999999999999999999999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=425.75 Aligned_cols=261 Identities=26% Similarity=0.437 Sum_probs=232.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+-.++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 45568999999999999999999999999999999999876554444567788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 90 FFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
|+||||++||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999999865 259999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC----hHHHHHHHhccCcCCCCCCCC
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS----NLIEMYRKIGKAEFKCPNWFP 240 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~ 240 (479)
.. .....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||... +...+...+.......|..+|
T Consensus 341 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s 417 (543)
T 3c4z_A 341 AG--QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417 (543)
T ss_dssp TT--CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred CC--CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence 22 1223456999999999999988886 8999999999999999999999875 345677777777788889999
Q ss_pred HHHHHHHHHhccCCccccCC-----hhhhhcChhhhcc
Q 011694 241 PEVRKLLCKILDPNPSTRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt-----~~eil~h~wf~~~ 273 (479)
+++.+||.+||.+||.+||+ +++|++||||+..
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 99999999999999999996 4899999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=439.41 Aligned_cols=261 Identities=30% Similarity=0.542 Sum_probs=236.2
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (479)
.+-.++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34567899999999999999999999999999999999876544444557788899999987 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+||||||++||+|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|.....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~-- 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--
Confidence 9999999999999999987 7899999999999999999999999999999999999999999999999999874321
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 247 (479)
......+.+||+.|+|||++.+.+|+ .++|||||||+||+|++|..||.+.+..+++..+......+|..+++++.+||
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 573 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 573 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 22335677999999999999988885 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCccccCCh-----hhhhcChhhhcc
Q 011694 248 CKILDPNPSTRISM-----AKIRESSWFRKG 273 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~-----~eil~h~wf~~~ 273 (479)
++||+.||.+||++ ++|++||||+..
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 99999999999998 999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=394.89 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=214.8
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
+.++|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 35789999999999999999999999999999999976543 23445778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 157 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SD 157 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--cc
Confidence 9999999999998875 57999999999999999999999999999999999999999999999999998754322 22
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------------
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------------- 231 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 231 (479)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2345689999999999987554468999999999999999999999887665443332110
Q ss_pred --cCCCC----------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 --EFKCP----------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 --~~~~~----------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..+.+ +.+++++.+||.+||+.||.+|||++++++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 11111 34788999999999999999999999999999997653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=389.48 Aligned_cols=262 Identities=37% Similarity=0.700 Sum_probs=226.0
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
+.++|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 457899999999999999999999999999999999765432 345788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999999986 479999999999999999999999999999999999999999999999999987654333333
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-HHHHHhccCc--CCCCCCCCHHHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI-EMYRKIGKAE--FKCPNWFPPEVRKLL 247 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~--~~~~~~~~~~~~~li 247 (479)
.....+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.. ..+..+.... ...+..+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 4456789999999999988777667899999999999999999999875532 2333333222 222345899999999
Q ss_pred HHhccCCccccCChhhhhcChhhhcccc
Q 011694 248 CKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
.+||..||.+|||++++++||||++...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9999999999999999999999986653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=402.51 Aligned_cols=257 Identities=34% Similarity=0.631 Sum_probs=209.0
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
....+.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT 121 (349)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence 34567788999999999999999999999999999999997643 2356789999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec---CCCeEEeecCchhhh
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---NENLKISDFGLSALA 163 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---~g~vkl~DFGla~~~ 163 (479)
.+|+||||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999999999976 56999999999999999999999999999999999999975 889999999998764
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-HHHHHhccCcCCCC----CC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI-EMYRKIGKAEFKCP----NW 238 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~----~~ 238 (479)
... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.... ..+..+.......+ ..
T Consensus 202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (349)
T 2w4o_A 202 EHQ---VLMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDE 277 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTT
T ss_pred Ccc---cccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhh
Confidence 322 233467899999999999887775 8999999999999999999999776544 35555555443322 45
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+++++.+||.+||..||.+|||+.++++||||...
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 78999999999999999999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=393.83 Aligned_cols=254 Identities=27% Similarity=0.494 Sum_probs=223.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 48889999999999999999999999999999976543 234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccc
Q 011694 95 YAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHT 174 (479)
Q Consensus 95 ~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~ 174 (479)
|++|++|.+++...++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 200 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKS 200 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--cccccc
Confidence 999999999999889999999999999999999999999999999999999999999999999998754322 122345
Q ss_pred cCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc---CCCCCCCCHHHHHHHHHhc
Q 011694 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPPEVRKLLCKIL 251 (479)
Q Consensus 175 ~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~L 251 (479)
.+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.... ...+..+++.+.+||.+||
T Consensus 201 ~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred ccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 6899999999999887775 89999999999999999999999887766666554432 2233457899999999999
Q ss_pred cCCccccCChhhhhcChhhhccc
Q 011694 252 DPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 252 ~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..||.+|||++++++||||....
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGGCC
T ss_pred cCChhhCcCHHHHhcChhhccCC
Confidence 99999999999999999997654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=420.79 Aligned_cols=260 Identities=27% Similarity=0.448 Sum_probs=213.8
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK---- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (479)
.+.++|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 346899999999999999999999999999999999986532 334567888999999999999999999999654
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 --SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
..+|+||||++++ |.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 138 ~~~~~~lv~E~~~~~-l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 138 EFQDVYLVMELMDAN-LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp TCCEEEEEEECCSEE-HHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred cCCeEEEEEeCCCCC-HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 4689999999874 6666654 59999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc------------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE------------ 232 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 232 (479)
. .......+||+.|+|||++.+..|+ .++|||||||+||+|++|+.||.+.+....+..+....
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 2334567899999999999988886 89999999999999999999999887666555442210
Q ss_pred ---------------CCC----CCC-----------CCHHHHHHHHHhccCCccccCChhhhhcChhhhcccchh
Q 011694 233 ---------------FKC----PNW-----------FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQK 277 (479)
Q Consensus 233 ---------------~~~----~~~-----------~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~~ 277 (479)
..+ |.. .++++.+||.+||..||.+|||++|+++||||+....+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~ 366 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA 366 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHH
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcc
Confidence 000 000 146789999999999999999999999999998765443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=389.30 Aligned_cols=261 Identities=26% Similarity=0.417 Sum_probs=222.0
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
-+.++.++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 46788999999999999999999999999999999999997766555566788999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.+|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999999999976 67999999999999999999999999999999999999999999999999998754322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-----CCCCCCCH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-----KCPNWFPP 241 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~~~ 241 (479)
. .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+............. ..++.+|+
T Consensus 165 ~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 165 S-LTQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred c-ccccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 1 1223456799999999999887775 899999999999999999999998876655444433322 23456899
Q ss_pred HHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
.+.++|.+||++||.+||+..+.+.+.|.
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 99999999999999999976666666664
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=399.30 Aligned_cols=265 Identities=27% Similarity=0.464 Sum_probs=222.7
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
.++..+.++|++.+.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 46778999999999999999999999999999999999999876655556667899999999999999999999998765
Q ss_pred C----EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 87 S----KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 87 ~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
. ..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 4 45999999999999999975 679999999999999999999999999999999999999999999999999997
Q ss_pred hhhccccC-CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCC----C
Q 011694 162 LAQCKHQD-GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC----P 236 (479)
Q Consensus 162 ~~~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----~ 236 (479)
........ ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+....... +
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 65432211 223345799999999999888775 89999999999999999999999887766655544433322 2
Q ss_pred CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 237 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
..+|+++.++|.+||+.||.+||++.+++.|+|++.
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 458999999999999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=420.86 Aligned_cols=259 Identities=36% Similarity=0.643 Sum_probs=222.6
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
..+.++|++++.||+|+||+||+|++..++..||||++.+..... .....+.+|+.+++.++||||+++++++.+.+.+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 346678999999999999999999999999999999998765433 2346788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC---CCeEEeecCchhhhhc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN---ENLKISDFGLSALAQC 165 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~---g~vkl~DFGla~~~~~ 165 (479)
|+|||||+||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+|.....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999999998875 689999999999999999999999999999999999999764 4599999999876542
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----CCCCH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPP 241 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 241 (479)
. ......+||+.|+|||++.+ .|+ .++||||+||++|+|++|..||.+.+..+....+....+..+ ..+|+
T Consensus 192 ~---~~~~~~~gt~~y~aPE~l~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 192 Q---KKMKERLGTAYYIAPEVLRK-KYD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp T---BCBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred C---ccccccCCCcCeeCHHHHcc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 2 23456789999999999864 464 899999999999999999999999988888888876655443 34899
Q ss_pred HHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+.+||.+||..||.+|||++++++||||+...
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 999999999999999999999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=421.33 Aligned_cols=258 Identities=34% Similarity=0.649 Sum_probs=225.6
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
.+.++|++++.||+|+||+||+|.+..+++.||||++.+..... .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 46789999999999999999999999999999999997654332 23577889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe---cCCCeEEeecCchhhhhcc
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD---ENENLKISDFGLSALAQCK 166 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~---~~g~vkl~DFGla~~~~~~ 166 (479)
+|||||.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC-
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC-
Confidence 99999999999998865 6899999999999999999999999999999999999995 456799999999975432
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCC--C--CCCCHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC--P--NWFPPE 242 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~--~~~~~~ 242 (479)
.......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+.......+....+.. | ..+|++
T Consensus 177 --~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 177 --NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp --C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred --CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 223456789999999999976 35 489999999999999999999999998888888876655433 3 347899
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+.+||.+||..||.+|||+.++++||||+...
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99999999999999999999999999998653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=400.77 Aligned_cols=254 Identities=36% Similarity=0.705 Sum_probs=202.3
Q ss_pred ccCCCeEEe---eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeC
Q 011694 11 VLTEKYEVG---RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATK 86 (479)
Q Consensus 11 il~~~y~i~---~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~ 86 (479)
.+.++|++. +.||+|+||.||+|.+..+|+.||||++.+. ....+.+|+.+++.+. ||||+++++++.+.
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 345678886 7899999999999999999999999999653 2356789999999997 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC---CeEEeecCchhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE---NLKISDFGLSAL 162 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g---~vkl~DFGla~~ 162 (479)
...|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 999999999999999999987 5799999999999999999999999999999999999998766 799999999875
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh-------HHHHHHHhccCcCCC
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-------LIEMYRKIGKAEFKC 235 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i~~~~~~~ 235 (479)
.... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||...+ ..+....+..+.+..
T Consensus 159 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 159 KPPD--NQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp CCC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred cCCC--CCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 4322 2234567899999999999888876 89999999999999999999998643 345666776666555
Q ss_pred CC----CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 236 PN----WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 236 ~~----~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+. .+|+++.+||.+||..||.+|||++++++||||+..
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 43 479999999999999999999999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=405.21 Aligned_cols=257 Identities=28% Similarity=0.409 Sum_probs=214.9
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK---- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (479)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 356899999999999999999999999999999999966432 334567889999999999999999999999765
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 --SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
..+|+||||+ |++|.+++..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3569999999 7899999998899999999999999999999999999999999999999999999999999987532
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc------------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE------------ 232 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 232 (479)
......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+....
T Consensus 180 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 -----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp -----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred -----cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 223456899999999999874434589999999999999999999999877655544432110
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 233 -------------------FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 233 -------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
...++.+++.+.+||.+||..||.+|||++++++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 012345689999999999999999999999999999997644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=387.56 Aligned_cols=255 Identities=34% Similarity=0.609 Sum_probs=217.3
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 4678999999999999999999999999999999999875432 23578899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE---ecCCCeEEeecCchhh
Q 011694 91 FVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSAL 162 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl---~~~g~vkl~DFGla~~ 162 (479)
+||||++||+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999999998853 569999999999999999999999999999999999999 4567899999999975
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC---CCC
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP---NWF 239 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~ 239 (479)
.... ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......+ ..+
T Consensus 177 ~~~~---~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (285)
T 3is5_A 177 FKSD---EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL 251 (285)
T ss_dssp -------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred cCCc---ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence 4332 22345679999999999864 45 4899999999999999999999998887766665543333222 337
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
++++.+||.+||+.||.+|||++|+++||||++
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 899999999999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=401.67 Aligned_cols=263 Identities=34% Similarity=0.573 Sum_probs=220.6
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM--RVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3468999999999999999999999999999999999765432 23455788999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 011694 89 IFFVMEYAKGGELFNKVAK-----------------------------------------GKLKEDAARRYFQQLINAVD 127 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-----------------------------------------~~l~e~~~~~i~~qll~aL~ 127 (479)
.|+||||++||+|.+++.. ..+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999998852 12467889999999999999
Q ss_pred HHHHCCCeeccCCCCCEEEecCC--CeEEeecCchhhhhccccCC--CccccCCCCcccChhhhhc--CCCCCCccchhh
Q 011694 128 FCHSRGVYHRDIKPENLLLDENE--NLKISDFGLSALAQCKHQDG--LLHTTCGTPAYVAPEVINR--KGYDGEKVDIWS 201 (479)
Q Consensus 128 ~LH~~givHrDLkp~NILl~~~g--~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPEvl~~--~~~~~~~~DvwS 201 (479)
|||++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++.+ ..+ +.++||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~Diws 261 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWS 261 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC-CTHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC-CcHHHHHH
Confidence 99999999999999999998776 89999999997654322211 2346689999999999975 344 58999999
Q ss_pred HHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC--C--CCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 202 CGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP--N--WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 202 lGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--~--~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
|||++|+|++|..||.+.+.......+.......+ . .+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999999887777766655443332 2 3789999999999999999999999999999997643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=404.02 Aligned_cols=255 Identities=31% Similarity=0.548 Sum_probs=223.4
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV-----GLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
+.++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45789999999999999999999999999999999987643221 1234567899999999999999999999999
Q ss_pred CEEEEEEeccCCC-ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGG-ELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg-~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
+.+++||||+.+| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999999776 99999987 479999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHH
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVR 244 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (479)
. .....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... ........|..+++++.
T Consensus 182 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l~ 252 (335)
T 3dls_A 182 R---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKELM 252 (335)
T ss_dssp T---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHHH
T ss_pred C---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHHH
Confidence 2 23345678999999999999888867899999999999999999999976432 23344566777899999
Q ss_pred HHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 245 KLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
+||.+||++||.+|||++++++||||+....
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 283 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred HHHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence 9999999999999999999999999987543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=393.01 Aligned_cols=259 Identities=30% Similarity=0.584 Sum_probs=215.0
Q ss_pred ccCCCeEEe-eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 011694 11 VLTEKYEVG-RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSK 88 (479)
Q Consensus 11 il~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (479)
.+.++|++. +.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 467889995 789999999999999999999999999976532 3356788999999885 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC---eEEeecCchhhhh
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN---LKISDFGLSALAQ 164 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~---vkl~DFGla~~~~ 164 (479)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999999999976 67999999999999999999999999999999999999988776 9999999987543
Q ss_pred cccc-----CCCccccCCCCcccChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCh--------------
Q 011694 165 CKHQ-----DGLLHTTCGTPAYVAPEVINR-----KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-------------- 220 (479)
Q Consensus 165 ~~~~-----~~~~~~~~gt~~y~aPEvl~~-----~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-------------- 220 (479)
.... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 2211 112335679999999999975 334 489999999999999999999997653
Q ss_pred -HHHHHHHhccCcCCCC----CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 221 -LIEMYRKIGKAEFKCP----NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 221 -~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
....+..+.......| ..+++++.+||.+||..||.+|||++++++||||+..
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2334555555555555 3588999999999999999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=385.32 Aligned_cols=260 Identities=31% Similarity=0.606 Sum_probs=225.2
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV---GLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
+++.++|++++.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 1 s~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CchhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 3567889999999999999999999999999999999987543321 2357889999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC----CeEEeecCchh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE----NLKISDFGLSA 161 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g----~vkl~DFGla~ 161 (479)
+..|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999999976 6799999999999999999999999999999999999998777 89999999987
Q ss_pred hhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----C
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----N 237 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~ 237 (479)
..... .......||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.......+ .
T Consensus 161 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T 3bhy_A 161 KIEAG---NEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred eccCC---CcccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc
Confidence 54322 223456799999999999877765 899999999999999999999999887777777665544433 4
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 578999999999999999999999999999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=397.13 Aligned_cols=264 Identities=28% Similarity=0.469 Sum_probs=225.4
Q ss_pred CCCCCccCCCeEEe-eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEE
Q 011694 6 HNKPSVLTEKYEVG-RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVM 83 (479)
Q Consensus 6 ~~~~~il~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~ 83 (479)
......+.++|.+. +.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+++.+. ||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34456678899998 89999999999999999999999999998754332 34577889999999995 69999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec---CCCeEEeec
Q 011694 84 ATKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---NENLKISDF 157 (479)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---~g~vkl~DF 157 (479)
.+.+.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999999999864 56999999999999999999999999999999999999987 789999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC---
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK--- 234 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--- 234 (479)
|++...... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+......
T Consensus 179 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 179 GMSRKIGHA---CELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred ccccccCCc---cccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 998754322 223456899999999999887775 8999999999999999999999988877776666444332
Q ss_pred -CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 235 -CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 235 -~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+..+++.+.+||.+||+.||.+|||++++++||||+...
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 2345789999999999999999999999999999997653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=407.63 Aligned_cols=250 Identities=32% Similarity=0.627 Sum_probs=205.9
Q ss_pred cCCCeEEe-eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceeEEEEEe----
Q 011694 12 LTEKYEVG-RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQLYEVMAT---- 85 (479)
Q Consensus 12 l~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il-~~l~hpnIv~l~~~~~~---- 85 (479)
+.++|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 45567776 7999999999999999999999999999643 3456888887 45589999999999876
Q ss_pred CCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec---CCCeEEeecCc
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---NENLKISDFGL 159 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---~g~vkl~DFGl 159 (479)
...+|+|||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 66799999999999999999863 4999999999999999999999999999999999999987 78999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH----HHHHHhccCcCCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI----EMYRKIGKAEFKC 235 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~ 235 (479)
+..... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+.. .....+..+.+..
T Consensus 211 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 211 AKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred ccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 875432 2234567899999999999887776 8999999999999999999999765432 1333444444433
Q ss_pred C----CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 236 P----NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 236 ~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
| ..+++++.+||.+||..||.+|||++++++||||...
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 3 3589999999999999999999999999999999753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=399.28 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=220.7
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----C
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK-----S 87 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 87 (479)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 479999999999999999999999999999999997533 234457788999999999999999999999765 4
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 88 KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
..|+||||+.| +|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred eEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 69999999985 99999998899999999999999999999999999999999999999999999999999997654332
Q ss_pred c-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc--------------
Q 011694 168 Q-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-------------- 232 (479)
Q Consensus 168 ~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------- 232 (479)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 2 2234566899999999998765544589999999999999999999998876554444332100
Q ss_pred --------C---------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 233 --------F---------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 233 --------~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
. ..++.+++++.+||.+||+.||.+|||++++++||||+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 0 012447899999999999999999999999999999987643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=397.35 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=209.1
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++++.||+|+||.||+|.+..+++.||||++....... ....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 68999999999999999999999999999999997543211 1123457999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||++| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~ 156 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKT 156 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--ccc
Confidence 99985 88888875 35999999999999999999999999999999999999999999999999998654322 223
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-------------------
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE------------------- 232 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------- 232 (479)
....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 3456789999999999875544689999999999999999999999887666555442210
Q ss_pred C-----------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 233 F-----------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 233 ~-----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
. ..++.+++++.+||.+||+.||.+|||++|+++||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0 01224688999999999999999999999999999997654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=398.24 Aligned_cols=262 Identities=25% Similarity=0.381 Sum_probs=217.9
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe------
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT------ 85 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~------ 85 (479)
..++|++++.||+|+||.||+|++..+|+.||||++....... .....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 3578999999999999999999999999999999997654332 334567799999999999999999999987
Q ss_pred --CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 86 --KSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 86 --~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
.+.+|+||||+++ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4579999999986 77777765 579999999999999999999999999999999999999999999999999987
Q ss_pred hhhccc--cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCC-
Q 011694 162 LAQCKH--QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNW- 238 (479)
Q Consensus 162 ~~~~~~--~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~- 238 (479)
...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......++.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 543221 12233456899999999999875544689999999999999999999999887766555543211111110
Q ss_pred -------------------------------CCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 239 -------------------------------FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 239 -------------------------------~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
.++.+.+||.+||..||.+|||++|+++||||.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 2678999999999999999999999999999976543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=392.59 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=208.3
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceeEEEEEeC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il-~~l~hpnIv~l~~~~~~~ 86 (479)
.+.++.++|++.+.||+|+||+||+|++..+|+.||||++............ ...|+..+ +..+||||+++++++.+.
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~-~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHH-HHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHH-HHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 3455668899999999999999999999999999999998765433333333 34455444 445899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
+.+|+||||+ +++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999999999 6688888765 469999999999999999999999999999999999999999999999999986543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc--CCCCCCCCHH
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--FKCPNWFPPE 242 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 242 (479)
. .......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||...+.... +.... ...+..++++
T Consensus 209 ~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 280 (311)
T 3p1a_A 209 T---AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAGLSSE 280 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTTTCCCHHHHTTSCHH
T ss_pred c---CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HhccCCCcccccCCCHH
Confidence 2 223345679999999999976 45 4899999999999999999777665443222 22221 1234568999
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
+.+||.+||++||.+|||++++++||||++
T Consensus 281 l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=393.11 Aligned_cols=262 Identities=37% Similarity=0.651 Sum_probs=226.5
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCcceeEEEE--EeCCE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR-VGLADQIKREISVMRIVRHPNIVQLYEVM--ATKSK 88 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~l~~Ei~il~~l~hpnIv~l~~~~--~~~~~ 88 (479)
+.++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ .+.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 5689999999999999999999999999999999997654322 23457889999999999999999999998 45568
Q ss_pred EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 89 IFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.|+||||+.++ |.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999999987 6666653 5799999999999999999999999999999999999999999999999999876543
Q ss_pred cccCCCccccCCCCcccChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKG-YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVR 244 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (479)
...........||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+.......+.......|..+++.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 33333345667999999999997643 33578999999999999999999999998888888888888888889999999
Q ss_pred HHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 245 KLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+||.+||..||.+|||++++++||||++..
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 999999999999999999999999997654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=402.97 Aligned_cols=256 Identities=31% Similarity=0.536 Sum_probs=218.2
Q ss_pred cCCCeEE--eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 12 LTEKYEV--GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 12 l~~~y~i--~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
+...|.+ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 4455666 6789999999999999999999999999976542 2346789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE--ecCCCeEEeecCchhhhhc
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL--DENENLKISDFGLSALAQC 165 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl--~~~g~vkl~DFGla~~~~~ 165 (479)
|+||||++||+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999999999998865 369999999999999999999999999999999999999 4567899999999875432
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----CCCCH
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPP 241 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 241 (479)
. ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.......+ ..+++
T Consensus 242 ~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 242 R---EKLKVNFGTPEFLAPEVVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp T---CBCCCCCSSCTTCCHHHHTTCBCC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred c---cccccccCCCcEeChhhccCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 2 233456799999999999876664 899999999999999999999999888777777765544433 45899
Q ss_pred HHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
++.+||.+||..||.+|||++++++||||+...
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 999999999999999999999999999997653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=414.23 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=199.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT----- 85 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~----- 85 (479)
.+.++|++++.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 45689999999999999999999999999999999996543 233445788999999999999999999999943
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
...+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 357999999985 589999887 469999999999999999999999999999999999999999999999999997654
Q ss_pred ccccC-------------------------CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh--------
Q 011694 165 CKHQD-------------------------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-------- 211 (479)
Q Consensus 165 ~~~~~-------------------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-------- 211 (479)
..... ......+||+.|+|||++......+.++|||||||+||+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 22111 123456899999999987544434589999999999999998
Q ss_pred ---CCCCCCCChH--------------------HHHHHHhc----cC---------------------------cCCCCC
Q 011694 212 ---GYLPFHDSNL--------------------IEMYRKIG----KA---------------------------EFKCPN 237 (479)
Q Consensus 212 ---G~~Pf~~~~~--------------------~~~~~~i~----~~---------------------------~~~~~~ 237 (479)
|.++|.+.+. ......+. .. .....+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 6777765431 11111110 00 001123
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+++++.+||.+||..||.+|||++|+++||||+...
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 4689999999999999999999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=388.84 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=214.8
Q ss_pred CCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 4 ~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
|......+..++|++.+.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 44556678889999999999999999999987 7889999999765443 24457788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCCEEEecCCCeEEeec
Q 011694 84 ATKSKIFFVMEYAKGGELFNKVAKGK----LKEDAARRYFQQLINAVDFCHSRG--VYHRDIKPENLLLDENENLKISDF 157 (479)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~i~~~~----l~e~~~~~i~~qll~aL~~LH~~g--ivHrDLkp~NILl~~~g~vkl~DF 157 (479)
.+.+.+|+||||++||+|.+++.... +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999999998743 999999999999999999999999 999999999999999999999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHh--ccCcCCC
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKC 235 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i--~~~~~~~ 235 (479)
|++...... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+ .......
T Consensus 184 g~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T 3p86_A 184 GLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260 (309)
T ss_dssp C-------------------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred CCCcccccc--ccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 998754322 1223456899999999999888775 8999999999999999999999988877666655 4455677
Q ss_pred CCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 236 PNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 236 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
|..+++++.+||.+||..||.+|||++++++
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8889999999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=398.51 Aligned_cols=257 Identities=33% Similarity=0.641 Sum_probs=224.3
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM-----RVGLADQIKREISVMRIV-RHPNIVQLYEVMAT 85 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (479)
+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 346899999999999999999999999999999999765321 123356788999999999 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
.+..|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999999976 579999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCCccccCCCCcccChhhhhcC------CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC--
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRK------GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP-- 236 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~------~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-- 236 (479)
. .......+||+.|+|||++.+. .+ +.++|||||||++|+|++|..||...+.......+.......+
T Consensus 252 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 252 P---GEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred C---CcccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 2 2234567899999999998643 34 4799999999999999999999998887777777765554433
Q ss_pred --CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 237 --NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 237 --~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
..+++.+.+||.+||..||.+|||++++++||||++
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 357899999999999999999999999999999963
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=407.61 Aligned_cols=263 Identities=25% Similarity=0.410 Sum_probs=210.2
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK---- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (479)
.+.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 46789999999999999999999999999999999997643 2334457889999999999999999999999766
Q ss_pred -CEEEEEEeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 -SKIFFVMEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
+.+|+||||+.+ +|.+.+..+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 579999999975 999999874 69999999999999999999999999999999999999999999999999997654
Q ss_pred ccccC--------------------CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCC-----------
Q 011694 165 CKHQD--------------------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGY----------- 213 (479)
Q Consensus 165 ~~~~~--------------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~----------- 213 (479)
..... ......+||+.|+|||++......+.++||||+||++|+|++|.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 32211 12466789999999999755444458999999999999999844
Q ss_pred CCCCCChH-----------------HHHHHH------------------------hccCcCCC-------CCCCCHHHHH
Q 011694 214 LPFHDSNL-----------------IEMYRK------------------------IGKAEFKC-------PNWFPPEVRK 245 (479)
Q Consensus 214 ~Pf~~~~~-----------------~~~~~~------------------------i~~~~~~~-------~~~~~~~~~~ 245 (479)
++|.+.+. ...... +....... .+.+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 44433220 011111 10001111 1347899999
Q ss_pred HHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 246 LLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
||.+||..||.+|||++|+++||||+....
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999999986543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=381.77 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=215.8
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (479)
..+.++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+..+..+ +||||+++++++.+.+.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 346788999999999999999999999999999999998754333 3346778899999998 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC--------------
Q 011694 89 IFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN-------------- 149 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~-------------- 149 (479)
.|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999999875 569999999999999999999999999999999999999844
Q ss_pred -----CCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHH
Q 011694 150 -----ENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEM 224 (479)
Q Consensus 150 -----g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~ 224 (479)
..+||+|||++..... ....+||+.|+|||++.+....+.++|||||||++|+|++|..|+........
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~ 239 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239 (289)
T ss_dssp ----CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH
T ss_pred ccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH
Confidence 4799999999875432 23356999999999998764545799999999999999999988766654332
Q ss_pred HHHhccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 225 YRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
... ......|..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 240 ~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 240 IRQ--GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHT--TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHc--CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 221 22235667799999999999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=388.55 Aligned_cols=257 Identities=34% Similarity=0.692 Sum_probs=223.8
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
...+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 345778999999999999999999999999999999999865422 23568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE---ecCCCeEEeecCchhhhh
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQ 164 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl---~~~g~vkl~DFGla~~~~ 164 (479)
.|+||||++|++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999999999875 679999999999999999999999999999999999999 778899999999986432
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCC----CCCCC
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKC----PNWFP 240 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~ 240 (479)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+....... +..+|
T Consensus 161 ----~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 161 ----NGIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp ----CBTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred ----CCccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCC
Confidence 1223456799999999999877775 89999999999999999999999888777777776554332 34588
Q ss_pred HHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+++.+||.+||..||.+|||++++++||||...
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=392.98 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=216.5
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
..++|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 45789999999999999999999999999999999976543 23445678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GE 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--cc
Confidence 9999999999888764 67999999999999999999999999999999999999999999999999998754322 22
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------------------
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------------- 231 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 231 (479)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 3345679999999999987644568999999999999999999999887655444332110
Q ss_pred cCCC------------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 232 EFKC------------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 232 ~~~~------------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.... .+.+++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0111 12468999999999999999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=394.75 Aligned_cols=261 Identities=25% Similarity=0.422 Sum_probs=214.7
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeEEEEEeC
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH--PNIVQLYEVMATK 86 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h--pnIv~l~~~~~~~ 86 (479)
.++..++|++.+.||+|+||.||+|.+ .+++.||||++...... ....+.+.+|+.+++.++| |||+++++++.+.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 356678899999999999999999988 56899999999876433 2445788999999999986 9999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
+.+|+||| +.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|.....
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99999999 557799999987 5799999999999999999999999999999999999996 68899999999976544
Q ss_pred cccCCCccccCCCCcccChhhhhc-----------CCCCCCccchhhHHHHHHHHHhCCCCCCCCh-HHHHHHHhc--cC
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINR-----------KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKIG--KA 231 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~-----------~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~--~~ 231 (479)
..........+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.... .......+. ..
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 333333456789999999999965 334 589999999999999999999998643 223333332 23
Q ss_pred cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
....|...++++.+||.+||..||.+|||+.++++||||+...
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 4566777889999999999999999999999999999997543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=381.71 Aligned_cols=262 Identities=33% Similarity=0.578 Sum_probs=225.8
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc------chhhHHHHHHHHHHHHhCC-CCCcceeEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM------RVGLADQIKREISVMRIVR-HPNIVQLYE 81 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~------~~~~~~~l~~Ei~il~~l~-hpnIv~l~~ 81 (479)
...+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+.+|+.+++.+. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 456789999999999999999999999999999999999765321 1233567889999999995 999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
++.+.+..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999999986 57999999999999999999999999999999999999999999999999998
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhc------CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINR------KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK 234 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~------~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 234 (479)
..... .......+||+.|+|||++.+ ..+ +.++||||||+++|+|++|..||...+.......+......
T Consensus 172 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 172 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred hhcCC---CcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence 75432 223455689999999999862 234 48999999999999999999999988877777776555443
Q ss_pred CC----CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 235 CP----NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 235 ~~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+ ..+++.+.+||.+||..||.+|||++++++||||++..
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 33 34789999999999999999999999999999997654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=394.69 Aligned_cols=260 Identities=24% Similarity=0.403 Sum_probs=222.3
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.+.+..++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 104 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence 45778899999999999999999999999999999999998653 2345678899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.+|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999999999986 6899999999999999999999996 999999999999999999999999999875533
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHh-----------------
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI----------------- 228 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i----------------- 228 (479)
. .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+
T Consensus 185 ~----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 185 S----MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp H----C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred c----cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 2 22356899999999999887775 8999999999999999999999876544322211
Q ss_pred -------------------------ccCc-CC-CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 229 -------------------------GKAE-FK-CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 229 -------------------------~~~~-~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.... .. .+..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 1111 11 1223688999999999999999999999999999997643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=391.86 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=220.7
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.+.|++.+.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999999999999999999876544445567889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||+. |+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 99998 478887753 5799999999999999999999999999999999999999999999999999865421
Q ss_pred CccccCCCCcccChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC--CCCCCCCHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVIN---RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF--KCPNWFPPEVRK 245 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~---~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~ 245 (479)
....+||+.|+|||++. ...+ +.++|||||||++|+|++|..||.+.+.......+..... ..+..+++.+.+
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 284 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 284 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred -CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 23568999999999985 3445 4799999999999999999999988776655555543322 234568899999
Q ss_pred HHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 246 LLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
||.+||+.||.+|||++++++||||.....
T Consensus 285 li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 285 FVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 999999999999999999999999976543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=395.39 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=209.9
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC---
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS--- 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~--- 87 (479)
.+.++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 35678999999999999999999999999999999997654 2245578899999999999999999999986543
Q ss_pred ------------------------------------------------------EEEEEEeccCCCChHHHHhcC----C
Q 011694 88 ------------------------------------------------------KIFFVMEYAKGGELFNKVAKG----K 109 (479)
Q Consensus 88 ------------------------------------------------------~~~lV~E~~~gg~L~~~i~~~----~ 109 (479)
.+|+|||||+||+|.+++... .
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 389999999999999999873 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc----------CCCccccCCCC
Q 011694 110 LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ----------DGLLHTTCGTP 179 (479)
Q Consensus 110 l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~----------~~~~~~~~gt~ 179 (479)
.++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 56777999999999999999999999999999999999999999999999876543221 11234467999
Q ss_pred cccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC-CCCCCCHHHHHHHHHhccCCcccc
Q 011694 180 AYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK-CPNWFPPEVRKLLCKILDPNPSTR 258 (479)
Q Consensus 180 ~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R 258 (479)
.|+|||++.+..++ .++|||||||++|+|++|..|+... ......+.....+ .+...++++.+||.+||+.||.+|
T Consensus 241 ~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 99999999888775 8999999999999999987775332 2222222222211 112356888999999999999999
Q ss_pred CChhhhhcChhhhc
Q 011694 259 ISMAKIRESSWFRK 272 (479)
Q Consensus 259 pt~~eil~h~wf~~ 272 (479)
||++++++||||+.
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999964
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=399.98 Aligned_cols=258 Identities=28% Similarity=0.405 Sum_probs=202.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK---- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (479)
.+.++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 346899999999999999999999999999999999976432 234457788999999999999999999999654
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 --SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
..+|+||||+ +++|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 6799999988899999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc------------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE------------ 232 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 232 (479)
. .....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 23456899999999999874444589999999999999999999999877655544432100
Q ss_pred -----------CC--------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 233 -----------FK--------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 233 -----------~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
.. ..+.+++.+.+||.+||..||.+|||++++++||||+....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 00 01246789999999999999999999999999999986543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=397.33 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=210.8
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC---
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS--- 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~--- 87 (479)
.+.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 356899999999999999999999999999999999976532 2345577889999999999999999999997665
Q ss_pred ---EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 88 ---KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 88 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 89999999986 7888775 469999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC----------
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK---------- 234 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---------- 234 (479)
.. ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+......
T Consensus 179 ~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 TS---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cc---cccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 21 223456899999999999988775 8999999999999999999999988776655554321100
Q ss_pred --------------------------CCCC------CCHHHHHHHHHhccCCccccCChhhhhcChhhhcccchh
Q 011694 235 --------------------------CPNW------FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQK 277 (479)
Q Consensus 235 --------------------------~~~~------~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~~ 277 (479)
.|.. .++++.+||.+||..||.+|||++++++||||+......
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 329 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 329 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCcc
Confidence 0000 146789999999999999999999999999998765543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=381.70 Aligned_cols=259 Identities=27% Similarity=0.471 Sum_probs=228.3
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
-..+.|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 3457899999999999999999999999999999999765432 34578899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 91 FVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
+||||++|++|.+++..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 174 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 174 (303)
T ss_dssp EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence 99999999999999998899999999999999999999999999999999999999999999999999986543221 1
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~ 249 (479)
.....+||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+... ....+..+++.+.+||.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 23456799999999999887775 7999999999999999999999987766655555433 334556789999999999
Q ss_pred hccCCccccCChhhhhcChhhhccc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
||..||.+|||++++++||||....
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HcCCChhhCcCHHHHhhChhhhcCC
Confidence 9999999999999999999997644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=399.44 Aligned_cols=260 Identities=24% Similarity=0.412 Sum_probs=215.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR--HPNIVQLYEVMATKSK 88 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~--hpnIv~l~~~~~~~~~ 88 (479)
+...+|++++.||+|+||.||+|.+.. ++.||||++...... ....+.+.+|+.+++.++ ||||+++++++...+.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 344569999999999999999999864 999999999876443 345678899999999996 5999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+|+||| +.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|.......
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999999 567899999986 5799999999999999999999999999999999999995 6899999999997654333
Q ss_pred cCCCccccCCCCcccChhhhhcC----------CCCCCccchhhHHHHHHHHHhCCCCCCCCh-HHHHHHHhcc--CcCC
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRK----------GYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKIGK--AEFK 234 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~----------~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~--~~~~ 234 (479)
........+||+.|+|||++.+. ...+.++|||||||+||+|++|..||.... .......+.. ....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 33334567899999999999752 223589999999999999999999998643 2333444433 3445
Q ss_pred CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 235 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.|.+.++++.+||.+||..||.+|||+.++++||||+...
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 6778899999999999999999999999999999997543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=390.78 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=220.3
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
......+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 3 KRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp TTCCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred cccccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 4455678899999999999999999999999999999999996432 23445678899999999999999999999865
Q ss_pred C-----CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 86 K-----SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 86 ~-----~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
. ...|+||||+. ++|.+.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccCccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 4 67999999997 48999999889999999999999999999999999999999999999999999999999998
Q ss_pred hhhhccccC--------CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc--
Q 011694 161 ALAQCKHQD--------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK-- 230 (479)
Q Consensus 161 ~~~~~~~~~--------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-- 230 (479)
......... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 754322111 1123457999999999987644445899999999999999999999988765443332211
Q ss_pred --C----------------------cC------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 231 --A----------------------EF------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 231 --~----------------------~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
. .. ..++.+++++.+||.+||..||.+|||++++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0 00 01235789999999999999999999999999999997643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=404.65 Aligned_cols=255 Identities=24% Similarity=0.430 Sum_probs=214.7
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC------CCCCcceeEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV------RHPNIVQLYEV 82 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l------~hpnIv~l~~~ 82 (479)
...+..+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +|+||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 4567789999999999999999999999999999999997643 3346677888888876 57799999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC--eEEeec
Q 011694 83 MATKSKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN--LKISDF 157 (479)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~--vkl~DF 157 (479)
+...+.+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999999996 5899988763 4999999999999999999999999999999999999999887 999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-----
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE----- 232 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----- 232 (479)
|+|.... ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+.......+....
T Consensus 247 G~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 247 GSSCYEH-----QRVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp TTCEETT-----CCCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccceecC-----CcccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9986432 233467899999999999988875 89999999999999999999999877655444332100
Q ss_pred -----------------C-------------------------------------CCCCCCCHHHHHHHHHhccCCcccc
Q 011694 233 -----------------F-------------------------------------KCPNWFPPEVRKLLCKILDPNPSTR 258 (479)
Q Consensus 233 -----------------~-------------------------------------~~~~~~~~~~~~li~~~L~~dP~~R 258 (479)
. ..+...++.+.+||.+||+.||.+|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 0 0011236889999999999999999
Q ss_pred CChhhhhcChhhhccc
Q 011694 259 ISMAKIRESSWFRKGM 274 (479)
Q Consensus 259 pt~~eil~h~wf~~~~ 274 (479)
||++|+++||||++..
T Consensus 401 pta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 401 MTPGQALRHPWLRRRL 416 (429)
T ss_dssp CCHHHHHTSTTTC---
T ss_pred CCHHHHhCChhhccCC
Confidence 9999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=397.05 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=210.9
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe----
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT---- 85 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~---- 85 (479)
+...++|++++.||+|+||.||+|.+..+|+.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 35678999999999999999999999999999999999765322 2379999999999999999999843
Q ss_pred ----------------------------------CCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHH
Q 011694 86 ----------------------------------KSKIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAV 126 (479)
Q Consensus 86 ----------------------------------~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL 126 (479)
...+++||||++| +|.+.+.. +.+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 3458999999985 77666542 5799999999999999999
Q ss_pred HHHHHCCCeeccCCCCCEEEe-cCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHH
Q 011694 127 DFCHSRGVYHRDIKPENLLLD-ENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVV 205 (479)
Q Consensus 127 ~~LH~~givHrDLkp~NILl~-~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvi 205 (479)
.|||++||+||||||+|||++ .++.+||+|||+|..... .......+||+.|+|||++.+....+.++||||+||+
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999999999999999999998 688999999999875432 2233456889999999999876644689999999999
Q ss_pred HHHHHhCCCCCCCChHHHHHHHhccC-----------------cC------------CCCCCCCHHHHHHHHHhccCCcc
Q 011694 206 LFVLLAGYLPFHDSNLIEMYRKIGKA-----------------EF------------KCPNWFPPEVRKLLCKILDPNPS 256 (479)
Q Consensus 206 l~~ll~G~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~~~~~~~li~~~L~~dP~ 256 (479)
+|+|++|..||.+.+..+....+... .. ..|..+|+++.+||.+||..||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999987766555444210 00 13455789999999999999999
Q ss_pred ccCChhhhhcChhhhccc
Q 011694 257 TRISMAKIRESSWFRKGM 274 (479)
Q Consensus 257 ~Rpt~~eil~h~wf~~~~ 274 (479)
+|||+.|+++||||+...
T Consensus 312 ~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GSCCHHHHHTSGGGHHHH
T ss_pred hCCCHHHHhcCHHHHHHH
Confidence 999999999999997653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=394.76 Aligned_cols=260 Identities=28% Similarity=0.417 Sum_probs=212.6
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR--VGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
...++|++++.||+|+||.||+|.+..+|+.||||++....... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 35688999999999999999999999999999999997643321 1223467899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 89 IFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.|+||||+++ +|.+.+... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999999987 888888763 5999999999999999999999999999999999999999999999999999765322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc--C---C-------
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--F---K------- 234 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~---~------- 234 (479)
.......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+..+.... . .
T Consensus 166 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 166 --NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp --CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred --cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 2334567899999999999765544589999999999999999999999887766555543210 0 0
Q ss_pred ----------------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 235 ----------------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 235 ----------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
....+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 013457899999999999999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=377.16 Aligned_cols=254 Identities=24% Similarity=0.484 Sum_probs=217.8
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe----CC
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT----KS 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~----~~ 87 (479)
-...|++.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 3456899999999999999999999999999999998655433 446788999999999999999999999875 46
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCCEEEe-cCCCeEEeecCchhhh
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRG--VYHRDIKPENLLLD-ENENLKISDFGLSALA 163 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~g--ivHrDLkp~NILl~-~~g~vkl~DFGla~~~ 163 (479)
.+|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 69999999999999999987 68999999999999999999999999 99999999999997 7899999999998643
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh-HHHHHHHhccCc--CCCCCCCC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKIGKAE--FKCPNWFP 240 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~--~~~~~~~~ 240 (479)
. .......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.... ....+..+.... ...+...+
T Consensus 183 ~----~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T 1t4h_A 183 R----ASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred c----ccccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence 2 2234456799999999998743 5 489999999999999999999998744 344444444332 23445578
Q ss_pred HHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
+++.+||.+||+.||.+|||++++++||||+.
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 99999999999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=384.38 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=214.6
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE---
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA--- 84 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~--- 84 (479)
.+..+.++|++++.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 56778999999999999999999999999999999999997543 344577889999999999999999999873
Q ss_pred -----------eCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe-cCCCe
Q 011694 85 -----------TKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD-ENENL 152 (479)
Q Consensus 85 -----------~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~-~~g~v 152 (479)
+.+..|+||||++ |+|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 4478999999998 5999999988999999999999999999999999999999999999998 56789
Q ss_pred EEeecCchhhhhccc-cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC
Q 011694 153 KISDFGLSALAQCKH-QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA 231 (479)
Q Consensus 153 kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~ 231 (479)
||+|||++....... .........+|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999987643221 1223345578999999999876444458999999999999999999999987765554444221
Q ss_pred cC------------------------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 232 EF------------------------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 232 ~~------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.. ..++.+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 10 1124578999999999999999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=379.82 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=203.4
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
++..++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.++...++.++||||+++++++.+.+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 56788999999999999999999999999999999999765322 23334555666668889999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 90 FFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
|+||||++| +|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999985 77776643 5799999999999999999999998 9999999999999999999999999998765
Q ss_pred hccccCCCccccCCCCcccChhhh----hcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-hH-HHHHHHhccCcCC-CC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVI----NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS-NL-IEMYRKIGKAEFK-CP 236 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl----~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~-~~-~~~~~~i~~~~~~-~~ 236 (479)
... ......+||+.|+|||++ .+..+ +.++||||+||++|+|++|..||... .. ......+...... .+
T Consensus 161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 161 VDD---VAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred ccc---ccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 332 223345799999999997 33344 58999999999999999999999853 22 2333333333222 23
Q ss_pred CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 237 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 4689999999999999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=406.36 Aligned_cols=250 Identities=18% Similarity=0.213 Sum_probs=206.9
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH---HHHhCCCCCcceeE-------EE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS---VMRIVRHPNIVQLY-------EV 82 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~---il~~l~hpnIv~l~-------~~ 82 (479)
.++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+. +++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999999999999999998765555556788999995 45555799999998 77
Q ss_pred EEeCCE-----------------EEEEEeccCCCChHHHHhc-CCCCH-------HHHHHHHHHHHHHHHHHHHCCCeec
Q 011694 83 MATKSK-----------------IFFVMEYAKGGELFNKVAK-GKLKE-------DAARRYFQQLINAVDFCHSRGVYHR 137 (479)
Q Consensus 83 ~~~~~~-----------------~~lV~E~~~gg~L~~~i~~-~~l~e-------~~~~~i~~qll~aL~~LH~~givHr 137 (479)
+.+.+. .|+||||+ +|+|.+++.. +.+++ ..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 776643 89999999 5799999975 34555 7888899999999999999999999
Q ss_pred cCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcC-----------CCCCCccchhhHHHHH
Q 011694 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK-----------GYDGEKVDIWSCGVVL 206 (479)
Q Consensus 138 DLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-----------~~~~~~~DvwSlGvil 206 (479)
||||+|||++.+|.+||+|||+|.... ......+| +.|+|||++.+. .|+ .++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHHHHH
Confidence 999999999999999999999987422 23445678 999999999877 564 899999999999
Q ss_pred HHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 207 FVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 207 ~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
|+|++|..||.+.+.......+. ..+..+|+++.+||.+||+.||.+|||+.++++||||+...
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 99999999998766443333332 33466899999999999999999999999999999997643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=394.39 Aligned_cols=261 Identities=25% Similarity=0.489 Sum_probs=227.5
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchh--------------hHHHHHHHHHHHHhCCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVG--------------LADQIKREISVMRIVRH 73 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~--------------~~~~l~~Ei~il~~l~h 73 (479)
.+.+..++|++++.||+|+||.||+|.+ +|+.||||++......... ..+.+.+|+.+++.++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 4556778999999999999999999999 9999999999765432211 12788999999999999
Q ss_pred CCcceeEEEEEeCCEEEEEEeccCCCChHHH------Hhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCC
Q 011694 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNK------VAK---GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPEN 143 (479)
Q Consensus 74 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------i~~---~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~N 143 (479)
|||+++++++.+.+.+|+||||++||+|.++ +.. +.+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999998 654 579999999999999999999999 999999999999
Q ss_pred EEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCChH-
Q 011694 144 LLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK-GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL- 221 (479)
Q Consensus 144 ILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~- 221 (479)
|+++.++.+||+|||++...... ......||+.|+|||++.+. .+.+.++|||||||++|+|++|..||...+.
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999998754322 33456799999999999877 5543499999999999999999999988766
Q ss_pred HHHHHHhccCcCCCC-------------------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 222 IEMYRKIGKAEFKCP-------------------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 222 ~~~~~~i~~~~~~~~-------------------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
......+.......| ..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 677777766666666 56899999999999999999999999999999997654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=393.40 Aligned_cols=263 Identities=31% Similarity=0.552 Sum_probs=223.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhC-CCCCcceeEEEEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIM-RVGLADQIKREISVMRIV-RHPNIVQLYEVMA 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~ 84 (479)
.+-.++|++.+.||+|+||.||+|++. .+|+.||||++.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 344579999999999999999999985 58999999999764332 122335567899999999 6999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
..+.+|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999999976 67999999999999999999999999999999999999999999999999998754
Q ss_pred hccccCCCccccCCCCcccChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCC----hHHHHHHHhccCcCCCCCC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKG-YDGEKVDIWSCGVVLFVLLAGYLPFHDS----NLIEMYRKIGKAEFKCPNW 238 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DvwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~ 238 (479)
..... ......+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||... ........+.......|..
T Consensus 210 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 1vzo_A 210 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288 (355)
T ss_dssp CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred ccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence 32211 2234568999999999998532 2358999999999999999999999743 2344555555666777888
Q ss_pred CCHHHHHHHHHhccCCccccC-----ChhhhhcChhhhcc
Q 011694 239 FPPEVRKLLCKILDPNPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
+++.+.+||.+||..||.+|| |++++++||||+..
T Consensus 289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 999999999999999999999 99999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=403.57 Aligned_cols=259 Identities=34% Similarity=0.637 Sum_probs=208.8
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR-----VGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-----~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
..+.++|.+.+.||+|+||.||+|.+..+++.||||++.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345789999999999999999999999999999999998754321 112235789999999999999999999985
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC---CeEEeecCch
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE---NLKISDFGLS 160 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g---~vkl~DFGla 160 (479)
. +..|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4 568999999999999999876 5799999999999999999999999999999999999997544 5999999999
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-HHHHHhccCcCCCC
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINR---KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI-EMYRKIGKAEFKCP 236 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~---~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~ 236 (479)
..... .....+.+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||...... .....+.......+
T Consensus 290 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 290 KILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp TSCC--------------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred eecCC---CccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence 76432 233456789999999999854 334 47999999999999999999999765432 33334444433332
Q ss_pred ----CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 237 ----NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 237 ----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 4578999999999999999999999999999999754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=381.43 Aligned_cols=264 Identities=27% Similarity=0.444 Sum_probs=218.5
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEE
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMA 84 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~ 84 (479)
........++|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 34455678999999999999999999999999999999999976532 236788999999998 7999999999998
Q ss_pred e------CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEe
Q 011694 85 T------KSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKIS 155 (479)
Q Consensus 85 ~------~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~ 155 (479)
. .+.+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 7 5689999999999999999975 469999999999999999999999999999999999999999999999
Q ss_pred ecCchhhhhccccCCCccccCCCCcccChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc
Q 011694 156 DFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN-----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK 230 (479)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~-----~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~ 230 (479)
|||++....... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.......+..
T Consensus 172 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 172 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred eCcCceecCcCc--cccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 999987543221 2234567999999999996 3344 4899999999999999999999988776655554433
Q ss_pred CcC--CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 231 AEF--KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 231 ~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
... ..+..+++.+.+||.+||..||.+|||++++++||||+.....
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTH
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccc
Confidence 322 2345578999999999999999999999999999999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=386.32 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=217.0
Q ss_pred CCCCCCccCCCeEEeeeeeecCCeEEEEEEE-cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC------Ccc
Q 011694 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARS-IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP------NIV 77 (479)
Q Consensus 5 ~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~-~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hp------nIv 77 (479)
....+.++.++|++.+.||+|+||.||+|.+ ..+++.||||++.... ...+.+.+|+.+++.++|+ +|+
T Consensus 5 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp TCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred eeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 3457889999999999999999999999998 5688999999996542 3456788999999988655 499
Q ss_pred eeEEEEEeCCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec------
Q 011694 78 QLYEVMATKSKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE------ 148 (479)
Q Consensus 78 ~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~------ 148 (479)
++++++.+.+.+|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 9999999999999999999 88999999763 5899999999999999999999999999999999999987
Q ss_pred -------------CCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC
Q 011694 149 -------------NENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLP 215 (479)
Q Consensus 149 -------------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~P 215 (479)
++.+||+|||++.... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..|
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCS
T ss_pred cCCccccccccccCCCceEeeCcccccCc-----cccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCC
Confidence 6789999999986532 223456899999999999888775 899999999999999999999
Q ss_pred CCCChHHHHHHHhccCcCC--------------------------------------------CCCCCCHHHHHHHHHhc
Q 011694 216 FHDSNLIEMYRKIGKAEFK--------------------------------------------CPNWFPPEVRKLLCKIL 251 (479)
Q Consensus 216 f~~~~~~~~~~~i~~~~~~--------------------------------------------~~~~~~~~~~~li~~~L 251 (479)
|...+.......+...... .+...++++.+||.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 9887655443332111000 11123467899999999
Q ss_pred cCCccccCChhhhhcChhhhcc
Q 011694 252 DPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 252 ~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+.||.+|||++|+++||||+..
T Consensus 314 ~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 314 EYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp CSSTTTSCCHHHHTTSGGGGGG
T ss_pred CcCcccccCHHHHhcCHHHHHH
Confidence 9999999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=383.26 Aligned_cols=251 Identities=25% Similarity=0.486 Sum_probs=210.7
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEe--CCEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMAT--KSKI 89 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~--~~~~ 89 (479)
.++|++++.||+|+||.||+|++..+++.||||++.... .+.+.+|+.+++.++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 578999999999999999999999999999999986432 367889999999997 9999999999988 6789
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-CeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-~vkl~DFGla~~~~~~~~ 168 (479)
++||||+++++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 109 ~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~--- 183 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--- 183 (330)
T ss_dssp EEEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT---
T ss_pred EEEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC---
Confidence 999999999999998864 99999999999999999999999999999999999999777 899999999875432
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-hHHHHHHH-------------hccCcCC
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS-NLIEMYRK-------------IGKAEFK 234 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~-~~~~~~~~-------------i~~~~~~ 234 (479)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +....... +......
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 223456689999999999987454468999999999999999999999543 21111111 1111111
Q ss_pred ------------------------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 235 ------------------------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 235 ------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1122789999999999999999999999999999997654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=379.47 Aligned_cols=260 Identities=31% Similarity=0.469 Sum_probs=219.5
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
.....++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 34567899999999999999999999999999999999976432 335678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 89 IFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
+|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999998875 57999999999999999999999999999999999999999999999999998643322
Q ss_pred ccCCCccccCCCCcccChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc---CCCCCC
Q 011694 167 HQDGLLHTTCGTPAYVAPEVIN-----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNW 238 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~-----~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~ 238 (479)
.. .....+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.......+.... ...+..
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T 2j7t_A 171 LQ--KRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK 247 (302)
T ss_dssp HH--C-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred cc--ccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccc
Confidence 11 123457999999999984 3444 489999999999999999999999887766665554432 234556
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+++.+.++|.+||..||.+|||++++++||||+...
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 889999999999999999999999999999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=395.71 Aligned_cols=261 Identities=22% Similarity=0.285 Sum_probs=225.1
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEE-----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
..+..++|++++.||+|+||+||+|. +..+++.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 35667899999999999999999999 45578899999996532 223445788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC---Ce
Q 011694 84 ATKSKIFFVMEYAKGGELFNKVAK--------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE---NL 152 (479)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~i~~--------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g---~v 152 (479)
.+....|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+| .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999999975 2499999999999999999999999999999999999999655 49
Q ss_pred EEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC
Q 011694 153 KISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA 231 (479)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 231 (479)
||+|||+|................||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999866544444444566789999999999888775 89999999999999998 99999998887777777554
Q ss_pred c-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 232 E-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 232 ~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
. ...+..+++.+.+||.+||+.||.+|||+++|+++.|+..
T Consensus 303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 3 4566779999999999999999999999999999998743
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=385.75 Aligned_cols=264 Identities=22% Similarity=0.363 Sum_probs=203.2
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQ---SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
...+..++|++++.||+|+||.||+|.+..++. .||||++....... ...+.+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 445678899999999999999999999887765 89999997654333 34578889999999999999999999998
Q ss_pred eCCEE------EEEEeccCCCChHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC
Q 011694 85 TKSKI------FFVMEYAKGGELFNKVAKG-------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN 151 (479)
Q Consensus 85 ~~~~~------~lV~E~~~gg~L~~~i~~~-------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~ 151 (479)
..... ++||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 77655 9999999999999998642 5999999999999999999999999999999999999999999
Q ss_pred eEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc
Q 011694 152 LKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK 230 (479)
Q Consensus 152 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 230 (479)
+||+|||+|................+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 999999999765443333333445678899999999888775 89999999999999999 9999998877766666544
Q ss_pred C-cCCCCCCCCHHHHHHHHHhccCCccccCC-------hhhhhcChhhhcc
Q 011694 231 A-EFKCPNWFPPEVRKLLCKILDPNPSTRIS-------MAKIRESSWFRKG 273 (479)
Q Consensus 231 ~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~eil~h~wf~~~ 273 (479)
. ....+..+++++.+||.+||+.||.+||| +++++.|||+...
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 3 45677789999999999999999999999 7778899998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=385.07 Aligned_cols=264 Identities=29% Similarity=0.524 Sum_probs=197.1
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
++.+..++|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++...+
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 5567789999999999999999999999999999999998765322 23467889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecC
Q 011694 88 KIFFVMEYAKGGELFNKVAK---------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFG 158 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFG 158 (479)
..|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999999863 459999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccc---CCCccccCCCCcccChhhhhc-CCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-
Q 011694 159 LSALAQCKHQ---DGLLHTTCGTPAYVAPEVINR-KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF- 233 (479)
Q Consensus 159 la~~~~~~~~---~~~~~~~~gt~~y~aPEvl~~-~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~- 233 (479)
++........ .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||...+.............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCC-CTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCC-CchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9876533211 122345679999999999976 344 4899999999999999999999987655443333222111
Q ss_pred ---------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 234 ---------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 234 ---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..+..+++++.+||.+||..||.+|||++++++||||++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 12345789999999999999999999999999999997654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=378.77 Aligned_cols=259 Identities=27% Similarity=0.463 Sum_probs=217.8
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
....++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++||||+++++++.+.+.+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 4567899999999999999999999999999999999976532 35678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVA--KGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
|+||||+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999987 3579999999999999999999999999999999999999999999999999986543221
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cCCCCCCCCHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVR 244 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~ 244 (479)
.......||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+... .+..+..+++.+.
T Consensus 180 --~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 256 (314)
T 3com_A 180 --AKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT 256 (314)
T ss_dssp --SCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred --cccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence 123456799999999999887775 8999999999999999999999887665444433222 2344556789999
Q ss_pred HHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 245 KLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
+||.+||..||.+|||+.++++||||+.....
T Consensus 257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 257 DFVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288 (314)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence 99999999999999999999999999865433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=392.81 Aligned_cols=256 Identities=23% Similarity=0.409 Sum_probs=220.7
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEc-------CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSI-------RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLY 80 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~ 80 (479)
+.+..++|++++.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.+ +||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 3556789999999999999999999975 345679999997653 224457789999999999 899999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCC
Q 011694 81 EVMATKSKIFFVMEYAKGGELFNKVAKG-----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPEN 143 (479)
Q Consensus 81 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~N 143 (479)
+++.+.+.+|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 9999999999999999999999999753 37899999999999999999999999999999999
Q ss_pred EEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHH
Q 011694 144 LLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLI 222 (479)
Q Consensus 144 ILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~ 222 (479)
||++.+|.+||+|||+|................+|+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+..
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999755433322233445678999999999887775 89999999999999999 99999988777
Q ss_pred HHHHHhccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 223 EMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 223 ~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+....+... ....|..+++++.++|.+||..||.+|||+.+++++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 313 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666666544 345677799999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=377.45 Aligned_cols=257 Identities=34% Similarity=0.640 Sum_probs=223.9
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
.+.++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.++||||+++++++.+.+..|
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 45679999999999999999999999999999999997654332 34577889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC---CCeEEeecCchhhhhcc
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN---ENLKISDFGLSALAQCK 166 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~---g~vkl~DFGla~~~~~~ 166 (479)
+||||+.+++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999999988865 689999999999999999999999999999999999999754 46999999998754322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----CCCCHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPPE 242 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~ 242 (479)
.......||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+.......+ ..+|++
T Consensus 178 ---~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 178 ---TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp ---SSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred ---CccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 223345689999999998764 4 4899999999999999999999999887777777665544332 458999
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+.++|.+||..||.+|||++++++||||++.
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=377.55 Aligned_cols=258 Identities=33% Similarity=0.583 Sum_probs=223.2
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA--TKSKI 89 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~--~~~~~ 89 (479)
..++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 3578999999999999999999999999999999998765432 44578899999999999999999999885 46789
Q ss_pred EEEEeccCCCChHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----CeeccCCCCCEEEecCCCeEEeecCc
Q 011694 90 FFVMEYAKGGELFNKVAKG-----KLKEDAARRYFQQLINAVDFCHSRG-----VYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~qll~aL~~LH~~g-----ivHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
|+||||++|++|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999998752 3999999999999999999999999 99999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNW 238 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 238 (479)
+....... ......+||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+..+.. ..|..
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 163 ARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHC---C--HHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred heeecccc--ccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 87543211 112345799999999999887775 899999999999999999999998887777766655544 56677
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+++++.++|.+||+.||.+|||+++|++|+|+...
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 89999999999999999999999999999999654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=397.91 Aligned_cols=256 Identities=29% Similarity=0.442 Sum_probs=209.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.+.....+|++.+.||+|+||.||+|++..+++ ||+|.+...... ..+|+.+++.++||||+++++++...+
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 456677899999999999999999999987776 888887654322 237999999999999999999995443
Q ss_pred ------EEEEEEeccCCCChHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe-cCCCeEEee
Q 011694 88 ------KIFFVMEYAKGGELFNKVA----KGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD-ENENLKISD 156 (479)
Q Consensus 88 ------~~~lV~E~~~gg~L~~~i~----~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~-~~g~vkl~D 156 (479)
.+|+||||++++.+..... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 3899999998854433221 35799999999999999999999999999999999999999 789999999
Q ss_pred cCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-----
Q 011694 157 FGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA----- 231 (479)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----- 231 (479)
||+|...... ......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 186 FG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 186 FGSAKILIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CTTCEECCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCcccccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9998754322 22345688999999999977654468999999999999999999999987765544443210
Q ss_pred ------------cC------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 ------------EF------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 ------------~~------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.. .+++.+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00 12344789999999999999999999999999999997643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=390.74 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=214.5
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE--
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI-- 89 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~-- 89 (479)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 56899999999999999999999999999999999976532 234567888999999999999999999999877654
Q ss_pred ----EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 90 ----FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 90 ----~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
|+||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred ceeEEEEEcccc-ccHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999998 48877774 3599999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc-------------
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE------------- 232 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 232 (479)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 197 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 197 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred -----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 23456799999999999874444589999999999999999999999877655554442100
Q ss_pred ------------------CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 233 ------------------FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 233 ------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
...++.+++++.+||.+||+.||.+|||++++++||||+....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 0112346899999999999999999999999999999976543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=386.46 Aligned_cols=261 Identities=34% Similarity=0.645 Sum_probs=213.3
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM-----RVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
+..+.++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++
T Consensus 5 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp CHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 345778999999999999999999999999999999999765421 112234578999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC---eEEeecCc
Q 011694 84 ATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN---LKISDFGL 159 (479)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~---vkl~DFGl 159 (479)
..++ .|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 7766 8999999999999998876 57999999999999999999999999999999999999987664 99999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-HHHHHhccCcCCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINR---KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI-EMYRKIGKAEFKC 235 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~---~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~ 235 (479)
+..... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||...... .....+.......
T Consensus 164 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 164 SKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239 (322)
T ss_dssp CEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred ceeccc---ccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence 865421 112235679999999999852 334 48999999999999999999999765432 2233333333322
Q ss_pred ----CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 236 ----PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 236 ----~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+..+++.+.+||.+||..||.+|||++++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 245789999999999999999999999999999997654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=370.54 Aligned_cols=254 Identities=22% Similarity=0.390 Sum_probs=221.1
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
.++.+-.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 455667789999999999999999999986 5778999999765432 35688999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
+..|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence 999999999999999999975 459999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHH
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPE 242 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 242 (479)
.... .......+|+.|+|||++.+..++ .++||||+|+++|+|++ |..||...+.......+... ....|..+++.
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T 4hcu_A 158 DDQY-TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 235 (269)
T ss_dssp CHHH-HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred cccc-ccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHH
Confidence 2221 122345678899999999888775 89999999999999999 99999998887777777554 44566678999
Q ss_pred HHHHHHHhccCCccccCChhhhhcC
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+.+++.+||+.||.+|||+.+++++
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=384.05 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=222.2
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
.+..++|++++.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456789999999999999999999997 456899999997653 2345678899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-------------------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDI 139 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDL 139 (479)
+.+..|+||||+++|+|.+++.. ..+++.+++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999999875 46999999999999999999999999999999
Q ss_pred CCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 011694 140 KPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHD 218 (479)
Q Consensus 140 kp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~ 218 (479)
||+|||++.++.+||+|||++................+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999866443332333456789999999999887775 89999999999999999 9999998
Q ss_pred ChHHHHHHHhccCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 219 SNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 219 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+..+....+.... ...|..+|+++.++|.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88777777665544 35677899999999999999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=394.12 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=208.8
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--------CCCcce
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR--------HPNIVQ 78 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~--------hpnIv~ 78 (479)
..+.++.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++ ||||++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 356788899999999999999999999999999999999997542 34567889999999885 788999
Q ss_pred eEEEEE----eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCC
Q 011694 79 LYEVMA----TKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENE 150 (479)
Q Consensus 79 l~~~~~----~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g 150 (479)
+++++. +...+|+||||+ +++|.+.+.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 999997 556899999999 5566666654 3699999999999999999999999 999999999999998775
Q ss_pred -------------------------------------------------CeEEeecCchhhhhccccCCCccccCCCCcc
Q 011694 151 -------------------------------------------------NLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181 (479)
Q Consensus 151 -------------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y 181 (479)
.+||+|||+|..... .....+||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcc
Confidence 799999999875432 23456899999
Q ss_pred cChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH------HHHHHHhcc---C---------------------
Q 011694 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL------IEMYRKIGK---A--------------------- 231 (479)
Q Consensus 182 ~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~------~~~~~~i~~---~--------------------- 231 (479)
+|||++.+..++ .++|||||||+||+|++|..||...+. ......+.. .
T Consensus 260 ~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 260 RSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp CCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred cCChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 999999988875 899999999999999999999975431 111111100 0
Q ss_pred ------------------cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhh
Q 011694 232 ------------------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 232 ------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
....+...++.+.+||.+||+.||.+|||++++++||||+
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0011122346788999999999999999999999999996
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=385.06 Aligned_cols=255 Identities=25% Similarity=0.448 Sum_probs=211.3
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.+.++.++|++.+.||+|+||+||+|.+..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp EEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred cccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 3567889999999999999999999999999999999999765432 23467789999999999999999999998765
Q ss_pred --EEEEEEeccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE----ecCCCeEEeec
Q 011694 88 --KIFFVMEYAKGGELFNKVAKG----KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL----DENENLKISDF 157 (479)
Q Consensus 88 --~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl----~~~g~vkl~DF 157 (479)
..|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 789999999999999999763 39999999999999999999999999999999999999 67778999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhc--------CCCCCCccchhhHHHHHHHHHhCCCCCCCCh----HHHHH
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINR--------KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN----LIEMY 225 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~--------~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~----~~~~~ 225 (479)
|+|..... .......+||+.|+|||++.. ..+ +.++|||||||++|+|++|..||.... .....
T Consensus 161 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 161 GAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp TTCEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred CCceecCC---CCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 99875432 223345679999999999863 444 589999999999999999999996422 23333
Q ss_pred HHhccCc---------------------CCCC----CCCCHHHHHHHHHhccCCccccCChhhhhcCh
Q 011694 226 RKIGKAE---------------------FKCP----NWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 226 ~~i~~~~---------------------~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
..+.... ++.+ ..+++.+.+||.+||+.||.+|||++|+++||
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 3332211 1111 12346788999999999999999999999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=395.47 Aligned_cols=253 Identities=30% Similarity=0.432 Sum_probs=207.5
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK---- 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (479)
....+|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 344579999999999999999999999999999999976432 224799999999999999999998532
Q ss_pred --CEEEEEEeccCCCChHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC-CCeEEeecC
Q 011694 87 --SKIFFVMEYAKGGELFNKVA-----KGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN-ENLKISDFG 158 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~-g~vkl~DFG 158 (479)
..+++||||+++ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 247799999987 5655543 2579999999999999999999999999999999999999965 568999999
Q ss_pred chhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc--------
Q 011694 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK-------- 230 (479)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------- 230 (479)
+|...... ......+||+.|+|||++.+....+.++|||||||+||+|++|+.||.+.+....+..+..
T Consensus 203 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 203 SAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp TCEECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred hhhhcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99754322 2234568999999999997754445899999999999999999999998775544443321
Q ss_pred ---------CcCC------------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 231 ---------AEFK------------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 231 ---------~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
..+. +++.+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 1111 2345689999999999999999999999999999997543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=385.29 Aligned_cols=261 Identities=30% Similarity=0.557 Sum_probs=224.0
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCC--CCCcceeEEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV---GLADQIKREISVMRIVR--HPNIVQLYEV 82 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~l~~Ei~il~~l~--hpnIv~l~~~ 82 (479)
.+..+.++|++++.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 456789999999999999999999999999999999999977543221 11245668999999996 5999999999
Q ss_pred EEeCCEEEEEEeccCC-CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe-cCCCeEEeecCc
Q 011694 83 MATKSKIFFVMEYAKG-GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD-ENENLKISDFGL 159 (479)
Q Consensus 83 ~~~~~~~~lV~E~~~g-g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~-~~g~vkl~DFGl 159 (479)
+...+..++|||++.+ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999986 899999876 6899999999999999999999999999999999999999 789999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWF 239 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (479)
+..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+. +.......+..+
T Consensus 197 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~ 266 (320)
T 3a99_A 197 GALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQRV 266 (320)
T ss_dssp CEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCCCCSSCC
T ss_pred cccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcccccccccC
Confidence 875432 2234567999999999998888766889999999999999999999976542 223445567789
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcChhhhcccchhh
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQ 278 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~~~ 278 (479)
++++.+||.+||+.||.+|||+++|++||||+....+..
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~ 305 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 305 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCccc
Confidence 999999999999999999999999999999987765433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=381.68 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=219.6
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQ---SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
.+++..++|++.+.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456778899999999999999999999986655 49999997543 2234577889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
+.+..|+||||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999999999965 4799999999999999999999999999999999999999999999999999976
Q ss_pred hhccccCC-CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCC
Q 011694 163 AQCKHQDG-LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWF 239 (479)
Q Consensus 163 ~~~~~~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 239 (479)
........ ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+... ....|..+
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGC 279 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCc
Confidence 54322111 12234567889999999887775 89999999999999999 99999988887777766544 45667779
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
++.+.+||.+||..||.+|||+.+|++
T Consensus 280 ~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 280 PHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=378.56 Aligned_cols=264 Identities=28% Similarity=0.443 Sum_probs=216.5
Q ss_pred CCCCCCccCCCeEEeeeeeecCCeEEEEEEEc-CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeE
Q 011694 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSI-RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV---RHPNIVQLY 80 (479)
Q Consensus 5 ~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l---~hpnIv~l~ 80 (479)
.+.......++|++.+.||+|+||.||+|.+. .+|+.||||++....... .....+.+|+.+++.+ +||||++++
T Consensus 2 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 2 EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp ---CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred CCccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 33444556799999999999999999999995 678999999997644322 1223455777777766 899999999
Q ss_pred EEEE-----eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCe
Q 011694 81 EVMA-----TKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENL 152 (479)
Q Consensus 81 ~~~~-----~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~v 152 (479)
+++. ....+++||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCE
Confidence 9987 5578999999998 599999876 249999999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-
Q 011694 153 KISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA- 231 (479)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~- 231 (479)
||+|||++....... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+...
T Consensus 160 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (326)
T 1blx_A 160 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235 (326)
T ss_dssp EECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEecCcccccccCCC---CccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence 999999987543221 23456799999999999887775 8999999999999999999999987766555444210
Q ss_pred --------------------------cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 --------------------------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 --------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
....+..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 0012345789999999999999999999999999999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=384.26 Aligned_cols=255 Identities=28% Similarity=0.425 Sum_probs=213.3
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE---
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK--- 88 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~--- 88 (479)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 56899999999999999999999999999999999976532 33456788899999999999999999999987654
Q ss_pred ---EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 89 ---IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 89 ---~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
+|+||||+. ++|.+.+.. ++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred ceeEEEEecccc-CCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999998 488887754 599999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--------------
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-------------- 231 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 231 (479)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 2345679999999999987444458999999999999999999999887755444433210
Q ss_pred -----------------cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 -----------------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 -----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
-...++.+++++.+||.+||..||.+|||++++++||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0112345789999999999999999999999999999997643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=391.03 Aligned_cols=258 Identities=25% Similarity=0.410 Sum_probs=217.1
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEE-----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeE
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLY 80 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~ 80 (479)
..+++..++|++++.||+|+||.||+|. +..+++.||||++..... ......+.+|+.+++.+ +||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3456778999999999999999999999 455778999999976432 23356789999999999 799999999
Q ss_pred EEEEeCC-EEEEEEeccCCCChHHHHhcCC--------------------------------------------------
Q 011694 81 EVMATKS-KIFFVMEYAKGGELFNKVAKGK-------------------------------------------------- 109 (479)
Q Consensus 81 ~~~~~~~-~~~lV~E~~~gg~L~~~i~~~~-------------------------------------------------- 109 (479)
+++.+.+ .+++||||++||+|.+++....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998755 4999999999999999997532
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 110 -----------------LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 110 -----------------l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 899999999999999999999999999999999999999999999999999755333222233
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHH-HHHhc-cCcCCCCCCCCHHHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEM-YRKIG-KAEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~-~~~i~-~~~~~~~~~~~~~~~~li~~ 249 (479)
....||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.... ...+. ......|..+++++.++|.+
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred cccCCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 456789999999999887775 89999999999999998 9999987654332 22222 23456777899999999999
Q ss_pred hccCCccccCChhhhhcC
Q 011694 250 ILDPNPSTRISMAKIRES 267 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h 267 (479)
||+.||.+|||++++++|
T Consensus 332 ~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCCCHHHHHHH
Confidence 999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=385.39 Aligned_cols=263 Identities=23% Similarity=0.367 Sum_probs=210.3
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc--------chhhHHHHHHHHHHHHhCCCCCcceeEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM--------RVGLADQIKREISVMRIVRHPNIVQLYE 81 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~--------~~~~~~~l~~Ei~il~~l~hpnIv~l~~ 81 (479)
..+.++|++++.||+|+||.||+|.+.. |+.||||++...... .....+.+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 3567899999999999999999999854 999999998653221 2234478899999999999999999999
Q ss_pred EEEe-----CCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEE
Q 011694 82 VMAT-----KSKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKI 154 (479)
Q Consensus 82 ~~~~-----~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl 154 (479)
++.. ...+|+||||+. |+|.+.+... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9844 347999999998 4888888753 6999999999999999999999999999999999999999999999
Q ss_pred eecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---
Q 011694 155 SDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--- 231 (479)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--- 231 (479)
+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 176 ~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 176 CDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999864332 222345679999999999987444458999999999999999999999987765554443210
Q ss_pred ---------------------cC--------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccchh
Q 011694 232 ---------------------EF--------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQK 277 (479)
Q Consensus 232 ---------------------~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~~ 277 (479)
.. ..++.+++.+.+||.+||+.||.+|||++++++||||+....+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 327 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL 327 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence 00 11234688999999999999999999999999999998765443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=387.33 Aligned_cols=257 Identities=23% Similarity=0.412 Sum_probs=224.0
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCccee
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRT-------NQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQL 79 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l 79 (479)
.+++..++|++++.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.+++.+ +||||+++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 4567889999999999999999999997643 3579999997653 223457788999999999 89999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 011694 80 YEVMATKSKIFFVMEYAKGGELFNKVAKG-----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPE 142 (479)
Q Consensus 80 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~ 142 (479)
++++.+.+..|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 99999999999999999999999999763 3999999999999999999999999999999999
Q ss_pred CEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChH
Q 011694 143 NLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNL 221 (479)
Q Consensus 143 NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~ 221 (479)
|||++.++.+||+|||+|................+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999765433332334455678999999999887775 89999999999999999 9999999888
Q ss_pred HHHHHHhccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 222 IEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 222 ~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
......+... ....|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 300 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7777766544 455677799999999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=397.34 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=195.8
Q ss_pred CccCCCeEE-eeeeeecCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-
Q 011694 10 SVLTEKYEV-GRLLGQGAFAKVYYARSI--RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT- 85 (479)
Q Consensus 10 ~il~~~y~i-~~~LG~G~fg~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~- 85 (479)
..+.+.|++ +++||+|+||+||+|+++ .+++.||||++..... ...+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 345677887 568999999999999976 5789999999976532 2467799999999999999999999954
Q ss_pred -CCEEEEEEeccCCCChHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE----ecCC
Q 011694 86 -KSKIFFVMEYAKGGELFNKVAK----------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL----DENE 150 (479)
Q Consensus 86 -~~~~~lV~E~~~gg~L~~~i~~----------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl----~~~g 150 (479)
...+|+||||+.| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 6789999999975 78777752 149999999999999999999999999999999999999 6778
Q ss_pred CeEEeecCchhhhhcccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-------
Q 011694 151 NLKISDFGLSALAQCKHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI------- 222 (479)
Q Consensus 151 ~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~------- 222 (479)
.+||+|||+|........ .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999999976543221 123356789999999999987665568999999999999999999999754321
Q ss_pred --HHHHHh----ccCc------------------------CC----------CCCCCCHHHHHHHHHhccCCccccCChh
Q 011694 223 --EMYRKI----GKAE------------------------FK----------CPNWFPPEVRKLLCKILDPNPSTRISMA 262 (479)
Q Consensus 223 --~~~~~i----~~~~------------------------~~----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 262 (479)
.....+ .... +. .....++.+.+||.+||..||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 111111 1000 00 0011267899999999999999999999
Q ss_pred hhhcChhhhccc
Q 011694 263 KIRESSWFRKGM 274 (479)
Q Consensus 263 eil~h~wf~~~~ 274 (479)
|+++||||....
T Consensus 330 e~L~hp~f~~~~ 341 (405)
T 3rgf_A 330 QAMQDPYFLEDP 341 (405)
T ss_dssp HHHTSGGGTSSS
T ss_pred HHhcChhhccCC
Confidence 999999997643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=393.43 Aligned_cols=254 Identities=16% Similarity=0.203 Sum_probs=196.9
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC--CCCCcceeE-------EEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV--RHPNIVQLY-------EVMA 84 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l--~hpnIv~l~-------~~~~ 84 (479)
..|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999887654445567788885555444 699987755 5665
Q ss_pred eC-----------------CEEEEEEeccCCCChHHHHhc--CCCCHHHH------HHHHHHHHHHHHHHHHCCCeeccC
Q 011694 85 TK-----------------SKIFFVMEYAKGGELFNKVAK--GKLKEDAA------RRYFQQLINAVDFCHSRGVYHRDI 139 (479)
Q Consensus 85 ~~-----------------~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~------~~i~~qll~aL~~LH~~givHrDL 139 (479)
.. ..+|+||||++ |+|.+++.. ..+++... ..++.||+.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 43 34899999999 799999986 24555555 567799999999999999999999
Q ss_pred CCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCC
Q 011694 140 KPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR--KGYDGEKVDIWSCGVVLFVLLAGYLPFH 217 (479)
Q Consensus 140 kp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~--~~~~~~~~DvwSlGvil~~ll~G~~Pf~ 217 (479)
||+|||++.+|.+||+|||+|..... ......+|+.|+|||++.+ ..| +.++|||||||+||+|++|..||.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999875432 1224567799999999976 556 489999999999999999999998
Q ss_pred CChHH--HHHHH-----hccCc--CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 218 DSNLI--EMYRK-----IGKAE--FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 218 ~~~~~--~~~~~-----i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
+.... ..+.. ..... ++.+..+|+.+.+||.+||+.||.+|||++++++||||+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 76322 11111 11112 223356899999999999999999999999999999997654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=391.75 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=220.9
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
...+.+-.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 4456667789999999999999999999999999999999987542 22344567899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
.+.+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 9999999999999999999976 36999999999999999999999999999999999999999999999999998643
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCH
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPP 241 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 241 (479)
.............+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+|+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD 342 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 221111111222356789999999877775 89999999999999998 99999988776666655443 4567788999
Q ss_pred HHHHHHHHhccCCccccCChhhhhc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
++.+||.+||+.||.+|||+++|++
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=377.89 Aligned_cols=259 Identities=23% Similarity=0.381 Sum_probs=222.5
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeE
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLY 80 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~ 80 (479)
....++..++|++++.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 3456777899999999999999999999984 456899999997543 234457789999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 011694 81 EVMATKSKIFFVMEYAKGGELFNKVAKG-------------------------KLKEDAARRYFQQLINAVDFCHSRGVY 135 (479)
Q Consensus 81 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~-------------------------~l~e~~~~~i~~qll~aL~~LH~~giv 135 (479)
+++.+.+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 9999999999999999999999999752 289999999999999999999999999
Q ss_pred eccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCC
Q 011694 136 HRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYL 214 (479)
Q Consensus 136 HrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~ 214 (479)
||||||+|||++.++.+||+|||++................+|+.|+|||++.+..++ .++|||||||++|+|++ |..
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998754332222223345678899999999887775 89999999999999999 999
Q ss_pred CCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 215 PFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 215 Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
||.+.+.......+... ....|..+++++.++|.+||+.||.+|||+.+++++
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99988776666665443 345667799999999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=373.62 Aligned_cols=257 Identities=29% Similarity=0.532 Sum_probs=208.7
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe------
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT------ 85 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~------ 85 (479)
+.++|++++.||+|+||.||+|++..+|+.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 457899999999999999999999999999999999643 2345778899999999999999999998865
Q ss_pred -------CCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEee
Q 011694 86 -------KSKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISD 156 (479)
Q Consensus 86 -------~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~D 156 (479)
.+.+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 45789999999999999999753 588999999999999999999999999999999999999999999999
Q ss_pred cCchhhhhccc------------cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-hHHH
Q 011694 157 FGLSALAQCKH------------QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS-NLIE 223 (479)
Q Consensus 157 FGla~~~~~~~------------~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~-~~~~ 223 (479)
||++....... ........+||+.|+|||++.+.+..+.++|||||||++|+|++ ||... +...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99987543211 01223456799999999999876444589999999999999998 66543 3334
Q ss_pred HHHHhccCcCCCC----CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 224 MYRKIGKAEFKCP----NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 224 ~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
....+.......| ...++.+.++|.+||..||.+|||++++++||||+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence 4555544443333 345678999999999999999999999999999976543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=381.48 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=213.8
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC------ccee
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTN-QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN------IVQL 79 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpn------Iv~l 79 (479)
..+.++.++|++.+.||+|+||+||+|.+..++ +.||||++.... ...+.+.+|+.+++.++|++ ++.+
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 457788999999999999999999999998877 689999997542 34467888999999887665 9999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE----------
Q 011694 80 YEVMATKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL---------- 146 (479)
Q Consensus 80 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl---------- 146 (479)
++++...+.+|+||||+ +++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence 99999999999999999 5577776654 269999999999999999999999999999999999999
Q ss_pred ---------ecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 011694 147 ---------DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH 217 (479)
Q Consensus 147 ---------~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~ 217 (479)
+.++.+||+|||++.... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCC
Confidence 667899999999986532 223456899999999999888775 89999999999999999999998
Q ss_pred CChHHHHHHHhccCcCCCC--------------------------------------------CCCCHHHHHHHHHhccC
Q 011694 218 DSNLIEMYRKIGKAEFKCP--------------------------------------------NWFPPEVRKLLCKILDP 253 (479)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~--------------------------------------------~~~~~~~~~li~~~L~~ 253 (479)
..+.......+.......| ...++++.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 8765543333211110110 11235788999999999
Q ss_pred CccccCChhhhhcChhhhccc
Q 011694 254 NPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 254 dP~~Rpt~~eil~h~wf~~~~ 274 (479)
||.+|||++++++||||+...
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGCC
T ss_pred ChhhCcCHHHHhcChhhcCCC
Confidence 999999999999999997643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=368.35 Aligned_cols=256 Identities=22% Similarity=0.371 Sum_probs=220.2
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
...+++-.++|++.+.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 4466778899999999999999999999885 6778999999765433 3568899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
.+.+|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999976 57999999999999999999999999999999999999999999999999998754
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCH
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPP 241 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 241 (479)
..... .......+|+.|+|||++.+..++ .++||||+|+++|+|++ |..||...+.......+... ....|..+++
T Consensus 171 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (283)
T 3gen_A 171 LDDEY-TSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 248 (283)
T ss_dssp CCHHH-HSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccccc-ccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCH
Confidence 32221 112344578899999999888775 89999999999999998 99999988877777766554 3456667899
Q ss_pred HHHHHHHHhccCCccccCChhhhhcCh
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
.+.++|.+||+.||.+|||+.++++|-
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=376.28 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=211.3
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
-.++|++++.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 358999999999999999999999999999999998543 23456788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC
Q 011694 92 VMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD 169 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~ 169 (479)
||||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999999986 57999999999999999999999999999999999999999999999999998754322211
Q ss_pred ------------CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHH---hccCcCC
Q 011694 170 ------------GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRK---IGKAEFK 234 (479)
Q Consensus 170 ------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~---i~~~~~~ 234 (479)
......+||+.|+|||++.+..++ .++||||+||++|+|++|..||........... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 011256899999999999887775 899999999999999999999875321110000 0001123
Q ss_pred CCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 235 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.|+.+|+.+.++|.+||+.||.+|||++++++
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 46778999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=387.34 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=213.5
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CC-----CcceeE
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HP-----NIVQLY 80 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hp-----nIv~l~ 80 (479)
..+..+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ |+ +|++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 345677899999999999999999999999999999999997542 34567778899888875 54 499999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCCeeccCCCCCEEEe--cCCCeE
Q 011694 81 EVMATKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCH--SRGVYHRDIKPENLLLD--ENENLK 153 (479)
Q Consensus 81 ~~~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH--~~givHrDLkp~NILl~--~~g~vk 153 (479)
+++...+.+|+||||+.+ +|.+++.. +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 999999999999999965 99999876 35999999999999999999999 57999999999999995 477899
Q ss_pred EeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC
Q 011694 154 ISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF 233 (479)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 233 (479)
|+|||+|.... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.....
T Consensus 202 L~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 202 IVDFGSSCQLG-----QRIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp ECCCTTCEETT-----CCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeccCceecc-----cccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999987542 223457899999999999988875 899999999999999999999998776655544422100
Q ss_pred -------------------------------------CCCCC---------------------------CCHHHHHHHHH
Q 011694 234 -------------------------------------KCPNW---------------------------FPPEVRKLLCK 249 (479)
Q Consensus 234 -------------------------------------~~~~~---------------------------~~~~~~~li~~ 249 (479)
..|.. .++++.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 00000 00378999999
Q ss_pred hccCCccccCChhhhhcChhhhcc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
||+.||.+|||++|+++||||+..
T Consensus 356 mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hcCCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=376.32 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=223.5
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEE
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~ 81 (479)
+.+++..++|++.+.||+|+||.||+|.+. .+++.||||++..... ......+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 456788899999999999999999999886 4678899999975432 233467889999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAK-----------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE 150 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g 150 (479)
++.+.+..|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 99999999999999999999999864 3579999999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhc
Q 011694 151 NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIG 229 (479)
Q Consensus 151 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 229 (479)
.+||+|||++................+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 9999999998765433322223345678999999999887775 89999999999999999 899999888777777665
Q ss_pred cCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 230 KAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 230 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
... ...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 543 45667799999999999999999999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=364.60 Aligned_cols=250 Identities=28% Similarity=0.497 Sum_probs=206.3
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR-VGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
+-.++|++.+.||+|+||.||+|.+ +|+.||||++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 4467999999999999999999998 58999999987654322 23457789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeeccCCCCCEEEec--------CCCeEEeecC
Q 011694 90 FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRG---VYHRDIKPENLLLDE--------NENLKISDFG 158 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~g---ivHrDLkp~NILl~~--------~g~vkl~DFG 158 (479)
|+||||++|++|.+++..+++++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999998889999999999999999999999999 899999999999985 6789999999
Q ss_pred chhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--cCCCC
Q 011694 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--EFKCP 236 (479)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~ 236 (479)
++...... ......||+.|+|||++.+..++ .++||||+|+++|+|++|..||.+.+.......+... ....|
T Consensus 162 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 162 LAREWHRT----TKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred cccccccc----cccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 98754322 22355799999999999887775 8999999999999999999999987766555554333 34566
Q ss_pred CCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 237 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 7789999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=364.65 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=218.3
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
..+..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 4567789999999999999999999875 5778999999765432 3568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 89 IFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999999976 35999999999999999999999999999999999999999999999999998754322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 244 (479)
.. .......+|+.|+|||++.+..++ .++||||+|+++|+|++ |..||...+.......+... ....|..+++.+.
T Consensus 158 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (268)
T 3sxs_A 158 QY-VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIY 235 (268)
T ss_dssp CE-EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred hh-hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHH
Confidence 11 112334567789999999887775 89999999999999999 99999988877766666544 3455667899999
Q ss_pred HHHHHhccCCccccCChhhhhcC
Q 011694 245 KLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h 267 (479)
++|.+||+.||.+|||+.+++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 236 QIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=370.87 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=209.7
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
.....++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.++||||+++++++...+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 34556899999999999999999999999999999999987655555566889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999999986 679999999999999999999999999999999999999999999999999987554322
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cCCCCCCCCHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVR 244 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~ 244 (479)
.......+||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+... ....++.+|+++.
T Consensus 189 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 189 -LTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred -cccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence 1223456799999999999877665 8999999999999999999999988766544444332 1234567899999
Q ss_pred HHHHHhccCCccccC-Chhhhhc
Q 011694 245 KLLCKILDPNPSTRI-SMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rp-t~~eil~ 266 (479)
++|.+||+.||.+|| |++++++
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999 7777764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=369.48 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=209.1
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
...||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 3499999999999999999999999999976532 3457788999999999999999999999999999999999999
Q ss_pred CChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-CCCeEEeecCchhhhhccccCCCcc
Q 011694 99 GELFNKVAKG----KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-NENLKISDFGLSALAQCKHQDGLLH 173 (479)
Q Consensus 99 g~L~~~i~~~----~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-~g~vkl~DFGla~~~~~~~~~~~~~ 173 (479)
++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++...... .....
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 181 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTE 181 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--CCccc
Confidence 9999999763 4679999999999999999999999999999999999997 899999999998754321 12234
Q ss_pred ccCCCCcccChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCChHH--HHHH-HhccCcCCCCCCCCHHHHHHHHH
Q 011694 174 TTCGTPAYVAPEVINRKG-YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI--EMYR-KIGKAEFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 174 ~~~gt~~y~aPEvl~~~~-~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~--~~~~-~i~~~~~~~~~~~~~~~~~li~~ 249 (479)
...||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...... .... .........|..+++++.+||.+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK 261 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHH
Confidence 567999999999997643 1348999999999999999999999754322 1221 12233445677799999999999
Q ss_pred hccCCccccCChhhhhcChhhhccc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
||..||.+|||++++++||||+...
T Consensus 262 ~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 262 CFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp TTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999997554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=381.88 Aligned_cols=256 Identities=27% Similarity=0.344 Sum_probs=199.8
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC---
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS--- 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~--- 87 (479)
...++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+++..++.++||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34578999999999999999999999999999999986653322 34567788888899999999999996543
Q ss_pred ----EEEEEEeccCCCChHHHH----hc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCeeccCCCCCEEEec-CCCeEEe
Q 011694 88 ----KIFFVMEYAKGGELFNKV----AK-GKLKEDAARRYFQQLINAVDFCH--SRGVYHRDIKPENLLLDE-NENLKIS 155 (479)
Q Consensus 88 ----~~~lV~E~~~gg~L~~~i----~~-~~l~e~~~~~i~~qll~aL~~LH--~~givHrDLkp~NILl~~-~g~vkl~ 155 (479)
.+++||||++++ |...+ .. ..+++..+..++.||+.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 389999999875 43333 22 57999999999999999999999 999999999999999996 8999999
Q ss_pred ecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc---
Q 011694 156 DFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE--- 232 (479)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--- 232 (479)
|||++...... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 175 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 175 DFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 99998754322 223456799999999999776655689999999999999999999999887665555442210
Q ss_pred -----------------------------CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 233 -----------------------------FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 233 -----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
...+...++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 011122567899999999999999999999999999997654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=368.57 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=209.0
Q ss_pred CCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEE
Q 011694 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRT---NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81 (479)
Q Consensus 5 ~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~ 81 (479)
+....++..++|++++.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++
T Consensus 6 s~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 4456678899999999999999999999998654 4579999986542 2345578899999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
++. .+..|+||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 84 VIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccc
Confidence 984 56789999999999999999753 699999999999999999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPN 237 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 237 (479)
+........ .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+... ....++
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 240 (281)
T 1mp8_A 163 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 240 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred ccccCcccc-cccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCC
Confidence 976543221 122344578899999999887775 89999999999999996 99999987766666666443 356777
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+|+.+.++|.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 899999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=368.22 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=213.6
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMAT 85 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (479)
..+.++.++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+ +|+||+++++++.+
T Consensus 3 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 3 GQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp ---CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CcCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 4678899999999999999999999999999999999999875432 23567899999999 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC-----eEEeecC
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN-----LKISDFG 158 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~-----vkl~DFG 158 (479)
....|+||||+ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99999999999 9999999985 46999999999999999999999999999999999999987776 9999999
Q ss_pred chhhhhccccC-----CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---hHHHHHHHhcc
Q 011694 159 LSALAQCKHQD-----GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS---NLIEMYRKIGK 230 (479)
Q Consensus 159 la~~~~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~ 230 (479)
+|......... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||... +....+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 99765433221 123456799999999999887775 8999999999999999999999873 23333333322
Q ss_pred CcC-----CCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 231 AEF-----KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 231 ~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
... ..+..+|+++.++|.+||+.||.+|||+++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 211 1234689999999999999999999999999753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=379.05 Aligned_cols=256 Identities=31% Similarity=0.592 Sum_probs=210.6
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhC----CCCCcceeE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV---GLADQIKREISVMRIV----RHPNIVQLY 80 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~l~~Ei~il~~l----~hpnIv~l~ 80 (479)
.++.+.++|++++.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 456788999999999999999999999999999999999976543221 1223456799999988 899999999
Q ss_pred EEEEeCCEEEEEEec-cCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe-cCCCeEEeec
Q 011694 81 EVMATKSKIFFVMEY-AKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD-ENENLKISDF 157 (479)
Q Consensus 81 ~~~~~~~~~~lV~E~-~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~-~~g~vkl~DF 157 (479)
+++.+.+..++|||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999999 789999999976 6799999999999999999999999999999999999999 7899999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCC
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN 237 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 237 (479)
|++..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... +.......+.
T Consensus 185 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~ 254 (312)
T 2iwi_A 185 GSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPA 254 (312)
T ss_dssp SSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCCCCCT
T ss_pred chhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------HhhhccCCcc
Confidence 99875432 2234567999999999998887766689999999999999999999976432 2234556778
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 899999999999999999999999999999999754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=369.76 Aligned_cols=256 Identities=21% Similarity=0.362 Sum_probs=210.1
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEV 82 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~ 82 (479)
..+.+..++|++++.||+|+||.||+|+ +..+++.||||++.... ....+.+.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 79 (295)
T 3ugc_A 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGV 79 (295)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4567888999999999999999999998 56789999999997542 2445778999999999999999999999
Q ss_pred EEe--CCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecC
Q 011694 83 MAT--KSKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFG 158 (479)
Q Consensus 83 ~~~--~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFG 158 (479)
+.. ...+|+||||+++|+|.+++... ++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 854 45689999999999999999763 59999999999999999999999999999999999999999999999999
Q ss_pred chhhhhccccC-CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH---------------
Q 011694 159 LSALAQCKHQD-GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI--------------- 222 (479)
Q Consensus 159 la~~~~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~--------------- 222 (479)
++......... .......+|+.|+|||++.+..++ .++||||+||++|+|++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 99765432211 222344577889999999988875 8999999999999999999998754321
Q ss_pred -HHHHHh-ccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 223 -EMYRKI-GKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 223 -~~~~~i-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.....+ .....+.|..+|+++.++|.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111112 22345667789999999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=375.84 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=209.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEE----EEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSV----AVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
+..++|++.+.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 44689999999999999999999998888765 666664332 223457788999999999999999999999876
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
+ .++|+||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|....
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999976 469999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHH
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPE 242 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 242 (479)
............+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+... ....+..++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 44333333445678899999999988775 89999999999999999 99999987766655555433 45667779999
Q ss_pred HHHHHHHhccCCccccCChhhhhcC
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+.+++.+||+.||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=379.32 Aligned_cols=255 Identities=30% Similarity=0.585 Sum_probs=186.6
Q ss_pred CCCccCCCeEEee-eeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-
Q 011694 8 KPSVLTEKYEVGR-LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT- 85 (479)
Q Consensus 8 ~~~il~~~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~- 85 (479)
+...+.++|.+.+ .||+|+||+||+|.+..+|+.||||++.... ....+....++.++||||+++++++..
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 3346789999965 6999999999999999999999999996542 112223334667799999999999976
Q ss_pred ---CCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec---CCCeEEee
Q 011694 86 ---KSKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---NENLKISD 156 (479)
Q Consensus 86 ---~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---~g~vkl~D 156 (479)
...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 45689999999999999999863 5999999999999999999999999999999999999976 45599999
Q ss_pred cCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHH----HHHhccCc
Q 011694 157 FGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEM----YRKIGKAE 232 (479)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~ 232 (479)
||++.... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.... ...+....
T Consensus 175 fg~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 175 FGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp CTTCEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred cccceecc----ccccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 99986433 2233466899999999999777665 799999999999999999999977654332 22222222
Q ss_pred CCCC----CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 233 FKCP----NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 233 ~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
...+ ..+++++.+||.+||..||.+|||++++++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 2222 45899999999999999999999999999999997643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=376.25 Aligned_cols=262 Identities=23% Similarity=0.286 Sum_probs=218.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEE-----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEV 82 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~ 82 (479)
-+.+..++|++++.||+|+||.||+|. +..+++.||||++.... .......+.+|+.+++.++||||++++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 345778999999999999999999999 55688899999996442 22345678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC---CC
Q 011694 83 MATKSKIFFVMEYAKGGELFNKVAKG--------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN---EN 151 (479)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~---g~ 151 (479)
+.+.+..|+||||++|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 99999999999999999999999763 38999999999999999999999999999999999999844 46
Q ss_pred eEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc
Q 011694 152 LKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK 230 (479)
Q Consensus 152 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 230 (479)
+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 999999999765443333333456789999999999887775 89999999999999998 9999998877776666654
Q ss_pred C-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 231 A-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 231 ~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
. ....+..+++.+.++|.+||..||.+|||+.+++++.|+..
T Consensus 261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 4 34566778999999999999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=378.44 Aligned_cols=256 Identities=21% Similarity=0.340 Sum_probs=215.4
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQS----VAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
...+-.++|++.+.||+|+||+||+|.+..+++. ||+|.+...... .....+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 3445568999999999999999999999888876 677766443211 2224567899999999999999999998
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 84 ATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
.+ +..++||||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 85 ~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 85 PG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp CB-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred cC-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 64 568999999999999999976 479999999999999999999999999999999999999999999999999998
Q ss_pred hhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCC
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWF 239 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 239 (479)
...............||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+... ....|..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQIC 242 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTB
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcC
Confidence 76544433344556788899999999888775 89999999999999999 99999987766666665544 45667778
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
++++.++|.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 243 TIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=370.01 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=211.5
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCC-------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTN-------QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEV 82 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~ 82 (479)
++..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 467789999999999999999999998877 469999996543 2345788999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC--------e
Q 011694 83 MATKSKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN--------L 152 (479)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~--------v 152 (479)
+.+.+..|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999999874 3999999999999999999999999999999999999998887 9
Q ss_pred EEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCChHHHHHHHhccC
Q 011694 153 KISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG-YLPFHDSNLIEMYRKIGKA 231 (479)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~ 231 (479)
||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++| .+||...+..... .....
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYED 233 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHT
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhc
Confidence 9999999864321 23346889999999998744445899999999999999995 5555555444333 33334
Q ss_pred cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 232 EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 232 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
....|...++++.+||.+||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 556667778999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=379.75 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=216.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~ 81 (479)
.+++..++|++++.||+|+||.||+|.+. .++..||||++..... ....+.+.+|+.+++.+ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34566789999999999999999999973 4667899999975432 23347788999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAKG------------------------KLKEDAARRYFQQLINAVDFCHSRGVYHR 137 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~~------------------------~l~e~~~~~i~~qll~aL~~LH~~givHr 137 (479)
++...+..|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 999999999999999999999999753 27899999999999999999999999999
Q ss_pred cCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 011694 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPF 216 (479)
Q Consensus 138 DLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf 216 (479)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999765433322233445678899999999887775 89999999999999998 99999
Q ss_pred CCChHHHHHHHhcc--CcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChh
Q 011694 217 HDSNLIEMYRKIGK--AEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSW 269 (479)
Q Consensus 217 ~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~w 269 (479)
.+.+.......+.. .....|..+++++.+||.+||..||.+|||+.+++++..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 87664433333322 234567778999999999999999999999999998753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=371.45 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=212.8
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CCCcceeEEEEEe
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR--HPNIVQLYEVMAT 85 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~--hpnIv~l~~~~~~ 85 (479)
...+..++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+.+|+.+++.++ ||||+++++++.+
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 44566788999999999999999999985 5899999999765433 245578899999999997 5999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
.+..|+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999999999 567899999976 5799999999999999999999999999999999999996 5899999999997654
Q ss_pred ccccCCCccccCCCCcccChhhhhcC----------CCCCCccchhhHHHHHHHHHhCCCCCCCCh-HHHHHHHhcc--C
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRK----------GYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKIGK--A 231 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~----------~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~--~ 231 (479)
...........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+.. .
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 33332233456799999999999752 223479999999999999999999997643 2233333322 2
Q ss_pred cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
....|...++++.++|.+||..||.+|||++++++||||+...
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 3456677889999999999999999999999999999997543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=378.58 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=211.6
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (479)
.++.++|++.+.||+|+||+||+|.+..+|+.||||++...... ..+.+|+.+++.+ +||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 46788999999999999999999999999999999999765322 3577999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC-----eEEeecCchh
Q 011694 89 IFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN-----LKISDFGLSA 161 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~-----vkl~DFGla~ 161 (479)
.|+||||+ |++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+|.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 8999999984 67999999999999999999999999999999999999998887 9999999997
Q ss_pred hhhccccCC-----CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---hHHHHHHHhccCcC
Q 011694 162 LAQCKHQDG-----LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS---NLIEMYRKIGKAEF 233 (479)
Q Consensus 162 ~~~~~~~~~-----~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~ 233 (479)
......... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+. +..+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 543322211 12467899999999999988775 8999999999999999999999873 34445555533322
Q ss_pred CCC-----CCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 234 KCP-----NWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 234 ~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
..+ ..+| ++.++|..||+.||.+||++++|++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222 2244 9999999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=374.25 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=217.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARS-----IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~ 81 (479)
..++..++|++++.||+|+||.||+|.+ ..+++.||||++..... ....+.+.+|+.+++.+ +||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 4456778999999999999999999985 45788999999976532 23457789999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAKG-------------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPE 142 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~~-------------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~ 142 (479)
++.+.+..|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 999999999999999999999999763 3899999999999999999999999999999999
Q ss_pred CEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChH
Q 011694 143 NLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNL 221 (479)
Q Consensus 143 NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~ 221 (479)
|||++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999998765433322223345678899999999887775 89999999999999998 9999987654
Q ss_pred HHHHHHhcc--CcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 222 IEMYRKIGK--AEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 222 ~~~~~~i~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
......... .....+..+|+.+.++|.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 333333222 2334566789999999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=367.95 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=224.3
Q ss_pred CCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 5 ~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
+...+++..++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 34678889999999999999999999999999999999999997543 23467889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
+.+..|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccce
Confidence 99999999999999999999975 359999999999999999999999999999999999999999999999999987
Q ss_pred hhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCC
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWF 239 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 239 (479)
...... ........+|+.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+... ....|..+
T Consensus 160 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 3kfa_A 160 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 237 (288)
T ss_dssp TSCSSS-SEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred eccCCc-cccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCC
Confidence 643221 1122334578899999999888775 89999999999999999 99999987766666655443 45667779
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
|+.+.+||.+||..||.+|||++++++
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 999999999999999999999999976
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=375.09 Aligned_cols=257 Identities=23% Similarity=0.414 Sum_probs=219.8
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEc-------CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCccee
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSI-------RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQL 79 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l 79 (479)
.+.+..++|++++.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.+ +||||+++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 45677899999999999999999999986 467789999997653 223457788999999999 89999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 011694 80 YEVMATKSKIFFVMEYAKGGELFNKVAKG-----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPE 142 (479)
Q Consensus 80 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~ 142 (479)
++++.+.+.+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 99999999999999999999999999753 3899999999999999999999999999999999
Q ss_pred CEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChH
Q 011694 143 NLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNL 221 (479)
Q Consensus 143 NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~ 221 (479)
|||++.++.+||+|||++................+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 999999999999999998754432221222344678899999999887765 89999999999999999 9999998887
Q ss_pred HHHHHHhccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 222 IEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 222 ~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+....+... ....+..+++++.++|.+||..||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 266 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7776666443 345667789999999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=383.43 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=208.5
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----------CCCcce
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-----------HPNIVQ 78 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-----------hpnIv~ 78 (479)
.+..++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 355689999999999999999999999999999999997543 23466788999998876 899999
Q ss_pred eEEEEEeCC----EEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecC-
Q 011694 79 LYEVMATKS----KIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDEN- 149 (479)
Q Consensus 79 l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~- 149 (479)
+++++...+ .+++||||+ +++|.+++.. +.+++..+..++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999997654 799999999 8899999875 4599999999999999999999998 99999999999999643
Q ss_pred -----CCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH---
Q 011694 150 -----ENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL--- 221 (479)
Q Consensus 150 -----g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~--- 221 (479)
+.+||+|||+|..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 3799999999875432 23456899999999999988775 899999999999999999999986431
Q ss_pred ---HHHHHHhc------------------------------------------cCcCCCCCCCCHHHHHHHHHhccCCcc
Q 011694 222 ---IEMYRKIG------------------------------------------KAEFKCPNWFPPEVRKLLCKILDPNPS 256 (479)
Q Consensus 222 ---~~~~~~i~------------------------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~ 256 (479)
......+. ......+..+++++.+||.+||+.||.
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 11111110 011123333467889999999999999
Q ss_pred ccCChhhhhcChhhhcccc
Q 011694 257 TRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 257 ~Rpt~~eil~h~wf~~~~~ 275 (479)
+|||++++++||||+....
T Consensus 324 ~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 324 KRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp TCBCHHHHHTCGGGTTCTT
T ss_pred ccCCHHHHhhChhhhcccC
Confidence 9999999999999987543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=361.78 Aligned_cols=250 Identities=20% Similarity=0.332 Sum_probs=216.5
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
....+..++|++.+.||+|+||.||+|.+ +++.||||++....... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 3 KHSGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp -CCCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CcCCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 35667788999999999999999999998 58899999998754332 3456789999999999999999999999887
Q ss_pred --CEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCCEEEecCCCeEEeecCc
Q 011694 87 --SKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRG--VYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~g--ivHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
+..++||||++||+|.+++... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence 7899999999999999999874 4899999999999999999999999 99999999999999999999999998
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCC--CccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhcc--CcCCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDG--EKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK--AEFKC 235 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~--~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~ 235 (479)
+... ......||+.|+|||++.+..+.. .++|||||||++|+|++|..||.+.+.......+.. .....
T Consensus 160 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3kmu_A 160 KFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232 (271)
T ss_dssp CCTT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred eeee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC
Confidence 6432 123457899999999998765542 279999999999999999999998877666555433 24456
Q ss_pred CCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 236 PNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 236 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
|..+|+++.++|.+||+.||.+|||++++++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7789999999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=367.22 Aligned_cols=255 Identities=25% Similarity=0.463 Sum_probs=200.3
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
...+++..++|++.+.||+|+||.||+|.+. ..||||++...... ....+.+.+|+.+++.++||||++++++. .
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 3567899999999999999999999999863 35999999765433 34457889999999999999999999965 5
Q ss_pred CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
....++||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 5668999999999999999964 46999999999999999999999999999999999999999999999999998765
Q ss_pred hccccCCCccccCCCCcccChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHH-HHHHhccCcC-----C
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVIN---RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE-MYRKIGKAEF-----K 234 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~---~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~~-----~ 234 (479)
.............||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+... ....+..... .
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 4333333445567999999999996 4444 479999999999999999999998755433 3333322222 2
Q ss_pred CCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 235 CPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 235 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+..+|+.+.+||.+||+.||.+|||++++++
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 23468899999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=373.85 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=209.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEE----EEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSV----AVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
+..++|++++.||+|+||.||+|.+..+++.| |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 44689999999999999999999999888866 555554322 223457889999999999999999999999876
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
. .++|+||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 8899999999999999975 569999999999999999999999999999999999999999999999999998664
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHH
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPE 242 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 242 (479)
............+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+... ....|..++++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999988775 89999999999999999 99999987776666555443 45667779999
Q ss_pred HHHHHHHhccCCccccCChhhhhcC
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+.++|.+||..||.+|||+.++++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=358.74 Aligned_cols=252 Identities=22% Similarity=0.385 Sum_probs=219.3
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
+.+-.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4455689999999999999999999986 6788999999875432 3578899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 89 IFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999999999976 45999999999999999999999999999999999999999999999999998754322
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 244 (479)
.. .......+|+.|+|||++.+..++ .++||||+|+++|+|++ |..||...+.......+... ....|..+++.+.
T Consensus 158 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 235 (267)
T 3t9t_A 158 QY-TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 235 (267)
T ss_dssp HH-HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred cc-cccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHH
Confidence 11 112345678899999999887775 89999999999999999 99999988877777776554 3445667899999
Q ss_pred HHHHHhccCCccccCChhhhhcC
Q 011694 245 KLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+++.+||+.||.+|||+.+++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=372.52 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=216.3
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARS-----IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~ 81 (479)
+..+..++|++++.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.+++.+ +||||+++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 3456778999999999999999999985 35778999999976532 23456788999999999 6999999999
Q ss_pred EEEeCC-EEEEEEeccCCCChHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCC
Q 011694 82 VMATKS-KIFFVMEYAKGGELFNKVAKGK-----------------LKEDAARRYFQQLINAVDFCHSRGVYHRDIKPEN 143 (479)
Q Consensus 82 ~~~~~~-~~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~N 143 (479)
++...+ .+|+||||++||+|.+++.... +++..+..++.||+.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987754 5999999999999999998642 8999999999999999999999999999999999
Q ss_pred EEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHH
Q 011694 144 LLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLI 222 (479)
Q Consensus 144 ILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~ 222 (479)
|+++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999999998755432222223345678999999999888775 89999999999999998 99999876543
Q ss_pred H-HHHHhcc-CcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcCh
Q 011694 223 E-MYRKIGK-AEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 223 ~-~~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
. ....+.. .....|..+++.+.++|.+||+.||.+|||+.++++|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2 3333322 33556777999999999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=372.87 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=194.0
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCcceeEEEEEeC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS-VMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~-il~~l~hpnIv~l~~~~~~~ 86 (479)
.+.+..++|++++.||+|+||.||+|.+..+|+.||||++...... .....+.+|+. +++.++||||+++++++.+.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 3456678999999999999999999999999999999999765322 23344555665 77888999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 87 SKIFFVMEYAKGGELFNKVA------KGKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~------~~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
+..|+||||+.+ +|.+++. .+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999999986 7777765 35799999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhh----cCCCCCCccchhhHHHHHHHHHhCCCCCCCChH-HHHHHHhccCcCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVIN----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-IEMYRKIGKAEFK 234 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~----~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~ 234 (479)
+...... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+. ......+......
T Consensus 173 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3aln_A 173 SGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248 (327)
T ss_dssp SCC---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred ceecccc---cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence 8754322 1223447999999999983 4445 4899999999999999999999987543 2333333322211
Q ss_pred -C----CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 235 -C----PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 235 -~----~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
. +..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 1 23578999999999999999999999999999999754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=362.05 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=218.7
Q ss_pred CCccCCCeEEee-eeeecCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 9 PSVLTEKYEVGR-LLGQGAFAKVYYARSI--RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 9 ~~il~~~y~i~~-~LG~G~fg~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
..+..++|.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 445678898887 9999999999999864 478889999997653 234567889999999999999999999999 4
Q ss_pred CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
.+..|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 5669999999999999999964 46999999999999999999999999999999999999999999999999998754
Q ss_pred hcccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCC
Q 011694 164 QCKHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFP 240 (479)
Q Consensus 164 ~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 240 (479)
..... ........+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+... ....|..+|
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 239 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence 32211 1122344578999999999877775 89999999999999998 99999987777666666544 356677899
Q ss_pred HHHHHHHHHhccCCccccCChhhhhcChh
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRESSW 269 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~h~w 269 (479)
+++.++|.+||..||.+|||+.+++++.+
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=361.44 Aligned_cols=252 Identities=24% Similarity=0.425 Sum_probs=211.3
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhh----HHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGL----ADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~----~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
.+.+..++|++.+.||+|+||+||+|.+..+++.||||++.......... .+.+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 44577899999999999999999999999999999999997654332211 16788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCCEEEecCCC-----eEE
Q 011694 84 ATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRG--VYHRDIKPENLLLDENEN-----LKI 154 (479)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~g--ivHrDLkp~NILl~~~g~-----vkl 154 (479)
.+.. ++||||+++|+|.+.+.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++. +||
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7766 799999999999998865 46999999999999999999999999 999999999999988776 999
Q ss_pred eecCchhhhhccccCCCccccCCCCcccChhhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCChHHH--HHHHh--c
Q 011694 155 SDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK-GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE--MYRKI--G 229 (479)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~--~~~~i--~ 229 (479)
+|||++.... ......+||+.|+|||++... ...+.++|||||||++|+|++|..||...+... ....+ .
T Consensus 171 ~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 171 ADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp CCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred CCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 9999986322 233456899999999998432 222479999999999999999999998654322 22222 2
Q ss_pred cCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 230 KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 230 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
......+..+|+++.++|.+||+.||.+|||++++++
T Consensus 246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2334567779999999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=373.41 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=203.5
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS---- 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (479)
-.++|++++.||+|+||+||+|++ .++.||||++.... .......+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred chhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 357899999999999999999988 48999999996543 22345567999999999999999999998743
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeeccCCCCCEEEecCCCeEEeec
Q 011694 88 KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR----------GVYHRDIKPENLLLDENENLKISDF 157 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~----------givHrDLkp~NILl~~~g~vkl~DF 157 (479)
.+|+||||+++|+|.+++..+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 489999999999999999998999999999999999999999999 9999999999999999999999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCC----CCCccchhhHHHHHHHHHhCCCCCCCCh-------------
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY----DGEKVDIWSCGVVLFVLLAGYLPFHDSN------------- 220 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~----~~~~~DvwSlGvil~~ll~G~~Pf~~~~------------- 220 (479)
|+|...............+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+..
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99976544433333455689999999999976322 1357899999999999999999997532
Q ss_pred ---HHHHHHHhccCcC--CCCCC-----CCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 221 ---LIEMYRKIGKAEF--KCPNW-----FPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 221 ---~~~~~~~i~~~~~--~~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.......+..... ..+.. .++++.+||.+||+.||.+|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1222222222111 11111 23559999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=373.51 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=217.4
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQ-----SVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~ 81 (479)
..++..++|++++.||+|+||.||+|.+..+++ .||+|++..... ....+.+.+|+.+++.+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 345667899999999999999999999987665 799999976532 23457789999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAK---------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL 146 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl 146 (479)
++.+.+.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 99999999999999999999998863 357999999999999999999999999999999999999
Q ss_pred ecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHH
Q 011694 147 DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMY 225 (479)
Q Consensus 147 ~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~ 225 (479)
+.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.......
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999765433222223345678899999999887775 89999999999999998 99999876544333
Q ss_pred HHhcc--CcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 226 RKIGK--AEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 226 ~~i~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
..+.. .....|..+|+.+.++|.+||+.||.+|||+.+++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 33322 2344567789999999999999999999999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=366.95 Aligned_cols=257 Identities=21% Similarity=0.351 Sum_probs=207.4
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
..+-.++|++++.||+|+||.||+|.+.. +++.||||++...... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34556899999999999999999998865 5668999999765433 2345778899999999999999999999977
Q ss_pred CC-----EEEEEEeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeE
Q 011694 86 KS-----KIFFVMEYAKGGELFNKVAK-------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLK 153 (479)
Q Consensus 86 ~~-----~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vk 153 (479)
.+ ..|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 55 35999999999999999832 4699999999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-
Q 011694 154 ISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA- 231 (479)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~- 231 (479)
|+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 9999998765433322233445678899999999887775 89999999999999999 99999887776666655443
Q ss_pred cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 232 EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 232 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
....|..+++.+.++|.+||..||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 455677799999999999999999999999999865
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=366.01 Aligned_cols=258 Identities=25% Similarity=0.390 Sum_probs=198.6
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+-.++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.++..+++.++||||+++++++.+.+.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 345678999999999999999999999999999999998654322 2334455566678889999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~-givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
|+||||+ ++.+...... +.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999999 5555555543 6799999999999999999999995 9999999999999999999999999998654322
Q ss_pred ccCCCccccCCCCcccChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCC-hHHHHHHHhccCcC-CC--CC
Q 011694 167 HQDGLLHTTCGTPAYVAPEVIN-----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS-NLIEMYRKIGKAEF-KC--PN 237 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~-----~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~-~~--~~ 237 (479)
......+||+.|+|||++. ...+ +.++|||||||++|+|++|..||... +.......+..... .. ..
T Consensus 179 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (318)
T 2dyl_A 179 ---KAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM 254 (318)
T ss_dssp -----------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred ---ccccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence 2234567999999999995 3334 48999999999999999999999863 33444444433322 22 23
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+++++.+||.+||..||.+|||++++++||||+..
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 579999999999999999999999999999999754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.09 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=215.5
Q ss_pred CCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeE
Q 011694 4 MDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLY 80 (479)
Q Consensus 4 ~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~ 80 (479)
|+.....+..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp --CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred CCCccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5566678888999999999999999999998754 34569999997653 223457889999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecC
Q 011694 81 EVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFG 158 (479)
Q Consensus 81 ~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFG 158 (479)
+++.++ ..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 80 GIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence 998754 56899999999999999975 459999999999999999999999999999999999999999999999999
Q ss_pred chhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc-CcCCCC
Q 011694 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK-AEFKCP 236 (479)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~ 236 (479)
++........ .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+.. .....|
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 159 LSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred CCcccccccc-cccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 9875433221 122345678899999999887775 89999999999999998 9999987665555544433 345567
Q ss_pred CCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 237 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
..+++.+.++|.+||..||.+|||+.+++++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 7789999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=361.37 Aligned_cols=255 Identities=28% Similarity=0.545 Sum_probs=206.4
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
....++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 34567899999999999999999999999999999999875555555667889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 90 FFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998863 469999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh--HHHHHHHhccCcCC--CCCCCC
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN--LIEMYRKIGKAEFK--CPNWFP 240 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~~--~~~~~~ 240 (479)
... .......||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.. .......+....+. .+..++
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence 221 223455799999999999887775 89999999999999999999997643 33444444443332 235589
Q ss_pred HHHHHHHHHhccCCccccCChhhhhcC
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+++.+||.+||..||.+|||+.+++++
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=368.97 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=215.2
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEE--EEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSV--AVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKS 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v--aiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (479)
+-.++|++.+.||+|+||.||+|++..++..+ |||.+.... .......+.+|+.+++.+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 34589999999999999999999999899865 999887532 223346788999999999 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC
Q 011694 88 KIFFVMEYAKGGELFNKVAKG-----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE 150 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g 150 (479)
.+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999999999999753 599999999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhc
Q 011694 151 NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIG 229 (479)
Q Consensus 151 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 229 (479)
.+||+|||++...... .......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+.
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999998643221 112344678899999999887765 89999999999999998 999999988877777775
Q ss_pred cC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcCh
Q 011694 230 KA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 230 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
.. ....|..+++.+.+||.+||..||.+|||+++++++-
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 54 3456677899999999999999999999999998763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=362.96 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=212.0
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEV 82 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~ 82 (479)
....+...+|++++.||+|+||.||+|+ +..+++.||||++..... ......+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGI 91 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 3445667789999999999999999999 567899999999976542 2345778999999999999999999999
Q ss_pred EEeC--CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecC
Q 011694 83 MATK--SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFG 158 (479)
Q Consensus 83 ~~~~--~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFG 158 (479)
+.+. +.+|+||||+++|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence 9876 679999999999999999954 579999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh---------------HH
Q 011694 159 LSALAQCKHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---------------LI 222 (479)
Q Consensus 159 la~~~~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~---------------~~ 222 (479)
++........ ........||+.|+|||++.+..++ .++|||||||++|+|++|..|+.... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 9875543221 1223455788899999999887775 89999999999999999998864321 11
Q ss_pred HHHHHh-ccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 223 EMYRKI-GKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 223 ~~~~~i-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.....+ .......|..+|+++.+||.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 222222 22345567789999999999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=377.72 Aligned_cols=255 Identities=21% Similarity=0.368 Sum_probs=207.9
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
.++..++|++.+.||+|+||.||+|++. .++..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 4556679999999999999999999987 467789999997643 22445778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
.+.+|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999999763 6999999999999999999999999999999999999999999999999999765
Q ss_pred hccccCC-CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCC
Q 011694 164 QCKHQDG-LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFP 240 (479)
Q Consensus 164 ~~~~~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 240 (479)
....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+... ..+.+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence 4322111 11223457889999999888775 89999999999999998 99999988777766666443 345566789
Q ss_pred HHHHHHHHHhccCCccccCChhhhhc
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+.+.++|.+||+.||.+|||+.+|++
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=362.00 Aligned_cols=256 Identities=24% Similarity=0.352 Sum_probs=214.0
Q ss_pred CCCccCCCeEEee-eeeecCCeEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 8 KPSVLTEKYEVGR-LLGQGAFAKVYYARS--IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 8 ~~~il~~~y~i~~-~LG~G~fg~Vy~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
...+-.++|++.+ .||+|+||.||+|.+ ..+++.||||++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 3445567899999 999999999999954 56788999999976532 224467899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
..+..|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 56778999999999999999987 46999999999999999999999999999999999999999999999999998754
Q ss_pred hccccC-CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCC
Q 011694 164 QCKHQD-GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFP 240 (479)
Q Consensus 164 ~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 240 (479)
...... .......+|+.|+|||++.+..++ .++||||||+++|+|++ |..||.+.+.......+... ....|..+|
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 246 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 322111 112234567899999999887765 89999999999999999 99999988877766666544 345677899
Q ss_pred HHHHHHHHHhccCCccccCChhhhhc
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+.+.++|.+||+.||.+|||+.++++
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=384.30 Aligned_cols=253 Identities=23% Similarity=0.417 Sum_probs=218.2
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
...+++..++|++.+.||+|+||+||+|.+. ++..||||++..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 3456778899999999999999999999985 567899999976542 2467889999999999999999999986
Q ss_pred CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
.+.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 5678999999999999999975 2699999999999999999999999999999999999999999999999999976
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCC
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFP 240 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 240 (479)
...... .......+|+.|+|||++....++ .++|||||||+||+|++ |..||.+.+..+....+..+ ..+.|..+|
T Consensus 334 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 411 (454)
T 1qcf_A 334 IEDNEY-TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 411 (454)
T ss_dssp BCCHHH-HTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred cCCCce-eccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 432211 112234567899999999887775 89999999999999999 99999988877776666443 456677899
Q ss_pred HHHHHHHHHhccCCccccCChhhhhc
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.+||.+||+.||.+|||+++|++
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 99999999999999999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=366.31 Aligned_cols=256 Identities=20% Similarity=0.342 Sum_probs=213.0
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTN----QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
.++...+|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4567789999999999999999999987653 459999997543 2234567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
+.+..|+||||+++|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999999999975 4699999999999999999999999999999999999999999999999999976
Q ss_pred hhccccCC-CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCC
Q 011694 163 AQCKHQDG-LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWF 239 (479)
Q Consensus 163 ~~~~~~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 239 (479)
........ ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+... ..+.+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 275 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 275 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred hccccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccC
Confidence 54322111 12233568899999999877775 89999999999999998 99999988777777666544 45566778
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
++.+.++|.+||+.||.+|||+.+++++
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=359.00 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=214.1
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe---
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT--- 85 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~--- 85 (479)
+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 4567789999999999999999999999999999999997653 245689999999999999999999865
Q ss_pred -------------CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC
Q 011694 86 -------------KSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN 149 (479)
Q Consensus 86 -------------~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~ 149 (479)
...+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 4568999999999999999964 479999999999999999999999999999999999999999
Q ss_pred CCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhc
Q 011694 150 ENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIG 229 (479)
Q Consensus 150 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~ 229 (479)
+.+||+|||++...... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||.... .....+.
T Consensus 159 ~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~ 232 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLR 232 (284)
T ss_dssp TEEEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH
T ss_pred CCEEECcchhheecccc---ccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh
Confidence 99999999998754322 223456799999999999887775 89999999999999999999885432 2333333
Q ss_pred cCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 230 KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 230 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
.. ..+..+++.+.++|.+||..||.+|||+.+++++.|.-.
T Consensus 233 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 233 DG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 22 345668999999999999999999999999999988754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=382.16 Aligned_cols=246 Identities=27% Similarity=0.482 Sum_probs=213.2
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.+.+-.++|++.+.||+|+||.||+|.+ +|+.||||++.... ..+.+.+|+.+++.++||||+++++++....
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 4566778999999999999999999988 57899999997653 2367889999999999999999999987665
Q ss_pred -EEEEEEeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 88 -KIFFVMEYAKGGELFNKVAK-G--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 88 -~~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
.+|+||||+++|+|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999986 2 3799999999999999999999999999999999999999999999999998643
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCH
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPP 241 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 241 (479)
.. ......+++.|+|||++.+..++ .++|||||||+||+|++ |..||...+..+....+..+ ....|..+|+
T Consensus 340 ~~-----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~ 413 (450)
T 1k9a_A 340 SS-----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 413 (450)
T ss_dssp C-----------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred cc-----cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 21 12234678999999999888775 89999999999999998 99999987766666665443 4567788999
Q ss_pred HHHHHHHHhccCCccccCChhhhhc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
++.+||.+||..||.+|||+.+|++
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=355.36 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=217.3
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
.+.+.+..++|++++.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC
Confidence 3467788899999999999999999999974 567899999976542 24678899999999999999999999874
Q ss_pred CCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
+..|+||||++|++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 80 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred -CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 4589999999999999999753 699999999999999999999999999999999999999999999999999875
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCC
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFP 240 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 240 (479)
...... .......+++.|+|||++.+..++ .++||||||+++|+|++ |..||.+.+.......+... ....+..++
T Consensus 159 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T 1qpc_A 159 IEDNEY-TAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236 (279)
T ss_dssp CSSSCE-ECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccc-ccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCccccc
Confidence 432211 112344578899999999877765 89999999999999999 99999988777766666443 345667789
Q ss_pred HHHHHHHHHhccCCccccCChhhhhc
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.++|.+||..||.+|||+.++++
T Consensus 237 ~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 237 EELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=390.70 Aligned_cols=254 Identities=25% Similarity=0.431 Sum_probs=221.3
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
..+++-..+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|+.++||||+++++++.+.
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3456777899999999999999999999999999999999976532 246788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
+.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 999999999999999999975 35999999999999999999999999999999999999999999999999999764
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCH
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPP 241 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 241 (479)
..... .......+++.|+|||++.+..++ .++|||||||+||+|++ |..||.+.+.......+... ....|..+|+
T Consensus 369 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (495)
T 1opk_A 369 TGDTY-TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 446 (495)
T ss_dssp TTCCE-ECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred cCCce-eecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 32211 112234567899999999887775 89999999999999999 99999988776666655443 4566778999
Q ss_pred HHHHHHHHhccCCccccCChhhhhc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+.+||.+||+.||.+|||+.+|++
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9999999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=358.22 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=207.2
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE-EeCCEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM-ATKSKI 89 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~-~~~~~~ 89 (479)
.+.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.++|++++..+..+ ...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 4678999999999999999999999999999999998765432 3578999999999988766655554 677889
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE---ecCCCeEEeecCchhhhh
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQ 164 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl---~~~g~vkl~DFGla~~~~ 164 (479)
|+||||+ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 8899999973 579999999999999999999999999999999999999 488999999999987654
Q ss_pred ccccC-----CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh---HHHHHHHhccCcCCC-
Q 011694 165 CKHQD-----GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKIGKAEFKC- 235 (479)
Q Consensus 165 ~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~- 235 (479)
..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+ ....+..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 32221 123456899999999999887765 89999999999999999999998632 222333332222222
Q ss_pred ----CCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 236 ----PNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 236 ----~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+..+|+++.++|.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 3668999999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=366.01 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=212.7
Q ss_pred CCccCCCe-EEeeeeeecCCeEEEEEEE----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 9 PSVLTEKY-EVGRLLGQGAFAKVYYARS----IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 9 ~~il~~~y-~i~~~LG~G~fg~Vy~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
+.++.++| ++++.||+|+||+||++.. ..+++.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 25 ~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp CCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 45678888 9999999999999988754 4588999999997653 234457789999999999999999999999
Q ss_pred Ee--CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 84 AT--KSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 84 ~~--~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
.+ ...+|+||||+++|+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 87 4689999999999999999999889999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH---------------HHH
Q 011694 162 LAQCKHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI---------------EMY 225 (479)
Q Consensus 162 ~~~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~---------------~~~ 225 (479)
....... ........+|+.|+|||++.+..++ .++|||||||++|+|++|..||...... ...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 5533211 1123345688899999999887775 8999999999999999999999764321 111
Q ss_pred HHhc-cCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 226 RKIG-KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 226 ~~i~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
..+. ......+..+|+++.+||.+||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1221 2244567779999999999999999999999999984
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=372.41 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=210.8
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
-....++|++.+.||+|+||.||+|.+ .+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 344678999999999999999999996 4789999999876432 345778999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 89 IFFVMEYAKGGELFNKVAKG-----KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
.|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999999998653 4899999999999999999999999999999999999999999999999998754
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHH------HH-HHhccCcC---
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE------MY-RKIGKAEF--- 233 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~------~~-~~i~~~~~--- 233 (479)
............+||+.|+|||++.+..++ .++|||||||++|+|++|..||....... .. .......+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 333333333455689999999999887775 89999999999999999999997543211 10 11111110
Q ss_pred -------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChh
Q 011694 234 -------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSW 269 (479)
Q Consensus 234 -------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~w 269 (479)
..++.++..+.+++.+||+.||.+|||+.+++++..
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111223567899999999999999999999997754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=382.59 Aligned_cols=254 Identities=24% Similarity=0.418 Sum_probs=214.7
Q ss_pred CCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 5 ~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
....+++..++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+++.++||||+++++++.
T Consensus 175 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~ 249 (452)
T 1fmk_A 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS 249 (452)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 355677888999999999999999999999864 466999999765422 367889999999999999999999987
Q ss_pred eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
+ +.+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 250 ~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred C-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccce
Confidence 6 678999999999999999974 469999999999999999999999999999999999999999999999999997
Q ss_pred hhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCC
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWF 239 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 239 (479)
...... ........+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+
T Consensus 329 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 406 (452)
T 1fmk_A 329 LIEDNE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406 (452)
T ss_dssp ---------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred ecCCCc-eecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 654221 1122334578899999999887775 89999999999999999 99999988877777666544 45667889
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
|+.+.+||.+||+.||.+|||+++|++
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=357.83 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=202.3
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE-EeCCEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM-ATKSKI 89 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~-~~~~~~ 89 (479)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+..+ ...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 4678999999999999999999999999999999997665432 3467899999999988766666554 778899
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE---ecCCCeEEeecCchhhhh
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQ 164 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl---~~~g~vkl~DFGla~~~~ 164 (479)
++||||+ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999 8999999983 579999999999999999999999999999999999999 788999999999997654
Q ss_pred ccccC-----CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH---HHHHHHhccCcCCCC
Q 011694 165 CKHQD-----GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL---IEMYRKIGKAEFKCP 236 (479)
Q Consensus 165 ~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~~ 236 (479)
..... ......+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+. ...+..+.......|
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 32221 123456899999999999887775 899999999999999999999976432 122222222222222
Q ss_pred -----CCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 237 -----NWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 237 -----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
..+|+++.+||.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 567899999999999999999999999976
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=354.84 Aligned_cols=249 Identities=21% Similarity=0.381 Sum_probs=209.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE-E
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQ---SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI-F 90 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~-~ 90 (479)
.|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57788999999999999999866554 79999986533 234457888999999999999999999999876655 9
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc-
Q 011694 91 FVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH- 167 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~- 167 (479)
+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999986 469999999999999999999999999999999999999999999999999997543322
Q ss_pred -cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHH
Q 011694 168 -QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244 (479)
Q Consensus 168 -~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 244 (479)
.........+|+.|+|||++.+..++ .++|||||||++|+|++ |.+||...+.......+... ....+..+++.+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 12233455788999999999887775 89999999999999999 55566666655555554433 3556777899999
Q ss_pred HHHHHhccCCccccCChhhhhc
Q 011694 245 KLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 245 ~li~~~L~~dP~~Rpt~~eil~ 266 (479)
++|.+||+.||.+|||+.++++
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999976
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=360.43 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=199.8
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--CCCCCcceeEEEEEe-
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI--VRHPNIVQLYEVMAT- 85 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~--l~hpnIv~l~~~~~~- 85 (479)
.+++.++|++.+.||+|+||+||+|.+ +|+.||||++.... .....+|..++.. ++||||+++++++..
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 357889999999999999999999988 79999999986542 2445566666666 789999999998654
Q ss_pred ---CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeccCCCCCEEEecCCCeEE
Q 011694 86 ---KSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH--------SRGVYHRDIKPENLLLDENENLKI 154 (479)
Q Consensus 86 ---~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH--------~~givHrDLkp~NILl~~~g~vkl 154 (479)
...+|+||||+++|+|.+++..+.+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred cCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 356899999999999999999889999999999999999999999 999999999999999999999999
Q ss_pred eecCchhhhhccccC--CCccccCCCCcccChhhhhcCCCC-----CCccchhhHHHHHHHHHhC----------CCCCC
Q 011694 155 SDFGLSALAQCKHQD--GLLHTTCGTPAYVAPEVINRKGYD-----GEKVDIWSCGVVLFVLLAG----------YLPFH 217 (479)
Q Consensus 155 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPEvl~~~~~~-----~~~~DvwSlGvil~~ll~G----------~~Pf~ 217 (479)
+|||+|......... ......+||+.|+|||++.+.... +.++||||+||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998654322111 112345899999999999876332 2589999999999999999 88885
Q ss_pred CCh----HHHHHHHhcc---CcCCCCC-----CCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 218 DSN----LIEMYRKIGK---AEFKCPN-----WFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 218 ~~~----~~~~~~~i~~---~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
... .......... .....|. .+++++.+||.+||+.||.+|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 431 1222222211 1122221 13477999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=355.42 Aligned_cols=246 Identities=27% Similarity=0.472 Sum_probs=207.6
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC-
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK- 86 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~- 86 (479)
.+.+..++|++.+.||+|+||.||+|.+ +|+.||||++.... ..+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3456678999999999999999999988 58899999997543 346788999999999999999999997544
Q ss_pred CEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
+.+|+||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 5799999999999999999763 3899999999999999999999999999999999999999999999999998754
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCH
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPP 241 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 241 (479)
... .....+++.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+... ....+..+|+
T Consensus 168 ~~~-----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (278)
T 1byg_A 168 SST-----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 241 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred ccc-----ccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCH
Confidence 322 2344688999999999887775 89999999999999998 99999987776666666443 4556777999
Q ss_pred HHHHHHHHhccCCccccCChhhhhc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+.++|.+||..||.+|||+.++++
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 242 AVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHH
Confidence 9999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=360.49 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=208.0
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcC-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIR-TNQ--SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
...+..++|++++.||+|+||.||+|.+.. +++ .||||++...........+.+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 344567899999999999999999998653 333 69999998765544456688999999999999999999999998
Q ss_pred eCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
+.+ .++||||+.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred cCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 766 8999999999999999875 4699999999999999999999999999999999999999999999999999875
Q ss_pred hhccccC-CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC--cCCCCCC
Q 011694 163 AQCKHQD-GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA--EFKCPNW 238 (479)
Q Consensus 163 ~~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~ 238 (479)
....... .......+|+.|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+... ....+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence 4322111 112345678899999999887775 89999999999999999 99999988877777766544 3445667
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+|+++.++|.+||..||.+|||+.++++
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=357.17 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=208.0
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE-EeCCE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRT---NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM-ATKSK 88 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~-~~~~~ 88 (479)
..+|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 45799999999999999999997543 3468999987533 234457788999999999999999999985 55678
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 89 IFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
.|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 8999999999999999975 46899999999999999999999999999999999999999999999999999754332
Q ss_pred cc--CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHH
Q 011694 167 HQ--DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPE 242 (479)
Q Consensus 167 ~~--~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 242 (479)
.. ........+|+.|+|||++.+..++ .++||||||+++|+|++ |.+||...+.......+... ....|..+|+.
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred chhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 21 1223345678899999999888775 89999999999999999 67788776665555544433 34456778999
Q ss_pred HHHHHHHhccCCccccCChhhhhc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+.++|.+||+.||.+|||+.++++
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=369.04 Aligned_cols=253 Identities=17% Similarity=0.224 Sum_probs=200.0
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcC---CCcEEEEEEeecccccchh--------hHHHHHHHHHHHHhCCCCCcceeE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIMRVG--------LADQIKREISVMRIVRHPNIVQLY 80 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vaiK~i~~~~~~~~~--------~~~~l~~Ei~il~~l~hpnIv~l~ 80 (479)
..++|++++.||+|+||.||+|.+.. ++..||||++......... ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34799999999999999999999987 7889999999765321100 113456788999999999999999
Q ss_pred EEEEe----CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC--CeE
Q 011694 81 EVMAT----KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE--NLK 153 (479)
Q Consensus 81 ~~~~~----~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g--~vk 153 (479)
+++.. ...+|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99988 78899999999 9999999986 4799999999999999999999999999999999999999877 999
Q ss_pred EeecCchhhhhccccC-----CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC--hHHHHHH
Q 011694 154 ISDFGLSALAQCKHQD-----GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS--NLIEMYR 226 (479)
Q Consensus 154 l~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~--~~~~~~~ 226 (479)
|+|||+|......... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||... +......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9999999765433211 122456899999999999887765 8999999999999999999999642 2221111
Q ss_pred HhccCcCCC---------CCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 227 KIGKAEFKC---------PNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 227 ~i~~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
......... +..+|+++.++|.+||..||.+|||+++|++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 111111111 1268899999999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=362.64 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=206.0
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe----C
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT----K 86 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~----~ 86 (479)
+..++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 34578999999999999999999999999999999986542 2445778899999999999999999999862 3
Q ss_pred CEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
...|+||||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 478999999999999998875 569999999999999999999999999999999999999999999999999876
Q ss_pred hhhccccCC-------CccccCCCCcccChhhhhcCCC--CCCccchhhHHHHHHHHHhCCCCCCCChHH--HHHHHh-c
Q 011694 162 LAQCKHQDG-------LLHTTCGTPAYVAPEVINRKGY--DGEKVDIWSCGVVLFVLLAGYLPFHDSNLI--EMYRKI-G 229 (479)
Q Consensus 162 ~~~~~~~~~-------~~~~~~gt~~y~aPEvl~~~~~--~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~--~~~~~i-~ 229 (479)
......... ......||+.|+|||++.+... .+.++|||||||++|+|++|..||...... .....+ .
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 432211110 0123467999999999875542 247999999999999999999999642110 111111 1
Q ss_pred cCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcCh
Q 011694 230 KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 230 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
....+.+..+++++.++|.+||+.||.+|||+++++++-
T Consensus 263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 223344567899999999999999999999999998763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=370.84 Aligned_cols=252 Identities=18% Similarity=0.238 Sum_probs=200.3
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeecccccchh--------hHHHHHHHHHHHHhCCCCCccee
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRT-----NQSVAVKVIDKDKIMRVG--------LADQIKREISVMRIVRHPNIVQL 79 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~--------~~~~l~~Ei~il~~l~hpnIv~l 79 (479)
.++|++++.||+|+||.||+|.+..+ ++.||||++......... ....+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 35999999999999999999998764 588999998765321100 01223456667788899999999
Q ss_pred EEEEEeC----CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe--cCCC
Q 011694 80 YEVMATK----SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD--ENEN 151 (479)
Q Consensus 80 ~~~~~~~----~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~--~~g~ 151 (479)
++++... ...|+||||+ |++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998764 5689999999 9999999976 5799999999999999999999999999999999999999 8899
Q ss_pred eEEeecCchhhhhccccC-----CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHH
Q 011694 152 LKISDFGLSALAQCKHQD-----GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYR 226 (479)
Q Consensus 152 vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~ 226 (479)
+||+|||+|......... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+......+.
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999999999765433221 112345699999999999888775 89999999999999999999998532211111
Q ss_pred Hhcc----C-------cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 227 KIGK----A-------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 227 ~i~~----~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.... . ....+..+|+++.++|..||..||.+||++.+|++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1100 0 00122567899999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=362.78 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=213.7
Q ss_pred CCCccC-CCeEEeeeeeecCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 011694 8 KPSVLT-EKYEVGRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEV 82 (479)
Q Consensus 8 ~~~il~-~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~ 82 (479)
..+++. ++|++.+.||+|+||.||+|+ +..+++.||||++.... ....+.+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 92 (327)
T 3lxl_A 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGV 92 (327)
T ss_dssp -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEE
Confidence 445554 799999999999999999999 46789999999997653 2345678999999999999999999999
Q ss_pred EE--eCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecC
Q 011694 83 MA--TKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFG 158 (479)
Q Consensus 83 ~~--~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFG 158 (479)
+. +.+.+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 93 SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp EECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred EecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 86 56779999999999999999976 469999999999999999999999999999999999999999999999999
Q ss_pred chhhhhccccC-CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH---------------
Q 011694 159 LSALAQCKHQD-GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI--------------- 222 (479)
Q Consensus 159 la~~~~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~--------------- 222 (479)
++......... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence 98754322211 122345688899999999887775 8999999999999999999999754432
Q ss_pred HHHHHhc-cCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 223 EMYRKIG-KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 223 ~~~~~i~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.....+. ......+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1222222 22345677799999999999999999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=379.19 Aligned_cols=254 Identities=25% Similarity=0.432 Sum_probs=208.4
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.++++.++|++.+.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp EEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 3567889999999999999999999999999999999999765432 23467789999999999999999999998765
Q ss_pred --EEEEEEeccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE----ecCCCeEEeec
Q 011694 88 --KIFFVMEYAKGGELFNKVAKG----KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL----DENENLKISDF 157 (479)
Q Consensus 88 --~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl----~~~g~vkl~DF 157 (479)
..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 789999999999999999762 39999999999999999999999999999999999999 66777999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhc--------CCCCCCccchhhHHHHHHHHHhCCCCCCCC----hHHHHH
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINR--------KGYDGEKVDIWSCGVVLFVLLAGYLPFHDS----NLIEMY 225 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~--------~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~----~~~~~~ 225 (479)
|+|...... ......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||... ...+..
T Consensus 161 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 161 GAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp GGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred CCceEccCC---CccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 998754322 22345679999999999875 334 47899999999999999999999642 223333
Q ss_pred HHhccCcC---------------------CCCC----CCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 226 RKIGKAEF---------------------KCPN----WFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 226 ~~i~~~~~---------------------~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
..+..+.. +.+. .+++.+.++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 33322211 1111 134678899999999999999999998654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=368.74 Aligned_cols=248 Identities=17% Similarity=0.257 Sum_probs=203.4
Q ss_pred CccCCCeEEeeeeeecCCeEEEEE-----EEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceeEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYA-----RSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR---HPNIVQLYE 81 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a-----~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~---hpnIv~l~~ 81 (479)
.+..++|.+.+.||+|+||.||+| .+..+++.||||++.... ...+.+|+.+++.++ |+||+++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 345678999999999999999999 467789999999997542 346678888888887 999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-------
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVA------KGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE------- 148 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~------~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~------- 148 (479)
++...+..|+||||++||+|.+++. .+.+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 9999999999999999999999996 246999999999999999999999999999999999999998
Q ss_pred ----CCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHH
Q 011694 149 ----NENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEM 224 (479)
Q Consensus 149 ----~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~ 224 (479)
++.+||+|||+|...............+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 899999999999755433334445667899999999999988875 89999999999999999999996543211
Q ss_pred HHHhccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcCh
Q 011694 225 YRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
..........+.++.+.+++..||+.+|.+|++..+.+.+.
T Consensus 293 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 293 ---CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp ---EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ---eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 00011111223567899999999999999997765554443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=374.42 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=196.9
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSK 88 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (479)
..+.+.|.+.+.||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred hhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 457788888999999999999875 45689999999986532 35667899999876 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcCCC--------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC-----------
Q 011694 89 IFFVMEYAKGGELFNKVAKGKL--------KEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN----------- 149 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~~l--------~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~----------- 149 (479)
+|+|||||. |+|.+++..... ++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 999999996 599999986432 233457899999999999999999999999999999754
Q ss_pred --CCeEEeecCchhhhhccccC--CCccccCCCCcccChhhhhcC------CCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 011694 150 --ENLKISDFGLSALAQCKHQD--GLLHTTCGTPAYVAPEVINRK------GYDGEKVDIWSCGVVLFVLLA-GYLPFHD 218 (479)
Q Consensus 150 --g~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPEvl~~~------~~~~~~~DvwSlGvil~~ll~-G~~Pf~~ 218 (479)
+.+||+|||+|......... ......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||.+
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 37999999999765432211 123356899999999999751 233589999999999999999 9999986
Q ss_pred ChHHHHHHHhccCcCCCC-------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 219 SNLIEMYRKIGKAEFKCP-------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~-------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
...... .+.......+ ..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 243 ~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 243 KYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp TTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred chhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 544321 2222222211 1245789999999999999999999999999999754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=365.05 Aligned_cols=244 Identities=16% Similarity=0.243 Sum_probs=201.9
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCC--------CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcce------
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRT--------NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQ------ 78 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--------~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~------ 78 (479)
.++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47999999999999999999999874 889999999754 35678999999999999988
Q ss_pred ---------eEEEEEe-CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEE
Q 011694 79 ---------LYEVMAT-KSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLL 145 (479)
Q Consensus 79 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NIL 145 (479)
+++++.. .+..|+||||+ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777776 78899999999 9999999986 57999999999999999999999999999999999999
Q ss_pred EecCC--CeEEeecCchhhhhccccC-----CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 011694 146 LDENE--NLKISDFGLSALAQCKHQD-----GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHD 218 (479)
Q Consensus 146 l~~~g--~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~ 218 (479)
++.++ .+||+|||++......... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCccc
Confidence 99988 8999999999765433221 122345899999999999887775 899999999999999999999986
Q ss_pred Ch--HHHHHHH---hccCcCCCC------CCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 219 SN--LIEMYRK---IGKAEFKCP------NWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 219 ~~--~~~~~~~---i~~~~~~~~------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.. ....... +.......+ ..+++++.+||.+||..||.+|||++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 53 2222221 111111111 246899999999999999999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=384.85 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=219.0
Q ss_pred CCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 5 DHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 5 ~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
....+++..++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.
T Consensus 258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 455677888999999999999999999999864 467999999765422 367889999999999999999999987
Q ss_pred eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
+ +.+||||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 333 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 6 678999999999999999974 459999999999999999999999999999999999999999999999999997
Q ss_pred hhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCC
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWF 239 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 239 (479)
....... .......+++.|+|||++.+..++ .++|||||||+||+|++ |..||.+.+..+....+..+ ....|..+
T Consensus 412 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 489 (535)
T 2h8h_A 412 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 489 (535)
T ss_dssp TCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred ecCCCce-ecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 5432211 111234567899999999887775 89999999999999999 99999988877777666544 45667789
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
++.+.+||.+||+.||.+|||+++|++
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=359.72 Aligned_cols=250 Identities=22% Similarity=0.412 Sum_probs=199.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--CCCCCcceeEEEEEeC-
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI--VRHPNIVQLYEVMATK- 86 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~--l~hpnIv~l~~~~~~~- 86 (479)
..+.++|++.+.||+|+||.||+|.+ +|+.||||++.... .....+|..++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 45678999999999999999999998 58999999986432 2333445555554 4899999999999887
Q ss_pred ---CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCCEEEecCCCeEEe
Q 011694 87 ---SKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR--------GVYHRDIKPENLLLDENENLKIS 155 (479)
Q Consensus 87 ---~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~--------givHrDLkp~NILl~~~g~vkl~ 155 (479)
..+|+||||+++|+|.+++....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999988999999999999999999999999 99999999999999999999999
Q ss_pred ecCchhhhhccccC--CCccccCCCCcccChhhhhcCCCCCC-----ccchhhHHHHHHHHHhC----------CCCCCC
Q 011694 156 DFGLSALAQCKHQD--GLLHTTCGTPAYVAPEVINRKGYDGE-----KVDIWSCGVVLFVLLAG----------YLPFHD 218 (479)
Q Consensus 156 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPEvl~~~~~~~~-----~~DvwSlGvil~~ll~G----------~~Pf~~ 218 (479)
|||+|......... ......+||+.|+|||++.+..+... ++|||||||++|+|++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99998654322211 11235689999999999987766522 38999999999999999 777754
Q ss_pred Ch-----HHHHHHHhc--cCcCCCCC-----CCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 219 SN-----LIEMYRKIG--KAEFKCPN-----WFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 219 ~~-----~~~~~~~i~--~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.. .......+. ......|. .+++++.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 21 112222221 11222222 345779999999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=353.92 Aligned_cols=241 Identities=31% Similarity=0.502 Sum_probs=199.0
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
-.++|++.+.||+|+||.||+|.+ +++.||||++... ...+.+.+|+.+++.++||||+++++++.+ ..|+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence 357899999999999999999988 5789999998643 234678899999999999999999998874 4799
Q ss_pred EEeccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeeccCCCCCEEEecCCC-eEEeecCchhhh
Q 011694 92 VMEYAKGGELFNKVAKG----KLKEDAARRYFQQLINAVDFCHS---RGVYHRDIKPENLLLDENEN-LKISDFGLSALA 163 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~----~l~e~~~~~i~~qll~aL~~LH~---~givHrDLkp~NILl~~~g~-vkl~DFGla~~~ 163 (479)
||||++||+|.+++... .+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999999999863 37899999999999999999999 89999999999999998887 799999998654
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh--HHHHHHHh-ccCcCCCCCCCC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN--LIEMYRKI-GKAEFKCPNWFP 240 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i-~~~~~~~~~~~~ 240 (479)
.. ......||+.|+|||++.+..++ .++|||||||++|+|++|..||.... .......+ .......+..+|
T Consensus 157 ~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
T 2eva_A 157 QT-----HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCC
T ss_pred cc-----ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccC
Confidence 32 12345699999999999887775 89999999999999999999997543 22222222 233345566789
Q ss_pred HHHHHHHHHhccCCccccCChhhhhcC
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+.+.++|.+||+.||.+|||+++++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=373.86 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=198.2
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV 92 (479)
.+|.+.+.||+|+||+||. ....+|+.||||++...... .+.+|+.+++.+ +||||+++++++.+.+..|+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 4699999999999999764 44568999999999765432 245899999999 799999999999999999999
Q ss_pred EeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec---CC--CeEEeecCchhhhhc
Q 011694 93 MEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---NE--NLKISDFGLSALAQC 165 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---~g--~vkl~DFGla~~~~~ 165 (479)
||||.| +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++ .+||+|||+|.....
T Consensus 97 ~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 999975 999999864 4666678899999999999999999999999999999953 23 578999999875542
Q ss_pred ccc-CCCccccCCCCcccChhhhhcC--CCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccCcCCC---CCC
Q 011694 166 KHQ-DGLLHTTCGTPAYVAPEVINRK--GYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAEFKC---PNW 238 (479)
Q Consensus 166 ~~~-~~~~~~~~gt~~y~aPEvl~~~--~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~---~~~ 238 (479)
... .......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||...........+....... +..
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence 211 1223456899999999999742 222479999999999999999 999997665544433333222221 222
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+..+.+||.+||+.||.+|||++++++||||....
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 356689999999999999999999999999997543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=351.55 Aligned_cols=231 Identities=29% Similarity=0.587 Sum_probs=191.3
Q ss_pred ccCCCeEEe-eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceeEEEEEe---
Q 011694 11 VLTEKYEVG-RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQLYEVMAT--- 85 (479)
Q Consensus 11 il~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il-~~l~hpnIv~l~~~~~~--- 85 (479)
.+.++|.+. +.||+|+||.||+|.+..+++.||||++... ....+|+.++ +.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 345567776 8899999999999999999999999999643 3456888887 66789999999999987
Q ss_pred -CCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec---CCCeEEeecC
Q 011694 86 -KSKIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---NENLKISDFG 158 (479)
Q Consensus 86 -~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---~g~vkl~DFG 158 (479)
...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 67899999999999999999863 5999999999999999999999999999999999999997 7889999999
Q ss_pred chhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHh----ccCcCC
Q 011694 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI----GKAEFK 234 (479)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i----~~~~~~ 234 (479)
++.... +..+ +.++|||||||++|+|++|..||.+.+.......+ ......
T Consensus 166 ~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 166 FAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp TCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred cccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 875321 1234 37899999999999999999999876654433222 222233
Q ss_pred CC----CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 235 CP----NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 235 ~~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.| ..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 33 45899999999999999999999999999999997654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=360.14 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=190.2
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEE----
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMA---- 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~---- 84 (479)
.+...+|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.+. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 455669999999999999999999999999999999985543 234567889999999996 999999999994
Q ss_pred ----eCCEEEEEEeccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCCEEEecCCCeEE
Q 011694 85 ----TKSKIFFVMEYAKGGELFNKVAK----GKLKEDAARRYFQQLINAVDFCHSRG--VYHRDIKPENLLLDENENLKI 154 (479)
Q Consensus 85 ----~~~~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~i~~qll~aL~~LH~~g--ivHrDLkp~NILl~~~g~vkl 154 (479)
....+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 3456899999996 588888754 56999999999999999999999999 999999999999999999999
Q ss_pred eecCchhhhhccccC----------CCccccCCCCcccChhhh---hcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH
Q 011694 155 SDFGLSALAQCKHQD----------GLLHTTCGTPAYVAPEVI---NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL 221 (479)
Q Consensus 155 ~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPEvl---~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~ 221 (479)
+|||++......... ......+||+.|+|||++ .+..+ +.++|||||||++|+|++|..||.....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999998754322111 011245799999999998 34444 4799999999999999999999987655
Q ss_pred HHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChh
Q 011694 222 IEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSW 269 (479)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~w 269 (479)
....... .....+..+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 259 ~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 259 LRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ---------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 4333222 123344557889999999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=385.63 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=211.2
Q ss_pred CccCCCeEEee-eeeecCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 10 SVLTEKYEVGR-LLGQGAFAKVYYARSIR--TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 10 ~il~~~y~i~~-~LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
.+..++|.+.+ .||+|+||.||+|.+.. ++..||||++..... ....+.+.+|+.+|+.++|||||++++++.+
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 34556777777 89999999999998763 566799999976532 2345788999999999999999999999976
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
+.+|+||||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 559999999999999999964 469999999999999999999999999999999999999999999999999997643
Q ss_pred cccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCH
Q 011694 165 CKHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPP 241 (479)
Q Consensus 165 ~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 241 (479)
.... ........+|+.|+|||++.+..++ .++|||||||+||+|++ |..||.+.+..+....+..+ ....|..+|+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 566 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 566 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 2211 1111233467899999999888775 89999999999999998 99999988877777776554 3567788999
Q ss_pred HHHHHHHHhccCCccccCChhhhhc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
++.+||.+||..||.+|||+++|++
T Consensus 567 ~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 567 ELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999853
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=367.55 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=201.1
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTN---QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA-TKSKI 89 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~-~~~~~ 89 (479)
..|++.+.||+|+||+||+|.+..++ ..||||.+.... .....+.+.+|+.+++.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35889999999999999999876433 468999986532 2345678899999999999999999999864 45688
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999999986 358999999999999999999999999999999999999999999999999997543322
Q ss_pred cCC--CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHH
Q 011694 168 QDG--LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEV 243 (479)
Q Consensus 168 ~~~--~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 243 (479)
... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |.+||.+.+.......+..+ ....|..+|+.+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 111 12334678899999999888775 89999999999999999 78889876655444444333 345667799999
Q ss_pred HHHHHHhccCCccccCChhhhhcC
Q 011694 244 RKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.++|.+||..||.+|||+.+++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=385.82 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=209.4
Q ss_pred CCeEEe-eeeeecCCeEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 14 EKYEVG-RLLGQGAFAKVYYARS--IRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 14 ~~y~i~-~~LG~G~fg~Vy~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
..+.+. +.||+|+||.||+|.+ ..+++.||||++..... .....+.+.+|+.+++.++|||||++++++.. +.++
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 344443 4899999999999955 45778999999976533 23456789999999999999999999999975 4589
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc-
Q 011694 91 FVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ- 168 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~- 168 (479)
+||||+++|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999999999999986 4699999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKL 246 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l 246 (479)
........+|+.|+|||++.+..++ .++|||||||+||+|++ |..||.+.+..+....+..+ ....|..+|+++.+|
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 604 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 604 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1122334578899999999888875 89999999999999998 99999998887777776554 456778899999999
Q ss_pred HHHhccCCccccCChhhhhc
Q 011694 247 LCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 247 i~~~L~~dP~~Rpt~~eil~ 266 (479)
|.+||..||.+|||+++|++
T Consensus 605 i~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 605 MNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=364.66 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=207.2
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
..+..++|++.+.||+|+||.||+|.+ .+|+.||||++....... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 346678999999999999999999985 478999999997654322 12367899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 89 IFFVMEYAKGGELFNKVAKG-----KLKEDAARRYFQQLINAVDFCHSR---GVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~qll~aL~~LH~~---givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
.++||||+++|+|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 99999999999999999763 399999999999999999999999 9999999999999999999999999998
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh--------HHHHHHHhccC-
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN--------LIEMYRKIGKA- 231 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~--------~~~~~~~i~~~- 231 (479)
....... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.... ...........
T Consensus 182 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 182 KLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp EECCSSS-SCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccCccc-ccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 7543222 2223445699999999999887775 89999999999999999999996221 11111111111
Q ss_pred cC----------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChh
Q 011694 232 EF----------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSW 269 (479)
Q Consensus 232 ~~----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~w 269 (479)
.. ..+...++.+.+++.+||+.||.+|||+.++++|-+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00 111112367899999999999999999999998764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=374.15 Aligned_cols=250 Identities=19% Similarity=0.210 Sum_probs=197.8
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCc---------ceeE---
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH-PNI---------VQLY--- 80 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h-pnI---------v~l~--- 80 (479)
..|++++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++| +|. +...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458899999999999999999999999999999985544433445788999999999987 221 1111
Q ss_pred ---------EEEEe-----CCEEEEEEeccCCCChHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 011694 81 ---------EVMAT-----KSKIFFVMEYAKGGELFNKVA--------KGKLKEDAARRYFQQLINAVDFCHSRGVYHRD 138 (479)
Q Consensus 81 ---------~~~~~-----~~~~~lV~E~~~gg~L~~~i~--------~~~l~e~~~~~i~~qll~aL~~LH~~givHrD 138 (479)
.++.. ...++++|+++ +++|.+++. .+.+++..+..++.||+.||.|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111 22467888876 569998885 23478889999999999999999999999999
Q ss_pred CCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhh----------cCCCCCCccchhhHHHHHHH
Q 011694 139 IKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN----------RKGYDGEKVDIWSCGVVLFV 208 (479)
Q Consensus 139 Lkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~----------~~~~~~~~~DvwSlGvil~~ 208 (479)
|||+|||++.++.+||+|||++...... ..+.+| +.|+|||++. +..+ +.++|||||||++|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHH
Confidence 9999999999999999999998754322 345678 9999999994 3334 479999999999999
Q ss_pred HHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 209 LLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 209 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
|++|+.||...+.......+. .....+|+++.+||.+||+.||.+|||+.++++||||+....
T Consensus 310 lltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHCCCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence 999999998876554433332 233467899999999999999999999999999999976543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=356.43 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=210.2
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYAR----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVM 83 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~ 83 (479)
...+..++|++++.||+|+||.||+|. +..+|+.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 455667889999999999999999998 45689999999997642 24457889999999999999999999998
Q ss_pred EeCC--EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 84 ATKS--KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 84 ~~~~--~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
...+ .+++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 6544 78999999999999999986 3599999999999999999999999999999999999999999999999999
Q ss_pred hhhhhccccC-CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH----------------
Q 011694 160 SALAQCKHQD-GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI---------------- 222 (479)
Q Consensus 160 a~~~~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~---------------- 222 (479)
+......... .......+++.|+|||++.+..++ .++|||||||++|+|++|..||......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 8764322111 112334678889999999887775 8999999999999999999998754211
Q ss_pred HHHHHhc-cCcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 223 EMYRKIG-KAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 223 ~~~~~i~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.....+. ....+.|..+|+++.++|.+||..||.+|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111121 2234567789999999999999999999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=355.74 Aligned_cols=248 Identities=28% Similarity=0.387 Sum_probs=203.0
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI-MRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~-~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (479)
|..++.||+|+||.||+|.+ +++.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44558999999999999986 788999999976432 233456789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 95 YAKGGELFNKVAK----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 95 ~~~gg~L~~~i~~----~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999863 359999999999999999999999999999999999999999999999999987544322222
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH----HHHHHhccCc-----------CCC
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI----EMYRKIGKAE-----------FKC 235 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~-----------~~~ 235 (479)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|..||...+.. .....+.... ...
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 23446799999999998754 4 48999999999999999999999865432 1111111111 112
Q ss_pred CCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 236 PNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 236 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+..+++.+.+++.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22245778999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=358.46 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=193.1
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe--
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT-- 85 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~-- 85 (479)
.+.+-.++|++++.||+|+||.||+|.+ +++.||||++...... ......|+..+..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheecccccc
Confidence 4456779999999999999999999977 7899999999754311 1122334444556899999999986542
Q ss_pred ---CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeccCCCCCEEEecCCCeE
Q 011694 86 ---KSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR---------GVYHRDIKPENLLLDENENLK 153 (479)
Q Consensus 86 ---~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~---------givHrDLkp~NILl~~~g~vk 153 (479)
...+|+||||+++|+|.+++.....++..+..++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 33689999999999999999988889999999999999999999999 999999999999999999999
Q ss_pred EeecCchhhhhccc------cCCCccccCCCCcccChhhhhcCC------CCCCccchhhHHHHHHHHHhCCCCCCCChH
Q 011694 154 ISDFGLSALAQCKH------QDGLLHTTCGTPAYVAPEVINRKG------YDGEKVDIWSCGVVLFVLLAGYLPFHDSNL 221 (479)
Q Consensus 154 l~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPEvl~~~~------~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~ 221 (479)
|+|||+|....... ........+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997543221 112233557999999999997631 123689999999999999999777632211
Q ss_pred ------------------HHHHHHh--ccCcCCCCCC------CCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 222 ------------------IEMYRKI--GKAEFKCPNW------FPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 222 ------------------~~~~~~i--~~~~~~~~~~------~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
......+ .......|.. +++++.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 1111111 1112223332 3357999999999999999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=357.25 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=209.8
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
..+.+..++|++++.||+|+||.||+|.+.. .||+|++....... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 4556778999999999999999999999853 49999997653322 2235567899999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
+.+++||||++|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999999999999874 599999999999999999999999999999999999997 7899999999986543
Q ss_pred ccc---cCCCccccCCCCcccChhhhhcC--------CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC
Q 011694 165 CKH---QDGLLHTTCGTPAYVAPEVINRK--------GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF 233 (479)
Q Consensus 165 ~~~---~~~~~~~~~gt~~y~aPEvl~~~--------~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 233 (479)
... .........||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+.....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence 211 22233455799999999999752 2234799999999999999999999998887776666654433
Q ss_pred C--CCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 234 K--CPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 234 ~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
. .+..+++++.++|.+||..||.+|||+.++++
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2 22357899999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=367.97 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=208.1
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceeEEEEEeCCEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH-PNIVQLYEVMATKSKI 89 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 89 (479)
++.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|..+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 5788999999999999999999999999999999998765432 346789999999986 5666677777888999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEE---ecCCCeEEeecCchhhhh
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLL---DENENLKISDFGLSALAQ 164 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl---~~~g~vkl~DFGla~~~~ 164 (479)
||||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8899999984 679999999999999999999999999999999999999 688999999999997654
Q ss_pred ccccC-----CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh---HHHHHHHhccCcC---
Q 011694 165 CKHQD-----GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKIGKAEF--- 233 (479)
Q Consensus 165 ~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~--- 233 (479)
..... ......+||+.|+|||++.+..+. .++|||||||+||+|++|..||.+.. ....+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 32221 122366899999999999888775 89999999999999999999998643 2333333322211
Q ss_pred --CCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 234 --KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 234 --~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
..+..+|+++.+||.+||..||.+||++.+|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223567899999999999999999999998765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=353.28 Aligned_cols=249 Identities=21% Similarity=0.372 Sum_probs=204.2
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--CCCCCcceeEEEEEeCC-
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI--VRHPNIVQLYEVMATKS- 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~--l~hpnIv~l~~~~~~~~- 87 (479)
.+.++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|+.+++. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 4567999999999999999999998 69999999986432 3566788888887 78999999999998876
Q ss_pred ---EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeccCCCCCEEEecCCCeEEee
Q 011694 88 ---KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH--------SRGVYHRDIKPENLLLDENENLKISD 156 (479)
Q Consensus 88 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH--------~~givHrDLkp~NILl~~~g~vkl~D 156 (479)
.+|+||||+++|+|.+++...++++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 8999999999999999999889999999999999999999999 89999999999999999999999999
Q ss_pred cCchhhhhccccC--CCccccCCCCcccChhhhhcCCCC-----CCccchhhHHHHHHHHHhC----------CCCCCCC
Q 011694 157 FGLSALAQCKHQD--GLLHTTCGTPAYVAPEVINRKGYD-----GEKVDIWSCGVVLFVLLAG----------YLPFHDS 219 (479)
Q Consensus 157 FGla~~~~~~~~~--~~~~~~~gt~~y~aPEvl~~~~~~-----~~~~DvwSlGvil~~ll~G----------~~Pf~~~ 219 (479)
||++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 9998654322110 023455799999999999765322 1579999999999999999 7898654
Q ss_pred h-----HHHHHHHhccCc--CCCCC-----CCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 220 N-----LIEMYRKIGKAE--FKCPN-----WFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 220 ~-----~~~~~~~i~~~~--~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
. .......+.... ...|. .+++.+.+||.+||+.||.+|||+++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2 233333333222 12222 123578999999999999999999999876
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=369.23 Aligned_cols=244 Identities=20% Similarity=0.276 Sum_probs=197.0
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCC---------CCCcc
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM-----RVGLADQIKREISVMRIVR---------HPNIV 77 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~l~~Ei~il~~l~---------hpnIv 77 (479)
..++|++++.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999998 7899999999876431 2234477889999998885 77777
Q ss_pred eeEEEEE------------------------------eCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 011694 78 QLYEVMA------------------------------TKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVD 127 (479)
Q Consensus 78 ~l~~~~~------------------------------~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~ 127 (479)
++.+++. +.+.+|+|||||++|++.+.+..+.+++..++.++.||+.||.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 7777643 2688999999999998888887788999999999999999999
Q ss_pred HHH-HCCCeeccCCCCCEEEecCC--------------------CeEEeecCchhhhhccccCCCccccCCCCcccChhh
Q 011694 128 FCH-SRGVYHRDIKPENLLLDENE--------------------NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186 (479)
Q Consensus 128 ~LH-~~givHrDLkp~NILl~~~g--------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEv 186 (479)
||| ++||+||||||+|||++.+| .+||+|||+|+.... ...+||+.|+|||+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhh
Confidence 999 99999999999999999887 899999999975432 24589999999999
Q ss_pred hhcCCCCCCccchhhHHHH-HHHHHhCCCCCCCChH-HHHHHHhc---cCcCCC----CCCCCHHHHHHHHHhccCCccc
Q 011694 187 INRKGYDGEKVDIWSCGVV-LFVLLAGYLPFHDSNL-IEMYRKIG---KAEFKC----PNWFPPEVRKLLCKILDPNPST 257 (479)
Q Consensus 187 l~~~~~~~~~~DvwSlGvi-l~~ll~G~~Pf~~~~~-~~~~~~i~---~~~~~~----~~~~~~~~~~li~~~L~~dP~~ 257 (479)
+.+.. +.++||||+|++ .+++++|..||.+... ......+. ...... ++.+|+++.+||.+||+.|
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 98765 589999998777 7788899999965321 11122221 111111 1236789999999999977
Q ss_pred cCChhhhh-cChhhh
Q 011694 258 RISMAKIR-ESSWFR 271 (479)
Q Consensus 258 Rpt~~eil-~h~wf~ 271 (479)
|++|++ +||||+
T Consensus 324 --sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 --SATDLLCQHSLFK 336 (336)
T ss_dssp --SHHHHHHHCGGGC
T ss_pred --CHHHHHhcCCCcC
Confidence 999999 999994
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=380.49 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=214.1
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRT---NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
..+..++|++++.||+|+||.||+|.+..+ +..||||.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 356678999999999999999999998654 4679999986532 2345578899999999999999999999985
Q ss_pred CCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
.+..|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 45689999999999999999853 6999999999999999999999999999999999999999999999999998754
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCH
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPP 241 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 241 (479)
..... .......+|+.|+|||++.+..++ .++||||+||++|+|++ |..||.+.+.......+... ....|+.+|+
T Consensus 542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 542 EDSTY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred CCCcc-eeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 32211 112334578899999999888775 89999999999999997 99999988877776666543 4567788999
Q ss_pred HHHHHHHHhccCCccccCChhhhhcC
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+.+||.+||..||.+|||+.+|++.
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=344.89 Aligned_cols=232 Identities=15% Similarity=0.201 Sum_probs=197.0
Q ss_pred CCCCCCC-ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 011694 4 MDHNKPS-VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEV 82 (479)
Q Consensus 4 ~~~~~~~-il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~ 82 (479)
.....+. ++.++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||++++++
T Consensus 20 ~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~ 99 (286)
T 3uqc_A 20 VQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDV 99 (286)
T ss_dssp CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEE
Confidence 3445666 888999999999999999999999999999999999987765555566888999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 83 MATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
+.+.+..|+||||++|++|.+++..+ ..+.++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 100 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 100 VHTRAGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp EEETTEEEEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EEECCcEEEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----
Confidence 99999999999999999999999765 4566788999999999999999999999999999999999999998554
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHH---HhccCcC----CC
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYR---KIGKAEF----KC 235 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i~~~~~----~~ 235 (479)
|++| + +.++|||||||++|+|++|..||.+.+...... ....... ..
T Consensus 175 ------------------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 175 ------------------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADI 228 (286)
T ss_dssp ------------------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHH
T ss_pred ------------------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhc
Confidence 2332 3 489999999999999999999998765432111 1111111 12
Q ss_pred CCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 236 PNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 236 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
++.+|+++.++|.+||+.||.+| |++++++.
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 35689999999999999999999 99999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=387.42 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=207.4
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-----
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT----- 85 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~----- 85 (479)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 34589999999999999999999999999999999987642 23445778999999999999999999999765
Q ss_pred -CCEEEEEEeccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC---eEEeec
Q 011694 86 -KSKIFFVMEYAKGGELFNKVAKG----KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN---LKISDF 157 (479)
Q Consensus 86 -~~~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~---vkl~DF 157 (479)
.+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 67789999999999999999862 5999999999999999999999999999999999999997775 999999
Q ss_pred CchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHH---------h
Q 011694 158 GLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRK---------I 228 (479)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~---------i 228 (479)
|++...... ......+||+.|+|||++.+..++ .++||||+||++|+|++|..||........+.. +
T Consensus 169 G~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 169 GYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred ccccccccc---cccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 998755322 233456899999999999887775 899999999999999999999976533221100 0
Q ss_pred -----ccCcC------CCC----CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 229 -----GKAEF------KCP----NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 229 -----~~~~~------~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..+.. +.| ..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 01111 111 1246889999999999999999999999999999753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=382.86 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=204.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIR-TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
.+.++.++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 467888999999999999999999999976 79999999986542 224456788999999999999999999999876
Q ss_pred CE-----EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 87 SK-----IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 87 ~~-----~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
+. .||||||++|++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 55 7999999999999988765 79999999999999999999999999999999999999874 99999999987
Q ss_pred hhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCH
Q 011694 162 LAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPP 241 (479)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (479)
.... ....+||+.|+|||++.+.. +.++|||||||+||+|++|..||.+...... . ........++
T Consensus 230 ~~~~------~~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----~--~~~~~~~~~~ 295 (681)
T 2pzi_A 230 RINS------FGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----P--EDDPVLKTYD 295 (681)
T ss_dssp ETTC------CSCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----C--TTCHHHHHCH
T ss_pred hccc------CCccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc----c--ccccccccCH
Confidence 5432 14567999999999997653 5899999999999999999999875321100 0 0000011357
Q ss_pred HHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
.+.++|.+||++||.+||+..+.+.|+|+.-
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 8999999999999999999999999999853
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=267.01 Aligned_cols=129 Identities=33% Similarity=0.609 Sum_probs=116.3
Q ss_pred CCCCCcccchhccccccCCCCCCCCCc--ccccceeEecCCHHHHHHHHHHHHHHcCcEEEeeCCceEEEEeeecCccee
Q 011694 314 QLPNLNAFDIISLSAGFDLSGFFDENP--LIREARFTSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGI 391 (479)
Q Consensus 314 ~~~~~~~~~~is~s~~~~ls~~~~~~~--~~r~trf~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 391 (479)
.|..+||||+||+|+|||||+||+... .+|+|||+|+.||++|+++|+++|+.+||+|+++++ .|++++..+|+||.
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~-~vkl~~~~~grkG~ 81 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNF-KTRLEGLSSIKAGQ 81 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSS-EEEEEECCSSGGGC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCc-EEEEEEecCCCcce
Confidence 466799999999999999999998654 588999999999999999999999999999998776 69999999999999
Q ss_pred EEEEEEEEEecCceEEEEEEecCCChHHHHHHHhhhhhhccccceeecccCCC
Q 011694 392 VSMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKDDIRPALQDIVWVWQGEQQ 444 (479)
Q Consensus 392 l~~~~~v~~~~~~~~lVe~~k~~Gd~le~~~~~~~~l~~~l~div~~~~~~~~ 444 (479)
|+|.+|||||+|+++||||||++||++||+++|++ |++.|+||||+|+++..
T Consensus 82 l~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~-Lr~~L~diV~~~~~~~~ 133 (143)
T 2ehb_D 82 LAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKK-LCSKLENIIWRATEGIP 133 (143)
T ss_dssp CEEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHH-HHHHSTTTBCC------
T ss_pred EEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHH-HHHHhhcceecCCCCCc
Confidence 99999999999999999999999999999999886 99999999999998653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=319.84 Aligned_cols=232 Identities=14% Similarity=0.092 Sum_probs=162.4
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc-------chhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEE
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM-------RVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-------~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 91 (479)
..++.|++|.+..++....|+.||+|++.+.... .....+++.+|+.+|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4567888888888888889999999999765321 122346799999999999 69999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
||||++|++|.++|.. +++++. .|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+..... ..
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CS 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Cc
Confidence 9999999999999987 467664 58999999999999999999999999999999999999999999754332 23
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHh
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 250 (479)
...+.+||+.|+|||++.+.. ..++|+||+|++++.++++..||. ..+.. .|.. ...+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCcHHHHHHHH
Confidence 356779999999999998653 368999999999988766644331 11111 1111 11245677778
Q ss_pred ccCCccccCChhhhhcChhhh
Q 011694 251 LDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 251 L~~dP~~Rpt~~eil~h~wf~ 271 (479)
+..+|..|+.......++|..
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHH
Confidence 888898898888888888864
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=247.01 Aligned_cols=121 Identities=35% Similarity=0.490 Sum_probs=106.4
Q ss_pred CCCCCcccchhccccccCCCCCCCCC-cccccceeEecCCHHHHHHHHHHHHHHcCcEEEeeCCceEEEEeeecCcceeE
Q 011694 314 QLPNLNAFDIISLSAGFDLSGFFDEN-PLIREARFTSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIV 392 (479)
Q Consensus 314 ~~~~~~~~~~is~s~~~~ls~~~~~~-~~~r~trf~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~l 392 (479)
.+..+||||+||+|+|+|||+||+.+ ..+|+|||+|+.||++|+++|+++|+++||+|++++++ ++..+|+||.|
T Consensus 2 ~~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~----~~~~~g~kG~l 77 (123)
T 2zfd_B 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW----GMKIEGQKGNF 77 (123)
T ss_dssp --CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT----EEEEEEGGGTE
T ss_pred CcccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc----cccccCCCccE
Confidence 35679999999999999999999753 34789999999999999999999999999999987765 55577899999
Q ss_pred EEEEEEEEecCceEEEEEEecCCChHHHHHHHhhhhhhccccceee
Q 011694 393 SMDAEIFQITPNFHLVEMKKSNGDTLEYKKLLKDDIRPALQDIVWV 438 (479)
Q Consensus 393 ~~~~~v~~~~~~~~lVe~~k~~Gd~le~~~~~~~~l~~~l~div~~ 438 (479)
+|.+|||||+|+++||||||++||++||++||.+.|++.|+||||+
T Consensus 78 ~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 78 AMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 9999999999999999999999999999998887799999999985
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=270.82 Aligned_cols=189 Identities=20% Similarity=0.235 Sum_probs=146.4
Q ss_pred EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchh-----hHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVG-----LADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~-----~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
...+.||+|+||+||+|. ..++.+++|........... ..+.+.+|+.+++.++||||+++..+....+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 446789999999999994 47889999987654332221 23568999999999999999966555557777899
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC-
Q 011694 92 VMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG- 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~- 170 (479)
||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999999876 6789999999999999999999999999999988 99999999997654321111
Q ss_pred ----CccccCCCCcccChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCC
Q 011694 171 ----LLHTTCGTPAYVAPEVINR--KGYDGEKVDIWSCGVVLFVLLAGYLPFH 217 (479)
Q Consensus 171 ----~~~~~~gt~~y~aPEvl~~--~~~~~~~~DvwSlGvil~~ll~G~~Pf~ 217 (479)
...+.+||+.|+|||++.. .+|. ..+|+||..+-..+...++.+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 1246689999999999976 5665 68899999988888777766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=224.93 Aligned_cols=147 Identities=20% Similarity=0.253 Sum_probs=118.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch---------------hhHHHHHHHHHHHHhCCCCCccee
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV---------------GLADQIKREISVMRIVRHPNIVQL 79 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---------------~~~~~l~~Ei~il~~l~hpnIv~l 79 (479)
.|.+++.||+|+||.||+|.+ .+|+.||||++........ .....+.+|+.+++.++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 345569999999999999999 8999999999965432110 13467889999999999 4 566
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 80 YEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 80 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
.+++.. +..|+||||++||+|.+ +.. .....++.|++.||.|||++||+||||||+|||++ +|.+||+|||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 665544 44699999999999988 422 34557999999999999999999999999999999 99999999998
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhh
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVIN 188 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~ 188 (479)
|. .+..|.|||.+.
T Consensus 239 a~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 239 SV---------------EVGEEGWREILE 252 (282)
T ss_dssp CE---------------ETTSTTHHHHHH
T ss_pred Ce---------------ECCCCCHHHHHH
Confidence 74 344678999885
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-22 Score=193.94 Aligned_cols=139 Identities=19% Similarity=0.263 Sum_probs=109.7
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcE--EEEEEeecccccc---------------------hhhHHHHHHHHHHHHhCC
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQS--VAVKVIDKDKIMR---------------------VGLADQIKREISVMRIVR 72 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~--vaiK~i~~~~~~~---------------------~~~~~~l~~Ei~il~~l~ 72 (479)
|++.+.||+|+||.||+|.+..+|+. ||||++......- ......+.+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999889999 9999975532110 011246789999999998
Q ss_pred CCCc--ceeEEEEEeCCEEEEEEeccCC-C----ChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCCE
Q 011694 73 HPNI--VQLYEVMATKSKIFFVMEYAKG-G----ELFNKVAKGKLKEDAARRYFQQLINAVDFCH-SRGVYHRDIKPENL 144 (479)
Q Consensus 73 hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH-~~givHrDLkp~NI 144 (479)
|++| ..+++. +..++||||+.+ | +|.+.... .++..+..++.||+.||.||| ++||+||||||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 8754 444443 246899999942 3 66665432 345678899999999999999 99999999999999
Q ss_pred EEecCCCeEEeecCchhh
Q 011694 145 LLDENENLKISDFGLSAL 162 (479)
Q Consensus 145 Ll~~~g~vkl~DFGla~~ 162 (479)
|++. .++|+|||+|..
T Consensus 203 Ll~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EESS--SEEECCCTTCEE
T ss_pred EEcC--cEEEEECccccc
Confidence 9987 999999999853
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.2e-19 Score=178.41 Aligned_cols=138 Identities=16% Similarity=0.209 Sum_probs=101.2
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc-----------c----hhh----HHHHHHHHHHHHhCCCCCc
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM-----------R----VGL----ADQIKREISVMRIVRHPNI 76 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~-----------~----~~~----~~~l~~Ei~il~~l~hpnI 76 (479)
|++++.||.|+||.||+|.+ .+|+.||||++...... . ... .-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999998 47999999998643211 0 000 0112457777777755544
Q ss_pred ceeEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC-----
Q 011694 77 VQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN----- 151 (479)
Q Consensus 77 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~----- 151 (479)
.-..-+.... .+|||||++|++|..... ...+..++.||+.+|.+||++||+||||||.|||++.+|.
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence 3222222222 279999999988865532 2245678999999999999999999999999999988773
Q ss_pred -----eEEeecCchh
Q 011694 152 -----LKISDFGLSA 161 (479)
Q Consensus 152 -----vkl~DFGla~ 161 (479)
+.|+||+-+.
T Consensus 249 ~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 249 SITLTPIIIXFPQMV 263 (397)
T ss_dssp SEEEEEEECCCTTCE
T ss_pred ccccceEEEEeCCcc
Confidence 8899999654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=6.4e-13 Score=127.49 Aligned_cols=139 Identities=18% Similarity=0.199 Sum_probs=112.7
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 92 (479)
+.|++...+|.|+.+.||++.. .++.+++|+........ ...+.+|+.+++.+. +.++.+++++..+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 5699999999999999999975 47889999986532111 235789999999885 67788999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHS----------------------------------------- 131 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~----------------------------------------- 131 (479)
|||++|.+|.+.+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 89 MSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp EECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred EEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 99999999877632 122345788999999999998
Q ss_pred ------------------CCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 132 ------------------RGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 132 ------------------~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999875556799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.4e-11 Score=117.26 Aligned_cols=135 Identities=13% Similarity=0.160 Sum_probs=101.5
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC--cceeEEEEEeCCEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN--IVQLYEVMATKSKIF 90 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~ 90 (479)
...|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++....+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 34677755555667799999964 567789999976531 135678999998886444 567899888888899
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------
Q 011694 91 FVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRG------------------------------------- 133 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~g------------------------------------- 133 (479)
+||||++|.+|. .. ... ...++.++...|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 999999998883 21 122 2356777888888888753
Q ss_pred ---------------------CeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 134 ---------------------VYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 134 ---------------------ivHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
++|+|++|.||+++.++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999764
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.23 E-value=7.1e-11 Score=99.24 Aligned_cols=85 Identities=15% Similarity=0.251 Sum_probs=75.3
Q ss_pred EecCCHHHHHHHHHHHHHHcCcEEEeeCCceEEEEeeecCcceeEEEEEEEEEec-CceEEEEEEecCCChHHHHHHHhh
Q 011694 348 TSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQIT-PNFHLVEMKKSNGDTLEYKKLLKD 426 (479)
Q Consensus 348 ~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~-~~~~lVe~~k~~Gd~le~~~~~~~ 426 (479)
+|+.+|++|+.+|+.|+..+|+.++.++.+.+++.......++.+.|.+||+++. +++++|+|+|.+||.+.|+++|.+
T Consensus 34 TS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc~~ 113 (120)
T 3ose_A 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK 113 (120)
T ss_dssp EECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHHHH
Confidence 7999999999999999999999999887777888764444567899999999995 899999999999999999999998
Q ss_pred hhhhccc
Q 011694 427 DIRPALQ 433 (479)
Q Consensus 427 ~l~~~l~ 433 (479)
|...|+
T Consensus 114 -il~~L~ 119 (120)
T 3ose_A 114 -IANELK 119 (120)
T ss_dssp -HHHHCC
T ss_pred -HHHHhc
Confidence 766654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=3.1e-11 Score=121.36 Aligned_cols=140 Identities=19% Similarity=0.381 Sum_probs=107.3
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEee--cccccchhhHHHHHHHHHHHHhCC--CCCcceeEEEEEeC---CEEE
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVID--KDKIMRVGLADQIKREISVMRIVR--HPNIVQLYEVMATK---SKIF 90 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~--~~~~~~~~~~~~l~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~~ 90 (479)
..+.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 467899999999999876 34678889875 33211 11356789999999987 45688899988776 4589
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 011694 91 FVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHS--------------------------------------- 131 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~--------------------------------------- 131 (479)
+||||++|..+.+... ..+++.....++.+++.+|+.||+
T Consensus 118 ~vme~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEEECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEEecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999999987754221 347888899999999999999997
Q ss_pred -------------------CCCeeccCCCCCEEEecCCC--eEEeecCchhh
Q 011694 132 -------------------RGVYHRDIKPENLLLDENEN--LKISDFGLSAL 162 (479)
Q Consensus 132 -------------------~givHrDLkp~NILl~~~g~--vkl~DFGla~~ 162 (479)
.+++|+|++|.|||++.++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 46899999999999987754 68999998763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.3e-10 Score=114.06 Aligned_cols=183 Identities=17% Similarity=0.229 Sum_probs=124.4
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCC--cceeEEEEEeCC---EEEEE
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPN--IVQLYEVMATKS---KIFFV 92 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpn--Iv~l~~~~~~~~---~~~lV 92 (479)
.+.++.|....||.+. ..+++|+.... .....+.+|..+++.+. +.. +.+++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4569999999999863 46888986432 23567899999998873 333 445555443333 35899
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHS----------------------------------------- 131 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~----------------------------------------- 131 (479)
||+++|.+|.+... ..++.++...++.+++..++.||+
T Consensus 95 m~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred EcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99999988865433 357888889999999999999996
Q ss_pred -----------------CCCeeccCCCCCEEEec--CCCeEEeecCchhhhhccccCCCccccCCCCcc---cChhhhhc
Q 011694 132 -----------------RGVYHRDIKPENLLLDE--NENLKISDFGLSALAQCKHQDGLLHTTCGTPAY---VAPEVINR 189 (479)
Q Consensus 132 -----------------~givHrDLkp~NILl~~--~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y---~aPEvl~~ 189 (479)
..++|+|++|.||+++. .+.+.|+||+.+....... .......+ ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHHHHH
Confidence 13699999999999987 4568899999876422110 00001111 23332210
Q ss_pred --CCCCC-----------CccchhhHHHHHHHHHhCCCCCCC
Q 011694 190 --KGYDG-----------EKVDIWSCGVVLFVLLAGYLPFHD 218 (479)
Q Consensus 190 --~~~~~-----------~~~DvwSlGvil~~ll~G~~Pf~~ 218 (479)
..|.. ...+.|++|.++|.+.+|..+|..
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 01111 125899999999999999887643
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.77 E-value=9.9e-09 Score=86.07 Aligned_cols=85 Identities=13% Similarity=0.227 Sum_probs=73.1
Q ss_pred EecCCHHHHHHHHHHHHHHcCcEEEeeCCceEEEEeeecCcceeEEEEEEEEEec-CceEEEEEEecCCChHHHHHHHhh
Q 011694 348 TSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQIT-PNFHLVEMKKSNGDTLEYKKLLKD 426 (479)
Q Consensus 348 ~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~-~~~~lVe~~k~~Gd~le~~~~~~~ 426 (479)
+|+.+|++||..|..+++.+|+.|+..+...+++.......+..+.|.+||+.+. .+++.|+|+|.+||...|+++|.+
T Consensus 34 TSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~~ 113 (126)
T 1v5s_A 34 GSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK 113 (126)
T ss_dssp CCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHHH
T ss_pred ecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHHH
Confidence 6788999999999999999999999877777887653333456899999999994 789999999999999999999998
Q ss_pred hhhhccc
Q 011694 427 DIRPALQ 433 (479)
Q Consensus 427 ~l~~~l~ 433 (479)
|-..|+
T Consensus 114 -IL~eLk 119 (126)
T 1v5s_A 114 -IANELK 119 (126)
T ss_dssp -HHHHTT
T ss_pred -HHHHHh
Confidence 666665
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.4e-07 Score=76.37 Aligned_cols=87 Identities=13% Similarity=0.176 Sum_probs=74.5
Q ss_pred cccceeEecCCHHHHHHHHHHHHHHcCcEEEeeCCceEEEEeeecCcceeEEEEEEEEEecCceEEEEEEecCCC-----
Q 011694 342 IREARFTSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGD----- 416 (479)
Q Consensus 342 ~r~trf~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k~~Gd----- 416 (479)
++.-...|...|.+||..|..+++.+|+.|++.+...|++..........+.|.+++|++.++.+|+||++..||
T Consensus 7 kW~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~ 86 (106)
T 4eai_A 7 KWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGG 86 (106)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSS
T ss_pred cceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCC
Confidence 344567899999999999999999999999988888898875433334579999999999999999999999995
Q ss_pred ---hHHHHHHHhhhh
Q 011694 417 ---TLEYKKLLKDDI 428 (479)
Q Consensus 417 ---~le~~~~~~~~l 428 (479)
+++|-.+|...|
T Consensus 87 ~~~~~~F~d~ca~li 101 (106)
T 4eai_A 87 GSHTIEFFEMCANLI 101 (106)
T ss_dssp SCHHHHHHHHHHHHH
T ss_pred CcCcEeHHHHHHHHH
Confidence 999999999833
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=1.9e-07 Score=81.04 Aligned_cols=87 Identities=13% Similarity=0.195 Sum_probs=66.6
Q ss_pred CCCCCCCcccccceeEecCCHHHHHHHHHHHHHHcCcEEEeeCCceEEEEeeecCcceeEEEEEEEEEecCceEEEEEEe
Q 011694 333 SGFFDENPLIREARFTSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKK 412 (479)
Q Consensus 333 s~~~~~~~~~r~trf~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k 412 (479)
|++-.....++.-..-|...|.+||..|..|++.||+.||+.+.+.|++..........+.|.+++|+|.++.+||||++
T Consensus 9 ~~~~~~k~~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~ 88 (173)
T 2y8l_A 9 SGLVPRGSMAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRS 88 (173)
T ss_dssp -------CCEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEE
T ss_pred cCCcccccceeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEe
Confidence 34433344567778889999999999999999999999999888889987643222236899999999999999999999
Q ss_pred cCCChHH
Q 011694 413 SNGDTLE 419 (479)
Q Consensus 413 ~~Gd~le 419 (479)
..||+-|
T Consensus 89 l~Gd~~e 95 (173)
T 2y8l_A 89 IDDEITE 95 (173)
T ss_dssp ECCC---
T ss_pred cCCCccc
Confidence 9998755
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=3.7e-07 Score=89.58 Aligned_cols=133 Identities=23% Similarity=0.247 Sum_probs=97.7
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC---CcceeEEEEE-eCCEEEEEEe
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP---NIVQLYEVMA-TKSKIFFVME 94 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E 94 (479)
.+.++.|....||.. |..+++|+... ......+.+|..+|+.+.+. .|.+++.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456899999999988 56788898532 13456889999999998742 3566666664 4556789999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 011694 95 YAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR------------------------------------------ 132 (479)
Q Consensus 95 ~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~------------------------------------------ 132 (479)
|++|..|.+.. -..++..+...+..++...|+.||+.
T Consensus 94 ~i~G~~l~~~~-~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 94 KVQGQILGEDG-MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCCSEECHHHH-HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ccCCeECchhh-hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99998886632 13456666666777777777777643
Q ss_pred ------------------CCeeccCCCCCEEEec---CCCe-EEeecCchhh
Q 011694 133 ------------------GVYHRDIKPENLLLDE---NENL-KISDFGLSAL 162 (479)
Q Consensus 133 ------------------givHrDLkp~NILl~~---~g~v-kl~DFGla~~ 162 (479)
.++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3489999999999987 4665 8999997753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=3.6e-07 Score=87.43 Aligned_cols=132 Identities=16% Similarity=0.189 Sum_probs=98.8
Q ss_pred eeeecCCe-EEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEeccCC
Q 011694 21 LLGQGAFA-KVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFFVMEYAKG 98 (479)
Q Consensus 21 ~LG~G~fg-~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~g 98 (479)
.+..|..| .||.......+..+++|+-... ....+.+|...|+.+. +--|.+++.+..+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 44556555 6998887777788999986432 3467889999998875 33477888999999999999999999
Q ss_pred CChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------------
Q 011694 99 GELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR---------------------------------------------- 132 (479)
Q Consensus 99 g~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~---------------------------------------------- 132 (479)
.++.+..... ......+..++...|.-||+.
T Consensus 105 ~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 105 KTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 8877665432 223345666777777777741
Q ss_pred ------------CCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 133 ------------GVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 133 ------------givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 26899999999999877767799999764
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.57 E-value=6.4e-07 Score=76.80 Aligned_cols=78 Identities=12% Similarity=0.156 Sum_probs=64.4
Q ss_pred cccceeEecCCHHHHHHHHHHHHHHcCcEEEeeCCceEEEEeeecCcceeEEEEEEEEEecCceEEEEEEecCCChHH
Q 011694 342 IREARFTSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLE 419 (479)
Q Consensus 342 ~r~trf~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k~~Gd~le 419 (479)
++.-..-|...|.+||..|..|++.||+.||+.+.+.|++..........+.|.+++|+|.++.+||||++..||+-|
T Consensus 4 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 4 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 455667788999999999999999999999998888899876433222368999999999999999999999999755
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.3e-06 Score=74.21 Aligned_cols=86 Identities=8% Similarity=0.060 Sum_probs=71.8
Q ss_pred ccccceeEecCCHHHHHHHHHHHHHHcCcEEEee---------CCceEEEEeeecCc-----ceeEEEEEEEEEecCceE
Q 011694 341 LIREARFTSKRPASVIISKLEEIAKSLRLKMMKK---------DGGLLKFEGLKEGR-----KGIVSMDAEIFQITPNFH 406 (479)
Q Consensus 341 ~~r~trf~s~~~~~~i~~~l~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~-----~g~l~~~~~v~~~~~~~~ 406 (479)
.++.-..-|...|.+||..|..|++.||+.|++. +.+.|++....... ...+.|.+++|+|.++.+
T Consensus 11 ~kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~Y 90 (137)
T 2qrd_A 11 NKWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCF 90 (137)
T ss_dssp CCCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEE
T ss_pred CccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcE
Confidence 3566678899999999999999999999999987 77778876533221 246899999999999999
Q ss_pred EEEEEecCCC---------------h----HHHHHHHhh
Q 011694 407 LVEMKKSNGD---------------T----LEYKKLLKD 426 (479)
Q Consensus 407 lVe~~k~~Gd---------------~----le~~~~~~~ 426 (479)
||||+...|+ . ++|-.+|..
T Consensus 91 LlDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~ 129 (137)
T 2qrd_A 91 MLDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAM 129 (137)
T ss_dssp EEEEEEEEEEESCC-------------CCCTTHHHHHHH
T ss_pred EEEEEecCCccccccCccccccCCccccccccHHHHHHH
Confidence 9999999999 5 889999887
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.2e-06 Score=89.02 Aligned_cols=80 Identities=14% Similarity=0.113 Sum_probs=50.9
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccc-cch---hhHHHHHHHHHHHHhCCC--CC-cceeEEEEEeCCEEE
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI-MRV---GLADQIKREISVMRIVRH--PN-IVQLYEVMATKSKIF 90 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~-~~~---~~~~~l~~Ei~il~~l~h--pn-Iv~l~~~~~~~~~~~ 90 (479)
-.+.||.|.++.||++....+++.++||....... ... ...+++..|..+++.+.. |. +.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35789999999999997666678899998653211 000 123456788888887742 33 4455544 344568
Q ss_pred EEEeccCCC
Q 011694 91 FVMEYAKGG 99 (479)
Q Consensus 91 lV~E~~~gg 99 (479)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.30 E-value=5.9e-06 Score=68.63 Aligned_cols=79 Identities=13% Similarity=0.137 Sum_probs=61.2
Q ss_pred ccceeEecCCHHHHHHHHHHHHHHcCcEEEeeCCceEEEEeeecCcceeEEEEEEEEEecCceEEEEEEecCCChHHHH
Q 011694 343 REARFTSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLEYK 421 (479)
Q Consensus 343 r~trf~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k~~Gd~le~~ 421 (479)
+.-..-|...|.+||..|..|++.+|+.|++.+...|++..........+.|.+++|++.++.+|+||+...||..|..
T Consensus 8 W~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~~ 86 (130)
T 4eag_A 8 WHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQG 86 (130)
T ss_dssp EEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-------
T ss_pred eeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhcc
Confidence 4445667888999999999999999999998888889887544444456889999999999999999999999965543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=5.8e-07 Score=89.77 Aligned_cols=86 Identities=16% Similarity=0.195 Sum_probs=57.0
Q ss_pred EEeeee-eecCCeEEEEEEEc--C----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-C--CCcceeEEEEEeC
Q 011694 17 EVGRLL-GQGAFAKVYYARSI--R----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-H--PNIVQLYEVMATK 86 (479)
Q Consensus 17 ~i~~~L-G~G~fg~Vy~a~~~--~----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-h--pnIv~l~~~~~~~ 86 (479)
...+.| +.|....+|+.... . ++..+++|+..............+.+|+.+++.+. + ..+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445778 88999999988653 1 26678899875432000000135678888888774 2 3577788877655
Q ss_pred ---CEEEEEEeccCCCChH
Q 011694 87 ---SKIFFVMEYAKGGELF 102 (479)
Q Consensus 87 ---~~~~lV~E~~~gg~L~ 102 (479)
+..|+||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3578999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.4e-05 Score=78.73 Aligned_cols=134 Identities=18% Similarity=0.199 Sum_probs=77.9
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----CCCcceeE-E--EEEeCCEEE
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-----HPNIVQLY-E--VMATKSKIF 90 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 90 (479)
.+.|+.|..+.||++.. .+..+++|+..... ..+..|..+++.+. .|.++... + +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 35667778899999876 33458999987521 23344555555442 34444311 0 223567889
Q ss_pred EEEeccCCCChH-----------HHHh---c--CCC--C-----------HH--------H-------------------
Q 011694 91 FVMEYAKGGELF-----------NKVA---K--GKL--K-----------ED--------A------------------- 114 (479)
Q Consensus 91 lV~E~~~gg~L~-----------~~i~---~--~~l--~-----------e~--------~------------------- 114 (479)
++|||++|..+. ..+. . ..+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 0111 0 111 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHH-------------HCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 115 ----ARRYFQQLINAVDFCH-------------SRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 115 ----~~~i~~qll~aL~~LH-------------~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
+..+..++..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223344566665 3589999999999999888899999999753
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=98.11 E-value=2e-05 Score=69.17 Aligned_cols=84 Identities=18% Similarity=0.166 Sum_probs=69.0
Q ss_pred cccceeEecCCHHHHHHHHHHHHHHcCcEEEeeC---CceEEEEeeec---------CcceeEEEEEEEEEecCceEEEE
Q 011694 342 IREARFTSKRPASVIISKLEEIAKSLRLKMMKKD---GGLLKFEGLKE---------GRKGIVSMDAEIFQITPNFHLVE 409 (479)
Q Consensus 342 ~r~trf~s~~~~~~i~~~l~~~~~~l~~~~~~~~---~~~~~~~~~~~---------~~~g~l~~~~~v~~~~~~~~lVe 409 (479)
++.-..-|...+.+||..|..|++.+|+.|++.+ .+.|+|...-. +....+.|.+++|++.++.+|||
T Consensus 50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD 129 (179)
T 3t4n_A 50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 129 (179)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence 4555678899999999999999999999999876 67788864211 11235999999999999999999
Q ss_pred EEecCC----------------------ChHHHHHHHhh
Q 011694 410 MKKSNG----------------------DTLEYKKLLKD 426 (479)
Q Consensus 410 ~~k~~G----------------------d~le~~~~~~~ 426 (479)
|+ +.| .++.|-.+|.+
T Consensus 130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~ 167 (179)
T 3t4n_A 130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTK 167 (179)
T ss_dssp EE-EEEEECC----------------CCCCHHHHHHHHH
T ss_pred EE-eccccccccccccccccccccccccCCccHHHHHHH
Confidence 99 888 77889888887
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.0002 Score=70.19 Aligned_cols=76 Identities=14% Similarity=0.267 Sum_probs=60.9
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEEe
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR---HPNIVQLYEVMATKSKIFFVME 94 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E 94 (479)
-.+.|+.|....+|+... ++..+++|+.... ....+.+|...|+.+. ...+.+++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 357799999999999875 5678889987643 2466788988888874 3568889988888889999999
Q ss_pred ccCCCCh
Q 011694 95 YAKGGEL 101 (479)
Q Consensus 95 ~~~gg~L 101 (479)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.79 E-value=6.2e-05 Score=76.90 Aligned_cols=77 Identities=12% Similarity=0.094 Sum_probs=45.9
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccc--cch----hhHHHHHHHHHHHH-hCCCCCcceeEEEEEeCCEEE
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI--MRV----GLADQIKREISVMR-IVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~--~~~----~~~~~l~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~ 90 (479)
-.+.||.|..+.||++.. +++.++||....... ... .....+..|+..+. ......+.+++.+. .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 357899999999999964 567899994321100 000 01223333433322 22234566777665 56679
Q ss_pred EEEecc-CC
Q 011694 91 FVMEYA-KG 98 (479)
Q Consensus 91 lV~E~~-~g 98 (479)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00027 Score=65.05 Aligned_cols=120 Identities=16% Similarity=0.127 Sum_probs=79.6
Q ss_pred ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccC
Q 011694 100 ELFNKVAK--GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTC 176 (479)
Q Consensus 100 ~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 176 (479)
+|.+.+.. .+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|+|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 68888875 689999999999999999877622 2222344457999999999998774 2110 1
Q ss_pred CCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhccC
Q 011694 177 GTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILDP 253 (479)
Q Consensus 177 gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 253 (479)
....+.|||... .-.+.+.=|||||+++|..+--..| -.-+..+|+.+-+||..|..-
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhc
Confidence 233567888763 2224678899999999988742222 122344899999999999866
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00014 Score=70.72 Aligned_cols=71 Identities=13% Similarity=0.084 Sum_probs=44.5
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEecc-
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI-VQLYEVMATKSKIFFVMEYA- 96 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~- 96 (479)
.+.|+.|....+|++ ..+++|+....... . ....+|+.+++.+...++ .+++.. +.+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---Y-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---e-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 688999999999998 56888987643111 0 122467777776642222 355544 333347899999
Q ss_pred CCCCh
Q 011694 97 KGGEL 101 (479)
Q Consensus 97 ~gg~L 101 (479)
+|.+|
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0002 Score=70.57 Aligned_cols=134 Identities=13% Similarity=0.157 Sum_probs=70.5
Q ss_pred eeeeeecCCeE-EEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeEEEEEeCCEEEEEEec
Q 011694 19 GRLLGQGAFAK-VYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH--PNIVQLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 19 ~~~LG~G~fg~-Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 95 (479)
.+.|+.|+... +|.... .+|..+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 35676665554 556643 2366777776543210 233456777766632 23556666643333 789999
Q ss_pred cCCCChHHHHhcCC---------------------------CCHHHHH-------HHH-------------HHHHHHHHH
Q 011694 96 AKGGELFNKVAKGK---------------------------LKEDAAR-------RYF-------------QQLINAVDF 128 (479)
Q Consensus 96 ~~gg~L~~~i~~~~---------------------------l~e~~~~-------~i~-------------~qll~aL~~ 128 (479)
+.|..+.+.+.... ++..... .++ ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 98766654332211 1111110 000 011112222
Q ss_pred H------HHCCCeeccCCCCCEEEecC----CCeEEeecCchh
Q 011694 129 C------HSRGVYHRDIKPENLLLDEN----ENLKISDFGLSA 161 (479)
Q Consensus 129 L------H~~givHrDLkp~NILl~~~----g~vkl~DFGla~ 161 (479)
+ +...++|+|+.|.||+++.+ +.+.|+||+.+.
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 2 23479999999999999864 679999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00074 Score=64.98 Aligned_cols=82 Identities=12% Similarity=0.072 Sum_probs=57.6
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC---CCcceeEEEEEeCCE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH---PNIVQLYEVMATKSK 88 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h---pnIv~l~~~~~~~~~ 88 (479)
......-.+.+|.|..+.||+... .+|+.|.+|+....... ....+.+|...|+.+.. -.+.+++.+ +.
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~-- 84 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD-- 84 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--
T ss_pred cCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--
Confidence 345667788999999999999986 57899999986544322 12456789999888742 234555554 22
Q ss_pred EEEEEeccCCCCh
Q 011694 89 IFFVMEYAKGGEL 101 (479)
Q Consensus 89 ~~lV~E~~~gg~L 101 (479)
-++||||+.++..
T Consensus 85 ~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 RTLAMEWVDERPP 97 (288)
T ss_dssp TEEEEECCCCCCC
T ss_pred ceEEEEeecccCC
Confidence 3789999987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00047 Score=67.28 Aligned_cols=138 Identities=14% Similarity=0.208 Sum_probs=77.6
Q ss_pred EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----CCCcceeE-E--EEEeCCE
Q 011694 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-----HPNIVQLY-E--VMATKSK 88 (479)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~ 88 (479)
.-.+.|+.|....+|++... +| .+++|+..... . ...+..|+.+++.+. -|.++... + +....+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-E----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-C----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 34567888998999998762 33 68899987531 1 134556777776653 33333211 0 1233567
Q ss_pred EEEEEeccCCCChHH-----------H---Hh---cC---C----CCHHHHHH---------------HHHHHHHHHHHH
Q 011694 89 IFFVMEYAKGGELFN-----------K---VA---KG---K----LKEDAARR---------------YFQQLINAVDFC 129 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~-----------~---i~---~~---~----l~e~~~~~---------------i~~qll~aL~~L 129 (479)
.+++|+|++|..+.. . +. .+ . .....-.. +-..+...+..+
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 899999999865310 0 10 00 0 01000000 001133445555
Q ss_pred HH-------CCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 130 HS-------RGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 130 H~-------~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
+. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 53 379999999999999876656899999763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0007 Score=69.37 Aligned_cols=75 Identities=13% Similarity=0.154 Sum_probs=50.6
Q ss_pred EeeeeeecCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCEE
Q 011694 18 VGRLLGQGAFAKVYYARSIR-------TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN-IVQLYEVMATKSKI 89 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 89 (479)
-.+.|+.|....||++.... ++..+++|+..... ..+.+.+|..+++.+...+ ..++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35778999999999998643 25789999884321 1134457888888875333 3566666542
Q ss_pred EEEEeccCCCCh
Q 011694 90 FFVMEYAKGGEL 101 (479)
Q Consensus 90 ~lV~E~~~gg~L 101 (479)
.+|+||++|.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00077 Score=67.90 Aligned_cols=135 Identities=21% Similarity=0.204 Sum_probs=81.7
Q ss_pred eeeeeecCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEE
Q 011694 19 GRLLGQGAFAKVYYARSIR-------TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (479)
.+.|..|-...+|++.... +++.+.+|+..... .....+.+|..+++.+. +.-..++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567778888899987642 35789999863311 12355668999998875 3223566666543 2
Q ss_pred EEEeccCCCChHH--------------HHhc--------CC-C--CHHHHHHHHHHHHH-------------------HH
Q 011694 91 FVMEYAKGGELFN--------------KVAK--------GK-L--KEDAARRYFQQLIN-------------------AV 126 (479)
Q Consensus 91 lV~E~~~gg~L~~--------------~i~~--------~~-l--~e~~~~~i~~qll~-------------------aL 126 (479)
+||||++|..|.. .+++ ++ . -...+.++..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 9999999855421 1111 11 1 13455666655422 23
Q ss_pred HHHH----H----CCCeeccCCCCCEEEecC----CCeEEeecCchh
Q 011694 127 DFCH----S----RGVYHRDIKPENLLLDEN----ENLKISDFGLSA 161 (479)
Q Consensus 127 ~~LH----~----~givHrDLkp~NILl~~~----g~vkl~DFGla~ 161 (479)
..|. . ..++|+|+.+.||+++.+ +.+.|+||..|.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3333 2 258999999999999876 789999999864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0016 Score=63.67 Aligned_cols=75 Identities=17% Similarity=0.174 Sum_probs=47.7
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeEEE-----EEeCCEEEEE
Q 011694 20 RLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH--PNIVQLYEV-----MATKSKIFFV 92 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h--pnIv~l~~~-----~~~~~~~~lV 92 (479)
..|+ |....||++.. .+|+.+++|+....... ...+..|..+++.+.. -.+.+++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998754 35667999998643221 2456678887776631 123333332 2335677899
Q ss_pred EeccCCCC
Q 011694 93 MEYAKGGE 100 (479)
Q Consensus 93 ~E~~~gg~ 100 (479)
||+++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998854
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00096 Score=66.63 Aligned_cols=76 Identities=14% Similarity=0.118 Sum_probs=45.4
Q ss_pred EeeeeeecCCeEEEEEEEcC--------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCE
Q 011694 18 VGRLLGQGAFAKVYYARSIR--------TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN-IVQLYEVMATKSK 88 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~--------~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpn-Iv~l~~~~~~~~~ 88 (479)
-.+.|+.|....+|++.... .+..+++|+...... .. .....|..+++.+...+ +.++++.. .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---EL-YNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GT-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ce-ecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 35678888889999998643 136788998754321 11 12357888888775333 44666554 23
Q ss_pred EEEEEeccCCCCh
Q 011694 89 IFFVMEYAKGGEL 101 (479)
Q Consensus 89 ~~lV~E~~~gg~L 101 (479)
++||||++|..+
T Consensus 110 -~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 -GRIEEWLYGDPL 121 (369)
T ss_dssp -EEEEECCCSEEC
T ss_pred -cEEEEEecCCcC
Confidence 689999998543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0053 Score=60.60 Aligned_cols=31 Identities=29% Similarity=0.440 Sum_probs=27.4
Q ss_pred CCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 132 RGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 132 ~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
.+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888999999987653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.011 Score=60.89 Aligned_cols=76 Identities=13% Similarity=0.211 Sum_probs=49.5
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEecc
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNI-VQLYEVMATKSKIFFVMEYA 96 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~ 96 (479)
-.+.|+.|-...+|++.....+..+++|+..... ....+ ..+|..+++.+...++ .++++.+. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 3578899999999999875445789999875421 11111 2588999998875444 46777663 3 2599999
Q ss_pred CCCCh
Q 011694 97 KGGEL 101 (479)
Q Consensus 97 ~gg~L 101 (479)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 88443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.63 E-value=0.018 Score=58.70 Aligned_cols=76 Identities=12% Similarity=0.137 Sum_probs=48.8
Q ss_pred EeeeeeecCCeEEEEEEEcCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEE
Q 011694 18 VGRLLGQGAFAKVYYARSIRT-------NQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKI 89 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 89 (479)
-++.|..|-...+|++..... ++.+++|+..... ... -...+|..+++.+. +.-..++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKF-YDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 346778888899999987521 5789999864421 111 12357888888775 22244555533 23
Q ss_pred EEEEeccCCCCh
Q 011694 90 FFVMEYAKGGEL 101 (479)
Q Consensus 90 ~lV~E~~~gg~L 101 (479)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.99 E-value=0.061 Score=54.21 Aligned_cols=29 Identities=34% Similarity=0.518 Sum_probs=24.6
Q ss_pred CeeccCCCCCEEEe------cCCCeEEeecCchhh
Q 011694 134 VYHRDIKPENLLLD------ENENLKISDFGLSAL 162 (479)
Q Consensus 134 ivHrDLkp~NILl~------~~g~vkl~DFGla~~ 162 (479)
++|+|+.+.|||+. .++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999993 457799999998753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.19 E-value=0.94 Score=41.44 Aligned_cols=82 Identities=16% Similarity=0.156 Sum_probs=64.7
Q ss_pred CCCCcceeEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCCeeccCCCCCEEEecCC
Q 011694 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVD-FCHSRGVYHRDIKPENLLLDENE 150 (479)
Q Consensus 72 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~-~LH~~givHrDLkp~NILl~~~g 150 (479)
.||++ -..+-.+++.+.|.++.-+++.=+..++ .++..+.++++.+|+.... ++ ..-+|--|.|+||+++.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCC
Confidence 58888 5666688888888888776665555554 4888899998888887766 44 4557888999999999999
Q ss_pred CeEEeecCc
Q 011694 151 NLKISDFGL 159 (479)
Q Consensus 151 ~vkl~DFGl 159 (479)
.++|.-.|+
T Consensus 122 ~p~i~hRGi 130 (219)
T 4ano_A 122 EPFFLHVGV 130 (219)
T ss_dssp CEEESCCEE
T ss_pred cEEEEEcCC
Confidence 999998886
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.37 E-value=1.2 Score=40.47 Aligned_cols=115 Identities=13% Similarity=0.263 Sum_probs=80.2
Q ss_pred CCCCcceeEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC
Q 011694 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN 151 (479)
Q Consensus 72 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~ 151 (479)
.||+++.. .+-++++.+.|.++.-+.+.=+..++ .++....++++.+|+....++ ..-+|--|.|+||+++.++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~~ 117 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDGL 117 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTSC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCCC
Confidence 68988877 67777787777777655443334443 488889999999999888544 44578889999999999999
Q ss_pred eEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchh-hHHHHHHHHHhCCCCCC
Q 011694 152 LKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIW-SCGVVLFVLLAGYLPFH 217 (479)
Q Consensus 152 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~Dvw-SlGvil~~ll~G~~Pf~ 217 (479)
+++.-.|+-.. ++| |.....|.| .+=|++..+++++..|+
T Consensus 118 p~i~~RGik~~-------------------l~P-------~~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 118 PIAKTRGLQNV-------------------VDP-------LPVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEESCCEETTT-------------------BSC-------CCCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEEEccCccC-------------------CCC-------CCCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99998886311 111 111122333 36678888888888774
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.20 E-value=0.094 Score=54.00 Aligned_cols=64 Identities=8% Similarity=0.134 Sum_probs=18.5
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEE------EEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAV------KVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vai------K~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
+.+.|| ||.||.+.......+||| |......... +....+.+|..+++.++|||+++.+.+...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~-e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSE-KRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccc-cccccccccccccccccccccCCCcceEEe
Confidence 445666 999999998765668888 6554322222 223456788899999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 479 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-90 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-87 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-86 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-84 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-84 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-80 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-79 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-79 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-78 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-77 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-77 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-76 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-76 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-76 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-74 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-74 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-74 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-72 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-71 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-71 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-70 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-69 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-68 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-68 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-68 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-66 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-65 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-63 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-62 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-62 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-61 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-61 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-60 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-60 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-60 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-59 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-58 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-57 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-57 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-57 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-52 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-51 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-24 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 1e-13 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (703), Expect = 1e-90
Identities = 96/260 (36%), Positives = 149/260 (57%), Gaps = 6/260 (2%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +E+GR LG+G F VY AR ++ +A+KV+ K ++ + G+ Q++RE+ + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSR 132
PNI++LY ++++ ++EYA G ++ ++ K K E Y +L NA+ +CHS+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
V HRDIKPENLLL LKI+DFG S T CGT Y+ PE+I + +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRMH 181
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
D EKVD+WS GV+ + L G PF + E Y++I + EF P++ R L+ ++L
Sbjct: 182 D-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 240
Query: 253 PNPSTRISMAKIRESSWFRK 272
NPS R + ++ E W
Sbjct: 241 HNPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (682), Expect = 2e-87
Identities = 101/267 (37%), Positives = 161/267 (60%), Gaps = 6/267 (2%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E +++ + LG+GA+ +V A + T ++VAVK++D + V + IK+EI + +++ H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNH 62
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCHSR 132
N+V+ Y + + +EY GGELF+++ + E A+R+F QL+ V + H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
G+ HRDIKPENLLLDE +NLKISDFGL+ + + +++ LL+ CGT YVAPE++ R+ +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFH-DSNLIEMYRKIGKAEFKCPNW--FPPEVRKLLCK 249
E VD+WSCG+VL +LAG LP+ S+ + Y + + W LL K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 250 ILDPNPSTRISMAKIRESSWFRKGMNQ 276
IL NPS RI++ I++ W+ K + +
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (673), Expect = 9e-86
Identities = 81/260 (31%), Positives = 150/260 (57%), Gaps = 2/260 (0%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E ++ G++LG+G+F+ V AR + T++ A+K+++K I++ + RE VM + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSR 132
P V+LY K++F + YAK GEL + K G E R Y ++++A+++ H +
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
G+ HRD+KPEN+LL+E+ +++I+DFG + + + + ++ GT YV+PE++ K
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
+ D+W+ G +++ L+AG PF N +++KI K E+ P F P+ R L+ K+L
Sbjct: 188 C-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246
Query: 253 PNPSTRISMAKIRESSWFRK 272
+ + R+ ++ +
Sbjct: 247 LDATKRLGCEEMEGYGPLKA 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (665), Expect = 2e-84
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 10/280 (3%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+KY +GQGA VY A + T Q VA++ ++ + + + I EI VMR +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENK 75
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
+PNIV + +++ VMEY GG L + V + + E ++ + A++F HS
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
V HRDIK +N+LL + ++K++DFG AQ + T GTP ++APEV+ RK Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI---GKAEFKCPNWFPPEVRKLLCK 249
KVDIWS G++ ++ G P+ + N + I G E + P R L +
Sbjct: 194 G-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 250 ILDPNPSTRISMAKIRESSWFRKGMNQKQ-KQKVTESKDA 288
LD + R S ++ + + + + +K+A
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEA 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (660), Expect = 7e-84
Identities = 73/283 (25%), Positives = 140/283 (49%), Gaps = 14/283 (4%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+ +E+ LG GAF KVY A++ T+ A KVID + + EI ++
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCD 67
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCH 130
HPNIV+L + ++ ++ ++E+ GG + + + L E + +Q ++A+++ H
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI--- 187
+ HRD+K N+L + ++K++DFG+S A+ + GTP ++APEV+
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 188 -NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPPEV 243
++ K D+WS G+ L + P H+ N + + KI K+E P+ +
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESK 286
+ L K L+ N R + +++ + + N+ ++ + E+K
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAK 288
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 9e-80
Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 17/269 (6%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E YEV +G G++ + R + + K +D + + E++++R ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKH 62
Query: 74 PNIVQLYEVM--ATKSKIFFVMEYAKGGELFNKVAKGK-----LKEDAARRYFQQLINAV 126
PNIV+ Y+ + T + ++ VMEY +GG+L + + KG L E+ R QL A+
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 127 DFCHSRG-----VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
CH R V HRD+KP N+ LD +N+K+ DFGL+ + H GTP Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYY 180
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWFP 240
++PE +NR Y+ EK DIWS G +L+ L A PF + E+ KI + +F + P +
Sbjct: 181 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239
Query: 241 PEVRKLLCKILDPNPSTRISMAKIRESSW 269
E+ +++ ++L+ R S+ +I E+
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 247 bits (631), Expect = 3e-79
Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 11/265 (4%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
+ + R +G G+F VY+AR +R ++ VA+K + I +E+ ++ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELF-NKVAKGKLKEDAARRYFQQLINAVDFCHS 131
HPN +Q + + VMEY G +V K L+E + + + HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI--NR 189
+ HRD+K N+LL E +K+ DFG +++ ++ GTP ++APEVI
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMD 187
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNW--FPPEVRKLL 247
+G KVD+WS G+ L P + N + I + E + R +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 248 CKILDPNPSTRISMAKIRESSWFRK 272
L P R + + + + +
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLR 272
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 248 bits (633), Expect = 5e-79
Identities = 81/294 (27%), Positives = 139/294 (47%), Gaps = 15/294 (5%)
Query: 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV 67
K + + Y++ LG GAF V+ T + A K + + +++EI
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQT 76
Query: 68 MRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINA 125
M ++RHP +V L++ +++ + E+ GGELF KVA K+ ED A Y +Q+
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 126 VDFCHSRGVYHRDIKPENLLLDENEN--LKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+ H H D+KPEN++ + LK+ DFGL+A K + T GT + A
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAA 193
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK----CPNWF 239
PEV K G D+WS GV+ ++LL+G PF N E R + ++ +
Sbjct: 194 PEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDA 293
+ + + K+L +P+TR+++ + E W G + ++ S+ +D+
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 246 bits (629), Expect = 2e-78
Identities = 73/307 (23%), Positives = 139/307 (45%), Gaps = 15/307 (4%)
Query: 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISV 67
K + + Y++ LG GAF V+ T + K I+ + +K EIS+
Sbjct: 23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISI 79
Query: 68 MRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINA 125
M + HP ++ L++ K ++ ++E+ GGELF+++A K+ E Y +Q
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139
Query: 126 VDFCHSRGVYHRDIKPENLLLDENEN--LKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+ H + H DIKPEN++ + + +KI DFG LA + D ++ T T + A
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTTATAEFAA 196
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWF 239
PE+++R+ D+W+ GV+ +VLL+G PF + +E + + + +++ +
Sbjct: 197 PEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESKDAASQDAGASAPQ 299
PE + + +L P R+++ E W + + + + + Q
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315
Query: 300 GSSSIAA 306
+ A
Sbjct: 316 WPAPQPA 322
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 241 bits (615), Expect = 2e-77
Identities = 90/276 (32%), Positives = 139/276 (50%), Gaps = 20/276 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV------GLADQIKREISV 67
E YE +LG+G + V T + AVK+ID L + +E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 68 MRIVR-HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINA 125
+R V HPNI+QL + T + F V + K GELF+ + K L E R+ + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
+ H + HRD+KPEN+LLD++ N+K++DFG S + L CGTP+Y+APE
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPE 179
Query: 186 VINRKGYD-----GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNW 238
+I D G++VD+WS GV+++ LLAG PF + M R I G +F P W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 239 --FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
+ V+ L+ + L P R + + +F++
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 5e-77
Identities = 67/283 (23%), Positives = 125/283 (44%), Gaps = 16/283 (5%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
L EKY + LG+G F V+ + ++ K + +V +K+EIS++ I
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILNIA 58
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFC 129
RH NI+ L+E + ++ + E+ G ++F ++ +L E Y Q+ A+ F
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 130 HSRGVYHRDIKPENLLLDENEN--LKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
HS + H DI+PEN++ + +KI +FG + + P Y APEV
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVH 175
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPPEV 243
D+WS G +++VLL+G PF ++ I AE+ E
Sbjct: 176 QHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTESK 286
+ ++L +R++ ++ + W ++ + + + + K
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLK 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 1e-76
Identities = 87/262 (33%), Positives = 142/262 (54%), Gaps = 6/262 (2%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVR 72
E + + ++LG+G+F KV+ A +TNQ A+K + KD ++ + E V+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCHS 131
HP + ++ TK +FFVMEY GG+L + + K A Y ++I + F HS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
+G+ +RD+K +N+LLD++ ++KI+DFG+ + D +T CGTP Y+APE++ +
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKIL 251
Y+ VD WS GV+L+ +L G PFH + E++ I P W E + LL K+
Sbjct: 180 YN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 238
Query: 252 DPNPSTRISMAK-IRESSWFRK 272
P R+ + IR+ FR+
Sbjct: 239 VREPEKRLGVRGDIRQHPLFRE 260
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 239 bits (612), Expect = 2e-76
Identities = 95/269 (35%), Positives = 152/269 (56%), Gaps = 14/269 (5%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
+ + Y+ +LG GAF++V A RT + VA+K I K + G ++ EI+V+ +
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKI 64
Query: 72 RHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVDFCH 130
+HPNIV L ++ + ++ +M+ GGELF+++ KG E A R Q+++AV + H
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 131 SRGVYHRDIKPENLLL---DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
G+ HRD+KPENLL DE+ + ISDFGLS + + +L T CGTP YVAPEV+
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 181
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI--GKAEFKCPNW--FPPEV 243
+K Y + VD WS GV+ ++LL GY PF+D N +++ +I + EF P W
Sbjct: 182 AQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRK 272
+ + +++ +P R + + + W
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 6e-76
Identities = 63/264 (23%), Positives = 121/264 (45%), Gaps = 15/264 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ VG+ +G G+F VY + + VAVK+++ L K E+ V+R RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRH 63
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHS 131
NI+ T ++ V ++ +G L++ + + K + +Q +D+ H+
Sbjct: 64 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
+ + HRD+K N+ L E+ +KI DFGL+ + G+ ++APEVI +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 192 YD--GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF------KCPNWFPPEV 243
+ + D+++ G+VL+ L+ G LP+ + N + + + K + P +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 244 RKLLCKILDPNPSTRISMAKIRES 267
++L+ + L R +I S
Sbjct: 243 KRLMAECLKKKRDERPLFPQILAS 266
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 238 bits (607), Expect = 1e-75
Identities = 88/265 (33%), Positives = 160/265 (60%), Gaps = 12/265 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ +++ R LG G+F +V+ RS + A+KV+ K+ ++R+ + E ++ IV H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN-KVAKGKLKEDAARRYFQQLINAVDFCHSR 132
P I++++ +IF +M+Y +GGELF+ + A+ Y ++ A+++ HS+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
+ +RD+KPEN+LLD+N ++KI+DFG K+ + +T CGTP Y+APEV++ K Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFG-----FAKYVPDVTYTLCGTPDYIAPEVVSTKPY 178
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
+ + +D WS G++++ +LAGY PF+DSN ++ Y KI AE + P +F +V+ LL +++
Sbjct: 179 N-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 237
Query: 253 PNPSTRI-----SMAKIRESSWFRK 272
+ S R+ ++ WF++
Sbjct: 238 RDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 2e-74
Identities = 64/308 (20%), Positives = 120/308 (38%), Gaps = 53/308 (17%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
+ + +E LG G V+ + +A K+I + ++ + +QI RE+ V+
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE 60
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFC 129
P IV Y + +I ME+ GG L + K G++ E + +I + +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 130 HSR-GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
+ + HRD+KP N+L++ +K+ DFG+S + D + ++ GT +Y++PE +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 189 RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPP------- 241
Y + DIWS G+ L + G P + E+ G PP
Sbjct: 177 GTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 242 -------------------------------------EVRKLLCKILDPNPSTRISMAKI 264
E + + K L NP+ R + ++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 265 RESSWFRK 272
++ ++
Sbjct: 296 MVHAFIKR 303
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 233 bits (595), Expect = 2e-74
Identities = 73/273 (26%), Positives = 127/273 (46%), Gaps = 11/273 (4%)
Query: 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
PS L+++YE+G +LG G ++V+ AR +R ++ VAVKV+ D + +RE
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 69 RIVRHPNIVQLYEVMATKSK----IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLI 123
+ HP IV +Y+ ++ + VMEY G L + V G + A
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121
Query: 124 NAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSA-LAQCKHQDGLLHTTCGTPAYV 182
A++F H G+ HRD+KP N+++ +K+ DFG++ +A + GT Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 183 APEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN----W 238
+PE D + D++S G VL+ +L G PF + + + + + + P+
Sbjct: 182 SPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 239 FPPEVRKLLCKILDPNPSTRISMAKIRESSWFR 271
++ ++ K L NP R A + R
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 4e-74
Identities = 65/267 (24%), Positives = 124/267 (46%), Gaps = 18/267 (6%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
+ +G+G+F VY T VA + K+ + + K E +++ ++HPN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQHPN 69
Query: 76 IVQLYEVMATKSK----IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCH 130
IV+ Y+ + K I V E G L + + +K R + +Q++ + F H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 131 SRG--VYHRDIKPENLLL-DENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
+R + HRD+K +N+ + ++KI D GL+ L + GTP ++APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMY 185
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS-NLIEMYRKI--GKAEFKCPNWFPPEVR 244
K YD E VD+++ G+ + + P+ + N ++YR++ G PEV+
Sbjct: 186 EEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 245 KLLCKILDPNPSTRISMAKIRESSWFR 271
+++ + N R S+ + ++F+
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 2e-72
Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 18/279 (6%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGL---ADQIKREISVM 68
L +Y+VG LLG G F VY + N VA+K ++KD+I G ++ E+ ++
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 69 RIVR--HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV--AKGKLKEDAARRYFQQLIN 124
+ V +++L + ++E + + +G L+E+ AR +F Q++
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENE-NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
AV CH+ GV HRDIK EN+L+D N LK+ DFG AL + GT Y
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 177
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV 243
PE I Y G +WS G++L+ ++ G +PF +I + + E
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231
Query: 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKV 282
+ L+ L PS R + +I+ W + + ++ ++
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 1e-71
Identities = 88/264 (33%), Positives = 140/264 (53%), Gaps = 9/264 (3%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++ +LLG+G F KV R T + A+K++ K+ I+ E V++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVDFCHSR 132
P + L T ++ FVMEYA GGELF +++ E+ AR Y ++++A+++ HSR
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
V +RDIK ENL+LD++ ++KI+DFGL + T CGTP Y+APEV+ Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDY 182
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
VD W GVV++ ++ G LPF++ + ++ I E + P PE + LL +L
Sbjct: 183 G-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 253 PNPSTRISMAK-----IRESSWFR 271
+P R+ + E +F
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 2e-71
Identities = 79/278 (28%), Positives = 138/278 (49%), Gaps = 16/278 (5%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM---RVGLADQIKREISVM 68
+ + Y+ G LG G FA V R T A K I K + R + I+RE+S++
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKV-AKGKLKEDAARRYFQQLINAVD 127
+ ++HPN++ L+EV K+ + ++E GGELF+ + K L E+ A + +Q++N V
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 128 FCHSRGVYHRDIKPENLLLDENE----NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVA 183
+ HS + H D+KPEN++L + +KI DFGL A GTP +VA
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKIDFGNEFKNIFGTPEFVA 184
Query: 184 PEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPP-- 241
PE++N + + D+WS GV+ ++LL+G PF E + ++ + +
Sbjct: 185 PEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 242 --EVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQK 277
+ + ++L +P R+++ + W + Q+
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 226 bits (578), Expect = 1e-70
Identities = 81/270 (30%), Positives = 133/270 (49%), Gaps = 16/270 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR- 72
+ V R++G+G F +VY R T + A+K +DK +I E ++ +V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 73 --HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFC 129
P IV + T K+ F+++ GG+L +++ G E R Y ++I ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
H+R V +RD+KP N+LLDE+ +++ISD GL+ C H + GT Y+APEV+ +
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQK 179
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKIGKAEFKCPNWFPPEVRKL 246
D +S G +LF LL G+ PF E+ R + P+ F PE+R L
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239
Query: 247 LCKILDPNPSTRISMAK-----IRESSWFR 271
L +L + + R+ ++ES +FR
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 7e-69
Identities = 81/289 (28%), Positives = 137/289 (47%), Gaps = 26/289 (8%)
Query: 8 KPSVLTEKYEV-GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREIS 66
K + + + Y+V ++LG G KV + RT + A+K++ + +RE+
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 56
Query: 67 VM-RIVRHPNIVQLYEV----MATKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRY 118
+ R + P+IV++ +V A + + VME GGELF+++ E A
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 119 FQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGT 178
+ + A+ + HS + HRD+KPENLL I A+ L T C T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI------GKAE 232
P YVAPEV+ + YD + D+WS GV++++LL GY PF+ ++ + + + G+ E
Sbjct: 177 PYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 233 FKCPNW--FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQK 279
F P W EV+ L+ +L P+ R+++ + W + Q
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 284
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 1e-68
Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 19/259 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++ ++ + +G+G F V VAVK I D + E SVM +RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRH 59
Query: 74 PNIVQLYEVMA-TKSKIFFVMEYAKGGELFN---KVAKGKLKEDAARRYFQQLINAVDFC 129
N+VQL V+ K ++ V EY G L + + L D ++ + A+++
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 130 HSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
HRD+ N+L+ E+ K+SDFG K T + APE +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFG-----LTKEASSTQDTGKLPVKWTAPEALRE 174
Query: 190 KGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLL 247
K + K D+WS G++L+ + + G +P+ L ++ ++ K P+ PP V +++
Sbjct: 175 KKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 248 CKILDPNPSTRISMAKIRE 266
+ + R S ++RE
Sbjct: 234 KNCWHLDAAMRPSFLQLRE 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 7e-68
Identities = 68/312 (21%), Positives = 120/312 (38%), Gaps = 38/312 (12%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
+ +Y +G+GA+ V A VA+K I + + REI ++
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF 63
Query: 72 RHPNIVQLYEVMATKS----KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVD 127
RH NI+ + +++ + K +++ + G +L+ + L D + Q++ +
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPAYVAPEV 186
+ HS V HRD+KP NLLL+ +LKI DFGL+ +A H T T Y APE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--------------- 231
+ + +DIWS G +L +L+ F + ++ I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 232 -----EFKCPNW-----------FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275
P+ + LL K+L NP RI + + + + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 276 QKQKQKVTESKD 287
+
Sbjct: 304 PSDEPIAEAPFK 315
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 8e-68
Identities = 62/261 (23%), Positives = 103/261 (39%), Gaps = 9/261 (3%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTN---QSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
+ + LG G+F V + SVAVK + D + + D RE++ M
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDF 128
+ H N+++LY V+ T + V E A G L +++ K G RY Q+ + +
Sbjct: 68 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
S+ HRD+ NLLL + +KI DFGL ++ P
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 189 RKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE--FKCPNWFPPEVRK 245
+ D W GV L+ + G P+ N ++ KI K P P ++
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
Query: 246 LLCKILDPNPSTRISMAKIRE 266
++ + P R + +R+
Sbjct: 247 VMVQCWAHKPEDRPTFVALRD 267
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (552), Expect = 5e-67
Identities = 81/265 (30%), Positives = 146/265 (55%), Gaps = 12/265 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
++++ + LG G+F +V + + A+K++DK K++++ + E +++ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSR 132
P +V+L S ++ VMEY GGE+F+ + + G+ E AR Y Q++ ++ HS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
+ +RD+KPENLL+D+ ++++DFG + K G T CGTP +APE+I KGY
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALAPEIILSKGY 215
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252
+ + VD W+ GV+++ + AGY PF I++Y KI + + P+ F +++ LL +L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274
Query: 253 PNPSTRI-----SMAKIRESSWFRK 272
+ + R + I+ WF
Sbjct: 275 VDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 1e-66
Identities = 58/257 (22%), Positives = 106/257 (41%), Gaps = 11/257 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ + LG G F V Y + R VA+K+I + + D+ E VM + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVDFCHS 131
+VQLY V + IF + EY G L N + + + + + + A+++ S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
+ HRD+ N L+++ +K+SDFGLS + + + PEV+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 192 YDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCK 249
+ K DIW+ GV+++ + + G +P+ E I + P+ +V ++
Sbjct: 178 FS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236
Query: 250 ILDPNPSTRISMAKIRE 266
R + +
Sbjct: 237 CWHEKADERPTFKILLS 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 2e-66
Identities = 64/267 (23%), Positives = 111/267 (41%), Gaps = 11/267 (4%)
Query: 20 RLLGQGAFAKVYYA--RSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIV 77
+ LG G F V + + ++VAVK++ + L D++ E +VM+ + +P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIV 71
Query: 78 QLYEVMATKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYH 136
++ + VME A+ G L + + +K+ Q+ + + H
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 137 RDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT-CGTPAYVAPEVINRKGYDGE 195
RD+ N+LL KISDFGLS + T + APE IN +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189
Query: 196 KVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCKILDP 253
K D+WS GV+++ + G P+ E+ + K E CP P E+ L+
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 254 NPSTRISMAKIRE--SSWFRKGMNQKQ 278
+ R A + +++ +N+
Sbjct: 250 DVENRPGFAAVELRLRNYYYDVVNEGH 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 4e-65
Identities = 63/258 (24%), Positives = 117/258 (45%), Gaps = 13/258 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E ++ LG G F +V+ + VAVK + + + D E ++M+ ++H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQH 67
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN---KVAKGKLKEDAARRYFQQLINAVDFCH 130
+V+LY V+ T+ I+ + EY + G L + + KL + Q+ + F
Sbjct: 68 QRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
R HRD++ N+L+ + + KI+DFGL+ L + ++ + APE IN
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINY- 184
Query: 191 GYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLC 248
G K D+WS G++L ++ G +P+ E+ + + + P+ P E+ +L+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244
Query: 249 KILDPNPSTRISMAKIRE 266
P R + +R
Sbjct: 245 LCWKERPEDRPTFDYLRS 262
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-64
Identities = 71/286 (24%), Positives = 114/286 (39%), Gaps = 33/286 (11%)
Query: 17 EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKI--MRVGLADQIKREISVMRIVRHP 74
E LG+G FA VY AR TNQ VA+K I + G+ REI +++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 75 NIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGK-LKEDAARRYFQQLINAVDFCHSRG 133
NI+ L + KS I V ++ + L + Y + +++ H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 134 VYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYD 193
+ HRD+KP NLLLDEN LK++DFGL+ + T Y APE++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 194 GEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-------------------- 233
G VD+W+ G +L LL + ++ +I +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 234 --------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFR 271
+ ++ L+ + NP RI+ + + +F
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-64
Identities = 61/286 (21%), Positives = 113/286 (39%), Gaps = 36/286 (12%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQS-----VAVKVIDKDKIMRVGLADQIKREISVM 68
E E G++LG GAF KV A + +++ VAVK++ + + + E+ +M
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMM 94
Query: 69 -RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-------------------- 107
++ H NIV L I+ + EY G+L N +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 108 ----GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163
L + + Q+ ++F + HRD+ N+L+ + +KI DFGL+
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLI 222
+ ++APE + Y K D+WS G++L+ + + G P+ +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 223 EMYRKIGKAEFK--CPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ K+ + FK P + E+ ++ + R S +
Sbjct: 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (526), Expect = 6e-64
Identities = 67/274 (24%), Positives = 126/274 (45%), Gaps = 16/274 (5%)
Query: 3 GMDHNKPS-----VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGL 57
MD + P+ + + LG G + +VY + + +VAVK + +D +
Sbjct: 1 AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--- 57
Query: 58 ADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN---KVAKGKLKEDA 114
++ +E +VM+ ++HPN+VQL V + + + E+ G L + + + ++
Sbjct: 58 -EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 116
Query: 115 ARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHT 174
Q+ +A+++ + HRD+ N L+ EN +K++DFGLS L
Sbjct: 117 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAG 175
Query: 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLL-AGYLPFHDSNLIEMYRKIGK-AE 232
+ APE + + K D+W+ GV+L+ + G P+ +L ++Y + K
Sbjct: 176 AKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 234
Query: 233 FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ P P +V +L+ NPS R S A+I +
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 7e-64
Identities = 52/264 (19%), Positives = 105/264 (39%), Gaps = 13/264 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQS---VAVKVIDKDKIMRVGLADQIKREISVMRI 70
++ +++G G F +V + VA+K + + E S+M
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMGQ 83
Query: 71 VRHPNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDF 128
HPN++ L V+ + + + E+ + G L F + G+ + + + +
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT---CGTPAYVAPE 185
HRD+ N+L++ N K+SDFGLS + D + + APE
Sbjct: 144 LADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEV 243
I + + D+WS G+V++ +++ G P+ D ++ I + P P +
Sbjct: 204 AIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSAL 262
Query: 244 RKLLCKILDPNPSTRISMAKIRES 267
+L+ + + R +I +
Sbjct: 263 HQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 9e-64
Identities = 57/257 (22%), Positives = 106/257 (41%), Gaps = 11/257 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ + +G G F V+ VA+K I + + + E VM + H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSH 59
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHS 131
P +VQLY V ++ I V E+ + G L + + +G + + + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
V HRD+ N L+ EN+ +K+SDFG++ Q T + +PEV +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 192 YDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCK 249
Y K D+WS GV+++ + + G +P+ + + E+ I P V +++
Sbjct: 179 YS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237
Query: 250 ILDPNPSTRISMAKIRE 266
P R + +++
Sbjct: 238 CWKERPEDRPAFSRLLR 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-63
Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 15/275 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E + LGQG F +V+ T + VA+K + + + +E VM+ +RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRH 71
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLK---EDAARRYFQQLINAVDFCH 130
+VQLY V+ ++ I+ V EY G L + + K Q+ + + +
Sbjct: 72 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
HRD++ N+L+ EN K++DFGL+ L + ++ + APE
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 189
Query: 191 GYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLC 248
+ K D+WS G++L L G +P+ E+ ++ + CP P + L+C
Sbjct: 190 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248
Query: 249 KILDPNPSTRISMAKIRE--SSWFRKGMNQKQKQK 281
+ P R + ++ +F Q Q +
Sbjct: 249 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-63
Identities = 64/262 (24%), Positives = 105/262 (40%), Gaps = 12/262 (4%)
Query: 13 TEKYEVGRL-LGQGAFAKVYYA--RSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR 69
+ + + LG G F V R + VA+KV+ + +++ RE +M
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMH 64
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN--KVAKGKLKEDAARRYFQQLINAVD 127
+ +P IV+L V + VME A GG L + ++ Q+ +
Sbjct: 65 QLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLS-ALAQCKHQDGLLHTTCGTPAYVAPEV 186
+ + HRD+ N+LL KISDFGLS AL + APE
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVR 244
IN + + + D+WS GV ++ L+ G P+ E+ I + + +CP PPE+
Sbjct: 184 INFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242
Query: 245 KLLCKILDPNPSTRISMAKIRE 266
L+ R + +
Sbjct: 243 ALMSDCWIYKWEDRPDFLTVEQ 264
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-63
Identities = 64/302 (21%), Positives = 111/302 (36%), Gaps = 44/302 (14%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
KYE +GQG F +V+ AR +T Q VA+K + + + G REI ++++++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKH 68
Query: 74 PNIVQLYEVMAT--------KSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLIN 124
N+V L E+ T K I+ V ++ + K +R Q L+N
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 125 AVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD--GLLHTTCGTPAYV 182
+ + H + HRD+K N+L+ + LK++DFGL+ T Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 183 APEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPE 242
PE++ + G +D+W G ++ + + I + P
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 243 VRK--------------------------------LLCKILDPNPSTRISMAKIRESSWF 270
V L+ K+L +P+ RI +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 271 RK 272
Sbjct: 309 WS 310
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-62
Identities = 61/292 (20%), Positives = 113/292 (38%), Gaps = 27/292 (9%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVR 72
+ ++G+G F +V AR + + + + E+ V+ ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFN-----------------KVAKGKLKEDAA 115
HPNI+ L + ++ +EYA G L + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 116 RRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT 175
+ + +D+ + HRD+ N+L+ EN KI+DFG L++ +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMG 186
Query: 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-F 233
++A E +N Y D+WS GV+L+ +++ G P+ E+Y K+ +
Sbjct: 187 RLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245
Query: 234 KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQKQKVTES 285
+ P EV L+ + P R S A+I S M +++K V +
Sbjct: 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS---LNRMLEERKTYVNTT 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-62
Identities = 77/290 (26%), Positives = 130/290 (44%), Gaps = 34/290 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
E ++ +G+G + VY AR+ T + VA+K I D G+ REIS+++ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGG--ELFNKVAKGKLKEDAARRYFQQLINAVDFCHS 131
PNIV+L +V+ T++K++ V E+ + + A + + Y QL+ + FCHS
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 132 RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKG 191
V HRD+KP+NLL++ +K++DFGL+ + T Y APE++
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCK 178
Query: 192 YDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------------EF 233
Y VDIWS G + ++ F + I+ +I + +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 234 KCPNW-----------FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
P W + R LL ++L +P+ RIS +F+
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 201 bits (512), Expect = 5e-62
Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 34/289 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
EKY +G+G + VY A++ ++ A+K I +K G+ REIS+++ ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKH 59
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFN-KVAKGKLKEDAARRYFQQLINAVDFCHSR 132
NIV+LY+V+ TK ++ V E+ V +G L+ A+ + QL+N + +CH R
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
V HRD+KP+NLL++ LKI+DFGL+ T Y AP+V+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLA--RAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 193 DGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF------------------- 233
+DIWS G + ++ G F + + +I +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 234 ----------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
LL K+L +P+ RI+ + E ++F++
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 6e-62
Identities = 54/256 (21%), Positives = 103/256 (40%), Gaps = 6/256 (2%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDK--DKIMRVGLADQIKREISVMRIVRH 73
++ ++LG GAF VY I + V + V K + +I E VM V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLK-EDAARRYFQQLINAVDFCHSR 132
P++ +L + T + G L + Q+ +++ R
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
+ HRD+ N+L+ +++KI+DFGL+ L + ++ ++A E I + Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 193 DGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLCKI 250
+ D+WS GV ++ L+ G P+ E+ + K E P +V ++ K
Sbjct: 191 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 251 LDPNPSTRISMAKIRE 266
+ +R ++
Sbjct: 250 WMIDADSRPKFRELII 265
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-61
Identities = 79/297 (26%), Positives = 127/297 (42%), Gaps = 50/297 (16%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
Y +++G G+F VY A+ + + VA+K + +DK + RE+ +MR + H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHCN 74
Query: 76 IVQLYEVMATKSK------IFFVMEYAKGGEL----FNKVAKGKLKEDAARRYFQQLINA 125
IV+L + + + V++Y AK L + Y QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 126 VDFCHSRGVYHRDIKPENLLLD-ENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAP 184
+ + HS G+ HRDIKP+NLLLD + LK+ DFG A+ + + + Y AP
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS---AKQLVRGEPNVSYICSRYYRAP 191
Query: 185 EVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGK-------------- 230
E+I +D+WS G VL LL G F + ++ +I K
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 231 ---AEFKCPNW------------FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
EFK P PPE L ++L+ P+ R++ + S+F +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-61
Identities = 67/258 (25%), Positives = 117/258 (45%), Gaps = 8/258 (3%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQS-VAVKVIDKDKIMRVGLADQIKREISVMRIVR 72
E+ E+GR +G+G F V+ + +AV + + ++ +E MR
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 73 HPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCH 130
HP+IV+L V+ T++ ++ +ME GEL + + L + Y QL A+ +
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 131 SRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRK 190
S+ HRDI N+L+ N+ +K+ DFGLS + ++APE IN +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 184
Query: 191 GYDGEKVDIWSCGVVLF-VLLAGYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLC 248
+ D+W GV ++ +L+ G PF ++ +I E P PP + L+
Sbjct: 185 RFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243
Query: 249 KILDPNPSTRISMAKIRE 266
K +PS R +++
Sbjct: 244 KCWAYDPSRRPRFTELKA 261
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 4e-61
Identities = 75/304 (24%), Positives = 131/304 (43%), Gaps = 43/304 (14%)
Query: 13 TEKYEVGRLLGQGAFAKVYYARSIRT-NQSVAVKVIDKDKIMRVGLADQIKREISVMRI- 70
++YE +G+GA+ KV+ AR ++ + VA+K + G+ RE++V+R
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHL 64
Query: 71 --VRHPNIVQLYEVMAT-----KSKIFFVMEYAKGG--ELFNKVAKGKLKEDAARRYFQQ 121
HPN+V+L++V ++K+ V E+ +KV + + + + Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 122 LINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAY 181
L+ +DF HS V HRD+KP+N+L+ + +K++DFGL+ + + + T Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWY 181
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKI------------- 228
APEV+ + Y VD+WS G + + F S+ ++ KI
Sbjct: 182 RAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 229 --------------GKAEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274
+ K + LL K L NP+ RIS +F+
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
Query: 275 NQKQ 278
K+
Sbjct: 301 RCKE 304
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 1e-60
Identities = 66/285 (23%), Positives = 107/285 (37%), Gaps = 35/285 (12%)
Query: 14 EKYEVGRLLGQGAFAKVYYARS-----IRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
E R +G+GAF +V+ AR+ VAVK++ ++ + +RE ++M
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 70
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN------------------------- 103
+PNIV+L V A + + EY G+L
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 104 KVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163
L +Q+ + + R HRD+ N L+ EN +KI+DFGLS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYL-PFHDSNLI 222
++ PE I Y + D+W+ GVVL+ + + L P++
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 223 EMYRKIGKAEF-KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
E+ + CP P E+ L+ P+ R S I
Sbjct: 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 2e-60
Identities = 73/298 (24%), Positives = 123/298 (41%), Gaps = 44/298 (14%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
+ Y + +G GA+ V A RT VA+K + + A + RE+ +++ +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHM 74
Query: 72 RHPNIVQLYEVMATKSK------IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINA 125
RH N++ L +V + VM + G +L + KL ED + Q++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKG 133
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
+ + H+ G+ HRD+KP NL ++E+ LKI DFGL+ + D + T Y APE
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPE 188
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWF------ 239
VI + VDIWS G ++ ++ G F S+ ++ ++I K P F
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 240 -------------------------PPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
P LL K+L + R++ + +F
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 6e-60
Identities = 70/297 (23%), Positives = 126/297 (42%), Gaps = 42/297 (14%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
+ E+Y+ +G GA+ V A +T VAVK + + + A + RE+ +++ +
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM 74
Query: 72 RHPNIVQLYEVMATKSKI-----FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAV 126
+H N++ L +V + +++ + G +L N V KL +D + Q++ +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 127 DFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEV 186
+ HS + HRD+KP NL ++E+ LKI DFGL+ + T Y APE+
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEI 189
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFP------ 240
+ + + VDIWS G ++ LL G F ++ I+ + I +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 241 -------------------------PEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
P LL K+L + RI+ A+ ++F +
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-59
Identities = 76/274 (27%), Positives = 133/274 (48%), Gaps = 15/274 (5%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIR---TNQSVAVKVIDKDKIM-RVGLADQIKREISVMR 69
E +E+ ++LG GA+ KV+ R I T + A+KV+ K I+ + + + E V+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 70 IVRH-PNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKG-KLKEDAARRYFQQLINAVD 127
+R P +V L+ T++K+ +++Y GGELF +++ + E + Y +++ A++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVI 187
H G+ +RDIK EN+LLD N ++ ++DFGLS + V
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 188 NRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN----LIEMYRKIGKAEFKCPNWFPPEV 243
+ VD WS GV+++ LL G PF E+ R+I K+E P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263
Query: 244 RKLLCKILDPNPSTRISMAK-----IRESSWFRK 272
+ L+ ++L +P R+ I+E +F+K
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-59
Identities = 61/258 (23%), Positives = 115/258 (44%), Gaps = 13/258 (5%)
Query: 19 GRLLGQGAFAKVYYARSIRTNQS---VAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN 75
++G+G F VY+ + + AVK +++ I +G Q E +M+ HPN
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 76 IVQLYEV-MATKSKIFFVMEYAKGGEL--FNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
++ L + + ++ V+ Y K G+L F + + Q+ + F S+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTT--CGTPAYVAPEVINRK 190
HRD+ N +LDE +K++DFGL+ K D + + T ++A E + +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL-QT 208
Query: 191 GYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE-FKCPNWFPPEVRKLLC 248
K D+WS GV+L+ L+ G P+ D N ++ + + P + P + +++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268
Query: 249 KILDPNPSTRISMAKIRE 266
K P R S +++
Sbjct: 269 KCWHPKAEMRPSFSELVS 286
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-58
Identities = 71/290 (24%), Positives = 125/290 (43%), Gaps = 34/290 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+KYE +G+G + V+ A++ T++ VA+K + D G+ REI +++ ++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60
Query: 74 PNIVQLYEVMATKSKIFFVMEYAKGGEL-FNKVAKGKLKEDAARRYFQQLINAVDFCHSR 132
NIV+L++V+ + K+ V E+ + G L + + + QL+ + FCHSR
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 133 GVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGY 192
V HRD+KP+NLL++ N LK+++FGL+ T Y P+V+
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLA--RAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 193 DGEKVDIWSCGVVLFVLLAGYLP-FHDSNLIEMYRKIGKAEF------------------ 233
+D+WS G + L P F +++ + ++I +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 234 -----------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272
R LL +L NP RIS + + +F
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-58
Identities = 63/281 (22%), Positives = 108/281 (38%), Gaps = 31/281 (11%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
+ G+ LG GAF KV A + +VAVK++ + + + E+ V+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVL 80
Query: 69 -RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK-------------------G 108
+ H NIV L + EY G+L N + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 109 KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168
L + + Q+ + F S+ HRD+ N+LL KI DFGL+ +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRK 227
+ ++APE I + D+WS G+ L+ L + G P+ + + K
Sbjct: 201 YVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 228 IGKAEFK--CPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ K F+ P P E+ ++ D +P R + +I +
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-57
Identities = 60/280 (21%), Positives = 118/280 (42%), Gaps = 30/280 (10%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQS-------VAVKVIDKDKIMRVGLADQIKREIS 66
++ +G+ LG+GAF +V A +I ++ VAVK++ D + + E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70
Query: 67 VM-RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFN-----------------KVAKG 108
+M I +H NI+ L ++ ++EYA G L +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 109 KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168
+L Q+ +++ S+ HRD+ N+L+ E+ +KI+DFGL+
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRK 227
++APE + + Y + D+WS GV+L+ + G P+ + E+++
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 228 IGKAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
+ + P+ E+ ++ PS R + ++ E
Sbjct: 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 190 bits (482), Expect = 2e-57
Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 28/288 (9%)
Query: 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRI 70
V+ Y+VGR +G+G+F ++ ++ NQ VA+K + A Q++ E ++
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKL 56
Query: 71 VRH-PNIVQLYEVMATKSKIFFVMEYA-KGGELFNKVAKGKLKEDAARRYFQQLINAVDF 128
+ I +Y V++ E + K +Q++ V
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 129 CHSRGVYHRDIKPENLLLDE-----NENLKISDFGLSALAQCKHQDGLLH-----TTCGT 178
H + + +RDIKP+N L+ + + DFG+ + + GT
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 179 PAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF---HDSNLIEMYRKIGKAEFKC 235
Y++ + + D+ + G V L G LP+ + + Y +IG+ +
Sbjct: 177 ARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 236 PNW-----FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQKQ 278
P FP E K + + ++ F K + +
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLERLN 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 191 bits (485), Expect = 2e-57
Identities = 68/300 (22%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVR 72
+ Y++ R LG+G +++V+ A +I N+ V VK++ K +IKREI ++ +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRG 88
Query: 73 HPNIVQLYEVMATKSK--IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCH 130
PNI+ L +++ V E+ + L + R Y +++ A+D+CH
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCH 146
Query: 131 SRGVYHRDIKPENLLLD-ENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINR 189
S G+ HRD+KP N+++D E+ L++ D+G LA+ H + + + PE++
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 190 KGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN--------------LIEMYRKIGKAEFKC 235
+D+WS G +L ++ PF + ++Y I K +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 236 PNWFP------------------------PEVRKLLCKILDPNPSTRISMAKIRESSWFR 271
F PE L K+L + +R++ + E +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-57
Identities = 52/262 (19%), Positives = 106/262 (40%), Gaps = 12/262 (4%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQS----VAVKVIDKDKIMRVGLADQIKREISVMR 69
+++G G F +VY ++ VA+K + + E +M
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMG 64
Query: 70 IVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVD 127
H NI++L V++ + + EY + G L + + G+ + + +
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 128 FCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHT-TCGTPAYVAPEV 186
+ + HRD+ N+L++ N K+SDFGLS + + + + + APE
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 187 INRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVR 244
I+ + + D+WS G+V++ ++ G P+ + + E+ + I P P +
Sbjct: 185 ISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243
Query: 245 KLLCKILDPNPSTRISMAKIRE 266
+L+ + + R A I
Sbjct: 244 QLMMQCWQQERARRPKFADIVS 265
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (471), Expect = 1e-55
Identities = 56/285 (19%), Positives = 101/285 (35%), Gaps = 27/285 (9%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
+ +Y +GR +G G+F +Y I + VA+K+ Q+ E + +++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMM 59
Query: 72 RHPN-IVQLYEVMATKSKIFFVMEYAKGGELF-NKVAKGKLKEDAARRYFQQLINAVDFC 129
+ I + A VME K Q+I+ +++
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 130 HSRGVYHRDIKPENLL---LDENENLKISDFGLS-----ALAQCKHQDGLLHTTCGTPAY 181
HS+ HRD+KP+N L + + I DFGL+ A GT Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 182 VAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF---HDSNLIEMYRKIGKAEFKCP-- 236
+ + D+ S G VL G LP+ + + Y +I + + P
Sbjct: 180 ASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 237 ---NWFPPEVRKLLCKILDPNPSTRISMAKIRE---SSWFRKGMN 275
+P E L + + +R+ + + R+G +
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-54
Identities = 57/272 (20%), Positives = 106/272 (38%), Gaps = 21/272 (7%)
Query: 14 EKYEVGRLLGQGAFAKVYYAR-----SIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
EK + R LGQG+F VY VA+K +++ MR + E SVM
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVM 77
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELF-----------NKVAKGKLKEDAARR 117
+ ++V+L V++ +ME G+L N +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 118 YFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCG 177
++ + + + ++ HRD+ N ++ E+ +KI DFG++
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 178 TPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG-YLPFHDSNLIEMYRKIGKAE-FKC 235
+++PE + + D+WS GVVL+ + P+ + ++ R + +
Sbjct: 198 PVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 236 PNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267
P+ P + +L+ NP R S +I S
Sbjct: 257 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 6e-53
Identities = 54/294 (18%), Positives = 116/294 (39%), Gaps = 47/294 (15%)
Query: 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH 73
+ +G+G F +V+ + + VAVK+ + + EI ++RH
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSW----FREAEIYQTVMLRH 56
Query: 74 PNIVQLYEVM----ATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFC 129
NI+ T ++++ V +Y + G LF+ + + + + + + +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 130 HS--------RGVYHRDIKPENLLLDENENLKISDFGLSALAQC--KHQDGLLHTTCGTP 179
H + HRD+K +N+L+ +N I+D GL+ D + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 180 AYVAPEVIN-----RKGYDGEKVDIWSCGVVLFVLLAGYLPFH---------------DS 219
Y+APEV++ + ++ DI++ G+V + + D
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 220 NLIEMYRKI--GKAEFKCPNWF-----PPEVRKLLCKILDPNPSTRISMAKIRE 266
++ EM + + K PN + + K++ + N + R++ +I++
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-52
Identities = 63/279 (22%), Positives = 116/279 (41%), Gaps = 28/279 (10%)
Query: 14 EKYEVGRLLGQGAFAKVYYARS-----IRTNQSVAVKVIDKDKIMRVGLADQIKREISVM 68
++ ++G+ LG+GAF +V A + T ++VAVK++ + + ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILI 71
Query: 69 RIVRHPNIVQLYEVMA-TKSKIFFVMEYAKGGELF-----------------NKVAKGKL 110
I H N+V L + ++E+ K G L + K L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 111 KEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170
+ Y Q+ ++F SR HRD+ N+LL E +KI DFGL+
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGY-LPFHDSNLIEMYRKIG 229
++APE I + Y + D+WS GV+L+ + + P+ + E + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 230 KA--EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266
K + P++ PE+ + + PS R + +++ E
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 9e-51
Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 55/309 (17%)
Query: 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV 71
+ ++Y+ + +G GA V A +++VA+K + + + A + RE+ +M+ V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCV 73
Query: 72 RHPNIVQLYEVMATKSK------IFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINA 125
H NI+ L V + ++ VME +V + +L + Q++
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSYLLYQMLCG 131
Query: 126 VDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPE 185
+ HS G+ HRD+KP N+++ + LKI DFGL A+ ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPE 188
Query: 186 VINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWF------ 239
VI GY E VDIWS G ++ ++ + F + I+ + K+ + F
Sbjct: 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 240 ------------------------------------PPEVRKLLCKILDPNPSTRISMAK 263
+ R LL K+L +P+ RIS+
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 264 IRESSWFRK 272
+ +
Sbjct: 308 ALQHPYINV 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 1e-40
Identities = 58/333 (17%), Positives = 118/333 (35%), Gaps = 72/333 (21%)
Query: 15 KYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP 74
+Y + R LG G F+ V+ A+ + N VA+K++ DK+ + + EI +++ V
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 69
Query: 75 NIVQL-------------YEVMATKSKIFFVMEYAKGG----ELFNKVAKGKLKEDAARR 117
+ + + + + VM + G L K + ++
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 118 YFQQLINAVDFC-HSRGVYHRDIKPENLLLDENE-NLKISDFGLSALAQCKHQDGLLHTT 175
+QL+ +D+ G+ H DIKPEN+L++ + + ++ L D +
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPF----------HDSNLIEMY 225
T Y +PEV+ + DIWS ++F L+ G F D ++ ++
Sbjct: 190 IQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 226 RKIGK--------------------------------------AEFKCPNWFPPEVRKLL 247
+G+ ++K E+ L
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 248 CKILDPNPSTRISMAKIRESSWFRKGMNQKQKQ 280
+L +P R + W + + ++ +
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 98.3 bits (244), Expect = 1e-24
Identities = 34/204 (16%), Positives = 64/204 (31%), Gaps = 25/204 (12%)
Query: 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKD-------KIMRVGLADQIKREISVM 68
+G+L+G+G + V+ S VK K R
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 69 RIVRHPNIVQLYEVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDF 128
+ +L + K ++ A EL + +++ + ++ V
Sbjct: 61 ARNEFRALQKLQGLAVPK--VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 129 CHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVIN 188
+ RG+ H D+ N+L+ E + I DF S + +L I
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDV--------RNII 169
Query: 189 ---RKGYDGEKVDIWSCGVVLFVL 209
+ Y + DI S + +L
Sbjct: 170 TYFSRTY-RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 64.8 bits (158), Expect = 1e-13
Identities = 11/80 (13%), Positives = 35/80 (43%), Gaps = 1/80 (1%)
Query: 348 TSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQI-TPNFH 406
TS S ++ ++ ++ + +++ LL + +V + E+ ++ + +
Sbjct: 16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLN 75
Query: 407 LVEMKKSNGDTLEYKKLLKD 426
V K+ +G ++ +K +
Sbjct: 76 GVRFKRISGTSIAFKNIASK 95
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 479 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.48 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.56 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.44 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.96 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.95 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.95 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.57 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.8 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.94 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-64 Score=484.37 Aligned_cols=256 Identities=38% Similarity=0.733 Sum_probs=237.9
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++++.||+|+||+||+|+++.+|+.||||++.+....+......+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 36799999999999999999999999999999999877665556678899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 93 MEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.... ...
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----CCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----CCc
Confidence 999999999999976 689999999999999999999999999999999999999999999999999986543 233
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhc
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKIL 251 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 251 (479)
....+||+.|+|||++.+.+|+ .++|||||||+||+|++|+.||.+.+..+.+..+.+..+..|..+|+++.+||.+||
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 4567899999999999998885 899999999999999999999999999999999999989999999999999999999
Q ss_pred cCCccccCChhhhhcChhhhcc
Q 011694 252 DPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 252 ~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
++||.+|||++|+++||||...
T Consensus 240 ~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 240 KHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp CSSGGGSCCHHHHHTCHHHHHH
T ss_pred cCCHhHCcCHHHHHcCcCcCCc
Confidence 9999999999999999999653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-63 Score=484.94 Aligned_cols=261 Identities=38% Similarity=0.693 Sum_probs=225.6
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
+.++|++++.||+|+||+||+|+++.+|+.||||++++.... +..+.+.+|+.+++.++|||||++++++.+++.+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 357899999999999999999999999999999999876432 234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||||+||+|++++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999999976 579999999999999999999999999999999999999999999999999998765544445
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH-HHHHHhccCcCC--CCCCCCHHHHHHH
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI-EMYRKIGKAEFK--CPNWFPPEVRKLL 247 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~--~~~~~~~~~~~li 247 (479)
...+.+||+.|+|||++.+.++++.++|||||||+||+|++|++||...+.. ..+..+...... .+..+|+++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 5667899999999999999888778899999999999999999999765432 333333333222 2345899999999
Q ss_pred HHhccCCccccCChhhhhcChhhhccc
Q 011694 248 CKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+||+.||.+|||++|+++||||++..
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 999999999999999999999997654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-63 Score=485.89 Aligned_cols=262 Identities=31% Similarity=0.638 Sum_probs=235.0
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
+..-++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.++++++|||||++++++.+++.+
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 34457899999999999999999999999999999999876655555668899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|+|||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|........
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999999998876 7899999999999999999999999999999999999999999999999999987654444
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLC 248 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 248 (479)
.....+.+||+.|+|||++.+..|+ .++|||||||+||+|++|..||.+.+....+.++....+.+|..+|+++.+||.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 242 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE 242 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 4455677899999999999988885 899999999999999999999999999999999988888899999999999999
Q ss_pred HhccCCccccCChhh------hhcChhhhc
Q 011694 249 KILDPNPSTRISMAK------IRESSWFRK 272 (479)
Q Consensus 249 ~~L~~dP~~Rpt~~e------il~h~wf~~ 272 (479)
+||++||.+|||++| |++||||+.
T Consensus 243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp TTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 999999999999998 478888865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-62 Score=479.20 Aligned_cols=255 Identities=31% Similarity=0.510 Sum_probs=228.2
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 45899999999999999999999999999999999865433 246789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 93 MEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||||+||+|.+++..+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..... ....
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKR 173 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCCB
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc--cccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999754322 2334
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---cCCCCCCCCHHHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA---EFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~~ 249 (479)
...+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.+.+.......+... .+..|..+|+++.+||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 567899999999999988886 8999999999999999999999988766555544332 345567799999999999
Q ss_pred hccCCccccCChhhhhcChhhhcc
Q 011694 250 ILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
||++||.+|||++|+++||||+..
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-61 Score=481.07 Aligned_cols=259 Identities=34% Similarity=0.617 Sum_probs=239.1
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
-.++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 34689999999999999999999999999999999988765555566888999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 92 VMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
|||||+||+|++++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.... ...
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~~ 160 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTC
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CCc
Confidence 9999999999999987 6899999999999999999999999999999999999999999999999999975432 223
Q ss_pred CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHh
Q 011694 171 LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKI 250 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 250 (479)
...+.||||.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+...++..+......+|..+|+++.+||++|
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhh
Confidence 44568999999999999999985 89999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCC-----hhhhhcChhhhcc
Q 011694 251 LDPNPSTRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 251 L~~dP~~Rpt-----~~eil~h~wf~~~ 273 (479)
|++||.+|++ +++|++||||+..
T Consensus 240 L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ccCCchhhcccccccHHHHHcCcccccC
Confidence 9999999995 8999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-61 Score=474.40 Aligned_cols=258 Identities=35% Similarity=0.689 Sum_probs=214.6
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
.+-+.+.|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++|||||++++++.+++.
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4457888999999999999999999999999999999998765432 23567899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe---cCCCeEEeecCchhhhh
Q 011694 89 IFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD---ENENLKISDFGLSALAQ 164 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~---~~g~vkl~DFGla~~~~ 164 (479)
+|+|||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||+. .+|.+||+|||+|....
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999999999976 5899999999999999999999999999999999999995 57899999999997543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----CCCC
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFP 240 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~ 240 (479)
. .....+.+||+.|+|||++.+.+|+ .++|||||||+||+|++|..||.+.+.......+.......+ +.+|
T Consensus 162 ~---~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 162 P---GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp --------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred C---CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence 2 2334567899999999999988886 899999999999999999999999888888888876654433 4689
Q ss_pred HHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
+++.+||.+||++||.+|||++|+++||||+.
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999999999964
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=468.48 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=225.1
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.+.|++++.||+|+||+||+|+++.+|+.||||++++... ...+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 4579999999999999999999999999999999976532 2346778999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCC
Q 011694 93 MEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDG 170 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~ 170 (479)
||||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|....... .
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~ 165 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 165 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--c
Confidence 999999999998764 469999999999999999999999999999999999999999999999999986543221 1
Q ss_pred CccccCCCCcccChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc---CCCCCCCCHH
Q 011694 171 LLHTTCGTPAYVAPEVIN-----RKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE---FKCPNWFPPE 242 (479)
Q Consensus 171 ~~~~~~gt~~y~aPEvl~-----~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~ 242 (479)
...+.+||+.|+|||++. +.+| +.++|||||||+||+|++|..||.+.+..+.+..+.... ...|..+|++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 234578999999999984 3345 489999999999999999999999988777777766553 3445668999
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
+.+||.+||++||.+|||++|+++||||+....
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~ 277 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999999999999999999999999975543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-60 Score=472.18 Aligned_cols=254 Identities=35% Similarity=0.721 Sum_probs=236.0
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+++.++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999999999999999998765555556688999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|||+||+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.... ...
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~-----~~~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVT 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----SCB
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec-----ccc
Confidence 99999999999887 579999999999999999999999999999999999999999999999999997543 234
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhcc
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKILD 252 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 252 (479)
.+.+||+.|+|||++.+.+|+ .++|||||||+||+|++|..||.+.+..+.+.++.......|+.+|+++.++|.+||.
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 237 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 237 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 567999999999999988886 8999999999999999999999999999999999888889999999999999999999
Q ss_pred CCccccC-----ChhhhhcChhhhcc
Q 011694 253 PNPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 253 ~dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
+||.+|+ |+++|++||||+..
T Consensus 238 ~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 238 RDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred hCHHhccccchhhHHHHHcCcccccC
Confidence 9999996 89999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-60 Score=462.42 Aligned_cols=254 Identities=32% Similarity=0.583 Sum_probs=216.1
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT--KSKIF 90 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 90 (479)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.....+ ...+.+.+|+.+++.++|||||++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 368999999999999999999999999999999998765543 445778999999999999999999999864 46689
Q ss_pred EEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeccCCCCCEEEecCCCeEEeecCch
Q 011694 91 FVMEYAKGGELFNKVAK-----GKLKEDAARRYFQQLINAVDFCHSRG-----VYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~qll~aL~~LH~~g-----ivHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
+|||||+||+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998863 46999999999999999999999976 999999999999999999999999999
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC-CCCCCC
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF-KCPNWF 239 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~ 239 (479)
...... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+....+..... ..|..+
T Consensus 162 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 162 RILNHD--TSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eecccC--CCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 875432 2234567899999999999888886 899999999999999999999999888888888876654 466779
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcChhh
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWF 270 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf 270 (479)
|+++.+||.+||++||.+|||++||++|||.
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=462.23 Aligned_cols=258 Identities=29% Similarity=0.568 Sum_probs=231.6
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRV---GLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 467899999999999999999999999999999999987544321 24578999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC----CeEEeecCchhh
Q 011694 88 KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE----NLKISDFGLSAL 162 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g----~vkl~DFGla~~ 162 (479)
.+|||||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999999976 6899999999999999999999999999999999999998776 599999999876
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----CC
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NW 238 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~ 238 (479)
... .....+.+||+.|+|||++.+..|+ .++|||||||+||+|++|..||.+.+..+.+..+.......+ +.
T Consensus 167 ~~~---~~~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 167 IDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp CTT---SCBCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred cCC---CccccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence 532 2334567899999999999887775 899999999999999999999999998888888877665544 56
Q ss_pred CCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 239 FPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
+|+++.+||++||++||.+|||++|+++||||+.
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 8999999999999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-59 Score=464.81 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=225.2
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
+.|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999999999999999998876655556678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|||.||+|..++.. +++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.... ..
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PA 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------SB
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC------CC
Confidence 99999999876654 679999999999999999999999999999999999999999999999999987532 23
Q ss_pred cccCCCCcccChhhhhcC---CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC--CCCCCCHHHHHHH
Q 011694 173 HTTCGTPAYVAPEVINRK---GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK--CPNWFPPEVRKLL 247 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~---~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li 247 (479)
...+||+.|+|||++.+. .|+ .++|||||||++|+|++|..||.+.+.......+.....+ .+..+|+++.+||
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~-~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcC-chhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 456899999999999643 354 7999999999999999999999988877766666554332 3445899999999
Q ss_pred HHhccCCccccCChhhhhcChhhhccc
Q 011694 248 CKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.+||++||.+|||++|+++||||.+..
T Consensus 248 ~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 248 DSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 999999999999999999999997654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-60 Score=471.45 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=219.2
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
++..++|++++.||+|+||+||+|+++.+|+.||+|++++.. .......+.+|+.+|+.++|||||++++++.+++.+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 466789999999999999999999999999999999997653 234567889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
|+|||||+||+|.+++.+ +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|......
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 999999999999999975 689999999999999999999997 59999999999999999999999999999865432
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHH--------------------
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRK-------------------- 227 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~-------------------- 227 (479)
...+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+.......
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ---ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 23467999999999999998886 899999999999999999999976543221100
Q ss_pred ----------------------hccC-cCCCC-CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 228 ----------------------IGKA-EFKCP-NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 228 ----------------------i~~~-~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+... ....| ..+|+++.+||.+||..||.+|||++|+++||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000 00111 1257899999999999999999999999999999754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-59 Score=454.27 Aligned_cols=255 Identities=24% Similarity=0.492 Sum_probs=220.3
Q ss_pred CccCCCe-EEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe---
Q 011694 10 SVLTEKY-EVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT--- 85 (479)
Q Consensus 10 ~il~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~--- 85 (479)
...+++| ++.+.||+|+||+||+|++..+++.||+|++....... ...+.+.+|+.+|+.++|||||++++++.+
T Consensus 4 ~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred cCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence 3456677 78889999999999999999999999999998765443 345778999999999999999999999875
Q ss_pred -CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCCEEEe-cCCCeEEeecCch
Q 011694 86 -KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRG--VYHRDIKPENLLLD-ENENLKISDFGLS 160 (479)
Q Consensus 86 -~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~g--ivHrDLkp~NILl~-~~g~vkl~DFGla 160 (479)
...+|+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred cCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 4568999999999999999976 68999999999999999999999999 99999999999996 5789999999999
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh-HHHHHHHhccCcC--CCCC
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN-LIEMYRKIGKAEF--KCPN 237 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~--~~~~ 237 (479)
+... .....+.+|||.|+|||++.+ .|+ .++|||||||++|+|++|..||.+.. ....+..+..+.. ..+.
T Consensus 163 ~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 236 (270)
T d1t4ha_ 163 TLKR----ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236 (270)
T ss_dssp GGCC----TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred eecc----CCccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCc
Confidence 7532 233456789999999999975 465 89999999999999999999997654 4556666654432 3345
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcChhhh
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
.+++++.+||.+||++||++|||++|+++||||+
T Consensus 237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 5789999999999999999999999999999995
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-59 Score=472.76 Aligned_cols=255 Identities=30% Similarity=0.560 Sum_probs=228.7
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (479)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999976542 234678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe--cCCCeEEeecCchhhhhccc
Q 011694 92 VMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD--ENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~--~~g~vkl~DFGla~~~~~~~ 167 (479)
|||||+||+|++++.. +++++..++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||+|+...
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~--- 177 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 177 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC---
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc---
Confidence 9999999999999954 5799999999999999999999999999999999999996 46789999999987543
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----CCCCHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWFPPEV 243 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~ 243 (479)
......+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.+.+..+.+..+.......+ +.+|+++
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred cccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 22334567899999999999998886 899999999999999999999999988888888876655444 3589999
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.+||.+||.+||.+|||++|+++||||+..
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-59 Score=472.41 Aligned_cols=258 Identities=27% Similarity=0.543 Sum_probs=230.5
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.+. +.++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+|+.+|+.++|||||++++++.+++
T Consensus 24 ~~~-~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 24 QGS-VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp CSC-GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred CCC-cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 344 346899999999999999999999999999999999875432 2467889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe--cCCCeEEeecCchhhh
Q 011694 88 KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD--ENENLKISDFGLSALA 163 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~--~~g~vkl~DFGla~~~ 163 (479)
.+|||||||+||+|++.+.. .++++.+++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||+|...
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 99999999999999998865 3699999999999999999999999999999999999998 5789999999999765
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC----CCC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP----NWF 239 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 239 (479)
. ......+.+||+.|+|||++.+.+|+ .++|||||||+||+|++|..||.+.+....+..+.......| +.+
T Consensus 180 ~---~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 255 (352)
T d1koba_ 180 N---PDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255 (352)
T ss_dssp C---TTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTS
T ss_pred C---CCCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 3 23345677899999999999988886 899999999999999999999999988888888876655444 468
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
|+++.+||.+||++||.+|||++|+++||||+..
T Consensus 256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999999754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-59 Score=472.81 Aligned_cols=255 Identities=31% Similarity=0.661 Sum_probs=236.8
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
.++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|+.++|||||++++++.+...+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47899999999999999999999999999999999876655555667889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 93 MEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|||+.||+|...+.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+... ..
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~-----~~ 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GR 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-----SC
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc-----cc
Confidence 999999999999876 689999999999999999999999999999999999999999999999999997543 22
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhc
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKIL 251 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 251 (479)
..+.+||+.|+|||++.+.+|+ .++|||||||+||+|++|..||.+.+....+..+.......|..+|+++.+||++||
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHS
T ss_pred cccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHh
Confidence 3467899999999999998886 899999999999999999999999999999999988888999999999999999999
Q ss_pred cCCccccC-----ChhhhhcChhhhcc
Q 011694 252 DPNPSTRI-----SMAKIRESSWFRKG 273 (479)
Q Consensus 252 ~~dP~~Rp-----t~~eil~h~wf~~~ 273 (479)
.+||.+|+ |+++|++||||+..
T Consensus 274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred hhCHHhccccccccHHHHHcCccccCC
Confidence 99999995 99999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-59 Score=463.68 Aligned_cols=257 Identities=34% Similarity=0.625 Sum_probs=232.3
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceeEEEEEeCCEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVM-RIVRHPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lV 92 (479)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++ +.++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999999999999999999876544444455666677665 478999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 93 MEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 93 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||||+||+|.+++.. +++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|...... ...
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--ccc
Confidence 999999999999976 68999999999999999999999999999999999999999999999999999754322 233
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHHHHHHHHhc
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEVRKLLCKIL 251 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 251 (479)
....+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+...++..+....+..|..+|+++.+||++||
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L 238 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 238 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHS
T ss_pred ccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhc
Confidence 4567899999999999998886 899999999999999999999999999999999988888999999999999999999
Q ss_pred cCCccccCChh-hhhcChhhhcc
Q 011694 252 DPNPSTRISMA-KIRESSWFRKG 273 (479)
Q Consensus 252 ~~dP~~Rpt~~-eil~h~wf~~~ 273 (479)
++||.+|||+. ++++||||+.-
T Consensus 239 ~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 239 VREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp CSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ccCCCCCcCHHHHHHhCchhccC
Confidence 99999999995 89999999763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-58 Score=449.96 Aligned_cols=259 Identities=32% Similarity=0.561 Sum_probs=228.2
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc------hhhHHHHHHHHHHHHhCC-CCCcceeEEEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR------VGLADQIKREISVMRIVR-HPNIVQLYEVMA 84 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~------~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~ 84 (479)
+.++|++++.||+|+||+||+|++..+|+.||||++++..... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 4589999999999999999999999999999999998764332 223457889999999997 999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
+++.+|||||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999975 78999999999999999999999999999999999999999999999999999765
Q ss_pred hccccCCCccccCCCCcccChhhhhcC-----CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCC--
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRK-----GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCP-- 236 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~-----~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-- 236 (479)
.. .......+||+.|+|||++.+. ...+.++||||+||+||+|++|..||.+.+.......+.......+
T Consensus 161 ~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 161 DP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp CT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 32 2234567899999999999642 2235799999999999999999999999988888877766654433
Q ss_pred --CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 237 --NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 237 --~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..+|+++.+||.+||++||.+|||++||++||||++.
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 2589999999999999999999999999999999753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-58 Score=458.89 Aligned_cols=255 Identities=25% Similarity=0.473 Sum_probs=229.5
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIF 90 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (479)
-+.++|++++.||+|+||+||+|.++.+|+.||||++++.... ...+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 3678999999999999999999999999999999999775422 356789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecC--CCeEEeecCchhhhhcc
Q 011694 91 FVMEYAKGGELFNKVAK-G-KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDEN--ENLKISDFGLSALAQCK 166 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~--g~vkl~DFGla~~~~~~ 166 (479)
+|||||+||+|++++.. + ++++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~-- 155 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-- 155 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc--
Confidence 99999999999999976 3 69999999999999999999999999999999999999854 489999999987543
Q ss_pred ccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCC----CCCHH
Q 011694 167 HQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN----WFPPE 242 (479)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~ 242 (479)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+....+.++. .+|++
T Consensus 156 -~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 156 -PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -cCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 22334567899999999999888775 8999999999999999999999999998899888877766553 58999
Q ss_pred HHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+.+||.+||.+||.+|||++|+++||||++.
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999999754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-58 Score=466.07 Aligned_cols=257 Identities=31% Similarity=0.487 Sum_probs=223.0
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHH---HHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIK---REISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~---~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+. +|+.+++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 35799999999999999999999999999999999875543333333333 446777788899999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~ 168 (479)
|+|||||+||+|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--- 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--- 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS---
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC---
Confidence 999999999999999976 6899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh---HHHHHHHhccCcCCCCCCCCHHHHH
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKIGKAEFKCPNWFPPEVRK 245 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (479)
......+||+.|+|||++.+....+.++|||||||+||+|++|..||.+.+ .......+.......|..+|+++.+
T Consensus 160 -~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 160 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp -SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred -CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 234567899999999999755444589999999999999999999998654 3345556666677788889999999
Q ss_pred HHHHhccCCccccCC-----hhhhhcChhhhcc
Q 011694 246 LLCKILDPNPSTRIS-----MAKIRESSWFRKG 273 (479)
Q Consensus 246 li~~~L~~dP~~Rpt-----~~eil~h~wf~~~ 273 (479)
||.+||++||.+||| +++|++||||+..
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 999999999999999 6999999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=450.22 Aligned_cols=255 Identities=31% Similarity=0.589 Sum_probs=223.2
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchh---hHHHHHHHHHHHHhCC--CCCcceeEEEEEeC
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVG---LADQIKREISVMRIVR--HPNIVQLYEVMATK 86 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~---~~~~l~~Ei~il~~l~--hpnIv~l~~~~~~~ 86 (479)
+.++|++++.||+|+||+||+|++..+|+.||||++.+....... ...++.+|+.+++.++ |||||++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 578999999999999999999999999999999999875443211 1234668999999986 89999999999999
Q ss_pred CEEEEEEeccCC-CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-CCCeEEeecCchhhh
Q 011694 87 SKIFFVMEYAKG-GELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-NENLKISDFGLSALA 163 (479)
Q Consensus 87 ~~~~lV~E~~~g-g~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-~g~vkl~DFGla~~~ 163 (479)
+.+|+||||+.+ +++.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|...
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999986 578888765 68999999999999999999999999999999999999985 478999999999754
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCCCCCHHH
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPNWFPPEV 243 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (479)
. .....+.+||+.|+|||++.+..+++.++|||||||++|+|++|..||...+ .+.......++.+|+++
T Consensus 162 ~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~ 231 (273)
T d1xwsa_ 162 K----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231 (273)
T ss_dssp C----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHH
T ss_pred c----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHH
Confidence 2 2334567899999999999988887788999999999999999999998754 24455677888899999
Q ss_pred HHHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 244 RKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 244 ~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
.+||.+||.+||.+|||++|+++||||++...+
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p 264 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence 999999999999999999999999999876543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=440.39 Aligned_cols=257 Identities=29% Similarity=0.449 Sum_probs=215.8
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++++.||+|+||+||+|.+..+|+.||||++...... ....+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 6899999999999999999999999999999999765432 234578889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+.++.+...... +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|...... ...
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~~ 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 158 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--SBC
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC--ccc
Confidence 99987544333332 46999999999999999999999999999999999999999999999999999765432 233
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC------------------cC
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------------------EF 233 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~ 233 (479)
....+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+.......+... ..
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 456689999999999988888789999999999999999999999987765544443210 00
Q ss_pred CC-----------CCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 234 KC-----------PNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 234 ~~-----------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.. .+.+++++.+||++||.+||.+|||++|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 01 12357899999999999999999999999999999754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-56 Score=437.25 Aligned_cols=263 Identities=27% Similarity=0.463 Sum_probs=220.6
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
+++.+.++|++.+.||+|+||+||+|++..+|+.||||++.+....+......+.+|+.+++.++|||||++++++...+
T Consensus 1 tp~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred CCcCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 46778999999999999999999999999999999999998876666667788999999999999999999999997654
Q ss_pred ----EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 88 ----KIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 88 ----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
.+|+|||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred CCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence 48999999999999998876 6899999999999999999999999999999999999999999999999998764
Q ss_pred hhccc-cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC----CCC
Q 011694 163 AQCKH-QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK----CPN 237 (479)
Q Consensus 163 ~~~~~-~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~----~~~ 237 (479)
..... ......+.+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+..+....+...... .++
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 43222 22234567899999999999888876 8999999999999999999999998887776666544433 335
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhcChhhh
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFR 271 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~ 271 (479)
.+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 6899999999999999999999655555677764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-57 Score=445.62 Aligned_cols=254 Identities=28% Similarity=0.383 Sum_probs=212.3
Q ss_pred EeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 011694 18 VGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMR--VGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEY 95 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 95 (479)
.++.||+|+||+||+|+++.+|+.||||+++...... ......+.+|+.+++.++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999999999999999997654322 12335688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCccc
Q 011694 96 AKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHT 174 (479)
Q Consensus 96 ~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~ 174 (479)
+.|+++...... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... .....+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--cccccc
Confidence 999888777665 47999999999999999999999999999999999999999999999999999754332 233456
Q ss_pred cCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcC--------------------C
Q 011694 175 TCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEF--------------------K 234 (479)
Q Consensus 175 ~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--------------------~ 234 (479)
.+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+..+....+..... .
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 78999999999997665556899999999999999999999998877666655432100 0
Q ss_pred --------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 235 --------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 235 --------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..+.+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 012357899999999999999999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-57 Score=450.40 Aligned_cols=257 Identities=32% Similarity=0.612 Sum_probs=215.9
Q ss_pred CCCCCCCccCCCeEEee-eeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH-hCCCCCcceeEE
Q 011694 4 MDHNKPSVLTEKYEVGR-LLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMR-IVRHPNIVQLYE 81 (479)
Q Consensus 4 ~~~~~~~il~~~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~-~l~hpnIv~l~~ 81 (479)
|.-.+..+ .++|++.. .||+|+||+||+|++..+|+.||||++... ..+.+|+.++. ..+|||||++++
T Consensus 2 ~~~~~~~i-~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~ 72 (335)
T d2ozaa1 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVD 72 (335)
T ss_dssp CCCBCSCG-GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred ccCCCCCc-ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEE
Confidence 34444444 46798875 699999999999999999999999999653 45678998865 458999999999
Q ss_pred EEEe----CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec---CCC
Q 011694 82 VMAT----KSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE---NEN 151 (479)
Q Consensus 82 ~~~~----~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~---~g~ 151 (479)
+|.+ .+.+|+|||||+||+|++++.. .++++.+++.|+.||+.||+|||++||+||||||+|||++. ++.
T Consensus 73 ~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCC
T ss_pred EEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccc
Confidence 9976 4679999999999999999976 26999999999999999999999999999999999999975 567
Q ss_pred eEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHH----HHHH
Q 011694 152 LKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIE----MYRK 227 (479)
Q Consensus 152 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~----~~~~ 227 (479)
+||+|||+|+.... .....+.+||+.|+|||++.+..|+ .++|||||||+||+|++|++||.+.+... +...
T Consensus 153 ~Kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~ 228 (335)
T d2ozaa1 153 LKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228 (335)
T ss_dssp EEECCCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------C
T ss_pred ccccccceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999975432 2344677899999999999988886 89999999999999999999998765433 3344
Q ss_pred hccCcCCCCC----CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 228 IGKAEFKCPN----WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 228 i~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
+....+.+|. .+|+++.+||++||++||.+|||++|+++||||.+.
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 4455555553 378999999999999999999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-55 Score=431.15 Aligned_cols=255 Identities=29% Similarity=0.452 Sum_probs=216.7
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++++.||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.+|+.++|||||++++++.+.+..|++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 68999999999999999999985 8899999999776543 344578899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
||+.++.+...... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....... ...
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 157 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKY 157 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc--ccc
Confidence 99998888777764 679999999999999999999999999999999999999999999999999997654322 223
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCc--------------------
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAE-------------------- 232 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------- 232 (479)
....|++.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+......++....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 455799999999999887777799999999999999999999999877665544432100
Q ss_pred ---------CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhc
Q 011694 233 ---------FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRK 272 (479)
Q Consensus 233 ---------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~ 272 (479)
...+..+++++.+||++||++||.+|||++|+++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0123346789999999999999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=433.12 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=209.7
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
.+++-.++|++++.||+|+||+||+|+.. ..||||+++...... ...+.+.+|+.++++++|||||++++++. .+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 57788899999999999999999999753 359999997654433 45678899999999999999999999865 45
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.+|+|||||+||+|.+++.. +++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 68999999999999999964 4699999999999999999999999999999999999999999999999999976654
Q ss_pred cccCCCccccCCCCcccChhhhhcC---CCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHH-HHhccCc-----CCCC
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRK---GYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMY-RKIGKAE-----FKCP 236 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~---~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~-~~i~~~~-----~~~~ 236 (479)
........+.+||+.|+|||++.+. .| +.++||||+||+||+|++|+.||.+.+..... ..+..+. ...+
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCC-CchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 4444445667899999999999643 34 47999999999999999999999876544333 3332221 1345
Q ss_pred CCCCHHHHHHHHHhccCCccccCChhhhhcCh
Q 011694 237 NWFPPEVRKLLCKILDPNPSTRISMAKIRESS 268 (479)
Q Consensus 237 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~ 268 (479)
..+|+++.+||.+||+.||.+|||+++|+++-
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 66899999999999999999999999999873
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=427.19 Aligned_cols=261 Identities=24% Similarity=0.402 Sum_probs=224.6
Q ss_pred CCCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 011694 3 GMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEV 82 (479)
Q Consensus 3 ~~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~ 82 (479)
|+-++.+++-.++|++++.||+|+||+||+|.++ +++.||||+++..... .+.+.+|+.++++++|||||+++++
T Consensus 2 p~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp CTTTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEee
Confidence 4456788899999999999999999999999985 6788999999765432 3678999999999999999999998
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 83 MATKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
+.+ +.+|+|||||++|+|.+++.. .++++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 77 ~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence 754 567999999999999997764 3699999999999999999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCChHHHHHHHhccC-cCCCCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG-YLPFHDSNLIEMYRKIGKA-EFKCPN 237 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~-~~~~~~ 237 (479)
|+...... ........||+.|+|||++.+..|+ .++||||+||++|+|+|| .+||...+..+....+..+ ....|.
T Consensus 156 a~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~ 233 (272)
T d1qpca_ 156 ARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233 (272)
T ss_dssp CEECSSSC-EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred eEEccCCc-cccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcc
Confidence 97654321 1223456799999999999887775 899999999999999995 5666777776777776554 456778
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhc--Chhhh
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRE--SSWFR 271 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~--h~wf~ 271 (479)
.+|+++.+||.+||+.||.+|||+++|++ ++||.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 89999999999999999999999999998 78885
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-56 Score=441.65 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=217.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQ-----SVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~ 81 (479)
++++-.++|++++.||+|+||+||+|++..+++ .||+|.+...... .....+.+|+.+++++ +|||||++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 345666899999999999999999999876554 6999998654322 2346788999999988 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAKG------------------------KLKEDAARRYFQQLINAVDFCHSRGVYHR 137 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~~------------------------~l~e~~~~~i~~qll~aL~~LH~~givHr 137 (479)
++.+.+.+|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 999999999999999999999999642 38999999999999999999999999999
Q ss_pred cCCCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 011694 138 DIKPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPF 216 (479)
Q Consensus 138 DLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf 216 (479)
||||+|||++.++.+||+|||+|+............+.+||+.|+|||++.+..|+ .++||||+||+||+|++ |..||
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSS
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999865544333334466789999999999988886 89999999999999997 89999
Q ss_pred CCChHHHHHHHhccC--cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 217 HDSNLIEMYRKIGKA--EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 217 ~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.+.+....+.++... ....|..+|+++.+||.+||+.||.+|||++||++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 886655444444333 456678899999999999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-55 Score=431.97 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=221.1
Q ss_pred CCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 6 HNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 6 ~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
.+++++-.++|++.+.||+|+||+||+|++..+|+.||||++..+.. ..+.+.+|+.+|+.++|||||++++++.+
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 34677888999999999999999999999999999999999976543 24678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
++.+|+|||||++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999999999999865 4699999999999999999999999999999999999999999999999999976
Q ss_pred hhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC-CCCChHHHHHHHhccC-cCCCCCCCC
Q 011694 163 AQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLP-FHDSNLIEMYRKIGKA-EFKCPNWFP 240 (479)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~P-f~~~~~~~~~~~i~~~-~~~~~~~~~ 240 (479)
..... ........||+.|+|||++.+..|+ .++||||+||++|+|++|..| |.+.+....+..+..+ ....|..+|
T Consensus 165 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 242 (287)
T d1opja_ 165 MTGDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 242 (287)
T ss_dssp CCSSS-SEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred cCCCC-ceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccch
Confidence 53221 1122334589999999999988886 899999999999999996555 5555666666555443 456777899
Q ss_pred HHHHHHHHHhccCCccccCChhhhhc
Q 011694 241 PEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+++.+||.+||+.||.+|||+++|++
T Consensus 243 ~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 243 EKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999999965
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=432.82 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=213.2
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCC-CcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEEe--
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRT-NQSVAVKVIDKDKIMRVGLADQIKREISVMRIV---RHPNIVQLYEVMAT-- 85 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l---~hpnIv~l~~~~~~-- 85 (479)
..++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 357999999999999999999999766 6789999997654322 2223455788777765 79999999999853
Q ss_pred ---CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 86 ---KSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 86 ---~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
...+|++|||++++.+...... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3578999999999876544433 57999999999999999999999999999999999999999999999999998
Q ss_pred hhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---------
Q 011694 161 ALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--------- 231 (479)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------- 231 (479)
...... ....+.+||+.|+|||++.+.+|+ .++||||+||++|+|++|.+||.+.+..+....+...
T Consensus 164 ~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 164 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCGG---GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhccc---ccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 754322 234567899999999999998886 8999999999999999999999988776665554210
Q ss_pred ------------------cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 232 ------------------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 232 ------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
....+..+++.+.+||.+||++||.+|||++|+++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 001234578999999999999999999999999999999754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-55 Score=439.27 Aligned_cols=255 Identities=28% Similarity=0.410 Sum_probs=215.3
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS---- 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (479)
+.++|++++.||+|+||+||+|.++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 68999999999999999999999999999999999976543 3355678899999999999999999999997654
Q ss_pred --EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 --KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 --~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.+|+||||| |++|...+..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 6688888888899999999999999999999999999999999999999999999999999987542
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--------------
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-------------- 231 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 231 (479)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 173 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 23456789999999999988777679999999999999999999999887655443332110
Q ss_pred -----------------cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 232 -----------------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 232 -----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
.......+++++.+||++||..||.+|||++||++||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 011234578999999999999999999999999999999764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=423.73 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=219.4
Q ss_pred ccCCCeEEeee-eeecCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 011694 11 VLTEKYEVGRL-LGQGAFAKVYYARSIR--TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS 87 (479)
Q Consensus 11 il~~~y~i~~~-LG~G~fg~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (479)
+-.++|.+.+. ||+|+||+||+|.++. ++..||||+++... .....+.+.+|+.+|++++|||||++++++.++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 33467899885 9999999999998764 45579999997643 223457889999999999999999999998754
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 88 KIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.+|+|||||+||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 58999999999999998764 4799999999999999999999999999999999999999999999999999976543
Q ss_pred ccc-CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHH
Q 011694 166 KHQ-DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPE 242 (479)
Q Consensus 166 ~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 242 (479)
... .......+||+.|+|||++.+..|+ .++||||+||++|+|+| |..||.+.+..+....+..+ ....|+.+|++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~ 240 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 240 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 221 1223456799999999999888775 89999999999999998 99999988877777777654 45678889999
Q ss_pred HHHHHHHhccCCccccCChhhh---hcChhhh
Q 011694 243 VRKLLCKILDPNPSTRISMAKI---RESSWFR 271 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~ei---l~h~wf~ 271 (479)
+.+||.+||+.||.+|||+.+| |+|+|+.
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999888 5677763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=420.30 Aligned_cols=247 Identities=23% Similarity=0.406 Sum_probs=207.8
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++++.||+|+||+||+|++. +++.||||++...... .+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 68999999999999999999985 6778999999765432 357889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
|||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+....... ..
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 99999999999875 4689999999999999999999999999999999999999999999999999976543322 22
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~ 249 (479)
.....||+.|+|||++.+..|+ .++||||+||++|+|++ |.+||...+..+....+..+ ....|..+|+++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3346799999999999988886 89999999999999999 67777777777777776554 445677789999999999
Q ss_pred hccCCccccCChhhhhcC
Q 011694 250 ILDPNPSTRISMAKIRES 267 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h 267 (479)
||+.||.+|||+++|++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-54 Score=427.13 Aligned_cols=255 Identities=20% Similarity=0.353 Sum_probs=209.6
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQ---SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK 86 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (479)
++-.++|++.+.||+|+||+||+|+++.+++ .||||.+..... ....+.+.+|+.+|++++|||||++++++.++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4556789999999999999999999987765 588998865432 23456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 87 SKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
+.+|+|||||+||+|.+++.. +.+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999999999998876 469999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCC---ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCC
Q 011694 165 CKHQDGL---LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWF 239 (479)
Q Consensus 165 ~~~~~~~---~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 239 (479)
....... .....||+.|+|||++.+..|+ .++|||||||+||+|+| |..||.+.+..+....+..+ ..+.|..+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC 258 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 3322211 1224579999999999888776 89999999999999998 89999998887777777554 45667779
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
|+++.+||.+||+.||.+|||+.+|+++
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=432.53 Aligned_cols=263 Identities=26% Similarity=0.412 Sum_probs=215.9
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS---- 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (479)
+..+|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|+.++||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 3488999999999999999999999999999999997644 2344577889999999999999999999997653
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 88 KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
..+++++|+.||+|++++..+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred ceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 23444556678999999998999999999999999999999999999999999999999999999999999997544332
Q ss_pred -cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC---------------
Q 011694 168 -QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA--------------- 231 (479)
Q Consensus 168 -~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------- 231 (479)
........+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+...........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2233466789999999999976666668999999999999999999999877654333322110
Q ss_pred ----------cC------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccch
Q 011694 232 ----------EF------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMNQ 276 (479)
Q Consensus 232 ----------~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~~ 276 (479)
.. ...+.+++++.+||.+||+.||.+|||++|+++||||+.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 00 0123467899999999999999999999999999999865433
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-55 Score=424.25 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=209.2
Q ss_pred eeeeecCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 011694 20 RLLGQGAFAKVYYARSI--RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVMEYAK 97 (479)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 97 (479)
+.||+|+||+||+|.+. .+++.||||++..... +....+.+.+|+.+|++++|||||++++++.++ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 47999999999999865 4567899999976543 334567899999999999999999999999654 5789999999
Q ss_pred CCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcccc-CCCcccc
Q 011694 98 GGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQ-DGLLHTT 175 (479)
Q Consensus 98 gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~ 175 (479)
+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999987 5799999999999999999999999999999999999999999999999999975432211 1122345
Q ss_pred CCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHHhccC
Q 011694 176 CGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDP 253 (479)
Q Consensus 176 ~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~ 253 (479)
.||+.|+|||++.+..|+ .++||||+||++|+|++ |..||.+.+..+....+..+ ..+.|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 799999999999888775 89999999999999998 89999998887777777654 4567888999999999999999
Q ss_pred CccccCChhhhh---cChhh
Q 011694 254 NPSTRISMAKIR---ESSWF 270 (479)
Q Consensus 254 dP~~Rpt~~eil---~h~wf 270 (479)
||.+|||+++|+ +|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 999999999984 55554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=429.84 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=212.1
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-------
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT------- 85 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~------- 85 (479)
.++|+++++||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 489999999999999999999999999999999997764432 445678899999999999999999999855
Q ss_pred -CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 86 -KSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 86 -~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
++.+|+||||+.++.+...... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 4568999999988766555443 57999999999999999999999999999999999999999999999999999654
Q ss_pred hccc--cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCCCCC----
Q 011694 164 QCKH--QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFKCPN---- 237 (479)
Q Consensus 164 ~~~~--~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~---- 237 (479)
.... ......+.+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+.......++
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 4222 2233455689999999999987654468999999999999999999999987766555444221111000
Q ss_pred ----------------------------CCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 238 ----------------------------WFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 238 ----------------------------~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
..++++.+||.+||++||.+|||++|+++||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 025678899999999999999999999999999753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=415.17 Aligned_cols=247 Identities=23% Similarity=0.405 Sum_probs=220.4
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|+++++||+|+||+||+|++ .+++.||||++.+.... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 5789999999999999999998 47889999999876543 357889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCC
Q 011694 94 EYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGL 171 (479)
Q Consensus 94 E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~ 171 (479)
||+++|+|.+++.. ..+++..+.+++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence 99999999998764 579999999999999999999999999999999999999999999999999997554322 222
Q ss_pred ccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHHHHHH
Q 011694 172 LHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRKLLCK 249 (479)
Q Consensus 172 ~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~ 249 (479)
....+||+.|+|||++.+..|+ .++||||+||++|+|+| |+.||.+.+..+....+..+ ....|..+|+++.+||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3346799999999999988886 79999999999999998 89999999888888877664 456777899999999999
Q ss_pred hccCCccccCChhhhhcC
Q 011694 250 ILDPNPSTRISMAKIRES 267 (479)
Q Consensus 250 ~L~~dP~~Rpt~~eil~h 267 (479)
||+.||.+|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=415.04 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=220.2
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKIFFVM 93 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (479)
++|++++.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+++.++||||+++++++.+....+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 689999999999999999999999999999999977653 3356788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccCCCc
Q 011694 94 EYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQDGLL 172 (479)
Q Consensus 94 E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~ 172 (479)
|++.|++|..++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|....... ...
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~~~ 158 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCY 158 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--SCC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC--ccc
Confidence 99999999888876 579999999999999999999999999999999999999999999999999997543322 223
Q ss_pred cccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC-CChHHHHHHHhccC--------------------
Q 011694 173 HTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFH-DSNLIEMYRKIGKA-------------------- 231 (479)
Q Consensus 173 ~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~-~~~~~~~~~~i~~~-------------------- 231 (479)
....+++.|+|||++.+..+.+.++||||+||++|+|++|..||. +.+..+....+...
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 445688999999999887766789999999999999999999864 44444444433110
Q ss_pred ---------cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 232 ---------EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 232 ---------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
....+..+++.+.+||++||++||.+|||++|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 011223467899999999999999999999999999999753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=416.73 Aligned_cols=262 Identities=24% Similarity=0.425 Sum_probs=219.1
Q ss_pred CCCCCCCCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 011694 3 GMDHNKPSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEV 82 (479)
Q Consensus 3 ~~~~~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~ 82 (479)
++.++.++|-.++|++++.||+|+||+||+|+++.+ +.||||++...... .+.+.+|+.++++++|||||+++++
T Consensus 6 ~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 6 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp SSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEE
Confidence 567888899999999999999999999999998655 56999999765432 3678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 83 MATKSKIFFVMEYAKGGELFNKVAK---GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
+.+ +.+|+|||||++|+|..++.. +.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 81 ~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 81 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred Eec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccch
Confidence 854 568999999999999988864 4699999999999999999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCChHHHHHHHhccC-cCCCCC
Q 011694 160 SALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG-YLPFHDSNLIEMYRKIGKA-EFKCPN 237 (479)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~-~~~~~~ 237 (479)
|+...... .......+||+.|+|||++....++ .++||||+||+||+|++| .+||...+..+....+... ..+.|.
T Consensus 160 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 237 (285)
T d1fmka3 160 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 237 (285)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred hhhccCCC-ceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc
Confidence 97653222 2223446799999999999988886 899999999999999995 5556666666666666543 456788
Q ss_pred CCCHHHHHHHHHhccCCccccCChhhhhc--Chhhhc
Q 011694 238 WFPPEVRKLLCKILDPNPSTRISMAKIRE--SSWFRK 272 (479)
Q Consensus 238 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~--h~wf~~ 272 (479)
.+|+++.+||.+||+.||++|||+++|++ ++||..
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 89999999999999999999999999987 777753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=427.62 Aligned_cols=255 Identities=29% Similarity=0.403 Sum_probs=210.5
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe----
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT---- 85 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~---- 85 (479)
....-+|+.++.||+|+||+||+|++..+|+.||||++...... ..+|+.+|+.++||||+++++++..
T Consensus 16 ~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp CCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 33445799999999999999999999999999999999765422 2479999999999999999999853
Q ss_pred --CCEEEEEEeccCCCChHHHH---hc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-CeEEeecC
Q 011694 86 --KSKIFFVMEYAKGGELFNKV---AK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISDFG 158 (479)
Q Consensus 86 --~~~~~lV~E~~~gg~L~~~i---~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-~vkl~DFG 158 (479)
..++|+|||||+++.+.... .. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence 34689999999876433332 22 4799999999999999999999999999999999999999775 89999999
Q ss_pred chhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC-------
Q 011694 159 LSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA------- 231 (479)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------- 231 (479)
+|..... .....+.+||+.|+|||++.+....+.++||||+||++|+|++|..||...+....+..+.+.
T Consensus 169 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 169 SAKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp TCEECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred chhhccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 9875432 233456789999999999877655569999999999999999999999887765554443210
Q ss_pred ----------cC------------CCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 232 ----------EF------------KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 232 ----------~~------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
.. ...+.+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00 11234789999999999999999999999999999997653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-54 Score=430.68 Aligned_cols=256 Identities=27% Similarity=0.378 Sum_probs=216.1
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----C
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATK-----S 87 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 87 (479)
.++|++++.||+|+||+||+|++..+|+.||||++.+.... ....+.+.+|+.+|+.++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 47899999999999999999999999999999999875433 23456788999999999999999999999643 3
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 88 KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
..+++|+|+.||+|.+++..+++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 446667788899999999888999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccCcCC-------------
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKAEFK------------- 234 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------------- 234 (479)
...+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+.......+......
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 2345689999999999888777779999999999999999999999987765555444221110
Q ss_pred ------------------CCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhccc
Q 011694 235 ------------------CPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGM 274 (479)
Q Consensus 235 ------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~ 274 (479)
....+++++.+||++||..||.+|||++|+++||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0124689999999999999999999999999999998653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=413.30 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=209.8
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTN---QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT 85 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~ 85 (479)
++|..++|++++.||+|+||+||+|++..++ ..||||.+.... .....+.+.+|+.+++.++|||||++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 5677889999999999999999999987543 568888885432 3344578899999999999999999999986
Q ss_pred CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 86 KSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
++.+|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 4678999999999999998765 46999999999999999999999999999999999999999999999999999765
Q ss_pred hccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCH
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPP 241 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 241 (479)
..... ......+||+.|+|||++.+..|+ .++||||+||++|+|++ |.+||.+.+..+.+..+..+ ..+.|+.+|+
T Consensus 159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 159 EDSTY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred cCCcc-eeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 43222 223456789999999999988876 89999999999999998 89999988887777777654 3567888999
Q ss_pred HHHHHHHHhccCCccccCChhhhhcC
Q 011694 242 EVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 242 ~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
++.+||.+||+.||.+|||+++|++|
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=422.94 Aligned_cols=262 Identities=31% Similarity=0.564 Sum_probs=223.3
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCC-CCcceeEEEEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSI---RTNQSVAVKVIDKDKIM-RVGLADQIKREISVMRIVRH-PNIVQLYEVMA 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~l~~Ei~il~~l~h-pnIv~l~~~~~ 84 (479)
++-.++|++++.||+|+||+||+|++. .+|+.||||++++.... +....+.+.+|+.++++++| |||+++++++.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 344478999999999999999999974 47899999999765432 22334677899999999976 89999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK-GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALA 163 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~ 163 (479)
+...+|++|||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999976 68999999999999999999999999999999999999999999999999998754
Q ss_pred hccccCCCccccCCCCcccChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCChH----HHHHHHhccCcCCCCCC
Q 011694 164 QCKHQDGLLHTTCGTPAYVAPEVINRKG-YDGEKVDIWSCGVVLFVLLAGYLPFHDSNL----IEMYRKIGKAEFKCPNW 238 (479)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~ 238 (479)
.... .....+.+|++.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+. ..............|..
T Consensus 180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred cccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 3322 22345678999999999997654 345799999999999999999999977543 23444444556677888
Q ss_pred CCHHHHHHHHHhccCCccccC-----ChhhhhcChhhhc
Q 011694 239 FPPEVRKLLCKILDPNPSTRI-----SMAKIRESSWFRK 272 (479)
Q Consensus 239 ~~~~~~~li~~~L~~dP~~Rp-----t~~eil~h~wf~~ 272 (479)
+|+++.+||.+||++||.+|| |++|+++||||+.
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 999999999999999999999 4899999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-53 Score=418.65 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=211.0
Q ss_pred CCeEEeeeeeecCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 011694 14 EKYEVGRLLGQGAFAKVYYARSIRTNQ----SVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSKI 89 (479)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (479)
.+|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.++++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 469999999999999999999988887 47777775432 223457889999999999999999999999875 46
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccc
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKH 167 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~ 167 (479)
+++|||+.+|+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 788999999999988875 479999999999999999999999999999999999999999999999999998765444
Q ss_pred cCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccC-cCCCCCCCCHHHHH
Q 011694 168 QDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKA-EFKCPNWFPPEVRK 245 (479)
Q Consensus 168 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 245 (479)
.........||+.|+|||++.+..|+ .++||||+||+||+|+| |.+||.+.+..+....+..+ ..+.|+.+|+++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 43334455789999999999988875 89999999999999998 89999988777666666554 35677889999999
Q ss_pred HHHHhccCCccccCChhhhhcChh
Q 011694 246 LLCKILDPNPSTRISMAKIRESSW 269 (479)
Q Consensus 246 li~~~L~~dP~~Rpt~~eil~h~w 269 (479)
||.+||..||.+|||+.+|++|..
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHHH
Confidence 999999999999999999998843
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-52 Score=418.80 Aligned_cols=250 Identities=26% Similarity=0.476 Sum_probs=208.3
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEe--CCEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMAT--KSKI 89 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~--~~~~ 89 (479)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+.++ ||||+++++++.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 468999999999999999999999999999999996543 357889999999995 9999999999974 4569
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC-CeEEeecCchhhhhcccc
Q 011694 90 FFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE-NLKISDFGLSALAQCKHQ 168 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g-~vkl~DFGla~~~~~~~~ 168 (479)
|+|||||.+++|.... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|......
T Consensus 108 ~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-- 183 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-- 183 (328)
T ss_dssp EEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--
T ss_pred eEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC--
Confidence 9999999999998764 4699999999999999999999999999999999999999765 5999999999754322
Q ss_pred CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChH-HHHHHHhc-------------cCc--
Q 011694 169 DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNL-IEMYRKIG-------------KAE-- 232 (479)
Q Consensus 169 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~-------------~~~-- 232 (479)
......+||+.|+|||++.+....+.++||||+||++|+|++|..||..... ......+. ...
T Consensus 184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 184 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred -CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 3345678999999999998766556899999999999999999999975432 11111110 000
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcc
Q 011694 233 ----------------------FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 233 ----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~ 273 (479)
......+++++.+||++||..||.+|||++|+|+||||+.-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 00112267899999999999999999999999999999753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=408.49 Aligned_cols=255 Identities=20% Similarity=0.328 Sum_probs=209.6
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTN----QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
.+|--..|++.+.||+|+||+||+|.++.++ ..||||++...... .....+.+|+.+++.++|||||++++++.
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh--HHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 3556678999999999999999999987655 47999999754322 33467889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhh
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSAL 162 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~ 162 (479)
+.+.+++|||||.+|++.+.+.. +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999999999998865 4799999999999999999999999999999999999999999999999999986
Q ss_pred hhccccC-CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCChHHHHHHHhccC-cCCCCCCC
Q 011694 163 AQCKHQD-GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG-YLPFHDSNLIEMYRKIGKA-EFKCPNWF 239 (479)
Q Consensus 163 ~~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 239 (479)
....... .......||+.|+|||++.+..|+ .++||||+||+||+|++| .+||...+..+.+..+..+ ..+.|..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhh
Confidence 5433221 123345789999999999888776 899999999999999995 5556666666666666543 45667779
Q ss_pred CHHHHHHHHHhccCCccccCChhhhhc
Q 011694 240 PPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 240 ~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
|+++.+||.+||+.||.+|||+.+|++
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=423.46 Aligned_cols=257 Identities=28% Similarity=0.436 Sum_probs=204.8
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe------
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT------ 85 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~------ 85 (479)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+.... .....++.+|+.+++.++|||||++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 347899999999999999999999999999999999876543 3455788999999999999999999999953
Q ss_pred CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhc
Q 011694 86 KSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQC 165 (479)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~ 165 (479)
.+.+|+|||||.|+.+ +.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 94 ~~~~~iv~Ey~~~~l~-~~~-~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 94 FQDVYLVMELMDANLC-QVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCEEEEEEECCSEEHH-HHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CceeEEEEeccchHHH-Hhh-hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 4789999999987544 444 35699999999999999999999999999999999999999999999999999875443
Q ss_pred cccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHHHhccC--------------
Q 011694 166 KHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYRKIGKA-------------- 231 (479)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 231 (479)
. ......+||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+.......+...
T Consensus 172 ~---~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 S---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred c---cccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 2 234566899999999999988775 8999999999999999999999877655443332110
Q ss_pred --------cCC--------------CC------CCCCHHHHHHHHHhccCCccccCChhhhhcChhhhcccc
Q 011694 232 --------EFK--------------CP------NWFPPEVRKLLCKILDPNPSTRISMAKIRESSWFRKGMN 275 (479)
Q Consensus 232 --------~~~--------------~~------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h~wf~~~~~ 275 (479)
... .+ ...++++.+||++||..||.+|||++|+|+||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 000 00 013567899999999999999999999999999987654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-52 Score=410.92 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=221.2
Q ss_pred CccCCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 011694 10 SVLTEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMA 84 (479)
Q Consensus 10 ~il~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~ 84 (479)
++..++|++++.||+|+||+||+|+++. +++.||||+++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 3456789999999999999999999753 56789999997643 2344578899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q 011694 85 TKSKIFFVMEYAKGGELFNKVAKG-------------------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDI 139 (479)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~i~~~-------------------------~l~e~~~~~i~~qll~aL~~LH~~givHrDL 139 (479)
+.+..+++|||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 999999999999999999988532 3889999999999999999999999999999
Q ss_pred CCCCEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCC-CCCCC
Q 011694 140 KPENLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGY-LPFHD 218 (479)
Q Consensus 140 kp~NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~-~Pf~~ 218 (479)
||+|||++.++.+||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|+|++|. +||.+
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCC
Confidence 999999999999999999999876555544455667899999999999998886 8999999999999999985 68988
Q ss_pred ChHHHHHHHhccCcC-CCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 219 SNLIEMYRKIGKAEF-KCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 219 ~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+..+....+..+.. ..|..+|+++.+||.+||+.||.+|||+.||++
T Consensus 246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888887766543 467789999999999999999999999999954
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=410.56 Aligned_cols=256 Identities=23% Similarity=0.418 Sum_probs=220.8
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEcCCC-------cEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCccee
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSIRTN-------QSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQL 79 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l 79 (479)
++.+-.++|++++.||+|+||.||+|++..++ ..||||+++++... .....+.+|...+.++ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh--HHHHHHHHHHHHHHHhcCCCeEEec
Confidence 47788899999999999999999999986654 36999999765432 3346778888888887 79999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 011694 80 YEVMATKSKIFFVMEYAKGGELFNKVAKG-----------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPE 142 (479)
Q Consensus 80 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~ 142 (479)
++++.+++.+|+|||||++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 99999999999999999999999999642 4899999999999999999999999999999999
Q ss_pred CEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChH
Q 011694 143 NLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNL 221 (479)
Q Consensus 143 NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~ 221 (479)
|||++.++.+||+|||++...............+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+.
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999877665555555667899999999999988886 89999999999999998 7999998888
Q ss_pred HHHHHHhccC-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 222 IEMYRKIGKA-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 222 ~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
...+..+..+ ....|.++|+++.+||.+||+.||.+|||+.||++
T Consensus 244 ~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8877777543 45678889999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=412.48 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=206.5
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeE
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLY 80 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~ 80 (479)
.++++-.++|++++.||+|+||+||+|.+.. +++.||||++...... .....+.+|..++.++ +||||+.++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc--HHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 3456777899999999999999999999764 4578999998754322 3345666777777666 689999999
Q ss_pred EEEEeC-CEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 011694 81 EVMATK-SKIFFVMEYAKGGELFNKVAK-----------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPE 142 (479)
Q Consensus 81 ~~~~~~-~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~ 142 (479)
+++... ..+++|||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 998654 568999999999999999863 24899999999999999999999999999999999
Q ss_pred CEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCChH
Q 011694 143 NLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG-YLPFHDSNL 221 (479)
Q Consensus 143 NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G-~~Pf~~~~~ 221 (479)
||||+.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++||||+||++|+|++| .+||.+.+.
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999865544433344567899999999999988775 899999999999999986 568877654
Q ss_pred HHHH-HHhcc-CcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 222 IEMY-RKIGK-AEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 222 ~~~~-~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
...+ ..+.. .....|..+|+++.+||.+||+.||.+|||+++|++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4333 33322 3456777899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=407.08 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=206.4
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcC-CC--cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIR-TN--QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKSK 88 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~-~~--~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (479)
-.++|++.+.||+|+||+||+|++.. ++ ..||||++.+......+..+.+.+|+.+|+.++|||||++++++.+ ..
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 35679999999999999999998653 33 3689999987766555667889999999999999999999999976 46
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhcc
Q 011694 89 IFFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCK 166 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~ 166 (479)
+++|||||++|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 7899999999999988764 57999999999999999999999999999999999999999999999999999865433
Q ss_pred ccCC-CccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhccCc--CCCCCCCCHH
Q 011694 167 HQDG-LLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGKAE--FKCPNWFPPE 242 (479)
Q Consensus 167 ~~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 242 (479)
.... .....+||+.|+|||++.+..++ .++||||+||++|+|++ |..||.+.+..+....+.... ++.|+.+|++
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred CCcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence 2221 22345678899999999987775 89999999999999998 899999999888888876554 3556779999
Q ss_pred HHHHHHHhccCCccccCChhhhhc
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
+.+||.+||..||.+|||+++|++
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999963
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-52 Score=400.50 Aligned_cols=246 Identities=27% Similarity=0.471 Sum_probs=209.8
Q ss_pred CCccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-CC
Q 011694 9 PSVLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT-KS 87 (479)
Q Consensus 9 ~~il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~-~~ 87 (479)
|++-.++|++++.||+|+||.||+|++ +|..||||+++++. ..+.+.+|+.++++++||||+++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 567778999999999999999999998 57899999997543 34678899999999999999999998854 56
Q ss_pred EEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhh
Q 011694 88 KIFFVMEYAKGGELFNKVAKG---KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQ 164 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~ 164 (479)
.+|+||||+++|+|.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||++....
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 789999999999999998653 49999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChHHHHHHHhcc-CcCCCCCCCCHH
Q 011694 165 CKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNLIEMYRKIGK-AEFKCPNWFPPE 242 (479)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~ 242 (479)
....+.++|+.|+|||++.+..++ .++||||+||++|+|++ |.+||...+..+....+.. ...+.|..++++
T Consensus 155 -----~~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (262)
T d1byga_ 155 -----STQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred -----CCCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 223456789999999999888875 89999999999999998 7999998887777777755 345678889999
Q ss_pred HHHHHHHhccCCccccCChhhhhcC
Q 011694 243 VRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 243 ~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+.+||.+||+.||.+|||+.+|+++
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=405.69 Aligned_cols=257 Identities=21% Similarity=0.294 Sum_probs=224.4
Q ss_pred CCCCccCCCeEEeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEE
Q 011694 7 NKPSVLTEKYEVGRLLGQGAFAKVYYARSIR-----TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYE 81 (479)
Q Consensus 7 ~~~~il~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~ 81 (479)
+.+++..++|++++.||+|+||+||+|.+.. ++..||||+++.... ......+.+|+.++++++|||||++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--hHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 4567888999999999999999999998853 457899999976432 233467889999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCC
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAK-----------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENE 150 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g 150 (479)
++..++..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 99999999999999999999998753 1368899999999999999999999999999999999999999
Q ss_pred CeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCChHHHHHHHhc
Q 011694 151 NLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG-YLPFHDSNLIEMYRKIG 229 (479)
Q Consensus 151 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~ 229 (479)
++||+|||+|+..............+||+.|+|||.+.+..++ .++||||+||++|+|++| .+||.+.+..+.+..+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876554443334555799999999999988876 799999999999999998 58899888888887776
Q ss_pred cCc-CCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 230 KAE-FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 230 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
.+. ...|+.+|+.+.++|.+||+.||.+|||+++|++
T Consensus 250 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 544 4567889999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=405.22 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=214.0
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcE--EEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQS--VAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYEVMATKSK 88 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (479)
-.++|++.+.||+|+||+||+|.++.+|.. ||||.+..... ....+.+.+|+.+|+++ +|||||++++++.+++.
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 347899999999999999999999988875 67777654322 23346789999999998 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCC
Q 011694 89 IFFVMEYAKGGELFNKVAK-----------------GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENEN 151 (479)
Q Consensus 89 ~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~ 151 (479)
+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 9999999999999999853 36899999999999999999999999999999999999999999
Q ss_pred eEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCChHHHHHHHhcc
Q 011694 152 LKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAG-YLPFHDSNLIEMYRKIGK 230 (479)
Q Consensus 152 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~ 230 (479)
+||+|||+|....... .....+||+.|+|||.+.+..|+ .++|||||||++|+|++| .+||.+.+..+++..+..
T Consensus 166 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred eEEccccccccccccc---cccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 9999999987543322 22455799999999999988885 899999999999999996 568988888888888765
Q ss_pred C-cCCCCCCCCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 231 A-EFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 231 ~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
+ .+..|..+|+++.+||.+||+.||++|||+.+|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4 456677899999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=403.90 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=217.9
Q ss_pred CCCccCCCeEEeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 011694 8 KPSVLTEKYEVGRLLGQGAFAKVYYARSI-----RTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIV-RHPNIVQLYE 81 (479)
Q Consensus 8 ~~~il~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l-~hpnIv~l~~ 81 (479)
++++-.++|++++.||+|+||.||+|.+. .+++.||||++..... ......+.+|+.+++.+ +|||||++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 46677899999999999999999999864 4677899999976543 23446788999999999 6999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 011694 82 VMATKSKIFFVMEYAKGGELFNKVAKG-------------------KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPE 142 (479)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~i~~~-------------------~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~ 142 (479)
++.+.+.+|+|||||++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 999999999999999999999998642 4899999999999999999999999999999999
Q ss_pred CEEEecCCCeEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCChH
Q 011694 143 NLLLDENENLKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLA-GYLPFHDSNL 221 (479)
Q Consensus 143 NILl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~-G~~Pf~~~~~ 221 (479)
|||++.++.+||+|||+++..............+||+.|+|||++.+..++ .++|||||||++|+|++ |.+||...+.
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999866544333334456899999999999887775 89999999999999998 6777766655
Q ss_pred HHHHHHhcc--CcCCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 222 IEMYRKIGK--AEFKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 222 ~~~~~~i~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
...+.++.. .....|..+|+++.+||.+||+.||.+|||+++|++
T Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 444444322 234556678999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=385.97 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=204.1
Q ss_pred EeeeeeecCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEE
Q 011694 18 VGRLLGQGAFAKVYYARSIRTN---QSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMAT-KSKIFFVM 93 (479)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~ 93 (479)
..++||+|+||+||+|++..++ ..||||.++... .....+.+.+|+.+|++++|||||++++++.+ ++..++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3678999999999999986643 369999996532 33456789999999999999999999999765 56899999
Q ss_pred eccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCchhhhhccccC--
Q 011694 94 EYAKGGELFNKVAKG--KLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLSALAQCKHQD-- 169 (479)
Q Consensus 94 E~~~gg~L~~~i~~~--~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla~~~~~~~~~-- 169 (479)
|||++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||+++........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999998763 5888999999999999999999999999999999999999999999999999765433221
Q ss_pred CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-hHHHHHHHhcc-CcCCCCCCCCHHHHHHH
Q 011694 170 GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDS-NLIEMYRKIGK-AEFKCPNWFPPEVRKLL 247 (479)
Q Consensus 170 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~-~~~~~~~~~~~~~~~li 247 (479)
.......||+.|+|||++....++ .++|||||||++|+|++|..||... +.......+.. .....|+.+++++.+||
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li 267 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM 267 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHH
Confidence 222345789999999999888775 8999999999999999977776543 33344444433 34567788999999999
Q ss_pred HHhccCCccccCChhhhhcC
Q 011694 248 CKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 248 ~~~L~~dP~~Rpt~~eil~h 267 (479)
.+||..||.+|||+.||++|
T Consensus 268 ~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 268 LKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=384.78 Aligned_cols=255 Identities=21% Similarity=0.281 Sum_probs=203.2
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCEEE
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN-IVQLYEVMATKSKIF 90 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 90 (479)
+.++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.++|+| |+.+.+++.+.+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 457899999999999999999999999999999998765322 34678999999998766 555566678889999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEe---cCCCeEEeecCchhhhhc
Q 011694 91 FVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLD---ENENLKISDFGLSALAQC 165 (479)
Q Consensus 91 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~---~~g~vkl~DFGla~~~~~ 165 (479)
+||||+.+ +|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+|||++ .+..+||+|||+|+....
T Consensus 80 ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99999955 66665543 5799999999999999999999999999999999999986 355799999999986543
Q ss_pred cccC-----CCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHHHHHH---HhccC-----c
Q 011694 166 KHQD-----GLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLIEMYR---KIGKA-----E 232 (479)
Q Consensus 166 ~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i~~~-----~ 232 (479)
.... ....+.+||+.|+|||++.+.+++ .++|||||||++|+|++|..||.......... ..... .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 3221 223456899999999999988876 89999999999999999999997654332221 11111 1
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccccCChhh---hhcChhhhcc
Q 011694 233 FKCPNWFPPEVRKLLCKILDPNPSTRISMAK---IRESSWFRKG 273 (479)
Q Consensus 233 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e---il~h~wf~~~ 273 (479)
...++.+|+++.++|.+||..||.+||++++ +++|+|.+..
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 1234568999999999999999999999875 4677766544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4e-48 Score=379.94 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=207.9
Q ss_pred ccCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceeEEEEEeCCEE
Q 011694 11 VLTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRH-PNIVQLYEVMATKSKI 89 (479)
Q Consensus 11 il~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 89 (479)
|+.++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+..++.++| +||+.+++++......
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 6789999999999999999999999999999999998665322 346788999999975 8999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEec-----CCCeEEeecCchhh
Q 011694 90 FFVMEYAKGGELFNKVAK--GKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDE-----NENLKISDFGLSAL 162 (479)
Q Consensus 90 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~-----~g~vkl~DFGla~~ 162 (479)
|+||||+ |++|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 6799988865 46999999999999999999999999999999999999974 57899999999986
Q ss_pred hhcccc-----CCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCh---HHHHHHHhccCc--
Q 011694 163 AQCKHQ-----DGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSN---LIEMYRKIGKAE-- 232 (479)
Q Consensus 163 ~~~~~~-----~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~-- 232 (479)
...... .....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+ ....+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 543221 1223456899999999999988875 89999999999999999999997543 223333332211
Q ss_pred ---CCCCCCCCHHHHHHHHHhccCCccccCChhhhhc
Q 011694 233 ---FKCPNWFPPEVRKLLCKILDPNPSTRISMAKIRE 266 (479)
Q Consensus 233 ---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~ 266 (479)
...++.+|+++.+++..|+..+|.+||+.+.+.+
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1223568899999999999999999999877643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=382.41 Aligned_cols=250 Identities=20% Similarity=0.333 Sum_probs=195.4
Q ss_pred cCCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 011694 12 LTEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPNIVQLYEVMATKS---- 87 (479)
Q Consensus 12 l~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (479)
+..+|.+.+.||+|+||.||+|++ +|+.||||+++.... .....+.|+..++.++|||||++++++.+.+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 356899999999999999999987 789999999965431 1122345666667889999999999997654
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeeccCCCCCEEEecCCCeEEeecCc
Q 011694 88 KIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHS--------RGVYHRDIKPENLLLDENENLKISDFGL 159 (479)
Q Consensus 88 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~--------~givHrDLkp~NILl~~~g~vkl~DFGl 159 (479)
.+|+|||||++|+|.+++.+.+++++....++.|++.||+|||+ +||+||||||+||||+.+|.+||+|||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 68999999999999999999899999999999999999999996 6999999999999999999999999999
Q ss_pred hhhhhcccc--CCCccccCCCCcccChhhhhcCCC-----CCCccchhhHHHHHHHHHhCCCCCCCC-------------
Q 011694 160 SALAQCKHQ--DGLLHTTCGTPAYVAPEVINRKGY-----DGEKVDIWSCGVVLFVLLAGYLPFHDS------------- 219 (479)
Q Consensus 160 a~~~~~~~~--~~~~~~~~gt~~y~aPEvl~~~~~-----~~~~~DvwSlGvil~~ll~G~~Pf~~~------------- 219 (479)
+........ .......+||+.|+|||++.+... .+.++|||||||+||+|++|..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 876533221 122345689999999999875432 136899999999999999998877421
Q ss_pred --hHHHHHHHhccCcC--CCCCC-----CCHHHHHHHHHhccCCccccCChhhhhcC
Q 011694 220 --NLIEMYRKIGKAEF--KCPNW-----FPPEVRKLLCKILDPNPSTRISMAKIRES 267 (479)
Q Consensus 220 --~~~~~~~~i~~~~~--~~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~eil~h 267 (479)
.............. .+|.. .+..+.+|+.+||+.||.+|||+.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12222222222222 12221 12458899999999999999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-46 Score=377.56 Aligned_cols=256 Identities=24% Similarity=0.430 Sum_probs=200.2
Q ss_pred CCCccC-CCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----------CCC
Q 011694 8 KPSVLT-EKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-----------HPN 75 (479)
Q Consensus 8 ~~~il~-~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-----------hpn 75 (479)
.|+++. ++|+++++||+|+||+||+|+++.+|+.||||+++++.. ..+.+.+|+.+++.++ |||
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 366665 679999999999999999999999999999999986542 3356778998888775 588
Q ss_pred cceeEEEEE--eCCEEEEEEeccCCCChHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCCEEEec
Q 011694 76 IVQLYEVMA--TKSKIFFVMEYAKGGELFNKVA----KGKLKEDAARRYFQQLINAVDFCHS-RGVYHRDIKPENLLLDE 148 (479)
Q Consensus 76 Iv~l~~~~~--~~~~~~lV~E~~~gg~L~~~i~----~~~l~e~~~~~i~~qll~aL~~LH~-~givHrDLkp~NILl~~ 148 (479)
|+++++++. .....+++|+++..+....... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence 999999875 4467788888776654433222 2479999999999999999999998 89999999999999987
Q ss_pred CCC------eEEeecCchhhhhccccCCCccccCCCCcccChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCChHH
Q 011694 149 NEN------LKISDFGLSALAQCKHQDGLLHTTCGTPAYVAPEVINRKGYDGEKVDIWSCGVVLFVLLAGYLPFHDSNLI 222 (479)
Q Consensus 149 ~g~------vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DvwSlGvil~~ll~G~~Pf~~~~~~ 222 (479)
++. ++++|||.|..... .....+||+.|+|||++.+..|+ .++||||+||++++|++|+.||...+..
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC------
T ss_pred cCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccc
Confidence 654 99999999865432 23567899999999999988886 7999999999999999999999754321
Q ss_pred ------HHH----HHhcc-----------------------C---------------cCCCCCCCCHHHHHHHHHhccCC
Q 011694 223 ------EMY----RKIGK-----------------------A---------------EFKCPNWFPPEVRKLLCKILDPN 254 (479)
Q Consensus 223 ------~~~----~~i~~-----------------------~---------------~~~~~~~~~~~~~~li~~~L~~d 254 (479)
... ..+.. . ....+...++++.+||.+||..|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 000 00000 0 00111123577899999999999
Q ss_pred ccccCChhhhhcChhhhcc
Q 011694 255 PSTRISMAKIRESSWFRKG 273 (479)
Q Consensus 255 P~~Rpt~~eil~h~wf~~~ 273 (479)
|.+|||++|+|+||||+..
T Consensus 316 P~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTC
T ss_pred hhHCcCHHHHhcCcccCCC
Confidence 9999999999999999844
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=5.2e-26 Score=207.56 Aligned_cols=135 Identities=20% Similarity=0.305 Sum_probs=108.2
Q ss_pred eEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeeccccc---------------chhhHHHHHHHHHHHHhCCCCCcceeE
Q 011694 16 YEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIM---------------RVGLADQIKREISVMRIVRHPNIVQLY 80 (479)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~---------------~~~~~~~l~~Ei~il~~l~hpnIv~l~ 80 (479)
|.+++.||+|+||+||+|.+ .+|+.||||++...... .........+|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 57899999999999999998 47999999987542111 011123456788999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCCEEEecCCCeEEeecCch
Q 011694 81 EVMATKSKIFFVMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHSRGVYHRDIKPENLLLDENENLKISDFGLS 160 (479)
Q Consensus 81 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~~givHrDLkp~NILl~~~g~vkl~DFGla 160 (479)
++.. .+++|||++++.+.. +++..+..++.||+.+|.|||++||+||||||+|||++++ .++|+|||+|
T Consensus 81 ~~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred EecC----CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence 7642 279999999865533 5556678899999999999999999999999999999865 4999999998
Q ss_pred hh
Q 011694 161 AL 162 (479)
Q Consensus 161 ~~ 162 (479)
..
T Consensus 150 ~~ 151 (191)
T d1zara2 150 VE 151 (191)
T ss_dssp EE
T ss_pred cc
Confidence 64
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.48 E-value=9.1e-14 Score=111.19 Aligned_cols=86 Identities=15% Similarity=0.232 Sum_probs=78.6
Q ss_pred eeEecCCHHHHHHHHHHHHHHcCcEEEeeCCceEEEEeeecCcceeEEEEEEEEEec-CceEEEEEEecCCChHHHHHHH
Q 011694 346 RFTSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQIT-PNFHLVEMKKSNGDTLEYKKLL 424 (479)
Q Consensus 346 rf~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~-~~~~lVe~~k~~Gd~le~~~~~ 424 (479)
.-+|+.+|++||.+|+++++.+|+.|+.++...+++.....+.++.|.|++||+++. +++++|+|+|.+||+++|+++|
T Consensus 14 ~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~ 93 (102)
T d1ul7a_ 14 KTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 93 (102)
T ss_dssp CCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHH
T ss_pred ecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHH
Confidence 458999999999999999999999999887777999988888999999999999995 8999999999999999999999
Q ss_pred hhhhhhcc
Q 011694 425 KDDIRPAL 432 (479)
Q Consensus 425 ~~~l~~~l 432 (479)
.+ |-..|
T Consensus 94 ~~-il~~l 100 (102)
T d1ul7a_ 94 SK-IANEL 100 (102)
T ss_dssp HH-HHHHC
T ss_pred HH-HHHhc
Confidence 98 65544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.56 E-value=1.2e-07 Score=88.06 Aligned_cols=140 Identities=17% Similarity=0.184 Sum_probs=97.5
Q ss_pred CCCeEEeeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEE
Q 011694 13 TEKYEVGRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-HPNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 91 (479)
.+.|++.+..+-++.+.||... ..++.+++|+........ ...+.+|...++.+. +--+.+++.+..+++..|+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 3577877776666668999875 366678889876543222 235678888887764 4346778888889999999
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 011694 92 VMEYAKGGELFNKVAKGKLKEDAARRYFQQLINAVDFCHS---------------------------------------- 131 (479)
Q Consensus 92 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~qll~aL~~LH~---------------------------------------- 131 (479)
||++++|..+.+...... ....+..++...++.||+
T Consensus 88 v~~~l~G~~~~~~~~~~~----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDEQ----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EEECCSSEEHHHHTTTCS----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEEecccccccccccccc----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 999999988765443221 122334455555555553
Q ss_pred -------------------CCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 132 -------------------RGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 132 -------------------~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
..++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 126899999999999876666799999764
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.44 E-value=6.4e-07 Score=74.11 Aligned_cols=74 Identities=12% Similarity=0.179 Sum_probs=63.2
Q ss_pred eeEecCCHHHHHHHHHHHHHHcCcEEEeeCCceEEEEeeecCcceeEEEEEEEEEecCceEEEEEEecCCChHH
Q 011694 346 RFTSKRPASVIISKLEEIAKSLRLKMMKKDGGLLKFEGLKEGRKGIVSMDAEIFQITPNFHLVEMKKSNGDTLE 419 (479)
Q Consensus 346 rf~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~v~~~~~~~~lVe~~k~~Gd~le 419 (479)
.+-|+..|.+||..+..|+++||+.||+.+.+.|++..........+.|.+++|+|.++.|||||+...|+-.|
T Consensus 4 GIrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 4 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 35688899999999999999999999998888899887544445678999999999999999999999998766
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.96 E-value=1.7e-05 Score=64.13 Aligned_cols=70 Identities=10% Similarity=0.148 Sum_probs=56.1
Q ss_pred cccceeEecCCHHHHHHHHHHHHHHcCcEEEeeCC---------ceEEEEeee-----cCcceeEEEEEEEEEecCceEE
Q 011694 342 IREARFTSKRPASVIISKLEEIAKSLRLKMMKKDG---------GLLKFEGLK-----EGRKGIVSMDAEIFQITPNFHL 407 (479)
Q Consensus 342 ~r~trf~s~~~~~~i~~~l~~~~~~l~~~~~~~~~---------~~~~~~~~~-----~~~~g~l~~~~~v~~~~~~~~l 407 (479)
|+.-..-|...|-+||..|..|+++||+.|++.+. +.|++.-.. .+....+.|.+++|+|.++.+|
T Consensus 2 KWhfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YL 81 (127)
T d2qrda1 2 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM 81 (127)
T ss_dssp CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred CceeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEE
Confidence 34455678999999999999999999999987554 568776321 2223468999999999999999
Q ss_pred EEEE
Q 011694 408 VEMK 411 (479)
Q Consensus 408 Ve~~ 411 (479)
|||+
T Consensus 82 lDFK 85 (127)
T d2qrda1 82 LDVK 85 (127)
T ss_dssp EEEE
T ss_pred EEEc
Confidence 9998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.95 E-value=1.1e-05 Score=79.62 Aligned_cols=81 Identities=15% Similarity=0.134 Sum_probs=50.5
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecc-cccch---hhHHHHHHHHHHHHhCC-C--CCcceeEEEEEeCCEEEE
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKD-KIMRV---GLADQIKREISVMRIVR-H--PNIVQLYEVMATKSKIFF 91 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~-~~~~~---~~~~~l~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 91 (479)
.+.||.|....||++.+..+++.|+||.-... ..... -..++...|...++.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 46799999999999988778889999965421 11100 11245667888887663 2 345566554 4445678
Q ss_pred EEeccCCCCh
Q 011694 92 VMEYAKGGEL 101 (479)
Q Consensus 92 V~E~~~gg~L 101 (479)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.95 E-value=1.3e-05 Score=73.45 Aligned_cols=78 Identities=13% Similarity=0.207 Sum_probs=54.0
Q ss_pred eEEeeeeeecCC-eEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCEEEEE
Q 011694 16 YEVGRLLGQGAF-AKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR--HPNIVQLYEVMATKSKIFFV 92 (479)
Q Consensus 16 y~i~~~LG~G~f-g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~lV 92 (479)
++. ..+..|.. +.||+... ..+..+++|....... ..+.+|...++.+. .-.+.+++.+..+.+..|+|
T Consensus 13 ~~~-~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 13 YDW-AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CEE-EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred Cce-EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 444 34455553 68898875 4566788897654422 34667888877664 33467788888888899999
Q ss_pred EeccCCCCh
Q 011694 93 MEYAKGGEL 101 (479)
Q Consensus 93 ~E~~~gg~L 101 (479)
|++++|.++
T Consensus 85 ~~~i~G~~~ 93 (255)
T d1nd4a_ 85 LGEVPGQDL 93 (255)
T ss_dssp EECCSSEET
T ss_pred EEeeecccc
Confidence 999998665
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.57 E-value=0.00012 Score=62.06 Aligned_cols=71 Identities=20% Similarity=0.121 Sum_probs=53.2
Q ss_pred cccceeEecCCHHHHHHHHHHHHHHcCcEEEeeC---CceEEEEeee---------cCcceeEEEEEEEEEecCceEEEE
Q 011694 342 IREARFTSKRPASVIISKLEEIAKSLRLKMMKKD---GGLLKFEGLK---------EGRKGIVSMDAEIFQITPNFHLVE 409 (479)
Q Consensus 342 ~r~trf~s~~~~~~i~~~l~~~~~~l~~~~~~~~---~~~~~~~~~~---------~~~~g~l~~~~~v~~~~~~~~lVe 409 (479)
++.-..-|...|-+||..|..|+++||+.|++.+ .+.|++.... ......+.|.+++|+|.++.+|||
T Consensus 45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD 124 (171)
T d2qlva1 45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 124 (171)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence 5667889999999999999999999999998654 3667775321 111235889999999999999999
Q ss_pred EEe
Q 011694 410 MKK 412 (479)
Q Consensus 410 ~~k 412 (479)
||-
T Consensus 125 FK~ 127 (171)
T d2qlva1 125 FKF 127 (171)
T ss_dssp EEE
T ss_pred Eec
Confidence 974
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.00068 Score=64.28 Aligned_cols=68 Identities=19% Similarity=0.233 Sum_probs=45.2
Q ss_pred eEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC-----Cccee--EEEEEeCCEEEEEEeccCCCC
Q 011694 28 AKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHP-----NIVQL--YEVMATKSKIFFVMEYAKGGE 100 (479)
Q Consensus 28 g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hp-----nIv~l--~~~~~~~~~~~lV~E~~~gg~ 100 (479)
-.||++.. .+|+.|++|+....... .+++..|+..+..|... ..+.. -..+...+..+.+++++.|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 47999876 57888999998765332 35677888888776421 11111 123355778899999998743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.80 E-value=0.0024 Score=62.10 Aligned_cols=77 Identities=13% Similarity=0.152 Sum_probs=52.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEEeC
Q 011694 15 KYEVGRLLGQGAFAKVYYARSIR-------TNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVRHPN-IVQLYEVMATK 86 (479)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~hpn-Iv~l~~~~~~~ 86 (479)
..+ ++.|+.|--=.+|++.... .++.|.+++.-... .. ....+|..+++.+.-.+ ..++++++.+
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred ceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 344 4788889999999998753 34668888875321 22 34568999999885334 4477777653
Q ss_pred CEEEEEEeccCCCCh
Q 011694 87 SKIFFVMEYAKGGEL 101 (479)
Q Consensus 87 ~~~~lV~E~~~gg~L 101 (479)
++||||++|..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 689999988544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.94 E-value=0.0075 Score=56.21 Aligned_cols=136 Identities=13% Similarity=0.173 Sum_probs=72.5
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----CCCcceeE---EEEEeCCEEE
Q 011694 19 GRLLGQGAFAKVYYARSIRTNQSVAVKVIDKDKIMRVGLADQIKREISVMRIVR-----HPNIVQLY---EVMATKSKIF 90 (479)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~l~~Ei~il~~l~-----hpnIv~l~---~~~~~~~~~~ 90 (479)
.+.|..|---+.|+.... +| .+++|++..... .+.+..|+.++..+. .|..+... .+........
T Consensus 23 ~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 344556666788998763 34 589999865321 134556676776653 23222211 1223355677
Q ss_pred EEEeccCCCChHH--------------H---HhcC-------CCCH------------------HHHHHHHHHHHHHHHH
Q 011694 91 FVMEYAKGGELFN--------------K---VAKG-------KLKE------------------DAARRYFQQLINAVDF 128 (479)
Q Consensus 91 lV~E~~~gg~L~~--------------~---i~~~-------~l~e------------------~~~~~i~~qll~aL~~ 128 (479)
.++.+..|..... . .... .... ......+..+...+.-
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 7777777643310 0 0000 0000 1112222233333333
Q ss_pred HH----HCCCeeccCCCCCEEEecCCCeEEeecCchh
Q 011694 129 CH----SRGVYHRDIKPENLLLDENENLKISDFGLSA 161 (479)
Q Consensus 129 LH----~~givHrDLkp~NILl~~~g~vkl~DFGla~ 161 (479)
.+ ..|++|+|+.+.||+++.++..-|.||+.+.
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 32 2479999999999999988777899999764
|